"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL4075954";"";"None";"571.54";"1";"4.34";"23";"CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"13.27";"0.25";"3.25";"5.94";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4065907";"";"None";"543.48";"1";"3.70";"21";"CC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"15.13";"0.29";"4.52";"6.44";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4079820";"";"None";"541.51";"1";"4.51";"20";"CC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.70";"0.28";"3.45";"6.72";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3699641";"";"None";"500.63";"2";"5.61";"BDBM149466";"Cc1c(-c2cc(Nc3cc(C4CC4)[nH]n3)c(=O)[nH]n2)cccc1N1Cc2cc(C(C)(C)C)sc2C1=O";"IC50";"'='";"4.0";"nM";"8.40";"";"287912";"UO_0000065";"16.77";"0.32";"2.79";"7.87";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3665118";"";"None";"591.67";"1";"3.74";"BDBM111589";"Cc1c(-c2cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c(=O)n(C)c2)cccc1-n1ncc2cc(N(C)C)ccc2c1=O";"IC50";"'='";"124.0";"nM";"6.91";"";"262414";"UO_0000065";"11.67";"0.21";"3.17";"6.03";"1";"CHEMBL3705524";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 um hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 uM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 uM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 uM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 uM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 uCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639153";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3397911";"";"None";"989.25";"4";"5.61";"CNX-500";"C=CC(=O)Nc1cccc(N(C)c2nc(Nc3cccc(OCCCN(C)C(=O)CCCC(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@H]4SC[C@H]5NC(=O)N[C@H]54)c3)ncc2C)c1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"9.40";"0.18";"3.69";"4.10";"0";"CHEMBL3399473";"Inhibition of BTK (unknown origin) using ATP and Y5 Sox15 substrate mix incubated for 30 mins by fluorescence based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3397013";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"15.96";"0.29";"3.09";"10.72";"0";"CHEMBL972524";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138507";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3612844";"";"None";"469.57";"1";"5.34";"13f";"CNC(=O)CCn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"25.5";"nM";"7.59";"";"";"UO_0000065";"16.17";"0.31";"2.25";"7.99";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3612843";"";"None";"422.51";"1";"5.83";"13e";"C#CCn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"7.4";"nM";"8.13";"";"";"UO_0000065";"19.24";"0.36";"2.30";"12.33";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4213547";"";"None";"566.66";"2";"5.32";"2g";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(O)nc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"8800.0";"nM";"5.06";"";"";"UO_0000065";"8.92";"0.16";"-0.26";"3.90";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209441";"SOFNOBRUTINIB";"2.0";"498.52";"0";"3.41";"4b";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"16.80";"0.31";"4.97";"6.12";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.33";"nM";"9.48";"";"";"UO_0000065";"21.52";"0.39";"5.26";"9.56";"1";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4214068";"";"None";"580.69";"2";"5.62";"2f";"COc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)nc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2C)n1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"12.22";"0.23";"1.48";"5.99";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4204802";"";"None";"537.62";"1";"4.32";"3c";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(NC(=O)c3ccc(C4CC4)cc3)c2CO)n1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"16.14";"0.30";"4.36";"6.26";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4212860";"";"None";"580.69";"1";"3.78";"3n";"CC1(C)Cc2cc3n(c2C1)CCN(c1cccc(-c2nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n2)c1CO)C3=O";"IC50";"'='";"0.62";"nM";"9.21";"";"";"UO_0000065";"15.86";"0.29";"5.43";"6.84";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4216862";"";"None";"524.56";"1";"4.21";"4c";"Nc1nc(Nc2cnn(C3CC3)c2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1";"IC50";"'='";"0.57";"nM";"9.24";"";"";"UO_0000065";"17.62";"0.32";"5.03";"6.76";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4248271";"";"None";"427.50";"0";"4.46";"8";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"17.87";"0.33";"3.18";"7.68";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4247992";"";"None";"347.42";"0";"3.70";"36";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1";"IC50";"'='";"0.23";"nM";"9.64";"";"";"UO_0000065";"27.74";"0.51";"5.94";"12.17";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4241958";"";"None";"431.54";"0";"4.24";"11";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"22.43";"0.41";"5.44";"8.94";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4238798";"";"None";"333.39";"0";"3.68";"29";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)cc23)c1C";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"22.40";"0.41";"3.79";"8.49";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4248550";"";"None";"467.59";"0";"3.72";"19";"C=CS(=O)(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"8.8";"nM";"8.06";"";"";"UO_0000065";"17.23";"0.33";"4.34";"6.92";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4643319";"";"None";"552.55";"1";"4.12";"33";"Cn1cc(-c2cc(F)cc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"13.45";"0.25";"3.31";"7.00";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4087095";"";"None";"568.56";"1";"3.15";"17";"COCCC(=O)N1CCN[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"377.0";"nM";"6.42";"";"";"UO_0000065";"11.30";"0.21";"3.27";"4.60";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4079225";"";"None";"585.61";"1";"4.30";"15";"COCCC(=O)N1CCSC(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"13.97";"0.27";"3.88";"6.40";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4097247";"";"None";"569.54";"1";"3.58";"14";"COCCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"14.89";"0.28";"4.90";"6.19";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"RN-486; 3, 12";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.44";"0.25";"3.39";"8.53";"0";"CHEMBL4152883";"Inhibition of BTK (unknown origin) assessed as reduction in TNF production";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4163691";"POSELTINIB";"2.0";"470.53";"0";"4.64";"HM-71224";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1";"IC50";"'='";"651.95";"nM";"6.19";"";"";"UO_0000065";"13.15";"0.24";"1.55";"6.46";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3953720";"";"None";"496.58";"0";"3.74";"10i";"C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(C(C)=O)C(C)C5)cc4)nc32)c1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"18.73";"0.34";"5.56";"8.59";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4528929";"";"None";"571.70";"2";"5.89";"5d";"CCOC(=O)c1sc(-c2cccc(NC(=O)c3ccc(N(C)C)cc3)c2)nc1Nc1ccc(N2CCOCC2)cc1";"IC50";"'='";"4195.0";"nM";"5.38";"";"";"UO_0000065";"9.41";"0.18";"-0.51";"5.60";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3972467";"";"None";"540.64";"2";"6.93";"BDBM200804";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCC4(CC3)OCCO4)cc12";"IC50";"'='";"110.0";"nM";"6.96";"";"356865";"UO_0000065";"12.87";"0.24";"0.03";"7.81";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4128415";"";"None";"646.75";"2";"4.40";"10";"C=CC(=O)Nc1cccc(-n2c(=O)n(Cc3ccccc3)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1";"IC50";"'='";"248.0";"nM";"6.61";"";"";"UO_0000065";"10.21";"0.19";"2.21";"5.22";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL3263640";"";"None";"589.70";"2";"6.09";"20";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"142.0";"nM";"6.85";"";"";"UO_0000065";"11.61";"0.21";"0.76";"5.47";"0";"CHEMBL3270981";"Inhibition of BTK-mediated CD86 surface expression in human peripheral blood mononuclear cells after 18 hrs by antibody-based FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4073491";"";"None";"543.60";"2";"6.91";"3f";"CC(=O)c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"13.79";"0.25";"0.58";"8.52";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4095573";"";"None";"577.66";"2";"5.81";"3p";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"14.23";"0.26";"2.41";"8.70";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4110169";"";"None";"537.55";"1";"4.22";"BDBM255306";"Nc1nccn2c([C@@H]3CC[C@H]4COCCN4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.3";"nM";"9.52";"";"445211";"UO_0000065";"17.72";"0.33";"5.30";"8.60";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3964420";"";"None";"551.53";"1";"3.48";"BDBM255325";"Nc1nccn2c([C@H]3CC[C@H]4CC(O)C(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"4.6";"nM";"8.34";"";"445230";"UO_0000065";"15.12";"0.28";"4.86";"6.01";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108688";"";"None";"551.53";"1";"3.48";"BDBM255326";"Nc1nccn2c([C@@H]3CC[C@@H]4C[C@H](O)C(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"7.6";"nM";"8.12";"";"445231";"UO_0000065";"14.72";"0.28";"4.64";"5.85";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4633295";"";"None";"586.64";"2";"6.61";"44";"C=CC(=O)NCCOc1cc(C(OC2CCOCC2)c2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"12.99";"0.24";"1.01";"7.52";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4074951";"";"None";"555.04";"1";"4.24";"7c";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N(CCOC)CCOC)cc3)ncc2Cl)c1";"IC50";"'='";"2.83";"nM";"8.55";"";"";"UO_0000065";"15.40";"0.30";"4.31";"6.73";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3977335";"";"None";"375.41";"0";"3.56";"6";"COc1cc(F)cc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)c1";"IC50";"'='";"1970.0";"nM";"5.71";"";"";"UO_0000065";"15.20";"0.28";"2.15";"7.24";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3925929";"";"None";"431.48";"0";"3.33";"(-)-33";"Nc1ccc2c(c1)CC(n1nc(-c3cc(F)c4c(c3)NCCO4)c3c(N)ncnc31)CC2";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"17.89";"0.33";"4.39";"6.61";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3612994";"";"None";"453.57";"1";"6.14";"15c";"C=CC(=O)N1CC=C(c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)CC1";"IC50";"'='";"183.3";"nM";"6.74";"";"";"UO_0000065";"14.85";"0.28";"0.60";"9.84";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3809874";"";"None";"456.51";"0";"3.31";"ONO-4059";"C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"23.9";"nM";"7.62";"";"";"UO_0000065";"16.70";"0.31";"4.31";"7.04";"0";"CHEMBL3813053";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4754834";"";"None";"456.51";"0";"3.51";"8";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"19.01";"0.35";"5.17";"7.28";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4764132";"";"None";"468.52";"0";"3.51";"15";"C=CC(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)n[nH]c(=O)c43)C2)C1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"15.66";"0.29";"3.83";"6.16";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3612077";"";"None";"499.64";"1";"7.36";"15a";"CC(C)(C)OC(=O)N1CC=C(c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)CC1";"IC50";"'='";"1659.0";"nM";"5.78";"";"";"UO_0000065";"11.57";"0.22";"-1.58";"7.44";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3612992";"";"None";"455.58";"1";"6.23";"14f";"C=CC(=O)N1CCCC(c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)C1";"IC50";"'='";"2295.0";"nM";"5.64";"";"";"UO_0000065";"12.38";"0.23";"-0.59";"8.24";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3605107";"";"None";"455.54";"0";"4.95";"8";"CNC(=O)Cn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"12.8";"nM";"7.89";"";"";"UO_0000065";"17.33";"0.33";"2.94";"8.30";"1";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3956377";"";"None";"341.77";"0";"4.37";"BDBM195835";"CCC#CC(=O)Nc1cc(-c2cnc3[nH]cc(Cl)c3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348539";"UO_0000065";"17.94";"0.35";"1.76";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4859528";"";"None";"510.45";"1";"4.99";"10";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5ccc(OC(F)(F)F)cc5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"14.83";"0.28";"2.58";"7.75";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4863505";"";"None";"434.48";"0";"4.25";"20";"CC(C)(C)c1noc(C(=O)NCc2ccc(-c3ccnc4[nH]c(C5CC5)nc34)cc2F)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"18.23";"0.34";"3.67";"7.23";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4762013";"";"None";"489.60";"0";"4.66";"B31";"C=CS(=O)(=O)N1CCC(Cn2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"21700.0";"nM";"4.66";"";"";"UO_0000065";"9.53";"0.18";"0.00";"4.51";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL3665117";"";"None";"608.70";"1";"4.23";"BDBM111588";"Cc1c(-c2cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c(=O)n(C)c2)cccc1N1CNc2cc(C(C)(C)O)ccc2C1=O";"IC50";"'='";"18.0";"nM";"7.75";"";"262413";"UO_0000065";"12.72";"0.24";"3.51";"6.00";"1";"CHEMBL3705524";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 um hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 uM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 uM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 uM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 uM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 uCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639153";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657229";"";"None";"345.41";"0";"4.27";"BDBM134234";"COc1ccc(-c2cnc(Nc3ccccc3C)c3[nH]nc(N)c23)cc1";"IC50";"'='";"260.0";"nM";"6.58";"";"267623";"UO_0000065";"19.06";"0.35";"2.32";"7.41";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3639560";"";"None";"489.50";"0";"4.43";"BDBM134239";"Nc1n[nH]c2cc(-c3ccc(C(=O)Nc4nnn[nH]4)cc3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"0.7";"nM";"9.15";"";"267628";"UO_0000065";"18.70";"0.34";"4.72";"5.71";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4466400";"";"None";"494.57";"1";"6.61";"11";"Cc1c(NC(=O)c2ccc(F)cc2)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(NC(C)C)ccc3c12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"16.09";"0.29";"1.35";"7.96";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4639092";"";"None";"340.43";"0";"2.47";"4n";"C=CC(=O)N1CCC(Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)CC1";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"24.91";"0.46";"6.01";"9.30";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4639092";"";"None";"340.43";"0";"2.47";"4n";"C=CC(=O)N1CCC(Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)CC1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"21.64";"0.40";"4.90";"8.08";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4648257";"";"None";"417.23";"None";"None";"14o";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)COB4O)ncc2OC)c1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"19.38";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL1916716";"";"None";"484.60";"0";"4.80";"13";"COc1cc2nc(Nc3ccccc3C)c3cncn3c2cc1N(CC1CC1)C(=O)/C=C/CN(C)C";"IC50";"'='";"45.3";"nM";"7.34";"";"";"UO_0000065";"15.15";"0.28";"2.54";"9.79";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3652678";"";"None";"545.57";"1";"2.78";"BDBM122439";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5ccc(C(O)CO)nc54)c3CO)ncc2c1";"IC50";"'='";"13.91";"nM";"7.86";"";"251019";"UO_0000065";"14.40";"0.27";"5.08";"5.02";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657221";"";"None";"471.54";"1";"5.04";"BDBM134226";"CS(=O)(=O)Nc1ccc(-c2ncc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c23)cc1";"IC50";"'='";"280.0";"nM";"6.55";"";"267615";"UO_0000065";"13.90";"0.26";"1.51";"5.33";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657234";"";"None";"446.47";"0";"4.85";"BDBM134241";"Nc1n[nH]c2cc(-c3ccc(-c4nnn[nH]4)cc3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"267630";"UO_0000065";"19.48";"0.35";"3.85";"6.63";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3670089";"";"None";"546.65";"1";"3.02";"BDBM111946";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CCCC5)C3=O)c2CO)nc(Nc2cnn(CCO)c2)c1=O";"IC50";"'='";"6.0";"nM";"8.22";"";"233001";"UO_0000065";"15.04";"0.29";"5.20";"6.55";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670090";"";"None";"574.71";"1";"3.79";"BDBM111947";"Cn1nc(Nc2cc(-c3cccc(N4CCc5c(sc6c5CCCC6)C4=O)c3CO)nn(C)c2=O)cc1C(C)(C)O";"IC50";"'='";"7.0";"nM";"8.15";"";"233002";"UO_0000065";"14.19";"0.27";"4.36";"6.50";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670097";"";"None";"627.79";"2";"5.77";"BDBM111955";"CN1CCC(c2ccc(Nc3cc(-c4cc(F)cc(N5CCc6c(sc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"3.8";"nM";"8.42";"";"233010";"UO_0000065";"13.41";"0.26";"2.65";"9.28";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4791249";"";"None";"443.51";"0";"4.11";"B8";"C=CC(=O)Nc1cccc(Nc2ncnc(Nc3ccc(C(=O)N4CCCCC4)cc3)n2)c1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.31";"0.32";"3.57";"6.85";"0";"CHEMBL4769955";"Inhibition of BTK (unknown origin) by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765318";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3612840";"";"None";"511.61";"2";"5.06";"13b";"Nc1ncc(-c2cnn(CC(=O)N3CCOCC3)c2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"11.8";"nM";"7.93";"";"";"UO_0000065";"15.50";"0.29";"2.87";"8.30";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3605105";"";"None";"474.59";"1";"7.25";"14e";"Nc1ncc(-c2cnn(Cc3ccccc3)c2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"699.2";"nM";"6.16";"";"";"UO_0000065";"12.97";"0.24";"-1.09";"9.33";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3216211";"";"None";"413.23";"0";"1.71";"K00592a, Pyrimidineamide1";"Cl.Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1";"IC50";"'='";"15500.0";"nM";"4.81";"";"";"UO_0000065";"14.13";"0.27";"3.10";"4.04";"0";"CHEMBL937067";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145498";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";""
"CHEMBL4211893";"";"None";"552.61";"1";"4.84";"4d";"CC(C1CC1)n1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"0.49";"nM";"9.31";"";"";"UO_0000065";"16.85";"0.31";"4.47";"6.81";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3400978";"";"None";"544.59";"2";"6.31";"4f";"CC(=O)c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1";"IC50";"'='";"41.7";"nM";"7.38";"";"";"UO_0000065";"13.55";"0.25";"1.07";"7.32";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402572";"";"None";"601.68";"2";"5.94";"4k";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c1CO";"IC50";"'='";"63.6";"nM";"7.20";"";"";"UO_0000065";"11.96";"0.22";"1.26";"7.48";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.02";"0.40";"5.48";"9.78";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4242598";"";"None";"456.50";"0";"3.74";"16";"C=CC(=O)N1C[C@@H]2C[C@H]1CN2c1ccc(C(N)=O)c(Oc2ccc(Oc3ccccc3)cc2)n1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"20.05";"0.37";"5.41";"9.34";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4248550";"";"None";"467.59";"0";"3.72";"19";"C=CS(=O)(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"0.18";"nM";"9.74";"";"";"UO_0000065";"20.84";"0.40";"6.02";"8.37";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4242527";"";"None";"369.45";"0";"3.44";"35";"C=CS(=O)(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"22.18";"0.43";"4.75";"7.80";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4249247";"";"None";"431.54";"0";"3.61";"20";"C=CC(=O)NCc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"19.59";"0.36";"4.85";"7.81";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4243299";"";"None";"444.49";"1";"5.09";"22";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4ccccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.98";"0.23";"0.68";"6.15";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL228043";"";"None";"360.01";"0";"3.51";"K00067, LFM-A13";"C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br";"IC50";"'='";"17200.0";"nM";"4.76";"";"";"UO_0000065";"13.23";"0.38";"1.25";"6.52";"0";"CHEMBL921719";"Inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145498";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";""
"CHEMBL3785991";"";"None";"487.52";"0";"3.21";"16g";"C=CC(=O)Nc1cccc(-n2c(=O)n(C3CCOCC3)c3cnc(Nc4ccc(OC)nc4)nc32)c1";"IC50";"'='";"318.0";"nM";"6.50";"";"";"UO_0000065";"13.33";"0.25";"3.29";"5.19";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4641507";"";"None";"517.56";"1";"3.42";"23";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)C2CC2)c1=O";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"16.07";"0.30";"4.90";"6.98";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4648439";"";"None";"535.55";"1";"3.37";"24";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@H]2F)c1=O";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"15.86";"0.30";"5.12";"7.13";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4644856";"";"None";"501.59";"1";"2.87";"8";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)C2CC2)c1=O";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"13.66";"0.25";"3.98";"6.26";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"6";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"12.18";"0.23";"4.53";"6.69";"1";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4457018";"";"None";"582.71";"1";"3.90";"40";"C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCN(CC)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"13.02";"0.24";"3.69";"5.95";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4280401";"";"None";"443.51";"0";"3.60";"11";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"17.94";"0.33";"4.36";"7.26";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1421";"DASATINIB";"4.0";"488.02";"0";"3.31";"dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"18.21";"0.37";"5.58";"8.34";"0";"CHEMBL924609";"Inhibition of TAP-tagged wild-type Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147060";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";""
"CHEMBL1916892";"";"None";"452.92";"0";"4.50";"37";"CN(C)C/C=C/C(=O)N(C)c1cc2c(cc1F)nc(Nc1ccccc1Cl)c1cncn12";"IC50";"'='";"1.82";"nM";"8.74";"";"";"UO_0000065";"19.30";"0.37";"4.24";"13.29";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3647970";"";"None";"497.60";"0";"4.15";"BDBM97675";"CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.1";"nM";"8.96";"";"342644";"UO_0000065";"18.00";"0.33";"4.81";"8.75";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3917698";"";"None";"497.60";"0";"4.15";"BDBM191612";"CN(C)C/C=C/C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"6.3";"nM";"8.20";"";"342649";"UO_0000065";"16.48";"0.30";"4.05";"8.01";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4109796";"";"None";"440.51";"0";"4.04";"BDBM191617";"C=CC(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"0.67";"nM";"9.17";"";"342655";"UO_0000065";"20.83";"0.38";"5.13";"9.25";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3894938";"";"None";"400.44";"0";"3.17";"BDBM191606";"C=CC(=O)NCCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"0.32";"nM";"9.49";"";"342665";"UO_0000065";"23.71";"0.43";"6.32";"8.80";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3657209";"";"None";"386.50";"1";"5.37";"BDBM134214";"Cc1cccc(Oc2ccc(-c3cc(C4CCCC4)nc(N)c3C(=N)N)cc2)c1";"IC50";"'='";"290.0";"nM";"6.54";"";"267603";"UO_0000065";"16.91";"0.31";"1.17";"6.67";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657215";"";"None";"307.36";"0";"2.44";"BDBM134220";"Nc1n[nH]c2cncc(-c3ccc(C(=O)N4CCCC4)cc3)c12";"IC50";"'='";"40570.0";"nM";"4.39";"";"267609";"UO_0000065";"14.29";"0.26";"1.95";"5.00";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL373882";"";"None";"598.61";"2";"5.57";"63";"CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"7.69";"0.15";"-0.97";"4.25";"0";"CHEMBL908525";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141380";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4748236";"";"None";"430.47";"0";"2.81";"18";"C=CC(=O)N(C)CCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)n[nH]c(=O)c21";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"18.40";"0.34";"5.11";"6.65";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4763637";"";"None";"470.53";"0";"3.52";"9";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)nn(C)c(=O)c32)C1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"14.44";"0.27";"3.28";"6.28";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4746704";"";"None";"470.53";"0";"3.95";"16";"C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)CC1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"18.69";"0.34";"4.85";"6.88";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3265032";"ENTOSPLETINIB";"3.0";"411.47";"0";"3.85";"GS-9973";"c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1";"IC50";"'='";"801.0";"nM";"6.10";"";"";"UO_0000065";"14.82";"0.27";"2.25";"7.31";"0";"CHEMBL4773121";"Inhibition of BTK (unknown origin) using poly(Glu, Tyr) 4:1 as substrate incubated in presence of [gamma33P]ATP by image analyser";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765406";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL1916889";"";"None";"430.51";"0";"3.72";"34";"Cc1cc(O)ccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"12.2";"nM";"7.91";"";"";"UO_0000065";"18.38";"0.34";"4.19";"9.20";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4640555";"";"None";"326.40";"0";"2.08";"4k";"C=CC(=O)N1CC[C@H](Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"26.95";"0.50";"6.72";"9.64";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4633949";"";"None";"447.23";"None";"None";"16d";"C=CC(=O)N1CCCC(Nc2nc(Nc3ccc4c(c3)COB4O)ncc2C(F)(F)F)C1";"IC50";"'='";"36.8";"nM";"7.43";"";"";"UO_0000065";"16.62";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL3647964";"";"None";"440.51";"0";"4.22";"90a";"C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"20.10";"0.37";"4.63";"8.93";"1";"CHEMBL4356095";"Inhibition of BTK (unknown origin) after 60 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354810";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4546324";"";"None";"503.55";"2";"5.10";"17";"C=CC(=O)N(C)C/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"17.32";"0.32";"3.62";"8.62";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4483575";"REMIBRUTINIB";"3.0";"507.54";"1";"4.47";"25; LOU064";"C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"17.51";"0.33";"4.42";"8.05";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4441128";"";"None";"564.64";"1";"4.40";"29";"Cc1c(NC(=O)c2ccc(C3CC3)cc2F)cc(F)cc1-c1ncnc(N)c1OCCN(C)C(=O)/C=C/CN(C)C";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.10";"0.27";"3.56";"7.00";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4559123";"";"None";"485.56";"0";"4.96";"10";"C=CC(=O)N(C)C/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2)c1C";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"16.39";"0.30";"3.00";"7.86";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4473820";"";"None";"406.52";"0";"3.77";"1";"CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1";"IC50";"'='";"1644.0";"nM";"5.78";"";"";"UO_0000065";"14.23";"0.27";"2.01";"5.97";"0";"CHEMBL4331124";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330071";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"Zanubrutinib";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"18.36";"0.34";"4.44";"8.45";"1";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4865458";"";"None";"459.48";"0";"3.86";"25c";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5F)cc4)[nH]c23)C1";"IC50";"'='";"149.0";"nM";"6.83";"";"";"UO_0000065";"14.86";"0.27";"2.97";"6.46";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4560385";"";"None";"438.44";"0";"3.42";"22";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.21";"0.40";"5.88";"7.55";"0";"CHEMBL4714263";"Inhibition of BTK (unknown origin) One-hour enzymatic assay without pre-incubation";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4747506";"";"None";"465.52";"0";"3.31";"17";"CC#CC(=O)N1CCC[C@@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"17.81";"0.32";"4.98";"7.00";"0";"CHEMBL4714264";"Inhibition of BTK (unknown origin) One-hour enzymatic assay with pre-incubation";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4249310";"";"None";"338.38";"0";"0.77";"11a";"C=CC(=O)N1CCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1";"IC50";"'='";"203.1";"nM";"6.69";"";"";"UO_0000065";"19.78";"0.37";"5.92";"6.21";"0";"CHEMBL4236389";"Inhibition of BTK (unknown origin) using TK-substrate-biotin measured after 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4249492";"";"None";"396.46";"0";"1.27";"12b";"C=CC(=O)N1CCCC(n2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1";"IC50";"'='";"159.0";"nM";"6.80";"";"";"UO_0000065";"17.15";"0.32";"5.53";"5.81";"0";"CHEMBL4236389";"Inhibition of BTK (unknown origin) using TK-substrate-biotin measured after 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4644856";"";"None";"501.59";"1";"2.87";"8";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)C2CC2)c1=O";"IC50";"'='";"7.1";"nM";"8.15";"";"";"UO_0000065";"16.25";"0.30";"5.28";"7.44";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4437246";"";"None";"609.80";"2";"6.04";"30ah";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCSC(=S)N4CCN(C(C)C)CC4)cc3)ncc2F)c1";"IC50";"'='";"63.2";"nM";"7.20";"";"";"UO_0000065";"11.81";"0.23";"1.16";"7.61";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4293010";"";"None";"464.53";"0";"1.28";"13";"C=CC(=O)N[C@@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)C1";"IC50";"'='";"16.2";"nM";"7.79";"";"";"UO_0000065";"16.77";"0.31";"6.51";"6.00";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1916712";"";"None";"470.53";"0";"3.22";"8";"COc1cc2nc(Nc3ccccc3C)c3cncn3c2cc1NC(=O)C#CCN1CCOCC1";"IC50";"'='";"0.847";"nM";"9.07";"";"";"UO_0000065";"19.28";"0.35";"5.85";"9.75";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4469132";"";"None";"664.74";"1";"4.26";"Rac-3";"Cn1c2c(cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c1=O)-c1cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c1CC(O)C2";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"11.46";"0.21";"3.36";"5.79";"0";"CHEMBL4321362";"Inhibition of BTK in goat F(ab')2 anti-human IgM-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 30 mins followed by goat F(ab')2 anti-human IgM-stimulation and measured after 20 hrs by flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4316621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4065460";"";"None";"569.02";"2";"5.69";"10c";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(F)cc4)c(OC)c3)ncc2Cl)c1";"IC50";"'='";"1.18";"nM";"8.93";"";"";"UO_0000065";"15.69";"0.31";"3.24";"6.65";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4086899";"";"None";"553.02";"2";"5.99";"10b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(F)cc4)c(C)c3)ncc2Cl)c1";"IC50";"'='";"78.6";"nM";"7.11";"";"";"UO_0000065";"12.85";"0.26";"1.11";"5.68";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4457802";"";"None";"393.45";"0";"2.13";"27e";"Nc1ncnc2c1c(-c1ccc3c(c1)OCO3)cn2C[C@@H]1CCN(C[C@@H]2CO2)C1";"IC50";"'='";"122.6";"nM";"6.91";"";"";"UO_0000065";"17.57";"0.33";"4.78";"7.60";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.34";"nM";"9.47";"";"";"UO_0000065";"21.49";"0.39";"5.25";"9.55";"1";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4094611";"";"None";"559.61";"2";"5.41";"10d";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(C)cc4)c(C)c3)ncc2[N+](=O)[O-])c1";"IC50";"'='";"48.6";"nM";"7.31";"";"";"UO_0000065";"13.07";"0.25";"1.90";"4.35";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3263640";"";"None";"589.70";"2";"6.09";"20";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.76";"0.23";"1.43";"6.01";"0";"CHEMBL3270979";"Inhibition of BTK in human tonsilar B cells assessed as inhibition of IL6 expression after 1 hr by EIA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"B";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3263640";"";"None";"589.70";"2";"6.09";"20";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.73";"0.25";"2.01";"6.47";"0";"CHEMBL3270980";"Inhibition of BTK-mediated proliferation in human tonsilar B cells assessed as [3H]thymidine incorporation after 1 hr by liquid scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"B";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3926871";"";"None";"569.67";"2";"5.50";"BDBM202169";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CC(O)C5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"41.0";"nM";"7.39";"";"358246";"UO_0000065";"12.97";"0.23";"1.89";"7.21";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4112596";"";"None";"479.54";"0";"4.97";"BDBM250075";"C=CC(=O)Nc1ccccc1[C@H]1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.4";"nM";"9.40";"";"435796";"UO_0000065";"19.60";"0.36";"4.43";"8.45";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890883";"";"None";"387.44";"0";"2.65";"BDBM249999";"NC(=O)c1c(-c2ccc(OCc3ccccc3)cc2)nn2c3c([nH]c12)CCNC3";"IC50";"'='";"5000.0";"nM";"5.30";"";"435928";"UO_0000065";"13.68";"0.25";"2.65";"5.44";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935234";"";"None";"437.46";"0";"4.50";"BDBM250004";"C=CC(=O)Nc1ccc2c(c1)[nH]c1c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn12";"IC50";"'='";"14.0";"nM";"7.85";"";"435933";"UO_0000065";"17.95";"0.33";"3.35";"6.86";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965262";"";"None";"401.47";"0";"3.49";"BDBM250042";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(C)cc3)nn21";"IC50";"'='";"1.6";"nM";"8.80";"";"435971";"UO_0000065";"21.91";"0.40";"5.31";"8.62";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927293";"";"None";"501.59";"1";"4.23";"BDBM250050";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)c(OC)c4)nn32)CC1";"IC50";"'='";"1.1";"nM";"8.96";"";"435979";"UO_0000065";"17.86";"0.33";"4.73";"8.02";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977236";"";"None";"415.45";"0";"2.59";"BDBM249919";"C=CC(=O)N1CC2(CNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"435849";"UO_0000065";"19.98";"0.37";"5.71";"8.10";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891285";"";"None";"552.68";"1";"4.14";"BDBM250062";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC[C@H]2C1CCN(C(=O)C#CCN2CCCC2)CC1";"IC50";"'='";"2.1";"nM";"8.68";"";"435994";"UO_0000065";"15.70";"0.29";"4.54";"8.21";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978311";"";"None";"465.46";"0";"3.22";"BDBM250065";"CC#CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccc(F)cc4F)cc3)nn21";"IC50";"'='";"38.0";"nM";"7.42";"";"435997";"UO_0000065";"15.94";"0.30";"4.20";"6.67";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909128";"";"None";"584.70";"2";"6.02";"BDBM200774";"COCC(C)(C)c1ccc(C(=O)Nc2cc(F)cc(-c3ncnc4[nH]c(C5=CCN(C(=O)N(C)C)CC5)cc34)c2C)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"356850";"UO_0000065";"14.36";"0.27";"2.38";"8.12";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907789";"";"None";"616.05";"2";"6.84";"BDBM214694";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)c(OP(=O)(OC(C)C)OC(C)C)c3)ncc2Cl)c1";"IC50";"'='";"3580.0";"nM";"5.45";"";"377109";"UO_0000065";"8.84";"0.18";"-1.39";"4.39";"0";"CHEMBL3888171";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 uM ATP, and 20 uM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes. The reagent stopped the kinase reaction and depleted the unconsumed ATP. Kinase Detection reagent (10 mL; Promega Corporation) was then added to each well. The Kinase Detection reagent comprises reagents to convert ADP to ATP and provide luciferase and luciferin to detect ATP. Luminescence was measured on an EnVision microplate reader (PerkinElmer). The amount of luminescence from each reaction is directly correlated with BTK kinase activity. Percent inhibition and IC50 values were calculated by comparing enzyme activity in drug-treated wells to the appropriate controls.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886607";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3657212";"";"None";"526.63";"2";"5.16";"BDBM134217";"Cc1csc(NC(=O)NC2CCN(c3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)n[nH]c4n3)C2)n1";"IC50";"'='";"9410.0";"nM";"5.03";"";"267606";"UO_0000065";"9.54";"0.18";"-0.13";"3.75";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657220";"";"None";"417.47";"1";"6.15";"BDBM134225";"Nc1n[nH]c2c(-c3ccc4[nH]ccc4c3)ncc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"250.0";"nM";"6.60";"";"267614";"UO_0000065";"15.81";"0.28";"0.45";"7.13";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657231";"";"None";"428.50";"1";"6.82";"BDBM134236";"Nc1n[nH]c2cc(-c3ccc4ccccc4c3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"260.0";"nM";"6.58";"";"267625";"UO_0000065";"15.37";"0.27";"-0.23";"8.57";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4129902";"";"None";"572.67";"2";"3.40";"14";"C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N(C)CCN(C)C)cc4OC)nc32)c1";"IC50";"'='";"982.0";"nM";"6.01";"";"";"UO_0000065";"10.49";"0.20";"2.61";"4.74";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL386760";"";"None";"686.81";"3";"6.22";"43";"COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"10.19";"0.19";"0.78";"5.83";"0";"CHEMBL870355";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145338";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL1916897";"";"None";"466.95";"0";"4.81";"42";"Cc1ccc(F)cc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"18.39";"0.36";"3.78";"13.05";"0";"CHEMBL1919046";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate preincubated for 60 mins measured after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4074833";"";"None";"552.56";"2";"5.57";"37";"C[C@]1(C(=O)O)CCC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"18.10";"0.34";"4.43";"7.38";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4097968";"";"None";"524.50";"2";"5.00";"21";"Nc1nccn2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nc2[C@H]1CC[C@H](C(=O)O)CC1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"13.56";"0.26";"2.11";"5.25";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4089318";"";"None";"508.46";"1";"4.15";"29";"Nc1nccn2c(C34CC(C(=O)O)(C3)C4)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"14.11";"0.26";"3.02";"5.29";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1916899";"";"None";"433.49";"0";"4.20";"44";"Cc1ccccc1Oc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"5.51";"nM";"8.26";"";"";"UO_0000065";"19.05";"0.35";"4.06";"13.12";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4087694";"";"None";"554.05";"1";"4.28";"7f";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(=O)CN(CCOC)CCOC)cc3)ncc2Cl)c1";"IC50";"'='";"22.6";"nM";"7.65";"";"";"UO_0000065";"13.80";"0.27";"3.37";"5.89";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3621495";"";"None";"469.55";"0";"3.43";"5";"CC(=O)Nc1ccc(-c2ccc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCN(C)CC5)cc4c23)cc1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"15.78";"0.29";"3.98";"6.64";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3746971";"";"None";"525.64";"1";"4.91";"25";"Cc1ccc(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)c(C)c1NC(=O)c1cc2ccccc2s1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"14.65";"0.28";"2.79";"7.13";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3747742";"";"None";"631.20";"2";"5.79";"20";"Cc1ccc(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)c(Cl)c1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.15";"0.26";"2.51";"8.34";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4865664";"";"None";"574.69";"2";"6.39";"37";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3cc4[nH]cnc4c(Nc4ccc(C(=O)N5CCOCC5)cc4)n3)c2)cc1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"13.17";"0.24";"1.18";"6.74";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4879055";"";"None";"533.59";"1";"4.80";"39";"Cc1c(NC(=O)c2cccnc2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"264.0";"nM";"6.58";"";"";"UO_0000065";"12.33";"0.22";"1.78";"5.26";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3647964";"";"None";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"17.53";"0.32";"3.50";"7.79";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4855825";"";"None";"602.74";"2";"6.71";"28";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc2c(ncn2C)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"527.0";"nM";"6.28";"";"";"UO_0000065";"10.42";"0.19";"-0.43";"6.19";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3621514";"";"None";"441.54";"0";"3.37";"24";"Cc1c(N)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"17.49";"0.32";"4.35";"7.12";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622194";"";"None";"549.61";"1";"4.87";"35";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(F)cc5)c4)c23)CC1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"13.48";"0.25";"2.54";"6.64";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4779908";"";"None";"597.57";"1";"4.53";"31";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)c(F)c4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"11.87";"0.23";"2.56";"5.55";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"21.62";"0.39";"5.30";"9.60";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL1614712";"";"None";"439.56";"0";"4.92";"NVP-AEW541";"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1";"IC50";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"11.65";"0.21";"0.20";"7.40";"0";"CHEMBL3789976";"Inhibition of BTK (unknown origin) in presence of [gamma33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785066";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3895072";"";"None";"559.99";"2";"6.78";"7d";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCP(=O)(OCC)OCC)cc3)ncc2Cl)c1";"IC50";"'='";"10.6";"nM";"7.97";"";"";"UO_0000065";"14.24";"0.29";"1.19";"6.45";"0";"CHEMBL3874808";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells measured after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872267";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308860";"";"";""
"CHEMBL3925929";"";"None";"431.48";"0";"3.33";"(+)-33";"Nc1ccc2c(c1)CC(n1nc(-c3cc(F)c4c(c3)NCCO4)c3c(N)ncnc31)CC2";"IC50";"'='";"176.0";"nM";"6.75";"";"";"UO_0000065";"15.65";"0.29";"3.42";"5.78";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4644786";"";"None";"340.43";"0";"2.15";"4a";"C=CC(=O)NC1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"20.56";"0.38";"4.85";"7.67";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4634162";"";"None";"338.41";"0";"1.60";"4f";"C#CC(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"22.89";"0.42";"6.14";"8.49";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4483575";"REMIBRUTINIB";"3.0";"507.54";"1";"4.47";"25; LOU064";"C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"14.13";"0.26";"2.70";"6.50";"0";"CHEMBL4358574";"Inhibition of BTK in human basophils assessed as reduction in anti-IgE mouse IgG1 antibody Le2-stimulated CD63 expression on basophil preincubated for 30 mins in presence of IgE antibody B11 followed by anti-IgE mouse IgG1 antibody Le2 stimulation and measured after 15 mins by flow cytometry";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4461398";"";"None";"492.53";"0";"4.16";"19";"C=CC(=O)NCCNc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1245.0";"nM";"5.91";"";"";"UO_0000065";"11.99";"0.22";"1.74";"4.84";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3787112";"";"None";"349.44";"0";"3.04";"2";"Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"17.85";"0.33";"3.20";"7.78";"0";"CHEMBL3789976";"Inhibition of BTK (unknown origin) in presence of [gamma33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785066";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3290125";"";"None";"605.62";"2";"5.94";"14";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(NC(=O)CCN(C)C)c2)nc1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"12.97";"0.24";"1.91";"6.12";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290147";"";"None";"614.58";"2";"6.28";"37";"C=CC(=O)N(C(=O)C=C)c1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"208.0";"nM";"6.68";"";"";"UO_0000065";"10.87";"0.20";"0.40";"5.01";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4475004";"";"None";"351.34";"0";"2.61";"25";"COc1cc2cn[nH]c2cc1-c1ccc(F)c2c(N)c(C(N)=O)cnc12";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"21.09";"0.39";"4.80";"6.18";"0";"CHEMBL4335771";"Reversible inhibition of FAM-labeled peptide binding to full-length human N-terminal GST-tagged BTK C481S mutant (2 to 659 residues) expressed in baculovirus infected Sf21 insect cells preincubated for 10 mins followed by FAM-labeled peptide addition and measured by off-chip mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334447";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4869409";"";"None";"471.49";"0";"3.70";"19c";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5F)cc4)[nH]c23)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"18.71";"0.34";"5.12";"8.35";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4755663";"";"None";"384.48";"0";"4.85";"6";"CC(C)(C)c1ccc(C(=O)NCc2ccc(-c3ncnc4[nH]ccc34)cc2)cc1";"IC50";"'='";"142.0";"nM";"6.85";"";"";"UO_0000065";"17.81";"0.32";"2.00";"9.69";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4763987";"";"None";"412.54";"1";"5.41";"8";"CCc1cc(-c2ncnc3[nH]ccc23)ccc1CNC(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"18.97";"0.34";"2.41";"11.07";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4749757";"";"None";"462.58";"0";"4.01";"22";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)c1nnc(C(C)(C)C)s1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"12.65";"0.24";"1.84";"5.30";"0";"CHEMBL4701077";"Inhibition of BTK in human whole blood assessed as reduction in BTK phosphorylation measured after 30 mins by phosphotyrosine detection method";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL2336005";"";"None";"417.53";"1";"5.24";"BDBM50430875";"Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1";"IC50";"'='";"17.7";"nM";"7.75";"";"306889";"UO_0000065";"18.57";"0.35";"2.51";"13.45";"0";"CHEMBL3707518";"Inhibition Assay: The inhibitory activity measurement against the kinases mentioned above was measured in the kinase inhibition reaction mixture containing 2 ul purified kinase protein (10-50 ng), 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.01 mM ATP, 4 ug of poly(D4Y)n peptide substrate (Promega), 0.2 uCi of 32P-ATP and the each compound shown in tablel. The mixture was incubated for 15 min at 30° C. and the reaction was then ended by adding a half volume of 30% phosphoric acid solution. Subsequently, the reaction mixture solution was spotted in avidin coated membrane (Promega). This membrane was washed using 50 mM phosphate, 0.1N NaCl buffer (pH 6.0) solution for 10 min 5 times and then the radioactivity of each spot was quantified by using a BAS image analyzer (Fuji).";"B";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638954";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3263640";"";"None";"589.70";"2";"6.09";"20";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.73";"0.25";"2.01";"6.47";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263650";"";"None";"601.59";"2";"5.82";"30";"Cc1c(NC(=O)c2ccc(C(F)(F)F)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"12.17";"0.23";"1.50";"5.85";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263659";"";"None";"507.58";"1";"2.92";"39";"Cc1c(NS(C)(=O)=O)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"14.55";"0.28";"4.47";"5.19";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3605101";"";"None";"384.46";"1";"5.73";"14a";"Nc1ncc(-c2cn[nH]c2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"1052.0";"nM";"5.98";"";"";"UO_0000065";"15.55";"0.29";"0.25";"7.78";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3605106";"";"None";"456.57";"1";"6.24";"14f";"COCCCn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"279.7";"nM";"6.55";"";"";"UO_0000065";"14.35";"0.27";"0.31";"8.72";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402578";"";"None";"497.53";"0";"4.14";"4q";"CN(C)C(=O)c1cc2c(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)ncnc2[nH]1";"IC50";"'='";"1560.0";"nM";"5.81";"";"";"UO_0000065";"11.67";"0.21";"1.67";"5.58";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3401284";"";"None";"472.57";"0";"4.48";"24";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccnnc2)n1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"13.35";"0.25";"1.83";"6.20";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401283";"";"None";"471.59";"1";"5.09";"23";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2cccnc2)n1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.48";"0.29";"2.21";"8.21";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401263";"";"None";"523.59";"1";"4.22";"3";"Cc1c(NC(=O)c2ccccc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"10.19";"0.19";"1.12";"5.06";"0";"CHEMBL3406072";"Inhibition of BTK (unknown origin) after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1916907";"";"None";"322.34";"0";"4.16";"21d";"CNc1cc2c(cc1F)nc(Oc1ccccc1C)c1cncn12";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"19.15";"0.35";"2.01";"12.00";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3621460";"";"None";"442.52";"0";"3.48";"4";"COc1ccc(-c2ccc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCN(C)CC5)cc4c23)cc1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"17.03";"0.31";"4.06";"8.22";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621500";"";"None";"469.55";"0";"3.43";"10";"CC(=O)Nc1ccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"16.66";"0.31";"4.39";"7.02";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621501";"";"None";"426.52";"0";"3.78";"11";"Cc1ccccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"17.87";"0.33";"3.84";"9.24";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621503";"";"None";"446.94";"0";"4.13";"13";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccccc4Cl)c23)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"17.51";"0.33";"3.69";"9.49";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622198";"";"None";"442.52";"0";"3.48";"42";"COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c3c2)c1";"IC50";"'='";"404.0";"nM";"6.39";"";"";"UO_0000065";"14.45";"0.26";"2.91";"6.98";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1916894";"";"None";"450.49";"0";"4.29";"39";"Cc1cc(F)ccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"5.35";"nM";"8.27";"";"";"UO_0000065";"18.36";"0.34";"3.98";"12.58";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1081198";"";"None";"503.49";"2";"6.07";"2";"O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"10.14";"0.19";"-0.96";"5.31";"0";"CHEMBL1109423";"Inhibition of Btk after 1 hr";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153704";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1916905";"";"None";"322.34";"0";"4.16";"21b";"CNc1ccc2nc(Oc3ccc(F)cc3C)c3cncn3c2c1";"IC50";"'='";"1220.0";"nM";"5.91";"";"";"UO_0000065";"18.35";"0.34";"1.75";"11.49";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3402588";"";"None";"563.63";"1";"4.93";"4zb";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.12";"0.26";"3.03";"8.27";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402575";"";"None";"492.51";"0";"4.83";"4n";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(-c4cc[nH]n4)cc23)c1CO";"IC50";"'='";"38.8";"nM";"7.41";"";"";"UO_0000065";"15.05";"0.27";"2.58";"6.59";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402583";"";"None";"549.61";"2";"5.07";"4v";"CC(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"15.3";"nM";"7.82";"";"";"UO_0000065";"14.22";"0.26";"2.75";"7.51";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400979";"";"None";"573.63";"2";"5.81";"4g";"CN(C)C(=O)c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"13.64";"0.25";"2.01";"7.52";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3290126";"";"None";"618.62";"2";"6.73";"15";"CCC(=O)N(C(=O)CC)c1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"1410.0";"nM";"5.85";"";"";"UO_0000065";"9.46";"0.18";"-0.88";"4.39";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4647623";"";"None";"405.20";"None";"None";"14b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4)ncc2F)c1";"IC50";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"19.92";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4646648";"";"None";"338.41";"0";"1.92";"4o";"C#CC(=O)N1CCC(Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)CC1";"IC50";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"26.80";"0.50";"7.15";"9.94";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"17.83";"0.33";"3.63";"7.92";"1";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"Acalabrutinib";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"18.28";"0.33";"5.20";"7.18";"0";"CHEMBL3813055";"Inhibition of recombinant BTK (unknown origin) preincubated for 1 hr followed by ATP addition by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3787615";"";"None";"462.58";"0";"4.65";"7b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2SC)c1";"IC50";"'='";"1.08";"nM";"8.97";"";"";"UO_0000065";"19.38";"0.37";"4.32";"9.81";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3746333";"";"None";"531.60";"1";"3.61";"31";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cnc(C(C)(C)C)cn1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"15.80";"0.29";"4.79";"6.28";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1916717";"";"None";"458.57";"0";"4.41";"14";"CCN(C(=O)/C=C/CN(C)C)c1cc2c(cc1OC)nc(Nc1ccccc1C)c1cncn12";"IC50";"'='";"19.1";"nM";"7.72";"";"";"UO_0000065";"16.83";"0.31";"3.31";"10.29";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL377085";"";"None";"221.28";"0";"1.59";"38";"Cc1cc(C)c2c(N)c(C(N)=O)sc2n1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"24.35";"0.49";"3.80";"6.57";"0";"CHEMBL861964";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147674";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4091991";"";"None";"524.60";"2";"5.01";"1; BMX-IN-1";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C";"IC50";"'='";"10.4";"nM";"7.98";"";"";"UO_0000065";"15.22";"0.29";"2.97";"7.25";"0";"CHEMBL4008371";"Inhibition of full-length recombinant human His-tagged BTK expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007402";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3953196";"";"None";"571.69";"2";"5.43";"BDBM202111";"CN1CCC(n2cc(-c3cc4c(-c5cccc(-n6ccc7cc(C8CC8)ccc7c6=O)c5CO)ncnc4[nH]3)cn2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"358189";"UO_0000065";"14.52";"0.26";"2.87";"7.92";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3401280";"";"None";"566.66";"1";"4.36";"20";"Cc1c(NC(=O)c2cc3n(c2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"11.86";"0.22";"2.36";"6.08";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401279";"";"None";"584.70";"1";"4.56";"19";"Cc1c(NC(=O)c2nc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"11.06";"0.21";"1.91";"5.46";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401278";"";"None";"585.69";"1";"4.36";"18";"Cc1c(NC(=O)c2cc3c(s2)CCOC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"11.65";"0.22";"2.46";"5.94";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401275";"";"None";"580.69";"1";"4.92";"15";"Cc1c(NC(=O)c2ccc(C(C)(C)C)nc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"11.86";"0.22";"1.97";"5.81";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401265";"";"None";"551.65";"1";"4.79";"5";"CCc1ccc(C(=O)Nc2cccc(-c3cn(C)c(=O)c(Nc4ccc(C(=O)N5CCOCC5)cc4)n3)c2C)cc1";"IC50";"'='";"225.0";"nM";"6.65";"";"";"UO_0000065";"12.05";"0.22";"1.86";"6.30";"0";"CHEMBL3406072";"Inhibition of BTK (unknown origin) after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401264";"";"None";"537.62";"1";"4.53";"4";"Cc1ccc(C(=O)Nc2cccc(-c3cn(C)c(=O)c(Nc4ccc(C(=O)N5CCOCC5)cc4)n3)c2C)cc1";"IC50";"'='";"860.0";"nM";"6.07";"";"";"UO_0000065";"11.28";"0.21";"1.54";"5.75";"0";"CHEMBL3406072";"Inhibition of BTK (unknown origin) after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3699643";"";"None";"475.57";"1";"5.30";"BDBM149468";"Cc1cc(Nc2cc(-c3cccc(N4Cc5cc(C(C)(C)C)sc5C4=O)c3C)n[nH]c2=O)no1";"IC50";"'='";"18.0";"nM";"7.75";"";"287914";"UO_0000065";"16.29";"0.31";"2.44";"7.44";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3263640";"";"None";"589.70";"2";"6.09";"20";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"12.38";"0.23";"1.21";"5.83";"0";"CHEMBL3270978";"Inhibition of BTK phosphorylation in human Ramos cells by Western blotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307664";"";"";""
"CHEMBL3647515";"";"None";"509.61";"1";"4.15";"BDBM143317";"CN(C)C/C=C/C(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"1.8";"nM";"8.74";"";"279477";"UO_0000065";"17.16";"0.31";"4.59";"8.54";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647528";"";"None";"510.60";"1";"3.54";"BDBM143330";"CN(C)C/C=C/C(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)cn4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"32.0";"nM";"7.50";"";"279490";"UO_0000065";"14.68";"0.27";"3.95";"6.50";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3652652";"";"None";"562.01";"1";"4.39";"BDBM122413";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccc(Cl)cn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.29";"nM";"9.54";"";"250993";"UO_0000065";"16.97";"0.33";"5.15";"6.77";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3402569";"";"None";"615.66";"2";"5.58";"4h";"O=C(c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1)N1CCOCC1";"IC50";"'='";"18.2";"nM";"7.74";"";"";"UO_0000065";"12.57";"0.23";"2.16";"6.83";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402574";"";"None";"550.62";"2";"6.37";"4m";"CC(=O)c1cc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cs1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"13.14";"0.25";"0.87";"7.17";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3921350";"";"None";"614.75";"2";"5.45";"BDBM202082";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"358160";"UO_0000065";"13.37";"0.24";"2.77";"8.41";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3358340";"";"None";"617.75";"1";"4.44";"5a";"CN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCc6cc(C(C)(C)C#N)ccc6C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"11.69";"0.21";"2.78";"6.13";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3913167";"";"None";"661.73";"2";"5.83";"BDBM202177";"CC1(O)CCN(C(=O)c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"358254";"UO_0000065";"12.24";"0.23";"2.27";"6.14";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4557061";"";"None";"493.51";"0";"4.12";"18";"C=CC(=O)NCCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"16.33";"0.31";"3.94";"6.76";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4576902";"";"None";"519.55";"1";"4.61";"23";"C=CC(=O)N1CC[C@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"16.38";"0.31";"3.90";"7.70";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4439622";"";"None";"521.57";"1";"4.86";"27";"C=CC(=O)N(CC)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"17.34";"0.33";"4.19";"8.19";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"2";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"16.59";"0.30";"4.41";"6.52";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"3";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"18.23";"0.33";"5.53";"7.65";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4450082";"";"None";"499.59";"1";"5.35";"11";"C=CC(=O)N(C)CC/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2)c1C";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"15.66";"0.29";"2.47";"7.73";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4546324";"";"None";"503.55";"2";"5.10";"17";"C=CC(=O)N(C)C/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.80";"0.29";"2.86";"7.86";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4461398";"";"None";"492.53";"0";"4.16";"19";"C=CC(=O)NCCNc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"671.0";"nM";"6.17";"";"";"UO_0000065";"12.53";"0.23";"2.01";"5.06";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4537231";"";"None";"533.58";"1";"5.00";"22";"C=CC(=O)N1CCC[C@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"15.08";"0.28";"3.05";"7.29";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4483575";"REMIBRUTINIB";"3.0";"507.54";"1";"4.47";"25; LOU064";"C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"16.95";"0.32";"4.13";"7.79";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"4";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"16.80";"0.31";"2.86";"7.73";"1";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"22.20";"0.42";"6.09";"9.01";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4463650";"";"None";"487.54";"0";"4.08";"13";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3)c2C)C1";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"14.40";"0.27";"2.94";"6.36";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4513614";"";"None";"523.54";"1";"3.57";"15";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C(C)(C)O)cc3F)c2C)C1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"12.61";"0.24";"3.03";"5.05";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4463185";"";"None";"541.53";"1";"3.71";"16";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C(C)(C)O)c(F)c3F)c2C)C1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"13.41";"0.25";"3.55";"5.56";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3745919";"";"None";"471.57";"0";"3.59";"18; CHMFL-FLT3-122";"CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"421.0";"nM";"6.38";"";"";"UO_0000065";"13.52";"0.25";"2.79";"6.23";"0";"CHEMBL3749079";"Inhibition of BTK (unknown origin) by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745617";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3979472";"";"None";"514.65";"2";"5.67";"BDBM195781";"CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348518";"UO_0000065";"11.91";"0.23";"0.46";"6.44";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3907847";"";"None";"315.74";"0";"4.15";"BDBM195809";"C=CC(=O)Nc1cc(-c2cnc3[nH]cc(Cl)c3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348527";"UO_0000065";"19.42";"0.38";"1.98";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3290128";"";"None";"510.45";"2";"5.46";"17";"Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3F)cn2)c1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"14.36";"0.27";"1.87";"6.01";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3786931";"";"None";"437.53";"0";"3.29";"8c";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N(C)C)nc3)ncc2[S+](C)[O-])c1";"IC50";"'='";"1.48";"nM";"8.83";"";"";"UO_0000065";"20.18";"0.39";"5.54";"7.47";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3936156";"";"None";"571.01";"2";"5.41";"10";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"11.53";"0.22";"1.18";"4.92";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3670085";"";"None";"581.68";"1";"3.19";"BDBM111942";"CC(=O)N1CCn2nc(Nc3cc(-c4cccc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)cc2C1";"IC50";"'='";"6.1";"nM";"8.21";"";"232997";"UO_0000065";"14.12";"0.26";"5.02";"6.98";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3290145";"";"None";"596.59";"2";"5.94";"34";"C=CS(=O)(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"13.07";"0.25";"1.86";"5.48";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290151";"";"None";"542.60";"2";"6.31";"41";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4ccc5ccccc5c4)ccc3C)cn2)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"14.11";"0.26";"1.35";"6.12";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290117";"";"None";"455.44";"0";"4.88";"6";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NC2CC2)nc1";"IC50";"'='";"2153.0";"nM";"5.67";"";"";"UO_0000065";"12.44";"0.23";"0.79";"5.90";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290138";"";"None";"540.93";"2";"6.29";"27";"Cc1ccc(NC(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.87";"0.29";"1.76";"6.59";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2216827";"";"None";"499.51";"0";"4.77";"30, CNX-774";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3)ncc2F)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.02";"0.33";"4.23";"6.91";"0";"CHEMBL2217247";"Inhibition of Btk in human Ramos cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2216750";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307664";"";"";""
"CHEMBL3400826";"";"None";"956.09";"4";"9.44";"1b";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)NCCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)n1";"IC50";"'='";"208.0";"nM";"6.68";"";"";"UO_0000065";"6.99";"0.13";"-2.76";"3.08";"0";"CHEMBL3407011";"Inhibition of biotinylated and activated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3402356";"";"None";"998.13";"4";"9.16";"1f";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOC(CNC(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)C3)cc2)n1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"8.33";"0.16";"-0.84";"3.83";"0";"CHEMBL3407012";"Inhibition of biotinylated and unactivated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3402580";"";"None";"524.62";"2";"5.96";"4s";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCSCC4)cc23)c1CO";"IC50";"'='";"67.1";"nM";"7.17";"";"";"UO_0000065";"13.67";"0.26";"1.21";"8.56";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3746293";"";"None";"529.60";"1";"4.74";"23";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.09";"0.31";"3.78";"7.90";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4101977";"";"None";"371.80";"0";"4.00";"8";"C=CC(=O)Nc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"21.78";"0.43";"4.10";"9.79";"0";"CHEMBL4020190";"Inhibition of human N-terminal His-tagged BTK expressed in bacmid transfected Sf21 insect cells using TK-substrate-biotin after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL1916890";"";"None";"430.51";"0";"3.72";"35";"Cc1c(O)cccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"76.5";"nM";"7.12";"";"";"UO_0000065";"16.53";"0.30";"3.40";"8.27";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4063859";"";"None";"532.58";"2";"6.11";"3k";"COc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cn1";"IC50";"'='";"196.0";"nM";"6.71";"";"";"UO_0000065";"12.59";"0.23";"0.60";"7.21";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3983770";"";"None";"615.74";"1";"4.84";"BDBM202132";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cnc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"35.0";"nM";"7.46";"";"358210";"UO_0000065";"12.11";"0.22";"2.62";"6.73";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904399";"";"None";"704.85";"2";"5.31";"BDBM202139";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(CN5CCN(S(=O)(=O)C6CC6)CC5)cn4)cc23)c1CO";"IC50";"'='";"7.0";"nM";"8.15";"";"358217";"UO_0000065";"11.57";"0.22";"2.84";"6.18";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958033";"";"None";"627.75";"2";"6.77";"BDBM202162";"COC1CCN(C(=O)c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5C)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"233.0";"nM";"6.63";"";"358239";"UO_0000065";"10.57";"0.19";"-0.14";"6.59";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3400978";"";"None";"544.59";"2";"6.31";"4f";"CC(=O)c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"13.42";"0.24";"1.00";"7.25";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14g; (S)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"10.70";"0.20";"1.72";"4.98";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3657224";"";"None";"446.43";"1";"6.69";"BDBM134229";"Nc1n[nH]c2c(-c3cccc(C(F)(F)F)c3)ncc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"16090.0";"nM";"4.79";"";"267618";"UO_0000065";"10.74";"0.20";"-1.90";"6.24";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657228";"";"None";"370.24";"1";"5.68";"BDBM134233";"COc1cccc(-c2cnc(Nc3ccccc3Cl)c(Cl)c2C#N)c1";"IC50";"'='";"230.0";"nM";"6.64";"";"267622";"UO_0000065";"17.93";"0.36";"0.96";"11.46";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657237";"";"None";"439.52";"0";"4.89";"BDBM134244";"C=CC(=O)N1CCCC(c2cc3[nH]nc(N)c3c(-c3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"267633";"UO_0000065";"19.11";"0.35";"3.51";"8.65";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657241";"";"None";"468.52";"0";"4.03";"BDBM134248";"CN(C)C(=O)Cn1ccc(Nc2cc3[nH]nc(N)c3c(-c3ccc(Oc4ccccc4)cc3)n2)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"267637";"UO_0000065";"18.19";"0.33";"4.49";"6.71";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3910697";"";"None";"421.89";"0";"3.83";"BDBM250010";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)cc3)nn21";"IC50";"'='";"0.78";"nM";"9.11";"";"435939";"UO_0000065";"21.59";"0.41";"5.28";"8.93";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962622";"";"None";"360.46";"0";"4.90";"BDBM249209";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc[nH]c(=O)c1";"IC50";"'='";"6911.39";"nM";"5.16";"";"434807";"UO_0000065";"14.32";"0.26";"0.26";"8.33";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3961487";"";"None";"409.45";"0";"4.47";"BDBM249922";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c(-c3cccc(N)c3)c[nH]c12";"IC50";"'='";"29.0";"nM";"7.54";"";"435852";"UO_0000065";"18.41";"0.33";"3.07";"6.76";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3652662";"";"None";"541.59";"1";"4.05";"BDBM122423";"Cc1ccc(Nc2nn(-c3cccc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cc2C(N)=O)nc1";"IC50";"'='";"0.24";"nM";"9.62";"";"251003";"UO_0000065";"17.76";"0.33";"5.57";"6.82";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652673";"";"None";"570.63";"1";"3.59";"BDBM122434";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5ccc(N6CCOCC6)nc54)c3CO)ncc2c1";"IC50";"'='";"10.28";"nM";"7.99";"";"251014";"UO_0000065";"14.00";"0.26";"4.40";"6.22";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL2057913";"";"None";"572.88";"2";"6.63";"23";"C=CC(=O)N1CCCC(c2c(Cl)c(-c3ccc(Oc4ccc(Cl)c(Cl)c4)c(OC)c3)c3c(N)ncnn23)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.18";"0.31";"2.07";"9.16";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2057916";"";"None";"460.58";"1";"5.05";"27";"CCNC(=O)Nc1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2C)cn(C)c1=O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.12";"0.32";"2.84";"8.55";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2057921";"";"None";"576.66";"1";"4.63";"32";"Cc1c(NC(=O)c2ccc(N(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nccn2n1";"IC50";"'='";"144.0";"nM";"6.84";"";"";"UO_0000065";"11.86";"0.22";"2.21";"5.85";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1916714";"";"None";"472.55";"0";"3.77";"10";"C=C(CN1CCOCC1)C(=O)Nc1cc2c(cc1OC)nc(Nc1ccccc1C)c1cncn12";"IC50";"'='";"2.52";"nM";"8.60";"";"";"UO_0000065";"18.20";"0.34";"4.83";"9.24";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4247992";"";"None";"347.42";"0";"3.70";"36";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"19.49";"0.36";"3.07";"8.55";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4248834";"";"None";"319.36";"0";"3.37";"28";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]ccc23)c1C";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"22.68";"0.41";"3.87";"8.23";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4237800";"";"None";"506.61";"1";"4.82";"10";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"13.66";"0.25";"2.10";"6.07";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4243995";"";"None";"333.39";"0";"3.68";"34";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"29.03";"0.53";"6.00";"11.00";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4246324";"";"None";"397.50";"0";"3.77";"33";"C=CS(=O)(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C";"IC50";"'='";"0.11";"nM";"9.96";"";"";"UO_0000065";"25.05";"0.49";"6.19";"10.35";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4245037";"";"None";"333.39";"0";"3.68";"30";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]cc(C)c23)c1C";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"26.76";"0.49";"5.24";"10.14";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4249677";"";"None";"408.46";"0";"4.25";"25";"Cc1c(-c2ccc(C(N)=O)c3[nH]cc(C)c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"17.23";"0.31";"2.79";"7.50";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4241272";"";"None";"366.43";"0";"1.23";"9a";"C=CC(=O)N1CCCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1";"IC50";"'='";"481.2";"nM";"6.32";"";"";"UO_0000065";"17.24";"0.32";"5.09";"5.86";"0";"CHEMBL4236389";"Inhibition of BTK (unknown origin) using TK-substrate-biotin measured after 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4059483";"";"None";"564.53";"1";"4.76";"19";"Nc1nccn2c([C@@H]3CCC[C@H](c4n[nH]c(=O)o4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.48";"0.31";"4.54";"5.92";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4066216";"";"None";"552.56";"2";"5.64";"35";"CC(C)[C@]1(C(=O)O)CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"16.21";"0.31";"3.32";"6.61";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4079697";"";"None";"552.56";"2";"5.57";"40";"C[C@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"16.29";"0.31";"3.43";"6.64";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4087240";"";"None";"449.49";"0";"4.79";"7k";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC4CCCO4)cc3)ncc2F)c1";"IC50";"'='";"22.4";"nM";"7.65";"";"";"UO_0000065";"17.02";"0.32";"2.86";"7.85";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3647973";"";"None";"440.51";"0";"4.22";"BDBM97678";"C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"3.6";"nM";"8.44";"";"213459";"UO_0000065";"19.17";"0.35";"4.22";"8.52";"1";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4060757";"";"None";"585.56";"1";"4.34";"27";"Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"13.47";"0.26";"3.55";"6.58";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4076024";"";"None";"571.54";"1";"4.14";"24";"COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"13.80";"0.26";"3.75";"6.17";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4078497";"";"None";"579.58";"1";"4.39";"10";"CC1(C(=O)N2CCC(c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC2)COC1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"12.24";"0.23";"2.71";"5.56";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4077588";"";"None";"583.59";"2";"5.14";"26";"Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"15.59";"0.30";"3.96";"8.22";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4104254";"";"None";"565.56";"1";"4.00";"9";"CC1(C(=O)N2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"15.77";"0.30";"4.92";"6.98";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3954122";"";"None";"598.65";"2";"5.40";"BDBM202201";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cc(F)cc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"1.3";"nM";"8.89";"";"358277";"UO_0000065";"14.84";"0.28";"3.49";"9.77";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892930";"";"None";"581.72";"2";"6.77";"BDBM202112";"CN1CCC(c2ccc(-c3cc4c(-c5cccc(-n6ccc7cc(C8CC8)ccc7c6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"358190";"UO_0000065";"14.65";"0.26";"1.75";"9.79";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952007";"";"None";"572.67";"1";"4.82";"BDBM202117";"CN1CCC(n2cc(-c3cc4c(-c5cccc(-n6ncc7cc(C8CC8)ccc7c6=O)c5CO)ncnc4[nH]3)cn2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"358195";"UO_0000065";"15.19";"0.28";"3.88";"7.39";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981782";"";"None";"307.33";"0";"3.72";"BDBM195834";"CCC#CC(=O)Nc1cc(-c2cnc3[nH]ccc3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348538";"UO_0000065";"19.95";"0.36";"2.41";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3893228";"";"None";"293.30";"0";"3.25";"BDBM195841";"C#CC(=O)Nc1cc(-c2cnc3[nH]cc(C)c3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348545";"UO_0000065";"20.90";"0.38";"2.88";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3906494";"";"None";"334.42";"0";"3.59";"BDBM195907";"Cc1c[nH]c2ncc(-c3cccc(NC(=O)/C=C/CN(C)C)c3)cc12";"IC50";"'='";"7558.0";"nM";"5.12";"";"348552";"UO_0000065";"15.31";"0.28";"1.53";"8.39";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647965";"";"None";"426.48";"0";"3.83";"BDBM97670";"C=CC(=O)N1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"327861";"UO_0000065";"20.45";"0.37";"4.89";"8.80";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4079354";"";"None";"318.74";"0";"3.58";"3";"Oc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1";"IC50";"'='";"1213.0";"nM";"5.92";"";"";"UO_0000065";"18.56";"0.37";"2.34";"8.01";"0";"CHEMBL4020190";"Inhibition of human N-terminal His-tagged BTK expressed in bacmid transfected Sf21 insect cells using TK-substrate-biotin after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3670094";"";"None";"611.72";"1";"3.91";"24";"CN1CCN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"27.6";"nM";"7.56";"";"";"UO_0000065";"12.36";"0.23";"3.65";"7.65";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3702853";"";"None";"624.72";"1";"4.81";"BDBM143211";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)CN1CCOCC1";"IC50";"'='";"5.2";"nM";"8.28";"";"279425";"UO_0000065";"13.26";"0.25";"3.47";"6.12";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3657239";"";"None";"504.59";"2";"6.41";"BDBM134246";"Nc1n[nH]c2cc(C3CCN(C(=O)Nc4ccccc4)CC3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"267635";"UO_0000065";"17.24";"0.31";"2.29";"7.97";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4281335";"";"None";"464.57";"0";"2.42";"9";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)cc3)n2)C1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"15.68";"0.29";"4.86";"6.46";"0";"CHEMBL4264032";"Inhibition of BTK in human WBC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4083867";"";"None";"505.55";"2";"5.44";"3l";"Cn1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)n1";"IC50";"'='";"20.6";"nM";"7.69";"";"";"UO_0000065";"15.20";"0.28";"2.25";"8.66";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4097010";"";"None";"573.63";"2";"5.81";"3u";"CN(C)C(=O)c1ccc(-c2nc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1";"IC50";"'='";"92.7";"nM";"7.03";"";"";"UO_0000065";"12.26";"0.22";"1.22";"6.76";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4068839";"";"None";"489.97";"0";"4.05";"19; CHMFL-EGFR-202";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(OCc4ccccn4)c(Cl)c3)c3c(N)ncnc32)C1";"IC50";"'='";"24.5";"nM";"7.61";"";"";"UO_0000065";"15.53";"0.30";"3.56";"6.79";"0";"CHEMBL4050459";"Inhibition of full-length recombinant human His-tagged BTK cytoplasmic domain expressed in baculovirus by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4049404";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4125940";"";"None";"570.65";"2";"3.15";"17";"C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)c(OC)c4)nc32)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"15.63";"0.29";"5.77";"7.05";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4456912";"";"None";"416.48";"0";"3.79";"5";"C=CC(=O)N1CCC[C@@H](n2cc(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"20.40";"0.37";"4.70";"9.39";"0";"CHEMBL4321373";"Inhibition of human BTK expressed in Sf9 cells using FAM-Srctide peptide substrate incubated for 60 mins by TR-FRET Lantha-screen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4316622";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3930113";"";"None";"425.49";"0";"4.43";"BDBM249874";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2c1cccc(N)c1";"IC50";"'='";"360.0";"nM";"6.44";"";"435787";"UO_0000065";"15.14";"0.28";"2.01";"5.96";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913277";"";"None";"563.54";"1";"3.86";"BDBM246402";"Nc1ncnc2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nn2[C@H]1CCCc2c1cnn2CCO";"IC50";"'='";"2.1";"nM";"8.68";"";"429708";"UO_0000065";"15.40";"0.29";"4.82";"5.80";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3924266";"";"None";"457.53";"0";"3.97";"BDBM250080";"C=CC(=O)Nc1ccccc1[C@@H]1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"110.0";"nM";"6.96";"";"435815";"UO_0000065";"15.21";"0.28";"2.99";"6.25";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"41";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"435824";"UO_0000065";"18.45";"0.34";"4.48";"8.49";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4212668";"";"None";"549.68";"2";"6.22";"2a";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cncc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.19";"0.19";"-0.62";"5.81";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4211893";"";"None";"552.61";"1";"4.84";"4d";"CC(C1CC1)n1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"15.67";"0.29";"3.82";"6.33";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4442732";"";"None";"467.48";"0";"3.65";"9b";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"16.62";"0.31";"4.12";"6.67";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4560385";"";"None";"438.44";"0";"3.42";"9a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"16.80";"0.31";"3.95";"5.98";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4520801";"";"None";"465.94";"0";"4.03";"11b";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"0.18";"nM";"9.74";"";"";"UO_0000065";"20.91";"0.40";"5.71";"8.37";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4572913";"";"None";"524.57";"1";"3.58";"9i";"CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"16.07";"0.30";"4.85";"7.04";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4440096";"";"None";"497.50";"0";"3.01";"9f";"NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/CO)C2)c1N";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"17.36";"0.33";"5.63";"6.32";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"22.70";"0.41";"5.78";"10.08";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4560385";"";"None";"438.44";"0";"3.42";"9a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"19.54";"0.37";"5.15";"6.96";"0";"CHEMBL4385492";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human B cells assessed as reduction in cell proliferation pretreated for 30 mins followed by goat anti-human IgM F(ab')2-stimulation and measured after 3 days by [3H]-thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4456974";"";"None";"471.44";"0";"3.56";"20b";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(C(F)(F)F)n4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"15.79";"0.30";"3.88";"5.47";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4571839";"";"None";"379.42";"0";"2.05";"17l";"Nc1ncnc2c1c(-c1ccc3c(c1)OCO3)cn2[C@H]1CCN(C[C@H]2CO2)C1";"IC50";"'='";"41.9";"nM";"7.38";"";"";"UO_0000065";"19.44";"0.36";"5.33";"8.11";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4063859";"";"None";"532.58";"2";"6.11";"3k";"COc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cn1";"IC50";"'='";"68.3";"nM";"7.17";"";"";"UO_0000065";"13.45";"0.24";"1.06";"7.70";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4094133";"";"None";"572.64";"2";"6.41";"3g";"CN(C)C(=O)c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1";"IC50";"'='";"12.1";"nM";"7.92";"";"";"UO_0000065";"13.83";"0.25";"1.51";"8.68";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4087347";"";"None";"548.62";"2";"5.68";"3n";"CC(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.44";"0.26";"2.24";"8.68";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4085393";"";"None";"613.72";"1";"4.94";"3s";"CN(C)S(=O)(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"12.33";"0.23";"2.63";"6.79";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"4";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"16.78";"0.31";"2.86";"7.72";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4441128";"";"None";"564.64";"1";"4.40";"29";"Cc1c(NC(=O)c2ccc(C3CC3)cc2F)cc(F)cc1-c1ncnc(N)c1OCCN(C)C(=O)/C=C/CN(C)C";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"12.61";"0.24";"2.72";"6.26";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4576902";"";"None";"519.55";"1";"4.61";"23";"C=CC(=O)N1CC[C@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"14.05";"0.26";"2.69";"6.61";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"2";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"203.0";"nM";"6.69";"";"";"UO_0000065";"14.38";"0.26";"3.38";"5.65";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4537231";"";"None";"533.58";"1";"5.00";"22";"C=CC(=O)N1CCC[C@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"16.59";"0.31";"3.85";"8.02";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4112223";"";"None";"525.59";"1";"4.51";"BDBM255267";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CC5)ccn4)cc3F)c12";"IC50";"'='";"0.2";"nM";"9.70";"";"445172";"UO_0000065";"18.45";"0.34";"5.19";"8.18";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112747";"";"None";"541.59";"1";"3.69";"BDBM255280";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5(F)COC5)ccn4)cc3)c12";"IC50";"'='";"1.9";"nM";"8.72";"";"445185";"UO_0000065";"16.10";"0.30";"5.03";"6.83";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114924";"";"None";"549.56";"1";"4.76";"BDBM255313";"C[C@@H]1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"6.7";"nM";"8.17";"";"445218";"UO_0000065";"14.87";"0.28";"3.41";"6.90";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113263";"";"None";"595.58";"2";"5.13";"BDBM255340";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@@H]3N(C2)C(=O)OC3(C)C)n2ccnc(N)c12";"IC50";"'='";"0.18";"nM";"9.74";"";"445246";"UO_0000065";"16.36";"0.31";"4.61";"7.11";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110940";"";"None";"607.64";"2";"5.55";"BDBM255363";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CC(C)(C)C(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.54";"nM";"9.27";"";"445269";"UO_0000065";"15.25";"0.29";"3.72";"7.26";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107443";"";"None";"525.49";"1";"4.11";"BDBM255423";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)no4)cc3)c12";"IC50";"'='";"240.6";"nM";"6.62";"";"445330";"UO_0000065";"12.60";"0.24";"2.51";"5.03";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3402584";"";"None";"578.65";"2";"5.21";"4w";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"14.09";"0.26";"2.94";"7.60";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3913116";"";"None";"441.49";"0";"3.33";"BDBM249995";"C=CC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2CC1";"IC50";"'='";"0.36";"nM";"9.44";"";"435924";"UO_0000065";"21.39";"0.39";"6.11";"8.93";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917828";"";"None";"431.50";"0";"3.50";"BDBM250007";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(C)c(OC)c3)nn21";"IC50";"'='";"0.53";"nM";"9.28";"";"435936";"UO_0000065";"21.50";"0.40";"5.78";"8.34";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939637";"";"None";"568.72";"2";"5.08";"BDBM250048";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2C1CCN(C(=O)/C=C/CN2CCCCC2)CC1";"IC50";"'='";"3.8";"nM";"8.42";"";"435977";"UO_0000065";"14.81";"0.27";"3.34";"7.96";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974783";"";"None";"484.56";"0";"3.95";"BDBM250057";"N#CCC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"87.0";"nM";"7.06";"";"435987";"UO_0000065";"14.57";"0.27";"3.11";"5.59";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965958";"";"None";"624.72";"2";"5.12";"BDBM143192";"CCN(C1COC1)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"279412";"UO_0000065";"14.48";"0.27";"3.93";"6.68";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3889963";"";"None";"511.56";"1";"4.57";"BDBM143194";"CC(C)/C=C(/C#N)C(=O)N1CC(Cn2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"20.4";"nM";"7.69";"";"279414";"UO_0000065";"15.03";"0.28";"3.12";"6.25";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3918024";"";"None";"651.75";"1";"4.56";"BDBM143215";"CCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1=O";"IC50";"'='";"1.3";"nM";"8.89";"";"279429";"UO_0000065";"13.63";"0.25";"4.33";"6.07";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647520";"";"None";"465.52";"0";"3.45";"BDBM143322";"CC#CC(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)nc4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"1.1";"nM";"8.96";"";"279482";"UO_0000065";"19.24";"0.35";"5.51";"8.00";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3941460";"";"None";"403.49";"0";"3.43";"BDBM249892";"NC(=O)c1c(-c2ccc(OCC3CC3)cc2)nn2c1NCCC2c1ccccc1N";"IC50";"'='";"5300.0";"nM";"5.28";"";"435812";"UO_0000065";"13.08";"0.24";"1.85";"4.88";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945749";"";"None";"389.46";"0";"2.95";"BDBM249912";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC21CCNCC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"435842";"UO_0000065";"15.03";"0.28";"2.90";"6.21";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954461";"";"None";"493.61";"1";"5.25";"BDBM249914";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC21CCN(Cc2ccccc2)CC1";"IC50";"'='";"180.0";"nM";"6.75";"";"435844";"UO_0000065";"13.66";"0.25";"1.49";"7.90";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963054";"";"None";"451.53";"0";"4.08";"BDBM249917";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC21CN(Cc2ccccc2)C1";"IC50";"'='";"220.0";"nM";"6.66";"";"435847";"UO_0000065";"14.74";"0.27";"2.58";"7.79";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906908";"";"None";"463.50";"1";"5.01";"BDBM249921";"C=CC(=O)Nc1cccc(-c2cn3nc(-c4ccc(Oc5ccccc5)cc4)c(C(N)=O)c3[nH]2)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"435851";"UO_0000065";"14.72";"0.27";"1.81";"5.96";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932096";"";"None";"557.61";"2";"5.53";"BDBM200884";"Cc1c(NC(=O)N2Cc3ccc(F)cc3C2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"3.0";"nM";"8.52";"";"356897";"UO_0000065";"15.28";"0.28";"2.99";"8.75";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3649458";"";"None";"460.53";"0";"2.77";"BDBM122406";"Cn1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)cc(CO)c4c3=O)c2CO)cc1C(N)=O";"IC50";"'='";"695.5";"nM";"6.16";"";"250986";"UO_0000065";"13.37";"0.25";"3.39";"4.99";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4087578";"";"None";"524.50";"2";"5.00";"34";"C[C@]1(C(=O)O)CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"16.94";"0.32";"3.89";"6.56";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4074833";"";"None";"552.56";"2";"5.57";"37";"C[C@]1(C(=O)O)CCC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.02";"0.26";"2.17";"5.72";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4103954";"";"None";"581.57";"2";"5.29";"3";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.44";"0.27";"3.11";"7.09";"1";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3976332";"";"None";"615.73";"2";"6.17";"BDBM202120";"CC(C)N1CC(Oc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)C1";"IC50";"'='";"11.0";"nM";"7.96";"";"358198";"UO_0000065";"12.93";"0.24";"1.79";"7.67";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962146";"";"None";"587.68";"2";"5.39";"BDBM202128";"CN1CC(Oc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"358206";"UO_0000065";"14.13";"0.26";"2.91";"8.00";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958922";"";"None";"678.81";"1";"4.78";"BDBM202135";"CS(=O)(=O)N1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"358213";"UO_0000065";"12.56";"0.24";"3.74";"6.46";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2441273";"";"None";"459.62";"1";"5.70";"13";"CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"14.14";"0.27";"0.80";"7.84";"0";"CHEMBL2446677";"Inhibition of Btk (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440060";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3905062";"";"None";"556.99";"2";"5.80";"7a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CP(=O)(OCC)N4CCOCC4)cc3)ncc2Cl)c1";"IC50";"'='";"112.0";"nM";"6.95";"";"";"UO_0000065";"12.48";"0.25";"1.15";"5.91";"0";"CHEMBL3874808";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells measured after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872267";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308860";"";"";""
"CHEMBL3895794";"";"None";"499.48";"1";"5.99";"7e";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CP(=O)(OCC)OCC)cc3)ncc2F)c1";"IC50";"'='";"32.1";"nM";"7.49";"";"";"UO_0000065";"15.00";"0.29";"1.50";"6.55";"0";"CHEMBL3874808";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells measured after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872267";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308860";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"Spebrutinib";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"0.72";"nM";"9.14";"";"";"UO_0000065";"21.59";"0.40";"4.89";"9.39";"0";"CHEMBL3874808";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells measured after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872267";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308860";"";"";""
"CHEMBL3808547";"";"None";"429.48";"0";"2.92";"III1";"C=CC(=O)N1CCN(c2ncnc(N)c2C(=O)c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"880.0";"nM";"6.06";"";"";"UO_0000065";"14.10";"0.26";"3.14";"5.96";"0";"CHEMBL3813051";"Inhibition of BTK (unknown origin) assessed as reduction in phosphorylation of coumarin and fluorescein-labeled FRET peptide substrate incubated for 1 hr by Z-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3809893";"";"None";"381.44";"0";"1.52";"III5";"C=CC(=O)N1CCN(c2ncnc(N)c2C(=O)c2ccc(OCC)cc2)CC1";"IC50";"'='";"1320.0";"nM";"5.88";"";"";"UO_0000065";"15.41";"0.29";"4.36";"5.78";"0";"CHEMBL3813051";"Inhibition of BTK (unknown origin) assessed as reduction in phosphorylation of coumarin and fluorescein-labeled FRET peptide substrate incubated for 1 hr by Z-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3745935";"";"None";"533.56";"1";"4.57";"24";"CN1CCn2nc(Nc3cc(-c4ccc(F)c(NC(=O)c5cc6ccccc6s5)c4F)n[nH]c3=O)cc2C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"16.87";"0.32";"4.43";"8.34";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3747551";"";"None";"600.72";"1";"4.97";"7";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(F)c(NC(=O)c5cc6c(s5)CCCC6)c4)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"12.68";"0.24";"2.65";"7.65";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4216862";"";"None";"524.56";"1";"4.21";"4c";"Nc1nc(Nc2cnn(C3CC3)c2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"15.41";"0.28";"3.87";"5.91";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4215004";"";"None";"559.70";"1";"4.80";"3f";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)s1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"15.00";"0.29";"3.60";"6.06";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4081444";"";"None";"564.57";"2";"5.71";"27";"Nc1nccn2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nc2[C@]12CCC[C@](C(=O)O)(CC1)CC2";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"14.56";"0.27";"2.51";"6.07";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4079697";"";"None";"552.56";"2";"5.57";"40";"C[C@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn32)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.06";"0.27";"2.20";"5.73";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4065778";"";"None";"516.58";"2";"6.29";"3e";"Nc1cccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)c1";"IC50";"'='";"110.3";"nM";"6.96";"";"";"UO_0000065";"13.47";"0.24";"0.67";"7.18";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3647521";"";"None";"453.51";"0";"3.61";"BDBM143323";"C=CC(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)nc4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"2.4";"nM";"8.62";"";"279483";"UO_0000065";"19.01";"0.35";"5.01";"7.69";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2031893";"";"None";"528.54";"2";"5.23";"1";"COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.14";"0.28";"2.77";"8.28";"0";"CHEMBL2032465";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029218";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4237999";"";"None";"383.47";"0";"3.46";"37";"C=CS(=O)(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"18.78";"0.36";"3.74";"7.48";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4242058";"";"None";"361.45";"0";"4.01";"32";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"19.96";"0.36";"3.20";"9.11";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4238297";"";"None";"488.63";"0";"4.17";"14";"Cc1c(NC(=O)/C=C/CN(C)C)cccc1-c1ccc(C(N)=O)c2[nH]c3c(c12)CCC(C(C)(C)O)C3";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"12.28";"0.23";"1.83";"5.38";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4241958";"";"None";"431.54";"0";"4.24";"11";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"19.32";"0.36";"4.10";"7.70";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4237436";"";"None";"408.46";"0";"4.25";"24";"Cc1cc2c(-c3cccc(-n4cnc5ccccc5c4=O)c3C)ccc(C(N)=O)c2[nH]1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"17.36";"0.31";"2.84";"7.56";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3746854";"";"None";"530.59";"1";"4.13";"28";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ncccc2s1";"IC50";"'='";"132.0";"nM";"6.88";"";"";"UO_0000065";"12.97";"0.25";"2.75";"5.69";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4091991";"";"None";"524.60";"2";"5.01";"7";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C";"IC50";"'='";"10.4";"nM";"7.98";"";"";"UO_0000065";"15.22";"0.29";"2.97";"7.25";"1";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4288562";"";"None";"554.66";"1";"3.45";"6";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)c1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"15.72";"0.29";"5.27";"7.43";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4077064";"";"None";"447.50";"0";"4.01";"2; QL47";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.70";"0.32";"3.91";"10.85";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4093722";"";"None";"527.67";"1";"4.70";"51";"C=CC(=O)NC1CCCC(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)C1";"IC50";"'='";"2946.0";"nM";"5.53";"";"";"UO_0000065";"10.48";"0.19";"0.83";"5.79";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4203409";"";"None";"549.68";"2";"6.22";"1";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccnc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.45";"0.19";"-0.48";"5.96";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209441";"SOFNOBRUTINIB";"2.0";"498.52";"0";"3.41";"4b";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"15.82";"0.29";"4.48";"5.77";"0";"CHEMBL4201931";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-stimulated B-cell activation by measuring CD86 expression";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4228867";"";"None";"416.49";"0";"2.58";"8b";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"39.8";"nM";"7.40";"";"";"UO_0000065";"17.77";"0.33";"4.82";"7.46";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4085043";"";"None";"625.75";"1";"4.30";"26";"C[C@H]1CN(C)CCN1c1ccc(Nc2cc(-c3cc(F)cc(N4CCn5c(cc6c5CCCC6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"13.32";"0.25";"4.04";"8.43";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4066176";"";"None";"664.81";"2";"3.57";"30";"C[C@@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"11.13";"0.21";"3.83";"6.11";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"29; GDC-0853";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"11.97";"0.22";"4.39";"6.58";"0";"CHEMBL4023692";"Inhibition of anti-IgM-induced BTK phosphorylation at Y233 in human whole blood after 6 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3967742";"";"None";"336.40";"0";"2.51";"BDBM250520";"O=C(NC1CCCC(Nc2ncnc3[nH]cnc23)C1)c1ccccc1";"IC50";"'='";"45.32";"nM";"7.34";"";"436768";"UO_0000065";"21.83";"0.40";"4.83";"7.68";"0";"CHEMBL3889150";"FRET (Forster/Flouresence Resonance Energy Transfer) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 ul of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission). The negative control well values were averaged to obtain the mean minimum. The positive 'no inhibitor' control wells were averaged to obtain the mean maximum.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886966";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4062498";"";"None";"573.51";"1";"3.33";"25";"COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.69";"0.26";"4.52";"5.73";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4075605";"";"None";"581.56";"1";"3.58";"13";"CC1(C(=O)N2CCO[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"12.58";"0.24";"3.74";"5.34";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4094125";"";"None";"579.58";"1";"4.39";"6";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.97";"0.26";"3.71";"6.34";"1";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4060757";"";"None";"585.56";"1";"4.34";"27";"Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.59";"nM";"9.23";"";"";"UO_0000065";"15.76";"0.30";"4.89";"7.70";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4075954";"";"None";"571.54";"1";"4.34";"23";"CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"16.44";"0.31";"5.06";"7.36";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4075605";"";"None";"581.56";"1";"3.58";"13";"CC1(C(=O)N2CCO[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"15.55";"0.29";"5.47";"6.60";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL490355";"SULFURETIN";"None";"270.24";"0";"2.42";"67";"O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21";"IC50";"'='";"6020.0";"nM";"5.22";"";"";"UO_0000065";"19.32";"0.36";"2.80";"6.00";"0";"CHEMBL4014528";"Inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014275";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4644786";"";"None";"340.43";"0";"2.15";"4a";"C=CC(=O)NC1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"24.91";"0.46";"6.33";"9.30";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4641586";"";"None";"376.48";"0";"1.92";"4c";"C=CS(=O)(=O)N[C@@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"23.70";"0.47";"7.00";"8.24";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4645440";"";"None";"376.48";"0";"1.92";"4d";"C=CS(=O)(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"20.78";"0.41";"5.90";"7.22";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4634526";"";"None";"324.38";"0";"1.21";"4j";"C#CC(=O)N[C@@H]1CCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"25.10";"0.46";"6.93";"8.93";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4649284";"";"None";"324.38";"0";"1.53";"4m";"C#CC(=O)N1CC[C@H](Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"24.75";"0.46";"6.50";"8.80";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"15.84";"0.29";"2.76";"7.04";"0";"CHEMBL4616762";"Inhibition of BTK in human whole blood cells after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5a; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"25.71";"0.48";"7.39";"10.44";"0";"CHEMBL4616773";"Inhibition of BTK in human PBMC assessed as reduction in TNFalpha expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308021";"";"";""
"CHEMBL31965";"CANERTINIB";"3.0";"485.95";"0";"4.39";"Cl-1033";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1";"IC50";"'='";"185.0";"nM";"6.73";"";"";"UO_0000065";"13.85";"0.27";"2.34";"7.60";"0";"CHEMBL1026513";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154498";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4755977";"";"None";"551.60";"1";"4.35";"21";"COc1cc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2cc1NC(=O)C#CCCN1CCOCC1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"15.95";"0.29";"4.45";"7.65";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3702841";"";"None";"636.73";"2";"5.09";"BDBM143193";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N(C1CC1)C1COC1";"IC50";"'='";"26.0";"nM";"7.58";"";"279413";"UO_0000065";"11.91";"0.22";"2.50";"5.60";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3979968";"";"None";"637.72";"1";"4.17";"BDBM143205";"CN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"279423";"UO_0000065";"13.99";"0.26";"4.75";"6.09";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3904226";"";"None";"687.80";"2";"3.98";"BDBM143206";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(S(C)(=O)=O)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"279424";"UO_0000065";"12.87";"0.25";"4.87";"5.41";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647519";"";"None";"576.64";"1";"3.92";"BDBM143321";"C=CC(=O)N1CC2(CC(n3nc(-c4ccc(-c5cnc(Cc6ccccc6)n(C)c5=O)cc4F)c4c(N)ncnc43)C2)C1";"IC50";"'='";"0.85";"nM";"9.07";"";"279481";"UO_0000065";"15.73";"0.29";"5.15";"7.27";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3586447";"";"None";"318.34";"0";"2.16";"11";"Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"16.96";"0.31";"3.24";"4.37";"0";"CHEMBL3588253";"Inhibition of BTK in human Raji cells after 30 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Raji";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585313";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307663";"";"";""
"CHEMBL3402576";"";"None";"506.54";"1";"4.84";"4o";"Cn1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)n1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"14.65";"0.27";"2.58";"7.30";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402581";"";"None";"507.57";"1";"4.81";"4t";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCNCC4)cc23)c1CO";"IC50";"'='";"96.5";"nM";"7.01";"";"";"UO_0000065";"13.82";"0.25";"2.21";"7.32";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL4100369";"";"None";"497.00";"0";"4.84";"7a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N(CCOC)CCOC)cc3)ncc2Cl)c1";"IC50";"'='";"4.94";"nM";"8.31";"";"";"UO_0000065";"16.71";"0.32";"3.47";"8.25";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4082353";"";"None";"480.54";"0";"4.33";"7b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N(CCOC)CCOC)cc3)ncc2F)c1";"IC50";"'='";"7.12";"nM";"8.15";"";"";"UO_0000065";"16.95";"0.32";"3.82";"8.10";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.34";"nM";"9.47";"";"";"UO_0000065";"21.49";"0.39";"5.25";"9.55";"1";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3657214";"";"None";"294.36";"0";"3.53";"BDBM134219";"Nc1n[nH]c2cncc(-c3ccc(OC4CCCC4)cc3)c12";"IC50";"'='";"9490.0";"nM";"5.02";"";"267608";"UO_0000065";"17.06";"0.31";"1.49";"6.54";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3941568";"";"None";"610.69";"1";"4.73";"BDBM143191";"CN(C1COC1)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.6";"nM";"9.22";"";"279411";"UO_0000065";"15.10";"0.28";"4.49";"6.81";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3975094";"";"None";"476.58";"1";"5.10";"BDBM249212";"Cn1cc(-c2cc(-c3ccc(CN4Cc5cc(C(C)(C)C)sc5C4=O)c(F)c3)cc(=O)[nH]2)cn1";"IC50";"'='";"7.11";"nM";"8.15";"";"434810";"UO_0000065";"17.10";"0.33";"3.05";"11.48";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4078497";"";"None";"579.58";"1";"4.39";"10";"CC1(C(=O)N2CCC(c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC2)COC1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"14.61";"0.28";"4.08";"6.63";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3902180";"";"None";"539.64";"1";"3.92";"BDBM191611";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)/C=C/CN2CCOCC2)C1";"IC50";"'='";"5.6";"nM";"8.25";"";"385039";"UO_0000065";"15.29";"0.28";"4.33";"7.39";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951652";"";"None";"608.71";"2";"6.05";"BDBM202211";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5CCOCC5)CC4)cc23)c1CO";"IC50";"'='";"3.4";"nM";"8.47";"";"358287";"UO_0000065";"13.91";"0.26";"2.42";"9.31";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891695";"";"None";"574.69";"2";"5.38";"BDBM202118";"CCN1CC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)C1";"IC50";"'='";"7.0";"nM";"8.15";"";"358196";"UO_0000065";"14.19";"0.26";"2.77";"8.20";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965546";"";"None";"616.74";"2";"7.20";"BDBM202152";"CN1CCCC(F)(c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cc2)C1";"IC50";"'='";"3.5";"nM";"8.46";"";"358229";"UO_0000065";"13.71";"0.25";"1.26";"10.35";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2151321";"";"None";"381.42";"0";"3.64";"2c";"CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"22.17";"0.41";"4.82";"9.04";"0";"CHEMBL2154705";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150905";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3621515";"";"None";"483.57";"0";"3.74";"25";"CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1C";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"16.12";"0.30";"4.06";"6.99";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622200";"";"None";"481.38";"0";"4.78";"44";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccc(Cl)c(Cl)c4)cc23)CC1";"IC50";"'='";"812.0";"nM";"6.09";"";"";"UO_0000065";"12.65";"0.25";"1.31";"7.39";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4757041";"";"None";"582.56";"1";"3.80";"32";"CN1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)CC[C@H]2C1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"13.38";"0.25";"4.00";"6.40";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL3747268";"";"None";"635.17";"2";"5.62";"18";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(Cl)c(NC(=O)c5cc6c(s5)CCCC6)c4F)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"12.67";"0.25";"2.43";"8.08";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3746848";"";"None";"607.74";"1";"4.70";"5";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(C#N)c(NC(=O)c5cc6c(s5)CCCC6)c4)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"9.63";"0.18";"1.15";"4.75";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL411632";"";"None";"415.38";"0";"3.89";"4";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1";"IC50";"'='";"3423.0";"nM";"5.47";"";"";"UO_0000065";"13.16";"0.25";"1.58";"4.97";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2010872";"CEP-11981";"2.0";"477.57";"0";"4.73";"11b, CEP-11981";"CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"14.72";"0.27";"2.30";"7.84";"0";"CHEMBL2016106";"Inhibition of human BTK using ATP as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010689";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3290132";"";"None";"390.45";"0";"3.71";"21";"CCC(=O)Nc1ccc(C)c(C(=O)Nc2cnc(Nc3cccc(N)c3)nc2)c1";"IC50";"'='";"8563.0";"nM";"5.07";"";"";"UO_0000065";"12.98";"0.24";"1.36";"4.15";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290143";"";"None";"574.56";"2";"6.57";"32";"C/C=C/C(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"12.96";"0.24";"0.87";"5.95";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3286434";"";"None";"582.97";"2";"6.23";"35";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(NC(=O)CCl)c2)nc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"13.42";"0.26";"1.59";"6.25";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4740933";"";"None";"509.59";"2";"5.70";"10";"C=CC(=O)N1CCC(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)C1";"IC50";"'='";"225.0";"nM";"6.65";"";"";"UO_0000065";"13.05";"0.24";"0.95";"7.31";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4762397";"";"None";"481.60";"1";"5.63";"4";"C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)c12";"IC50";"'='";"0.014";"nM";"10.85";"";"";"UO_0000065";"22.54";"0.41";"5.22";"11.93";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3942550";"";"None";"361.38";"0";"3.26";"16";"Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1Cc2ccccc2C1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"22.57";"0.41";"4.89";"9.08";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4754459";"";"None";"548.60";"1";"4.40";"5d";"COc1cccn2c(=O)n(-c3cccc(-c4ccc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)cc12";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"16.92";"0.31";"4.88";"7.04";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5i";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"16.34";"0.30";"4.24";"7.15";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6d; BMS-986143";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"11.48";"0.22";"1.05";"5.50";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6d; BMS-986143";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.23";"0.26";"2.08";"6.34";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4741884";"";"None";"518.57";"1";"4.39";"5b";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2ccccn2c1=O";"IC50";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"15.56";"0.28";"3.68";"6.58";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"1";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"12.46";"0.22";"0.94";"5.49";"1";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL4754459";"";"None";"548.60";"1";"4.40";"5d";"COc1cccn2c(=O)n(-c3cccc(-c4ccc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)cc12";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"12.49";"0.23";"2.45";"5.20";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL3932000";"";"None";"515.94";"2";"6.51";"7c";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CP(=O)(OCC)OCC)cc3)ncc2Cl)c1";"IC50";"'='";"1.23";"nM";"8.91";"";"";"UO_0000065";"17.27";"0.35";"2.40";"7.78";"0";"CHEMBL3874808";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells measured after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872267";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308860";"";"";""
"CHEMBL3946923";"";"None";"556.62";"2";"6.05";"BDBM200756";"Cc1c(NC(=O)c2ccc(C3(F)CC3)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"1.0";"nM";"9.00";"";"356839";"UO_0000065";"16.17";"0.30";"2.95";"9.55";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908775";"";"None";"572.71";"2";"6.28";"BDBM200765";"Cc1c(NC(=O)c2cc3c(s2)CCC(C)C3)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"5.0";"nM";"8.30";"";"356841";"UO_0000065";"14.49";"0.28";"2.02";"8.81";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948911";"";"None";"556.64";"2";"5.88";"BDBM200772";"Cc1c(NC(=O)c2ccc(OC(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"15.0";"nM";"7.82";"";"356848";"UO_0000065";"14.06";"0.26";"1.94";"7.56";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972813";"";"None";"610.61";"2";"5.87";"BDBM200784";"Cc1c(NC(=O)c2ccc(C(C)(O)C(F)(F)F)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"6.0";"nM";"8.22";"";"356856";"UO_0000065";"13.46";"0.26";"2.35";"7.18";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926072";"";"None";"534.60";"2";"5.73";"BDBM200819";"Cc1c(NC(=O)c2ccc(C3CC3)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)CC#N)CC3)cc12";"IC50";"'='";"4.0";"nM";"8.40";"";"356871";"UO_0000065";"15.71";"0.29";"2.67";"7.32";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968367";"";"None";"549.65";"1";"4.87";"BDBM200888";"Cc1c(-c2ncnc3[nH]c(C4=CCN(C(=O)N(C)C)CC4)cc23)ccc(F)c1NC(=O)N1CC(OC(C)(C)C)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"356901";"UO_0000065";"15.83";"0.30";"3.83";"8.15";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"31a; BGB-3111";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"19.16";"0.35";"4.82";"8.82";"0";"CHEMBL4414913";"Inhibition of human BTK using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3924979";"";"None";"567.55";"2";"5.04";"BDBM255295";"Nc1nccn2c([C@H]3CC[C@@H]4CCCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.095";"nM";"10.02";"";"445200";"UO_0000065";"17.66";"0.33";"4.98";"8.46";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3958000";"";"None";"584.72";"2";"6.27";"BDBM202106";"Cc1c(-c2ncnc3[nH]c(-c4ccc(N5CCN(C)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"21.0";"nM";"7.68";"";"358184";"UO_0000065";"13.13";"0.24";"1.41";"9.90";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647969";"";"None";"438.49";"0";"3.66";"BDBM97674";"C#CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"214872";"UO_0000065";"20.85";"0.38";"5.48";"9.22";"1";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3669312";"";"None";"426.48";"0";"3.83";"BDBM98655";"C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"214876";"UO_0000065";"20.45";"0.37";"4.89";"8.80";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3945408";"";"None";"575.04";"1";"4.90";"BDBM230126";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"0.26";"nM";"9.59";"";"401990";"UO_0000065";"16.67";"0.32";"4.69";"7.15";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926317";"";"None";"323.78";"0";"4.24";"BDBM195770";"CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348507";"UO_0000065";"18.94";"0.36";"1.89";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3946420";"";"None";"405.40";"1";"5.31";"BDBM195779";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc(F)cc(F)c4OC)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348516";"UO_0000065";"15.12";"0.28";"0.82";"9.15";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3976245";"";"None";"264.29";"0";"2.75";"BDBM195806";"C=CC(=O)Nc1cccc(-c2cnc3[nH]ccc3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348524";"UO_0000065";"23.20";"0.42";"3.38";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3915825";"";"None";"295.73";"0";"3.46";"BDBM195769";"C#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348506";"UO_0000065";"20.73";"0.40";"2.67";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4110614";"";"None";"539.64";"1";"3.92";"BDBM191628";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)/C=C/CN2CCOCC2)C1";"IC50";"'='";"0.89";"nM";"9.05";"";"342666";"UO_0000065";"16.77";"0.31";"5.13";"8.11";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4754065";"";"None";"461.60";"0";"4.61";"21";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"21.01";"0.40";"5.09";"9.94";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4647100";"";"None";"443.19";"None";"None";"14l";"C=CC(=O)Nc1cccc(Nc2nc(Nc3cccc(B(O)O)c3)ncc2C(F)(F)F)c1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"18.47";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4086354";"";"None";"600.69";"2";"6.54";"3i";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c1CO";"IC50";"'='";"18.1";"nM";"7.74";"";"";"UO_0000065";"12.89";"0.23";"1.20";"9.29";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4093393";"";"None";"531.59";"2";"6.72";"3d";"COc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1";"IC50";"'='";"27.3";"nM";"7.56";"";"";"UO_0000065";"14.23";"0.26";"0.84";"9.44";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4081221";"";"None";"517.56";"2";"6.42";"3c";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]c(-c4ccc(O)cc4)cc23)c1CO";"IC50";"'='";"39.8";"nM";"7.40";"";"";"UO_0000065";"14.30";"0.26";"0.98";"8.12";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400977";"";"None";"517.56";"2";"5.69";"4e";"Nc1cccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)c1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"13.89";"0.25";"1.50";"6.54";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3657222";"";"None";"450.54";"1";"6.70";"BDBM134227";"CC(C)COc1cccc(-c2ncc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c23)c1";"IC50";"'='";"14000.0";"nM";"4.85";"";"267616";"UO_0000065";"10.77";"0.19";"-1.85";"5.64";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4082346";"";"None";"497.56";"0";"2.81";"6";"Cn1cc(-c2cccc(N3CCc4c(nc5n4CCCC5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"16700.0";"nM";"4.78";"";"";"UO_0000065";"9.60";"0.18";"1.97";"4.04";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4077625";"";"None";"495.58";"0";"4.54";"12";"Cn1cc(-c2cccc(N3Cc4cc(C(C)(C)C)ccc4C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"17.20";"0.31";"3.98";"8.49";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3936224";"";"None";"403.46";"0";"4.24";"BDBM249203";"CC(C)(C)c1cc(F)c2c(=O)n(Cc3ccc(-c4cc[nH]c(=O)c4)cc3)ncc2c1";"IC50";"'='";"3319.09";"nM";"5.48";"";"434801";"UO_0000065";"13.58";"0.25";"1.24";"8.09";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896294";"";"None";"369.38";"0";"3.77";"BDBM249932";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c1cnccc12";"IC50";"'='";"140.0";"nM";"6.85";"";"435864";"UO_0000065";"18.56";"0.33";"3.08";"6.97";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949761";"";"None";"464.53";"1";"5.04";"BDBM249943";"C=CC(=O)Nc1ccc2c(c1)CCCc1c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn1-2";"IC50";"'='";"4.1";"nM";"8.39";"";"435875";"UO_0000065";"18.06";"0.33";"3.35";"8.45";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3953494";"";"None";"458.52";"0";"2.62";"BDBM249979";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(OCc5ccccn5)cc4)nn32)C1";"IC50";"'='";"18.0";"nM";"7.75";"";"435908";"UO_0000065";"16.89";"0.31";"5.12";"6.71";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916800";"";"None";"445.52";"0";"3.88";"BDBM249983";"C=CC(=O)NC(C)(C)C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"41.0";"nM";"7.39";"";"435912";"UO_0000065";"16.58";"0.31";"3.51";"6.64";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958729";"";"None";"643.56";"2";"5.57";"BDBM200885";"Cc1c(NC(=O)N2CC(OC(C(F)(F)F)C(F)(F)F)C2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"8.0";"nM";"8.10";"";"356898";"UO_0000065";"12.58";"0.25";"2.53";"7.59";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912412";"";"None";"493.57";"0";"4.76";"BDBM249883";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCc4ccccc4)cc3)nn21";"IC50";"'='";"1.5";"nM";"8.82";"";"435801";"UO_0000065";"17.88";"0.33";"4.06";"7.93";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977070";"";"None";"429.48";"0";"2.88";"BDBM249959";"C=CC(=O)N1CC2(CNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3C2)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"435891";"UO_0000065";"18.15";"0.33";"4.92";"7.61";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955425";"";"None";"513.99";"2";"5.62";"BDBM249970";"C=CC(=O)Nc1ccc(Cl)c(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"435899";"UO_0000065";"14.64";"0.28";"1.90";"6.76";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4113487";"";"None";"597.57";"2";"5.05";"BDBM255410";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(F)cnc(N)c12";"IC50";"'='";"0.99";"nM";"9.00";"";"445317";"UO_0000065";"15.07";"0.29";"3.95";"7.05";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110276";"";"None";"615.56";"2";"5.19";"BDBM255418";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(F)cnc(N)c12";"IC50";"'='";"3.7";"nM";"8.43";"";"445325";"UO_0000065";"13.70";"0.26";"3.24";"6.60";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111703";"";"None";"650.58";"2";"5.27";"BDBM255464";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(C(F)(F)F)cnc(N)c12";"IC50";"'='";"4.0";"nM";"8.40";"";"445371";"UO_0000065";"12.91";"0.25";"3.13";"6.33";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3702834";"";"None";"623.74";"1";"4.47";"BDBM143183";"CN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H]2Cn2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)CC1";"IC50";"'='";"3.8";"nM";"8.42";"";"279405";"UO_0000065";"13.50";"0.25";"3.95";"6.51";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3918726";"";"None";"651.79";"2";"5.42";"BDBM143202";"CC(C)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"0.7";"nM";"9.15";"";"279420";"UO_0000065";"14.05";"0.26";"3.73";"7.07";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4108697";"";"None";"498.01";"0";"3.73";"BDBM235156";"NC(=O)c1nc(N2CCC[C@@H](NC(=O)N3Cc4ccc(Cl)cc4C3)C2)sc1Nc1ccccn1";"IC50";"'='";"7735.2";"nM";"5.11";"";"409808";"UO_0000065";"10.26";"0.21";"1.38";"4.39";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982806";"";"None";"637.71";"2";"5.05";"15";"CC1(O)CN(C(=O)N2CC=C(c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)CC2)C1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"14.05";"0.26";"3.91";"7.33";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4215147";"";"None";"588.73";"1";"4.85";"44";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(CNCC(C)(C)CO)ccc31)C2";"IC50";"'='";"0.66";"nM";"9.18";"";"";"UO_0000065";"15.59";"0.30";"4.33";"7.31";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4214683";"";"None";"498.61";"0";"4.86";"149";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4ccnc(C)n4)s3)nc3ccccc31)C2";"IC50";"'='";"0.68";"nM";"9.17";"";"";"UO_0000065";"18.39";"0.35";"4.31";"9.86";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3948209";"";"None";"596.78";"2";"6.82";"BDBM202085";"CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCc7cc(C8CC8)ccc7C6=O)c5C)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"358163";"UO_0000065";"12.38";"0.22";"0.57";"10.81";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4202618";"";"None";"520.70";"2";"5.01";"13";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3cncs3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"16.79";"0.32";"3.73";"9.49";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4206487";"";"None";"569.72";"2";"6.55";"15";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C(F)F)s3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"14.67";"0.29";"1.81";"10.54";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4208358";"";"None";"491.55";"0";"4.88";"57";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(F)ccc31)C2";"IC50";"'='";"1.09";"nM";"8.96";"";"";"UO_0000065";"18.23";"0.35";"4.08";"9.61";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4207292";"";"None";"498.61";"0";"4.73";"128";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4ccnc(N)c4)s3)nc3ccccc31)C2";"IC50";"'='";"0.63";"nM";"9.20";"";"";"UO_0000065";"18.45";"0.35";"4.47";"8.67";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"13.38";"nM";"7.87";"";"";"UO_0000065";"16.88";"0.31";"3.52";"11.34";"0";"CHEMBL4145854";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145442";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4163217";"";"None";"489.53";"1";"5.41";"23";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc6c(c5)OCCO6)cc4c32)ccc1C";"IC50";"'='";"16.3";"nM";"7.79";"";"";"UO_0000065";"15.91";"0.29";"2.38";"9.45";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4555459";"";"None";"481.60";"1";"5.59";"43";"O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.71";"0.31";"2.46";"9.02";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4448363";"";"None";"481.60";"1";"5.59";"41, Mixture of enantiomer";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"15.99";"0.29";"2.11";"8.63";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4542554";"";"None";"430.49";"1";"5.13";"30";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1F";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"14.64";"0.27";"1.17";"7.33";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4589916";"";"None";"433.54";"0";"4.14";"22";"O=S(=O)(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)c1ccccc1";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"10.89";"0.21";"0.58";"5.19";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4448573";"";"None";"397.48";"0";"4.59";"21";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)c1ccccc1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"13.36";"0.24";"0.72";"7.18";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4444491";"";"None";"372.43";"0";"4.26";"9";"O=C(Nc1ccccc1)Nc1cccc(CCNc2ncnc3[nH]ccc23)c1";"IC50";"'='";"8300.0";"nM";"5.08";"";"";"UO_0000065";"13.64";"0.25";"0.82";"5.36";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4576203";"";"None";"338.42";"0";"3.36";"6";"O=C(NCCCCCNc1ncnc2[nH]ccc12)Nc1ccccc1";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"14.17";"0.26";"1.44";"5.06";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3810080";"";"None";"395.46";"0";"2.28";"I7";"C=CC(=O)N1CCC[C@@H](Nc2ncnc(N)c2C(=O)c2ccc(OCC)cc2)C1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"14.53";"0.27";"3.46";"5.20";"0";"CHEMBL3813051";"Inhibition of BTK (unknown origin) assessed as reduction in phosphorylation of coumarin and fluorescein-labeled FRET peptide substrate incubated for 1 hr by Z-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL2057920";"";"None";"581.73";"1";"3.61";"31";"CC(C)(C)c1ccc(C(=O)N[C@@H]2CCCN(c3nc(Nc4ccc(C(=O)N5CCNCC5)cc4)c4nccn4n3)C2)cc1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"13.56";"0.25";"4.28";"6.58";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3919260";"";"None";"309.76";"0";"3.85";"BDBM195768";"CC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348505";"UO_0000065";"19.79";"0.38";"2.28";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3967741";"";"None";"306.37";"0";"3.84";"BDBM195800";"CC/C=C/C(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348523";"UO_0000065";"20.01";"0.36";"2.29";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4461455";"";"None";"423.47";"1";"6.04";"A5";"C=CC(=O)Nc1cccc(Oc2ccnc(N)c2-c2ccc(Oc3ccccc3)cc2)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.60";"0.35";"2.26";"9.60";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4542934";"";"None";"415.50";"0";"4.15";"A11";"C=CC(=O)N[C@@H]1CC[C@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"18.48";"0.34";"3.53";"7.52";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4586433";"";"None";"415.50";"0";"4.11";"A17";"C=CC(=O)N1CCC(Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"1510.0";"nM";"5.82";"";"";"UO_0000065";"14.01";"0.26";"1.71";"6.23";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4476695";"";"None";"445.52";"0";"3.47";"A19";"C=CC(=O)N1CCC(O)(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"18.47";"0.34";"4.76";"7.24";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4539748";"";"None";"447.51";"0";"4.49";"A22";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccc(F)cc3)cc2)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"15.25";"0.28";"2.33";"7.31";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4459438";"";"None";"465.58";"0";"4.12";"A28";"C=CS(=O)(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"19.54";"0.38";"4.98";"8.24";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4466205";"";"None";"423.52";"1";"5.85";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3ccccc32)C1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.90";"0.41";"3.85";"20.48";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4528630";"";"None";"424.46";"1";"5.43";"A3";"C=CC(=O)Nc1cccc(Oc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)c1";"IC50";"'='";"9.9";"nM";"8.00";"";"";"UO_0000065";"18.86";"0.34";"2.57";"8.06";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3670079";"";"None";"520.60";"1";"3.75";"BDBM111936";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)cccc1N1CCn2c(cc3ccccc32)C1=O";"IC50";"'='";"22.9";"nM";"7.64";"";"232991";"UO_0000065";"14.68";"0.27";"3.89";"7.34";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670093";"";"None";"558.61";"1";"3.49";"BDBM111950";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2cc3n(n2)CCOC3)c1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"233005";"UO_0000065";"14.86";"0.28";"4.81";"7.79";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3647964";"";"None";"440.51";"0";"4.22";"BDBM97669";"C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"214878";"UO_0000065";"20.10";"0.37";"4.63";"8.93";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3290118";"";"None";"491.47";"1";"6.05";"7";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccccc2)nc1";"IC50";"'='";"133.0";"nM";"6.88";"";"";"UO_0000065";"13.99";"0.26";"0.83";"7.16";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4794025";"";"None";"487.56";"0";"2.74";"19";"CN(C)C/C=C/C(=O)N(C)CCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)n[nH]c(=O)c21";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"15.29";"0.28";"4.72";"6.09";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4776688";"";"None";"521.58";"1";"4.18";"23";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"14.68";"0.27";"3.48";"5.36";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.75";"0.36";"4.48";"8.77";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4163399";"";"None";"432.48";"1";"5.03";"12";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cccnc5)cc4c32)ccc1C";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"16.05";"0.29";"1.91";"9.03";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4077107";"";"None";"447.50";"0";"4.62";"11";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(N)nc5)cc4c32)ccc1C";"IC50";"'='";"16.4";"nM";"7.79";"";"";"UO_0000065";"17.40";"0.31";"3.17";"7.57";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4068097";"";"None";"578.69";"2";"5.36";"28";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6ccc(S(=O)(=O)NC(C)(C)C)cc6)cc5c43)cc21";"IC50";"'='";"10.7";"nM";"7.97";"";"";"UO_0000065";"13.77";"0.26";"2.61";"7.86";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4113636";"";"None";"593.61";"2";"5.30";"38";"CC(C)Oc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"13.89";"0.26";"2.94";"6.45";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4106651";"";"None";"521.55";"1";"4.99";"29";"Nc1nccn2c([C@@H]3CC[C@H]4CCCN4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"14.21";"0.27";"2.42";"7.30";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4110264";"";"None";"599.56";"2";"5.62";"43";"CC(F)(F)c1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"831.0";"nM";"6.08";"";"";"UO_0000065";"10.14";"0.19";"0.46";"5.13";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4106978";"";"None";"535.53";"1";"4.51";"4";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"16.06";"0.30";"4.09";"7.26";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4106651";"";"None";"521.55";"1";"4.99";"29";"Nc1nccn2c([C@@H]3CC[C@H]4CCCN4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"204.0";"nM";"6.69";"";"";"UO_0000065";"12.83";"0.24";"1.70";"6.60";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL3402575";"";"None";"492.51";"0";"4.83";"4n";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(-c4cc[nH]n4)cc23)c1CO";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"14.88";"0.27";"2.50";"6.51";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL4796367";"";"None";"433.56";"0";"4.12";"25";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(CC(C)C)C1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"14.27";"0.26";"2.07";"7.03";"0";"CHEMBL4701077";"Inhibition of BTK in human whole blood assessed as reduction in BTK phosphorylation measured after 30 mins by phosphotyrosine detection method";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3263637";"";"None";"604.76";"2";"5.92";"17";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)NCCN(C)C)cc2)c2ncn(C)c2n1";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"11.67";"0.21";"1.14";"6.03";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263645";"";"None";"647.74";"2";"5.65";"25";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2ncn(CC(=O)O)c2n1";"IC50";"'='";"970.0";"nM";"6.01";"";"";"UO_0000065";"9.28";"0.17";"0.36";"3.97";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263649";"";"None";"595.75";"2";"6.34";"29";"Cc1c(NC(=O)C2CCC(C(C)(C)C)CC2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"12.58";"0.23";"1.15";"5.99";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL4640192";"";"None";"456.19";"None";"None";"16b";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc4c(c3)COB4O)ncc2C(F)(F)F)c1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"17.95";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4066104";"";"None";"625.69";"2";"5.53";"41; CHMFL-BMX-078";"C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C";"IC50";"'='";"437.0";"nM";"6.36";"";"";"UO_0000065";"10.16";"0.19";"0.83";"3.86";"0";"CHEMBL4008337";"Inhibition of full-length recombinant human His-tagged BTK expressed in baculovirus expression system using Poly(4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo kinase assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007402";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4062634";"";"None";"652.80";"2";"3.43";"19";"COCCN1CCN(c2ccc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"36.6";"nM";"7.44";"";"";"UO_0000065";"11.39";"0.21";"4.01";"6.15";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4097832";"";"None";"666.83";"2";"3.82";"20";"COCCCN1CCN(c2ccc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"32.2";"nM";"7.49";"";"";"UO_0000065";"11.24";"0.21";"3.67";"6.19";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"29; GDC-0853";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"12.80";"0.24";"4.94";"7.03";"0";"CHEMBL4023750";"Inhibition of anti-IgM-induced BTK phosphorylation at Y233 in human primary B cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4082411";"";"None";"562.56";"1";"4.61";"17";"Cn1nnc([C@H]2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.76";"0.28";"3.69";"5.85";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4066585";"";"None";"497.48";"0";"3.48";"7";"Nc1nccn2c(CN3CCOCC3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"1225.0";"nM";"5.91";"";"";"UO_0000065";"11.88";"0.22";"2.43";"5.34";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4062498";"";"None";"573.51";"1";"3.33";"25";"COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"0.37";"nM";"9.43";"";"";"UO_0000065";"16.45";"0.31";"6.10";"6.89";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4217692";"";"None";"462.56";"1";"6.31";"1";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3ccnc(Nc4ccc5cn[nH]c5c4)n3)c2)cc1";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"11.10";"0.20";"-1.17";"5.37";"0";"CHEMBL4182608";"Inhibition of BTK (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4210336";"";"None";"497.53";"0";"4.02";"18g";"Cn1ccc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)n1";"IC50";"'='";"13.9";"nM";"7.86";"";"";"UO_0000065";"15.79";"0.29";"3.84";"6.34";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3358401";"";"None";"589.70";"1";"4.01";"16g";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)ncc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"255.0";"nM";"6.59";"";"";"UO_0000065";"11.18";"0.20";"2.58";"6.08";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4239747";"";"None";"427.50";"0";"4.75";"5";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1C";"IC50";"'='";"7.1";"nM";"8.15";"";"";"UO_0000065";"19.06";"0.35";"3.40";"7.53";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3290142";"";"None";"560.54";"2";"6.18";"31";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"14.01";"0.26";"1.67";"6.28";"0";"CHEMBL3292448";"Inhibition of Btk phosphorylation at Tyr551 in human Ramos cells after 1 hr by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307664";"";"";""
"CHEMBL4549626";"";"None";"554.66";"1";"4.20";"45";"C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4ccnc(NC)c4)c23)CC1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"13.42";"0.25";"3.24";"6.18";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3605109";"";"None";"426.50";"1";"5.86";"14i";"CC(=O)n1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"454.2";"nM";"6.34";"";"";"UO_0000065";"14.87";"0.28";"0.48";"7.64";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4483575";"REMIBRUTINIB";"3.0";"507.54";"1";"4.47";"25; LOU064";"C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"15.26";"0.29";"3.27";"7.01";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4550284";"";"None";"521.57";"1";"4.86";"26";"C=CC(=O)N(C)CCCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.90";"0.28";"2.91";"7.04";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4471613";"";"None";"505.53";"1";"3.91";"30";"C#CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"16.20";"0.30";"4.28";"7.41";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4557061";"";"None";"493.51";"0";"4.12";"18";"C=CC(=O)NCCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"14.14";"0.26";"2.86";"5.85";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4445790";"";"None";"533.58";"1";"5.00";"20";"C=CC(=O)N1CCC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3F)c2C)CC1";"IC50";"'='";"201.0";"nM";"6.70";"";"";"UO_0000065";"12.55";"0.23";"1.70";"6.06";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3358407";"";"None";"590.70";"2";"5.57";"16m";"Cc1c(-c2cc(Nc3ccc(N4CCN(C)CC4)cn3)c(=O)n(C)c2)cccc1-n1ccc2cc(C3CC3)cc(F)c2c1=O";"IC50";"'='";"365.0";"nM";"6.44";"";"";"UO_0000065";"10.90";"0.20";"0.87";"8.54";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3621497";"";"None";"442.52";"0";"3.48";"7";"COc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"16.94";"0.31";"4.01";"8.18";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621517";"";"None";"448.47";"0";"3.75";"27";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cc(F)ccc4F)c23)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"17.38";"0.32";"4.05";"9.46";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL2179805";"";"None";"523.64";"2";"5.11";"41, PF-06465469";"C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc(C(=O)Nc4ccc(C(C)C)c(C)c4)c3)c3c(N)ncnc32)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.61";"0.30";"3.59";"7.31";"0";"CHEMBL2185026";"Inhibition of BTK in presence of 50 uM ATP";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177048";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4103618";"";"None";"302.74";"0";"3.88";"2";"Fc1cccc(Cl)c1CNc1nc(-c2ccccc2)n[nH]1";"IC50";"'='";"1380.0";"nM";"5.86";"";"";"UO_0000065";"19.36";"0.38";"1.98";"10.93";"0";"CHEMBL4020190";"Inhibition of human N-terminal His-tagged BTK expressed in bacmid transfected Sf21 insect cells using TK-substrate-biotin after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4073371";"";"None";"331.78";"0";"3.92";"5";"CNc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1";"IC50";"'='";"271.0";"nM";"6.57";"";"";"UO_0000065";"19.79";"0.39";"2.65";"10.01";"0";"CHEMBL4020190";"Inhibition of human N-terminal His-tagged BTK expressed in bacmid transfected Sf21 insect cells using TK-substrate-biotin after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3957182";"";"None";"588.71";"2";"5.77";"BDBM202193";"CC(C)N1CC(n2cnc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)c2)C1";"IC50";"'='";"7.0";"nM";"8.15";"";"358270";"UO_0000065";"13.85";"0.25";"2.38";"8.20";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921953";"";"None";"637.71";"2";"5.32";"BDBM202203";"O=C(N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1)N1CCOCC1";"IC50";"'='";"1.7";"nM";"8.77";"";"358279";"UO_0000065";"13.75";"0.25";"3.45";"7.88";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4779219";"";"None";"419.49";"0";"3.22";"B30";"C=CC(=O)N1CCC(CCn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'='";"77040.0";"nM";"4.11";"";"";"UO_0000065";"9.81";"0.18";"0.89";"4.31";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4798432";"";"None";"453.55";"0";"4.90";"B27";"C=CC(=O)N1CCC[C@H](Cn2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1710.0";"nM";"5.77";"";"";"UO_0000065";"12.72";"0.23";"0.87";"6.68";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4755698";"";"None";"405.46";"0";"2.83";"B16";"C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'='";"21700.0";"nM";"4.66";"";"";"UO_0000065";"11.50";"0.21";"1.83";"4.88";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL3402578";"";"None";"497.53";"0";"4.14";"4q";"CN(C)C(=O)c1cc2c(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)ncnc2[nH]1";"IC50";"'='";"1357.0";"nM";"5.87";"";"";"UO_0000065";"11.79";"0.22";"1.73";"5.64";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402582";"";"None";"521.60";"2";"5.16";"4u";"CN1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"125.0";"nM";"6.90";"";"";"UO_0000065";"13.23";"0.24";"1.74";"7.93";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3652651";"";"None";"584.65";"1";"4.57";"BDBM122412";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccc(C(C)(C)O)cc5)n4)c3CO)ncc2c1";"IC50";"'='";"91.54";"nM";"7.04";"";"250992";"UO_0000065";"12.04";"0.22";"2.47";"4.75";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4758840";"";"None";"513.60";"1";"3.44";"21";"CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"16.72";"0.31";"5.15";"7.02";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3928872";"";"None";"597.72";"2";"7.14";"BDBM202157";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCCCC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"171.0";"nM";"6.77";"";"358234";"UO_0000065";"11.32";"0.21";"-0.37";"7.40";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3402570";"";"None";"613.69";"2";"6.73";"4i";"O=C(c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1)N1CCCCC1";"IC50";"'='";"50.8";"nM";"7.29";"";"";"UO_0000065";"11.89";"0.22";"0.56";"7.01";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402573";"";"None";"573.63";"2";"5.81";"4l";"CN(C)C(=O)c1cccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)c1";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"12.48";"0.23";"1.35";"6.88";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402582";"";"None";"521.60";"2";"5.16";"4u";"CN1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"57.1";"nM";"7.24";"";"";"UO_0000065";"13.89";"0.25";"2.08";"8.32";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"3, RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"13.2";"nM";"7.88";"";"";"UO_0000065";"12.99";"0.24";"3.12";"8.24";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402569";"";"None";"615.66";"2";"5.58";"4h";"O=C(c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1)N1CCOCC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"12.99";"0.24";"2.42";"7.06";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL4749037";"";"None";"537.50";"1";"4.34";"3";"Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"13.85";"0.26";"3.10";"5.83";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4108825";"";"None";"569.52";"1";"3.89";"31";"Nc1nccn2c([C@@H]3CC[C@H]4COCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"12.48";"0.24";"3.22";"5.56";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4111338";"";"None";"601.54";"2";"5.11";"35";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC(F)F)c12";"IC50";"'='";"415.0";"nM";"6.38";"";"";"UO_0000065";"10.61";"0.20";"1.27";"5.00";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4865369";"";"None";"472.48";"0";"3.53";"6";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5nc(C6(C)CC6)no5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"19.89";"0.37";"5.87";"7.38";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4877846";"";"None";"566.71";"2";"6.56";"30";"Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"16.58";"0.31";"2.84";"7.38";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4850235";"";"None";"474.50";"0";"3.78";"5";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5nc(C(C)(C)C)no5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"15.57";"0.29";"3.61";"5.80";"0";"CHEMBL4822449";"Inhibition of BTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4857217";"";"None";"482.56";"1";"5.39";"4";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"151.0";"nM";"6.82";"";"";"UO_0000065";"14.14";"0.26";"1.43";"7.71";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4872092";"";"None";"580.69";"2";"5.64";"25";"Cc1nn(C2CCOCC2)cc1-c1nc2c(-c3ccc4c(c3)CCC[C@@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"12.16";"0.22";"1.42";"5.17";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"2.25";"nM";"8.65";"";"";"UO_0000065";"14.25";"0.26";"3.89";"9.04";"0";"CHEMBL4822489";"Inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3647966";"";"None";"426.48";"0";"3.83";"BDBM97671";"C=CC(=O)N1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"327860";"UO_0000065";"20.62";"0.38";"4.97";"8.87";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3685421";"";"None";"299.72";"0";"2.80";"BDBM120744";"C=CC(=O)Nc1cccc(-c2nc(Cl)nc3n[nH]cc23)c1";"IC50";"'='";"3770.0";"nM";"5.42";"";"248813";"UO_0000065";"18.10";"0.35";"2.62";"6.49";"0";"CHEMBL3705216";"Time Resolved-FRET Assay: Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay. Test compound are diluted to desired concentrations in kinase reaction buffer and briefly incubated with BTK kinase (as described above; Invitrogen). The reaction is initiated by the addition of ATP and enzyme substrate, HTRF® KinEASE-TK Substrate-biotin (Cisbio US, Bedford, Mass.). The composition of the reaction (10 μl) was: 1% v/v DMSO, 10 nM BTK, 60 μM ATP, and 1 μM substrate. After incubation at room temperature for 60 min, the enzyme reaction is stopped by EDTA-containing buffer, which also contains europium-labeled (Eu3+-Cryptate) anti-phosphotyrosine antibody (Cisbio) and Streptavidin-XL665 (Cisbio). The europium-labeled antibody generates a time-resolved FRET signal with the Stepavidin-XL665, which binds to the biotinylated TK substrate through the streptavidin conjugate when the substrate is phosphorylated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3670122";"";"None";"624.76";"2";"5.22";"BDBM111981";"CN1CCC(c2ccc(Nc3nc(-c4cc(F)cc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"233036";"UO_0000065";"12.48";"0.23";"2.58";"8.15";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670126";"";"None";"613.76";"2";"5.24";"BDBM111985";"CN1CC(c2ccc(Nc3nc(-c4cc(F)cc(N5CCc6c(sc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2)C1";"IC50";"'='";"5.3";"nM";"8.28";"";"233040";"UO_0000065";"13.48";"0.26";"3.04";"9.12";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670115";"";"None";"630.79";"1";"4.96";"BDBM111974";"CN(C)CCN(C)c1ccc(Nc2cc(-c3cc(F)cc(N4CCc5c(sc6c5CCCC6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"3.4";"nM";"8.47";"";"233029";"UO_0000065";"13.43";"0.26";"3.51";"9.01";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670116";"";"None";"627.79";"2";"5.98";"BDBM111975";"CN1CCCC1c1ccc(Nc2cc(-c3cc(F)cc(N4CCc5c(sc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"1.4";"nM";"8.85";"";"233030";"UO_0000065";"14.10";"0.27";"2.87";"9.76";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3290123";"";"None";"506.49";"2";"5.63";"12";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.51";"0.29";"2.22";"6.44";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290141";"";"None";"488.55";"1";"5.77";"30";"Cc1ccc(NC(=O)c2ccc3ccccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"15.17";"0.27";"1.64";"6.07";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290150";"";"None";"594.98";"2";"6.83";"40";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4ccc(Cl)c(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"13.38";"0.26";"1.13";"6.36";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4867619";"";"None";"532.60";"2";"5.40";"35";"Cc1c(NC(=O)c2ccccc2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"12.79";"0.23";"1.41";"6.07";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4868893";"";"None";"588.71";"2";"6.70";"38";"Cc1c(NC(=O)c2cccc(C(C)(C)C)c2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"709.0";"nM";"6.15";"";"";"UO_0000065";"10.45";"0.19";"-0.55";"5.48";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL493940";"";"None";"279.30";"0";"2.82";"12";"CNc1nc2oc(-c3ccccc3)nc2c2c1ncn2C";"IC50";"'='";"23000.0";"nM";"4.64";"";"";"UO_0000065";"16.61";"0.30";"1.82";"6.74";"0";"CHEMBL960929";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153345";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL454973";"";"None";"366.45";"0";"2.92";"36a";"CNc1nc2sc(-c3cccc(CNC(C)=O)c3)nc2c2c1ncn2C";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"13.02";"0.25";"1.85";"5.63";"0";"CHEMBL960929";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153345";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL4069186";"";"None";"622.73";"1";"4.92";"42";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)NCCOC";"IC50";"'='";"667.0";"nM";"6.18";"";"";"UO_0000065";"9.92";"0.18";"1.26";"4.62";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4075774";"";"None";"647.78";"2";"6.25";"11";"C=CC(=O)Nc1ccc(NC(=O)c2ccc(C(C)(C)C)cc2)c(C)c1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cc2)c(=O)n(C)c1";"IC50";"'='";"1697.0";"nM";"5.77";"";"";"UO_0000065";"8.91";"0.16";"-0.48";"4.74";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4063526";"";"None";"647.78";"2";"6.25";"10";"C=CC(=O)Nc1cc(C(=O)N2CCOCC2)ccc1Nc1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2C)cn(C)c1=O";"IC50";"'='";"231.0";"nM";"6.64";"";"";"UO_0000065";"10.24";"0.19";"0.39";"5.45";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4077123";"";"None";"647.78";"2";"6.25";"9; CHMFL-BTK-01";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"12.59";"0.23";"1.90";"6.70";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4076543";"";"None";"578.71";"2";"6.13";"6; CGI1746";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cc2)c(=O)n(C)c1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"13.27";"0.24";"1.55";"8.29";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL228043";"";"None";"360.01";"0";"3.51";"K00067, LFM-A13";"C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"15.56";"0.45";"2.09";"7.66";"0";"CHEMBL921720";"Inhibition of recombinant BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145498";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";""
"CHEMBL3621516";"";"None";"448.47";"0";"3.75";"26";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccc(F)cc4F)c23)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"17.07";"0.32";"3.91";"9.29";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4105560";"";"None";"601.61";"1";"3.99";"13";"CS(=O)(=O)NC(=O)[C@H]1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"14.83";"0.29";"4.93";"5.53";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4101367";"";"None";"510.48";"1";"4.61";"23";"Nc1nccn2c([C@@H]3CC[C@H](C(=O)O)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"17.82";"0.34";"4.49";"6.71";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4210972";"";"None";"553.60";"1";"3.96";"25e";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(C3(CO)CC3)c2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.31";"0.26";"3.96";"5.50";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3647964";"";"None";"440.51";"0";"4.22";"PCl-32765; 1";"C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"0";"CHEMBL4152868";"Inhibition of BTK (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4859382";"";"None";"408.50";"0";"1.98";"3";"C=CC(=O)N1CCC[C@H](CC(=O)N2Cc3[nH]c4ccccc4c3C[C@@H]2C(=O)NC)C1";"IC50";"'='";"4760.0";"nM";"5.32";"";"";"UO_0000065";"13.03";"0.24";"3.34";"6.22";"0";"CHEMBL4813334";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4064893";"";"None";"612.70";"2";"7.34";"3h";"O=C(c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1)N1CCCCC1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"12.11";"0.22";"0.08";"8.13";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4518667";"";"None";"481.50";"0";"4.04";"9c";"C=C(C)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"176.0";"nM";"6.75";"";"";"UO_0000065";"14.03";"0.26";"2.71";"5.80";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4548556";"";"None";"481.50";"0";"4.04";"9d";"C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"14.98";"0.28";"3.17";"6.19";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4456974";"";"None";"471.44";"0";"3.56";"20b";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(C(F)(F)F)n4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"14.9";"nM";"7.83";"";"";"UO_0000065";"16.60";"0.31";"4.27";"5.75";"0";"CHEMBL4385492";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human B cells assessed as reduction in cell proliferation pretreated for 30 mins followed by goat anti-human IgM F(ab')2-stimulation and measured after 3 days by [3H]-thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4560385";"";"None";"438.44";"0";"3.42";"9a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"16.41";"0.31";"3.77";"5.84";"0";"CHEMBL4385494";"Inhibition of BTK in human whole blood assessed as reduction in anti-human IgE antibody-stimulated histamine release pretreated for 2 hrs followed by anti-human IgE antibody-stimulation and measured after 30 mins by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4246409";"";"None";"456.50";"0";"3.74";"15";"C=CC(=O)N1C[C@H]2C[C@@H]1CN2c1ccc(C(N)=O)c(Oc2ccc(Oc3ccccc3)cc2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.35";"0.32";"4.18";"8.08";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL2057915";"";"None";"596.76";"2";"5.14";"2, GDC-0834";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@@H]3C(=O)N(C)CCN3C)cc2)n1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.78";"0.26";"3.08";"8.26";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401292";"";"None";"596.76";"2";"5.14";"32";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@H]3C(=O)N(C)CCN3C)cc2)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"12.90";"0.24";"2.56";"7.73";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401291";"";"None";"536.66";"2";"6.08";"31";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(-c3ncc[nH]3)cc2)n1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"13.60";"0.26";"1.22";"6.97";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401268";"";"None";"563.66";"2";"5.10";"8";"Cc1c(NC(=O)c2ccc(C3CC3)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"12.35";"0.23";"1.86";"6.59";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401266";"";"None";"566.66";"1";"4.29";"6";"Cc1c(NC(=O)c2ccc(N(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"11.71";"0.22";"2.35";"6.10";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4062247";"";"None";"548.53";"1";"4.60";"14";"Nc1nccn2c([C@@H]3CCC[C@H](c4nn[nH]n4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.96";"0.32";"4.70";"6.09";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4090257";"";"None";"564.53";"1";"4.76";"15";"Nc1nccn2c([C@@H]3CCC[C@H](c4noc(=O)[nH]4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"15.68";"0.29";"4.09";"5.64";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4082411";"";"None";"562.56";"1";"4.61";"17";"Cn1nnc([C@H]2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)n1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"16.39";"0.31";"4.61";"6.50";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4059473";"";"None";"550.54";"2";"5.32";"26";"Nc1nccn2c(C34CCC(C(=O)O)(CC3)CC4)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.08";"0.28";"2.98";"6.13";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4095276";"";"None";"538.53";"2";"5.39";"36";"CC1(C(=O)O)CCC(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)CC1";"IC50";"'='";"546.0";"nM";"6.26";"";"";"UO_0000065";"11.63";"0.22";"0.87";"4.62";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL2312646";"";"None";"477.44";"0";"4.57";"12";"CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1";"IC50";"'='";"25670.0";"nM";"4.59";"";"";"UO_0000065";"9.61";"0.20";"0.02";"5.59";"0";"CHEMBL2317786";"Inhibition of BTK (unknown origin) in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311250";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL4077588";"";"None";"583.59";"2";"5.14";"26";"Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"12.32";"0.23";"2.05";"6.49";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4059723";"";"None";"597.57";"1";"4.87";"19";"CC1(C(=O)N2CCO[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)CCC1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"12.48";"0.24";"2.59";"5.84";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4104951";"";"None";"617.61";"1";"2.98";"16";"COCCC(=O)N1CCS(=O)(=O)C(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"294.0";"nM";"6.53";"";"";"UO_0000065";"10.58";"0.21";"3.55";"4.03";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4107734";"";"None";"476.56";"0";"3.98";"BDBM181017";"C=CS(=O)(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.52";"nM";"9.28";"";"327855";"UO_0000065";"19.48";"0.37";"5.30";"7.99";"0";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"BDBM1773";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"327863";"UO_0000065";"20.10";"0.37";"4.63";"8.93";"0";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3702838";"";"None";"511.56";"1";"4.71";"BDBM143190";"CC(C)/C=C(\C#N)C(=O)N1CCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"4.0";"nM";"8.40";"";"369512";"UO_0000065";"16.42";"0.30";"3.69";"6.83";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3747130";"";"None";"530.59";"1";"4.13";"29";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2cccnc2s1";"IC50";"'='";"103.0";"nM";"6.99";"";"";"UO_0000065";"13.17";"0.25";"2.86";"5.78";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3745934";"";"None";"618.71";"2";"5.11";"10";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(F)c(NC(=O)c5cc6c(s5)CCCC6)c4F)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.57";"0.26";"3.29";"8.43";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3941531";"";"None";"541.63";"2";"5.25";"BDBM200835";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3ncnc4[nH]c(C5=CCN(C(=O)CF)CC5)cc34)c2CO)cc1";"IC50";"'='";"27.0";"nM";"7.57";"";"356876";"UO_0000065";"13.97";"0.26";"2.32";"6.81";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920235";"";"None";"574.63";"2";"5.46";"BDBM200838";"Cc1c(NC(=O)c2ccc(C(C)(C)O)cc2F)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"13.0";"nM";"7.89";"";"356877";"UO_0000065";"13.72";"0.26";"2.43";"6.89";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921217";"";"None";"538.65";"2";"5.98";"BDBM200877";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3ncnc4[nH]c(C5=CCC6(CC5)OCCO6)cc34)c2CO)cc1";"IC50";"'='";"24.0";"nM";"7.62";"";"356892";"UO_0000065";"14.15";"0.26";"1.64";"6.97";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3622196";"";"None";"429.48";"0";"3.57";"38";"COc1ccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCOCC5)cc4c3c2)cc1";"IC50";"'='";"327.0";"nM";"6.49";"";"";"UO_0000065";"15.10";"0.28";"2.92";"6.64";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622199";"";"None";"442.52";"0";"3.48";"43";"COc1ccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c3c2)cc1";"IC50";"'='";"436.0";"nM";"6.36";"";"";"UO_0000065";"14.37";"0.26";"2.88";"6.94";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4090257";"";"None";"564.53";"1";"4.76";"15";"Nc1nccn2c([C@@H]3CCC[C@H](c4noc(=O)[nH]4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"979.0";"nM";"6.01";"";"";"UO_0000065";"10.64";"0.20";"1.25";"3.83";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4059483";"";"None";"564.53";"1";"4.76";"19";"Nc1nccn2c([C@@H]3CCC[C@H](c4n[nH]c(=O)o4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"13.16";"0.25";"2.67";"4.73";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4070853";"";"None";"566.58";"2";"5.89";"25";"CC(C)[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C[C@H]1C(=O)O";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"13.52";"0.26";"1.77";"5.65";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4280795";"";"None";"474.95";"0";"4.78";"25";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)/C=C/Cl)C1";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"19.55";"0.37";"4.50";"9.36";"0";"CHEMBL4271410";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270507";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4113445";"";"None";"551.53";"1";"4.73";"BDBM255342";"Nc1nccn2c([C@@H]3CC[C@H]4CCOC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.075";"nM";"10.12";"";"445248";"UO_0000065";"18.36";"0.35";"5.39";"7.93";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3917607";"";"None";"551.53";"1";"4.73";"BDBM255343";"Nc1nccn2c([C@H]3CC[C@@H]4CCOC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"2.6";"nM";"8.59";"";"445249";"UO_0000065";"15.57";"0.29";"3.86";"6.72";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112448";"";"None";"535.53";"1";"4.51";"BDBM255471";"Nc1nccn2c([C@@H]3CC[C@@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"14.7";"nM";"7.83";"";"445166";"UO_0000065";"14.63";"0.27";"3.32";"6.61";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112420";"";"None";"521.63";"1";"4.68";"BDBM255279";"Cc1cc(-c2nc([C@@H]3CC[C@H]4CCC(=O)N4C3)n3ccnc(N)c23)ccc1C(=O)Nc1cc(C2CC2)ccn1";"IC50";"'='";"0.64";"nM";"9.19";"";"445184";"UO_0000065";"17.63";"0.32";"4.51";"7.76";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108545";"";"None";"569.52";"1";"4.87";"BDBM255282";"C[C@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.096";"nM";"10.02";"";"445187";"UO_0000065";"17.59";"0.33";"5.15";"7.84";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106896";"";"None";"553.62";"1";"4.60";"BDBM255304";"COc1cc(C(=O)Nc2cc(C3CC3)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3[C@@H](C)OC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.5";"nM";"9.30";"";"445209";"UO_0000065";"16.80";"0.31";"4.70";"6.79";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108773";"";"None";"551.53";"1";"3.48";"BDBM255323";"Nc1nccn2c([C@@H]3CC[C@@H]4CC(O)C(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.45";"nM";"9.35";"";"445228";"UO_0000065";"16.95";"0.32";"5.87";"6.74";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3927614";"";"None";"304.35";"0";"3.29";"BDBM195839";"CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348543";"UO_0000065";"20.15";"0.36";"2.84";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3925725";"";"None";"480.49";"1";"5.38";"BDBM195901";"COc1c(F)cc(F)cc1-c1c[nH]c2ncc(-c3cc(NC(=O)/C=C/CN(C)C)ccc3F)cc12";"IC50";"'='";"7558.0";"nM";"5.12";"";"348546";"UO_0000065";"10.66";"0.20";"-0.26";"7.29";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3948029";"";"None";"458.54";"1";"5.41";"BDBM195902";"COc1cc(F)c(C)cc1-c1c[nH]c2ncc(-c3cccc(NC(=O)/C=C/CN(C)C)c3)cc12";"IC50";"'='";"7558.0";"nM";"5.12";"";"348547";"UO_0000065";"11.17";"0.21";"-0.29";"7.29";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3902509";"";"None";"277.33";"0";"3.66";"BDBM195757";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348503";"UO_0000065";"22.11";"0.40";"2.47";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3953949";"";"None";"303.72";"0";"3.79";"BDBM195771";"O=C(CF)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348508";"UO_0000065";"20.19";"0.40";"2.34";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3962690";"";"None";"303.37";"0";"3.89";"BDBM195773";"CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348510";"UO_0000065";"20.21";"0.36";"2.24";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3918545";"";"None";"411.46";"1";"5.20";"BDBM195778";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(C(=O)OCC)c4)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348515";"UO_0000065";"14.90";"0.27";"0.93";"7.29";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3964955";"";"None";"298.73";"0";"3.40";"BDBM195807";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348525";"UO_0000065";"20.52";"0.40";"2.73";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3935716";"";"None";"601.71";"2";"5.53";"BDBM202086";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ncnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c1CO";"IC50";"'='";"8.0";"nM";"8.10";"";"358164";"UO_0000065";"13.46";"0.25";"2.57";"7.80";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952062";"";"None";"580.74";"2";"6.53";"BDBM202090";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCN(C)CC5)cc4)cc23)cccc1-n1ccc2cc(C3CC3)ccc2c1=O";"IC50";"'='";"10.0";"nM";"8.00";"";"358168";"UO_0000065";"13.78";"0.25";"1.47";"11.42";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969286";"";"None";"466.59";"1";"6.29";"BDBM200891";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(C3=CCOCC3)cc12";"IC50";"'='";"15.0";"nM";"7.82";"";"356902";"UO_0000065";"16.77";"0.31";"1.53";"9.79";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982378";"";"None";"500.64";"2";"7.14";"BDBM200798";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCSCC3)cc12";"IC50";"'='";"94.0";"nM";"7.03";"";"356908";"UO_0000065";"14.04";"0.27";"-0.11";"9.94";"0";"CHEMBL3887839";"Cellular Assay: Alternatively, the present compounds might also be assessed for their capacity to inhibit Btk-dependent FcG receptor-induced IL-8 secretion in human cells. The human myeloid leukemia THP1 cell line (ATCC TIB202) was grown in RPMI 1640 medium supplemented with 10% FCS and 15 nM 1, 25-dihydroxy Vitamin D3 during 4 days before use to induced myeloid differentiation. A sufficient number of tissue-culture grade 384-well plates was coated with human IgG of unknown specificity by incubating overnight at 4° C. with 40 ul/well of a 50 ug/ml IgG solution in PBS. On the day of the experiment, plates were washed 5 times with 80 ul water on a Molecular Devices Aquamax DW4 plate washer. Solutions of the test compounds in 90% DMSO were added to each well on a Hamilton Microlab Star liquid handling station to 40 ul/well tissue culture medium and the total DMSO concentration was adjusted to 0.1%. Differentiated THP1 cells were then added in 40 ul/well to reach a final density of 5'000 cells/well in 80 ul culture medium. After 24 hours, IL-8 secretion was measured in the supernatant by the IL-8 HTRF assay following the protocol of the vendor (CisBio international).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"CHEMBL3307574";"";"";""
"CHEMBL3647967";"";"None";"454.53";"0";"4.65";"BDBM97672";"C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"0.58";"nM";"9.24";"";"327859";"UO_0000065";"20.32";"0.37";"4.59";"8.56";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3670104";"";"None";"593.73";"1";"3.78";"BDBM111963";"CN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCc6c(cc7n6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"16.3";"nM";"7.79";"";"233018";"UO_0000065";"13.12";"0.24";"4.01";"7.88";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3954175";"";"None";"455.44";"0";"4.20";"28";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(C(F)(F)F)cc3)nn21";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"18.39";"0.35";"4.18";"8.21";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4292468";"";"None";"539.04";"1";"4.85";"7h";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)c(OC)c3)ncc2Cl)c1";"IC50";"'='";"31.3";"nM";"7.50";"";"";"UO_0000065";"13.92";"0.27";"2.65";"6.83";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3702836";"";"None";"610.69";"1";"4.56";"BDBM143185";"CN(C1COC1)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"2.1";"nM";"8.68";"";"279408";"UO_0000065";"14.21";"0.26";"4.12";"6.41";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"29; GDC-0853";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"30.7";"nM";"7.51";"";"";"UO_0000065";"11.30";"0.21";"3.94";"6.21";"0";"CHEMBL4023752";"Inhibition of BTK in human whole blood derived-basophils assessed as suppression of IgE mediated-FcepsilonR ligation-stimulated CD63 expression";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"17.70";"0.32";"3.58";"7.86";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4567040";"";"None";"505.53";"1";"4.22";"14";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3F)c2C)C1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"13.98";"0.26";"2.85";"6.40";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4537231";"";"None";"533.58";"1";"5.00";"22";"C=CC(=O)N1CCC[C@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"13.58";"0.25";"2.24";"6.56";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4247870";"";"None";"510.94";"1";"3.41";"7d";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)NCC(=O)OC)cc3)ncc2Cl)c1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"16.02";"0.31";"4.78";"5.70";"0";"CHEMBL4233700";"Inhibition of full length recombinant human N-terminal His-tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229440";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4582791";"";"None";"391.43";"0";"2.59";"17a";"Nc1ncnc2c1c(-c1ccc3c(c1)OCO3)cn2[C@H]1CCN(C(=O)C2CC2)C1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"18.77";"0.35";"4.76";"7.69";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4567040";"";"None";"505.53";"1";"4.22";"14";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3F)c2C)C1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"16.51";"0.31";"4.13";"7.56";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4437701";"";"None";"519.55";"1";"4.30";"31";"CC#CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"15.94";"0.30";"3.98";"7.50";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4544821";"";"None";"427.51";"0";"4.12";"24d";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CCN(C[C@@H]2CO2)C1";"IC50";"'='";"31.1";"nM";"7.51";"";"";"UO_0000065";"17.56";"0.32";"3.39";"9.19";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4525187";"";"None";"441.54";"0";"4.34";"28a";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C[C@H]1CCCN1C[C@@H]1CO1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.30";"0.35";"4.18";"10.43";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4465231";"";"None";"535.61";"1";"4.66";"30";"CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(Oc4ccccc4)c23)n1";"IC50";"'='";"1456.0";"nM";"5.84";"";"";"UO_0000065";"10.90";"0.20";"1.18";"4.70";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4593230";"";"None";"596.70";"1";"3.42";"37";"C=CC(=O)N1CCC[C@@H]1COc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)nc2[nH]cc(-c3cncc(NC)n3)c12";"IC50";"'='";"286.0";"nM";"6.54";"";"";"UO_0000065";"10.97";"0.20";"3.12";"4.53";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4636316";"";"None";"519.58";"1";"2.97";"18";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)C2(F)CC2)c1=O";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"13.90";"0.26";"4.25";"6.60";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4646964";"";"None";"536.54";"1";"2.77";"29";"Cn1nc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O";"IC50";"'='";"214.0";"nM";"6.67";"";"";"UO_0000065";"12.43";"0.23";"3.90";"5.05";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3665117";"";"None";"608.70";"1";"4.23";"BDBM111588";"Cc1c(-c2cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c(=O)n(C)c2)cccc1N1CNc2cc(C(C)(C)O)ccc2C1=O";"IC50";"'='";"18.0";"nM";"7.75";"";"232404";"UO_0000065";"12.72";"0.24";"3.51";"6.00";"0";"CHEMBL3705846";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter. Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 um hydrophilic PVDF filter plates (Millipore).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638395";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3894975";"";"None";"441.40";"0";"3.64";"BDBM249947";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c(=O)c1cc([N+](=O)[O-])ccc12";"IC50";"'='";"5500.0";"nM";"5.26";"";"435879";"UO_0000065";"11.92";"0.22";"1.62";"3.61";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913669";"";"None";"536.64";"1";"4.90";"BDBM249966";"CN(C)C/C=C/C(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"1.1";"nM";"8.96";"";"435895";"UO_0000065";"16.69";"0.31";"4.06";"7.82";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4112206";"";"None";"569.64";"1";"4.91";"BDBM255386";"CCOc1cc(C(=O)Nc2cc(C3CC3)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"445293";"UO_0000065";"15.27";"0.28";"3.79";"6.81";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113559";"";"None";"502.60";"1";"3.51";"BDBM255427";"CCc1nsc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)n1";"IC50";"'='";"27.6";"nM";"7.56";"";"445334";"UO_0000065";"15.04";"0.29";"4.05";"5.75";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109557";"";"None";"510.53";"1";"3.50";"BDBM255266";"N#Cc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)c(F)c2)c1";"IC50";"'='";"0.21";"nM";"9.68";"";"445171";"UO_0000065";"18.96";"0.35";"6.18";"6.80";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114502";"";"None";"641.65";"2";"6.09";"BDBM255321";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OCc3ccccc3)c12";"IC50";"'='";"10.7";"nM";"7.97";"";"445226";"UO_0000065";"12.42";"0.23";"1.88";"6.24";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111825";"";"None";"578.60";"1";"4.05";"BDBM255331";"CCN1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]2C1";"IC50";"'='";"0.27";"nM";"9.57";"";"445236";"UO_0000065";"16.54";"0.31";"5.52";"7.86";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109792";"";"None";"564.57";"1";"4.65";"BDBM255334";"CN1CC[C@@H]2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"0.092";"nM";"10.04";"";"445239";"UO_0000065";"17.78";"0.33";"5.39";"8.24";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107779";"";"None";"591.59";"2";"5.05";"BDBM255370";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12";"IC50";"'='";"0.58";"nM";"9.24";"";"445277";"UO_0000065";"15.61";"0.29";"4.19";"7.23";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113085";"";"None";"418.52";"0";"2.87";"BDBM235157";"CC(C)(C)OC(=O)N[C@@H]1CCCN(c2nc(C(N)=O)c(Nc3ccccn3)s2)C1";"IC50";"'='";"1214.6";"nM";"5.92";"";"409809";"UO_0000065";"14.13";"0.28";"3.05";"4.83";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4110962";"";"None";"479.61";"0";"3.47";"BDBM235158";"CC(C)(C)c1ccc(C(=O)N[C@@H]2CCCN(c3nc(C(N)=O)c(Nc4ccccn4)s3)C2)cn1";"IC50";"'='";"1728.8";"nM";"5.76";"";"409810";"UO_0000065";"12.01";"0.23";"2.29";"4.57";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"342643";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3931858";"";"None";"527.63";"1";"3.51";"BDBM191609";"CN(C/C=C/C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1)CCO";"IC50";"'='";"2.1";"nM";"8.68";"";"342645";"UO_0000065";"16.45";"0.30";"5.17";"7.08";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3910496";"";"None";"440.51";"0";"4.04";"BDBM191605";"C=CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"0.39";"nM";"9.41";"";"342656";"UO_0000065";"21.36";"0.39";"5.37";"9.49";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4106607";"";"None";"452.52";"0";"4.05";"BDBM191621";"CC#CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"342659";"UO_0000065";"19.22";"0.35";"4.65";"8.77";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4436563";"";"None";"423.48";"1";"5.39";"A7";"C=CC(=O)Nc1cccc(-c2c(N)ncnc2Nc2ccc(Oc3ccccc3)cc2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"19.12";"0.35";"2.71";"7.93";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4475457";"";"None";"429.52";"0";"4.54";"A10";"C=CC(=O)N[C@H]1CC[C@@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"17.42";"0.32";"2.94";"7.32";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4114462";"";"None";"486.00";"0";"3.23";"BDBM235165";"NC(=O)c1nc(N2CCC[C@@H](NC(=O)CNc3cccc(Cl)c3)C2)sc1Nc1ccccn1";"IC50";"'='";"5368.6";"nM";"5.27";"";"409817";"UO_0000065";"10.84";"0.22";"2.04";"4.21";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4079595";"";"None";"662.79";"2";"5.80";"46";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCC(OC)CC1";"IC50";"'='";"596.0";"nM";"6.22";"";"";"UO_0000065";"9.39";"0.17";"0.42";"4.98";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4071818";"";"None";"746.91";"2";"7.47";"39";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCN(C(=O)OC(C)(C)C)CC1";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"9.60";"0.18";"-0.30";"5.04";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4088485";"";"None";"649.70";"1";"4.72";"28";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc5c(c4)OCCO5)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"10.85";"0.20";"2.33";"5.03";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4071893";"";"None";"635.68";"1";"4.68";"27";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc5c(c4)OCO5)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"282.0";"nM";"6.55";"";"";"UO_0000065";"10.30";"0.19";"1.87";"4.67";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4081428";"";"None";"649.79";"2";"6.48";"13";"CCC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"163.0";"nM";"6.79";"";"";"UO_0000065";"10.45";"0.19";"0.31";"5.57";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4635803";"";"None";"455.21";"None";"None";"14g";"C=CC(=O)Nc1cccc(Nc2nc(Nc3cccc4c3COB4O)ncc2C(F)(F)F)c1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"15.82";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4634634";"";"None";"365.44";"0";"1.44";"29";"C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C";"IC50";"'='";"39550.0";"nM";"4.40";"";"";"UO_0000065";"12.05";"0.22";"2.96";"4.84";"0";"CHEMBL4603300";"Inhibition of recombinant full length human His-tagged BTK expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3621510";"";"None";"481.38";"0";"4.78";"20";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccc(Cl)c(Cl)c4)c23)CC1";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"14.53";"0.29";"2.22";"8.49";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3589164";"";"None";"468.34";"0";"4.87";"40";"NC(=O)c1cc(-c2ccc(Cl)c(Cl)c2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12";"IC50";"'='";"461.0";"nM";"6.34";"";"";"UO_0000065";"13.53";"0.27";"1.47";"7.17";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4087679";"";"None";"524.50";"2";"5.00";"4";"Nc1nccn2c([C@@H]3CCC[C@H](C(=O)O)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"13.36";"0.25";"2.01";"5.17";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4100424";"";"None";"547.55";"2";"5.20";"16";"Nc1nccn2c([C@@H]3CCC[C@H](c4nnc[nH]4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.19";"0.27";"2.57";"5.56";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4063275";"";"None";"538.53";"2";"5.39";"32";"C[C@]1(C(=O)O)CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"14.08";"0.27";"2.20";"5.60";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4068919";"";"None";"538.53";"2";"5.18";"38";"C[C@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"15.04";"0.28";"2.92";"5.98";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3939699";"";"None";"409.45";"0";"4.47";"BDBM249920";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2cc(-c3cccc(N)c3)[nH]c12";"IC50";"'='";"110.0";"nM";"6.96";"";"435850";"UO_0000065";"17.00";"0.31";"2.49";"6.24";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962133";"";"None";"427.46";"0";"3.29";"BDBM249934";"C=CC(=O)N1CCc2c([nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)C1";"IC50";"'='";"0.18";"nM";"9.74";"";"435866";"UO_0000065";"22.80";"0.42";"6.45";"9.22";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895210";"";"None";"479.50";"0";"4.05";"BDBM249946";"C=CC(=O)Nc1ccc2c(c1)CC(=O)Nc1c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn1-2";"IC50";"'='";"41.0";"nM";"7.39";"";"435878";"UO_0000065";"15.41";"0.28";"3.34";"5.76";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924383";"";"None";"349.39";"0";"2.19";"BDBM249955";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC(N)C2";"IC50";"'='";"2900.0";"nM";"5.54";"";"435887";"UO_0000065";"15.85";"0.29";"3.35";"5.12";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940302";"";"None";"431.50";"0";"2.89";"BDBM249985";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(OCc4ccccc4)cc3)nn21";"IC50";"'='";"24.0";"nM";"7.62";"";"435914";"UO_0000065";"17.66";"0.33";"4.73";"6.85";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4207762";"";"None";"550.66";"2";"5.61";"2b";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cnnc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"9.54";"0.17";"-0.36";"4.80";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3905432";"";"None";"452.52";"0";"3.88";"BDBM191620";"CC#CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"3.14";"nM";"8.50";"";"342658";"UO_0000065";"18.79";"0.34";"4.62";"8.58";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4762397";"";"None";"481.60";"1";"5.63";"4";"C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)c12";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"14.74";"0.27";"1.47";"7.80";"0";"CHEMBL4668244";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by immunoblot analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 24.0 hr";"INHIBITOR";""
"CHEMBL3904000";"";"None";"601.04";"2";"6.07";"7b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCP(=O)(OCC)N4CCOCC4)cc3)ncc2Cl)c1";"IC50";"'='";"0.82";"nM";"9.09";"";"";"UO_0000065";"15.12";"0.30";"3.02";"7.16";"0";"CHEMBL3874808";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells measured after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872267";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308860";"";"";""
"CHEMBL4281335";"";"None";"464.57";"0";"2.42";"9";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)cc3)n2)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.91";"0.32";"5.43";"6.96";"0";"CHEMBL4264031";"Inhibition of BTK in human PBMC";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3952795";"";"None";"572.61";"1";"4.40";"BMS-986142";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"88.3";"nM";"7.05";"";"";"UO_0000065";"12.32";"0.23";"2.65";"5.73";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4069387";"";"None";"569.56";"2";"5.15";"22";"CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.57";"0.28";"3.15";"7.00";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4076024";"";"None";"571.54";"1";"4.14";"24";"COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"16.97";"0.32";"5.56";"7.59";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4081661";"";"None";"595.60";"2";"5.68";"18";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)CCC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"15.99";"0.30";"3.84";"8.04";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3891185";"";"None";"589.70";"2";"5.16";"8";"CN1CCC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cn2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.94";"0.26";"3.06";"7.31";"1";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4212285";"";"None";"525.59";"2";"5.06";"25b";"CC(C)n1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"18.45";"0.34";"4.64";"7.83";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4216909";"";"None";"521.56";"1";"4.49";"18i";"Cn1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"16.81";"0.31";"4.28";"6.51";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"4";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"0.72";"nM";"9.14";"";"";"UO_0000065";"21.59";"0.40";"4.89";"9.39";"1";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4071567";"";"None";"552.01";"2";"5.60";"10j";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(NS(=O)(=O)c4ccc(OC)cc4)cc3)ncc2Cl)c1";"IC50";"'='";"0.42";"nM";"9.38";"";"";"UO_0000065";"16.99";"0.34";"3.78";"7.13";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4070521";"";"None";"534.57";"2";"5.04";"10i";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(OC)cc4)cc3)ncc2F)c1";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"16.90";"0.32";"4.00";"6.73";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4209148";"";"None";"565.68";"2";"5.20";"2e";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(N)nc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"11.88";"0.22";"1.52";"4.97";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4212436";"";"None";"610.65";"2";"4.01";"4i";"COCCOCCn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"0.54";"nM";"9.27";"";"";"UO_0000065";"15.18";"0.28";"5.26";"5.58";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3685429";"";"None";"368.80";"0";"4.80";"BDBM120752";"C=CC(=O)Nc1cccc(-c2nc(Cl)ncc2Nc2cccc(F)c2)c1";"IC50";"'='";"829.0";"nM";"6.08";"";"248809";"UO_0000065";"16.49";"0.32";"1.28";"9.09";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4764139";"";"None";"622.58";"2";"5.49";"44";"Cc1oncc1C(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"13.44";"0.25";"2.88";"5.79";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL3787652";"";"None";"457.49";"0";"3.26";"16e";"C=CC(=O)Nc1cccc(-n2c(=O)n(CC3CC3)c3cnc(Nc4ccc(OC)nc4)nc32)c1";"IC50";"'='";"222.0";"nM";"6.65";"";"";"UO_0000065";"14.54";"0.27";"3.39";"5.74";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3953428";"";"None";"477.95";"0";"4.10";"BDBM249980";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccc(Cl)cc5)cc4)nn32)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"435909";"UO_0000065";"18.52";"0.36";"4.75";"8.64";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939337";"";"None";"377.45";"0";"2.54";"BDBM249984";"NCC1CCNc2c(C(N)=O)c(-c3ccc(OCc4ccccc4)cc3)nn21";"IC50";"'='";"3000.0";"nM";"5.52";"";"435913";"UO_0000065";"14.63";"0.27";"2.98";"5.10";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960383";"";"None";"387.44";"0";"2.91";"BDBM249994";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c3c([nH]c12)CCNCC3";"IC50";"'='";"180.0";"nM";"6.75";"";"435923";"UO_0000065";"17.41";"0.32";"3.83";"6.92";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985149";"";"None";"491.98";"0";"4.62";"BDBM250025";"C=CC(=O)Nc1cc(Cl)ccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"2.7";"nM";"8.57";"";"435954";"UO_0000065";"17.42";"0.33";"3.95";"7.70";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903899";"";"None";"519.55";"1";"4.34";"BDBM250056";"CC#CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5F)cc4)nn32)CC1";"IC50";"'='";"48.0";"nM";"7.32";"";"435986";"UO_0000065";"14.09";"0.26";"2.98";"7.14";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4109975";"";"None";"629.04";"2";"5.05";"BDBM255394";"Cn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)c(OC3CC3)c2)cc1C(F)(F)F";"IC50";"'='";"0.44";"nM";"9.36";"";"445301";"UO_0000065";"14.87";"0.29";"4.31";"7.05";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106682";"";"None";"600.58";"1";"4.39";"BDBM255401";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"1.3";"nM";"8.89";"";"445308";"UO_0000065";"14.80";"0.28";"4.50";"6.70";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3949083";"";"None";"425.49";"0";"4.43";"BDBM249878";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2c1ccccc1N";"IC50";"'='";"200.0";"nM";"6.70";"";"435794";"UO_0000065";"15.74";"0.29";"2.27";"6.19";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940428";"";"None";"405.46";"0";"1.55";"BDBM249910";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3cnn(Cc4ccccc4)c3)nn21";"IC50";"'='";"640.0";"nM";"6.19";"";"435840";"UO_0000065";"15.28";"0.28";"4.64";"5.17";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943321";"";"None";"377.45";"0";"3.02";"BDBM249907";"CNCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"1900.0";"nM";"5.72";"";"435837";"UO_0000065";"15.16";"0.28";"2.70";"6.07";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974534";"";"None";"440.46";"0";"3.02";"BDBM249928";"N#CCC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"110.0";"nM";"6.96";"";"435859";"UO_0000065";"15.80";"0.29";"3.94";"5.37";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3670081";"";"None";"513.62";"1";"4.22";"BDBM111938";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CCCC5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"0.87";"nM";"9.06";"";"232993";"UO_0000065";"17.64";"0.33";"4.84";"9.03";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670082";"";"None";"527.65";"1";"4.47";"BDBM111939";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"10.0";"nM";"8.00";"";"232994";"UO_0000065";"15.16";"0.29";"3.53";"7.97";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670086";"";"None";"496.57";"0";"3.42";"BDBM111943";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"6.2";"nM";"8.21";"";"232998";"UO_0000065";"16.53";"0.30";"4.79";"7.80";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3903500";"";"None";"628.77";"1";"4.72";"BDBM111953";"CN1CCN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCc6c(sc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"233008";"UO_0000065";"14.31";"0.27";"4.28";"9.58";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL228043";"";"None";"360.01";"0";"3.51";"10, LFM-A13";"C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"15.56";"0.45";"2.09";"7.66";"1";"CHEMBL2060513";"Inhibition of human recombinant BTK expressed in baculovirus expression vector system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2057919";"";"None";"522.54";"1";"4.26";"30";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(O)CO)ccc4c23)cccc1-n1cnc2ccc(F)cc2c1=O";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"17.52";"0.32";"4.89";"6.82";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4643808";"";"None";"408.41";"0";"4.42";"33";"C=CC(=O)N1CC(Oc2cccc3[nH]c(-c4n[nH]c5cc(C(F)F)ccc45)cc23)C1";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"17.50";"0.33";"2.73";"9.66";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4642453";"";"None";"500.55";"2";"6.23";"49";"C=CC(=O)NCCOc1cc(Cc2cccc(C)c2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"235.0";"nM";"6.63";"";"";"UO_0000065";"13.24";"0.24";"0.40";"8.01";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4638921";"";"None";"505.58";"1";"2.11";"16";"COCC(=O)Nc1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cn(C)c1=O";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"14.10";"0.26";"5.02";"6.01";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4633058";"";"None";"535.55";"1";"3.37";"26";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@@H]2F)c1=O";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"13.99";"0.26";"4.12";"6.29";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4634904";"";"None";"535.55";"1";"3.37";"25";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"13.27";"0.25";"3.74";"5.97";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4282745";"";"None";"276.30";"0";"-0.96";"8";"C=CC(=O)N[C@@H]1CCN(c2ncc(C(N)=O)c(N)n2)C1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"22.81";"0.43";"7.26";"4.95";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4286664";"";"None";"478.55";"0";"1.67";"22";"C=CC(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"16.29";"0.30";"6.13";"6.00";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4279353";"";"None";"474.61";"0";"2.83";"21";"C=CC(=O)N[C@@H]1CN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)CC12CC2";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"17.51";"0.32";"5.48";"8.02";"0";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"18.93";"0.35";"4.12";"8.41";"1";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4237999";"";"None";"383.47";"0";"3.46";"37";"C=CS(=O)(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1";"IC50";"'='";"0.068";"nM";"10.17";"";"";"UO_0000065";"26.51";"0.51";"6.71";"10.56";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4238798";"";"None";"333.39";"0";"3.68";"29";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)cc23)c1C";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"28.48";"0.52";"5.81";"10.79";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4248834";"";"None";"319.36";"0";"3.37";"28";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]ccc23)c1C";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"28.05";"0.51";"5.59";"10.18";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4248719";"";"None";"417.51";"0";"3.93";"15";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"23.40";"0.43";"5.84";"9.03";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4238297";"";"None";"488.63";"0";"4.17";"14";"Cc1c(NC(=O)/C=C/CN(C)C)cccc1-c1ccc(C(N)=O)c2[nH]c3c(c12)CCC(C(C)(C)O)C3";"IC50";"'='";"0.82";"nM";"9.09";"";"";"UO_0000065";"18.60";"0.34";"4.92";"8.15";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4246005";"";"None";"441.53";"1";"5.14";"6";"C/C=C/C(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1C";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"20.20";"0.37";"3.78";"8.24";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"BMS-935177; 1";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"17.08";"0.31";"3.27";"7.53";"1";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4466633";"";"None";"664.74";"1";"4.26";"Ent-3";"Cn1c2c(cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c1=O)-c1cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c1C[C@@H](O)C2";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"13.37";"0.25";"4.63";"6.75";"0";"CHEMBL4321361";"Inhibition of Kinase Tracer 178 binding to biotinylated-BTK (unknown origin) measured after 18 to 24 hrs by Europium-labeled Streptavidin conjugate based TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4316621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL288441";"BOSUTINIB";"4.0";"530.46";"2";"5.19";"SKI-606";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"16.22";"0.33";"3.41";"10.38";"0";"CHEMBL1244330";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240341";"1";"Scientific Literature";"Leukemia";"2009";"None";"";"";""
"CHEMBL4215184";"";"None";"550.66";"2";"5.61";"2c";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.43";"0.19";"0.13";"5.25";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4204675";"";"None";"522.54";"1";"3.89";"4e";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"7.4";"nM";"8.13";"";"";"UO_0000065";"15.56";"0.28";"4.24";"5.51";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4634904";"";"None";"535.55";"1";"3.37";"25";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"16.10";"0.30";"5.25";"7.24";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4647569";"";"None";"536.54";"1";"2.77";"28";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)nc(NC(=O)[C@@H]2C[C@@H]2F)c1=O";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"14.14";"0.27";"4.82";"5.75";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4641507";"";"None";"517.56";"1";"3.42";"23";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)C2CC2)c1=O";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"13.73";"0.26";"3.69";"5.97";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"XIX";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.31";"0.33";"5.21";"7.19";"1";"CHEMBL4355290";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354798";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3665115";"";"None";"471.56";"0";"4.11";"BDBM111586";"CNC(=O)Nc1cc(-c2cccc(-n3cnc4cc(C(C)(C)C)ccc4c3=O)c2C)cn(C)c1=O";"IC50";"'='";"112.0";"nM";"6.95";"";"232402";"UO_0000065";"14.74";"0.27";"2.84";"7.09";"0";"CHEMBL3705846";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter. Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 um hydrophilic PVDF filter plates (Millipore).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638395";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3945746";"";"None";"491.50";"0";"3.56";"BDBM250064";"CC#CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5F)cc4)nn32)C1";"IC50";"'='";"42.0";"nM";"7.38";"";"435996";"UO_0000065";"15.01";"0.28";"3.82";"7.20";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4115382";"";"None";"600.58";"1";"4.39";"BDBM255412";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(F)cnc(N)c12";"IC50";"'='";"3.1";"nM";"8.51";"";"445319";"UO_0000065";"14.17";"0.27";"4.12";"6.41";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107901";"";"None";"568.56";"1";"3.86";"BDBM255437";"COc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"2.7";"nM";"8.57";"";"445344";"UO_0000065";"15.07";"0.29";"4.71";"6.46";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108011";"";"None";"522.03";"1";"4.52";"BDBM255444";"Cc1cnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)c(Cl)c2)s1";"IC50";"'='";"0.63";"nM";"9.20";"";"445351";"UO_0000065";"17.62";"0.35";"4.68";"7.76";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106878";"";"None";"567.55";"1";"4.96";"BDBM255447";"Cc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"8.2";"nM";"8.09";"";"445354";"UO_0000065";"14.25";"0.27";"3.13";"6.82";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3948238";"";"None";"533.52";"1";"4.40";"BDBM246398";"Cn1ncc2c1CCC[C@@H]2n1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"2.7";"nM";"8.57";"";"429700";"UO_0000065";"16.06";"0.30";"4.17";"6.62";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"2";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"4.61";"nM";"8.34";"";"";"UO_0000065";"19.69";"0.37";"4.09";"8.56";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3785329";"";"None";"536.55";"1";"3.53";"16a";"C=CC(=O)Nc1cccc(-n2c(=O)n(C)c3cnc(Nc4ccc(Oc5ccnc(C(=O)NC)c5)cc4)nc32)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"14.70";"0.27";"4.36";"5.44";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4249872";"";"None";"410.48";"0";"1.34";"9b";"C=CC(=O)N1CCCC(Cn2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1";"IC50";"'='";"420.4";"nM";"6.38";"";"";"UO_0000065";"15.53";"0.29";"5.04";"5.45";"0";"CHEMBL4236389";"Inhibition of BTK (unknown origin) using TK-substrate-biotin measured after 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4244148";"";"None";"352.40";"0";"1.16";"12a";"C=CC(=O)N1CCCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1";"IC50";"'='";"180.3";"nM";"6.74";"";"";"UO_0000065";"19.14";"0.35";"5.58";"6.26";"0";"CHEMBL4236389";"Inhibition of BTK (unknown origin) using TK-substrate-biotin measured after 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4112500";"";"None";"487.59";"0";"3.86";"BDBM255260";"Cc1cnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)s1";"IC50";"'='";"2.2";"nM";"8.66";"";"445164";"UO_0000065";"17.76";"0.34";"4.80";"7.31";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3921655";"";"None";"466.55";"0";"4.49";"BDBM191626";"CC#CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.57";"nM";"8.80";"";"342664";"UO_0000065";"18.87";"0.34";"4.31";"8.16";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4112641";"";"None";"450.57";"0";"3.02";"BDBM235160";"Cc1cccc(CC(=O)N[C@@H]2CCCN(c3nc(C(N)=O)c(Nc4ccccn4)s3)C2)c1";"IC50";"'='";"7506.4";"nM";"5.12";"";"409812";"UO_0000065";"11.37";"0.22";"2.10";"4.53";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894476";"";"None";"505.58";"1";"4.89";"BDBM197178";"N#C/C(=C\C1CC1)C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"175.0";"nM";"6.76";"";"350368";"UO_0000065";"13.36";"0.24";"1.87";"5.50";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114753";"";"None";"541.56";"1";"5.00";"BDBM197188";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2)c2c(N)ncnc21";"IC50";"'='";"2.0";"nM";"8.70";"";"350374";"UO_0000065";"16.06";"0.30";"3.70";"7.08";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114709";"";"None";"541.56";"1";"5.00";"BDBM197186";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3c(F)cccc3F)cc2)c2c(N)ncnc21";"IC50";"'='";"17.0";"nM";"7.77";"";"350375";"UO_0000065";"14.35";"0.27";"2.77";"6.32";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114819";"";"None";"576.58";"1";"4.46";"BDBM197233";"CC(C)(N)/C=C(\C#N)C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"20.0";"nM";"7.70";"";"350453";"UO_0000065";"13.35";"0.25";"3.24";"5.17";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4447710";"";"None";"565.67";"2";"5.51";"CGI1746";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1c[nH]c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"13.78";"0.25";"2.29";"6.70";"0";"CHEMBL4360844";"Inhibition of human recombinant full length N-terminal His tagged BTK C481S mutant expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"17.64";"0.32";"3.55";"7.84";"0";"CHEMBL4360844";"Inhibition of human recombinant full length N-terminal His tagged BTK C481S mutant expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4468913";"";"None";"582.73";"2";"5.73";"30n";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CC(C)OC(C)C4)cc3)ncc2F)c1";"IC50";"'='";"27.1";"nM";"7.57";"";"";"UO_0000065";"12.99";"0.26";"1.84";"7.52";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4100228";"";"None";"317.76";"0";"3.46";"4";"Nc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1";"IC50";"'='";"526.0";"nM";"6.28";"";"";"UO_0000065";"19.76";"0.39";"2.82";"7.89";"0";"CHEMBL4020190";"Inhibition of human N-terminal His-tagged BTK expressed in bacmid transfected Sf21 insect cells using TK-substrate-biotin after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4064000";"";"None";"347.78";"0";"3.47";"6";"COc1ccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)cc1N";"IC50";"'='";"334.0";"nM";"6.48";"";"";"UO_0000065";"18.62";"0.37";"3.01";"7.29";"0";"CHEMBL4020190";"Inhibition of human N-terminal His-tagged BTK expressed in bacmid transfected Sf21 insect cells using TK-substrate-biotin after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4238256";"";"None";"429.52";"0";"4.97";"9";"CCC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1C";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"16.83";"0.31";"2.26";"6.68";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4242527";"";"None";"369.45";"0";"3.44";"35";"C=CS(=O)(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1";"IC50";"'='";"0.077";"nM";"10.11";"";"";"UO_0000065";"27.37";"0.53";"6.67";"9.63";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4243995";"";"None";"333.39";"0";"3.68";"34";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"23.38";"0.43";"4.12";"8.86";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4241723";"";"None";"422.49";"0";"4.56";"26";"Cc1[nH]c2c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3C)c2c1C";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"14.32";"0.26";"1.49";"6.45";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4251151";"";"None";"455.56";"1";"5.53";"7";"CC(C)=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1C";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"18.92";"0.35";"3.09";"7.97";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4548939";"";"None";"540.69";"2";"5.97";"30f";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N(CC)CC)cc3)ncc2F)c1";"IC50";"'='";"23.3";"nM";"7.63";"";"";"UO_0000065";"14.12";"0.28";"1.66";"8.35";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4434679";"";"None";"653.81";"2";"6.18";"30s";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCN(C(=O)OC(C)(C)C)CC4)cc3)ncc2F)c1";"IC50";"'='";"263.7";"nM";"6.58";"";"";"UO_0000065";"10.06";"0.20";"0.40";"5.44";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4551071";"";"None";"664.79";"3";"6.44";"30z";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4cc(OC)c(OC)c(OC)c4)cc3)ncc2F)c1";"IC50";"'='";"48.6";"nM";"7.31";"";"";"UO_0000065";"11.00";"0.22";"0.87";"5.72";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4464989";"";"None";"575.70";"2";"5.81";"30ad";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4ccncc4)cc3)ncc2F)c1";"IC50";"'='";"7.36";"nM";"8.13";"";"";"UO_0000065";"14.13";"0.28";"2.32";"7.19";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4521840";"";"None";"574.71";"2";"6.41";"30v";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4ccccc4)cc3)ncc2F)c1";"IC50";"'='";"10.8";"nM";"7.97";"";"";"UO_0000065";"13.86";"0.27";"1.56";"7.95";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3647973";"";"None";"440.51";"0";"4.22";"BDBM97678";"C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"0.58";"nM";"9.24";"";"214874";"UO_0000065";"20.97";"0.38";"5.02";"9.31";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4872106";"";"None";"573.70";"2";"6.62";"1";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccnc2[nH]c(-c3ccc(C(=O)N4CCOCC4)cc3)nc12";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"14.45";"0.26";"1.67";"8.28";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4861612";"";"None";"544.59";"1";"4.59";"17";"CC(C)(C)c1noc(C(=O)NCc2ccc(-c3ccnc4[nH]c(-c5cnn(C6CCOCC6)c5)nc34)cc2F)n1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"16.81";"0.31";"4.56";"6.70";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4851951";"";"None";"538.66";"2";"5.87";"27";"Cc1nn(C(C)C)cc1-c1nc2c(-c3ccc4c(c3)CCC[C@@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"16.63";"0.31";"3.09";"7.03";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4800034";"";"None";"579.58";"1";"4.45";"17";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.71";"nM";"9.15";"";"";"UO_0000065";"15.79";"0.30";"4.70";"7.16";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3948173";"";"None";"578.72";"2";"5.39";"BDBM200854";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCc6cc(C(C)(C)C)ccc6C5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"356883";"UO_0000065";"13.99";"0.26";"2.71";"7.66";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977671";"";"None";"471.54";"1";"5.19";"BDBM200868";"Cc1c(NC(=O)c2ccc(N(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCOCC3)cc12";"IC50";"'='";"47.0";"nM";"7.33";"";"356888";"UO_0000065";"15.54";"0.29";"2.14";"8.81";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647967";"";"None";"454.53";"0";"4.65";"BDBM97672";"C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"385014";"UO_0000065";"19.80";"0.36";"4.35";"8.34";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3956698";"";"None";"312.38";"0";"2.57";"BDBM250517";"Cn1cc(Nc2nc(NC3CCCCC3)c3nc[nH]c3n2)cn1";"IC50";"'='";"2821.72";"nM";"5.55";"";"436765";"UO_0000065";"17.77";"0.33";"2.98";"5.76";"0";"CHEMBL3889150";"FRET (Forster/Flouresence Resonance Energy Transfer) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 ul of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission). The negative control well values were averaged to obtain the mean minimum. The positive 'no inhibitor' control wells were averaged to obtain the mean maximum.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886966";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4097019";"";"None";"594.59";"2";"5.72";"31";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc(C23CCC(C(=O)O)(CC2)CC3)n2ccnc(N)c12";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"12.82";"0.24";"1.90";"5.26";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1761512";"";"None";"425.55";"0";"3.85";"14a";"CCCS(=O)(=O)N1CCC(c2c[nH]c3c(C(N)=O)cc(-c4ccccc4)cc23)CC1";"IC50";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"13.63";"0.26";"1.95";"6.03";"0";"CHEMBL1764212";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759890";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL579353";"";"None";"517.50";"2";"7.05";"KIN-236";"CCN(CC)CCCC(C)Nc1nc(/C=C/c2cc(OC)c(OC)cc2Cl)nc2cc(Cl)ccc12";"IC50";"'='";"5150.0";"nM";"5.29";"";"";"UO_0000065";"10.22";"0.21";"-1.76";"8.89";"0";"CHEMBL4412216";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411283";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4075253";"";"None";"636.76";"2";"2.94";"9";"Cn1cc(-c2nccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"387.0";"nM";"6.41";"";"";"UO_0000065";"10.07";"0.19";"3.47";"5.30";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4063638";"";"None";"665.86";"2";"5.08";"11";"CC1C=C(c2ccnc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)C=C(Nc2ccc(N3CCN(C4COC4)CC3)cc2)C1=O";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"11.13";"0.21";"2.33";"7.54";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4095248";"";"None";"665.80";"2";"2.97";"33";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)nn(C)c2=O)nc1";"IC50";"'='";"16.1";"nM";"7.79";"";"";"UO_0000065";"11.70";"0.22";"4.82";"5.82";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"3; GS-4059; ONO-4059";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"312.3";"nM";"6.50";"";"";"UO_0000065";"14.31";"0.26";"3.76";"6.01";"0";"CHEMBL4023752";"Inhibition of BTK in human whole blood derived-basophils assessed as suppression of IgE mediated-FcepsilonR ligation-stimulated CD63 expression";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4105195";"";"None";"312.32";"0";"3.42";"40";"CCOc1cc(/C=C2\Oc3ccc(OC)cc3C2=O)ccc1O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"16.97";"0.31";"1.88";"8.16";"0";"CHEMBL4014528";"Inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014275";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4090189";"";"None";"510.60";"1";"3.66";"8";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"17.04";"0.31";"5.04";"8.26";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4096404";"";"None";"525.61";"1";"4.41";"14";"Cn1cc(-c2cccc(N3CCOc4cc(C(C)(C)C)ccc4C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.79";"0.29";"3.89";"7.58";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4856652";"";"None";"471.49";"0";"3.70";"19b";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"632.0";"nM";"6.20";"";"";"UO_0000065";"13.15";"0.24";"2.50";"5.86";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4874306";"";"None";"503.51";"1";"4.23";"18e";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5F)cc4)[nH]c23)CC1";"IC50";"'='";"78.7";"nM";"7.10";"";"";"UO_0000065";"14.11";"0.26";"2.87";"6.72";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3786922";"";"None";"483.55";"0";"3.52";"9a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2S(C)(=O)=O)c1";"IC50";"'='";"31.2";"nM";"7.51";"";"";"UO_0000065";"15.52";"0.30";"3.99";"5.71";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4634526";"";"None";"324.38";"0";"1.21";"4j";"C#CC(=O)N[C@@H]1CCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"25.24";"0.47";"6.98";"8.98";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"21.62";"0.39";"5.30";"9.60";"1";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4639063";"";"None";"473.20";"None";"None";"14k";"C=CC(=O)Nc1cccc(Nc2nc(Nc3cc4c(cc3F)COB4O)ncc2C(F)(F)F)c1";"IC50";"'='";"156.2";"nM";"6.81";"";"";"UO_0000065";"14.38";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL5272587";"";"None";"412.50";"0";"0.61";"47";"C=CC(=O)N1CCCC(N2NC(c3cc(C(C)(C)O)n(C)n3)c3c(N)ncnc32)C1";"IC50";"'='";"7.95";"nM";"8.10";"";"";"UO_0000065";"19.64";"0.37";"7.49";"6.46";"0";"CHEMBL5228539";"Inhibition of human BTK using biotin as a substrate preincubated for 5 mins followed by substrate addition incubated for 30 mins in presence of ATP by fluorescence based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5226337";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.5833 hr";"INHIBITOR";""
"CHEMBL5276339";"";"None";"433.34";"0";"4.17";"28";"O=C(CNc1cc(Cl)cc(Cl)c1)N1CCCCC(Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"16.79";"0.34";"3.11";"8.47";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5268773";"";"None";"428.90";"0";"3.29";"48";"O=C(CNc1cc(F)cc(Cl)c1)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.87";"0.39";"5.23";"11.05";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL1916898";"";"None";"466.95";"0";"4.81";"43";"Cc1cc(F)ccc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"9.53";"nM";"8.02";"";"";"UO_0000065";"17.18";"0.33";"3.21";"12.20";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916900";"";"None";"451.48";"0";"4.34";"45";"Cc1ccc(F)cc1Oc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.47";"0.33";"3.55";"12.52";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916906";"";"None";"321.36";"0";"4.12";"21c";"CNc1cc2c(cc1F)nc(Nc1ccccc1C)c1cncn12";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"23.02";"0.42";"3.28";"13.64";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3647968";"";"None";"476.56";"0";"3.98";"BDBM97673";"C=CS(=O)(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.52";"nM";"9.28";"";"213456";"UO_0000065";"19.48";"0.37";"5.30";"7.99";"1";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4297640";"VECABRUTINIB";"2.0";"529.93";"1";"2.65";"15";"NC(=O)[C@H]1CCN(c2ncnc(N)c2F)C[C@@H]1N1CCC[C@@H](Nc2cc(Cl)cc(C(F)(F)F)c2)C1=O";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"16.11";"0.32";"5.89";"6.54";"0";"CHEMBL4668340";"Inhibition of wild type BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665674";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3612842";"";"None";"440.53";"1";"5.79";"13d";"CC(=O)Cn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"18.40";"0.35";"2.32";"9.77";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3605111";"";"None";"482.57";"0";"4.41";"19b";"CNC(=O)Cn1cc(-c2cnc(N)c3c(-c4ccc(C(=O)Nc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"137.0";"nM";"6.86";"";"";"UO_0000065";"14.22";"0.27";"2.45";"5.97";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3621458";"";"None";"442.52";"0";"3.48";"2";"COc1cccc(-c2ccc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCN(C)CC5)cc4c23)c1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"17.07";"0.31";"4.07";"8.24";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3358402";"";"None";"592.70";"2";"3.20";"16h";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(N(C)C)ncc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"431.0";"nM";"6.37";"";"";"UO_0000065";"10.74";"0.20";"3.17";"5.70";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL398422";"";"None";"359.39";"0";"3.25";"37";"Cc1ccc2[nH]ncc2c1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1";"IC50";"'='";"97.0";"nM";"7.01";"";"";"UO_0000065";"19.51";"0.35";"3.76";"5.77";"0";"CHEMBL923138";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140683";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL3657244";"";"None";"440.43";"1";"5.50";"BDBM134251";"Nc1n[nH]c2cc(-c3ccc(C(=O)O)cc3)nc(-c3ccc(Oc4cccc(F)c4)cc3)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"267640";"UO_0000065";"19.75";"0.36";"3.20";"7.62";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657243";"";"None";"388.43";"0";"4.36";"BDBM134250";"CC(C)Oc1ccc(-c2nc(-c3ccc(C(=O)O)cc3)cc3[nH]nc(N)c23)cc1";"IC50";"'='";"290.0";"nM";"6.54";"";"267639";"UO_0000065";"16.83";"0.31";"2.18";"5.73";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"16.69";"0.31";"4.02";"7.48";"0";"CHEMBL4701172";"Inhibition of BTK in human whole blood derived neutrophils assessed as reduction in SLE IC/FcgammaR-induced ROS generation preincubated for 30 mins followed by SLE IC/FcgammaR stimulation and measured after 1 hr by DHR123 dye based fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"Neutrophil";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL3685421";"";"None";"299.72";"0";"2.80";"BDBM120744";"C=CC(=O)Nc1cccc(-c2nc(Cl)nc3n[nH]cc23)c1";"IC50";"'='";"263.0";"nM";"6.58";"";"248801";"UO_0000065";"21.95";"0.43";"3.78";"7.87";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4204140";"";"None";"563.66";"1";"4.27";"3j";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(N3CCc4cc(C5CC5)ccc4C3=O)c2CO)n1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"14.86";"0.27";"4.11";"6.46";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217816";"";"None";"579.64";"1";"4.51";"3m";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"16.19";"0.30";"4.88";"7.14";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3959777";"";"None";"538.63";"2";"5.97";"BDBM200811";"Cc1c(NC(=O)c2ccc(C3CC3)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"13.0";"nM";"7.89";"";"356867";"UO_0000065";"14.64";"0.27";"1.92";"8.37";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4781173";"";"None";"613.62";"1";"4.90";"47";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C(C)(C)CO";"IC50";"'='";"0.54";"nM";"9.27";"";"";"UO_0000065";"15.10";"0.29";"4.37";"6.68";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4779908";"";"None";"597.57";"1";"4.53";"31";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)c(F)c4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"14.40";"0.27";"4.07";"6.73";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4783242";"";"None";"595.64";"1";"3.69";"22";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(-n6cccn6)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.53";"nM";"9.28";"";"";"UO_0000065";"15.57";"0.29";"5.59";"6.37";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4756290";"";"None";"599.59";"1";"4.65";"48";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C(C)(C)O";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"13.83";"0.26";"3.64";"5.98";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4764215";"";"None";"573.63";"1";"3.91";"20";"CCOc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"13.46";"0.25";"3.81";"5.64";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4794031";"";"None";"569.64";"1";"4.38";"18";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C6CC6)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"13.03";"0.24";"3.04";"5.81";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4094125";"";"None";"579.58";"1";"4.39";"1";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"11.94";"0.23";"2.53";"5.42";"0";"CHEMBL4717036";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL3621504";"";"None";"446.94";"0";"4.13";"14";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(Cl)c4)c23)CC1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"16.60";"0.32";"3.29";"9.00";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622193";"";"None";"592.68";"1";"4.93";"34";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(N(C)C)cc5)c4F)c23)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.38";"0.26";"3.59";"7.43";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3589169";"";"None";"446.94";"0";"4.13";"41";"CN1CCN(C(=O)c2ccc3[nH]c4c(C(N)=O)cc(-c5ccc(Cl)cc5)cc4c3c2)CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"15.57";"0.30";"2.83";"8.44";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"4";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"0.72";"nM";"9.14";"";"";"UO_0000065";"21.59";"0.40";"4.89";"9.39";"1";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4070865";"";"None";"523.52";"1";"4.40";"20";"NC(=O)[C@H]1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"18.53";"0.35";"5.30";"6.86";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4062247";"";"None";"548.53";"1";"4.60";"14";"Nc1nccn2c([C@@H]3CCC[C@H](c4nn[nH]n4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"1587.0";"nM";"5.80";"";"";"UO_0000065";"10.57";"0.20";"1.20";"3.80";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3787217";"";"None";"511.59";"1";"3.70";"16c";"C=CC(=O)Nc1cccc(-n2c(=O)n(CC3CC3)c3cnc(Nc4ccc(N5CCOCC5)cc4)nc32)c1";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"14.68";"0.27";"3.81";"7.06";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4084927";"";"None";"566.58";"2";"6.03";"33";"CC(C)[C@]1(C(=O)O)CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"15.04";"0.28";"2.49";"6.29";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4079005";"";"None";"562.48";"1";"3.86";"30";"Nc1nccn2c(C34C5C6C3C3C4C5C63C(=O)O)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"13.00";"0.24";"3.45";"5.39";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4087578";"";"None";"524.50";"2";"5.00";"34";"C[C@]1(C(=O)O)CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"13.74";"0.26";"2.21";"5.32";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4792826";"";"None";"461.60";"0";"4.61";"20";"Cc1cc(-c2ccnc(Nc3ccn(C)n3)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"18.80";"0.36";"4.07";"8.89";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4852053";"";"None";"533.59";"1";"4.80";"40";"Cc1c(NC(=O)c2ccccn2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"166.0";"nM";"6.78";"";"";"UO_0000065";"12.71";"0.23";"1.98";"5.42";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4852342";"";"None";"522.57";"1";"4.12";"45";"Cc1c(NC(=O)c2ncc[nH]2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"14.14";"0.26";"3.27";"5.24";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4567040";"";"None";"505.53";"1";"4.22";"14";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3F)c2C)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"15.23";"0.28";"3.48";"6.97";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4439622";"";"None";"521.57";"1";"4.86";"27";"C=CC(=O)N(CC)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.92";"0.30";"3.44";"7.52";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4576801";"";"None";"521.57";"1";"4.86";"28";"C/C=C/C(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"263.0";"nM";"6.58";"";"";"UO_0000065";"12.62";"0.24";"1.72";"5.96";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4865983";"";"None";"469.55";"0";"4.50";"13a";"C=C(C)C(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"11736.0";"nM";"4.93";"";"";"UO_0000065";"10.50";"0.19";"0.43";"4.66";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3647971";"";"None";"454.53";"0";"4.61";"BDBM97676";"C/C=C/C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"214869";"UO_0000065";"16.94";"0.31";"3.09";"7.76";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670107";"";"None";"641.81";"2";"6.02";"BDBM111966";"CN1CCC(c2ccc(Nc3nc(-c4cc(F)cc(N5CCc6c(sc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2)CC1";"IC50";"'='";"2.6";"nM";"8.59";"";"233021";"UO_0000065";"13.38";"0.25";"2.57";"9.47";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670135";"";"None";"613.76";"2";"5.38";"BDBM111994";"CN1CCC(c2ccc(Nc3cc(-c4cc(F)cc(N5CCc6c(sc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)C1";"IC50";"'='";"3.3";"nM";"8.48";"";"233049";"UO_0000065";"13.82";"0.26";"3.10";"9.35";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3893004";"";"None";"511.63";"1";"4.59";"BDBM191622";"CN(C)C/C=C/C(=O)N[C@H]1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.38";"nM";"8.86";"";"342660";"UO_0000065";"17.32";"0.32";"4.27";"7.97";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL5285015";"";"None";"419.32";"0";"3.78";"9";"O=C(CNc1cc(Cl)cc(Cl)c1)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"18.36";"0.38";"3.92";"8.96";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5274934";"";"None";"516.63";"1";"3.33";"52";"O=C(CNc1ccccc1S(=O)(=O)c1ccccc1)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"15.14";"0.29";"4.49";"7.03";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL3657217";"";"None";"471.54";"1";"5.04";"BDBM134222";"CS(=O)(=O)Nc1cccc(-c2ncc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c23)c1";"IC50";"'='";"270.0";"nM";"6.57";"";"267611";"UO_0000065";"13.93";"0.26";"1.53";"5.34";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657227";"";"None";"331.38";"0";"3.96";"BDBM134232";"COc1cccc(-c2cnc(Nc3ccccc3)c3[nH]nc(N)c23)c1";"IC50";"'='";"290.0";"nM";"6.54";"";"267621";"UO_0000065";"19.73";"0.36";"2.58";"7.36";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657230";"";"None";"373.46";"1";"5.05";"BDBM134235";"Cc1ccccc1Nc1ncc(-c2cccc(OC(C)C)c2)c2c(N)n[nH]c12";"IC50";"'='";"240.0";"nM";"6.62";"";"267624";"UO_0000065";"17.73";"0.32";"1.57";"7.45";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657235";"";"None";"379.42";"1";"5.06";"BDBM134242";"Nc1n[nH]c2c(-c3ccccn3)cnc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"267631";"UO_0000065";"23.72";"0.42";"3.94";"10.03";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL5289250";"";"None";"473.96";"0";"3.10";"19";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(Cl)c(OC)c4)nn32)CC1";"IC50";"'='";"54.2";"nM";"7.27";"";"";"UO_0000065";"15.33";"0.30";"4.17";"6.50";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5266481";"";"None";"453.54";"0";"2.76";"20";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C)c(OC)c4)nn32)CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"16.50";"0.31";"4.72";"6.70";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5266823";"";"None";"479.61";"0";"3.96";"30";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5c(C)csc5c4)nn32)CC1";"IC50";"'='";"22.1";"nM";"7.66";"";"";"UO_0000065";"15.96";"0.31";"3.70";"7.47";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5272404";"";"None";"487.56";"0";"4.07";"36";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cc(OC)c(C4CC4)c(OC)c3)nn21";"IC50";"'='";"20.3";"nM";"7.69";"";"";"UO_0000065";"15.78";"0.29";"3.62";"6.38";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"Evobrutinib";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"17.83";"0.33";"3.31";"8.20";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4650323";"TOLEBRUTINIB";"3.0";"455.52";"0";"3.91";"PRN2246";"C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"18.02";"0.33";"4.30";"8.61";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5266481";"";"None";"453.54";"0";"2.76";"20";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C)c(OC)c4)nn32)CC1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"19.34";"0.36";"6.01";"7.85";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"4";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"198.0";"nM";"6.70";"";"";"UO_0000065";"14.40";"0.26";"3.39";"5.66";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4246324";"";"None";"397.50";"0";"3.77";"33";"C=CS(=O)(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"19.08";"0.37";"3.82";"7.88";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4238212";"";"None";"459.59";"0";"4.35";"21";"C=CC(=O)NC(C)(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"16.20";"0.30";"3.09";"6.88";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4237800";"";"None";"506.61";"1";"4.82";"10";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"9.3";"nM";"8.03";"";"";"UO_0000065";"15.85";"0.29";"3.21";"7.05";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4209666";"";"None";"540.63";"1";"3.51";"3d";"CN(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)cc1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"13.73";"0.25";"3.91";"5.23";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4213416";"";"None";"557.68";"1";"4.39";"3g";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(NC(=O)c3cc4c(s3)CCCC4)c2CO)n1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"13.54";"0.26";"3.16";"5.45";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209020";"";"None";"562.63";"2";"3.77";"3i";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(-n3ncc4cc(C5CC5)ccc4c3=O)c2CO)n1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"11.65";"0.21";"2.78";"4.54";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4212436";"";"None";"610.65";"2";"4.01";"4i";"COCCOCCn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"13.58";"0.25";"4.28";"4.99";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4205586";"";"None";"608.68";"1";"4.34";"3k";"CC(C)(C#N)c1cc(F)c2c(c1)CCN(c1cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c1CO)C2=O";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"14.45";"0.27";"4.46";"5.73";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3355049";"";"None";"457.46";"0";"2.42";"I-4";"COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C(O)CO)c3)n2)cc1";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"15.29";"0.29";"4.58";"5.07";"0";"CHEMBL3379054";"Inhibition of BTK (unknown origin) by Omnia continuous read kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351331";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3358399";"";"None";"588.71";"1";"4.62";"16e";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)ccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"11.79";"0.22";"2.32";"7.26";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3358408";"";"None";"632.74";"2";"5.34";"16n";"Cc1c(-c2cc(Nc3ccc(N4CCN(C5COC5)CC4)cn3)c(=O)n(C)c2)cccc1-n1ccc2cc(C3CC3)cc(F)c2c1=O";"IC50";"'='";"203.0";"nM";"6.69";"";"";"UO_0000065";"10.58";"0.19";"1.35";"7.91";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3358405";"";"None";"633.72";"1";"4.87";"16k";"CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)cc2)CC1";"IC50";"'='";"818.0";"nM";"6.09";"";"";"UO_0000065";"9.61";"0.18";"1.22";"6.10";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4784149";"";"None";"412.46";"0";"3.48";"5";"c1cc(N2CCOCC2)ccc1Nc1nc(-c2ccc3cn[nH]c3c2)nc2[nH]ncc12";"IC50";"'='";"167.0";"nM";"6.78";"";"";"UO_0000065";"16.43";"0.30";"3.30";"6.30";"0";"CHEMBL4773121";"Inhibition of BTK (unknown origin) using poly(Glu, Tyr) 4:1 as substrate incubated in presence of [gamma33P]ATP by image analyser";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765406";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3358397";"";"None";"661.78";"1";"4.44";"16c";"CN1CC(N2CCN(c3ccc(Nc4cc(-c5cccc(-n6ccc7cc(C8CC8)cc(F)c7c6=O)c5CO)cn(C)c4=O)nc3)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"12.16";"0.22";"3.61";"8.14";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4744759";"";"None";"611.60";"1";"4.91";"37";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1(C)COC1";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"15.97";"0.30";"4.86";"7.65";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4741355";"";"None";"544.59";"1";"3.21";"27";"Cc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)n1";"IC50";"'='";"104.0";"nM";"6.98";"";"";"UO_0000065";"12.82";"0.24";"3.77";"4.97";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4796764";"";"None";"543.60";"1";"3.82";"16";"Cc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"13.43";"0.25";"3.48";"5.72";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL3263658";"";"None";"625.75";"2";"5.64";"38";"Cc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"12.10";"0.23";"1.93";"5.32";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3621457";"";"None";"430.48";"0";"3.61";"1";"CN1CCN(C(=O)c2ccc3[nH]c4c(C(N)=O)ccc(-c5ccccc5F)c4c3c2)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"18.11";"0.33";"4.19";"9.46";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621508";"";"None";"469.55";"0";"2.83";"18";"CNC(=O)c1ccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)cc1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"15.67";"0.29";"4.53";"6.60";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621512";"";"None";"448.47";"0";"3.75";"22";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(F)c4F)c23)CC1";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"18.20";"0.34";"4.41";"9.90";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621519";"";"None";"545.64";"2";"5.04";"29";"Cc1c(NC(=O)c2ccccc2)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"14.92";"0.27";"3.10";"7.30";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3940151";"";"None";"541.56";"1";"5.00";"BDBM197241";"N#C/C(=C\C1CC1)C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3cc(F)ccc3F)cc2)c2c(N)ncnc21";"IC50";"'='";"3.8";"nM";"8.42";"";"350380";"UO_0000065";"15.55";"0.29";"3.42";"6.85";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114732";"";"None";"525.59";"2";"5.10";"BDBM197245";"CC(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"4.4";"nM";"8.36";"";"350441";"UO_0000065";"15.90";"0.29";"3.26";"6.80";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4550284";"";"None";"521.57";"1";"4.86";"26";"C=CC(=O)N(C)CCCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"16.19";"0.30";"3.58";"7.65";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL228043";"";"None";"360.01";"0";"3.51";"6, LFM-A13";"C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"15.56";"0.45";"2.09";"7.66";"1";"CHEMBL960391";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140982";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";""
"CHEMBL3904110";"";"None";"595.75";"2";"6.95";"BDBM202129";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C5CCN(CCO)CC5)cc4)cc23)cccc1-n1ccc2cc(C3CC3)ccc2c1=O";"IC50";"'='";"13.0";"nM";"7.89";"";"358207";"UO_0000065";"13.24";"0.24";"0.94";"9.06";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913119";"";"None";"568.73";"2";"6.09";"BDBM202075";"Cc1c(-c2ncnc3[nH]c(-c4cccc(CN5CCNCC5)c4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"515.0";"nM";"6.29";"";"358154";"UO_0000065";"11.06";"0.20";"0.20";"8.15";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968928";"";"None";"598.75";"2";"6.26";"BDBM202073";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCN(C)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"31.0";"nM";"7.51";"";"358161";"UO_0000065";"12.54";"0.23";"1.25";"9.68";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942801";"";"None";"582.71";"2";"5.72";"BDBM202104";"CN1CCN(c2ccc(-c3cc4c(-c5cccc(-n6ccc7cc(C8CC8)ccc7c6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"358182";"UO_0000065";"14.25";"0.26";"2.58";"9.19";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930057";"";"None";"600.72";"2";"5.45";"BDBM202119";"CN1CCN(c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"358197";"UO_0000065";"13.07";"0.24";"2.40";"8.03";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921994";"";"None";"574.69";"2";"5.30";"BDBM202123";"Cc1nn(C2CN(C)C2)cc1-c1cc2c(-c3cccc(N4CCOc5cc(C6CC6)ccc5C4=O)c3CO)ccnc2[nH]1";"IC50";"'='";"9.0";"nM";"8.05";"";"358201";"UO_0000065";"14.00";"0.26";"2.75";"8.09";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967108";"";"None";"646.77";"2";"5.98";"BDBM202141";"CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"358219";"UO_0000065";"13.45";"0.25";"2.72";"8.89";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937906";"";"None";"617.73";"2";"6.59";"BDBM202151";"CN1CCC(F)(c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"358228";"UO_0000065";"13.02";"0.24";"1.46";"8.51";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3685420";"";"None";"459.49";"0";"3.86";"BDBM120743";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)c(F)c3)nc3n[nH]cc23)c1";"IC50";"'='";"230.0";"nM";"6.64";"";"248800";"UO_0000065";"14.45";"0.27";"2.78";"6.14";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4126654";"";"None";"529.56";"2";"2.19";"3";"C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCOCC5)cc4OC)nc32)c1";"IC50";"'='";"852.0";"nM";"6.07";"";"";"UO_0000065";"11.46";"0.21";"3.88";"4.58";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4111707";"";"None";"593.59";"2";"5.53";"BDBM255461";"Nc1ncc(C(F)(F)F)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CC5)ccn4)cc3F)c12";"IC50";"'='";"3.8";"nM";"8.42";"";"445368";"UO_0000065";"14.19";"0.27";"2.89";"7.11";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110723";"";"None";"536.52";"1";"3.91";"BDBM255368";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)nc3)c12";"IC50";"'='";"3.3";"nM";"8.48";"";"445275";"UO_0000065";"15.81";"0.30";"4.57";"6.45";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114626";"";"None";"597.57";"2";"5.05";"BDBM255400";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.75";"nM";"9.12";"";"445307";"UO_0000065";"15.27";"0.29";"4.07";"7.14";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110295";"";"None";"522.03";"1";"4.52";"BDBM255403";"Cc1cnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)cc2)s1";"IC50";"'='";"0.81";"nM";"9.09";"";"445310";"UO_0000065";"17.42";"0.34";"4.57";"7.67";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106703";"";"None";"562.03";"1";"4.16";"BDBM255457";"COc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)c(OC)c2)c1";"IC50";"'='";"1.6";"nM";"8.80";"";"445364";"UO_0000065";"15.65";"0.30";"4.64";"6.42";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4284156";"";"None";"543.46";"2";"5.50";"7f";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)c(Cl)c3)ncc2Cl)c1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"16.85";"0.34";"3.65";"9.10";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4247514";"";"None";"523.59";"1";"3.99";"15g";"COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCN(C)CC6)cc5)c4c3c2)cn1";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"13.10";"0.24";"2.87";"7.39";"0";"CHEMBL4235188";"Inhibition of recombinant full length human N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4241577";"";"None";"510.55";"1";"4.08";"15c";"COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCOCC6)cc5)c4c3c2)cn1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"13.12";"0.24";"2.62";"6.78";"0";"CHEMBL4235188";"Inhibition of recombinant full length human N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL285063";"";"None";"369.22";"0";"4.26";"PD-168393";"C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1";"IC50";"'='";"5830.0";"nM";"5.23";"";"";"UO_0000065";"14.18";"0.31";"0.97";"7.82";"0";"CHEMBL1026513";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154498";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3605108";"";"None";"491.60";"0";"4.86";"14h";"CN(C)S(=O)(=O)n1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"527.6";"nM";"6.28";"";"";"UO_0000065";"12.77";"0.25";"1.42";"6.07";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3621498";"";"None";"469.55";"0";"3.43";"8";"CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"16.02";"0.29";"4.09";"6.75";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621507";"";"None";"468.60";"0";"4.77";"17";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccc(C(C)(C)C)cc4)c23)CC1";"IC50";"'='";"103.0";"nM";"6.99";"";"";"UO_0000065";"14.91";"0.27";"2.22";"8.48";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622201";"";"None";"469.55";"0";"3.43";"45";"CC(=O)Nc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c3c2)c1";"IC50";"'='";"379.0";"nM";"6.42";"";"";"UO_0000065";"13.68";"0.25";"2.99";"5.76";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4104307";"";"None";"632.77";"1";"3.98";"13";"CC1C=C(c2ccnc(-n3ccn4c5c(cc4c3=O)CCCC5)c2CO)C=C(Nc2ccc(N3CCN(C4COC4)CC3)cc2)C1=O";"IC50";"'='";"77.8";"nM";"7.11";"";"";"UO_0000065";"11.23";"0.21";"3.13";"6.81";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4090946";"";"None";"652.77";"1";"4.17";"14";"CC1C=C(c2ccnc(N3CCn4c5c(c(F)c4C3=O)CCCC5)c2CO)C=C(Nc2ccc(N3CCN(C4COC4)CC3)cc2)C1=O";"IC50";"'='";"42.4";"nM";"7.37";"";"";"UO_0000065";"11.29";"0.21";"3.20";"7.15";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4070991";"";"None";"665.80";"2";"2.97";"34";"C[C@H]1CN(C2COC2)CCN1c1cnc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)cn1";"IC50";"'='";"51.5";"nM";"7.29";"";"";"UO_0000065";"10.95";"0.20";"4.32";"5.44";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4287960";"";"None";"536.08";"2";"5.07";"7k";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(C)CC4)cc3C)ncc2Cl)c1";"IC50";"'='";"81.7";"nM";"7.09";"";"";"UO_0000065";"13.22";"0.25";"2.02";"7.49";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4248719";"";"None";"417.51";"0";"3.93";"15";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"19.86";"0.37";"4.36";"7.66";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4245876";"";"None";"394.43";"0";"3.94";"23";"Cc1c(-c2ccc(C(N)=O)c3[nH]ccc23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"15.87";"0.28";"2.32";"6.68";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4443198";"";"None";"379.42";"0";"2.05";"17k";"Nc1ncnc2c1c(-c1ccc3c(c1)OCO3)cn2[C@H]1CCN(C[C@@H]2CO2)C1";"IC50";"'='";"36.6";"nM";"7.44";"";"";"UO_0000065";"19.60";"0.36";"5.39";"8.18";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3649452";"";"None";"432.48";"0";"3.24";"BDBM122400";"Cc1nc(-c2cccc(-n3ncc4cc(C(C)(C)C)ccc4c3=O)c2CO)oc1C(N)=O";"IC50";"'='";"1255.0";"nM";"5.90";"";"250980";"UO_0000065";"13.65";"0.25";"2.66";"4.75";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3904442";"";"None";"281.29";"0";"3.49";"BDBM195808";"C=CC(=O)Nc1cc(-c2cnc3[nH]ccc3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348526";"UO_0000065";"21.80";"0.40";"2.64";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3968455";"";"None";"276.30";"0";"2.59";"BDBM195830";"CC#CC(=O)Nc1cccc(-c2cnc3[nH]ccc3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348534";"UO_0000065";"22.19";"0.40";"3.54";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3957855";"";"None";"504.59";"2";"5.32";"BDBM197202";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H]1Cn1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"3.7";"nM";"8.43";"";"350367";"UO_0000065";"16.71";"0.30";"3.11";"7.66";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3942924";"";"None";"552.68";"2";"5.44";"BDBM200826";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(NC(=O)c5ccc(C(C)(C)C)cc5)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"356875";"UO_0000065";"13.72";"0.25";"2.15";"6.63";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933092";"";"None";"569.64";"2";"5.26";"BDBM197253";"CCOC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"6600.0";"nM";"5.18";"";"350449";"UO_0000065";"9.09";"0.17";"-0.08";"3.92";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3939895";"";"None";"387.41";"1";"5.17";"BDBM195775";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(F)c4OC)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348512";"UO_0000065";"15.83";"0.29";"0.96";"9.15";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3928203";"";"None";"632.74";"2";"5.59";"BDBM202131";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"358209";"UO_0000065";"14.22";"0.26";"3.41";"9.20";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919488";"";"None";"646.72";"2";"5.11";"BDBM202144";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1=O";"IC50";"'='";"1.5";"nM";"8.82";"";"358222";"UO_0000065";"13.64";"0.25";"3.71";"7.68";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950703";"";"None";"700.74";"2";"6.52";"BDBM202145";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(CN5CCN(CC(F)(F)F)CC5)cn4)cc23)c1CO";"IC50";"'='";"1.6";"nM";"8.80";"";"358223";"UO_0000065";"12.55";"0.24";"2.28";"8.99";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904999";"";"None";"718.73";"2";"6.66";"BDBM202148";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cc(F)cc(-c2ccnc3[nH]c(-c4ccc(CN5CCN(CC(F)(F)F)CC5)cn4)cc23)c1CO";"IC50";"'='";"1.9";"nM";"8.72";"";"358225";"UO_0000065";"12.13";"0.23";"2.06";"8.92";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4115692";"";"None";"541.56";"1";"5.00";"BDBM197197";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccc(F)c(F)c3)cc2)c2c(N)ncnc21";"IC50";"'='";"140.0";"nM";"6.85";"";"350378";"UO_0000065";"12.66";"0.23";"1.85";"5.57";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3901377";"";"None";"523.57";"1";"4.86";"BDBM197218";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)c(F)c2)c2c(N)ncnc21";"IC50";"'='";"2.8";"nM";"8.55";"";"350386";"UO_0000065";"16.34";"0.30";"3.69";"6.96";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3921017";"";"None";"414.47";"0";"3.51";"BDBM191623";"C=CC(=O)N(C)CCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"1.58";"nM";"8.80";"";"385053";"UO_0000065";"21.24";"0.39";"5.29";"8.88";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1761510";"";"None";"319.41";"0";"3.40";"12";"NC(=O)c1cc(-c2ccccc2)cc2c(C3CCCNC3)c[nH]c12";"IC50";"'='";"1258.93";"nM";"5.90";"";"";"UO_0000065";"18.47";"0.34";"2.50";"8.32";"0";"CHEMBL1764212";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759890";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"3; GS-4059; ONO-4059";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"103.0";"nM";"6.99";"";"";"UO_0000065";"15.37";"0.28";"4.24";"6.45";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"29, RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"15.70";"0.29";"4.76";"9.96";"0";"CHEMBL2060652";"Competitive inhibition of BTK by TR-FRET based competitive assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4097968";"";"None";"524.50";"2";"5.00";"21";"Nc1nccn2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nc2[C@H]1CC[C@H](C(=O)O)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.01";"0.32";"3.92";"6.58";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4103954";"";"None";"581.57";"2";"5.29";"3";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"16.37";"0.31";"4.23";"8.04";"1";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4095386";"";"None";"538.58";"1";"3.73";"7d";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N(CCOC)CCOC)cc3)ncc2F)c1";"IC50";"'='";"27.2";"nM";"7.57";"";"";"UO_0000065";"14.05";"0.26";"3.84";"5.96";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3889694";"";"None";"511.63";"1";"4.59";"BDBM191613";"CN(C)C/C=C/C(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"342650";"UO_0000065";"17.31";"0.32";"4.26";"7.96";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3903870";"";"None";"497.60";"0";"3.98";"BDBM191608";"CN(C)C/C=C/C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"0.92";"nM";"9.04";"";"342653";"UO_0000065";"18.16";"0.33";"5.06";"8.82";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3400975";"";"None";"518.55";"2";"5.81";"4c";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(-c4ccc(O)cc4)cc23)c1CO";"IC50";"'='";"73.9";"nM";"7.13";"";"";"UO_0000065";"13.75";"0.25";"1.32";"6.86";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400977";"";"None";"517.56";"2";"5.69";"4e";"Nc1cccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)c1";"IC50";"'='";"135.5";"nM";"6.87";"";"";"UO_0000065";"13.27";"0.24";"1.18";"6.25";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400979";"";"None";"573.63";"2";"5.81";"4g";"CN(C)C(=O)c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1";"IC50";"'='";"17.8";"nM";"7.75";"";"";"UO_0000065";"13.51";"0.25";"1.94";"7.44";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4752522";"";"None";"483.62";"1";"5.85";"5";"CCC(=O)N(C)Cc1c[nH]c2ncnc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)c12";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"11.18";"0.21";"-0.44";"5.95";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4744271";"";"None";"523.61";"2";"6.09";"11";"C=CC(=O)N1CCCC(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)C1";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"12.24";"0.22";"0.32";"7.04";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4793026";"";"None";"483.55";"1";"5.35";"7";"C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cc(F)cc(NC(=O)c4ccc(C5CC5)cc4)c3C)c12";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.69";"0.29";"2.24";"8.34";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4756476";"NEMTABRUTINIB";"3.0";"478.94";"0";"4.59";"16; ARQ531";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@@H]3CC[C@@H](CO)OC3)c12";"IC50";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"18.94";"0.36";"4.48";"8.29";"0";"CHEMBL4668352";"Inhibition of wild type human BTK using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665674";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"16.30";"0.30";"2.96";"7.24";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4744536";"";"None";"452.47";"0";"4.26";"10";"COCC#CC(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1";"IC50";"'='";"0.15";"nM";"9.82";"";"";"UO_0000065";"21.71";"0.39";"5.56";"9.59";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4791702";"";"None";"438.44";"0";"3.61";"11";"O=C(C#CCO)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1";"IC50";"'='";"0.33";"nM";"9.48";"";"";"UO_0000065";"21.63";"0.39";"5.87";"8.36";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3967766";"";"None";"392.51";"0";"3.80";"BDBM250515";"CC(C)(C)c1ccc(C(=O)NC2CCCC(Nc3ncnc4[nH]cnc34)C2)cc1";"IC50";"'='";"9572.72";"nM";"5.02";"";"436763";"UO_0000065";"12.79";"0.24";"1.22";"5.25";"0";"CHEMBL3889150";"FRET (Forster/Flouresence Resonance Energy Transfer) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 ul of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission). The negative control well values were averaged to obtain the mean minimum. The positive 'no inhibitor' control wells were averaged to obtain the mean maximum.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886966";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894014";"";"None";"604.64";"2";"5.07";"BDBM197258";"CN(C)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"1.5";"nM";"8.82";"";"350404";"UO_0000065";"14.59";"0.27";"3.75";"6.99";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114716";"";"None";"523.57";"1";"4.86";"BDBM197185";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3)cc2)c2c(N)ncnc21";"IC50";"'='";"6.2";"nM";"8.21";"";"350421";"UO_0000065";"15.68";"0.29";"3.35";"6.68";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114695";"";"None";"554.63";"1";"4.45";"BDBM197199";"CNC(C)(C)/C=C(\C#N)C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"1.4";"nM";"8.85";"";"350445";"UO_0000065";"15.96";"0.29";"4.40";"6.56";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114726";"";"None";"568.66";"1";"4.84";"BDBM197250";"CCNC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"0.4";"nM";"9.40";"";"350447";"UO_0000065";"16.53";"0.31";"4.56";"6.96";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3971384";"";"None";"590.73";"2";"5.52";"BDBM200850";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(S(=O)(=O)N(C)C)CC3)cc12";"IC50";"'='";"140.0";"nM";"6.85";"";"356881";"UO_0000065";"11.60";"0.22";"1.33";"6.16";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974518";"";"None";"510.52";"1";"4.93";"BDBM197206";"CC(C)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"6.0";"nM";"8.22";"";"350452";"UO_0000065";"16.10";"0.30";"3.29";"8.29";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3977187";"";"None";"383.41";"0";"3.96";"5";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c1ccc(N)cc12";"IC50";"'='";"322.2";"nM";"6.49";"";"";"UO_0000065";"16.93";"0.31";"2.53";"5.83";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3921167";"";"None";"479.54";"0";"4.97";"18a";"C=CC(=O)Nc1cccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.14";"0.33";"3.73";"7.82";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3921167";"";"None";"479.54";"0";"4.97";"18a";"C=CC(=O)Nc1cccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"16.81";"0.31";"3.09";"7.24";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"19.97";"0.37";"5.27";"8.11";"0";"CHEMBL4358574";"Inhibition of BTK in human basophils assessed as reduction in anti-IgE mouse IgG1 antibody Le2-stimulated CD63 expression on basophil preincubated for 30 mins in presence of IgE antibody B11 followed by anti-IgE mouse IgG1 antibody Le2 stimulation and measured after 15 mins by flow cytometry";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4584007";"";"None";"531.64";"2";"5.33";"5r";"CCOC(=O)c1sc(-c2cccc(NC(=O)c3ccco3)c2)nc1Nc1ccc(N2CCN(C)CC2)cc1";"IC50";"'='";"161.0";"nM";"6.79";"";"";"UO_0000065";"12.78";"0.24";"1.46";"6.80";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4547271";"";"None";"530.63";"1";"4.80";"7m";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccccc5F)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"2671.0";"nM";"5.57";"";"";"UO_0000065";"10.50";"0.20";"0.77";"5.38";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4541650";"";"None";"565.07";"2";"5.45";"7o";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccc(F)c(Cl)c5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.47";"0.25";"1.60";"6.80";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4455183";"";"None";"512.64";"1";"4.66";"7k";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccccc5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"159.0";"nM";"6.80";"";"";"UO_0000065";"13.26";"0.25";"2.14";"6.56";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4525695";"";"None";"568.75";"2";"5.95";"7j";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccc(C(C)(C)C)cc5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"5254.0";"nM";"5.28";"";"";"UO_0000065";"9.28";"0.18";"-0.67";"5.10";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4470618";"";"None";"569.73";"2";"6.30";"7t";"CNC(=O)c1sc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2)nc1Nc1ccc(N2CCOCC2)cc1";"IC50";"'='";"8529.0";"nM";"5.07";"";"";"UO_0000065";"8.90";"0.17";"-1.23";"5.30";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4447710";"";"None";"565.67";"2";"5.51";"CGI1746";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1c[nH]c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"14.23";"0.26";"2.54";"6.92";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4550271";"";"None";"409.45";"1";"5.85";"A4";"C=CC(=O)Nc1cccc(Oc2ncncc2-c2ccc(Oc3ccccc3)cc2)c1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"18.65";"0.34";"1.79";"10.41";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4588680";"";"None";"408.46";"1";"6.46";"A6";"C=CC(=O)Nc1cccc(Oc2ccncc2-c2ccc(Oc3ccccc3)cc2)c1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"18.01";"0.32";"0.90";"12.17";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4515024";"";"None";"427.51";"0";"4.11";"A16";"C=CC(=O)N1CC2(CC(Nc3ncnc(N)c3-c3ccc(Oc4ccccc4)cc3)C2)C1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"20.30";"0.37";"4.57";"9.29";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3670086";"";"None";"496.57";"0";"3.42";"3";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"16.56";"0.30";"4.80";"7.81";"1";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.08";"nM";"10.10";"";"";"UO_0000065";"22.92";"0.42";"5.88";"10.18";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4645440";"";"None";"376.48";"0";"1.92";"4d";"C=CS(=O)(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"21.5";"nM";"7.67";"";"";"UO_0000065";"20.37";"0.40";"5.75";"7.08";"0";"CHEMBL4616857";"Inhibition of BTK in human whole blood cells after 120 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4647555";"";"None";"421.65";"None";"None";"14c";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4)ncc2Cl)c1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"19.75";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4648837";"";"None";"455.21";"None";"None";"14a; 9";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4)ncc2C(F)(F)F)c1";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"18.76";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4097957";"";"None";"522.49";"1";"4.47";"24";"Nc1nccn2c([C@H]3C[C@@H]4[C@H](C3)[C@H]4C(=O)O)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.23";"0.29";"3.49";"5.87";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4097019";"";"None";"594.59";"2";"5.72";"31";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc(C23CCC(C(=O)O)(CC2)CC3)n2ccnc(N)c12";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"16.02";"0.30";"3.80";"6.58";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4085200";"";"None";"568.08";"1";"4.58";"7i";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(=O)CN(CCOC)CCOC)c(C)c3)ncc2Cl)c1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"13.55";"0.26";"3.12";"5.93";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3894155";"";"None";"417.47";"0";"2.79";"BDBM249957";"C=CC(=O)NCC1CNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn2C1";"IC50";"'='";"2.2";"nM";"8.66";"";"435889";"UO_0000065";"20.74";"0.38";"5.87";"7.78";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947816";"";"None";"375.43";"0";"2.46";"BDBM249958";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC1(CNC1)C2";"IC50";"'='";"2000.0";"nM";"5.70";"";"435890";"UO_0000065";"15.18";"0.28";"3.24";"6.05";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984082";"";"None";"512.40";"1";"4.75";"BDBM250006";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccc(Cl)c(Cl)c5)cc4)nn32)C1";"IC50";"'='";"1.7";"nM";"8.77";"";"435935";"UO_0000065";"17.11";"0.34";"4.02";"8.56";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897758";"";"None";"501.56";"1";"4.20";"BDBM250069";"CC#CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)nn32)CC1";"IC50";"'='";"45.0";"nM";"7.35";"";"436001";"UO_0000065";"14.65";"0.27";"3.15";"7.17";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114242";"";"None";"608.62";"2";"5.14";"BDBM255448";"COCCOc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"1.9";"nM";"8.72";"";"445355";"UO_0000065";"14.33";"0.27";"3.58";"7.03";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110969";"";"None";"623.64";"1";"4.93";"BDBM255450";"CCOCCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"3.2";"nM";"8.49";"";"445357";"UO_0000065";"13.62";"0.26";"3.56";"6.20";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108663";"";"None";"650.01";"2";"6.16";"BDBM255465";"CC(F)(F)Oc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"6.6";"nM";"8.18";"";"445372";"UO_0000065";"12.59";"0.25";"2.02";"6.40";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3979355";"";"None";"665.77";"2";"4.42";"PRN1008";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"13.35";"0.25";"4.47";"6.41";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4175428";"";"None";"468.52";"0";"3.14";"10";"CC#CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"18.48";"0.34";"5.52";"8.00";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3907763";"";"None";"629.76";"2";"6.05";"5";"CC1(O)CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"12.97";"0.24";"2.12";"7.11";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3652654";"";"None";"585.64";"2";"2.98";"BDBM122415";"CN1CCn2nc(Nc3nn(-c4cccc(-n5ncc6cc(C(C)(C)C)cc(F)c6c5=O)c4CO)cc3C(N)=O)cc2C1";"IC50";"'='";"0.09";"nM";"10.05";"";"250995";"UO_0000065";"17.15";"0.32";"7.07";"6.74";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4561220";"";"None";"427.51";"0";"4.12";"24e";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CCN(C[C@H]2CO2)C1";"IC50";"'='";"89.4";"nM";"7.05";"";"";"UO_0000065";"16.49";"0.30";"2.93";"8.62";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4440181";"";"None";"393.45";"0";"2.27";"27c";"Nc1ncnc2c1c(-c1ccc3c(c1)OCO3)cn2C[C@H]1CCCN1C[C@@H]1CO1";"IC50";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"20.46";"0.38";"5.78";"8.85";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4224933";"";"None";"406.49";"0";"2.77";"8a1";"C=CC(=O)N1CCC[C@@H](n2nc(CCCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"22.18";"nM";"7.65";"";"";"UO_0000065";"18.83";"0.35";"4.88";"7.72";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4225333";"";"None";"404.47";"0";"2.85";"8a3";"C=CC(=O)N1CCC[C@@H](n2nc(/C=C/COc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"11.3";"nM";"7.95";"";"";"UO_0000065";"19.65";"0.36";"5.10";"8.01";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4239634";"";"None";"458.52";"0";"4.04";"10";"C=CC(=O)N[C@@H]1CCCN(c2ccc(C(N)=O)c(Oc3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"13.88";"0.26";"2.33";"5.96";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4243203";"";"None";"444.49";"0";"3.96";"8";"C=CC(=O)N1CC[C@@H](Nc2ccc(C(N)=O)c(Oc3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.74";"0.33";"3.93";"7.39";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4241920";"";"None";"444.49";"0";"3.65";"7";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Oc3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"17.10";"0.31";"3.95";"7.12";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3685422";"";"None";"350.81";"0";"4.67";"BDBM120745";"C=CC(=O)Nc1cccc(-c2nc(Cl)ncc2Nc2ccccc2)c1";"IC50";"'='";"1810.0";"nM";"5.74";"";"248802";"UO_0000065";"16.37";"0.31";"1.07";"8.58";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3685425";"";"None";"435.92";"0";"4.50";"BDBM120748";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2Cl)c1";"IC50";"'='";"33.0";"nM";"7.48";"";"248805";"UO_0000065";"17.16";"0.33";"2.98";"9.42";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4438747";"";"None";"595.77";"2";"5.65";"30p";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCN(C(C)C)CC4)cc3)ncc2F)c1";"IC50";"'='";"56.9";"nM";"7.25";"";"";"UO_0000065";"12.16";"0.24";"1.59";"7.65";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4590126";"";"None";"599.72";"2";"6.29";"30y";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4ccc(C#N)cc4)cc3)ncc2F)c1";"IC50";"'='";"8.58";"nM";"8.07";"";"";"UO_0000065";"13.45";"0.26";"1.78";"6.51";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"3.89";"nM";"8.41";"";"";"UO_0000065";"19.09";"0.35";"4.19";"8.48";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4517522";"";"None";"526.66";"2";"5.58";"30ag";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCSC(=S)N(C)C)cc3)ncc2F)c1";"IC50";"'='";"13.9";"nM";"7.86";"";"";"UO_0000065";"14.92";"0.30";"2.28";"8.60";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4212668";"";"None";"549.68";"2";"6.22";"2a";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cncc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.73";"0.23";"0.78";"7.26";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4207762";"";"None";"550.66";"2";"5.61";"2b";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cnnc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"14.53";"0.27";"2.39";"7.32";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217003";"";"None";"553.67";"1";"4.74";"3a";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)cc1";"IC50";"'='";"0.74";"nM";"9.13";"";"";"UO_0000065";"16.49";"0.30";"4.39";"6.59";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4237249";"";"None";"431.54";"0";"3.96";"16";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"17.50";"0.32";"3.59";"7.60";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4791249";"";"None";"443.51";"0";"4.11";"B8";"C=CC(=O)Nc1cccc(Nc2ncnc(Nc3ccc(C(=O)N4CCCCC4)cc3)n2)c1";"IC50";"'='";"4360.0";"nM";"5.36";"";"";"UO_0000065";"12.09";"0.22";"1.25";"4.78";"0";"CHEMBL4769972";"Inhibition of BTK in human TMD8 cells assessed as reduction in cell proliferation incubated for 24 hrs by CCK-8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TMD8";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765318";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 24.0 hr";"INHIBITOR";""
"CHEMBL4778259";"";"None";"452.48";"1";"5.87";"9";"CC(C)(C)c1ccc(C(=O)NCc2ccc(-c3ncnc4[nH]ccc34)cc2C(F)(F)F)cc1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"15.53";"0.29";"1.16";"9.94";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4788285";"";"None";"457.60";"1";"5.88";"14";"Cc1cc(-c2ccnc(Nc3ccccc3)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"19.11";"0.36";"2.86";"10.96";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4103138";"";"None";"465.94";"1";"5.30";"7j";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC4CCCO4)cc3)ncc2Cl)c1";"IC50";"'='";"12.1";"nM";"7.92";"";"";"UO_0000065";"16.99";"0.33";"2.62";"8.13";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4443805";"";"None";"555.64";"1";"3.59";"9";"C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1";"IC50";"'='";"996.0";"nM";"6.00";"";"";"UO_0000065";"10.80";"0.20";"2.41";"4.50";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4458344";"";"None";"555.64";"1";"3.59";"41";"C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"13.42";"0.25";"3.87";"5.59";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4589396";"";"None";"501.56";"1";"4.47";"12";"C=CC(=O)N1CCC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3)c2C)C1";"IC50";"'='";"3651.0";"nM";"5.44";"";"";"UO_0000065";"10.84";"0.20";"0.97";"4.92";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4593663";"";"None";"521.60";"2";"6.00";"8";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)CC1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"17.34";"0.32";"3.05";"9.94";"1";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4546324";"";"None";"503.55";"2";"5.10";"17";"C=CC(=O)N(C)C/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"14.61";"0.27";"2.26";"7.27";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"17.83";"0.33";"3.63";"7.92";"1";"CHEMBL4264032";"Inhibition of BTK in human WBC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"2";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"16.37";"0.30";"4.31";"6.43";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4591291";"";"None";"519.55";"1";"4.61";"24";"C=CC(=O)N1CC[C@@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"354.0";"nM";"6.45";"";"";"UO_0000065";"12.42";"0.23";"1.84";"5.84";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"20.91";"0.39";"5.61";"8.49";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14f; (R)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.30";"0.23";"2.65";"5.72";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14f; (R)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"12.31";"0.23";"2.65";"5.73";"0";"CHEMBL3858937";"Inhibition of BTK in human whole blood basophils assessed as suppression of FceRI/anti-IgE-stimulated CD63 surface expression";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4559123";"";"None";"485.56";"0";"4.96";"10";"C=CC(=O)N(C)C/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2)c1C";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"17.34";"0.32";"3.46";"8.32";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"19.61";"0.36";"4.42";"8.71";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4589396";"";"None";"501.56";"1";"4.47";"12";"C=CC(=O)N1CCC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3)c2C)C1";"IC50";"'='";"1437.0";"nM";"5.84";"";"";"UO_0000065";"11.65";"0.22";"1.37";"5.29";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL1916719";"";"None";"343.82";"0";"2.62";"23";"CN(C)C/C=C/C(=O)N(C)c1ccc2nc(Cl)c3cncn3c2c1";"IC50";"'='";"4290.0";"nM";"5.37";"";"";"UO_0000065";"15.61";"0.31";"2.75";"9.99";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916883";"";"None";"448.96";"0";"4.67";"28";"Cc1cccc(Cl)c1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"10.3";"nM";"7.99";"";"";"UO_0000065";"17.79";"0.34";"3.32";"12.14";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916885";"";"None";"448.96";"0";"4.67";"30";"Cc1cc(Cl)ccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"7.56";"nM";"8.12";"";"";"UO_0000065";"18.09";"0.35";"3.45";"12.35";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916896";"";"None";"469.38";"1";"5.01";"41";"CN(C)C/C=C/C(=O)N(C)c1cc2c(cc1Cl)nc(Nc1ccccc1Cl)c1cncn12";"IC50";"'='";"5.03";"nM";"8.30";"";"";"UO_0000065";"17.68";"0.35";"3.29";"12.62";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4281823";"";"None";"481.48";"0";"4.73";"22b";"CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21";"IC50";"'='";"862.0";"nM";"6.06";"";"";"UO_0000065";"12.60";"0.24";"1.33";"7.03";"0";"CHEMBL4261403";"Inhibition of recombinant full length human BTK using KVEKIGEGTYGVV as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257593";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4291033";"";"None";"370.39";"0";"1.34";"10";"C=CC(=O)N[C@H]1CCN(c2ncc(C(N)=O)c(Nc3ccc(F)cc3)n2)C1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"21.86";"0.41";"6.76";"7.15";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4277875";"";"None";"448.57";"0";"2.44";"19";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"19.44";"0.36";"6.28";"8.42";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"18.93";"0.35";"4.12";"8.41";"0";"CHEMBL4236258";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced CD69 expression incubated for 1 hr by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3605110";"";"None";"482.57";"0";"4.41";"19a";"CNC(=O)Cn1cc(-c2cnc(N)c3c(-c4cccc(C(=O)Nc5ccccc5)c4)csc23)cn1";"IC50";"'='";"291.5";"nM";"6.54";"";"";"UO_0000065";"13.54";"0.26";"2.13";"5.69";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4437669";"";"None";"384.40";"1";"5.16";"10b";"O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1";"IC50";"'='";"880.0";"nM";"6.06";"";"";"UO_0000065";"15.75";"0.29";"0.90";"5.98";"0";"CHEMBL4412233";"Inhibition of BTK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411283";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4111790";"";"None";"593.57";"2";"5.11";"BDBM255330";"COC(=O)Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"7.3";"nM";"8.14";"";"445235";"UO_0000065";"13.71";"0.26";"3.03";"6.22";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113649";"";"None";"563.54";"1";"4.90";"BDBM255360";"C=C[C@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"16.8";"nM";"7.78";"";"445266";"UO_0000065";"13.80";"0.26";"2.87";"6.09";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3670099";"";"None";"642.80";"2";"5.11";"BDBM111957";"CCN1CCN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCc6c(sc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"233012";"UO_0000065";"13.06";"0.25";"3.29";"8.94";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670121";"";"None";"598.68";"1";"3.86";"BDBM111980";"CN1CC(Oc2ccc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)C1";"IC50";"'='";"9.8";"nM";"8.01";"";"233035";"UO_0000065";"13.38";"0.25";"4.15";"7.64";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4159459";"";"None";"503.56";"2";"5.39";"21";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NC(=O)NC)cc5)cc4c32)ccc1C";"IC50";"'='";"79.1";"nM";"7.10";"";"";"UO_0000065";"14.10";"0.26";"1.71";"6.76";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4161149";"";"None";"459.51";"0";"4.26";"26";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6ccc(N)nc6)cc5c43)cc21";"IC50";"'='";"6.01";"nM";"8.22";"";"";"UO_0000065";"17.89";"0.32";"3.96";"8.74";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4107331";"";"None";"533.52";"1";"4.40";"BDBM246397";"Cn1ncc2c1CCC[C@H]2n1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"5.9";"nM";"8.23";"";"429698";"UO_0000065";"15.42";"0.29";"3.83";"6.36";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3902516";"";"None";"547.55";"1";"4.88";"BDBM246412";"CCn1cc2c(n1)CCC[C@@H]2n1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"54.0";"nM";"7.27";"";"429705";"UO_0000065";"13.27";"0.25";"2.39";"5.62";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113220";"";"None";"563.54";"1";"3.86";"BDBM246401";"Nc1ncnc2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nn2[C@@H]1CCCc2c1cnn2CCO";"IC50";"'='";"1.1";"nM";"8.96";"";"429706";"UO_0000065";"15.90";"0.30";"5.10";"5.99";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108484";"";"None";"479.54";"0";"4.97";"BDBM250073";"C=CC(=O)Nc1cccc([C@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"2.5";"nM";"8.60";"";"435791";"UO_0000065";"17.94";"0.33";"3.63";"7.73";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964332";"";"None";"479.54";"0";"4.97";"BDBM250074";"C=CC(=O)Nc1cccc([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"1.7";"nM";"8.77";"";"435792";"UO_0000065";"18.29";"0.33";"3.80";"7.88";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893163";"";"None";"481.56";"1";"5.19";"BDBM249877";"CCC(=O)Nc1cccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"435793";"UO_0000065";"15.75";"0.29";"2.40";"6.82";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"214868";"UO_0000065";"20.75";"0.38";"4.92";"9.22";"1";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3958612";"";"None";"276.30";"0";"2.51";"BDBM195838";"C#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348542";"UO_0000065";"22.19";"0.40";"3.62";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3984974";"";"None";"559.55";"2";"5.14";"BDBM197211";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3cc(F)cc(F)c3)cc2F)c2c(N)ncnc21";"IC50";"'='";"3.2";"nM";"8.49";"";"350381";"UO_0000065";"15.18";"0.28";"3.35";"6.91";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114808";"";"None";"568.66";"1";"4.79";"BDBM197247";"CN(C)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"3.6";"nM";"8.44";"";"350395";"UO_0000065";"14.85";"0.27";"3.65";"6.69";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3927641";"";"None";"568.66";"1";"4.84";"BDBM197251";"CCNC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"17.2";"nM";"7.76";"";"350397";"UO_0000065";"13.65";"0.25";"2.92";"5.75";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114704";"";"None";"541.56";"2";"5.17";"BDBM197195";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cc(F)ccc4F)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.2";"nM";"8.38";"";"350426";"UO_0000065";"15.47";"0.29";"3.21";"6.81";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4290449";"";"None";"522.58";"1";"4.34";"7n";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OCCCN4CCOCC4)c3)ncc2F)c1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"17.52";"0.33";"4.81";"8.33";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"Spebrutinib";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"21.78";"0.41";"4.97";"9.47";"1";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"21.62";"0.39";"5.30";"9.60";"1";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL2216827";"";"None";"499.51";"0";"4.77";"4; CNX-774";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3)ncc2F)c1";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"16.06";"0.30";"3.25";"6.16";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4096207";"";"None";"651.79";"2";"5.89";"30";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4cc5c(s4)CCCC5)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"16.5";"nM";"7.78";"";"";"UO_0000065";"11.94";"0.23";"1.89";"6.39";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4069348";"";"None";"591.67";"1";"4.95";"14";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccccc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"3736.0";"nM";"5.43";"";"";"UO_0000065";"9.17";"0.17";"0.48";"4.46";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3903416";"";"None";"605.45";"2";"5.76";"BDBM230115";"Cn1c(=O)n(-c2cccc(-c3c(Cl)cc(C(N)=O)c4[nH]c5cc(C(C)(C)O)ccc5c34)c2Cl)c(=O)c2cccc(F)c21";"IC50";"'='";"4.7";"nM";"8.33";"";"401979";"UO_0000065";"13.75";"0.27";"2.57";"6.76";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901137";"";"None";"558.59";"1";"4.16";"BDBM230137";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.56";"nM";"9.25";"";"402003";"UO_0000065";"16.56";"0.31";"5.09";"7.55";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921017";"";"None";"414.47";"0";"3.51";"BDBM191623";"C=CC(=O)N(C)CCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"1.58";"nM";"8.80";"";"342661";"UO_0000065";"21.24";"0.39";"5.29";"8.88";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3950862";"";"None";"580.67";"2";"5.10";"BDBM143177";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCC1";"IC50";"'='";"4.1";"nM";"8.39";"";"279399";"UO_0000065";"14.44";"0.27";"3.29";"6.65";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3702838";"";"None";"511.56";"1";"4.71";"BDBM143190";"CC(C)/C=C(\C#N)C(=O)N1CCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"4.0";"nM";"8.40";"";"279410";"UO_0000065";"16.42";"0.30";"3.69";"6.83";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647518";"";"None";"466.55";"0";"4.61";"BDBM143320";"C=CC(=O)N1CCC2(CC(n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"0.87";"nM";"9.06";"";"279480";"UO_0000065";"19.42";"0.35";"4.45";"9.14";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4475004";"";"None";"351.34";"0";"2.61";"25";"COc1cc2cn[nH]c2cc1-c1ccc(F)c2c(N)c(C(N)=O)cnc12";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"23.55";"0.43";"5.67";"6.90";"0";"CHEMBL4335770";"Reversible inhibition of FAM-labeled peptide binding to full-length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus infected Sf21 insect cells at preincubated for 10 mins followed by FAM-labeled peptide addition and measured by off-chip mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334447";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3263631";"";"None";"534.62";"2";"6.33";"11";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)O)cc2)c2ncn(C)c2n1";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"13.46";"0.25";"0.86";"5.90";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263647";"";"None";"589.70";"2";"6.09";"27";"Cc1ccc(NC(=O)c2ccc(C(C)(C)C)cc2)cc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"12.19";"0.22";"1.10";"5.74";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263657";"";"None";"554.66";"1";"5.00";"37";"Cc1c(NC(=O)NC2CCCCC2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"13.18";"0.24";"2.31";"5.33";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL4087337";"";"None";"284.27";"0";"2.72";"41";"COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2";"IC50";"'='";"5030.0";"nM";"5.30";"";"";"UO_0000065";"18.64";"0.34";"2.58";"6.97";"0";"CHEMBL4014528";"Inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014275";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4159628";"";"None";"421.46";"1";"5.23";"15";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccoc5)cc4c32)ccc1C";"IC50";"'='";"17.4";"nM";"7.76";"";"";"UO_0000065";"18.41";"0.33";"2.53";"10.06";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4112842";"";"None";"443.51";"0";"3.27";"BDBM249904";"C=CC(=O)N1CC[C@H]2Nc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3C[C@H]2C1";"IC50";"'='";"15.0";"nM";"7.82";"";"435832";"UO_0000065";"17.64";"0.32";"4.55";"7.63";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897911";"";"None";"493.57";"0";"5.00";"BDBM249887";"C=CC(=O)N(C)c1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"4.7";"nM";"8.33";"";"435807";"UO_0000065";"16.87";"0.31";"3.33";"8.13";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904623";"";"None";"457.51";"1";"5.03";"BDBM249888";"CNc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccc(F)cc4)cc3)nn21";"IC50";"'='";"2700.0";"nM";"5.57";"";"435808";"UO_0000065";"12.17";"0.22";"0.54";"5.91";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912307";"";"None";"417.51";"0";"3.80";"BDBM249899";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2C1CCNCC1";"IC50";"'='";"1700.0";"nM";"5.77";"";"435821";"UO_0000065";"13.82";"0.25";"1.97";"6.12";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947318";"";"None";"389.46";"0";"3.02";"BDBM249901";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2C1CNC1";"IC50";"'='";"3400.0";"nM";"5.47";"";"435825";"UO_0000065";"14.04";"0.26";"2.45";"5.81";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969979";"";"None";"479.58";"0";"4.86";"BDBM249911";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC21CCN(Cc2ccccc2)CC1";"IC50";"'='";"490.0";"nM";"6.31";"";"435841";"UO_0000065";"13.16";"0.24";"1.45";"7.39";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978821";"";"None";"411.47";"0";"3.98";"BDBM249942";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCc1cc(N)ccc1-2";"IC50";"'='";"55.0";"nM";"7.26";"";"435874";"UO_0000065";"17.64";"0.32";"3.28";"6.71";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942135";"";"None";"497.60";"0";"4.59";"BDBM249962";"CN(C)CCOc1cccc(C2CNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3C2)c1";"IC50";"'='";"1900.0";"nM";"5.72";"";"435894";"UO_0000065";"11.50";"0.21";"1.13";"6.05";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3976076";"";"None";"387.44";"0";"3.18";"BDBM250028";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccccc3)nn21";"IC50";"'='";"4.7";"nM";"8.33";"";"435957";"UO_0000065";"21.49";"0.39";"5.15";"8.16";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945450";"";"None";"435.46";"0";"3.33";"BDBM250037";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(F)c(OC)c3)nn21";"IC50";"'='";"1.0";"nM";"9.00";"";"435966";"UO_0000065";"20.67";"0.38";"5.67";"8.09";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959393";"";"None";"451.91";"0";"3.84";"BDBM250038";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)c(OC)c3)nn21";"IC50";"'='";"0.49";"nM";"9.31";"";"435967";"UO_0000065";"20.60";"0.40";"5.47";"8.37";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940696";"";"None";"488.59";"0";"3.43";"BDBM250043";"COc1cc(-c2nn3c(c2C(N)=O)NCCC3c2ccccc2NC(=O)/C=C/CN(C)C)ccc1C";"IC50";"'='";"1.6";"nM";"8.80";"";"435972";"UO_0000065";"18.00";"0.33";"5.37";"7.68";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954730";"";"None";"486.36";"0";"4.49";"BDBM250047";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cc(Cl)c(OC)c(Cl)c3)nn21";"IC50";"'='";"0.15";"nM";"9.82";"";"435976";"UO_0000065";"20.20";"0.41";"5.33";"8.83";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932338";"";"None";"483.57";"0";"4.06";"BDBM250054";"CC#CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"435983";"UO_0000065";"17.62";"0.32";"4.46";"8.32";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4107336";"";"None";"1155.48";"None";"None";"BDBM249963";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC[C@H]2C1CCN(C(=O)/C=C/CN2CCN(CCNC(=O)CCCC(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]3C[C@@H]4NC(=O)N[C@@H]4S3)CC2)CC1";"IC50";"'='";"46.0";"nM";"7.34";"";"435985";"UO_0000065";"6.35";"None";"None";"None";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"5.49";"nM";"8.26";"";"";"UO_0000065";"18.75";"0.34";"4.04";"8.33";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4239031";"";"None";"445.56";"0";"4.27";"17";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"20.11";"0.37";"4.69";"9.01";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4239747";"";"None";"427.50";"0";"4.75";"5";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1C";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"21.84";"0.40";"4.59";"8.63";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4243975";"";"None";"551.00";"1";"4.28";"7b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCCC4C(=O)OC)cc3)ncc2Cl)c1";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"14.63";"0.28";"3.78";"5.98";"0";"CHEMBL4233700";"Inhibition of full length recombinant human N-terminal His-tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229440";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4242058";"";"None";"361.45";"0";"4.01";"32";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C";"IC50";"'='";"0.59";"nM";"9.23";"";"";"UO_0000065";"25.53";"0.47";"5.22";"11.65";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4076040";"";"None";"660.82";"2";"6.17";"38";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCN(C)CC1";"IC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"10.44";"0.19";"0.73";"5.96";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4078155";"";"None";"681.75";"1";"4.98";"31";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4cc(OC)c(OC)c(OC)c4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"1426.0";"nM";"5.85";"";"";"UO_0000065";"8.57";"0.16";"0.87";"3.91";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4109100";"";"None";"493.57";"0";"4.76";"BDBM250077";"C=CC(=O)Nc1ccccc1[C@H]1CCNc2c(C(N)=O)c(-c3ccc(OCc4ccccc4)cc3)nn21";"IC50";"'='";"0.51";"nM";"9.29";"";"435802";"UO_0000065";"18.83";"0.34";"4.53";"8.35";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965549";"";"None";"443.51";"0";"3.44";"BDBM249902";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"0.48";"nM";"9.32";"";"435826";"UO_0000065";"21.01";"0.39";"5.88";"9.09";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959202";"";"None";"439.44";"0";"4.51";"BDBM249206";"CC(C)(C)c1cc(F)c2c(=O)n(Cc3c(F)cc(-c4cc[nH]c(=O)c4)cc3F)ncc2c1";"IC50";"'='";"13314.57";"nM";"4.88";"";"434804";"UO_0000065";"11.10";"0.21";"0.37";"7.20";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1230541";"";"None";"579.70";"2";"5.52";"CGI-1746; 4";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"15.04";"0.28";"3.20";"8.26";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3939090";"";"None";"413.39";"0";"4.28";"BDBM249936";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c1ccc([N+](=O)[O-])cc12";"IC50";"'='";"320.0";"nM";"6.50";"";"435868";"UO_0000065";"15.71";"0.29";"2.21";"5.05";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904241";"";"None";"375.43";"0";"2.56";"BDBM249992";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC21CNC1";"IC50";"'='";"410.0";"nM";"6.39";"";"435921";"UO_0000065";"17.01";"0.31";"3.83";"6.78";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962144";"";"None";"421.89";"0";"3.83";"BDBM250012";"C=CC(=O)Nc1ccccc1[C@@H]1CCNc2c(C(N)=O)c(-c3ccc(Cl)cc3)nn21";"IC50";"'='";"1500.0";"nM";"5.82";"";"435941";"UO_0000065";"13.80";"0.27";"1.99";"5.71";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946624";"";"None";"537.04";"1";"4.83";"BDBM250031";"NC(=O)c1c(-c2ccc(F)c(Cl)c2)nn2c1NCCC2c1ccccc1NC(=O)/C=C/CN1CCCCC1";"IC50";"'='";"6.1";"nM";"8.21";"";"435960";"UO_0000065";"15.30";"0.30";"3.38";"7.80";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982014";"";"None";"539.64";"1";"3.92";"BDBM191624";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(C(=O)/C=C/CN2CCOCC2)CC1";"IC50";"'='";"4.07";"nM";"8.39";"";"385054";"UO_0000065";"15.55";"0.29";"4.47";"7.52";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3652674";"";"None";"606.66";"2";"5.21";"BDBM122435";"CCOc1ccc(-c2ccc3c(C(N)=O)cn(-c4cccc(-n5ncc6cc(C(C)(C)C)cc(F)c6c5=O)c4CO)c3n2)cn1";"IC50";"'='";"11.04";"nM";"7.96";"";"251015";"UO_0000065";"13.12";"0.24";"2.75";"5.76";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4867850";"";"None";"532.40";"1";"4.32";"19h";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(Br)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"7.3";"nM";"8.14";"";"";"UO_0000065";"15.28";"0.32";"3.82";"7.70";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4870651";"";"None";"469.55";"0";"4.42";"12i";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(C)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"14.73";"0.27";"2.50";"6.54";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4873984";"";"None";"469.50";"0";"3.18";"27g";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5OC)cc4)[nH]c23)C1";"IC50";"'='";"7.4";"nM";"8.13";"";"";"UO_0000065";"17.32";"0.32";"4.95";"7.07";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3358334";"";"None";"489.58";"0";"2.95";"2a";"CCNC(=O)Nc1cc(-c2cccc(N3CCc4cc(N(C)C)ccc4C3=O)c2CO)cn(C)c1=O";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"11.84";"0.22";"2.85";"5.42";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3652681";"";"None";"509.57";"1";"3.60";"BDBM122443";"CC(C)(C)c1ccc2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccccn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.95";"nM";"9.02";"";"251023";"UO_0000065";"17.71";"0.32";"5.42";"6.40";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3964073";"";"None";"422.29";"0";"3.88";"18";"Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1Cc2ccccc2C1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"18.76";"0.40";"4.04";"8.82";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4111479";"";"None";"603.01";"1";"4.51";"BDBM255438";"COc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"1.5";"nM";"8.82";"";"445345";"UO_0000065";"14.63";"0.29";"4.31";"6.65";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109244";"";"None";"607.42";"2";"5.16";"BDBM255440";"Cn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)c(Cl)c2)cc1C(F)(F)F";"IC50";"'='";"1.9";"nM";"8.72";"";"445347";"UO_0000065";"14.36";"0.29";"3.56";"7.07";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3903659";"";"None";"548.53";"1";"3.95";"BDBM246393";"Cn1ncc2c1CCCC2(O)c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)nccn12";"IC50";"'='";"7.2";"nM";"8.14";"";"429692";"UO_0000065";"14.84";"0.28";"4.19";"5.98";"0";"CHEMBL3889024";"IMAP-FP Assay: Assay Method A: BTK enzymatic activity was determined in an IMAP-FP assay (Immobilized Metal ion Affinity-based fluorescence Polarization; Molecular Devices). Using this assay format, the potency (IC50) of each compound was determined from a 10 point (1:3 serial dilution, final compound concentration range in assay from 10 μM to 0.508 nM) titration curve using the following outlined procedure. To each well of a black Corning 384-well microplate (Corning Catalog #3575), 200 nL of compound (100 fold dilution in final assay volume of 20 μL) was dispensed, followed by the addition of 10 μL of 1× kinase buffer (10 mM Tris pH 7.2, 10 mM MgCl2, 0.01% Tween 20, 2 mM MnCl2, and 1 mM DTT) containing 0.16 ng/μL (2.1 nM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 10 μL kinase buffer containing 100 nM â¿¿Blk/Lyntideâ¿ IMAP substrate peptide (5-carboxyfluorescein-EFPIYDFLPAKKK-NH2; Molecular Devices Catalog #R7188), and 10 μM ATP. The final reaction in each well of 20 μL consists of 1.05 nM hBTK, 50 nM Blk/Lyntide IMAP substrate, and 5 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes and were immediately quenched by the addition of 40 μL IMAP detection beads resuspended in IMAP progressive binding buffer (beads were diluted 1:600 in 75% and 25% progressive binding buffer A and B, respectively; Molecular Devices). Plates were read on Packard microplate reader after 60 minutes binding equilibration using Fluorescence Polarization protocol. Specifically, fluorescence at 535 nm is measured using emission filters oriented both parallel and perpendicular to the polarized excitation filter.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114536";"";"None";"558.59";"1";"4.39";"BDBM230136";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"0.49";"nM";"9.31";"";"402002";"UO_0000065";"16.67";"0.31";"4.92";"6.95";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"BDBM230144";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"2.6";"nM";"8.59";"";"402010";"UO_0000065";"17.08";"0.31";"3.27";"7.53";"1";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894102";"";"None";"553.67";"1";"4.36";"BDBM191629";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CC[C@@H](NC(=O)/C=C/CN2CCOCC2)CC1";"IC50";"'='";"3.48";"nM";"8.46";"";"342667";"UO_0000065";"15.28";"0.28";"4.10";"7.02";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647527";"";"None";"479.54";"0";"3.84";"BDBM143329";"CC#CC(=O)N1CC[C@]2(C1)C[C@H](n1nc(-c3ccc(Oc4ccccc4)cn3)c3c(N)ncnc31)C2";"IC50";"'='";"4.0";"nM";"8.40";"";"279489";"UO_0000065";"17.51";"0.32";"4.56";"7.49";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647530";"";"None";"524.63";"1";"3.93";"BDBM143332";"CN(C)C/C=C/C(=O)N1CC[C@]2(C1)C[C@H](n1nc(-c3ccc(Oc4ccccc4)cn3)c3c(N)ncnc31)C2";"IC50";"'='";"7.1";"nM";"8.15";"";"279492";"UO_0000065";"15.53";"0.29";"4.22";"7.07";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3699639";"";"None";"523.64";"1";"4.59";"BDBM149464";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)cccc1N1Cc2ccc(C(C)(C)C)cc2C1=O";"IC50";"'='";"14.0";"nM";"7.85";"";"287910";"UO_0000065";"15.00";"0.28";"3.26";"7.92";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3699644";"";"None";"505.58";"1";"4.83";"BDBM149469";"CC(C)(C)c1cc2c(s1)C(=O)N(c1nc(-c3cc(Nc4cc(C5CC5)[nH]n4)c(=O)[nH]n3)ccc1F)C2";"IC50";"'='";"35.0";"nM";"7.46";"";"287915";"UO_0000065";"14.75";"0.28";"2.63";"6.23";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3905197";"";"None";"540.60";"2";"5.30";"BDBM200785";"CC(=O)c1ccc(C(=O)Nc2cc(F)cc(-c3ncnc4[nH]c(C5=CCN(C(=O)N(C)C)CC5)cc34)c2C)cc1";"IC50";"'='";"23.0";"nM";"7.64";"";"356857";"UO_0000065";"14.13";"0.26";"2.34";"6.86";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2312652";"";"None";"481.38";"0";"2.52";"19";"CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.40";"0.19";"2.00";"4.05";"0";"CHEMBL2317786";"Inhibition of BTK (unknown origin) in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311250";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3358399";"";"None";"588.71";"1";"4.62";"16e";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)ccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"12.62";"0.23";"2.81";"7.77";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"13.00";"0.24";"3.13";"8.25";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3358403";"";"None";"548.65";"1";"3.74";"16i";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6ccccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"1030.0";"nM";"5.99";"";"";"UO_0000065";"10.91";"0.20";"2.25";"6.26";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3965549";"";"None";"443.51";"0";"3.44";"32b";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"18.89";"0.35";"4.94";"8.17";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4447328";"";"None";"431.50";"0";"3.37";"I-2";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.86";"0.38";"5.63";"7.73";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3977187";"";"None";"383.41";"0";"3.96";"5";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c1ccc(N)cc12";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"20.26";"0.37";"3.81";"6.97";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3921373";"";"None";"475.51";"1";"5.08";"17";"C=CC(=O)Nc1cccc(-c2ccnc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)c1";"IC50";"'='";"860.0";"nM";"6.07";"";"";"UO_0000065";"12.76";"0.23";"0.99";"5.43";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3921167";"";"None";"479.54";"0";"4.97";"18a";"C=CC(=O)Nc1cccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"18.05";"0.33";"3.69";"7.78";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3917026";"";"None";"457.53";"0";"3.97";"23";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"19.22";"0.35";"4.83";"7.90";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3926191";"";"None";"417.47";"0";"3.19";"25a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC)cc3)nn21";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"21.56";"0.40";"5.81";"8.09";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3910697";"";"None";"421.89";"0";"3.83";"29a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)cc3)nn21";"IC50";"'='";"0.64";"nM";"9.19";"";"";"UO_0000065";"21.79";"0.42";"5.36";"9.01";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3973435";"";"None";"471.56";"0";"4.22";"31";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.63";"nM";"9.20";"";"";"UO_0000065";"19.51";"0.36";"4.98";"8.98";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3979851";"";"None";"568.73";"2";"6.09";"BDBM202074";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCNCC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"7.0";"nM";"8.15";"";"358153";"UO_0000065";"14.34";"0.26";"2.06";"10.57";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975009";"";"None";"584.72";"2";"5.92";"BDBM202076";"Cc1c(-c2ncnc3[nH]c(-c4cccc(CN5CCNCC5)c4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"396.0";"nM";"6.40";"";"358155";"UO_0000065";"10.95";"0.20";"0.48";"7.41";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966506";"";"None";"569.71";"2";"6.51";"BDBM202078";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"143.0";"nM";"6.84";"";"358157";"UO_0000065";"12.01";"0.22";"0.33";"9.21";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898339";"";"None";"589.70";"2";"5.16";"BDBM202114";"CN1CCCC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cn2)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"358192";"UO_0000065";"14.08";"0.26";"3.14";"7.39";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905596";"";"None";"586.70";"2";"5.21";"BDBM202121";"CCN1CCC(n2cc(-c3cc4c(-c5cccc(-n6ncc7cc(C8CC8)ccc7c6=O)c5CO)ncnc4[nH]3)cn2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"358199";"UO_0000065";"14.53";"0.26";"3.31";"7.24";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900184";"";"None";"615.73";"2";"6.17";"BDBM202127";"CN1CCC(Oc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"358205";"UO_0000065";"13.84";"0.25";"2.35";"8.21";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984930";"";"None";"682.75";"2";"6.38";"BDBM202138";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(CN5CCN(CC(F)(F)F)CC5)cn4)cc23)c1CO";"IC50";"'='";"8.0";"nM";"8.10";"";"358216";"UO_0000065";"11.86";"0.22";"1.72";"8.28";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967515";"";"None";"637.69";"2";"5.81";"BDBM202150";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cc(F)cc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cn4)cc23)c1CO";"IC50";"'='";"0.55";"nM";"9.26";"";"358227";"UO_0000065";"14.52";"0.27";"3.45";"8.92";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983885";"";"None";"585.66";"2";"5.33";"BDBM202160";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CC(O)C5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"360.0";"nM";"6.44";"";"358237";"UO_0000065";"11.00";"0.20";"1.11";"5.77";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982192";"";"None";"535.65";"1";"4.93";"BDBM202185";"Cc1c(-c2ncnc3[nH]c(C4=CCN(CCO)CC4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"272.0";"nM";"6.57";"";"358262";"UO_0000065";"12.26";"0.22";"1.64";"6.94";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891434";"";"None";"602.69";"1";"4.83";"BDBM202196";"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"358272";"UO_0000065";"13.27";"0.25";"3.17";"6.91";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957821";"";"None";"357.42";"0";"3.43";"19";"Cc1ccc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)cc1O";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"20.61";"0.37";"3.94";"8.20";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3972321";"";"None";"543.54";"2";"6.26";"7f";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCP(=O)(OCC)OCC)cc3)ncc2F)c1";"IC50";"'='";"21.6";"nM";"7.67";"";"";"UO_0000065";"14.10";"0.28";"1.41";"6.20";"0";"CHEMBL3874808";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells measured after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872267";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308860";"";"";""
"CHEMBL3647972";"";"None";"462.94";"0";"4.27";"BDBM97677";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)CCl)C1";"IC50";"'='";"0.58";"nM";"9.24";"";"214871";"UO_0000065";"19.95";"0.38";"4.97";"9.31";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670123";"";"None";"641.81";"2";"6.02";"BDBM111982";"CN1CCC(c2ccc(Nc3cc(-c4cc(F)cc(N5CCc6c(sc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"2.2";"nM";"8.66";"";"233037";"UO_0000065";"13.49";"0.26";"2.64";"9.55";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3702828";"";"None";"580.67";"2";"5.10";"BDBM143177";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCC1";"IC50";"'='";"4.1";"nM";"8.39";"";"369501";"UO_0000065";"14.44";"0.27";"3.29";"6.65";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702829";"";"None";"555.61";"1";"4.64";"BDBM143178";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)CO";"IC50";"'='";"8.1";"nM";"8.09";"";"369502";"UO_0000065";"14.56";"0.27";"3.45";"5.65";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702833";"";"None";"596.67";"1";"4.08";"BDBM143182";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CC(O)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"369506";"UO_0000065";"15.16";"0.28";"4.97";"6.18";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702835";"";"None";"609.71";"1";"4.13";"BDBM143184";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCNCC1";"IC50";"'='";"4.7";"nM";"8.33";"";"369509";"UO_0000065";"13.66";"0.25";"4.20";"6.03";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702840";"";"None";"624.72";"2";"5.12";"BDBM143192";"CCN(C1COC1)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"369514";"UO_0000065";"14.48";"0.27";"3.93";"6.68";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702852";"";"None";"687.80";"2";"3.98";"BDBM143206";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(S(C)(=O)=O)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"369526";"UO_0000065";"12.87";"0.25";"4.87";"5.41";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702858";"";"None";"623.69";"1";"3.83";"BDBM143216";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCNC(=O)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"369532";"UO_0000065";"14.25";"0.26";"5.06";"5.72";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3263652";"";"None";"539.64";"2";"5.06";"32";"Cc1c(NC(=O)C2CCCCC2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"169.0";"nM";"6.77";"";"";"UO_0000065";"12.55";"0.23";"1.71";"5.41";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3910496";"";"None";"440.51";"0";"4.04";"BDBM191605";"C=CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"0.39";"nM";"9.41";"";"385048";"UO_0000065";"21.36";"0.39";"5.37";"9.49";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2179806";"";"None";"537.67";"1";"4.65";"42";"C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc(C(=O)NCc4ccc(C(C)(C)C)cc4)c3)c3c(N)ncnc32)C1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.73";"0.27";"3.27";"6.65";"0";"CHEMBL2185026";"Inhibition of BTK in presence of 50 uM ATP";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177048";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3670109";"";"None";"655.80";"1";"4.97";"BDBM111968";"Cn1cc(-c2cc(F)cc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc3c(n2)CCN(C2COC2)C3)c1=O";"IC50";"'='";"4.2";"nM";"8.38";"";"233023";"UO_0000065";"12.77";"0.24";"3.41";"8.38";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670127";"";"None";"683.85";"2";"5.79";"BDBM111986";"Cn1cc(-c2cc(F)cc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(C3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"8.7";"nM";"8.06";"";"233041";"UO_0000065";"11.79";"0.22";"2.27";"8.07";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670134";"";"None";"594.72";"1";"3.17";"BDBM111993";"CN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)nn(C)c3=O)nc2)CC1";"IC50";"'='";"7.1";"nM";"8.15";"";"233048";"UO_0000065";"13.70";"0.25";"4.98";"7.29";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3702832";"";"None";"609.71";"1";"4.66";"BDBM143181";"[C-]#[N+]/C(=C\C(C)(C)N1CCNCC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"369505";"UO_0000065";"15.41";"0.29";"4.74";"7.91";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647971";"";"None";"454.53";"0";"4.61";"BDBM97676";"C/C=C/C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"327854";"UO_0000065";"16.94";"0.31";"3.09";"7.76";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4115903";"";"None";"None";"None";"None";"BDBM200773";"";"IC50";"'='";"5.0";"nM";"8.30";"";"356849";"UO_0000065";"";"";"";"";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971224";"";"None";"541.63";"2";"5.16";"BDBM200777";"Cc1c(NC(=O)c2ccc(N(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"17.0";"nM";"7.77";"";"356853";"UO_0000065";"14.34";"0.27";"2.61";"7.97";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935663";"";"None";"556.64";"2";"5.06";"BDBM200789";"CN(C)C(=O)N1CC=C(c2cc3c(-c4ccc(F)c(NC(=O)c5ccc(C(C)(C)CO)cc5)c4)ncnc3[nH]2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"356859";"UO_0000065";"14.77";"0.27";"3.16";"7.18";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967153";"";"None";"516.64";"2";"6.16";"BDBM200802";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CC[S+]([O-])CC3)cc12";"IC50";"'='";"2.0";"nM";"8.70";"";"356863";"UO_0000065";"16.84";"0.32";"2.54";"9.28";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908428";"";"None";"535.62";"1";"4.48";"BDBM200883";"Cc1c(NC(=O)N2CC(OC(C)C)C2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"16.0";"nM";"7.80";"";"356896";"UO_0000065";"14.55";"0.27";"3.32";"7.31";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963489";"";"None";"522.65";"2";"6.79";"BDBM200897";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(C3=CCC4(CC3)OCCO4)cc12";"IC50";"'='";"9.0";"nM";"8.05";"";"356903";"UO_0000065";"15.39";"0.28";"1.26";"9.03";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973521";"";"None";"480.61";"1";"6.41";"BDBM200898";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(C3=CCC(O)CC3)cc12";"IC50";"'='";"12.0";"nM";"7.92";"";"356904";"UO_0000065";"16.48";"0.30";"1.51";"8.71";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968447";"";"None";"572.64";"1";"4.51";"BDBM200778";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(NC(=O)c5ccc(C(C)(C)O)cc5F)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"356854";"UO_0000065";"15.19";"0.28";"4.19";"6.46";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982378";"";"None";"500.64";"2";"7.14";"BDBM200798";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCSCC3)cc12";"IC50";"'='";"23.0";"nM";"7.64";"";"356862";"UO_0000065";"15.26";"0.29";"0.50";"10.81";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905597";"";"None";"425.49";"0";"4.43";"BDBM250072";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC[C@H]2c1cccc(N)c1";"IC50";"'='";"210.0";"nM";"6.68";"";"435789";"UO_0000065";"15.69";"0.29";"2.25";"6.17";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921167";"";"None";"479.54";"0";"4.97";"BDBM249876";"C=CC(=O)Nc1cccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"3.6";"nM";"8.44";"";"435790";"UO_0000065";"17.61";"0.32";"3.47";"7.59";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917732";"";"None";"479.54";"0";"4.97";"BDBM249879";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.71";"nM";"9.15";"";"435795";"UO_0000065";"19.08";"0.35";"4.18";"8.22";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974343";"";"None";"443.48";"0";"4.57";"BDBM249884";"NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3)cc2)nn2c1NCCC2c1ccccc1N";"IC50";"'='";"4500.0";"nM";"5.35";"";"435804";"UO_0000065";"12.06";"0.22";"0.78";"4.94";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4110931";"";"None";"457.53";"0";"3.97";"BDBM250079";"C=CC(=O)Nc1ccccc1[C@H]1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"1.2";"nM";"8.92";"";"435814";"UO_0000065";"19.50";"0.36";"4.95";"8.02";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974859";"";"None";"567.05";"2";"5.28";"BDBM230082";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2ccccc2n(C)c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"401938";"UO_0000065";"15.87";"0.30";"3.72";"7.31";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"BDBM230090";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.4";"nM";"9.40";"";"401946";"UO_0000065";"16.06";"0.31";"3.98";"7.63";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4107735";"";"None";"488.58";"0";"3.26";"BDBM255425";"Cc1nsc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)n1";"IC50";"'='";"14.9";"nM";"7.83";"";"445332";"UO_0000065";"16.02";"0.31";"4.57";"5.96";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115206";"";"None";"552.56";"1";"4.16";"BDBM255435";"Cc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"6.9";"nM";"8.16";"";"445342";"UO_0000065";"14.77";"0.28";"4.00";"6.61";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3924953";"";"None";"596.76";"2";"5.12";"BDBM205242";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)NCCN4C)cc3)n2)cccc1N1Cc2cc(C(C)(C)C)sc2C1=O";"IC50";"'='";"24.7";"nM";"7.61";"";"363331";"UO_0000065";"12.75";"0.24";"2.49";"7.64";"0";"CHEMBL3887917";"Biochemical Btk Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2), 0.5 μM Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer, 0.5 μM PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6xHis tag was subcloned into pFastBac vector for making baculovirus carrying this epitope-tagged Btk.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886504";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979176";"";"None";"479.54";"0";"4.97";"BDBM249973";"C=CC(=O)Nc1ccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)cc1";"IC50";"'='";"9.5";"nM";"8.02";"";"435902";"UO_0000065";"16.73";"0.30";"3.05";"7.21";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926815";"";"None";"441.49";"0";"3.72";"BDBM249991";"C=CC(=O)N1CCC(c2cn3nc(-c4ccc(Oc5ccccc5)cc4)c(C(N)=O)c3[nH]2)C1";"IC50";"'='";"34.0";"nM";"7.47";"";"435920";"UO_0000065";"16.92";"0.31";"3.75";"7.06";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897152";"";"None";"405.46";"0";"2.29";"BDBM250001";"C=CC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(OCC5CC5)cc4)nn3c2C1";"IC50";"'='";"300.0";"nM";"6.52";"";"435930";"UO_0000065";"16.09";"0.30";"4.23";"6.17";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4112625";"";"None";"421.89";"0";"3.83";"BDBM250011";"C=CC(=O)Nc1ccccc1[C@H]1CCNc2c(C(N)=O)c(-c3ccc(Cl)cc3)nn21";"IC50";"'='";"0.64";"nM";"9.19";"";"435940";"UO_0000065";"21.79";"0.42";"5.36";"9.01";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946044";"";"None";"477.52";"0";"3.20";"BDBM250045";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cc(OC)c(OC)c(OC)c3)nn21";"IC50";"'='";"2.4";"nM";"8.62";"";"435974";"UO_0000065";"18.05";"0.34";"5.42";"6.64";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983090";"";"None";"526.64";"1";"3.60";"BDBM250063";"CN(C)CC#CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.1";"nM";"8.96";"";"435995";"UO_0000065";"17.01";"0.31";"5.36";"8.47";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940423";"";"None";"499.57";"0";"3.03";"BDBM250066";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC[C@H]2C1CCN(C(=O)C#CCO)CC1";"IC50";"'='";"0.67";"nM";"9.17";"";"435998";"UO_0000065";"18.36";"0.34";"6.14";"7.48";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973770";"";"None";"293.30";"0";"3.33";"BDBM195836";"CC#CC(=O)Nc1cc(-c2cnc3[nH]ccc3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348540";"UO_0000065";"20.90";"0.38";"2.80";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3902180";"";"None";"539.64";"1";"3.92";"BDBM191611";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)/C=C/CN2CCOCC2)C1";"IC50";"'='";"5.6";"nM";"8.25";"";"342647";"UO_0000065";"15.29";"0.28";"4.33";"7.39";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4107879";"";"None";"452.52";"0";"3.88";"BDBM191619";"CC#CC(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"4.16";"nM";"8.38";"";"342657";"UO_0000065";"18.52";"0.34";"4.50";"8.45";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4245422";"";"None";"382.43";"0";"0.88";"11b";"C=CC(=O)N1CCC(n2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1";"IC50";"'='";"126.4";"nM";"6.90";"";"";"UO_0000065";"18.04";"0.34";"6.02";"5.90";"0";"CHEMBL4236389";"Inhibition of BTK (unknown origin) using TK-substrate-biotin measured after 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4228086";"";"None";"416.49";"0";"2.50";"8h";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3cccc(C)c3)c3c(N)ncnc32)C1";"IC50";"'='";"20.85";"nM";"7.68";"";"";"UO_0000065";"18.44";"0.34";"5.18";"7.75";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4226585";"";"None";"470.46";"0";"3.21";"8n";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3cccc(C(F)(F)F)c3)c3c(N)ncnc32)C1";"IC50";"'='";"209.2";"nM";"6.68";"";"";"UO_0000065";"14.20";"0.27";"3.47";"6.74";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4248386";"";"None";"383.47";"0";"3.74";"31";"C=CS(=O)(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C";"IC50";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"25.70";"0.50";"6.11";"9.38";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4245037";"";"None";"333.39";"0";"3.68";"30";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]cc(C)c23)c1C";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"23.47";"0.43";"4.14";"8.89";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4237557";"";"None";"347.42";"0";"3.98";"27";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C";"IC50";"'='";"9.2";"nM";"8.04";"";"";"UO_0000065";"23.13";"0.42";"4.06";"9.13";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL481968";"";"None";"559.24";"1";"4.00";"6c";"O=C(N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F)c1ccc(CO)o1";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"9.22";"0.22";"1.15";"4.15";"0";"CHEMBL963874";"Binding affinity to BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139272";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3665116";"";"None";"593.69";"1";"4.07";"BDBM111587";"Cc1c(-c2cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c(=O)n(C)c2)cccc1N1CNc2cc(N(C)C)ccc2C1=O";"IC50";"'='";"22.0";"nM";"7.66";"";"262412";"UO_0000065";"12.90";"0.24";"3.59";"6.83";"1";"CHEMBL3705524";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 um hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 uM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 uM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 uM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 uM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 uCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639153";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3669312";"";"None";"426.48";"0";"3.83";"BDBM98655";"C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"214875";"UO_0000065";"20.62";"0.38";"4.97";"8.87";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3652683";"";"None";"405.43";"0";"3.11";"BDBM122445";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)cn4)c3)ncc2c1";"IC50";"'='";"3700.0";"nM";"5.43";"";"251025";"UO_0000065";"13.40";"0.25";"2.32";"5.67";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3670081";"";"None";"513.62";"1";"4.22";"2b";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CCCC5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.52";"0.33";"4.78";"8.97";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4071845";"";"None";"496.57";"0";"3.42";"4";"Cn1cc(-c2cccc(N3CCc4c(cc5n4CCCC5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"14.28";"0.26";"3.67";"6.74";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4080943";"";"None";"624.81";"1";"4.82";"15";"CN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCc6c(sc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"13.64";"0.26";"3.70";"9.07";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4102294";"";"None";"497.62";"1";"5.04";"2a";"Cc1c(-c2cc(Nc3ccncn3)c(=O)n(C)c2)cccc1N1CCc2c(sc3c2CCCC3)C1=O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.99";"0.30";"2.92";"9.93";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3670088";"";"None";"593.73";"1";"3.78";"17";"CN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"12.37";"0.23";"3.57";"7.43";"0";"CHEMBL4036701";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of BCR-induced CD69 expression on B cells preincubated for 1 hr followed by blood stimulation measured after 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3290133";"";"None";"402.46";"0";"3.71";"22";"Cc1ccc(NC(=O)C2CC2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"4946.0";"nM";"5.31";"";"";"UO_0000065";"13.18";"0.24";"1.60";"4.35";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"BDBM230081";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"1.1";"nM";"8.96";"";"401937";"UO_0000065";"15.31";"0.29";"3.54";"7.28";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3944101";"";"None";"571.01";"2";"5.18";"BDBM230108";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.28";"nM";"9.55";"";"401971";"UO_0000065";"16.73";"0.32";"4.37";"7.79";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3657236";"";"None";"504.59";"2";"6.41";"BDBM134243";"Nc1n[nH]c2cc(C3CCCN(C(=O)Nc4ccccc4)C3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"3.0";"nM";"8.52";"";"267632";"UO_0000065";"16.89";"0.31";"2.11";"7.81";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3263640";"";"None";"589.70";"2";"6.09";"8";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.73";"0.25";"2.01";"6.47";"1";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4162057";"";"None";"596.76";"2";"5.14";"GDC-0834; 5";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C3C(=O)N(C)CCN3C)cc2)n1";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"13.79";"0.26";"3.09";"8.26";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4115904";"";"None";"None";"None";"None";"BDBM200820";"";"IC50";"'='";"34.0";"nM";"7.47";"";"356872";"UO_0000065";"";"";"";"";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4115905";"";"None";"None";"None";"None";"BDBM200824";"";"IC50";"'='";"14.0";"nM";"7.85";"";"356873";"UO_0000065";"";"";"";"";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920088";"";"None";"496.61";"1";"5.60";"BDBM200878";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3ncnc4[nH]c(C5=CCC(O)CC5)cc34)c2CO)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"356893";"UO_0000065";"16.91";"0.31";"2.80";"7.56";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958072";"";"None";"419.46";"0";"3.67";"BDBM249205";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-c4cc[nH]c(=O)c4)c3CO)ncc2c1";"IC50";"'='";"365.77";"nM";"6.44";"";"434803";"UO_0000065";"15.35";"0.28";"2.77";"7.32";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114570";"";"None";"535.53";"1";"4.57";"BDBM255277";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)F)ccn4)c(F)c3)c12";"IC50";"'='";"1.5";"nM";"8.82";"";"445182";"UO_0000065";"16.48";"0.31";"4.25";"7.45";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3939414";"";"None";"550.55";"1";"3.32";"BDBM255292";"Nc1nccn2c([C@H]3CC[C@@H]4CNCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"4.0";"nM";"8.40";"";"445197";"UO_0000065";"15.25";"0.29";"5.08";"6.43";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107727";"";"None";"606.61";"2";"5.07";"BDBM255312";"CCNC(=O)Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"17.7";"nM";"7.75";"";"445217";"UO_0000065";"12.78";"0.24";"2.68";"5.80";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113153";"";"None";"539.47";"1";"3.54";"BDBM255327";"Nc1nccn2c([C@H]3CN4C(=O)OC[C@H]4CO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"24.9";"nM";"7.60";"";"445232";"UO_0000065";"14.09";"0.27";"4.06";"5.55";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114094";"";"None";"537.50";"1";"3.71";"BDBM255357";"Nc1nccn2c([C@H]3CN4C(=O)CC[C@@H]4CO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.26";"nM";"9.59";"";"445263";"UO_0000065";"17.83";"0.34";"5.88";"7.50";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3657210";"";"None";"486.58";"1";"5.10";"BDBM134215";"CC(C)(C)OC(=O)NC1CCN(c2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c3n2)C1";"IC50";"'='";"8640.0";"nM";"5.06";"";"267604";"UO_0000065";"10.41";"0.19";"-0.04";"4.28";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3918651";"";"None";"643.74";"2";"5.69";"BDBM202175";"CC1(O)CCN(C(=O)c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"358252";"UO_0000065";"12.58";"0.23";"2.41";"6.14";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647972";"";"None";"462.94";"0";"4.27";"BDBM97677";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)CCl)C1";"IC50";"'='";"0.58";"nM";"9.24";"";"327856";"UO_0000065";"19.95";"0.38";"4.97";"9.31";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4107818";"";"None";"496.62";"0";"4.70";"BDBM220128";"Cc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C[C@H]1CCCN1C(=O)/C=C/CN(C)C";"IC50";"'='";"0.92";"nM";"9.04";"";"385045";"UO_0000065";"18.20";"0.33";"4.34";"11.83";"0";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910496";"";"None";"440.51";"0";"4.04";"BDBM191605";"C=CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"0.67";"nM";"9.17";"";"385047";"UO_0000065";"20.83";"0.38";"5.13";"9.25";"0";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894000";"";"None";"572.54";"2";"5.03";"BDBM230120";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cc(F)cc2c1=O";"IC50";"'='";"0.77";"nM";"9.11";"";"401984";"UO_0000065";"15.92";"0.30";"4.08";"6.80";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984475";"";"None";"575.04";"1";"4.67";"BDBM230133";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.46";"nM";"9.34";"";"402000";"UO_0000065";"16.24";"0.31";"4.67";"7.62";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949916";"";"None";"545.60";"1";"4.80";"BDBM202174";"NC(=O)c1ccc(-c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)ccc6C5=O)c4CO)ccnc3[nH]2)nc1";"IC50";"'='";"2.0";"nM";"8.70";"";"358251";"UO_0000065";"15.94";"0.29";"3.90";"6.47";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943053";"";"None";"563.54";"1";"3.86";"BDBM246414";"Nc1ncnc2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nn2[C@H]1CCCc2nn(CCO)cc21";"IC50";"'='";"1.3";"nM";"8.89";"";"429709";"UO_0000065";"15.77";"0.30";"5.03";"5.94";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3966831";"";"None";"324.77";"0";"3.63";"BDBM195829";"CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348533";"UO_0000065";"18.88";"0.36";"2.50";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3951591";"";"None";"290.33";"0";"2.98";"BDBM195827";"CCC#CC(=O)Nc1cccc(-c2cnc3[nH]ccc3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348531";"UO_0000065";"21.12";"0.38";"3.15";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3979355";"";"None";"665.77";"2";"4.42";"BDBM143212";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"279426";"UO_0000065";"13.25";"0.25";"4.40";"6.36";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1916884";"";"None";"448.96";"0";"4.67";"29";"Cc1ccc(Cl)cc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"13.2";"nM";"7.88";"";"";"UO_0000065";"17.55";"0.34";"3.21";"11.98";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3290121";"";"None";"509.46";"2";"6.19";"10";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(F)c2)nc1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"14.30";"0.27";"1.09";"7.59";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290127";"";"None";"526.91";"2";"5.98";"16";"Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3Cl)cn2)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.10";"0.29";"1.98";"6.52";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290136";"";"None";"456.48";"0";"4.75";"25";"Cc1ccc(NC(=O)c2cccc(F)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"166.0";"nM";"6.78";"";"";"UO_0000065";"14.85";"0.27";"2.03";"5.56";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3652669";"";"None";"435.46";"0";"2.60";"BDBM122430";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4ccc(C(N)=O)n4)c3CO)ncc2c1";"IC50";"'='";"333.06";"nM";"6.48";"";"251010";"UO_0000065";"14.88";"0.28";"3.88";"5.58";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3893465";"";"None";"499.58";"0";"3.78";"10j";"C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(OCCCN5CCOCC5)cc4)nc32)c1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"18.81";"0.35";"5.62";"8.83";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3657219";"";"None";"394.43";"1";"5.37";"BDBM134224";"Nc1n[nH]c2c(-c3ccc(O)cc3)ncc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"280.0";"nM";"6.55";"";"267613";"UO_0000065";"16.61";"0.30";"1.18";"6.75";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3901657";"";"None";"596.76";"2";"5.12";"BDBM205241";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4NCCN(C)C4=O)cc3)n2)cccc1N1Cc2cc(C(C)(C)C)sc2C1=O";"IC50";"'='";"11.5";"nM";"7.94";"";"363326";"UO_0000065";"13.30";"0.25";"2.82";"7.97";"0";"CHEMBL3887917";"Biochemical Btk Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2), 0.5 μM Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer, 0.5 μM PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6xHis tag was subcloned into pFastBac vector for making baculovirus carrying this epitope-tagged Btk.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886504";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114723";"";"None";"540.60";"1";"4.19";"BDBM197205";"CC(C)(N)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"2.2";"nM";"8.66";"";"350443";"UO_0000065";"16.01";"0.30";"4.47";"5.81";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3699646";"";"None";"532.70";"2";"5.11";"BDBM149471";"Cc1c(-c2cc(Nc3nc4c(s3)CNCC4)c(=O)[nH]n2)cccc1N1Cc2cc(C(C)(C)C)sc2C1=O";"IC50";"'='";"65.0";"nM";"7.19";"";"287917";"UO_0000065";"13.49";"0.27";"2.08";"6.98";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114764";"";"None";"505.58";"1";"4.72";"BDBM197190";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"1.8";"nM";"8.74";"";"350372";"UO_0000065";"17.30";"0.31";"4.02";"7.11";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL246356";"";"None";"528.47";"2";"5.57";"5";"CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)n1";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"8.71";"0.17";"-0.97";"4.14";"0";"CHEMBL887093";"Inhibition of BTK by radioactive filtration assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139197";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL3649459";"";"None";"431.47";"0";"3.60";"BDBM122407";"Cn1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)cc1C(N)=O";"IC50";"'='";"39.35";"nM";"7.41";"";"250987";"UO_0000065";"17.16";"0.32";"3.81";"8.21";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652658";"";"None";"528.55";"1";"3.13";"BDBM122419";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5cnccn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.43";"nM";"9.37";"";"250999";"UO_0000065";"17.72";"0.33";"6.24";"6.09";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3982421";"";"None";"532.63";"1";"3.15";"10h";"C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(S(C)(=O)=O)C(C)C5)cc4)nc32)c1";"IC50";"'='";"13.2";"nM";"7.88";"";"";"UO_0000065";"14.79";"0.28";"4.73";"6.29";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3702853";"";"None";"624.72";"1";"4.81";"BDBM143211";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)CN1CCOCC1";"IC50";"'='";"5.2";"nM";"8.28";"";"369527";"UO_0000065";"13.26";"0.25";"3.47";"6.12";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4111521";"";"None";"541.59";"1";"4.73";"BDBM255283";"C[C@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C6CC6)ccn5)cc4F)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.21";"nM";"9.68";"";"445188";"UO_0000065";"17.87";"0.33";"4.95";"7.58";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107939";"";"None";"560.54";"1";"4.38";"BDBM255372";"N#Cc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"6.3";"nM";"8.20";"";"445279";"UO_0000065";"14.63";"0.27";"3.82";"5.76";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109533";"";"None";"614.03";"2";"5.57";"BDBM255377";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.27";"nM";"9.57";"";"445284";"UO_0000065";"15.58";"0.30";"4.00";"7.49";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3657211";"";"None";"424.46";"1";"5.80";"BDBM134216";"COc1ccc(Oc2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c3n2)cc1";"IC50";"'='";"27910.0";"nM";"4.55";"";"267605";"UO_0000065";"10.73";"0.19";"-1.25";"4.78";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3647526";"";"None";"479.54";"0";"3.84";"BDBM143328";"CC#CC(=O)N1CC[C@]2(C1)C[C@@H](n1nc(-c3ccc(Oc4ccccc4)cn3)c3c(N)ncnc31)C2";"IC50";"'='";"0.74";"nM";"9.13";"";"279488";"UO_0000065";"19.04";"0.35";"5.29";"8.15";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3605103";"";"None";"412.52";"1";"6.22";"14c";"CCn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"176.2";"nM";"6.75";"";"";"UO_0000065";"16.37";"0.31";"0.53";"10.24";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3958017";"";"None";"613.77";"2";"5.85";"BDBM202182";"Cc1c(-c2nc(N)nc3[nH]c(-c4ccc(CN5CCN(C)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"33.0";"nM";"7.48";"";"358259";"UO_0000065";"12.19";"0.22";"1.63";"7.22";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894094";"";"None";"561.64";"2";"5.33";"BDBM202192";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(C(O)CO)cc4)cc23)c1CO";"IC50";"'='";"25.0";"nM";"7.60";"";"358269";"UO_0000065";"13.54";"0.25";"2.27";"6.39";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982806";"";"None";"637.71";"2";"5.05";"BDBM202200";"CC1(O)CN(C(=O)N2CC=C(c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"358276";"UO_0000065";"14.11";"0.26";"3.95";"7.36";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972631";"";"None";"621.71";"2";"5.10";"BDBM202213";"O=C(CN1CCC1)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"3.1";"nM";"8.51";"";"358289";"UO_0000065";"13.69";"0.25";"3.41";"8.34";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915538";"";"None";"539.64";"1";"3.75";"BDBM191625";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C[C@@H]1CCCN1C(=O)/C=C/CN1CCOCC1";"IC50";"'='";"4.15";"nM";"8.38";"";"385055";"UO_0000065";"15.53";"0.29";"4.63";"7.51";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3612993";"";"None";"399.52";"1";"5.71";"15b";"Nc1ncc(C2=CCNCC2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"853.9";"nM";"6.07";"";"";"UO_0000065";"15.19";"0.29";"0.36";"10.09";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3964529";"";"None";"585.71";"2";"6.35";"BDBM202077";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"92.0";"nM";"7.04";"";"358156";"UO_0000065";"12.01";"0.22";"0.69";"8.42";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891638";"";"None";"585.71";"2";"6.35";"BDBM202079";"Cc1c(-c2ncnc3[nH]c(-c4cccc(CN5CCOCC5)c4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"415.0";"nM";"6.38";"";"358158";"UO_0000065";"10.90";"0.20";"0.03";"7.64";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930318";"";"None";"569.71";"2";"6.51";"BDBM202080";"Cc1c(-c2ncnc3[nH]c(-c4cccc(CN5CCOCC5)c4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"825.0";"nM";"6.08";"";"358159";"UO_0000065";"10.68";"0.19";"-0.43";"8.18";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958477";"";"None";"588.71";"2";"5.77";"BDBM202113";"CN1CCC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"358191";"UO_0000065";"14.10";"0.26";"2.53";"8.34";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906723";"";"None";"628.78";"2";"5.84";"BDBM202133";"CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"358211";"UO_0000065";"13.83";"0.25";"2.86";"8.89";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971512";"";"None";"649.77";"1";"4.93";"BDBM202137";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(CN5CCS(=O)(=O)CC5)cn4)cc23)c1CO";"IC50";"'='";"9.0";"nM";"8.05";"";"358215";"UO_0000065";"12.38";"0.23";"3.12";"6.25";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984106";"";"None";"587.68";"2";"5.33";"BDBM202183";"Cc1c(-c2nc(N)nc3[nH]c(-c4ccc(N5CCOCC5)nc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"181.0";"nM";"6.74";"";"358260";"UO_0000065";"11.47";"0.21";"1.41";"5.50";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4113933";"";"None";"519.49";"1";"4.39";"BDBM246395";"Nc1ncnc2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nn2[C@@H]1CCCc2[nH]ncc21";"IC50";"'='";"0.52";"nM";"9.28";"";"429696";"UO_0000065";"17.87";"0.33";"4.89";"6.62";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3621496";"";"None";"430.48";"0";"3.61";"6";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccccc4F)c23)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"18.17";"0.33";"4.21";"9.49";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621518";"";"None";"448.47";"0";"3.75";"28";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4c(F)cccc4F)c23)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.66";"0.33";"4.17";"9.61";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622192";"";"None";"567.60";"2";"5.01";"33";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(F)cc5)c4F)c23)CC1";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"14.14";"0.26";"3.02";"7.20";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL3877212";"Inhibition of PF-06658607 binding to BTK in human Ramos cells after 1 hr by gel-based ABPP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875233";"1";"Scientific Literature";"Nat Rev Drug Discov";"2017";"CHEMBL3307664";"";"";""
"CHEMBL3612847";"";"None";"481.58";"1";"5.50";"13i";"C=CC(=O)NCCn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"9.9";"nM";"8.00";"";"";"UO_0000065";"16.62";"0.31";"2.50";"8.42";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3685420";"";"None";"459.49";"0";"3.86";"BDBM120743";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)c(F)c3)nc3n[nH]cc23)c1";"IC50";"'='";"126.0";"nM";"6.90";"";"248812";"UO_0000065";"15.02";"0.28";"3.04";"6.38";"0";"CHEMBL3705216";"Time Resolved-FRET Assay: Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay. Test compound are diluted to desired concentrations in kinase reaction buffer and briefly incubated with BTK kinase (as described above; Invitrogen). The reaction is initiated by the addition of ATP and enzyme substrate, HTRF® KinEASE-TK Substrate-biotin (Cisbio US, Bedford, Mass.). The composition of the reaction (10 μl) was: 1% v/v DMSO, 10 nM BTK, 60 μM ATP, and 1 μM substrate. After incubation at room temperature for 60 min, the enzyme reaction is stopped by EDTA-containing buffer, which also contains europium-labeled (Eu3+-Cryptate) anti-phosphotyrosine antibody (Cisbio) and Streptavidin-XL665 (Cisbio). The europium-labeled antibody generates a time-resolved FRET signal with the Stepavidin-XL665, which binds to the biotinylated TK substrate through the streptavidin conjugate when the substrate is phosphorylated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3290149";"";"None";"510.53";"2";"5.30";"39";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(F)c4)ccc3C)cn2)c1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"14.34";"0.26";"2.02";"5.85";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3647525";"";"None";"465.52";"0";"3.45";"BDBM143327";"CC#CC(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)cn4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"279487";"UO_0000065";"19.33";"0.35";"5.55";"8.03";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3967476";"";"None";"524.60";"2";"5.66";"BDBM200786";"CN(C)C(=O)N1CC=C(c2cc3c(-c4ccc(F)c(NC(=O)c5ccc(C6CC6)cc5)c4)ncnc3[nH]2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"356858";"UO_0000065";"15.67";"0.29";"2.56";"8.73";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3670092";"";"None";"544.68";"1";"4.29";"BDBM111949";"CCn1cc(Nc2nc(-c3cccc(N4CCc5c(sc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)cn1";"IC50";"'='";"2.0";"nM";"8.70";"";"233004";"UO_0000065";"15.97";"0.30";"4.41";"8.26";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670095";"";"None";"653.76";"1";"3.68";"BDBM111952";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"3.9";"nM";"8.41";"";"233007";"UO_0000065";"12.86";"0.24";"4.73";"7.78";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670119";"";"None";"610.73";"2";"5.18";"BDBM111978";"CN1CCC[C@@H]1c1ccc(Nc2cc(-c3cc(F)cc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"1.74";"nM";"8.76";"";"233033";"UO_0000065";"14.34";"0.27";"3.58";"9.16";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3949721";"";"None";"507.60";"1";"4.87";"BDBM197213";"CC(C)(CNC(=O)/C(C#N)=C/C1CC1)Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"27.0";"nM";"7.57";"";"350385";"UO_0000065";"14.91";"0.27";"2.70";"5.75";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4110649";"";"None";"543.58";"2";"5.24";"BDBM197235";"CC(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cc(F)ccc3F)cc2)c2c(N)ncnc21";"IC50";"'='";"7.0";"nM";"8.15";"";"350389";"UO_0000065";"15.00";"0.28";"2.91";"6.63";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3290134";"";"None";"472.94";"1";"5.27";"23";"Cc1ccc(NC(=O)c2cccc(Cl)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"16.28";"0.31";"2.43";"6.31";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290142";"";"None";"560.54";"2";"6.18";"31";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.81";"0.28";"2.12";"6.63";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3969541";"";"None";"560.66";"1";"4.99";"BDBM202115";"CN1CC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"358193";"UO_0000065";"14.98";"0.27";"3.41";"8.44";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930909";"";"None";"493.57";"0";"4.76";"BDBM250078";"C=CC(=O)Nc1ccccc1[C@@H]1CCNc2c(C(N)=O)c(-c3ccc(OCc4ccccc4)cc3)nn21";"IC50";"'='";"42.0";"nM";"7.38";"";"435803";"UO_0000065";"14.95";"0.27";"2.62";"6.63";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3944462";"";"None";"415.45";"0";"3.13";"BDBM250089";"CC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"82.0";"nM";"7.09";"";"435858";"UO_0000065";"17.06";"0.31";"3.96";"6.70";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951926";"";"None";"421.89";"0";"3.83";"BDBM250033";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cccc(Cl)c3)nn21";"IC50";"'='";"0.96";"nM";"9.02";"";"435962";"UO_0000065";"21.37";"0.41";"5.19";"8.84";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"327853";"UO_0000065";"20.75";"0.38";"4.92";"9.22";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3652650";"";"None";"484.53";"0";"4.36";"BDBM122411";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5ccccc54)c3CO)ncc2c1";"IC50";"'='";"4.1";"nM";"8.39";"";"250991";"UO_0000065";"17.31";"0.32";"4.03";"8.13";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652675";"";"None";"579.61";"2";"5.56";"BDBM122436";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5ccc(-c6ccccc6F)nc54)c3CO)ncc2c1";"IC50";"'='";"14.28";"nM";"7.84";"";"251016";"UO_0000065";"13.54";"0.25";"2.29";"6.76";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4111146";"";"None";"532.53";"1";"4.85";"BDBM246406";"Cn1ncc2c1CCC[C@H]2c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)nccn12";"IC50";"'='";"1000.0";"nM";"6.00";"";"429714";"UO_0000065";"11.27";"0.21";"1.15";"5.17";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115483";"";"None";"577.61";"2";"5.64";"BDBM255374";"CC(C)c1cc(C(F)(F)F)cc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)n1";"IC50";"'='";"278.3";"nM";"6.55";"";"445281";"UO_0000065";"11.35";"0.21";"0.92";"5.53";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111886";"";"None";"579.54";"1";"4.21";"BDBM255376";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3C(=O)O)c12";"IC50";"'='";"83.5";"nM";"7.08";"";"445283";"UO_0000065";"12.21";"0.23";"2.87";"4.54";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114985";"";"None";"583.55";"1";"4.66";"BDBM255383";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)cc(F)c1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.28";"nM";"9.55";"";"445290";"UO_0000065";"16.37";"0.31";"4.89";"7.48";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114840";"";"None";"549.63";"1";"4.40";"BDBM255413";"CCOc1cc(C(=O)Nc2ncc(C)s2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(F)cnc(N)c12";"IC50";"'='";"1.9";"nM";"8.72";"";"445320";"UO_0000065";"15.87";"0.31";"4.32";"6.83";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114433";"";"None";"543.58";"1";"4.65";"BDBM255416";"Nc1ncc(F)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CC5)ccn4)cc3F)c12";"IC50";"'='";"1.3";"nM";"8.89";"";"445323";"UO_0000065";"16.35";"0.30";"4.24";"7.50";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114097";"";"None";"607.64";"2";"5.55";"BDBM255470";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@@H]3N(C2)C(=O)CC3(C)C)n2ccnc(N)c12";"IC50";"'='";"0.2";"nM";"9.70";"";"445377";"UO_0000065";"15.96";"0.30";"4.15";"7.59";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109249";"";"None";"531.64";"1";"4.26";"BDBM255408";"CCOc1cc(C(=O)Nc2ncc(C)s2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.63";"nM";"9.20";"";"445315";"UO_0000065";"17.31";"0.33";"4.94";"7.20";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115294";"";"None";"583.55";"1";"4.66";"BDBM255411";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(F)cnc(N)c12";"IC50";"'='";"1.3";"nM";"8.89";"";"445318";"UO_0000065";"15.23";"0.29";"4.23";"6.96";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106492";"";"None";"560.06";"1";"4.72";"BDBM255456";"CCc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)c(OC)c2)c1";"IC50";"'='";"0.58";"nM";"9.24";"";"445363";"UO_0000065";"16.49";"0.32";"4.52";"7.23";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4093610";"";"None";"660.77";"2";"5.55";"21";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N5CCCC5)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"10.69";"0.20";"1.52";"5.65";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"342601";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2006765";"";"None";"392.39";"0";"3.82";"5";"CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1";"IC50";"'='";"4950.0";"nM";"5.30";"";"";"UO_0000065";"13.52";"0.26";"1.49";"5.60";"0";"CHEMBL4007688";"Inhibition of BTK (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4089318";"";"None";"508.46";"1";"4.15";"29";"Nc1nccn2c(C34CC(C(=O)O)(C3)C4)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"18.48";"0.35";"5.25";"6.94";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4102992";"";"None";"625.75";"1";"4.30";"27";"C[C@H]1CN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CCN1C";"IC50";"'='";"27.5";"nM";"7.56";"";"";"UO_0000065";"12.08";"0.22";"3.26";"7.65";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4081452";"";"None";"562.56";"1";"4.61";"18";"Cn1nnnc1[C@H]1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"16.93";"0.32";"4.91";"6.72";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4059723";"";"None";"597.57";"1";"4.87";"19";"CC1(C(=O)N2CCO[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)CCC1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"15.32";"0.29";"4.28";"7.17";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3968928";"";"None";"598.75";"2";"6.26";"1";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCN(C)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"12.82";"0.23";"1.42";"9.90";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3912266";"";"None";"454.53";"0";"4.65";"BDBM191614";"C=CC(=O)N[C@H]1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.31";"nM";"8.88";"";"385044";"UO_0000065";"19.54";"0.36";"4.23";"8.23";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905432";"";"None";"452.52";"0";"3.88";"BDBM191620";"CC#CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"3.14";"nM";"8.50";"";"385050";"UO_0000065";"18.79";"0.34";"4.62";"8.58";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926657";"";"None";"506.57";"1";"4.47";"BDBM191610";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)/C=C/c2c[nH]cn2)C1";"IC50";"'='";"22.2";"nM";"7.65";"";"385038";"UO_0000065";"15.11";"0.28";"3.18";"5.99";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"7; CC-292, AVL-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"21.62";"0.40";"4.90";"9.40";"1";"CHEMBL5242619";"Irreversible inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5197174";"";"None";"490.56";"0";"4.75";"86";"CN1CCN(c2ccc(Nc3nc(Nc4ccc(F)c(F)c4)c4ncn(CC5CC5)c4n3)cc2)CC1";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"12.71";"0.24";"1.49";"8.41";"0";"CHEMBL5242663";"Inhibition of BTK (unknown origin) in the presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3652665";"";"None";"510.56";"1";"2.99";"BDBM122426";"CC(C)(C)c1ccc2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5cnccn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.83";"nM";"9.08";"";"251006";"UO_0000065";"17.79";"0.33";"6.09";"5.90";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652671";"";"None";"486.51";"0";"3.15";"BDBM122432";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5cncnc54)c3CO)ncc2c1";"IC50";"'='";"7.32";"nM";"8.13";"";"251012";"UO_0000065";"16.72";"0.31";"4.99";"6.31";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652672";"";"None";"583.67";"1";"3.50";"BDBM122433";"CN1CCN(c2ccc3c(C(N)=O)cn(-c4cccc(-n5ncc6cc(C(C)(C)C)cc(F)c6c5=O)c4CO)c3n2)CC1";"IC50";"'='";"2.83";"nM";"8.55";"";"251013";"UO_0000065";"14.65";"0.27";"5.05";"6.98";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4112629";"";"None";"572.98";"1";"4.50";"BDBM255439";"Cn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)c(Cl)c2)cc1C(F)(F)F";"IC50";"'='";"2.2";"nM";"8.66";"";"445346";"UO_0000065";"15.11";"0.30";"4.16";"7.01";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114207";"";"None";"604.42";"2";"5.82";"BDBM255443";"Nc1ncc(Cl)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3Cl)c12";"IC50";"'='";"0.39";"nM";"9.41";"";"445350";"UO_0000065";"15.57";"0.31";"3.59";"7.94";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114832";"";"None";"596.61";"1";"4.56";"BDBM255454";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(C)cnc(N)c12";"IC50";"'='";"1.2";"nM";"8.92";"";"445361";"UO_0000065";"14.95";"0.28";"4.36";"6.72";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112704";"";"None";"633.67";"2";"6.22";"BDBM255387";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CCCCC3)c12";"IC50";"'='";"135.3";"nM";"6.87";"";"445294";"UO_0000065";"10.84";"0.20";"0.65";"5.38";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL500517";"";"None";"566.65";"1";"3.47";"8x";"CN(C(=O)c1ccccc1)c1ccc2c(c1)[nH]/c(=N\C(=O)c1ccc(/C=C/c3ncc(N)cn3)s1)n2CCC(N)=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.65";"0.28";"4.83";"5.02";"0";"CHEMBL942223";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152261";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4240087";"";"None";"456.50";"0";"3.74";"13";"C=CC(=O)N1C2CC1CN(c1ccc(C(N)=O)c(Oc3ccc(Oc4ccccc4)cc3)n1)C2";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"16.42";"0.30";"3.75";"7.65";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4246190";"";"None";"465.51";"0";"1.33";"6";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Oc3ccc(C(=O)N4CCOCC4)cc3)n2)C1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.74";"0.20";"3.67";"3.93";"0";"CHEMBL4236278";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4237249";"";"None";"431.54";"0";"3.96";"16";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"0.24";"nM";"9.62";"";"";"UO_0000065";"22.29";"0.41";"5.66";"9.68";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3263629";"";"None";"588.71";"2";"6.47";"9";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nccn2n1";"IC50";"'='";"213.0";"nM";"6.67";"";"";"UO_0000065";"11.33";"0.21";"0.20";"6.61";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263632";"";"None";"602.74";"2";"5.68";"12";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCNCC3)cc2)c2ncn(C)c2n1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"12.61";"0.23";"1.92";"6.49";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263633";"";"None";"646.80";"2";"5.38";"13";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCN(CCO)CC3)cc2)c2ncn(C)c2n1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"11.68";"0.21";"2.17";"5.88";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263634";"";"None";"616.77";"2";"6.02";"14";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCN(C)CC3)cc2)c2ncn(C)c2n1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"12.60";"0.23";"1.75";"7.18";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263641";"";"None";"631.78";"2";"6.98";"21";"CCCn1cnc2c(Nc3ccc(C(=O)N4CCOCC4)cc3)nc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)nc21";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"10.72";"0.20";"-0.21";"5.92";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263654";"";"None";"429.48";"0";"3.13";"34";"Cc1c(N)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"16.56";"0.30";"3.98";"5.83";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL1421";"DASATINIB";"4.0";"488.02";"0";"3.31";"dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.01";"0.34";"4.99";"7.79";"0";"CHEMBL923536";"Inhibition of recombinant Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147060";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";""
"CHEMBL58";"MITOXANTRONE";"4.0";"444.49";"1";"-0.14";"MX";"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.50";"0.26";"6.14";"3.68";"0";"CHEMBL2330105";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321759";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4059473";"";"None";"550.54";"2";"5.32";"26";"Nc1nccn2c(C34CCC(C(=O)O)(CC3)CC4)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.62";"0.33";"4.38";"7.16";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4105560";"";"None";"601.61";"1";"3.99";"13";"CS(=O)(=O)NC(=O)[C@H]1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"648.0";"nM";"6.19";"";"";"UO_0000065";"10.29";"0.20";"2.20";"3.83";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4101367";"";"None";"510.48";"1";"4.61";"23";"Nc1nccn2c([C@@H]3CC[C@H](C(=O)O)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"132.0";"nM";"6.88";"";"";"UO_0000065";"13.48";"0.25";"2.27";"5.08";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3900330";"";"None";"598.68";"1";"4.46";"BDBM197217";"COCCNC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"29.0";"nM";"7.54";"";"350398";"UO_0000065";"12.59";"0.23";"3.08";"5.23";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114814";"";"None";"556.62";"2";"6.24";"BDBM197264";"CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1cc(-c2ccc(Oc3cccc(F)c3F)cc2)c2c(N)ncnc21";"IC50";"'='";"34.0";"nM";"7.47";"";"350407";"UO_0000065";"13.42";"0.25";"1.23";"6.79";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114762";"";"None";"514.57";"1";"3.70";"BDBM197225";"C[C@H](Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)NC(=O)/C(C#N)=C/C(C)(C)N";"IC50";"'='";"0.7";"nM";"9.15";"";"350411";"UO_0000065";"17.79";"0.33";"5.45";"5.80";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3922858";"";"None";"559.55";"2";"5.14";"BDBM197214";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3c(F)cccc3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"5.0";"nM";"8.30";"";"350429";"UO_0000065";"14.84";"0.28";"3.16";"6.75";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4464404";"";"None";"533.59";"2";"5.52";"21";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4ccncc4)c23)c1";"IC50";"'='";"3.9";"nM";"8.41";"";"";"UO_0000065";"15.76";"0.29";"2.89";"7.17";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4438914";"";"None";"604.68";"1";"4.79";"33";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.39";"0.25";"3.31";"5.28";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL2179780";"";"None";"650.83";"1";"3.75";"61";"CC(C)c1ccc(NC(=O)c2cccc(-c3nn([C@@H]4CCCN(C(=O)/C=C/CN5CCN(CCN)CC5)C4)c4ncnc(N)c34)c2)cc1";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"9.19";"0.17";"2.23";"3.95";"0";"CHEMBL2185026";"Inhibition of BTK in presence of 50 uM ATP";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177048";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4246005";"";"None";"441.53";"1";"5.14";"6";"C/C=C/C(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1C";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"16.23";"0.30";"2.03";"6.62";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4237557";"";"None";"347.42";"0";"3.98";"27";"C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C";"IC50";"'='";"0.38";"nM";"9.42";"";"";"UO_0000065";"27.11";"0.49";"5.44";"10.71";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4243299";"";"None";"444.49";"1";"5.09";"22";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4ccccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"17.54";"0.31";"2.71";"8.31";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3702859";"";"None";"637.76";"1";"4.86";"BDBM143217";"CCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H]2Cn2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)CC1";"IC50";"'='";"0.9";"nM";"9.05";"";"369508";"UO_0000065";"14.18";"0.26";"4.19";"6.99";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702836";"";"None";"610.69";"1";"4.56";"BDBM143185";"CN(C1COC1)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"2.1";"nM";"8.68";"";"369510";"UO_0000065";"14.21";"0.26";"4.12";"6.41";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4639930";"";"None";"578.62";"2";"6.61";"41";"C=CC(=O)NCCOc1cc(C(O)(c2ccccc2)c2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"676.0";"nM";"6.17";"";"";"UO_0000065";"10.66";"0.20";"-0.44";"5.99";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL3402585";"";"None";"620.69";"1";"4.98";"4x";"O=C(N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1)N1CCOCC1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"12.52";"0.23";"2.79";"6.66";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL2216828";"";"None";"538.44";"2";"5.98";"29";"C=CC(=O)N1CCCC(c2c(Cl)c(-c3ccc(Oc4cccc(Cl)c4)c(OC)c3)c3c(N)ncnn23)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.16";"0.32";"2.72";"9.16";"0";"CHEMBL2217246";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2216750";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4469908";"";"None";"429.52";"0";"4.54";"A9";"C=CC(=O)N[C@@H]1CCC[C@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"18.29";"0.34";"3.31";"7.69";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4554990";"";"None";"423.48";"1";"5.39";"A8";"C=CC(=O)Nc1cccc(Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"18.23";"0.33";"2.33";"7.56";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"A18; M2951";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"16.80";"0.31";"2.86";"7.73";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4462332";"";"None";"455.88";"0";"3.33";"20c";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ncc(Cl)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"17.81";"0.35";"4.79";"5.97";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4560385";"";"None";"438.44";"0";"3.42";"9a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"20.13";"0.38";"5.40";"7.16";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4462332";"";"None";"455.88";"0";"3.33";"20c";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ncc(Cl)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"16.02";"0.31";"3.97";"5.37";"0";"CHEMBL4385494";"Inhibition of BTK in human whole blood assessed as reduction in anti-human IgE antibody-stimulated histamine release pretreated for 2 hrs followed by anti-human IgE antibody-stimulation and measured after 30 mins by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4092943";"";"None";"537.60";"1";"3.76";"7g";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(=O)CN(CCOC)CCOC)cc3)ncc2F)c1";"IC50";"'='";"91.3";"nM";"7.04";"";"";"UO_0000065";"13.09";"0.25";"3.28";"5.43";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4068131";"";"None";"536.51";"1";"4.93";"28";"Nc1nccn2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nc2[C@]12CC[C@](C(=O)O)(CC1)C2";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"18.08";"0.34";"4.77";"7.16";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4065778";"";"None";"516.58";"2";"6.29";"3e";"Nc1cccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)c1";"IC50";"'='";"2410.0";"nM";"5.62";"";"";"UO_0000065";"10.88";"0.20";"-0.67";"5.80";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4081221";"";"None";"517.56";"2";"6.42";"3c";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]c(-c4ccc(O)cc4)cc23)c1CO";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"13.45";"0.24";"0.54";"7.64";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402584";"";"None";"578.65";"2";"5.21";"2";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"14.09";"0.26";"2.94";"7.60";"1";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4085393";"";"None";"613.72";"1";"4.94";"3s";"CN(C)S(=O)(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"9.7";"nM";"8.01";"";"";"UO_0000065";"13.06";"0.25";"3.07";"7.18";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4103325";"";"None";"584.67";"2";"5.09";"3r";"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"7.1";"nM";"8.15";"";"";"UO_0000065";"13.94";"0.26";"3.06";"7.52";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4638741";"";"None";"376.48";"0";"1.92";"4b";"C=CS(=O)(=O)NC1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"23.52";"0.47";"6.93";"8.18";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4643248";"";"None";"326.40";"0";"2.08";"4l";"C=CC(=O)N1CC[C@@H](Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"8.4";"nM";"8.08";"";"";"UO_0000065";"24.74";"0.46";"6.00";"8.85";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5a; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"27.00";"0.51";"7.87";"10.96";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4640555";"";"None";"326.40";"0";"2.08";"4k";"C=CC(=O)N1CC[C@H](Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"25.00";"0.46";"6.08";"8.95";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"57.5";"nM";"7.24";"";"";"UO_0000065";"16.44";"0.30";"3.02";"7.30";"0";"CHEMBL4616857";"Inhibition of BTK in human whole blood cells after 120 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"CC292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"18.91";"0.35";"3.76";"8.22";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4649397";"";"None";"418.22";"None";"None";"14p";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc4c(c3)COB4O)ncc2OC)c1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"20.97";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4648104";"";"None";"469.23";"None";"None";"14i";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OCC4)ncc2C(F)(F)F)c1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"18.59";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4647822";"";"None";"401.24";"None";"None";"14d";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4)ncc2C)c1";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"20.47";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL3923822";"";"None";"554.55";"1";"4.66";"BDBM230112";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.46";"nM";"9.34";"";"401975";"UO_0000065";"16.84";"0.31";"4.68";"7.62";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943055";"";"None";"589.00";"2";"5.55";"BDBM230119";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cc(F)cc2c1=O";"IC50";"'='";"0.33";"nM";"9.48";"";"401983";"UO_0000065";"16.10";"0.31";"3.93";"7.08";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4071759";"";"None";"482.54";"1";"6.19";"24";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cnc6ccccc6c5)cc4c32)ccc1C";"IC50";"'='";"24.5";"nM";"7.61";"";"";"UO_0000065";"15.77";"0.28";"1.42";"9.90";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3290116";"";"None";"443.43";"0";"4.74";"5";"CCNc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2C)cn1";"IC50";"'='";"1106.0";"nM";"5.96";"";"";"UO_0000065";"13.43";"0.25";"1.22";"6.20";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3649454";"";"None";"449.49";"0";"2.81";"BDBM122402";"Cn1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)nc1C(N)=O";"IC50";"'='";"18.23";"nM";"7.74";"";"250982";"UO_0000065";"17.22";"0.32";"4.93";"6.67";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4166664";"";"None";"421.46";"0";"4.16";"18";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-n5cccn5)cc4c32)ccc1C";"IC50";"'='";"75.6";"nM";"7.12";"";"";"UO_0000065";"16.90";"0.30";"2.96";"8.70";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4166849";"";"None";"433.47";"0";"4.31";"10";"C=CC(=O)Nc1cccc(-n2c(=O)ccc3cnc4ccc(-c5ccc(N)nc5)cc4c32)c1";"IC50";"'='";"19.1";"nM";"7.72";"";"";"UO_0000065";"17.81";"0.32";"3.41";"7.50";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3358400";"";"None";"589.70";"1";"4.01";"16f";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6nc(C7CC7)ccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"3250.0";"nM";"5.49";"";"";"UO_0000065";"9.31";"0.17";"1.48";"5.06";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL4077064";"";"None";"447.50";"0";"4.01";"8";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21";"IC50";"'='";"6.59";"nM";"8.18";"";"";"UO_0000065";"18.28";"0.33";"4.17";"11.20";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3358346";"";"None";"623.73";"1";"4.57";"8";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ncc6cc(C(C)(C)C)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"13.66";"0.25";"3.95";"7.85";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3657233";"";"None";"479.50";"0";"4.48";"BDBM134240";"Nc1n[nH]c2cc(-c3ccc(C(=O)NCC(=O)O)cc3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"267629";"UO_0000065";"18.77";"0.34";"4.52";"6.28";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657238";"";"None";"471.52";"0";"3.88";"BDBM134245";"COC(=O)C(=O)N1CCCC(c2cc3[nH]nc(N)c3c(-c3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"267634";"UO_0000065";"18.45";"0.34";"4.82";"7.05";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657240";"";"None";"440.43";"1";"5.50";"BDBM134247";"Nc1n[nH]c2cc(-c3ccc(C(=O)O)c(F)c3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"267636";"UO_0000065";"20.43";"0.37";"3.50";"7.89";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3605102";"";"None";"398.49";"1";"5.74";"14b";"Cn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"107.4";"nM";"6.97";"";"";"UO_0000065";"17.49";"0.33";"1.23";"10.57";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3977725";"";"None";"506.54";"2";"5.15";"4";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3F)c12";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"14.85";"0.27";"2.37";"6.60";"1";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3702856";"";"None";"667.75";"2";"4.78";"BDBM143214";"COC(=O)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"369530";"UO_0000065";"13.03";"0.24";"3.92";"5.59";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4107623";"";"None";"647.03";"2";"5.19";"BDBM255399";"Cn1nc(NC(=O)c2cc(OC3CC3)c(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)cc2F)cc1C(F)(F)F";"IC50";"'='";"1.8";"nM";"8.74";"";"445306";"UO_0000065";"13.52";"0.27";"3.55";"6.59";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112426";"";"None";"553.52";"1";"4.65";"BDBM255409";"Nc1ncc(F)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.28";"nM";"9.55";"";"445316";"UO_0000065";"17.26";"0.33";"4.90";"8.06";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110111";"";"None";"524.51";"1";"3.84";"BDBM255419";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)[nH]n4)cc3)c12";"IC50";"'='";"36.9";"nM";"7.43";"";"445326";"UO_0000065";"14.17";"0.27";"3.59";"5.53";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112798";"";"None";"625.41";"2";"5.30";"BDBM255441";"Cn1nc(NC(=O)c2cc(Cl)c(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)cc2F)cc1C(F)(F)F";"IC50";"'='";"24.6";"nM";"7.61";"";"445348";"UO_0000065";"12.17";"0.25";"2.31";"6.16";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3954211";"";"None";"555.61";"1";"4.64";"BDBM143178";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)CO";"IC50";"'='";"8.1";"nM";"8.09";"";"279400";"UO_0000065";"14.56";"0.27";"3.45";"5.65";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3909430";"";"None";"621.71";"2";"5.10";"BDBM202222";"CC(=O)N1CC(N2CC=C(c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)CC2)C1";"IC50";"'='";"2.2";"nM";"8.66";"";"358296";"UO_0000065";"13.93";"0.26";"3.56";"8.49";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"10.34";"0.19";"0.47";"6.95";"0";"CHEMBL4018335";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017480";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4214732";"";"None";"483.51";"0";"4.01";"18e";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cn[nH]c2)n1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"19.07";"0.35";"5.21";"6.84";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4215160";"";"None";"537.60";"1";"4.89";"25f";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(CC3CC3)c2)n1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"15.75";"0.29";"3.58";"6.84";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3972359";"";"None";"505.58";"1";"4.89";"BDBM197176";"N#C/C(=C\C1CC1)C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"3.1";"nM";"8.51";"";"350366";"UO_0000065";"16.83";"0.31";"3.62";"6.92";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4159852";"";"None";"605.62";"2";"8.24";"22";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(COc6cccc(C(F)(F)F)c6)cc5)cc4c32)ccc1C";"IC50";"'='";"37.2";"nM";"7.43";"";"";"UO_0000065";"12.27";"0.23";"-0.81";"10.15";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4160923";"";"None";"433.47";"0";"4.00";"25";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cn[nH]c6)cc5c43)cc21";"IC50";"'='";"12.3";"nM";"7.91";"";"";"UO_0000065";"18.25";"0.33";"3.91";"9.43";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4171756";"";"None";"494.55";"1";"5.83";"27";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc21";"IC50";"'='";"7.15";"nM";"8.15";"";"";"UO_0000065";"16.47";"0.29";"2.32";"11.96";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4174577";"";"None";"423.48";"0";"4.38";"19";"CCC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-n5cccn5)cc4c32)ccc1C";"IC50";"'='";"6873.0";"nM";"5.16";"";"";"UO_0000065";"12.19";"0.22";"0.78";"6.31";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL447602";"";"None";"612.66";"3";"5.18";"62";"COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1";"IC50";"'='";"126.0";"nM";"6.90";"";"";"UO_0000065";"11.26";"0.21";"1.72";"6.11";"0";"CHEMBL971826";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140082";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL1230541";"";"None";"579.70";"2";"5.52";"1, CGI-1746";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.97";"0.26";"2.58";"7.67";"0";"CHEMBL3406074";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3908310";"";"None";"550.59";"1";"4.76";"7a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"14.02";"0.26";"2.96";"6.27";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL2312654";"";"None";"461.40";"1";"5.78";"21";"Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1";"IC50";"'='";"950.0";"nM";"6.02";"";"";"UO_0000065";"13.05";"0.27";"0.24";"7.61";"0";"CHEMBL2317786";"Inhibition of BTK (unknown origin) in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311250";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2312649";"";"None";"520.51";"1";"4.64";"15";"CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"8.69";"0.18";"-0.12";"5.29";"0";"CHEMBL2317786";"Inhibition of BTK (unknown origin) in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311250";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916879";"";"None";"601.63";"2";"6.29";"24";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"16.8";"nM";"7.78";"";"";"UO_0000065";"12.92";"0.24";"1.48";"8.20";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916891";"";"None";"432.50";"0";"4.15";"36";"Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"1.93";"nM";"8.71";"";"";"UO_0000065";"20.15";"0.37";"4.56";"13.25";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3906546";"";"None";"471.44";"0";"4.08";"BDBM250027";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC(F)(F)F)cc3)nn21";"IC50";"'='";"4.2";"nM";"8.38";"";"435956";"UO_0000065";"17.77";"0.34";"4.30";"7.53";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3787531";"";"None";"451.55";"0";"4.84";"7a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2SC)c1";"IC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"18.12";"0.35";"3.34";"8.40";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL2403108";"CERITINIB";"4.0";"558.15";"2";"6.36";"15b, LDK378";"Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1";"IC50";"'='";"3360.0";"nM";"5.47";"";"";"UO_0000065";"9.81";"0.20";"-0.89";"5.20";"0";"CHEMBL2406346";"Inhibition of BTK (unknown origin) after 60 mins";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401692";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3930926";"";"None";"581.70";"2";"6.09";"BDBM200769";"Cc1c(NC(=O)c2ccc(N3CCCCC3)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"3.0";"nM";"8.52";"";"356845";"UO_0000065";"14.65";"0.27";"2.43";"8.75";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894539";"";"None";"525.58";"1";"4.81";"BDBM200818";"Cc1c(NC(=O)c2ccc(C3CC3)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)CO)CC3)cc12";"IC50";"'='";"7.0";"nM";"8.15";"";"356870";"UO_0000065";"15.52";"0.29";"3.34";"7.33";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984599";"";"None";"580.69";"1";"4.32";"BDBM200860";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCc6cc(C(C)(C)O)ccc6C5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"356885";"UO_0000065";"14.98";"0.28";"4.38";"6.91";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891532";"";"None";"482.58";"1";"5.47";"BDBM200866";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3ncnc4[nH]c(C5=CCOCC5)cc34)c2CO)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"356886";"UO_0000065";"16.90";"0.31";"2.68";"8.14";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903249";"";"None";"497.60";"0";"3.98";"BDBM191616";"CN(C)C/C=C/C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"1.33";"nM";"8.88";"";"385046";"UO_0000065";"17.84";"0.33";"4.90";"8.67";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921655";"";"None";"466.55";"0";"4.49";"BDBM191626";"CC#CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.57";"nM";"8.80";"";"385056";"UO_0000065";"18.87";"0.34";"4.31";"8.16";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4112398";"";"None";"563.54";"1";"3.86";"BDBM246413";"Nc1ncnc2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nn2[C@@H]1CCCc2nn(CCO)cc21";"IC50";"'='";"0.45";"nM";"9.35";"";"429707";"UO_0000065";"16.59";"0.31";"5.49";"6.25";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115449";"";"None";"521.63";"1";"4.76";"BDBM255259";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CCC5)ccn4)cc3)c12";"IC50";"'='";"60.6";"nM";"7.22";"";"445163";"UO_0000065";"13.84";"0.25";"2.46";"6.09";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109282";"";"None";"555.49";"1";"4.48";"BDBM255263";"Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.083";"nM";"10.08";"";"445168";"UO_0000065";"18.15";"0.34";"5.60";"7.89";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110803";"";"None";"522.57";"1";"3.37";"BDBM255286";"COc1cc(C(=O)Nc2cc(C#N)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"1.1";"nM";"8.96";"";"445191";"UO_0000065";"17.14";"0.31";"5.59";"5.91";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3952685";"";"None";"523.60";"1";"4.59";"BDBM255297";"C[C@@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C6CC6)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.53";"nM";"9.28";"";"445202";"UO_0000065";"17.72";"0.32";"4.69";"7.26";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112108";"";"None";"550.55";"1";"3.32";"BDBM255305";"Nc1nccn2c([C@@H]3CC[C@@H]4CNCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"9.6";"nM";"8.02";"";"445210";"UO_0000065";"14.56";"0.27";"4.70";"6.14";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3929022";"";"None";"551.53";"1";"3.48";"BDBM255309";"Nc1nccn2c([C@H]3CC[C@@H]4C[C@H](O)C(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"4.1";"nM";"8.39";"";"445214";"UO_0000065";"15.21";"0.29";"4.91";"6.05";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113670";"";"None";"549.56";"1";"4.76";"BDBM255314";"C[C@@H]1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]12";"IC50";"'='";"0.058";"nM";"10.24";"";"445219";"UO_0000065";"18.63";"0.35";"5.48";"8.64";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3893811";"";"None";"551.53";"1";"3.48";"BDBM255318";"Nc1nccn2c([C@H]3CC[C@@H]4C[C@@H](O)C(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"3.7";"nM";"8.43";"";"445223";"UO_0000065";"15.29";"0.29";"4.95";"6.08";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110264";"";"None";"599.56";"2";"5.62";"BDBM255364";"CC(F)(F)c1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"830.9";"nM";"6.08";"";"445270";"UO_0000065";"10.14";"0.19";"0.46";"5.13";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114368";"";"None";"560.54";"1";"4.38";"BDBM255366";"N#Cc1cnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)cc1C(F)(F)F";"IC50";"'='";"2.1";"nM";"8.68";"";"445273";"UO_0000065";"15.48";"0.29";"4.30";"6.10";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110993";"";"None";"551.53";"1";"4.22";"BDBM255367";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3O)c12";"IC50";"'='";"0.58";"nM";"9.24";"";"445274";"UO_0000065";"16.75";"0.32";"5.02";"6.66";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3984475";"";"None";"575.04";"1";"4.67";"BDBM230133";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.34";"nM";"9.47";"";"401999";"UO_0000065";"16.47";"0.32";"4.80";"7.72";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4111797";"";"None";"516.63";"1";"4.07";"BDBM255428";"CC(C)c1nsc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)n1";"IC50";"'='";"68.9";"nM";"7.16";"";"445335";"UO_0000065";"13.86";"0.26";"3.09";"5.45";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113598";"";"None";"517.62";"1";"3.87";"BDBM255451";"COc1cc(C(=O)Nc2ncc(C)s2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"5.2";"nM";"8.28";"";"445358";"UO_0000065";"16.00";"0.31";"4.41";"6.49";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115363";"";"None";"603.60";"1";"4.92";"BDBM255453";"C#CCCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.75";"nM";"9.12";"";"445360";"UO_0000065";"15.12";"0.28";"4.20";"7.14";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3647973";"";"None";"440.51";"0";"4.22";"BDBM97678";"C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"3.1";"nM";"8.51";"";"342648";"UO_0000065";"19.32";"0.35";"4.29";"8.58";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"BDBM230150";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.19";"nM";"9.72";"";"401966";"UO_0000065";"17.02";"0.32";"4.54";"7.93";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3944101";"";"None";"571.01";"2";"5.18";"BDBM230108";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.25";"nM";"9.60";"";"401970";"UO_0000065";"16.82";"0.32";"4.42";"7.83";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891767";"";"None";"583.04";"2";"5.05";"BDBM230110";"COc1cccn2c(=O)n(-c3cccc(-c4c(Cl)cc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)cc12";"IC50";"'='";"0.91";"nM";"9.04";"";"401972";"UO_0000065";"15.51";"0.29";"3.99";"6.86";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917869";"";"None";"559.05";"2";"5.10";"BDBM230153";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2sccn2c1=O";"IC50";"'='";"0.34";"nM";"9.47";"";"401973";"UO_0000065";"16.94";"0.33";"4.37";"7.72";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4566033";"";"None";"541.68";"2";"5.73";"5k";"CCOC(=O)c1sc(-c2cccc(NC(=O)c3ccccc3)c2)nc1Nc1ccc(N2CCN(C)CC2)cc1";"IC50";"'='";"37114.0";"nM";"4.43";"";"";"UO_0000065";"8.18";"0.16";"-1.30";"5.10";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4454852";"";"None";"580.64";"2";"5.68";"7h";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccc(C(F)(F)F)cc5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"206.0";"nM";"6.69";"";"";"UO_0000065";"11.52";"0.22";"1.01";"6.45";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3982014";"";"None";"539.64";"1";"3.92";"BDBM191624";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(C(=O)/C=C/CN2CCOCC2)CC1";"IC50";"'='";"4.07";"nM";"8.39";"";"342662";"UO_0000065";"15.55";"0.29";"4.47";"7.52";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5a; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"24.42";"0.46";"6.92";"9.92";"0";"CHEMBL4616776";"Inhibition of BTK in human memory B cells assessed as reduction in CD86 surface expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3401285";"";"None";"472.57";"0";"4.48";"25";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccncn2)n1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"13.09";"0.25";"1.71";"6.08";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401273";"";"None";"581.68";"1";"4.31";"13";"Cc1c(NC(=O)c2cnc(C(C)(C)C)nc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"11.29";"0.21";"2.26";"5.00";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4556566";"";"None";"559.67";"2";"5.87";"5l";"CCOC(=O)c1sc(-c2cccc(NC(=O)c3cccc(F)c3)c2)nc1Nc1ccc(N2CCN(C)CC2)cc1";"IC50";"'='";"19155.0";"nM";"4.72";"";"";"UO_0000065";"8.43";"0.16";"-1.15";"5.44";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4290066";"";"None";"450.54";"0";"2.33";"1";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)NC(C)(C)C)cc3)n2)C1";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"18.03";"0.34";"5.79";"6.28";"0";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"18.93";"0.35";"4.12";"8.41";"1";"CHEMBL4264031";"Inhibition of BTK in human PBMC";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4645440";"";"None";"376.48";"0";"1.92";"4d";"C=CS(=O)(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"46.6";"nM";"7.33";"";"";"UO_0000065";"19.47";"0.39";"5.41";"6.77";"0";"CHEMBL4616762";"Inhibition of BTK in human whole blood cells after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4640054";"";"None";"512.30";"None";"None";"16c";"CN(C)C/C=C/C(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)COB4O)ncc2C(F)(F)F)c1";"IC50";"'='";"11.8";"nM";"7.93";"";"";"UO_0000065";"15.48";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4642827";"";"None";"352.44";"0";"1.99";"4g";"CC#CC(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"26.34";"0.49";"7.29";"10.18";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4646406";"";"None";"326.40";"0";"1.76";"4h";"C=CC(=O)NC1CCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"25.66";"0.48";"6.62";"9.18";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4648442";"";"None";"356.40";"0";"1.74";"5b";"C#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"0.07";"nM";"10.15";"";"";"UO_0000065";"28.49";"0.53";"8.41";"11.13";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4646406";"";"None";"326.40";"0";"1.76";"4h";"C=CC(=O)NC1CCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"20.12";"0.37";"4.81";"7.20";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5h";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.00";"0.26";"2.70";"6.32";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6g";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"11.86";"0.23";"1.59";"5.52";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4562744";"";"None";"543.63";"1";"3.43";"35";"CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(OC4CCOCC4)c23)n1";"IC50";"'='";"1607.0";"nM";"5.79";"";"";"UO_0000065";"10.66";"0.20";"2.36";"4.34";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4543893";"";"None";"596.70";"1";"3.42";"36";"C=CC(=O)N1CCC[C@H]1COc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)nc2[nH]cc(-c3cncc(NC)n3)c12";"IC50";"'='";"434.0";"nM";"6.36";"";"";"UO_0000065";"10.66";"0.20";"2.94";"4.40";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3746575";"";"None";"631.20";"2";"5.79";"9";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)ccc(Cl)c1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"11.18";"0.22";"1.27";"7.09";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3747554";"";"None";"617.18";"2";"5.48";"4";"CN1CCN(C)C(c2ccc(Nc3nc(-c4cccc(NC(=O)c5cc6c(s5)CCCC6)c4Cl)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.32";"0.26";"2.74";"8.26";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3916524";"";"None";"417.47";"0";"3.10";"BDBM250088";"C=CC(=O)NC[C@@H]1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"11.0";"nM";"7.96";"";"435836";"UO_0000065";"19.06";"0.35";"4.86";"7.15";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968222";"";"None";"427.46";"0";"3.29";"BDBM249925";"C=CC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"0.14";"nM";"9.85";"";"435855";"UO_0000065";"23.05";"0.42";"6.56";"9.32";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4108989";"";"None";"396.50";"0";"0.90";"BDBM235162";"CS(=O)(=O)N[C@@H]1CCCN(c2nc(C(N)=O)c(Nc3ccccn3)s2)C1";"IC50";"'='";"5065.1";"nM";"5.29";"";"409814";"UO_0000065";"13.36";"0.28";"4.40";"4.06";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936156";"";"None";"571.01";"2";"5.41";"11";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"13.48";"0.26";"2.29";"5.75";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3764684";"";"None";"267.25";"0";"-1.67";"PI-4";"N=C(N/C(=N/O)c1nonc1N)N1CCCN=C1N";"IC50";"'='";"46510.0";"nM";"4.33";"";"";"UO_0000065";"16.21";"0.31";"6.00";"2.48";"0";"CHEMBL3767269";"Antagonist activity at human BTK-PH domain (2 to 170 residues) assessed as reduction in PI(3,4,5)P3/BTK-PH interaction after 30 mins by competitive SPR analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763051";"1";"Scientific Literature";"Medchemcomm";"2015";"None";"";"";""
"CHEMBL3939935";"";"None";"549.65";"1";"4.87";"BDBM200882";"Cc1c(NC(=O)N2CC(OC(C)(C)C)C2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"7.0";"nM";"8.15";"";"356895";"UO_0000065";"14.84";"0.28";"3.28";"7.64";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"BDBM230090";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"1.8";"nM";"8.74";"";"401947";"UO_0000065";"14.95";"0.28";"3.32";"7.10";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936156";"";"None";"571.01";"2";"5.41";"BDBM230091";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"401949";"UO_0000065";"15.62";"0.30";"3.51";"6.66";"1";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896019";"";"None";"568.58";"1";"4.90";"BDBM230096";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.45";"nM";"9.35";"";"401954";"UO_0000065";"16.44";"0.30";"4.45";"7.59";"1";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913962";"";"None";"597.05";"2";"5.72";"BDBM230099";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)ccn(-c2ccc(F)cc2)c1=O";"IC50";"'='";"0.44";"nM";"9.36";"";"401958";"UO_0000065";"15.67";"0.30";"3.64";"7.60";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954590";"";"None";"587.46";"2";"5.62";"BDBM230113";"Cn1c(=O)n(-c2cccc(-c3c(Cl)cc(C(N)=O)c4[nH]c5cc(C(C)(C)O)ccc5c34)c2Cl)c(=O)c2ccccc21";"IC50";"'='";"0.47";"nM";"9.33";"";"401978";"UO_0000065";"15.88";"0.31";"3.71";"7.58";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901137";"";"None";"558.59";"1";"4.16";"BDBM230137";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.84";"nM";"9.08";"";"402004";"UO_0000065";"16.25";"0.30";"4.92";"7.40";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959154";"";"None";"540.53";"1";"3.97";"BDBM230139";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(CCO)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.59";"nM";"9.23";"";"402005";"UO_0000065";"17.07";"0.32";"5.26";"7.53";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932965";"";"None";"567.05";"2";"5.35";"BDBM230140";"Cc1cc(C(N)=O)c2[nH]c3cc(C(C)(C)O)ccc3c2c1-c1cccc(-n2c(=O)cc3c(Cl)cccn3c2=O)c1C";"IC50";"'='";"0.41";"nM";"9.39";"";"402006";"UO_0000065";"16.55";"0.31";"4.04";"7.66";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894721";"";"None";"519.49";"1";"4.39";"BDBM246396";"Nc1ncnc2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nn2[C@H]1CCCc2[nH]ncc21";"IC50";"'='";"60.0";"nM";"7.22";"";"429697";"UO_0000065";"13.90";"0.26";"2.83";"5.15";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114231";"";"None";"533.52";"1";"4.40";"BDBM246409";"Cn1cc2c(n1)CCC[C@H]2n1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"3.2";"nM";"8.49";"";"429699";"UO_0000065";"15.92";"0.30";"4.09";"6.56";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109802";"";"None";"589.62";"2";"5.78";"BDBM255375";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)cc(C5CCC5)n4)cc3)c12";"IC50";"'='";"765.9";"nM";"6.12";"";"445282";"UO_0000065";"10.37";"0.19";"0.34";"5.16";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110893";"";"None";"626.04";"2";"5.71";"BDBM255393";"Nc1ncc(Cl)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12";"IC50";"'='";"0.5";"nM";"9.30";"";"445300";"UO_0000065";"14.86";"0.29";"3.59";"7.28";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107684";"";"None";"609.61";"1";"3.20";"BDBM255398";"Cn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)c(OC3CNC3)c2)cc1C(F)(F)F";"IC50";"'='";"96.7";"nM";"7.01";"";"445305";"UO_0000065";"11.51";"0.22";"3.81";"4.85";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106573";"";"None";"569.98";"2";"5.17";"BDBM255402";"Nc1ncc(Cl)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.16";"nM";"9.80";"";"445309";"UO_0000065";"17.19";"0.33";"4.63";"8.27";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108849";"";"None";"569.52";"1";"4.36";"BDBM255414";"Nc1ncc(F)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3O)c12";"IC50";"'='";"2.3";"nM";"8.64";"";"445321";"UO_0000065";"15.17";"0.29";"4.28";"6.23";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108415";"";"None";"587.49";"1";"4.98";"BDBM246415";"Nc1nccn2c([C@@H]3CCn4c(nnc4C(F)(F)F)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"11.0";"nM";"7.96";"";"429713";"UO_0000065";"13.55";"0.26";"2.98";"6.17";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.43";"0.37";"4.78";"9.08";"0";"CHEMBL4235188";"Inhibition of recombinant full length human N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3263642";"";"None";"693.85";"2";"7.81";"22";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2ncn(CCc3ccccc3)c2n1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.88";"0.18";"-0.96";"6.00";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263655";"";"None";"428.50";"0";"3.85";"35";"Cc1cccc(-c2nc(Nc3ccc(C(=O)N4CCOCC4)cc3)c3nc[nH]c3n2)c1C";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"17.40";"0.32";"3.61";"7.76";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263656";"";"None";"548.61";"2";"5.19";"36";"Cc1c(NC(=O)Nc2ccccc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.12";"0.26";"2.55";"5.65";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL4208439";"";"None";"539.62";"2";"5.23";"25c";"CC(C)(C)n1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.75";"0.27";"2.73";"6.42";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4214229";"";"None";"523.57";"2";"5.29";"18d";"COc1ccc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"14.15";"0.26";"2.12";"6.43";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4208439";"";"None";"539.62";"2";"5.23";"25c";"CC(C)(C)n1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"17.09";"0.31";"3.99";"7.44";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4214229";"";"None";"523.57";"2";"5.29";"18d";"COc1ccc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"16.43";"0.30";"3.31";"7.46";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4093188";"";"None";"639.82";"2";"5.21";"15";"CC1C=C(c2ccnc(N3Cc4cc(C(C)(C)C)sc4C3=O)c2CO)C=C(Nc2ccc(N3CCN(C4COC4)CC3)cc2)C1=O";"IC50";"'='";"61.9";"nM";"7.21";"";"";"UO_0000065";"11.27";"0.21";"2.00";"7.34";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4082268";"";"None";"650.78";"2";"3.19";"16";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2cccc(N3CCN(C4COC4)CC3)n2)c1=O";"IC50";"'='";"240.9";"nM";"6.62";"";"";"UO_0000065";"10.17";"0.19";"3.43";"5.47";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4087543";"";"None";"678.84";"2";"3.96";"31";"CC[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"15.9";"nM";"7.80";"";"";"UO_0000065";"11.49";"0.21";"3.84";"6.45";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1916902";"";"None";"433.49";"0";"4.20";"47";"Cc1cc(F)ccc1Oc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"6.58";"nM";"8.18";"";"";"UO_0000065";"18.87";"0.35";"3.98";"12.99";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4789404";"";"None";"548.60";"1";"4.40";"5c";"COc1ccn2c(=O)n(-c3cccc(-c4ccc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)cc2c1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"12.49";"0.23";"2.45";"5.20";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL3263343";"";"None";"192.07";"0";"-1.09";"8";"O=C(O)c1cc(P(=O)(O)O)n[nH]1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"24.83";"0.54";"5.86";"3.86";"0";"CHEMBL3267160";"Inhibition of PtdIns(3,4,5)P3 binding to Btk PH domain (unknown origin) expressed in Escherichia coli BL21(DE3) RIL cells by surface plasmon resonance assay relative to untreated control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259747";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5a; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"21.48";"0.40";"5.83";"8.72";"0";"CHEMBL4616777";"Inhibition of BTK in human peripheral B cells assessed as reduction in CD69 surface expression by whole blood assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3263644";"";"None";"703.84";"2";"6.91";"24";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2ncn(CC(=O)OC(C)(C)C)c2n1";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"6.45";"0.12";"-2.37";"3.23";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3952795";"";"None";"572.61";"1";"4.40";"14e";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"13.00";"0.24";"3.04";"6.05";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3952795";"";"None";"572.61";"1";"4.40";"14e";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"11.92";"0.22";"2.42";"5.54";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"2; BMS-935177";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.63";"0.28";"2.53";"6.89";"1";"CHEMBL3858933";"Inhibition of BTK in human PBM cells assessed as suppression of FCRgammaR/immune complex-stimulated TNFalpha production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBM";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3939772";"";"None";"488.55";"1";"5.01";"3";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3)c12";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"15.06";"0.27";"2.35";"6.45";"1";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3939772";"";"None";"488.55";"1";"5.01";"3";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3)c12";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"13.07";"0.24";"1.38";"5.60";"1";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3976719";"";"None";"554.62";"1";"4.26";"14b";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"12.98";"0.24";"2.94";"5.85";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL4788086";"";"None";"465.56";"1";"5.21";"6";"C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cccc(NC(=O)c4ccc(C5CC5)cc4)c3C)c12";"IC50";"'='";"7470.0";"nM";"5.13";"";"";"UO_0000065";"11.01";"0.20";"-0.08";"5.63";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL3290142";"";"None";"560.54";"2";"6.18";"31";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"14.40";"0.27";"1.89";"6.45";"0";"CHEMBL3292449";"Inhibition of Btk in human Ramos cells assessed as inhibition of PLC-gamma2 phosphorylation at Tyr1217 after 1 hr by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307664";"";"";""
"CHEMBL3358336";"";"None";"580.69";"1";"3.79";"3a";"CN(C)c1ccc2c(c1)CCN(c1cccc(-c3cc(Nc4ccc(N5CCOCC5)cn4)c(=O)n(C)c3)c1CO)C2=O";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"11.57";"0.21";"2.93";"6.51";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3358337";"";"None";"598.68";"1";"3.93";"3b";"CN(C)c1ccc2c(c1)CCN(c1cc(F)cc(-c3cc(Nc4ccc(N5CCOCC5)cn4)c(=O)n(C)c3)c1CO)C2=O";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"11.19";"0.21";"2.77";"6.49";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3290146";"";"None";"697.70";"2";"7.07";"36";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(NC(=O)Cn3sc4ccccc4c3=O)c2)nc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"11.10";"0.21";"0.67";"5.26";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290135";"";"None";"481.56";"0";"4.68";"24";"Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"15.22";"0.28";"2.65";"5.85";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290144";"";"None";"617.63";"2";"6.11";"33";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(NC(=O)/C=C/CN(C)C)c2)nc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"12.67";"0.24";"1.71";"6.10";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6d; BMS-986143";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"12.94";"0.25";"1.91";"6.20";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL4763135";"";"None";"490.57";"1";"5.37";"5";"C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3cc4c(N)ncnc4cc32)C1";"IC50";"'='";"1244.0";"nM";"5.91";"";"";"UO_0000065";"12.04";"0.22";"0.54";"5.96";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4877846";"";"None";"566.71";"2";"6.56";"30";"Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"4.15";"nM";"8.38";"";"";"UO_0000065";"14.79";"0.27";"1.82";"6.58";"0";"CHEMBL4822489";"Inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"14.69";"0.27";"3.15";"6.58";"0";"CHEMBL4701115";"Inhibition of BTK in human Ramos cells assessed as reduction in BCR mediated PLCgamma2 phosphorylation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL4170077";"";"None";"457.53";"1";"6.14";"20";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(/C=C/c5ccccc5)cc4c32)ccc1C";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"15.25";"0.27";"0.84";"10.91";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4753001";"";"None";"665.57";"2";"5.46";"40";"CC1(C(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)CC[C@@H]2C(F)(F)F)COC1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"12.67";"0.25";"2.97";"6.60";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4746292";"";"None";"623.64";"1";"4.40";"39";"COC[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)CN1C(=O)C1(C)COC1";"IC50";"'='";"0.31";"nM";"9.51";"";"";"UO_0000065";"15.25";"0.29";"5.11";"6.94";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4103954";"";"None";"581.57";"2";"5.29";"3";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"12.08";"0.23";"1.74";"5.93";"0";"CHEMBL4717036";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4752314";"";"None";"555.54";"1";"4.90";"41";"CC(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"17.59";"0.33";"4.87";"8.24";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4087347";"";"None";"548.62";"2";"5.68";"3n";"CC(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"6.7";"nM";"8.17";"";"";"UO_0000065";"14.90";"0.27";"2.49";"8.96";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3903249";"";"None";"497.60";"0";"3.98";"BDBM191616";"CN(C)C/C=C/C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"1.33";"nM";"8.88";"";"342654";"UO_0000065";"17.84";"0.33";"4.90";"8.67";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3605094";"";"None";"384.46";"1";"6.60";"12f";"Nc1ncc(-c2ccco2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"767.5";"nM";"6.12";"";"";"UO_0000065";"15.91";"0.30";"-0.49";"9.98";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3263636";"";"None";"561.69";"2";"6.33";"16";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N(C)C)cc2)c2ncn(C)c2n1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"13.11";"0.24";"1.04";"7.01";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL1230541";"";"None";"579.70";"2";"5.52";"CGI1746";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"0.61";"nM";"9.21";"";"";"UO_0000065";"15.90";"0.29";"3.69";"8.73";"0";"CHEMBL3407012";"Inhibition of biotinylated and unactivated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3402587";"";"None";"614.70";"1";"4.33";"4z";"CN(C)S(=O)(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"12.34";"0.24";"3.26";"6.10";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3401272";"";"None";"585.73";"2";"5.58";"12";"Cc1c(NC(=O)c2ccc(C(C)(C)C)s2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"12.33";"0.23";"1.64";"6.84";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4741884";"";"None";"518.57";"1";"4.39";"5b";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2ccccn2c1=O";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"16.86";"0.31";"4.35";"7.13";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5h";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.32";"0.27";"2.88";"6.46";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5h";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"12.95";"0.24";"2.12";"5.84";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL3400976";"";"None";"532.58";"2";"6.11";"4d";"COc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1";"IC50";"'='";"58.3";"nM";"7.23";"";"";"UO_0000065";"13.58";"0.25";"1.12";"7.78";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4281335";"";"None";"464.57";"0";"2.42";"17";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)cc3)n2)C1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"15.68";"0.29";"4.86";"6.46";"1";"CHEMBL4264700";"Inhibition of BTK in human whole blood";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3402577";"";"None";"533.56";"2";"5.51";"4p";"COc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cn1";"IC50";"'='";"197.4";"nM";"6.71";"";"";"UO_0000065";"12.57";"0.23";"1.19";"6.33";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3957567";"";"None";"313.72";"0";"3.59";"BDBM195833";"C#CC(=O)Nc1cc(-c2cnc3[nH]cc(Cl)c3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348537";"UO_0000065";"19.54";"0.38";"2.54";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"17.83";"0.33";"3.63";"7.92";"1";"CHEMBL4236259";"Inhibition of BTK in whole blood (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4242598";"";"None";"456.50";"0";"3.74";"16";"C=CC(=O)N1C[C@@H]2C[C@H]1CN2c1ccc(C(N)=O)c(Oc2ccc(Oc3ccccc3)cc2)n1";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"15.52";"0.28";"3.35";"7.23";"0";"CHEMBL4236259";"Inhibition of BTK in whole blood (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4245727";"";"None";"464.53";"0";"1.28";"5";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"18.94";"0.35";"7.52";"6.77";"0";"CHEMBL4236278";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4251151";"";"None";"455.56";"1";"5.53";"7";"CC(C)=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1C";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"15.64";"0.29";"1.59";"6.58";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1, PCI-32765, Imbruvica";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL3607386";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3605104";"";"None";"440.57";"1";"7.00";"14d";"CCCCn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"387.1";"nM";"6.41";"";"";"UO_0000065";"14.55";"0.27";"-0.59";"9.72";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3746036";"";"None";"515.57";"1";"4.43";"27";"CN1CCn2nc(Nc3cc(-c4ccc(F)c(NC(=O)c5cc6ccccc6s5)c4)n[nH]c3=O)cc2C1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.52";"0.30";"3.57";"7.41";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3747551";"";"None";"600.72";"1";"4.97";"8";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(F)c(NC(=O)c5cc6c(s5)CCCC6)c4)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"13.39";"0.26";"3.08";"8.08";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3896019";"";"None";"568.58";"1";"4.90";"12c";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.39";"0.23";"2.15";"5.72";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14g; (S)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"13.28";"0.25";"3.20";"6.18";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3941224";"";"None";"532.60";"1";"4.63";"5";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2ccccc2n(C)c1=O";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"11.90";"0.22";"1.71";"5.15";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3263651";"";"None";"533.59";"1";"4.80";"31";"Cc1c(NC(=O)c2ccccc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"13.27";"0.24";"2.28";"5.66";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL4204719";"";"None";"511.56";"1";"4.50";"25a";"CCn1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.64";"0.29";"3.50";"6.46";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3605097";"";"None";"395.49";"1";"6.40";"12b";"Nc1ncc(-c2ccncc2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"1954.0";"nM";"5.71";"";"";"UO_0000065";"14.44";"0.27";"-0.69";"9.35";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL5285357";"";"None";"440.51";"0";"3.39";"4; ONO-4059, GS-4059";"CC#CC(=O)N1CC[C@H](N2CN(c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"19.65";"0.36";"5.27";"9.86";"0";"CHEMBL5242619";"Irreversible inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3263630";"";"None";"587.72";"2";"7.08";"10";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nccn2c1";"IC50";"'='";"574.0";"nM";"6.24";"";"";"UO_0000065";"10.62";"0.19";"-0.84";"7.09";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL4749522";"";"None";"604.73";"2";"6.47";"14";"Cc1c(NC(=O)c2ccc(C3CC3)cc2)cc(F)cc1-c1ncnc2[nH]cc(C3=CCN(C(=O)/C=C/CN4CCCC4)CC3)c12";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"15.25";"0.28";"2.75";"9.79";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3967362";"";"None";"631.78";"2";"5.09";"BDBM205249";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)cccc1N1Cc2cc(N3CCCCC3)ccc2C1=O";"IC50";"'='";"245.0";"nM";"6.61";"";"363332";"UO_0000065";"10.46";"0.19";"1.52";"7.03";"0";"CHEMBL3887917";"Biochemical Btk Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2), 0.5 μM Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer, 0.5 μM PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6xHis tag was subcloned into pFastBac vector for making baculovirus carrying this epitope-tagged Btk.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886504";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702847";"";"None";"637.76";"2";"5.04";"BDBM143201";"CCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"0.9";"nM";"9.05";"";"369521";"UO_0000065";"14.18";"0.26";"4.01";"6.99";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702854";"RILZABRUTINIB";"3.0";"665.77";"2";"4.42";"BDBM143212";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"369528";"UO_0000065";"13.25";"0.25";"4.40";"6.36";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3699642";"";"None";"492.58";"0";"4.88";"BDBM149467";"Cc1cc(Nc2cc(-c3ccc(F)c(N4Cc5cc(C(C)(C)C)sc5C4=O)c3)n[nH]c2=O)nn1C";"IC50";"'='";"9.0";"nM";"8.05";"";"287913";"UO_0000065";"16.33";"0.31";"3.17";"8.39";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3699645";"";"None";"493.57";"0";"4.28";"BDBM149470";"Cc1cc(Nc2cc(-c3ccc(F)c(N4Cc5cc(C(C)(C)C)sc5C4=O)n3)n[nH]c2=O)nn1C";"IC50";"'='";"45.0";"nM";"7.35";"";"287916";"UO_0000065";"14.88";"0.29";"3.07";"6.75";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3699649";"";"None";"545.67";"1";"3.83";"BDBM149474";"CN1CCn2nc(Nc3cc(-c4cccc(N5Cc6cc(C(C)(C)C)sc6C5=O)c4CO)n[nH]c3=O)cc2C1";"IC50";"'='";"48.0";"nM";"7.32";"";"287920";"UO_0000065";"13.41";"0.26";"3.49";"6.13";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL3813052";"Irreversible inhibition of recombinant BTK (unknown origin) incubated for 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1916881";"";"None";"432.50";"0";"4.15";"26";"Cc1cc(F)ccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"2.96";"nM";"8.53";"";"";"UO_0000065";"19.72";"0.36";"4.38";"12.97";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3290120";"";"None";"521.50";"2";"6.06";"9";"COc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"13.95";"0.26";"1.22";"6.91";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3358344";"";"None";"619.77";"1";"4.82";"7a";"CCN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ncc6cc(C(C)(C)C)ccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"11.97";"0.22";"2.60";"6.84";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401290";"";"None";"582.77";"2";"5.83";"30";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(N3CC[C@@H](N(C)C)C3)cc2)n1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"12.39";"0.23";"1.39";"8.75";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401289";"";"None";"567.76";"2";"6.50";"29";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C3CCN(C)CC3)cc2)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"14.09";"0.27";"1.50";"10.09";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401287";"";"None";"511.61";"2";"5.83";"27";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc3ocnc3c2)n1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"13.05";"0.25";"0.85";"6.54";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401286";"";"None";"509.64";"2";"6.17";"26";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc3[nH]ccc3c2)n1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"14.45";"0.27";"1.20";"8.02";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401282";"";"None";"470.60";"1";"5.69";"22";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccccc2)n1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"14.11";"0.27";"0.95";"8.73";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3402571";"";"None";"559.65";"2";"6.17";"4j";"CN(C)Cc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1";"IC50";"'='";"31.6";"nM";"7.50";"";"";"UO_0000065";"13.40";"0.24";"1.33";"8.62";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402576";"";"None";"506.54";"1";"4.84";"4o";"Cn1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)n1";"IC50";"'='";"21.3";"nM";"7.67";"";"";"UO_0000065";"15.15";"0.28";"2.83";"7.55";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3263638";"";"None";"577.69";"2";"5.35";"18";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)NCCO)cc2)c2ncn(C)c2n1";"IC50";"'='";"126.0";"nM";"6.90";"";"";"UO_0000065";"11.94";"0.22";"1.55";"5.15";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263639";"";"None";"574.73";"2";"6.04";"19";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(N3CCNCC3)cc2)c2ncn(C)c2n1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"13.43";"0.25";"1.68";"7.72";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263315";"";"None";"589.70";"2";"5.80";"4";"Cn1ncc2c(Nc3ccc(C(=O)N4CCOCC4)cc3)nc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3)nc21";"IC50";"'='";"12700.0";"nM";"4.90";"";"";"UO_0000065";"8.30";"0.15";"-0.90";"4.28";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3263313";"";"None";"588.71";"2";"6.40";"5";"Cn1cnc2c(Nc3ccc(C(=O)N4CCOCC4)cc3)nc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3)cc21";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"11.59";"0.21";"0.42";"6.73";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3912266";"";"None";"454.53";"0";"4.65";"BDBM191614";"C=CC(=O)N[C@H]1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.31";"nM";"8.88";"";"342652";"UO_0000065";"19.54";"0.36";"4.23";"8.23";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647969";"";"None";"438.49";"0";"3.66";"23";"C#CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"";"UO_0000065";"20.85";"0.38";"5.48";"9.22";"1";"CHEMBL4271410";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270507";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4111419";"";"None";"463.57";"0";"3.07";"BDBM235155";"NC(=O)c1nc(N2CCC[C@@H](NC(=O)N3Cc4ccccc4C3)C2)sc1Nc1ccccn1";"IC50";"'='";"254.3";"nM";"6.59";"";"409807";"UO_0000065";"14.23";"0.27";"3.52";"5.66";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4638717";"";"None";"554.60";"2";"6.46";"45";"C#CCCOC(c1ccccc1)c1cc(OCCNC(=O)C=C)c2cc(-c3n[nH]c4cc(C(F)F)ccc34)[nH]c2c1";"IC50";"'='";"91.0";"nM";"7.04";"";"";"UO_0000065";"12.70";"0.23";"0.58";"7.65";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4088999";"";"None";"661.80";"2";"6.38";"40";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCCC(O)C1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"11.60";"0.21";"1.30";"5.78";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4064326";"";"None";"659.67";"2";"5.97";"18";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(F)(F)F)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"10.79";"0.20";"1.15";"5.85";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3290140";"";"None";"464.53";"1";"5.02";"29";"Cc1ccc(NC(=O)/C=C/c2ccccc2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"16.40";"0.30";"2.60";"6.24";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290124";"";"None";"562.55";"2";"6.40";"13";"CCC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"13.91";"0.26";"1.42";"6.25";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290129";"";"None";"492.46";"1";"5.33";"18";"Nc1cccc(Nc2ncc(NC(=O)c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cn2)c1";"IC50";"'='";"233.0";"nM";"6.63";"";"";"UO_0000065";"13.47";"0.25";"1.30";"5.44";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290137";"";"None";"540.93";"2";"6.29";"26";"Cc1ccc(NC(=O)c2cc(Cl)cc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.32";"0.28";"1.45";"6.35";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4207689";"";"None";"479.54";"0";"3.26";"22";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(C(=O)N[C@@H](C)c4ccccn4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"50.4";"nM";"7.30";"";"";"UO_0000065";"15.22";"0.28";"4.04";"5.71";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3612849";"";"None";"499.64";"1";"7.71";"14a";"CC(C)(C)OC(=O)N1C=C(c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)CCC1";"IC50";"'='";"2867.0";"nM";"5.54";"";"";"UO_0000065";"11.09";"0.21";"-2.17";"7.14";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3612850";"";"None";"399.52";"1";"6.06";"14b";"Nc1ncc(C2=CNCCC2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"3601.0";"nM";"5.44";"";"";"UO_0000065";"13.63";"0.26";"-0.62";"9.05";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"29; GDC-0853";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"13.42";"0.25";"5.35";"7.37";"0";"CHEMBL4023691";"Inhibition of BTK in human isolated primary B cells assessed as inhibition of anti-IgM-induced cell proliferation by [3H]thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3702831";"";"None";"594.69";"2";"5.32";"BDBM143180";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCCC1";"IC50";"'='";"1.9";"nM";"8.72";"";"369504";"UO_0000065";"14.67";"0.27";"3.40";"6.91";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1916903";"";"None";"431.57";"0";"4.42";"48";"Cc1ccccc1Sc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"283.0";"nM";"6.55";"";"";"UO_0000065";"15.17";"0.29";"2.13";"12.18";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3400973";"";"None";"426.45";"0";"4.44";"4a";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]ccc23)c1CO";"IC50";"'='";"1568.0";"nM";"5.80";"";"";"UO_0000065";"13.61";"0.25";"1.36";"6.93";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400974";"";"None";"502.55";"2";"6.10";"4b";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(-c4ccccc4)cc23)c1CO";"IC50";"'='";"90.3";"nM";"7.04";"";"";"UO_0000065";"14.02";"0.25";"0.94";"8.41";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402574";"";"None";"550.62";"2";"6.37";"4m";"CC(=O)c1cc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cs1";"IC50";"'='";"118.8";"nM";"6.92";"";"";"UO_0000065";"12.58";"0.24";"0.56";"6.87";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402579";"";"None";"506.58";"2";"6.40";"4r";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCCCC4)cc23)c1CO";"IC50";"'='";"77.8";"nM";"7.11";"";"";"UO_0000065";"14.03";"0.26";"0.71";"8.48";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402581";"";"None";"507.57";"1";"4.81";"4t";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCNCC4)cc23)c1CO";"IC50";"'='";"32.5";"nM";"7.49";"";"";"UO_0000065";"14.75";"0.27";"2.68";"7.81";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402585";"";"None";"620.69";"1";"4.98";"4x";"O=C(N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1)N1CCOCC1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"13.40";"0.25";"3.34";"7.14";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400976";"";"None";"532.58";"2";"6.11";"4d";"COc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1";"IC50";"'='";"38.8";"nM";"7.41";"";"";"UO_0000065";"13.92";"0.25";"1.30";"7.97";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402570";"";"None";"613.69";"2";"6.73";"4i";"O=C(c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1)N1CCCCC1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"11.71";"0.21";"0.46";"6.90";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402577";"";"None";"533.56";"2";"5.51";"4p";"COc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cn1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"13.36";"0.24";"1.62";"6.73";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402584";"";"None";"578.65";"2";"5.21";"2";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"21.6";"nM";"7.67";"";"";"UO_0000065";"13.25";"0.24";"2.46";"7.14";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL1916882";"";"None";"432.50";"0";"4.15";"27";"Cc1c(F)cccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"1.89";"nM";"8.72";"";"";"UO_0000065";"20.17";"0.37";"4.57";"13.26";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916895";"";"None";"448.96";"0";"4.67";"40";"Cc1ccccc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"4.83";"nM";"8.32";"";"";"UO_0000065";"18.52";"0.35";"3.65";"12.64";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3939795";"";"None";"597.07";"2";"5.29";"BDBM230147";"COc1ccc2c(=O)n(-c3cccc(-c4c(Cl)cc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)n(C)c2c1";"IC50";"'='";"1.1";"nM";"8.96";"";"401941";"UO_0000065";"15.00";"0.28";"3.67";"6.77";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907348";"";"None";"554.55";"1";"4.89";"BDBM230149";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"0.46";"nM";"9.34";"";"401955";"UO_0000065";"16.84";"0.31";"4.45";"6.97";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897349";"";"None";"589.07";"1";"4.91";"BDBM230101";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.9";"nM";"9.05";"";"401960";"UO_0000065";"15.36";"0.29";"4.14";"7.35";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908440";"";"None";"571.01";"2";"5.41";"BDBM230124";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(Cl)cccc2c1=O";"IC50";"'='";"1.1";"nM";"8.96";"";"401988";"UO_0000065";"15.69";"0.30";"3.55";"6.69";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.64";"nM";"9.19";"";"";"UO_0000065";"20.87";"0.38";"4.97";"9.27";"0";"CHEMBL3813051";"Inhibition of BTK (unknown origin) assessed as reduction in phosphorylation of coumarin and fluorescein-labeled FRET peptide substrate incubated for 1 hr by Z-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3612845";"";"None";"617.75";"2";"5.56";"13g";"CS(=O)(=O)OC1CCCN(C(=O)CCn2cc(-c3cnc(N)c4c(-c5ccc(Oc6ccccc6)cc5)csc34)cn2)C1";"IC50";"'='";"54.9";"nM";"7.26";"";"";"UO_0000065";"11.75";"0.23";"1.70";"5.60";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3605098";"";"None";"479.61";"1";"6.84";"12c";"Nc1ncc(-c2ccc(N3CCOCC3)cc2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"2295.0";"nM";"5.64";"";"";"UO_0000065";"11.76";"0.22";"-1.20";"9.30";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3401270";"";"None";"581.67";"1";"4.45";"10";"Cc1c(NC(=O)c2ccc(C(C)(C)O)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"11.73";"0.22";"2.37";"5.42";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3746128";"";"None";"600.72";"1";"4.97";"3";"CN1CCN(C)C(c2ccc(Nc3nc(-c4cccc(NC(=O)c5cc6c(s5)CCCC6)c4F)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.48";"0.26";"3.13";"8.13";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3702842";"";"None";"511.56";"1";"4.57";"BDBM143194";"CC(C)/C=C(\C#N)C(=O)N1CC(Cn2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"20.4";"nM";"7.69";"";"369516";"UO_0000065";"15.03";"0.28";"3.12";"6.25";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702844";"";"None";"624.72";"1";"4.86";"BDBM143198";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCC(O)CC1";"IC50";"'='";"0.7";"nM";"9.15";"";"369518";"UO_0000065";"14.65";"0.27";"4.29";"6.25";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702850";"";"None";"667.79";"2";"4.66";"BDBM143204";"COCCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"369524";"UO_0000065";"13.48";"0.25";"4.34";"6.49";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890581";"";"None";"471.56";"0";"3.27";"BDBM250019";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(OCCc5ccccc5)cc4)nn32)C1";"IC50";"'='";"7.0";"nM";"8.15";"";"435948";"UO_0000065";"17.29";"0.32";"4.88";"7.96";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892137";"";"None";"385.86";"0";"2.30";"BDBM250023";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Cl)cc4)nn32)C1";"IC50";"'='";"72.0";"nM";"7.14";"";"435952";"UO_0000065";"18.51";"0.36";"4.84";"7.66";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983966";"";"None";"439.88";"0";"3.97";"BDBM250032";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)c(F)c3)nn21";"IC50";"'='";"1.2";"nM";"8.92";"";"435961";"UO_0000065";"20.28";"0.39";"4.95";"8.74";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4645290";"";"None";"483.26";"None";"None";"14j";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4(C)C)ncc2C(F)(F)F)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.00";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL3787671";"";"None";"470.54";"0";"3.32";"16d";"C=CC(=O)Nc1cccc(-n2c(=O)n(CC3CC3)c3cnc(Nc4ccc(N(C)C)nc4)nc32)c1";"IC50";"'='";"30.6";"nM";"7.51";"";"";"UO_0000065";"15.97";"0.29";"4.19";"6.83";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1, PCI-32765, Imbruvica";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.06";"0.35";"4.18";"8.47";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4110727";"";"None";"578.56";"1";"3.61";"BDBM255373";"NC(=O)c1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"347.5";"nM";"6.46";"";"445280";"UO_0000065";"11.16";"0.21";"2.85";"4.00";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3928675";"";"None";"632.74";"2";"5.43";"BDBM205246";"CN1CCN(C)[C@@H](c2ccc(Nc3nc(-c4ccc(F)c(N5Cc6cc(C(C)(C)C)sc6C5=O)c4F)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"33.7";"nM";"7.47";"";"363329";"UO_0000065";"11.81";"0.23";"2.04";"8.23";"0";"CHEMBL3887917";"Biochemical Btk Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2), 0.5 μM Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer, 0.5 μM PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6xHis tag was subcloned into pFastBac vector for making baculovirus carrying this epitope-tagged Btk.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886504";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3263635";"";"None";"605.74";"2";"6.35";"15";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)OCCN(C)C)cc2)c2ncn(C)c2n1";"IC50";"'='";"143.0";"nM";"6.84";"";"";"UO_0000065";"11.30";"0.21";"0.49";"5.99";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3290122";"";"None";"506.49";"2";"5.63";"11";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N)cc2)nc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"15.99";"0.30";"2.47";"6.64";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3402590";"";"None";"580.66";"2";"5.30";"4zd";"CN(C)C(=O)N1CCC(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"574.0";"nM";"6.24";"";"";"UO_0000065";"10.75";"0.20";"0.94";"5.81";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400975";"";"None";"518.55";"2";"5.81";"4c";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(-c4ccc(O)cc4)cc23)c1CO";"IC50";"'='";"211.0";"nM";"6.68";"";"";"UO_0000065";"12.87";"0.23";"0.87";"6.42";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402354";"";"None";"1030.17";"None";"None";"1d";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)NCCOCCOCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)n1";"IC50";"'='";"305.0";"nM";"6.52";"";"";"UO_0000065";"6.32";"None";"None";"None";"0";"CHEMBL3407011";"Inhibition of biotinylated and activated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3968716";"";"None";"539.64";"1";"3.92";"BDBM191628";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CCCN(C(=O)/C=C/CN2CCOCC2)C1";"IC50";"'='";"0.89";"nM";"9.05";"";"385058";"UO_0000065";"16.77";"0.31";"5.13";"8.11";"0";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917698";"";"None";"497.60";"0";"4.15";"BDBM191612";"CN(C)C/C=C/C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"6.3";"nM";"8.20";"";"385041";"UO_0000065";"16.48";"0.30";"4.05";"8.01";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4175202";"";"None";"541.66";"2";"5.03";"29";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6ccc(N7CCN(C)CC7)cc6)cc5c43)cc21";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"12.57";"0.23";"1.78";"11.04";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL1808264";"";"None";"667.74";"2";"6.58";"26";"CC(C)c1nc(-c2ccc(F)c(NS(=O)(=O)c3c(F)cccc3F)c2)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"11.98";"0.24";"1.42";"6.55";"0";"CHEMBL1811527";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1806396";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2312645";"";"None";"438.58";"0";"3.28";"11";"COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"10.31";"0.19";"1.24";"4.95";"0";"CHEMBL2317786";"Inhibition of BTK (unknown origin) in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311250";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL4109690";"";"None";"563.54";"1";"4.90";"BDBM255359";"C=C[C@@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"6.3";"nM";"8.20";"";"445265";"UO_0000065";"14.55";"0.27";"3.30";"6.42";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108221";"";"None";"632.02";"2";"5.70";"BDBM255382";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.55";"nM";"9.26";"";"445289";"UO_0000065";"14.65";"0.29";"3.56";"7.25";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113108";"";"None";"621.66";"2";"5.94";"BDBM255391";"CC(C)(C)COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"17.5";"nM";"7.76";"";"445298";"UO_0000065";"12.48";"0.24";"1.82";"6.07";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114465";"";"None";"633.55";"2";"5.54";"BDBM255462";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(C(F)(F)F)cnc(N)c12";"IC50";"'='";"2.7";"nM";"8.57";"";"445369";"UO_0000065";"13.52";"0.26";"3.03";"6.71";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111005";"";"None";"567.55";"1";"4.96";"BDBM255463";"Cc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)cc(F)c1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"2.2";"nM";"8.66";"";"445370";"UO_0000065";"15.25";"0.29";"3.70";"7.31";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111363";"";"None";"617.99";"2";"5.31";"BDBM255466";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)cc(F)c1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.17";"nM";"9.77";"";"445373";"UO_0000065";"15.81";"0.31";"4.46";"7.65";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL1916891";"";"None";"432.50";"0";"4.15";"36";"Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"21.17";"0.39";"5.00";"13.92";"0";"CHEMBL1919046";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate preincubated for 60 mins measured after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916715";"";"None";"430.51";"0";"4.00";"11";"COc1cc2nc(Nc3ccccc3C)c3cncn3c2cc1NC(=O)/C=C/CN(C)C";"IC50";"'='";"0.884";"nM";"9.05";"";"";"UO_0000065";"21.03";"0.39";"5.05";"10.81";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916880";"";"None";"432.50";"0";"4.15";"25";"Cc1ccc(F)cc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"3.33";"nM";"8.48";"";"";"UO_0000065";"19.60";"0.36";"4.33";"12.89";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916887";"";"None";"430.51";"0";"3.72";"32";"Cc1cccc(O)c1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"10.4";"nM";"7.98";"";"";"UO_0000065";"18.54";"0.34";"4.26";"9.28";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3263628";"";"None";"603.73";"2";"6.10";"8";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2ncn(C)c2n1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"12.29";"0.23";"1.32";"6.49";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL1916901";"";"None";"451.48";"0";"4.34";"46";"Cc1cc(F)ccc1Oc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"9.53";"nM";"8.02";"";"";"UO_0000065";"17.77";"0.33";"3.68";"12.74";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4074645";"";"None";"605.70";"2";"5.26";"15";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"114.0";"nM";"6.94";"";"";"UO_0000065";"11.46";"0.21";"1.68";"5.70";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3647971";"";"None";"454.53";"0";"4.61";"BDBM97676";"C/C=C/C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"213455";"UO_0000065";"16.94";"0.31";"3.09";"7.76";"1";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4173695";"";"None";"437.52";"1";"5.70";"14";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccsc5)cc4c32)ccc1C";"IC50";"'='";"38.6";"nM";"7.41";"";"";"UO_0000065";"16.94";"0.32";"1.71";"11.59";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"28, PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL2217245";"Inhibition of recombinant Btk after 60 mins";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2216750";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4069790";"";"None";"621.74";"1";"3.46";"23";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(C3CN(C4COC4)C3)cn2)c1=O";"IC50";"'='";"23.5";"nM";"7.63";"";"";"UO_0000065";"12.27";"0.23";"4.17";"6.48";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3747161";"";"None";"614.75";"2";"5.28";"15";"Cc1ccc(-c2cn(C)c(=O)c(Nc3ccc([C@H]4C(=O)N(C)CCN4C)cc3)n2)c(F)c1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.37";"0.26";"2.94";"8.26";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4077618";"";"None";"670.21";"2";"6.30";"12";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)c(NC(=O)CCl)c2)c(=O)n(C)c1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"10.74";"0.20";"0.90";"5.91";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4473365";"";"None";"602.16";"1";"4.93";"7c";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.45";"0.29";"3.77";"6.75";"0";"CHEMBL4382831";"Inhibition of recombinant full length His-tagged human BTK cytoplasmic domain expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382192";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3358406";"";"None";"576.68";"2";"5.26";"16l";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4)cn(C)c3=O)nc2)CC1";"IC50";"'='";"503.0";"nM";"6.30";"";"";"UO_0000065";"10.92";"0.20";"1.04";"8.35";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4277319";"";"None";"533.65";"1";"4.94";"7j";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(CC)CC4)cc3C)ncc2F)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"13.20";"0.25";"2.11";"7.44";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14f; (R)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.88";"0.28";"4.12";"6.92";"0";"CHEMBL3858933";"Inhibition of BTK in human PBM cells assessed as suppression of FCRgammaR/immune complex-stimulated TNFalpha production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBM";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3746115";"";"None";"511.61";"1";"4.60";"22";"Cc1c(NC(=O)c2cc3ccccc3s2)cccc1-c1cc(Nc2cc3n(n2)CCN(C)C3)c(=O)[nH]n1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.41";"0.31";"3.80";"7.78";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3745795";"";"None";"582.73";"1";"4.83";"2";"CN1CCN(C)C(c2ccc(Nc3nc(-c4cccc(NC(=O)c5cc6c(s5)CCCC6)c4)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"14.11";"0.27";"3.39";"8.26";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1916904";"";"None";"321.36";"0";"4.12";"21a";"CNc1ccc2nc(Nc3cc(F)ccc3C)c3cncn3c2c1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"22.23";"0.41";"3.02";"13.17";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4105457";"";"None";"648.76";"2";"5.14";"44";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCC(O)CC1";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"10.37";"0.19";"1.59";"4.95";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4093800";"";"None";"592.70";"2";"6.57";"35";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)OC";"IC50";"'='";"197.0";"nM";"6.71";"";"";"UO_0000065";"11.31";"0.21";"0.14";"5.66";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.98";"0.33";"3.70";"7.99";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4085868";"";"None";"634.74";"2";"5.02";"19";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"12.98";"0.24";"3.22";"6.59";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4211185";"";"None";"422.29";"0";"4.08";"2";"Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCc2ccccc21";"IC50";"'='";"123.0";"nM";"6.91";"";"";"UO_0000065";"16.36";"0.35";"2.83";"7.69";"0";"CHEMBL4190836";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190187";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3402580";"";"None";"524.62";"2";"5.96";"4s";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCSCC4)cc23)c1CO";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"13.99";"0.26";"1.38";"8.76";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3903970";"";"None";"581.07";"2";"5.59";"BDBM230083";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(C)c2n(C)c1=O";"IC50";"'='";"1.3";"nM";"8.89";"";"401939";"UO_0000065";"15.29";"0.29";"3.30";"7.22";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"2; BMS-935177";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.11";"0.29";"2.78";"7.10";"1";"CHEMBL3858930";"Inhibition of BTK in human peripheral B cells assessed as suppression of BCR/anti-IgM/IgG-stimulated cell proliferation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"B";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"2; BMS-935177";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.72";"0.27";"2.08";"6.49";"0";"CHEMBL3858931";"Inhibition of BTK in human peripheral B cells assessed as suppression of BCR/anti-IgM/IgG-stimulated CD86 surface expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"B";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3891391";"";"None";"554.62";"1";"4.26";"14a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.35";"0.27";"3.70";"6.46";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3897349";"";"None";"589.07";"1";"4.91";"14d";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"14.98";"0.29";"3.91";"7.17";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3892739";"";"None";"389.43";"0";"3.95";"8";"COc1cc(F)cc(-c2nn(C3CCc4ccccc4C3)c3ncnc(N)c23)c1";"IC50";"'='";"891.0";"nM";"6.05";"";"";"UO_0000065";"15.54";"0.28";"2.10";"7.67";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3905578";"";"None";"375.41";"0";"3.65";"11";"Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCc2ccccc2C1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"18.82";"0.34";"3.42";"7.86";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"8, rac";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"11.10";"0.21";"1.07";"5.28";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"2; BMS-935177";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"14.97";"0.27";"2.20";"6.60";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3977725";"";"None";"506.54";"2";"5.15";"4";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3F)c12";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"16.37";"0.30";"3.14";"7.27";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3931086";"";"None";"564.62";"2";"5.07";"12a";"Cc1cc(C(N)=O)c2[nH]c3cc(C(C)(C)O)ccc3c2c1-c1cccc(-n2c(=O)c3cccc(F)c3n(C)c2=O)c1C";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"11.72";"0.22";"1.55";"5.38";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3899411";"";"None";"575.60";"1";"4.64";"12b";"Cc1c(-c2c(C#N)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.27";"nM";"9.57";"";"";"UO_0000065";"16.62";"0.30";"4.93";"6.51";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3747315";"";"None";"614.75";"2";"5.28";"16";"Cc1ccc(-c2cn(C)c(=O)c(Nc3ccc([C@@H]4C(=O)N(C)CCN4C)cc3)n2)c(F)c1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.37";"0.26";"2.94";"8.26";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4640218";"";"None";"520.97";"2";"6.57";"47";"C=CC(=O)NCCOc1cc(Cc2cccc(Cl)c2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"287.0";"nM";"6.54";"";"";"UO_0000065";"12.56";"0.24";"-0.03";"7.90";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL3746205";"";"None";"617.18";"2";"5.48";"6";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(Cl)c(NC(=O)c5cc6c(s5)CCCC6)c4)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"11.69";"0.23";"1.73";"7.25";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4109377";"";"None";"654.65";"1";"4.88";"BDBM255355";"Nc1nccn2c([C@@H]3CC[C@H]4CN(C(=O)c5ccccc5)CC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.23";"nM";"9.64";"";"445261";"UO_0000065";"14.72";"0.27";"4.76";"6.94";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112025";"";"None";"535.53";"1";"4.57";"BDBM255265";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.12";"nM";"9.92";"";"445170";"UO_0000065";"18.53";"0.35";"5.35";"8.37";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107764";"";"None";"549.56";"1";"4.82";"BDBM255371";"Cc1c(C(F)(F)F)ccnc1NC(=O)c1ccc(-c2nc([C@@H]3CC[C@H]4CCC(=O)N4C3)n3ccnc(N)c23)cc1";"IC50";"'='";"12.4";"nM";"7.91";"";"445278";"UO_0000065";"14.39";"0.27";"3.09";"6.67";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109428";"";"None";"563.66";"1";"4.91";"BDBM255397";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CC5)ccn4)cc3OC3CC3)c12";"IC50";"'='";"1.4";"nM";"8.85";"";"445304";"UO_0000065";"15.71";"0.29";"3.94";"6.93";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107513";"";"None";"647.58";"2";"5.93";"BDBM255455";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(C(F)(F)F)cnc(N)c12";"IC50";"'='";"0.72";"nM";"9.14";"";"445362";"UO_0000065";"14.12";"0.27";"3.21";"7.16";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3900591";"";"None";"423.42";"0";"3.46";"BDBM250015";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(F)c(F)c3)nn21";"IC50";"'='";"3.2";"nM";"8.49";"";"435944";"UO_0000065";"20.06";"0.37";"5.03";"8.33";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901100";"";"None";"431.50";"0";"3.27";"BDBM250021";"C=CC(=O)NCC1(C)CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.89";"nM";"9.05";"";"435950";"UO_0000065";"20.97";"0.39";"5.78";"8.13";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891595";"";"None";"456.33";"0";"4.49";"BDBM250034";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)c(Cl)c3)nn21";"IC50";"'='";"0.55";"nM";"9.26";"";"435963";"UO_0000065";"20.29";"0.41";"4.77";"9.07";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935034";"";"None";"507.54";"1";"4.50";"BDBM250058";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5F)cc4)nn32)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"435990";"UO_0000065";"17.58";"0.33";"4.42";"8.70";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912667";"";"None";"439.88";"0";"3.97";"BDBM250071";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(F)c(Cl)c3)nn21";"IC50";"'='";"1.1";"nM";"8.96";"";"436003";"UO_0000065";"20.37";"0.39";"4.99";"8.78";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973566";"";"None";"484.56";"0";"3.22";"BDBM249927";"CN(C)C/C=C/C(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"0.19";"nM";"9.72";"";"435857";"UO_0000065";"20.06";"0.37";"6.50";"8.92";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931363";"";"None";"483.53";"0";"3.47";"BDBM249952";"C=CC(=O)N1CCC(c2cc(=O)[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)CC1";"IC50";"'='";"5900.0";"nM";"5.23";"";"435884";"UO_0000065";"10.81";"0.20";"1.76";"4.26";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984995";"";"None";"363.42";"0";"2.64";"BDBM249967";"COc1ccc(-c2nn3c(c2C(N)=O)NCCC3c2ccccc2N)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"435896";"UO_0000065";"16.03";"0.29";"3.18";"5.38";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969976";"";"None";"513.60";"1";"3.69";"BDBM250067";"COCC#CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.91";"nM";"9.04";"";"435999";"UO_0000065";"17.60";"0.32";"5.35";"8.09";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4109460";"";"None";"425.49";"0";"4.43";"BDBM249875";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC[C@@H]2c1cccc(N)c1";"IC50";"'='";"270.0";"nM";"6.57";"";"435788";"UO_0000065";"15.44";"0.28";"2.14";"6.07";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982342";"";"None";"439.52";"0";"4.22";"BDBM249882";"NC(=O)c1c(-c2ccc(OCc3ccccc3)cc2)nn2c1NCCC2c1ccccc1N";"IC50";"'='";"3700.0";"nM";"5.43";"";"435800";"UO_0000065";"12.36";"0.22";"1.21";"5.02";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917026";"";"None";"457.53";"0";"3.97";"BDBM249893";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"1.6";"nM";"8.80";"";"435813";"UO_0000065";"19.22";"0.35";"4.83";"7.90";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890068";"";"None";"461.52";"0";"3.20";"BDBM249895";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCCOC)cc3)nn21";"IC50";"'='";"2.7";"nM";"8.57";"";"435817";"UO_0000065";"18.57";"0.34";"5.37";"7.11";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940305";"";"None";"517.63";"2";"5.45";"BDBM249898";"CC(C)(C)OC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"3100.0";"nM";"5.51";"";"435820";"UO_0000065";"10.64";"0.20";"0.06";"4.93";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114482";"";"None";"443.51";"0";"3.44";"BDBM250083";"C=CC(=O)N1CC([C@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"0.43";"nM";"9.37";"";"435827";"UO_0000065";"21.12";"0.39";"5.93";"9.14";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962583";"";"None";"443.51";"0";"3.44";"BDBM249903";"C=CC(=O)N1CCC2C(CNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"435829";"UO_0000065";"20.29";"0.37";"5.56";"8.78";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934154";"";"None";"463.93";"0";"3.73";"BDBM249926";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c3c([nH]c12)CCN(C(=O)CCCl)C3";"IC50";"'='";"7.7";"nM";"8.11";"";"435856";"UO_0000065";"17.49";"0.34";"4.38";"7.67";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3953696";"";"None";"411.42";"0";"3.32";"BDBM249950";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c(=O)c1ccc(N)cc12";"IC50";"'='";"50.0";"nM";"7.30";"";"435882";"UO_0000065";"17.75";"0.32";"3.98";"5.68";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941442";"";"None";"457.49";"0";"2.90";"BDBM249954";"C=CC(=O)N1CCC2(CC1)C(=O)Nc1c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn12";"IC50";"'='";"130.0";"nM";"6.89";"";"435886";"UO_0000065";"15.05";"0.28";"3.99";"5.76";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898115";"";"None";"459.94";"1";"5.08";"BDBM249969";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2c1cc(N)ccc1Cl";"IC50";"'='";"470.0";"nM";"6.33";"";"435898";"UO_0000065";"13.76";"0.26";"1.25";"5.85";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950138";"";"None";"425.49";"0";"4.43";"BDBM249972";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2c1ccc(N)cc1";"IC50";"'='";"77.0";"nM";"7.11";"";"435901";"UO_0000065";"16.72";"0.30";"2.68";"6.58";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928597";"";"None";"411.47";"0";"4.24";"BDBM249974";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2c1ccncc1";"IC50";"'='";"260.0";"nM";"6.58";"";"435903";"UO_0000065";"16.00";"0.29";"2.35";"6.93";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895268";"";"None";"457.53";"0";"3.98";"BDBM249977";"C=CC(=O)N1CCCC1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"1.1";"nM";"8.96";"";"435906";"UO_0000065";"19.58";"0.36";"4.98";"8.74";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895297";"";"None";"441.49";"0";"3.08";"BDBM250000";"C=CC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(OCc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"20.0";"nM";"7.70";"";"435929";"UO_0000065";"17.44";"0.32";"4.62";"7.28";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903037";"";"None";"431.50";"0";"3.50";"BDBM250009";"C=CC(=O)Nc1ccccc1[C@@H]1CCNc2c(C(N)=O)c(-c3ccc(C)c(OC)c3)nn21";"IC50";"'='";"16.0";"nM";"7.80";"";"435938";"UO_0000065";"18.07";"0.33";"4.30";"7.01";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972744";"";"None";"468.52";"0";"3.31";"BDBM250013";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5C#N)cc4)nn32)C1";"IC50";"'='";"0.38";"nM";"9.42";"";"435942";"UO_0000065";"20.11";"0.37";"6.11";"7.46";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940779";"";"None";"596.70";"2";"5.64";"BDBM202205";"CC(C)(O)CN1CC=C(c2cc3c(-c4cc(F)cc(N5CCOc6cc(C7CC7)ccc6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"358281";"UO_0000065";"14.07";"0.26";"2.76";"8.24";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911350";"";"None";"596.66";"1";"4.77";"BDBM202214";"CC(O)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"358290";"UO_0000065";"14.89";"0.28";"4.12";"7.47";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960244";"";"None";"547.62";"2";"5.07";"BDBM202124";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4cnn(C5COC5)c4)cc23)c1CO";"IC50";"'='";"3.0";"nM";"8.52";"";"358202";"UO_0000065";"15.56";"0.28";"3.45";"8.08";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4115686";"";"None";"604.64";"2";"5.07";"BDBM197257";"CN(C)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"6.0";"nM";"8.22";"";"350403";"UO_0000065";"13.60";"0.26";"3.15";"6.52";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4172284";"";"None";"318.34";"0";"2.16";"TAK-020; 7";"Cc1cc2[nH]ncc2cc1-c1cccc2c(N)c(C(N)=O)nnc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"27.33";"0.50";"6.54";"7.04";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1230541";"";"None";"579.70";"2";"5.52";"CGI1746";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"12.23";"0.23";"1.57";"6.72";"0";"CHEMBL3407011";"Inhibition of biotinylated and activated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3400825";"";"None";"942.07";"4";"9.05";"1a";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)NCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)n1";"IC50";"'='";"5.6";"nM";"8.25";"";"";"UO_0000065";"8.76";"0.16";"-0.80";"3.80";"0";"CHEMBL3407012";"Inhibition of biotinylated and unactivated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3402353";"";"None";"970.12";"4";"9.83";"1c";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)NCCCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)n1";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"8.62";"0.16";"-1.46";"3.86";"0";"CHEMBL3407012";"Inhibition of biotinylated and unactivated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3402354";"";"None";"1030.17";"None";"None";"1d";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)NCCOCCOCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)n1";"IC50";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"7.87";"None";"None";"None";"0";"CHEMBL3407012";"Inhibition of biotinylated and unactivated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3903534";"";"None";"593.61";"2";"5.16";"BDBM255351";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@H]2CC[C@@H]3CC(C)(C)C(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"45.4";"nM";"7.34";"";"445257";"UO_0000065";"12.37";"0.23";"2.18";"5.75";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110406";"";"None";"617.03";"1";"4.90";"BDBM255384";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.23";"nM";"9.64";"";"445291";"UO_0000065";"15.62";"0.31";"4.74";"7.26";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL207028";"";"None";"218.28";"0";"2.10";"3";"NC(=O)c1sc(-c2ccccc2)cc1N";"IC50";"'='";"15100.0";"nM";"4.82";"";"";"UO_0000065";"22.09";"0.44";"2.72";"6.98";"0";"CHEMBL861964";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147674";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL2057912";"";"None";"371.44";"0";"4.98";"1; PCI-29732";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCC1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"21.77";"0.39";"3.11";"10.26";"1";"CHEMBL3865719";"Inhibition of BTK (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3358343";"";"None";"623.16";"2";"5.27";"6c";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(Cl)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"10.27";"0.19";"1.13";"6.69";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3946439";"";"None";"585.04";"2";"5.42";"BDBM230087";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2ccc(F)cc2n(C)c1=O";"IC50";"'='";"0.62";"nM";"9.21";"";"401944";"UO_0000065";"15.74";"0.30";"3.79";"7.48";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895530";"";"None";"597.07";"2";"5.29";"BDBM230085";"COc1cccc2c(=O)n(-c3cccc(-c4c(Cl)cc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)n(C)c12";"IC50";"'='";"0.81";"nM";"9.09";"";"401942";"UO_0000065";"15.23";"0.29";"3.80";"6.87";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3358400";"";"None";"589.70";"1";"4.01";"16f";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6nc(C7CC7)ccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"564.0";"nM";"6.25";"";"";"UO_0000065";"10.60";"0.19";"2.24";"5.76";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3358396";"";"None";"648.74";"1";"4.52";"16b";"Cn1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"12.02";"0.22";"3.28";"7.43";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3941224";"";"None";"532.60";"1";"4.63";"5";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2ccccc2n(C)c1=O";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"16.12";"0.29";"3.96";"6.97";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3747268";"";"None";"635.17";"2";"5.62";"17";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(Cl)c(NC(=O)c5cc6c(s5)CCCC6)c4F)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"12.03";"0.24";"2.02";"7.67";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3746820";"";"None";"610.78";"2";"5.45";"21";"Cc1ccc(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)c(C)c1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"12.61";"0.24";"2.25";"7.73";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3747322";"";"None";"614.75";"2";"5.28";"13";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)ccc(F)c1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"12.64";"0.24";"2.49";"7.80";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3952795";"";"None";"572.61";"1";"4.40";"14e";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"15.12";"0.28";"4.26";"7.03";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4107483";"";"None";"637.97";"2";"6.19";"BDBM255460";"Nc1ncc(C(F)(F)F)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3Cl)c12";"IC50";"'='";"9.0";"nM";"8.05";"";"445367";"UO_0000065";"12.61";"0.25";"1.86";"6.79";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3290148";"";"None";"617.59";"2";"5.29";"38";"C=CC(=O)NCC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"12.77";"0.24";"2.60";"5.11";"0";"CHEMBL3292448";"Inhibition of Btk phosphorylation at Tyr551 in human Ramos cells after 1 hr by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307664";"";"";""
"CHEMBL4638741";"";"None";"376.48";"0";"1.92";"4b";"C=CS(=O)(=O)NC1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"19.98";"0.40";"5.60";"6.95";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4649352";"";"None";"338.41";"0";"1.60";"4e";"C#CC(=O)N[C@@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"22.41";"0.41";"5.99";"8.32";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"8, rac";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.35";"0.27";"2.98";"6.82";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3670095";"";"None";"653.76";"1";"3.68";"20";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"12.85";"0.24";"4.72";"7.77";"1";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"AVL-292, CC-292; 11";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"21.62";"0.40";"4.90";"9.40";"1";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3402589";"";"None";"585.64";"2";"5.52";"4zc";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCN(c5ncccn5)CC4)cc23)c1CO";"IC50";"'='";"69.7";"nM";"7.16";"";"";"UO_0000065";"12.22";"0.22";"1.64";"6.34";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402590";"";"None";"580.66";"2";"5.30";"4zd";"CN(C)C(=O)N1CCC(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"1648.0";"nM";"5.78";"";"";"UO_0000065";"9.96";"0.18";"0.48";"5.39";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"3, RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"27.3";"nM";"7.56";"";"";"UO_0000065";"12.47";"0.23";"2.80";"7.91";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14f; (R)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.88";"0.28";"4.12";"6.92";"0";"CHEMBL3858930";"Inhibition of BTK in human peripheral B cells assessed as suppression of BCR/anti-IgM/IgG-stimulated cell proliferation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"B";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"8, rac";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"11.77";"0.22";"1.47";"5.59";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3402573";"";"None";"573.63";"2";"5.81";"4l";"CN(C)C(=O)c1cccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)c1";"IC50";"'='";"87.3";"nM";"7.06";"";"";"UO_0000065";"12.31";"0.22";"1.25";"6.78";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3702836";"";"None";"610.69";"1";"4.56";"14";"CN(C1COC1)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"14.28";"0.26";"4.16";"6.44";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"RN-486; 3, 12";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.84";"0.25";"3.64";"8.78";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1916897";"";"None";"466.95";"0";"4.81";"42";"Cc1ccc(F)cc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"3.98";"nM";"8.40";"";"";"UO_0000065";"17.99";"0.35";"3.59";"12.77";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4112832";"";"None";"592.63";"1";"4.44";"BDBM255332";"CC(C)N1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]2C1";"IC50";"'='";"0.29";"nM";"9.54";"";"445237";"UO_0000065";"16.09";"0.30";"5.10";"7.83";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114251";"";"None";"567.53";"1";"3.72";"BDBM255341";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@H]2CN3C(=O)CC[C@@H]3CO2)n2ccnc(N)c12";"IC50";"'='";"0.52";"nM";"9.28";"";"445247";"UO_0000065";"16.36";"0.31";"5.56";"6.78";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107333";"";"None";"525.61";"1";"3.72";"BDBM255348";"CC(C)(O)c1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)c1";"IC50";"'='";"49.3";"nM";"7.31";"";"445254";"UO_0000065";"13.90";"0.26";"3.59";"5.27";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112030";"";"None";"593.61";"2";"5.16";"BDBM255350";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CC(C)(C)C(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.51";"nM";"9.29";"";"445256";"UO_0000065";"15.65";"0.30";"4.13";"7.27";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111802";"";"None";"582.59";"1";"4.25";"BDBM255380";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.74";"nM";"9.13";"";"445287";"UO_0000065";"15.67";"0.30";"4.88";"6.88";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4100365";"";"None";"497.56";"0";"2.81";"5";"Cn1cc(-c2cccc(N3CCn4c(nc5c4CCCC5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"11.22";"0.21";"2.78";"4.73";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3670082";"";"None";"527.65";"1";"4.47";"7; G-744";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"13.38";"0.25";"2.59";"7.04";"0";"CHEMBL4036701";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of BCR-induced CD69 expression on B cells preincubated for 1 hr followed by blood stimulation measured after 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4114770";"";"None";"541.56";"2";"5.17";"BDBM197193";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4c(F)cccc4F)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.3";"nM";"8.37";"";"350425";"UO_0000065";"15.45";"0.29";"3.20";"6.80";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2057915";"";"None";"596.76";"2";"5.14";"26, GDC-0834";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@@H]3C(=O)N(C)CCN3C)cc2)n1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"14.48";"0.27";"3.50";"8.68";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2057923";"";"None";"422.44";"1";"5.36";"34";"Nc1n[nH]c2cc(-c3ccc(C(=O)O)cc3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"21.30";"0.38";"3.64";"7.89";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1421";"DASATINIB";"4.0";"488.02";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.01";"0.34";"4.99";"7.79";"1";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3952795";"";"None";"572.61";"1";"4.40";"BMS-986142";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"374.3";"nM";"6.43";"";"";"UO_0000065";"11.22";"0.21";"2.03";"5.22";"0";"CHEMBL4023752";"Inhibition of BTK in human whole blood derived-basophils assessed as suppression of IgE mediated-FcepsilonR ligation-stimulated CD63 expression";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3785165";"";"None";"478.58";"0";"3.66";"8b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2[S+](C)[O-])c1";"IC50";"'='";"0.903";"nM";"9.04";"";"";"UO_0000065";"18.90";"0.36";"5.38";"7.90";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3358401";"";"None";"589.70";"1";"4.01";"16g";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)ncc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"124.0";"nM";"6.91";"";"";"UO_0000065";"11.71";"0.21";"2.90";"6.36";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3358395";"";"None";"647.75";"2";"5.58";"16a";"Cn1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)cc(Nc2ccc(C3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"11.85";"0.22";"2.10";"7.56";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL4098453";"";"None";"435.49";"0";"4.37";"17";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cnn(C)c5)cc4c32)ccc1C";"IC50";"'='";"13.5";"nM";"7.87";"";"";"UO_0000065";"18.07";"0.33";"3.50";"9.62";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4107322";"";"None";"564.57";"1";"4.65";"BDBM255361";"CN1CC[C@H]2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"5.2";"nM";"8.28";"";"445267";"UO_0000065";"14.67";"0.28";"3.63";"6.80";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108437";"";"None";"569.98";"2";"5.17";"BDBM255362";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3Cl)c12";"IC50";"'='";"0.57";"nM";"9.24";"";"445268";"UO_0000065";"16.22";"0.32";"4.07";"7.80";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113883";"";"None";"478.62";"0";"4.08";"BDBM235161";"CC(C)(C)c1ccc(C(=O)N[C@@H]2CCCN(c3nc(C(N)=O)c(Nc4ccccn4)s3)C2)cc1";"IC50";"'='";"469.9";"nM";"6.33";"";"409813";"UO_0000065";"13.22";"0.25";"2.25";"5.59";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4111841";"";"None";"360.44";"0";"1.49";"BDBM235166";"CC(=O)N[C@@H]1CCCN(c2nc(C(N)=O)c(Nc3ccccn3)s2)C1";"IC50";"'='";"6027.1";"nM";"5.22";"";"409818";"UO_0000065";"14.48";"0.29";"3.73";"4.61";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943055";"";"None";"589.00";"2";"5.55";"BDBM230088";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cc(F)cc2c1=O";"IC50";"'='";"0.83";"nM";"9.08";"";"401945";"UO_0000065";"15.42";"0.30";"3.53";"6.78";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907348";"";"None";"554.55";"1";"4.89";"BDBM230149";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"0.33";"nM";"9.48";"";"401957";"UO_0000065";"17.10";"0.32";"4.59";"7.08";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963114";"";"None";"373.42";"0";"2.87";"BDBM249933";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c3c([nH]c12)CNCC3";"IC50";"'='";"240.0";"nM";"6.62";"";"435865";"UO_0000065";"17.73";"0.32";"3.75";"6.79";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955025";"";"None";"441.45";"0";"4.31";"BDBM249941";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCc1cc([N+](=O)[O-])ccc1-2";"IC50";"'='";"19.0";"nM";"7.72";"";"435873";"UO_0000065";"17.49";"0.32";"3.41";"6.16";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926191";"";"None";"417.47";"0";"3.19";"BDBM249968";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC)cc3)nn21";"IC50";"'='";"1.9";"nM";"8.72";"";"435897";"UO_0000065";"20.89";"0.38";"5.53";"7.84";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4107491";"";"None";"456.51";"0";"2.82";"BDBM255421";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4ncc[nH]4)cc3)c12";"IC50";"'='";"50.7";"nM";"7.29";"";"445328";"UO_0000065";"15.98";"0.29";"4.47";"5.43";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3900253";"";"None";"552.61";"1";"4.98";"BDBM200776";"Cc1c(NC(=O)c2ccc3ccn(C)c3n2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"16.0";"nM";"7.80";"";"356852";"UO_0000065";"14.11";"0.26";"2.82";"6.96";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911315";"";"None";"564.67";"2";"6.51";"BDBM200816";"Cc1c(NC(=O)c2ccc(C3CC3)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N4CCCC4)CC3)cc12";"IC50";"'='";"6.0";"nM";"8.22";"";"356868";"UO_0000065";"14.56";"0.27";"1.71";"8.73";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954590";"";"None";"587.46";"2";"5.62";"BDBM230113";"Cn1c(=O)n(-c2cccc(-c3c(Cl)cc(C(N)=O)c4[nH]c5cc(C(C)(C)O)ccc5c34)c2Cl)c(=O)c2ccccc21";"IC50";"'='";"2.0";"nM";"8.70";"";"401977";"UO_0000065";"14.81";"0.29";"3.08";"7.07";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114699";"";"None";"541.56";"2";"5.17";"BDBM197192";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(F)c4F)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.4";"nM";"8.36";"";"350377";"UO_0000065";"15.43";"0.29";"3.19";"6.80";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114690";"";"None";"523.57";"1";"4.86";"BDBM197275";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"0.6";"nM";"9.22";"";"350379";"UO_0000065";"17.61";"0.32";"4.36";"7.50";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4109085";"";"None";"563.71";"2";"5.56";"BDBM197236";"Cc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C[C@H]1CCCN1C(=O)/C(C#N)=C\C(C)(C)N(C)C";"IC50";"'='";"7.0";"nM";"8.15";"";"350388";"UO_0000065";"14.47";"0.27";"2.59";"7.20";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114755";"";"None";"542.62";"1";"4.30";"BDBM197272";"C[C@H](Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)NC(=O)/C(C#N)=C/C(C)(C)N(C)C";"IC50";"'='";"11.0";"nM";"7.96";"";"350410";"UO_0000065";"14.67";"0.27";"3.66";"5.90";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114774";"";"None";"646.67";"2";"5.01";"BDBM197262";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(F)c4F)cc3F)c3c(N)ncnc32)C1)N1CCOCC1";"IC50";"'='";"0.9";"nM";"9.05";"";"350413";"UO_0000065";"13.99";"0.26";"4.04";"6.68";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3980662";"";"None";"595.70";"1";"4.76";"BDBM202194";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C(C)(C)O)ccc6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"358271";"UO_0000065";"13.80";"0.26";"3.46";"6.73";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899641";"";"None";"467.53";"0";"3.49";"BDBM255261";"Nc1nccn2c([C@H]3CC[C@@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4ccccn4)cc3)c12";"IC50";"'='";"194.0";"nM";"6.71";"";"445165";"UO_0000065";"14.36";"0.26";"3.22";"5.66";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110507";"";"None";"525.61";"1";"4.20";"BDBM255349";"COC(C)c1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"445255";"UO_0000065";"16.79";"0.31";"4.62";"6.91";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112274";"";"None";"655.64";"1";"4.27";"BDBM255352";"Nc1nccn2c([C@@H]3CC[C@H]4CN(C(=O)c5ccncc5)CC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.21";"nM";"9.68";"";"445258";"UO_0000065";"14.76";"0.28";"5.41";"6.38";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114929";"";"None";"565.56";"1";"4.52";"BDBM255338";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.22";"nM";"9.66";"";"445272";"UO_0000065";"17.08";"0.32";"5.14";"7.56";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110379";"";"None";"497.56";"0";"3.50";"BDBM255378";"COc1cccc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)n1";"IC50";"'='";"81.2";"nM";"7.09";"";"445285";"UO_0000065";"14.25";"0.26";"3.59";"5.55";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111374";"";"None";"583.55";"1";"4.66";"BDBM255379";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"2.5";"nM";"8.60";"";"445286";"UO_0000065";"14.74";"0.28";"3.94";"6.73";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111257";"";"None";"619.65";"2";"5.83";"BDBM255390";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CCCC3)c12";"IC50";"'='";"23.7";"nM";"7.62";"";"445297";"UO_0000065";"12.31";"0.23";"1.80";"5.97";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107715";"";"None";"600.00";"2";"5.18";"BDBM255392";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.22";"nM";"9.66";"";"445299";"UO_0000065";"16.10";"0.31";"4.48";"7.56";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113960";"";"None";"609.61";"1";"4.26";"BDBM255406";"COCCN(C(=O)c1ccc(-c2nc([C@@H]3CC[C@H]4CCC(=O)N4C3)n3ccnc(N)c23)c(O)c1)c1cc(C(F)(F)F)ccn1";"IC50";"'='";"291.6";"nM";"6.54";"";"445313";"UO_0000065";"10.72";"0.20";"2.28";"4.70";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111910";"";"None";"566.09";"1";"4.92";"BDBM255407";"CCOc1cc(C(=O)Nc2ncc(C)s2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.45";"nM";"9.35";"";"445314";"UO_0000065";"16.51";"0.33";"4.43";"7.32";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106893";"";"None";"571.51";"1";"4.79";"BDBM255415";"Nc1ncc(F)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.34";"nM";"9.47";"";"445322";"UO_0000065";"16.57";"0.32";"4.68";"7.99";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4067714";"";"None";"501.61";"1";"4.60";"10";"Cn1cc(-c2cccc(N3Cc4cc(C(C)(C)C)sc4C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.99";"0.32";"3.92";"8.49";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4069030";"";"None";"524.63";"1";"4.45";"13";"Cn1cc(-c2cccc(N3CCNc4cc(C(C)(C)C)ccc4C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.01";"0.29";"3.95";"7.47";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3939270";"";"None";"567.62";"2";"5.38";"BDBM200817";"CC(=O)OCC(=O)N1CC=C(c2cc3c(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)ncnc3[nH]2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"356869";"UO_0000065";"15.02";"0.28";"3.14";"7.27";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL453737";"";"None";"629.66";"2";"5.92";"51";"COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"12.02";"0.22";"1.65";"7.57";"0";"CHEMBL971826";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140082";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL4217820";"";"None";"479.58";"1";"5.47";"16";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccc(C(C)(C)C)cc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"17.58";"0.32";"2.96";"8.87";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4109651";"";"None";"510.52";"1";"4.93";"BDBM60902";"CC(C)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"2.0";"nM";"8.70";"";"350400";"UO_0000065";"17.04";"0.32";"3.77";"8.77";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4081768";"";"None";"619.72";"2";"5.52";"16";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(CC)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"10.78";"0.20";"1.16";"5.48";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4114688";"";"None";"541.56";"1";"5.00";"BDBM197210";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cc(F)ccc3F)cc2)c2c(N)ncnc21";"IC50";"'='";"7.1";"nM";"8.15";"";"350427";"UO_0000065";"15.05";"0.28";"3.15";"6.63";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3940287";"";"None";"451.91";"0";"4.21";"BDBM214693";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)c(O)c3)ncc2Cl)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"377108";"UO_0000065";"18.58";"0.36";"4.19";"8.43";"0";"CHEMBL3888171";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 uM ATP, and 20 uM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes. The reagent stopped the kinase reaction and depleted the unconsumed ATP. Kinase Detection reagent (10 mL; Promega Corporation) was then added to each well. The Kinase Detection reagent comprises reagents to convert ADP to ATP and provide luciferase and luciferin to detect ATP. Luminescence was measured on an EnVision microplate reader (PerkinElmer). The amount of luminescence from each reaction is directly correlated with BTK kinase activity. Percent inhibition and IC50 values were calculated by comparing enzyme activity in drug-treated wells to the appropriate controls.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886607";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936413";"";"None";"593.70";"2";"5.18";"BDBM202225";"CN1CC(N2CC=C(c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)CC2)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"358299";"UO_0000065";"14.82";"0.27";"3.62";"10.36";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4109483";"";"None";"548.53";"1";"3.95";"BDBM246408";"Cn1ncc2c1CCC[C@]2(O)c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)nccn12";"IC50";"'='";"2.0";"nM";"8.70";"";"429694";"UO_0000065";"15.86";"0.30";"4.75";"6.38";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107900";"";"None";"552.56";"1";"4.33";"BDBM255434";"CCn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)cc1C(F)(F)F";"IC50";"'='";"237.4";"nM";"6.62";"";"445341";"UO_0000065";"11.99";"0.23";"2.29";"5.37";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114033";"";"None";"549.56";"1";"4.82";"BDBM255436";"Cc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.46";"nM";"9.34";"";"445343";"UO_0000065";"16.99";"0.32";"4.52";"7.88";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115000";"";"None";"595.58";"1";"3.88";"BDBM255449";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OCCO)c12";"IC50";"'='";"1.1";"nM";"8.96";"";"445356";"UO_0000065";"15.04";"0.28";"5.08";"6.05";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108779";"";"None";"561.57";"2";"5.38";"BDBM197249";"CC(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3c(F)cccc3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"7.5";"nM";"8.12";"";"350393";"UO_0000065";"14.47";"0.27";"2.74";"6.61";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3898929";"";"None";"522.58";"2";"5.46";"BDBM197223";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H]1Cn1cc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"26.0";"nM";"7.58";"";"350439";"UO_0000065";"14.51";"0.27";"2.13";"6.89";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4112201";"";"None";"549.56";"1";"4.75";"BDBM255272";"CC(F)(F)c1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)c(F)c2)c1";"IC50";"'='";"0.21";"nM";"9.68";"";"445177";"UO_0000065";"17.61";"0.33";"4.93";"8.17";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112427";"";"None";"527.60";"1";"4.70";"BDBM255281";"CC(C)(F)c1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)c1";"IC50";"'='";"0.85";"nM";"9.07";"";"445186";"UO_0000065";"17.19";"0.32";"4.37";"7.65";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108825";"";"None";"569.52";"1";"3.89";"BDBM255290";"Nc1nccn2c([C@@H]3CC[C@H]4COCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.12";"nM";"9.92";"";"445195";"UO_0000065";"17.42";"0.33";"6.03";"7.77";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109294";"";"None";"541.59";"1";"4.17";"BDBM255294";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(OC5CC5)ccn4)cc3F)c12";"IC50";"'='";"0.13";"nM";"9.89";"";"445199";"UO_0000065";"18.25";"0.34";"5.72";"7.74";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113994";"";"None";"564.57";"1";"3.66";"BDBM255301";"CN1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]2C1";"IC50";"'='";"0.26";"nM";"9.59";"";"445206";"UO_0000065";"16.98";"0.32";"5.93";"7.87";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3906813";"";"None";"537.55";"1";"4.22";"BDBM255307";"Nc1nccn2c([C@H]3CC[C@@H]4COCCN4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"1.8";"nM";"8.74";"";"445212";"UO_0000065";"16.27";"0.31";"4.52";"7.90";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3954000";"";"None";"479.56";"0";"4.91";"BDBM200886";"Cc1c(NC(=O)N2CC(OC(C)(C)C)C2)cc(F)cc1-c1ncnc2[nH]c(C3=CCOCC3)cc12";"IC50";"'='";"6.0";"nM";"8.22";"";"356899";"UO_0000065";"17.14";"0.32";"3.31";"8.90";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929806";"";"None";"535.62";"1";"4.57";"BDBM200887";"CN(C)C(=O)N1CC=C(c2cc3c(-c4ccc(F)c(NC(=O)N5CC(OC(C)(C)C)C5)c4)ncnc3[nH]2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"356900";"UO_0000065";"16.24";"0.30";"4.13";"8.15";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL386661";"";"None";"549.60";"2";"6.39";"32";"CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1";"IC50";"'='";"3330.0";"nM";"5.48";"";"";"UO_0000065";"9.97";"0.19";"-0.91";"6.90";"0";"CHEMBL853494";"Inhibition of Btk by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149344";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3976719";"";"None";"554.62";"1";"4.26";"14b";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"15.45";"0.29";"4.31";"6.96";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3897349";"";"None";"589.07";"1";"4.91";"14d";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"11.54";"0.22";"1.89";"5.52";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3944049";"";"None";"589.07";"1";"4.91";"14c";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"12.01";"0.23";"2.17";"5.75";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3621502";"";"None";"442.52";"0";"3.48";"12";"COc1ccccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"144.0";"nM";"6.84";"";"";"UO_0000065";"15.46";"0.28";"3.36";"7.46";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621506";"";"None";"446.94";"0";"4.13";"16";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccc(Cl)cc4)c23)CC1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"16.17";"0.31";"3.10";"8.77";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3647970";"";"None";"497.60";"0";"4.15";"BDBM97675";"CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.5";"nM";"8.60";"";"213465";"UO_0000065";"17.29";"0.32";"4.45";"8.40";"1";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4278325";"";"None";"572.67";"2";"3.40";"8";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N(C)CCN(C)C)cc4OC)nc32)c1";"IC50";"'='";"20.8";"nM";"7.68";"";"";"UO_0000065";"13.41";"0.25";"4.28";"6.07";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4107402";"";"None";"471.56";"0";"4.22";"BDBM250081";"C=CC(=O)N1CCC([C@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.33";"nM";"9.48";"";"435823";"UO_0000065";"20.11";"0.37";"5.26";"9.25";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924160";"";"None";"463.50";"1";"5.01";"BDBM249923";"C=CC(=O)Nc1cccc(-c2c[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)c1";"IC50";"'='";"2.7";"nM";"8.57";"";"435853";"UO_0000065";"18.49";"0.33";"3.56";"7.48";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890197";"";"None";"403.44";"0";"2.47";"BDBM249953";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NC(=O)C21CCNCC1";"IC50";"'='";"3100.0";"nM";"5.51";"";"435885";"UO_0000065";"13.65";"0.25";"3.04";"4.95";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945892";"";"None";"475.55";"0";"4.27";"BDBM249988";"CC(C)(C)OC(=O)N1C[C@@H]2CNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3[C@H]2C1";"IC50";"'='";"6000.0";"nM";"5.22";"";"435917";"UO_0000065";"10.98";"0.20";"0.95";"4.67";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"15.41";"0.28";"2.84";"10.35";"0";"CHEMBL3820474";"Inhibition of BTK (unknown origin) incubated for 1 hr by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817824";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14f; (R)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.67";"0.27";"4.00";"6.82";"0";"CHEMBL3858931";"Inhibition of BTK in human peripheral B cells assessed as suppression of BCR/anti-IgM/IgG-stimulated CD86 surface expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"B";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3402587";"";"None";"614.70";"1";"4.33";"4z";"CN(C)S(=O)(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"16.5";"nM";"7.78";"";"";"UO_0000065";"12.66";"0.24";"3.45";"6.26";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402589";"";"None";"585.64";"2";"5.52";"4zc";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCN(c5ncccn5)CC4)cc23)c1CO";"IC50";"'='";"45.3";"nM";"7.34";"";"";"UO_0000065";"12.54";"0.23";"1.82";"6.51";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL209148";"";"None";"623.85";"2";"5.69";"3";"COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"8.64";"0.17";"-0.30";"5.19";"0";"CHEMBL865400";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138957";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL3902892";"";"None";"473.53";"0";"3.45";"BDBM250018";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)c(OC)c4)nn32)C1";"IC50";"'='";"3000.0";"nM";"5.52";"";"435947";"UO_0000065";"11.66";"0.22";"2.07";"4.94";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982878";"";"None";"457.87";"0";"4.11";"BDBM250036";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cc(F)c(F)c(Cl)c3)nn21";"IC50";"'='";"2.9";"nM";"8.54";"";"435965";"UO_0000065";"18.65";"0.36";"4.43";"8.37";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918344";"";"None";"423.52";"0";"2.75";"BDBM250052";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(C)c(OC)c4)nn32)CC1";"IC50";"'='";"4.8";"nM";"8.32";"";"435981";"UO_0000065";"19.64";"0.37";"5.57";"8.12";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3263640";"";"None";"589.70";"2";"6.09";"20";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"13.64";"0.25";"1.96";"6.43";"0";"CHEMBL3270977";"Inhibition of BTK-induced calcium flux in human Ramos cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307664";"";"";""
"CHEMBL3896635";"";"None";"361.38";"0";"3.26";"9";"Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1Cc2ccccc2C1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"19.85";"0.36";"3.91";"7.98";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3290119";"";"None";"559.47";"2";"7.07";"8";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(C(F)(F)F)c2)nc1";"IC50";"'='";"304.0";"nM";"6.52";"";"";"UO_0000065";"11.65";"0.22";"-0.55";"6.79";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290130";"";"None";"492.46";"1";"5.33";"19";"Nc1cccc(Nc2ncc(NC(=O)c3cccc(C(=O)Nc4cccc(C(F)(F)F)c4)c3)cn2)c1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"14.92";"0.28";"2.02";"6.02";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3290131";"";"None";"521.50";"2";"6.03";"20";"Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"13.81";"0.26";"1.17";"5.37";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3401271";"";"None";"595.78";"None";"None";"11";"Cc1c(NC(=O)c2ccc([Si](C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"11.83";"None";"None";"None";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3586446";"";"None";"304.31";"0";"1.85";"10";"NC(=O)c1nnc2c(-c3ccc4cn[nH]c4c3)cccc2c1N";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"16.17";"0.29";"3.07";"3.98";"0";"CHEMBL3588253";"Inhibition of BTK in human Raji cells after 30 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Raji";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585313";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307663";"";"";""
"CHEMBL3586445";"";"None";"303.32";"0";"2.46";"9";"NC(=O)c1nnc2c(-c3ccc4cc[nH]c4c3)cccc2c1N";"IC50";"'='";"850000.0";"nM";"3.07";"";"";"UO_0000065";"10.12";"0.18";"0.61";"2.77";"0";"CHEMBL3588253";"Inhibition of BTK in human Raji cells after 30 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Raji";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585313";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307663";"";"";""
"CHEMBL3586443";"";"None";"268.28";"0";"0.71";"7";"Cn1cc(-c2cccc3c(N)c(C(N)=O)nnc23)cn1";"IC50";"'='";"240000.0";"nM";"3.62";"";"";"UO_0000065";"13.49";"0.25";"2.91";"3.21";"0";"CHEMBL3588253";"Inhibition of BTK in human Raji cells after 30 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Raji";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585313";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307663";"";"";""
"CHEMBL449216";"";"None";"188.19";"0";"0.31";"2";"NC(=O)c1nnc2ccccc2c1N";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"28.99";"0.53";"5.15";"5.75";"0";"CHEMBL3588253";"Inhibition of BTK in human Raji cells after 30 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Raji";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585313";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307663";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"2; BMS-935177";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"17.08";"0.31";"3.27";"7.53";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3402353";"";"None";"970.12";"4";"9.83";"1c";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)NCCCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)n1";"IC50";"'='";"189.0";"nM";"6.72";"";"";"UO_0000065";"6.93";"0.13";"-3.11";"3.10";"0";"CHEMBL3407011";"Inhibition of biotinylated and activated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3402355";"";"None";"968.10";"3";"9.49";"1e";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)cc2)n1";"IC50";"'='";"0.61";"nM";"9.21";"";"";"UO_0000065";"9.52";"0.18";"-0.28";"4.62";"0";"CHEMBL3407012";"Inhibition of biotinylated and unactivated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3290139";"";"None";"506.49";"2";"5.63";"28";"Cc1ccc(NC(=O)c2ccc(C(F)(F)F)cc2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"15.01";"0.28";"1.97";"6.23";"0";"CHEMBL3296229";"Inhibition of Btk (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3685418";"";"None";"441.50";"0";"3.72";"BDBM120741";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)nc3n[nH]cc23)c1";"IC50";"'='";"79.0";"nM";"7.10";"";"248798";"UO_0000065";"16.09";"0.29";"3.38";"6.57";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3685427";"";"None";"338.59";"0";"3.68";"BDBM120750";"C=CC(=O)Nc1cccc(-c2nc(Cl)ncc2Br)c1";"IC50";"'='";"4700.0";"nM";"5.33";"";"248807";"UO_0000065";"15.74";"0.38";"1.65";"9.71";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL1916886";"";"None";"448.96";"0";"4.67";"31";"Cc1c(Cl)cccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"60.6";"nM";"7.22";"";"";"UO_0000065";"16.08";"0.31";"2.55";"10.97";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916888";"";"None";"430.51";"0";"3.72";"33";"Cc1ccc(O)cc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"1.55";"nM";"8.81";"";"";"UO_0000065";"20.46";"0.38";"5.09";"10.24";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3401281";"";"None";"579.68";"2";"5.44";"21";"Cc1c(NC(=O)c2cc3ccccc3s2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.98";"0.24";"2.08";"7.13";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL215943";"";"None";"535.57";"2";"5.62";"47";"Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1";"IC50";"'='";"545.0";"nM";"6.26";"";"";"UO_0000065";"11.70";"0.22";"0.64";"7.89";"0";"CHEMBL853494";"Inhibition of Btk by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149344";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4103300";"";"None";"535.03";"2";"5.85";"10a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(C)cc4)cc3)ncc2Cl)c1";"IC50";"'='";"58.5";"nM";"7.23";"";"";"UO_0000065";"13.52";"0.27";"1.38";"5.78";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4289625";"";"None";"410.48";"0";"0.93";"15";"NC(=O)c1ccc(N2CC[C@H](N)C2)nc1Nc1ccc(C(=O)N2CCOCC2)cc1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"14.12";"0.26";"4.87";"4.57";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4285813";"";"None";"482.56";"0";"2.56";"18";"C=CC(=O)N[C@H]1CCN(c2nc(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)cc3)c(C(N)=O)cc2F)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"18.23";"0.34";"6.24";"7.80";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4281335";"";"None";"464.57";"0";"2.42";"9";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)cc3)n2)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"19.13";"0.36";"6.47";"7.88";"0";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL522011";"";"None";"292.35";"0";"2.56";"17";"CNc1nc2c(nc(-c3ccccc3)n2C)c2c1ncn2C";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"16.60";"0.30";"2.29";"8.01";"0";"CHEMBL960929";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153345";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL4089960";"";"None";"563.57";"2";"5.24";"10f";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(F)cc4)c(C)c3)ncc2[N+](=O)[O-])c1";"IC50";"'='";"85.4";"nM";"7.07";"";"";"UO_0000065";"12.54";"0.24";"1.83";"4.20";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3967108";"";"None";"646.77";"2";"5.98";"11";"CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"13.27";"0.24";"2.61";"8.78";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3962146";"";"None";"587.68";"2";"5.39";"7";"CN1CC(Oc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)C1";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"14.11";"0.26";"2.90";"7.99";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4215160";"";"None";"537.60";"1";"4.89";"25f";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(CC3CC3)c2)n1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"17.71";"0.33";"4.63";"7.69";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4205446";"";"None";"496.55";"0";"4.62";"18h";"Cn1ccc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"15.65";"0.29";"3.15";"7.00";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4214872";"";"None";"425.49";"0";"4.09";"5S";"C=CC(=O)N[C@H]1CCc2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2C1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"20.10";"0.37";"4.46";"9.00";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209773";"";"None";"435.49";"0";"4.01";"13";"C=C1c2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2CC1NC(=O)C#CC";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"19.93";"0.36";"4.67";"9.13";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3946460";"";"None";"596.70";"2";"5.64";"16";"CC(C)(O)CN1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"14.84";"0.27";"3.21";"8.69";"1";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4575729";"";"None";"629.79";"2";"6.45";"30t";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCN(c5ccccc5)CC4)cc3)ncc2F)c1";"IC50";"'='";"385.9";"nM";"6.41";"";"";"UO_0000065";"10.18";"0.20";"-0.04";"6.78";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4434879";"";"None";"604.73";"2";"6.42";"30w";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4ccc(OC)cc4)cc3)ncc2F)c1";"IC50";"'='";"5.68";"nM";"8.25";"";"";"UO_0000065";"13.64";"0.27";"1.83";"7.54";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL2179790";"";"None";"523.64";"1";"4.97";"(+/-)-52";"C=CC(=O)N1CCCC(n2nc(-c3cccc(C(=O)Nc4cccc(C(C)(C)C)c4)c3)c3c(N)ncnc32)C1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"14.94";"0.27";"2.85";"6.57";"0";"CHEMBL2185026";"Inhibition of BTK in presence of 50 uM ATP";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177048";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2179804";"";"None";"509.61";"1";"4.80";"40";"C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc(C(=O)Nc4ccc(C(C)C)cc4)c3)c3c(N)ncnc32)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.29";"0.30";"3.50";"6.97";"0";"CHEMBL2185026";"Inhibition of BTK in presence of 50 uM ATP";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177048";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4637414";"";"None";"502.52";"2";"5.41";"42";"C=CC(=O)NCCOc1cc(C(O)c2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"14.86";"0.28";"2.06";"7.25";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL47940";"";"None";"370.46";"1";"5.59";"B43";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"17.57";"0.32";"0.92";"9.87";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4553343";"";"None";"417.51";"0";"4.19";"A27";"CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"8600.0";"nM";"5.07";"";"";"UO_0000065";"12.13";"0.22";"0.88";"5.43";"0";"CHEMBL4375216";"Inhibition of BTK Cys481S mutant (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4456283";"";"None";"436.90";"0";"3.79";"10";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.57";"0.34";"3.89";"6.23";"0";"CHEMBL4385494";"Inhibition of BTK in human whole blood assessed as reduction in anti-human IgE antibody-stimulated histamine release pretreated for 2 hrs followed by anti-human IgE antibody-stimulation and measured after 30 mins by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4469663";"";"None";"437.89";"0";"3.19";"20a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cn4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"16.04";"0.31";"3.83";"5.16";"0";"CHEMBL4385494";"Inhibition of BTK in human whole blood assessed as reduction in anti-human IgE antibody-stimulated histamine release pretreated for 2 hrs followed by anti-human IgE antibody-stimulation and measured after 30 mins by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4114094";"";"None";"537.50";"1";"3.71";"26";"Nc1nccn2c([C@H]3CN4C(=O)CC[C@@H]4CO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.26";"nM";"9.59";"";"";"UO_0000065";"17.83";"0.34";"5.88";"7.50";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4110412";"";"None";"550.55";"1";"4.26";"28";"CN1C[C@@H]2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"14.79";"0.28";"3.88";"6.69";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4110388";"";"None";"579.58";"1";"4.91";"34";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"16.90";"0.32";"4.89";"7.67";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4111338";"";"None";"601.54";"2";"5.11";"35";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC(F)F)c12";"IC50";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"15.49";"0.30";"4.21";"7.30";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4111886";"";"None";"579.54";"1";"4.21";"41";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3C(=O)O)c12";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"12.22";"0.23";"2.87";"4.54";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4640647";"";"None";"443.19";"None";"None";"14m";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(B(O)O)cc3)ncc2C(F)(F)F)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"19.91";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"17.83";"0.33";"3.63";"7.92";"0";"CHEMBL3292449";"Inhibition of Btk in human Ramos cells assessed as inhibition of PLC-gamma2 phosphorylation at Tyr1217 after 1 hr by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307664";"";"";""
"CHEMBL4875125";"";"None";"556.55";"1";"4.35";"52";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(=O)OCC)n1N";"IC50";"'='";"5157.0";"nM";"5.29";"";"";"UO_0000065";"9.50";"0.18";"0.94";"3.99";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"3";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"363.0";"nM";"6.44";"";"";"UO_0000065";"14.17";"0.26";"3.69";"5.95";"0";"CHEMBL4358574";"Inhibition of BTK in human basophils assessed as reduction in anti-IgE mouse IgG1 antibody Le2-stimulated CD63 expression on basophil preincubated for 30 mins in presence of IgE antibody B11 followed by anti-IgE mouse IgG1 antibody Le2 stimulation and measured after 15 mins by flow cytometry";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4648442";"";"None";"356.40";"0";"1.74";"5b";"C#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"24.68";"0.46";"7.06";"9.64";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3670082";"";"None";"527.65";"1";"4.47";"7; G-744";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.49";"0.31";"4.23";"8.67";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3670095";"";"None";"653.76";"1";"3.68";"20";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"11.40";"0.21";"3.78";"6.90";"0";"CHEMBL4036701";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of BCR-induced CD69 expression on B cells preincubated for 1 hr followed by blood stimulation measured after 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3908310";"";"None";"550.59";"1";"4.76";"7a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"15.14";"0.28";"3.58";"6.77";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3896019";"";"None";"568.58";"1";"4.90";"12c";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.45";"nM";"9.35";"";"";"UO_0000065";"16.44";"0.30";"4.45";"7.59";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4238212";"";"None";"459.59";"0";"4.35";"21";"C=CC(=O)NC(C)(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.40";"0.23";"1.35";"5.27";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4069365";"";"None";"421.38";"0";"4.14";"13";"CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21";"IC50";"'='";"5020.0";"nM";"5.30";"";"";"UO_0000065";"12.58";"0.24";"1.16";"5.23";"0";"CHEMBL4007688";"Inhibition of BTK (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4759528";"";"None";"537.58";"1";"3.96";"22";"COc1cc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2cc1NC(=O)C#CCN1CCOCC1";"IC50";"'='";"0.47";"nM";"9.33";"";"";"UO_0000065";"17.35";"0.32";"5.37";"8.12";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3786656";"";"None";"467.55";"0";"3.85";"8a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2[S+](C)[O-])c1";"IC50";"'='";"3.76";"nM";"8.43";"";"";"UO_0000065";"18.02";"0.35";"4.57";"6.99";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1916891";"";"None";"432.50";"0";"4.15";"36";"Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"3.31";"nM";"8.48";"";"";"UO_0000065";"19.61";"0.36";"4.33";"12.89";"0";"CHEMBL1919252";"Inhibition of BTK relative to control";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.42";"nM";"9.38";"";"";"UO_0000065";"21.29";"0.39";"5.16";"9.46";"1";"CHEMBL5145630";"Inhibition of BTK (unknown origin) by lanthascreen Tb kinase activity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143580";"1";"Scientific Literature";"J Nat Prod";"2022";"None";"";"INHIBITOR";""
"CHEMBL5276857";"";"None";"433.34";"0";"3.80";"35";"CN(c1ncnc2[nH]ccc12)[C@H]1CCCN(C(=O)CNc2cc(Cl)cc(Cl)c2)C1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"15.56";"0.32";"2.94";"8.74";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL4650321";"ORELABRUTINIB";"3.0";"427.50";"0";"4.53";"5; ICP-022";"C=CC(=O)N1CCC(c2ccc(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)n2)CC1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"20.58";"0.38";"4.27";"10.29";"0";"CHEMBL5242619";"Irreversible inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5203118";"";"None";"515.57";"1";"3.89";"103";"C=CC(=O)Nc1cccc(N2C(=O)OCc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"16.15";"0.30";"4.44";"7.43";"0";"CHEMBL5242665";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5200275";"";"None";"529.60";"1";"4.45";"104";"C=CC(=O)Nc1cccc(N2C(=O)OC(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"15.40";"0.29";"3.70";"7.27";"1";"CHEMBL5242665";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL410295";"";"None";"530.64";"1";"4.69";"25";"Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"12.04";"0.22";"1.70";"7.64";"0";"CHEMBL934202";"Inhibition of Btk by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143254";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL5075191";"";"None";"486.58";"0";"2.93";"47";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CNCC[C@H]4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"18.33";"0.34";"5.99";"7.00";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5093189";"";"None";"544.66";"2";"3.29";"50";"COCCN1CC[C@@H](NC(=O)c2cn(C(C)(C)C)nn2)c2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"17.08";"0.32";"6.01";"7.27";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3651854";"";"None";"591.78";"2";"6.24";"20b";"Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1";"IC50";"'='";"9400.0";"nM";"5.03";"";"";"UO_0000065";"8.49";"0.16";"-1.21";"4.02";"0";"CHEMBL4716835";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715698";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"INHIBITOR";""
"CHEMBL4743911";"";"None";"630.03";"1";"4.68";"23";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(OC(F)(F)Cl)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.42";"nM";"9.38";"";"";"UO_0000065";"14.88";"0.29";"4.70";"6.85";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4764215";"";"None";"573.63";"1";"3.91";"20";"CCOc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)c1";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"16.36";"0.31";"5.48";"6.85";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4794031";"";"None";"569.64";"1";"4.38";"18";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C6CC6)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.74";"nM";"9.13";"";"";"UO_0000065";"16.03";"0.30";"4.75";"7.15";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4788780";"";"None";"611.60";"1";"4.79";"49";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1(O)CCC1";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"13.09";"0.25";"3.22";"5.77";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4784814";"";"None";"585.56";"1";"4.26";"46";"C[C@H](O)C(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"14.72";"0.28";"4.36";"6.21";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4744759";"";"None";"611.60";"1";"4.91";"37";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1(C)COC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"13.94";"0.26";"3.61";"6.67";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4799627";"";"None";"597.57";"1";"4.53";"2";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"13.60";"0.26";"3.59";"6.36";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL5170919";"";"None";"484.00";"0";"3.03";"20";"CC(C)CN1CCN(Cc2ccc(-c3ccnc(Nc4cnn(CCO)c4)n3)cc2Cl)C(=O)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.35";"0.34";"5.37";"8.45";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL4861612";"";"None";"544.59";"1";"4.59";"17";"CC(C)(C)c1noc(C(=O)NCc2ccc(-c3ccnc4[nH]c(-c5cnn(C6CCOCC6)c5)nc34)cc2F)n1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"14.03";"0.26";"3.05";"5.59";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4852395";"";"None";"501.52";"1";"4.45";"19";"COc1ccnc(-c2nc3c(-c4ccc(CNC(=O)c5nc(C(C)(C)C)no5)c(F)c4)ccnc3[nH]2)c1";"IC50";"'='";"251.0";"nM";"6.60";"";"";"UO_0000065";"13.16";"0.24";"2.15";"5.01";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3290142";"";"None";"560.54";"2";"6.18";"1; PLS-058";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"13.82";"0.26";"1.56";"6.19";"0";"CHEMBL5156277";"Inhibition of (S)-3-(3-(5-acrylamido-6-(3-(5-(2-methyl-5-(3-(trifluoromethyl)benzamido)benzamido)pyrimidin-2-ylamino)phenylamino)-6-oxohexylamino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide binding to BTK in human NAMALVA cells preincubated for 1 hr followed by compound washout for three times and treated with probe for 1 hr by competitive labeling assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NAMALVA";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"45";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5209939";"Affinity Phenotypic Cellular interaction (CellTiter-Glo® Luminescent Cell Viability Assay  (Promega; growth inhibitory activity in Rec-1 cells)) EUB0000646a BTK";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Covalent inhibitor | Protein family: Protein Kinase | Recommended concentration = 1.0 µM";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5209897";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Affinity Phenotypic Cellular Source Knowledge: https://doi.org/10.1021/acs.jmedchem.9b00687";"INHIBITOR";""
"CHEMBL5185980";"";"None";"471.54";"1";"5.34";"65";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Cn4cc(C)nc4CC)cc3)ncc2F)c1";"IC50";"'='";"42.4";"nM";"7.37";"";"";"UO_0000065";"15.64";"0.29";"2.03";"7.62";"1";"CHEMBL5242642";"Inhibition of BTK (unknown origin) incubated for 60 mins in the presence of ATP by ADP-Glo reagent based luminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5172511";"";"None";"488.00";"1";"5.86";"64";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Cn4cc(C)nc4CC)cc3)ncc2Cl)c1";"IC50";"'='";"17.67";"nM";"7.75";"";"";"UO_0000065";"15.89";"0.30";"1.89";"8.01";"1";"CHEMBL5242642";"Inhibition of BTK (unknown origin) incubated for 60 mins in the presence of ATP by ADP-Glo reagent based luminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL505896";"";"None";"610.69";"2";"5.63";"22";"COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"12.64";"0.23";"2.09";"8.78";"0";"CHEMBL971826";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140082";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"19.91";"0.36";"4.55";"8.84";"0";"CHEMBL5045470";"Inhibition of BTK phosphorylation in human U-937 cells incubated for 4 hrs by Western blot assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-937";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4865369";"";"None";"472.48";"0";"3.53";"6";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5nc(C6(C)CC6)no5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"118.0";"nM";"6.93";"";"";"UO_0000065";"14.66";"0.27";"3.40";"5.44";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3352876";"";"None";"620.73";"2";"5.15";"6b";"CCN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.53";"0.25";"3.25";"8.78";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.43";"nM";"9.37";"";"";"UO_0000065";"21.26";"0.39";"5.15";"9.45";"0";"CHEMBL4726192";"Inhibition of His-tagged recombinant human His-tagged full length BTK expressed in baculovirus expression system using Tyr01 peptide as substrate preincubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"2; ACP-196";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"18.28";"0.33";"5.20";"7.18";"1";"CHEMBL4726192";"Inhibition of His-tagged recombinant human His-tagged full length BTK expressed in baculovirus expression system using Tyr01 peptide as substrate preincubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3908310";"";"None";"550.59";"1";"4.76";"7a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"10.91";"0.20";"1.24";"4.88";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3931086";"";"None";"564.62";"2";"5.07";"12a";"Cc1cc(C(N)=O)c2[nH]c3cc(C(C)(C)O)ccc3c2c1-c1cccc(-n2c(=O)c3cccc(F)c3n(C)c2=O)c1C";"IC50";"'='";"0.65";"nM";"9.19";"";"";"UO_0000065";"16.27";"0.30";"4.12";"7.46";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3931086";"";"None";"564.62";"2";"5.07";"12a";"Cc1cc(C(N)=O)c2[nH]c3cc(C(C)(C)O)ccc3c2c1-c1cccc(-n2c(=O)c3cccc(F)c3n(C)c2=O)c1C";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.76";"0.25";"2.70";"6.31";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3891391";"";"None";"554.62";"1";"4.26";"14a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"12.12";"0.22";"2.46";"5.46";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3975962";"";"None";"441.50";"0";"3.52";"10a";"C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCOCC5)cc4)nc32)c1";"IC50";"'='";"15.1";"nM";"7.82";"";"";"UO_0000065";"17.71";"0.32";"4.30";"8.05";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL5086077";"";"None";"455.95";"0";"3.59";"10";"CC(C)OC1CN(C(=O)NCc2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2Cl)C1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"13.78";"0.27";"2.69";"6.47";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5184198";"";"None";"404.47";"0";"3.05";"4";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)Nc4ccccc4)c23)CC1";"IC50";"'='";"98.7";"nM";"7.01";"";"";"UO_0000065";"17.32";"0.32";"3.96";"6.80";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4114766";"ATUZABRUTINIB";"1.0";"539.62";"2";"5.67";"11; PRN473";"CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"16.21";"0.30";"3.07";"7.11";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5206964";"";"None";"419.32";"0";"3.46";"28";"O=C(CNc1cc(Cl)cc(Cl)c1)N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"18.98";"0.39";"4.50";"9.26";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5196883";"";"None";"402.86";"0";"2.95";"24";"O=C(CNc1cc(F)cc(Cl)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"18.48";"0.36";"4.49";"8.66";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5193836";"";"None";"632.70";"2";"5.95";"24";"Cc1ccc(NC(=O)c2ccc3cnccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(NC3CCN(C(=O)CF)CC3)c2)nc1";"IC50";"'='";"63.4";"nM";"7.20";"";"";"UO_0000065";"11.38";"0.21";"1.25";"5.10";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"PCI-32765; 29";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL5153404";"Inhibition of recombinant wild-type BTK (unknown origin) assessed as inhibition of substrate phosphorylation using peptide substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150054";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5174919";"";"None";"508.55";"1";"4.89";"40";"CN1CCN(c2ccc(Nc3nc(Nc4ccc(F)c(F)c4)c4ncn(CC5CC5)c4n3)cc2F)CC1";"IC50";"'='";"2650.0";"nM";"5.58";"";"";"UO_0000065";"10.97";"0.21";"0.69";"7.52";"0";"CHEMBL5150924";"Inhibition of BTK (unknown origin) using Poly(Glu4,Tyr1) as substrate in presence of ATP by radiometric kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3897349";"";"None";"589.07";"1";"4.91";"14d";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"13.11";"0.25";"2.81";"6.27";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL5206888";"";"None";"612.74";"2";"2.93";"16";"COCCN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2C1";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"13.43";"0.25";"5.30";"6.71";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4760364";"";"None";"406.45";"0";"2.23";"B37";"C=CC(=O)N1CCC(Cn2nc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'='";"70700.0";"nM";"4.15";"";"";"UO_0000065";"10.21";"0.19";"1.92";"3.83";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4784737";"";"None";"467.57";"1";"5.29";"B29";"C=CC(=O)N1CCC(CCn2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"6090.0";"nM";"5.21";"";"";"UO_0000065";"11.15";"0.20";"-0.07";"6.05";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4798332";"";"None";"405.46";"0";"2.83";"B26";"C=CC(=O)N1CCC[C@@H](Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)C1";"IC50";"'='";"83550.0";"nM";"4.08";"";"";"UO_0000065";"10.06";"0.19";"1.25";"4.27";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4790832";"";"None";"453.55";"0";"4.90";"B25";"C=CC(=O)N1CCC[C@@H](Cn2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"7340.0";"nM";"5.13";"";"";"UO_0000065";"11.32";"0.21";"0.23";"5.95";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4759514";"";"None";"467.57";"0";"4.68";"B2";"C=CC(=O)N1CCC(Cn2cc(-c3ccc(OCc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"77040.0";"nM";"4.11";"";"";"UO_0000065";"8.80";"0.16";"-0.57";"4.77";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"12.21";"0.22";"2.65";"7.75";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3934587";"";"None";"243.30";"0";"2.15";"BDBM250521";"CC(C)(C)OC(=O)NC1CCCC(C(=O)O)C1";"IC50";"'='";"109.0";"nM";"6.96";"";"436769";"UO_0000065";"28.62";"0.56";"4.81";"9.21";"0";"CHEMBL3889150";"FRET (Forster/Flouresence Resonance Energy Transfer) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 ul of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission). The negative control well values were averaged to obtain the mean minimum. The positive 'no inhibitor' control wells were averaged to obtain the mean maximum.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886966";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4861473";"";"None";"408.50";"0";"1.68";"4";"C=CC(=O)N1[C@H](C(=O)N[C@@H](Cc2ccc(C#N)cc2)C(=O)NC)C[C@@H]2CCCC[C@@H]21";"IC50";"'='";"36400.0";"nM";"4.44";"";"";"UO_0000065";"10.87";"0.20";"2.76";"4.34";"0";"CHEMBL4813334";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4867490";"";"None";"406.44";"0";"0.59";"7";"CNC(=O)[C@@H](Cc1ccc(C#N)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CO1)c1ccccc1";"IC50";"'='";"84.2";"nM";"7.08";"";"";"UO_0000065";"17.41";"0.32";"6.48";"5.72";"0";"CHEMBL4813334";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3621511";"";"None";"481.38";"0";"4.78";"21";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(Cl)c4Cl)c23)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"16.38";"0.33";"3.11";"9.57";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3589166";"";"None";"429.48";"0";"3.57";"36";"COc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCOCC5)cc4c3c2)c1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"15.00";"0.28";"2.87";"6.60";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621513";"";"None";"460.97";"0";"4.44";"23";"Cc1c(Cl)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"16.26";"0.31";"3.05";"9.09";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3670087";"";"None";"540.62";"1";"3.36";"BDBM111944";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2cc3n(n2)CCOC3)c1=O";"IC50";"'='";"7.7";"nM";"8.11";"";"232999";"UO_0000065";"15.01";"0.28";"4.75";"7.61";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670088";"";"None";"593.73";"1";"3.78";"BDBM111945";"CN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"233000";"UO_0000065";"13.98";"0.26";"4.52";"8.40";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670096";"";"None";"652.77";"1";"4.74";"BDBM111954";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(C3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"2.8";"nM";"8.55";"";"233009";"UO_0000065";"13.10";"0.24";"3.81";"8.16";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4460419";"";"None";"413.49";"0";"4.38";"27";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccn1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"13.47";"0.25";"1.19";"5.63";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4546811";"";"None";"409.50";"0";"4.96";"24";"c1cc(Nc2nc3ccccc3[nH]2)cc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"13.16";"0.24";"0.43";"6.30";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4474166";"";"None";"352.44";"0";"3.75";"5";"O=C(NCCCCCCNc1ncnc2[nH]ccc12)Nc1ccccc1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"14.07";"0.26";"1.21";"5.23";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3670128";"";"None";"558.61";"1";"3.81";"BDBM111987";"COc1nccc(Nc2cc(-c3cc(F)cc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)n1";"IC50";"'='";"3.4";"nM";"8.47";"";"233042";"UO_0000065";"15.16";"0.28";"4.66";"7.40";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670138";"";"None";"649.80";"1";"3.79";"BDBM111997";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"5.2";"nM";"8.28";"";"233052";"UO_0000065";"12.75";"0.24";"4.49";"7.66";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4281367";"";"None";"528.57";"1";"2.10";"1";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)[nH]c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"15.64";"0.29";"6.17";"6.01";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4867982";"";"None";"487.56";"0";"2.46";"7";"C=CC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(CC)ccn4)cc3)c(C(N)=O)n2N)C1";"IC50";"'='";"18.9";"nM";"7.72";"";"";"UO_0000065";"15.84";"0.29";"5.26";"5.18";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4846437";"";"None";"473.54";"0";"2.56";"18";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccc(C)cn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"18.4";"nM";"7.74";"";"";"UO_0000065";"16.33";"0.30";"5.18";"5.18";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4873239";"";"None";"471.52";"0";"2.09";"36";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.85";"0.27";"4.91";"4.69";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4847802";"";"None";"529.52";"1";"3.49";"51";"CCC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"4755.0";"nM";"5.32";"";"";"UO_0000065";"10.05";"0.19";"1.83";"3.57";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL1354522";"";"None";"292.70";"0";"3.47";"1";"Fc1cccc(Cl)c1CNc1nc(-c2ccco2)n[nH]1";"IC50";"'='";"1091.0";"nM";"5.96";"";"";"UO_0000065";"20.37";"0.41";"2.49";"8.93";"0";"CHEMBL4020190";"Inhibition of human N-terminal His-tagged BTK expressed in bacmid transfected Sf21 insect cells using TK-substrate-biotin after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4642103";"";"None";"362.46";"0";"1.53";"4i";"C=CS(=O)(=O)NC1CCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"23.33";"0.46";"6.93";"7.81";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3968892";"";"None";"600.72";"2";"5.45";"3";"CN1CCN(c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"11.7";"nM";"7.93";"";"";"UO_0000065";"13.20";"0.24";"2.48";"8.11";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3891434";"";"None";"602.69";"1";"4.83";"17";"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"13.70";"0.26";"3.43";"7.13";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3916236";"";"None";"548.53";"1";"3.95";"BDBM246392";"Cn1ncc2c1CCC[C@@]2(O)c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)nccn12";"IC50";"'='";"0.33";"nM";"9.48";"";"429693";"UO_0000065";"17.29";"0.32";"5.53";"6.96";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL5076743";"";"None";"514.59";"1";"4.37";"18k";"C=CC(=O)Nc1cccc(-n2c(=O)c(C(C)(C)C)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"92.3";"nM";"7.04";"";"";"UO_0000065";"13.67";"0.25";"2.66";"5.85";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5204655";"";"None";"445.57";"0";"3.37";"8";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC2CCC2)CC1=O";"IC50";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"13.54";"0.25";"2.66";"7.62";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL3933784";"";"None";"622.71";"1";"4.73";"BDBM143199";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CC2(COC2)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"279417";"UO_0000065";"14.17";"0.26";"4.09";"6.52";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3890002";"";"None";"667.75";"2";"4.78";"BDBM143214";"COC(=O)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"279428";"UO_0000065";"13.03";"0.24";"3.92";"5.59";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3902505";"";"None";"623.69";"1";"4.67";"BDBM143216";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN=C(O)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"279430";"UO_0000065";"12.64";"0.23";"3.22";"4.97";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647523";"";"None";"467.53";"0";"4.00";"BDBM143325";"C/C=C/C(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)cn4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"65.0";"nM";"7.19";"";"279485";"UO_0000065";"15.37";"0.28";"3.19";"6.41";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.99";"nM";"9.00";"";"";"UO_0000065";"20.44";"0.37";"4.78";"9.08";"0";"CHEMBL5054208";"Inhibition of BTK in human Ramos cells assessed as reduction of IgM stimulated PLCgamma2 (Y1217) phosphorylation after 24 hrs by western blot assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"8.14";"nM";"8.09";"";"";"UO_0000065";"18.36";"0.33";"3.87";"8.16";"0";"CHEMBL5054209";"Inhibition of BTK in human whole blood assessed as activation of anti-IgM-induced CD69 expression by flow cytometry analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5077961";"MILREBRUTINIB";"2.0";"578.65";"1";"4.51";"13f; AS-1763";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCN(C4COC4)CC3)[nH]c2n1";"IC50";"'='";"10.9";"nM";"7.96";"";"";"UO_0000065";"13.76";"0.25";"3.45";"6.51";"0";"CHEMBL5054209";"Inhibition of BTK in human whole blood assessed as activation of anti-IgM-induced CD69 expression by flow cytometry analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5073639";"";"None";"461.95";"1";"5.32";"5";"N[C@H]1CC[C@@H](Nc2ncnc3[nH]cc(C(=O)c4ccc(Oc5ccccc5)cc4Cl)c23)CC1";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"18.11";"0.35";"3.05";"7.90";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5082685";"";"None";"853.29";"2";"3.73";"4d";"O=C(CNc1ncnc2[nH]cc(C(=O)c3ccc(Oc4ccccc4)cc3Cl)c12)NCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O";"IC50";"'='";"1931.5";"nM";"5.71";"";"";"UO_0000065";"6.70";"0.13";"1.98";"2.46";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5087717";"";"None";"980.48";"4";"5.24";"6d";"O=C1CCC(N2C(=O)c3cccc(NCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](Nc5ncnc6[nH]cc(C(=O)c7ccc(Oc8ccccc8)cc7Cl)c56)CC4)c3C2=O)C(=O)N1";"IC50";"'='";"46.9";"nM";"7.33";"";"";"UO_0000065";"7.47";"0.14";"2.09";"2.89";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL3670114";"";"None";"599.71";"1";"4.05";"BDBM111973";"CCN1CCn2nc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2C1";"IC50";"'='";"3.6";"nM";"8.44";"";"233028";"UO_0000065";"14.08";"0.26";"4.39";"8.40";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670108";"";"None";"602.74";"1";"4.46";"BDBM111967";"CN1CCn2nc(Nc3cc(-c4cc(F)cc(N5CCc6c(sc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2C1";"IC50";"'='";"4.9";"nM";"8.31";"";"233022";"UO_0000065";"13.79";"0.26";"3.85";"8.69";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670118";"";"None";"615.73";"1";"4.80";"BDBM111977";"Cn1cc(-c2cc(F)cc(N3CCc4c(sc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCOCC3)cn2)c1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"233032";"UO_0000065";"13.48";"0.26";"3.50";"8.31";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4871950";"";"None";"459.51";"0";"2.25";"3";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"13.1";"nM";"7.88";"";"";"UO_0000065";"17.15";"0.32";"5.63";"5.28";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4874550";"";"None";"489.54";"0";"2.26";"20";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(OC)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"16.43";"0.31";"5.78";"5.07";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3290142";"";"None";"560.54";"2";"6.18";"1; PLS-058";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"20.5";"nM";"7.69";"";"";"UO_0000065";"13.72";"0.26";"1.51";"6.15";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL4762469";"";"None";"405.46";"0";"2.83";"B28";"C=CC(=O)N1CCC[C@H](Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)C1";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"15.02";"0.28";"3.26";"6.38";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4849220";"";"None";"474.50";"0";"3.78";"7";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5noc(C(C)(C)C)n5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.55";"0.31";"4.07";"6.16";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5193128";"";"None";"473.58";"0";"2.71";"3; BGB-3111";"C=CC(=O)N1CCC([C@@H]2CCNC3C(C(N)=O)C(c4ccc(Oc5ccccc5)cc4)=NN32)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.64";"0.36";"6.59";"9.28";"0";"CHEMBL5127254";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4217006";"";"None";"423.48";"0";"4.17";"7";"C=CC(=O)NC1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"463.6";"nM";"6.33";"";"";"UO_0000065";"14.96";"0.27";"2.16";"6.66";"0";"CHEMBL4189647";"Inhibition of recombinant full-length N-terminal His-tagged human BTK C481S mutant expressed in baculovirus infected Sf9 insect cells using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4208616";"";"None";"465.52";"0";"2.70";"23";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(C(=O)NCc4ccccn4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"18.28";"0.33";"5.81";"6.66";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4218760";"";"None";"494.56";"0";"3.68";"11";"C=CC(=O)NCCC(=O)NC1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"725.2";"nM";"6.14";"";"";"UO_0000065";"12.41";"0.23";"2.46";"4.94";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217006";"";"None";"423.48";"0";"4.17";"7";"C=CC(=O)NC1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"20.20";"0.37";"4.38";"9.00";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5073995";"";"None";"500.61";"1";"2.93";"46";"CN1CCc2cc(-c3ccnc(Nc4cnn(C)c4)n3)ccc2[C@H](NC(=O)c2cn(C(C)(C)C)nn2)C1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"16.89";"0.31";"5.53";"7.12";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5080861";"";"None";"486.58";"0";"4.50";"37";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3noc(C(C)(C)C)n3)n2)cn1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"16.21";"0.30";"3.39";"6.38";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5200377";"";"None";"533.57";"2";"5.82";"12";"Cc1ccc(NC(=O)c2cccc(-c3ccc(F)nc3)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"506.7";"nM";"6.29";"";"";"UO_0000065";"11.80";"0.21";"0.48";"4.67";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5206407";"";"None";"463.93";"0";"3.67";"38";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)nc1)nn2C1CCCN(C(=O)CCl)C1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"16.04";"0.31";"3.77";"6.64";"1";"CHEMBL5150921";"Inhibition of BTK (unknown origin) incubated for 40 mins by radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL4243975";"";"None";"551.00";"1";"4.28";"22";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCCC4C(=O)OC)cc3)ncc2Cl)c1";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"14.63";"0.28";"3.78";"5.98";"1";"CHEMBL5150907";"Inhibition of BTK (unknown origin) incubated for 60 mins by ADP-Glo kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5170025";"";"None";"461.53";"0";"2.09";"26";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccn5)C4)c23)CC1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"19.71";"0.37";"7.01";"7.82";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5170833";"";"None";"545.69";"2";"5.80";"29";"CC#CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(C)c4)c23)CC1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"16.42";"0.30";"3.16";"9.85";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5178389";"";"None";"537.64";"2";"5.79";"30";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(F)c4)c23)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"16.53";"0.30";"3.10";"9.77";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5176551";"";"None";"535.69";"2";"6.05";"34";"C=CC(=O)N1CCC(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(C)c4)c23)CC1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"16.98";"0.31";"3.05";"10.00";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3647420";"PYROTINIB";"3.0";"583.09";"2";"6.47";"Pyrotinib";"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C";"IC50";"'='";"31.7";"nM";"7.50";"";"";"UO_0000065";"12.86";"0.24";"1.03";"6.67";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5176093";"";"None";"515.58";"2";"5.68";"11";"Cc1ccc(NC(=O)c2cccc(-c3cccnc3)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"226.9";"nM";"6.64";"";"";"UO_0000065";"12.89";"0.23";"0.96";"4.92";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5290736";"";"None";"433.34";"0";"4.03";"38";"CC1CCN(C(=O)CNc2cc(Cl)cc(Cl)c2)CC1Nc1ncnc2[nH]ccc12";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"12.78";"0.26";"1.51";"6.44";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL3973435";"";"None";"471.56";"0";"4.22";"Zanubrutinib (BGB-3111)";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"20.19";"0.37";"5.30";"9.29";"0";"CHEMBL5241479";"Irreversible inhibition of recombinant human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3622195";"";"None";"433.90";"0";"4.21";"37";"NC(=O)c1cc(-c2cccc(Cl)c2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12";"IC50";"'='";"189.0";"nM";"6.72";"";"";"UO_0000065";"15.50";"0.30";"2.51";"7.60";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4583265";"";"None";"464.53";"0";"4.43";"25";"O=c1c(Nc2ccccc2)c(Nc2cccc(C3CCCN(c4ncnc5[nH]ccc45)C3)c2)c1=O";"IC50";"'='";"44000.0";"nM";"4.36";"";"";"UO_0000065";"9.38";"0.17";"-0.07";"4.23";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3358338";"";"None";"606.68";"1";"3.53";"4a";"CN(C)c1ccc2c(=O)n(-c3cccc(-c4cc(Nc5ccc(C(=O)N6CCOCC6)cn5)c(=O)n(C)c4)c3CO)ccc2c1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"10.80";"0.20";"3.02";"5.37";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3358345";"";"None";"637.76";"1";"4.96";"7b";"CCN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ncc6cc(C(C)(C)C)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"13.64";"0.25";"3.74";"8.02";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3908310";"";"None";"550.59";"1";"4.76";"7a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"11.26";"0.21";"1.44";"5.04";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"2; BMS-935177";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"12.46";"0.22";"0.94";"5.49";"1";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"9a";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"13.60";"0.26";"2.54";"6.46";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL4543998";"";"None";"427.51";"0";"3.80";"A30";"C#CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.69";"0.41";"5.90";"10.39";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3763907";"";"None";"261.25";"0";"-0.02";"PI-3";"N=C(N/C(=N/O)c1nonc1N)c1ccccc1N";"IC50";"'='";"3180.0";"nM";"5.50";"";"";"UO_0000065";"21.04";"0.40";"5.52";"3.45";"0";"CHEMBL3767269";"Antagonist activity at human BTK-PH domain (2 to 170 residues) assessed as reduction in PI(3,4,5)P3/BTK-PH interaction after 30 mins by competitive SPR analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763051";"1";"Scientific Literature";"Medchemcomm";"2015";"None";"";"";""
"CHEMBL3649448";"";"None";"431.50";"0";"2.67";"BDBM122396";"Cn1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)ccc4c3=O)c2CO)nc1C(N)=O";"IC50";"'='";"50.0";"nM";"7.30";"";"250976";"UO_0000065";"16.92";"0.31";"4.63";"6.29";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3649450";"";"None";"416.48";"0";"3.27";"BDBM122398";"CC(C)(C)c1ccc2c(=O)n(-c3cccc(-c4c[nH]c(C(N)=O)c4)c3CO)ncc2c1";"IC50";"'='";"27.02";"nM";"7.57";"";"250978";"UO_0000065";"18.17";"0.33";"4.30";"6.64";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3649451";"";"None";"430.51";"0";"3.28";"BDBM122399";"Cn1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)ccc4c3=O)c2CO)cc1C(N)=O";"IC50";"'='";"11.57";"nM";"7.94";"";"250979";"UO_0000065";"18.44";"0.34";"4.66";"7.70";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3649460";"";"None";"446.55";"0";"3.59";"BDBM122408";"CN1Cc2cc(C(C)(C)C)ccc2C(=O)N1c1cccc(-c2cc(C(N)=O)n(C)c2)c1CO";"IC50";"'='";"26.73";"nM";"7.57";"";"250988";"UO_0000065";"16.96";"0.31";"3.98";"8.25";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3647517";"";"None";"468.52";"0";"3.43";"BDBM143319";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CC2(C1)CN(C(=O)C1CO1)C2";"IC50";"'='";"13.0";"nM";"7.89";"";"279479";"UO_0000065";"16.83";"0.31";"4.46";"7.06";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4248386";"";"None";"383.47";"0";"3.74";"31";"C=CS(=O)(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"19.92";"0.39";"3.90";"7.27";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL5286643";"";"None";"465.55";"0";"2.59";"34";"CC#CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C)c(OC)c4)nn32)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"16.75";"0.31";"5.21";"6.98";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3652663";"";"None";"526.60";"1";"3.25";"BDBM122424";"Cc1cc(Nc2nn(-c3cccc(-n4ncc5cc(C(C)(C)C)ccc5c4=O)c3CO)cc2C(N)=O)nn1C";"IC50";"'='";"0.51";"nM";"9.29";"";"251004";"UO_0000065";"17.65";"0.33";"6.04";"6.37";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652680";"";"None";"550.62";"1";"4.41";"BDBM122442";"CC(=O)c1ccc(Nc2nn(-c3cccc(-n4ncc5cc(C(C)(C)C)ccc5c4=O)c3CO)cc2C(N)=O)cc1";"IC50";"'='";"0.12";"nM";"9.92";"";"251022";"UO_0000065";"18.02";"0.33";"5.51";"6.84";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3702846";"";"None";"622.70";"1";"4.56";"BDBM143200";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CC2(COC2)C1";"IC50";"'='";"5.6";"nM";"8.25";"";"279418";"UO_0000065";"13.25";"0.24";"3.69";"6.09";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3913230";"";"None";"667.79";"2";"4.66";"BDBM143204";"COCCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"279422";"UO_0000065";"13.48";"0.25";"4.34";"6.49";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647529";"";"None";"524.63";"1";"3.93";"BDBM143331";"CN(C)C/C=C/C(=O)N1CC[C@]2(C1)C[C@@H](n1nc(-c3ccc(Oc4ccccc4)cn3)c3c(N)ncnc31)C2";"IC50";"'='";"8.1";"nM";"8.09";"";"279491";"UO_0000065";"15.42";"0.28";"4.16";"7.02";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4644099";"";"None";"422.44";"0";"4.81";"34";"C=CC(=O)N1CCC(Oc2cccc3[nH]c(-c4n[nH]c5cc(C(F)F)ccc45)cc23)C1";"IC50";"'='";"1339.0";"nM";"5.87";"";"";"UO_0000065";"13.90";"0.26";"1.06";"7.94";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4632698";"";"None";"408.41";"0";"4.17";"40";"CC#CC(=O)NCCOc1cccc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"15.84";"0.29";"2.30";"7.81";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4646281";"";"None";"486.52";"1";"5.92";"43";"C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"133.0";"nM";"6.88";"";"";"UO_0000065";"14.13";"0.26";"0.96";"8.30";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4640845";"";"None";"528.60";"2";"6.85";"54";"C=CC(=O)NCCOc1cc(Cc2c(C)cc(C)cc2C)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"445.0";"nM";"6.35";"";"";"UO_0000065";"12.02";"0.22";"-0.50";"7.67";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4241723";"";"None";"422.49";"0";"4.56";"26";"Cc1[nH]c2c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3C)c2c1C";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"18.75";"0.34";"3.36";"8.45";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4240731";"";"None";"445.56";"0";"4.63";"12";"C/C=C/C(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.78";"0.33";"3.29";"7.32";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4238256";"";"None";"429.52";"0";"4.97";"9";"CCC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1C";"IC50";"'='";"7.3";"nM";"8.14";"";"";"UO_0000065";"18.94";"0.35";"3.17";"7.52";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4246399";"";"None";"470.53";"0";"4.13";"14";"C=CC(=O)N1C2CCC1CN(c1ccc(C(N)=O)c(Oc3ccc(Oc4ccccc4)cc3)n1)C2";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"17.76";"0.33";"4.23";"8.53";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4215807";"";"None";"520.70";"2";"5.01";"25";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccns3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"17.58";"0.34";"4.14";"9.93";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4204572";"";"None";"470.55";"1";"5.20";"30";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C(C)(F)F)s3)nc3ccccc31)C2";"IC50";"'='";"2.11";"nM";"8.68";"";"";"UO_0000065";"18.44";"0.36";"3.48";"12.90";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4219011";"";"None";"512.64";"2";"5.19";"131";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4ccnc(NC)c4)s3)nc3ccccc31)C2";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"18.21";"0.34";"4.15";"10.13";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4217959";"";"None";"499.60";"0";"4.13";"138";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4ccnc(N)n4)s3)nc3ccccc31)C2";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"18.79";"0.36";"5.26";"7.89";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4276669";"";"None";"378.44";"0";"1.60";"24";"C=CC(=O)N1C[C@H]2C[C@@H]1CN2c1ccc(C(N)=O)c(Nc2ccc(C)nc2)n1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"26.42";"0.49";"8.40";"9.57";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4277754";"";"None";"493.57";"0";"1.45";"16";"C=CC(=O)N[C@H]1CCN(c2ncc(C(N)=O)c(Nc3ccc(C(=O)N4CC(C)OC(C)C4)cc3)n2)C1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"14.90";"0.28";"5.91";"5.15";"0";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL5150444";"Inhibition of BTK in human DOHH-2 cells preincubated for 1 hr followed by compound washout and anti-IgG stimulation for 2 mins by chemiluminescence based Western blotting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DOHH-2";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149968";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3290142";"";"None";"560.54";"2";"6.18";"5";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"13.56";"0.25";"1.42";"6.08";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"3; CC-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"19.00";"0.35";"3.80";"8.26";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4062079";"";"None";"708.86";"2";"6.06";"43";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N(CCOCC)CCOCC";"IC50";"'='";"3187.0";"nM";"5.50";"";"";"UO_0000065";"7.75";"0.14";"-0.56";"4.09";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4068683";"";"None";"548.69";"2";"7.09";"33";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C";"IC50";"'='";"365.0";"nM";"6.44";"";"";"UO_0000065";"11.73";"0.21";"-0.65";"6.98";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4067226";"";"None";"645.76";"2";"5.83";"29";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc5c(c4)CCCC5)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"11.22";"0.21";"1.41";"5.95";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4857263";"";"None";"473.51";"0";"4.38";"8";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5cc(C(C)(C)C)no5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.64";"0.36";"4.92";"8.12";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4872092";"";"None";"580.69";"2";"5.64";"25";"Cc1nn(C2CCOCC2)cc1-c1nc2c(-c3ccc4c(c3)CCC[C@@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"15.58";"0.29";"3.41";"6.62";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4857459";"";"None";"538.66";"2";"5.87";"26";"Cc1c(-c2nc3c(-c4ccc5c(c4)CCC[C@@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cnn1C(C)C";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"16.71";"0.31";"3.13";"7.06";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4875984";"";"None";"501.59";"1";"3.20";"5";"C=CC(=O)N1CCCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(CC)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"226.0";"nM";"6.65";"";"";"UO_0000065";"13.25";"0.25";"3.45";"4.45";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL281957";"";"None";"484.43";"1";"6.54";"43";"CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"19.40";"0.39";"2.86";"14.19";"0";"CHEMBL648220";"Inhibition of Brutons tyrosine kinase";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136753";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL4104254";"";"None";"565.56";"1";"4.00";"9";"CC1(C(=O)N2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"13.14";"0.25";"3.43";"5.82";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3263314";"";"None";"589.70";"2";"5.80";"3";"Cn1cnc2c(Nc3ccc(C(=O)N4CCOCC4)cc3)nc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3)nc21";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"12.17";"0.22";"1.37";"6.28";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"20.25";"0.37";"4.70";"9.00";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4554856";"";"None";"417.87";"0";"3.45";"11";"CC(C)N1Cc2cc(cc(F)c2Cl)O[C@@H](C)CNC(=O)c2cnn3cc1cnc23";"IC50";"'='";"0.536";"nM";"9.27";"";"";"UO_0000065";"22.19";"0.44";"5.82";"12.92";"0";"CHEMBL4349461";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL5178256";"";"None";"457.97";"0";"3.19";"4";"CNc1nc(NCC(NC(=O)CCl)c2ccccc2)nc(Nc2cc(C(C)(C)C)[nH]n2)n1";"IC50";"'='";"637.75";"nM";"6.20";"";"";"UO_0000065";"13.53";"0.26";"3.01";"4.67";"0";"CHEMBL5130942";"Inhibition of BTK (unknown origin) using TK peptide as substrate incubated for 1 hr in presence of ATP by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126642";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"17.2";"nM";"7.76";"";"";"UO_0000065";"16.64";"0.30";"3.41";"11.18";"0";"CHEMBL4720822";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715818";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4450999";"";"None";"517.59";"1";"4.88";"7b";"NC(=O)c1sc(-c2cccc(NC(=O)c3ccc(F)cc3)c2)nc1Nc1ccc(N2CCOCC2)cc1";"IC50";"'='";"258.0";"nM";"6.59";"";"";"UO_0000065";"12.73";"0.24";"1.71";"6.01";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4548804";"";"None";"545.60";"1";"4.52";"7f";"NC(=O)c1sc(-c2cccc(NC(=O)c3ccc(F)cc3)c2)nc1Nc1ccc(C(=O)N2CCOCC2)cc1";"IC50";"'='";"733.0";"nM";"6.13";"";"";"UO_0000065";"11.24";"0.21";"1.61";"4.84";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4756629";"";"None";"555.64";"1";"3.21";"22";"Nc1n[nH]c(=O)c2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)/C=C/CN2CCOCC2)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"14.19";"0.26";"4.68";"5.99";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4797320";"";"None";"627.63";"2";"6.31";"39";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3Oc3ccccc3)c12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"12.68";"0.24";"1.65";"6.23";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4849446";"";"None";"478.60";"1";"5.56";"3";"Cc1cc(-c2ccnc3[nH]c(-c4cnn(C)c4)nc23)ccc1CNC(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"15.19";"0.28";"1.71";"8.21";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4878102";"";"None";"573.63";"1";"3.57";"18";"CC(C)(C)c1noc(C(=O)NCc2ccc(-c3ccnc4[nH]c(-c5cnn(CCN6CCOCC6)c5)nc34)cc2F)n1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"12.55";"0.23";"3.63";"5.15";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4855916";"";"None";"482.55";"0";"4.13";"21";"Cn1cc(-c2nc3c(-c4ccc(C5(NC(=O)c6nc(C(C)(C)C)no6)CC5)cc4)ccnc3[nH]2)cn1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"15.43";"0.28";"3.31";"5.84";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4859888";"";"None";"496.58";"0";"4.51";"22B";"Cn1cc(-c2nc3c(-c4ccc5c(c4)CCC[C@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cn1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"14.92";"0.27";"2.90";"5.82";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3895544";"";"None";"487.56";"0";"3.74";"BDBM249897";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC4CCOCC4)cc3)nn21";"IC50";"'='";"39.0";"nM";"7.41";"";"435819";"UO_0000065";"15.20";"0.28";"3.67";"6.15";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973435";"";"None";"471.56";"0";"4.22";"BDBM249900";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"435822";"UO_0000065";"19.09";"0.35";"4.78";"8.78";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929771";"";"None";"363.42";"0";"2.76";"BDBM249905";"NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"1700.0";"nM";"5.77";"";"435833";"UO_0000065";"15.88";"0.29";"3.01";"5.33";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978314";"";"None";"443.51";"0";"3.37";"BDBM249913";"C=CC(=O)N1CCC2(CC1)CNc1c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn12";"IC50";"'='";"13.0";"nM";"7.89";"";"435843";"UO_0000065";"17.78";"0.33";"4.52";"7.70";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983095";"";"None";"403.49";"0";"3.34";"BDBM249915";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC21CCNCC1";"IC50";"'='";"330.0";"nM";"6.48";"";"435845";"UO_0000065";"16.06";"0.30";"3.14";"6.88";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947976";"";"None";"361.41";"0";"2.17";"BDBM249918";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC21CNC1";"IC50";"'='";"510.0";"nM";"6.29";"";"435848";"UO_0000065";"17.41";"0.32";"4.12";"6.68";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905984";"";"None";"484.56";"0";"3.22";"BDBM249935";"CN(C)C/C=C/C(=O)N1CCc2c([nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)C1";"IC50";"'='";"0.17";"nM";"9.77";"";"435867";"UO_0000065";"20.16";"0.37";"6.55";"8.97";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977187";"";"None";"383.41";"0";"3.96";"BDBM249937";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c1ccc(N)cc12";"IC50";"'='";"14.0";"nM";"7.85";"";"435869";"UO_0000065";"20.48";"0.37";"3.89";"7.05";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907456";"";"None";"425.45";"0";"3.51";"BDBM249945";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NC(=O)Cc1cc(N)ccc1-2";"IC50";"'='";"240.0";"nM";"6.62";"";"435877";"UO_0000065";"15.56";"0.28";"3.11";"5.28";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921373";"";"None";"475.51";"1";"5.08";"BDBM249881";"C=CC(=O)Nc1cccc(-c2ccnc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)c1";"IC50";"'='";"860.0";"nM";"6.07";"";"435799";"UO_0000065";"12.76";"0.23";"0.99";"5.43";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3914651";"";"None";"441.49";"0";"3.68";"BDBM249930";"C/C=C/C(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"0.43";"nM";"9.37";"";"435861";"UO_0000065";"21.22";"0.39";"5.69";"8.86";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895077";"";"None";"438.49";"0";"3.66";"BDBM249931";"N#C/C=C\CN1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"43.0";"nM";"7.37";"";"435862";"UO_0000065";"16.80";"0.30";"3.71";"6.55";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978173";"";"None";"413.39";"0";"4.28";"BDBM250002";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c1cc([N+](=O)[O-])ccc12";"IC50";"'='";"930.0";"nM";"6.03";"";"435931";"UO_0000065";"14.59";"0.27";"1.75";"4.69";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925102";"";"None";"455.52";"0";"4.11";"BDBM250014";"C=CC(=O)N1CCC(c2c[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)CC1";"IC50";"'='";"0.13";"nM";"9.89";"";"435943";"UO_0000065";"21.70";"0.40";"5.78";"9.35";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3961123";"";"None";"379.46";"0";"2.43";"BDBM250022";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccccc4)nn32)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"435951";"UO_0000065";"18.06";"0.33";"4.42";"7.35";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969461";"";"None";"518.02";"1";"4.71";"BDBM250070";"CC#CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5cccc(Cl)c5)cc4)nn32)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"436002";"UO_0000065";"15.63";"0.30";"3.39";"7.90";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL249097";"";"None";"335.37";"0";"3.08";"2";"Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"23.99";"0.44";"4.97";"7.11";"0";"CHEMBL923138";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140683";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL4109186";"";"None";"537.62";"1";"4.38";"BDBM255289";"COc1cc(C(=O)Nc2cc(C3CC3)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"1.9";"nM";"8.72";"";"445194";"UO_0000065";"16.22";"0.30";"4.34";"6.83";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107273";"";"None";"569.98";"2";"5.17";"BDBM255293";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)c(Cl)c3)c12";"IC50";"'='";"0.52";"nM";"9.28";"";"445198";"UO_0000065";"16.29";"0.32";"4.11";"7.83";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108219";"";"None";"597.55";"1";"4.28";"BDBM255433";"CCOC(=O)c1oc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)nc1C(F)(F)F";"IC50";"'='";"155.3";"nM";"6.81";"";"445340";"UO_0000065";"11.39";"0.22";"2.53";"4.31";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4564973";"";"None";"544.64";"1";"4.20";"50";"O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"12.15";"0.23";"2.42";"5.88";"0";"CHEMBL4389556";"Inhibition of BTK in human PBMC assessed as reduction in CD69 expression";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL5080968";"";"None";"455.49";"0";"4.33";"9";"Cc1cc2c(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)nc(N)nc2[nH]1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"16.05";"0.29";"2.98";"6.66";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5091338";"";"None";"518.55";"2";"5.08";"10";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(-c3cccnc3)[nH]c2n1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"16.73";"0.30";"3.60";"7.07";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5091956";"";"None";"593.66";"1";"4.79";"13c";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)nc(N)nc3[nH]2)CC1";"IC50";"'='";"0.54";"nM";"9.27";"";"";"UO_0000065";"15.61";"0.29";"4.48";"6.95";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3904945";"";"None";"554.67";"2";"6.39";"BDBM200848";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"23.0";"nM";"7.64";"";"356879";"UO_0000065";"13.77";"0.25";"1.25";"8.11";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5192748";"";"None";"474.57";"0";"3.01";"21";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5cccc(C)c5)C4)c23)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.60";"0.36";"6.29";"8.99";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5196392";"";"None";"614.67";"2";"5.21";"22";"C=CC(=O)NCCC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4ccc5cnccc5c4)ccc3C)cn2)c1";"IC50";"'='";"387.6";"nM";"6.41";"";"";"UO_0000065";"10.43";"0.19";"1.20";"3.84";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL4117175";"";"None";"639.69";"2";"3.69";"11b";"Cn1nc(-c2cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"11.94";"0.22";"3.95";"5.29";"1";"CHEMBL5104720";"Inhibition of BTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104099";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5196390";"";"None";"477.40";"0";"3.60";"43";"CC(C)(O)[C@@H](Nc1cc(Cl)cc(Cl)c1)C(=O)N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"15.13";"0.31";"3.62";"6.80";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5196736";"";"None";"443.91";"0";"3.12";"48";"O=C(N[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1)[C@H](Nc1cc(F)cc(Cl)c1)C1CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"17.93";"0.35";"4.84";"8.05";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5178356";"";"None";"474.95";"0";"4.78";"42";"C=C(Cl)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"18.11";"0.35";"3.82";"8.67";"0";"CHEMBL5150927";"Inhibition of BTK (unknown origin) incubated for 10 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5183111";"";"None";"447.37";"0";"4.24";"40";"CC[C@@H](Nc1cc(Cl)cc(Cl)c1)C(=O)N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"18.56";"0.38";"4.06";"9.66";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5172976";"";"None";"514.59";"2";"6.28";"5";"Cc1ccc(NC(=O)c2ccc(-c3ccccc3)cc2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"255.2";"nM";"6.59";"";"";"UO_0000065";"12.81";"0.23";"0.31";"5.40";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL4638802";"";"None";"433.51";"0";"2.11";"7";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(N)c1=O";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"14.86";"0.28";"4.33";"6.06";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4640083";"";"None";"517.59";"1";"2.11";"15";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)C2COC2)c1=O";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"13.78";"0.26";"5.02";"6.01";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"19; CC-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"16.83";"0.31";"2.87";"7.32";"0";"CHEMBL5124384";"Inhibition of BTK T474M mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474M";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5195945";"";"None";"527.56";"1";"3.61";"22";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"15.43";"0.29";"4.53";"6.37";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4097689";"";"None";"561.58";"1";"4.81";"10h";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(OC)cc4)cc3)ncc2[N+](=O)[O-])c1";"IC50";"'='";"23.8";"nM";"7.62";"";"";"UO_0000065";"13.57";"0.26";"2.81";"4.30";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4066966";"";"None";"675.83";"2";"7.03";"41";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCC(OC)CC1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"10.63";"0.20";"0.16";"5.90";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4098885";"";"None";"651.72";"1";"4.97";"26";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(OC)c(OC)c4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"4996.0";"nM";"5.30";"";"";"UO_0000065";"8.13";"0.15";"0.33";"3.78";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4102259";"";"None";"621.69";"1";"4.96";"24";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4cccc(OC)c4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"1191.0";"nM";"5.92";"";"";"UO_0000065";"9.53";"0.18";"0.96";"4.52";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4439761";"";"None";"489.58";"1";"5.78";"13";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1N1Cc2ccccc2C1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.96";"0.31";"2.52";"8.35";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL1916893";"";"None";"450.49";"0";"4.29";"38";"Cc1ccc(F)cc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"6.76";"nM";"8.17";"";"";"UO_0000065";"18.14";"0.34";"3.88";"12.42";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL4218481";"";"None";"581.68";"1";"4.38";"2h";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(C(=O)N5CCOCC5)cc4)n3)c2CO)cc1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"12.66";"0.23";"2.99";"4.73";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209441";"SOFNOBRUTINIB";"2.0";"498.52";"0";"3.41";"4b";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"15.49";"0.29";"4.31";"5.65";"0";"CHEMBL4201928";"Inhibition of anti-IgM-stimulated BTK phosphorylation at Tyr551 in human Ramos cells pre-incubated for 1 hr followed by anti-IgM stimulation for 10 mins by Western blotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3892767";"";"None";"454.49";"0";"2.75";"Tirabrutinib";"CC#CC(=O)N1CC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"19.05";"0.35";"5.91";"8.00";"0";"CHEMBL5241480";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4097010";"";"None";"573.63";"2";"5.81";"3u";"CN(C)C(=O)c1ccc(-c2nc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1";"IC50";"'='";"33.3";"nM";"7.48";"";"";"UO_0000065";"13.04";"0.24";"1.67";"7.18";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4064893";"";"None";"612.70";"2";"7.34";"3h";"O=C(c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1)N1CCCCC1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"11.89";"0.22";"-0.06";"7.99";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4086354";"";"None";"600.69";"2";"6.54";"3i";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c1CO";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"11.92";"0.22";"0.62";"8.59";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4095573";"";"None";"577.66";"2";"5.81";"3p";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.60";"0.25";"2.04";"8.31";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402584";"";"None";"578.65";"2";"5.21";"2";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"21.6";"nM";"7.67";"";"";"UO_0000065";"13.25";"0.24";"2.46";"7.14";"1";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4217295";"";"None";"581.65";"1";"4.41";"3l";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(N3CCc4cc(C5CC5)cc(F)c4C3=O)c2CO)n1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"14.88";"0.27";"4.25";"6.67";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4214343";"";"None";"484.50";"0";"3.40";"4a";"Nc1nc(Nc2cn[nH]c2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1";"IC50";"'='";"0.51";"nM";"9.29";"";"";"UO_0000065";"19.18";"0.35";"5.89";"6.29";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3942777";"";"None";"551.53";"1";"4.73";"24A";"C[C@@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"17.92";"0.34";"5.16";"7.74";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4110993";"";"None";"551.53";"1";"4.22";"36";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3O)c12";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"16.75";"0.32";"5.02";"6.66";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4113636";"";"None";"593.61";"2";"5.30";"38";"CC(C)Oc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"12.44";"0.23";"2.09";"5.78";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4797320";"";"None";"627.63";"2";"6.31";"39";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3Oc3ccccc3)c12";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"10.37";"0.19";"0.20";"5.10";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4107939";"";"None";"560.54";"1";"4.38";"42";"N#Cc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"267.0";"nM";"6.57";"";"";"UO_0000065";"11.73";"0.22";"2.19";"4.62";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4108563";"";"None";"553.52";"1";"4.65";"33";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"12.64";"0.24";"2.35";"5.90";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL3647968";"";"None";"476.56";"0";"3.98";"BDBM97673";"C=CS(=O)(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.52";"nM";"9.28";"";"214870";"UO_0000065";"19.48";"0.37";"5.30";"7.99";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4251204";"";"None";"410.43";"0";"4.26";"16h";"C=CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5cnn(C)c5)cc4c32)cc1";"IC50";"'='";"217.0";"nM";"6.66";"";"";"UO_0000065";"16.24";"0.29";"2.40";"8.12";"0";"CHEMBL4235188";"Inhibition of recombinant full length human N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4289688";"";"None";"508.97";"1";"3.98";"7a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)cc3)ncc2Cl)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.68";"0.34";"5.02";"7.65";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4856243";"";"None";"487.56";"0";"2.81";"4";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(CC)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"11.3";"nM";"7.95";"";"";"UO_0000065";"16.30";"0.30";"5.14";"5.33";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"BGB-3111";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"18.36";"0.34";"4.44";"8.45";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5200741";"";"None";"369.47";"1";"5.09";"5";"c1ccc(Nc2cccc(C3CCCN(c4ncnc5[nH]ccc45)C3)c2)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"15.03";"0.27";"0.46";"9.77";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5183177";"";"None";"350.43";"0";"2.15";"8";"O=C(CNc1ccccc1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"18.29";"0.34";"4.26";"7.46";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5198129";"";"None";"396.28";"0";"1.96";"33";"Nc1ncnc(N2CCC[C@@H](NC(=O)CNc3cc(Cl)cc(Cl)c3)C2)n1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"15.95";"0.33";"4.36";"5.79";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4575423";"";"None";"531.61";"2";"5.40";"6f";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5cccc(F)c5)c4)sc3C(=O)O)cc2)CC1";"IC50";"'='";"27822.0";"nM";"4.56";"";"";"UO_0000065";"8.57";"0.16";"-0.84";"4.66";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4460489";"";"None";"530.63";"1";"4.80";"7i";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccc(F)cc5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"862.0";"nM";"6.06";"";"";"UO_0000065";"11.43";"0.22";"1.26";"5.85";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4450409";"";"None";"596.63";"2";"6.84";"5a";"CCOC(=O)c1sc(-c2cccc(NC(=O)c3ccc(C(F)(F)F)cc3)c2)nc1Nc1ccc(N2CCOCC2)cc1";"IC50";"'='";"2422.0";"nM";"5.62";"";"";"UO_0000065";"9.41";"0.18";"-1.22";"6.05";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL5183811";"";"None";"523.57";"1";"4.86";"28";"N#C/C(=C/C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"14.01";"0.26";"2.48";"5.97";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5174021";"";"None";"540.60";"1";"4.19";"30";"CC(C)(N)/C=C(/C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5184084";"";"None";"610.69";"1";"4.56";"31";"CC(C)(/C=C(/C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCOCC1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"11.70";"0.22";"2.58";"5.27";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702851";"";"None";"637.72";"1";"4.17";"33";"CN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"13.99";"0.26";"4.75";"6.09";"1";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702854";"RILZABRUTINIB";"3.0";"665.77";"2";"4.42";"12; PRN1008";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"13.35";"0.25";"4.47";"6.41";"1";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4114766";"ATUZABRUTINIB";"1.0";"539.62";"2";"5.67";"11; PRN473";"CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"30.1";"nM";"7.52";"";"";"UO_0000065";"13.94";"0.26";"1.85";"6.12";"0";"CHEMBL5104909";"Inhibition of biotinylated-labeled BTK-selective probe binding to BTK in human Ramos assessed as target occupancy pretreated for 1 hr followed by probe addition measured for 18 hrs by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL3352876";"";"None";"620.73";"2";"5.15";"11d";"CCN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.53";"0.25";"3.25";"8.78";"1";"CHEMBL5104720";"Inhibition of BTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104099";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL5107926";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104233";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"acalabrutinib";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.31";"0.33";"5.21";"7.19";"1";"CHEMBL5107926";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104233";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4450082";"";"None";"499.59";"1";"5.35";"11";"C=CC(=O)N(C)CC/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2)c1C";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"17.50";"0.32";"3.39";"8.64";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4513614";"";"None";"523.54";"1";"3.57";"15";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C(C)(C)O)cc3F)c2C)C1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"14.59";"0.27";"4.07";"5.85";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4456471";"";"None";"419.49";"0";"3.56";"46";"CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1";"IC50";"'='";"161.0";"nM";"6.79";"";"";"UO_0000065";"16.19";"0.30";"3.23";"7.42";"0";"CHEMBL4353141";"Inhibition of human BTK using poly(Glu,Tyr) 4:1 as substrate in presence of 33P-gamma ATP by hotspot kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350983";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4463650";"";"None";"487.54";"0";"4.08";"13";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3)c2C)C1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"15.94";"0.29";"3.69";"7.04";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4559123";"";"None";"485.56";"0";"4.96";"10";"C=CC(=O)N(C)C/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2)c1C";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"14.36";"0.26";"2.01";"6.89";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4471613";"";"None";"505.53";"1";"3.91";"30";"C#CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"14.46";"0.27";"3.40";"6.62";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4060363";"";"None";"523.98";"1";"4.84";"7l";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)OCC4CCCO4)cc3)ncc2Cl)c1";"IC50";"'='";"0.23";"nM";"9.64";"";"";"UO_0000065";"18.39";"0.36";"4.80";"7.79";"0";"CHEMBL3992978";"Inhibition of N-terminal His-tagged full length human recombinant BTK expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3992502";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3908905";"";"None";"405.43";"0";"3.32";"BDBM250029";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(F)cc3)nn21";"IC50";"'='";"1.9";"nM";"8.72";"";"435958";"UO_0000065";"21.51";"0.40";"5.40";"8.55";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114721";"";"None";"536.64";"1";"4.90";"BDBM249964";"N#C/C(=C\C1CC1)C(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"435988";"UO_0000065";"14.17";"0.26";"2.70";"6.02";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114929";"";"None";"565.56";"1";"4.52";"BDBM255338";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.19";"nM";"9.72";"";"445244";"UO_0000065";"17.19";"0.32";"5.20";"7.61";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3984000";"";"None";"569.69";"2";"5.94";"BDBM200766";"Cc1c(NC(=O)c2ccc(N(C)C(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"2.0";"nM";"8.70";"";"356842";"UO_0000065";"15.27";"0.28";"2.76";"8.93";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936156";"";"None";"571.01";"2";"5.41";"BDBM230091";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"2.9";"nM";"8.54";"";"401948";"UO_0000065";"14.95";"0.28";"3.13";"6.37";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913962";"";"None";"597.05";"2";"5.72";"BDBM230099";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)ccn(-c2ccc(F)cc2)c1=O";"IC50";"'='";"0.33";"nM";"9.48";"";"401959";"UO_0000065";"15.88";"0.30";"3.76";"7.70";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114795";"";"None";"590.61";"1";"4.72";"BDBM197255";"CNC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"1.3";"nM";"8.89";"";"350402";"UO_0000065";"15.05";"0.28";"4.17";"6.58";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114741";"";"None";"540.03";"2";"5.37";"BDBM197232";"N#C/C(=C\C1CC1)C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2Cl)c2c(N)ncnc21";"IC50";"'='";"11.0";"nM";"7.96";"";"350435";"UO_0000065";"14.74";"0.28";"2.59";"6.47";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114727";"";"None";"540.60";"1";"4.19";"BDBM197277";"CC(C)(N)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"113.0";"nM";"6.95";"";"350444";"UO_0000065";"12.85";"0.24";"2.76";"4.66";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4115694";"";"None";"540.57";"2";"5.60";"BDBM197263";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1cc(-c2ccc(Oc3cccc(F)c3F)cc2)c2c(N)ncnc21";"IC50";"'='";"7.0";"nM";"8.15";"";"350458";"UO_0000065";"15.09";"0.28";"2.55";"7.41";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3918201";"";"None";"548.69";"2";"6.60";"BDBM197265";"CC(C)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"3.0";"nM";"8.52";"";"350459";"UO_0000065";"15.53";"0.28";"1.92";"7.74";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"BDBM194087";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1057.0";"nM";"5.98";"";"346408";"UO_0000065";"13.15";"0.24";"3.23";"5.52";"0";"CHEMBL3887629";"Z'-LYTE Kinase Assay: The measurement of Btk enzyme inhibitory activity was performed using the following reagents: Z'-LYTE Kinase Assay Kit-Tyr 1 (containing Tyr 1 peptide, Thy 1 phospho-peptide, 5x kinase buffer, ATP, development reagent B, development buffer, and stop reagent), Tyr 1 peptide (Invitrogen), and Btk (Invitrogen) according to the instructions accompanying the kit.First 5 uL/well of either a solution prepared by diluting the test compound in dimethyl sulfoxide (DMSO) or DMSO alone was added to the wells of a 96-well assay plate together with 10 uL/well of substrate/enzyme mixture and allowed to react for 20 minutes at 30° C. The substrate/enzyme mixture solutions were prepared by dilution in kinase buffer (DL-dithiothreitol (DTT; 2.7 mM) and 1.33x kinase buffer) so that the final concentration of Tyr-1 peptide would be 4 uM, and the final concentration of Btk would be 5 nM. Next 5 uL/well of adenosine triphosphate was added (ATP; final concentration 36 uM).";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886389";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114691";"";"None";"513.58";"2";"5.01";"BDBM197269";"C[C@H](Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)NC(=O)/C(C#N)=C/C(C)(C)C";"IC50";"'='";"2.0";"nM";"8.70";"";"350460";"UO_0000065";"16.94";"0.31";"3.69";"6.60";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3966597";"";"None";"582.71";"2";"5.61";"BDBM202092";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCNC(=O)C5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"254.0";"nM";"6.59";"";"358170";"UO_0000065";"11.32";"0.20";"0.99";"7.00";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3976070";"";"None";"627.79";"2";"6.44";"BDBM202097";"CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"358175";"UO_0000065";"13.38";"0.24";"1.96";"9.89";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924327";"";"None";"628.78";"2";"5.84";"BDBM202102";"CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"358180";"UO_0000065";"12.88";"0.24";"2.26";"8.28";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973506";"";"None";"583.74";"2";"6.64";"BDBM202103";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCC(O)CC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"32.5";"nM";"7.49";"";"358181";"UO_0000065";"12.83";"0.23";"0.85";"8.77";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3956789";"";"None";"600.72";"2";"6.31";"BDBM202108";"CN1CCOC(c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cc2)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"358186";"UO_0000065";"14.19";"0.26";"2.21";"9.37";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3670139";"";"None";"666.85";"1";"4.59";"16";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"12.59";"0.24";"3.81";"8.14";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3702834";"";"None";"623.74";"1";"4.47";"BDBM143183";"CN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H]2Cn2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)CC1";"IC50";"'='";"3.8";"nM";"8.42";"";"369507";"UO_0000065";"13.50";"0.25";"3.95";"6.51";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702848";"";"None";"651.79";"2";"5.42";"BDBM143202";"CC(C)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"0.7";"nM";"9.15";"";"369522";"UO_0000065";"14.05";"0.26";"3.73";"7.07";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647967";"";"None";"454.53";"0";"4.65";"BDBM97672";"C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"342651";"UO_0000065";"19.80";"0.36";"4.35";"8.34";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3980912";"";"None";"597.72";"2";"5.11";"BDBM202091";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(-n6ncc7cc(C8CC8)ccc7c6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"358169";"UO_0000065";"14.55";"0.26";"3.59";"8.43";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931607";"";"None";"623.76";"2";"7.04";"BDBM202095";"N#CC1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cc2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"358173";"UO_0000065";"13.07";"0.24";"1.11";"7.73";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896019";"";"None";"568.58";"1";"4.90";"BDBM230143";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.59";"nM";"9.23";"";"401952";"UO_0000065";"16.23";"0.30";"4.33";"7.50";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952795";"";"None";"572.61";"1";"4.40";"BDBM230103";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"2.2";"nM";"8.66";"";"401962";"UO_0000065";"15.12";"0.28";"4.26";"7.03";"1";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903416";"";"None";"605.45";"2";"5.76";"BDBM230115";"Cn1c(=O)n(-c2cccc(-c3c(Cl)cc(C(N)=O)c4[nH]c5cc(C(C)(C)O)ccc5c34)c2Cl)c(=O)c2cccc(F)c21";"IC50";"'='";"0.45";"nM";"9.35";"";"401980";"UO_0000065";"15.44";"0.30";"3.59";"7.59";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910427";"";"None";"593.03";"2";"5.04";"BDBM230128";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)[nH]c2c(F)cc(F)cc2c1=O";"IC50";"'='";"0.25";"nM";"9.60";"";"401992";"UO_0000065";"16.19";"0.31";"4.56";"7.17";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912426";"";"None";"589.00";"2";"5.25";"BDBM230130";"Cn1c(=O)n(-c2cccc(-c3c(F)cc(C(N)=O)c4[nH]c5cc(C(C)(C)O)ccc5c34)c2Cl)c(=O)c2cccc(F)c21";"IC50";"'='";"0.41";"nM";"9.39";"";"401997";"UO_0000065";"15.94";"0.31";"4.14";"7.63";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896019";"";"None";"568.58";"1";"4.90";"BDBM230143";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.79";"nM";"9.10";"";"402009";"UO_0000065";"16.01";"0.30";"4.20";"7.39";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973901";"";"None";"517.59";"2";"5.03";"BDBM230145";"Cc1nc(C(N)=O)c2[nH]c3cc(C(C)(C)O)ccc3c2c1-c1cccc(-n2cnc3ccccc3c2=O)c1C";"IC50";"'='";"6.9";"nM";"8.16";"";"402011";"UO_0000065";"15.77";"0.29";"3.13";"6.43";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702831";"";"None";"594.69";"2";"5.32";"BDBM143180";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCCC1";"IC50";"'='";"1.9";"nM";"8.72";"";"279402";"UO_0000065";"14.67";"0.27";"3.40";"6.91";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647522";"";"None";"467.53";"0";"4.00";"BDBM143324";"C/C=C/C(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)nc4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"83.0";"nM";"7.08";"";"279484";"UO_0000065";"15.15";"0.28";"3.08";"6.32";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3982520";"";"None";"570.67";"2";"5.98";"BDBM200775";"COC(C)(C)c1ccc(C(=O)Nc2cc(F)cc(-c3ncnc4[nH]c(C5=CCN(C(=O)N(C)C)CC5)cc34)c2C)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"356851";"UO_0000065";"14.72";"0.27";"2.42";"8.12";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702859";"";"None";"637.76";"1";"4.86";"BDBM143217";"CCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H]2Cn2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)CC1";"IC50";"'='";"0.9";"nM";"9.05";"";"279406";"UO_0000065";"14.18";"0.26";"4.19";"6.99";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114678";"";"None";"577.73";"2";"6.03";"BDBM197268";"CCN(CC)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"4.0";"nM";"8.40";"";"350464";"UO_0000065";"14.54";"0.27";"2.37";"7.41";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114766";"ATUZABRUTINIB";"1.0";"539.62";"2";"5.67";"BDBM197260";"CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"350466";"UO_0000065";"16.12";"0.30";"3.03";"7.08";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3974246";"";"None";"582.75";"2";"6.43";"BDBM202084";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCN(C)CC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"30.0";"nM";"7.52";"";"358162";"UO_0000065";"12.91";"0.23";"1.09";"11.00";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903267";"";"None";"597.76";"2";"7.03";"BDBM202093";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCC(C)(O)CC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"115.0";"nM";"6.94";"";"358171";"UO_0000065";"11.61";"0.21";"-0.09";"8.13";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949342";"";"None";"615.75";"2";"7.01";"BDBM202100";"Cc1c(-c2ccnc3[nH]c(-c4ccc(CN5CCN(C)CC5)c(F)c4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"190.0";"nM";"6.72";"";"358178";"UO_0000065";"10.92";"0.20";"-0.29";"10.39";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4786447";"";"None";"469.55";"0";"4.06";"C3";"C=CC(=O)N1CCc2ccc(Nc3ncnc(Nc4ccc(C(=O)N5CCCCC5)cc4)n3)cc21";"IC50";"'='";"54.3";"nM";"7.26";"";"";"UO_0000065";"15.47";"0.28";"3.21";"7.03";"0";"CHEMBL4769955";"Inhibition of BTK (unknown origin) by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765318";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3914552";"";"None";"377.84";"0";"3.77";"15";"Nc1ncnc2c1c(-c1cc(O)cc(Cl)c1)nn2C1Cc2ccccc2C1";"IC50";"'='";"142.0";"nM";"6.85";"";"";"UO_0000065";"18.12";"0.35";"3.08";"7.62";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4749037";"";"None";"537.50";"1";"4.34";"3";"Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.083";"nM";"10.08";"";"";"UO_0000065";"18.76";"0.35";"5.74";"7.89";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4110644";"";"None";"551.53";"1";"4.73";"24B";"C[C@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.11";"nM";"9.96";"";"";"UO_0000065";"18.06";"0.34";"5.23";"7.80";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4759341";"";"None";"539.47";"1";"3.54";"27";"Nc1nccn2c([C@H]3CN4C(=O)OC[C@@H]4CO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"14.09";"0.27";"4.06";"5.55";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4759341";"";"None";"539.47";"1";"3.54";"27";"Nc1nccn2c([C@H]3CN4C(=O)OC[C@@H]4CO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"582.0";"nM";"6.24";"";"";"UO_0000065";"11.56";"0.22";"2.70";"4.55";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4114929";"";"None";"565.56";"1";"4.52";"5";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.74";"0.26";"3.25";"6.08";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4107779";"";"None";"591.59";"2";"5.05";"37";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"13.39";"0.25";"2.87";"6.20";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4114929";"";"None";"565.56";"1";"4.52";"5";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"13.30";"0.25";"3.00";"5.89";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4445919";"";"None";"495.63";"1";"5.98";"42, Mixture of enantiomer";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCCC1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"12.63";"0.23";"0.28";"7.02";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4461065";"";"None";"446.94";"1";"5.64";"33";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1Cl";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"15.48";"0.30";"1.28";"8.05";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4461313";"";"None";"378.48";"0";"3.78";"10";"O=C(NCCCC1CCCN(c2ncnc3[nH]ccc23)C1)Nc1ccccc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"15.06";"0.28";"1.92";"6.63";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4517563";"";"None";"348.41";"0";"2.98";"7";"O=C(NCCC#CCCNc1ncnc2[nH]ccc12)Nc1ccccc1";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"13.55";"0.25";"1.74";"4.98";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4877846";"";"None";"566.71";"2";"6.56";"30";"Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"12.77";"0.24";"0.68";"5.68";"0";"CHEMBL4822449";"Inhibition of BTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4865481";"";"None";"483.55";"0";"4.79";"11";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cn5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"12.59";"0.23";"1.30";"6.00";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4855455";"";"None";"508.60";"2";"5.66";"13";"Cn1cc(-c2nc3c(-c4ccc(CN5CCc6cc(C(C)(C)C)ccc6C5=O)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"14.14";"0.26";"1.53";"9.03";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4850235";"";"None";"474.50";"0";"3.78";"5";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5nc(C(C)(C)C)no5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.99";"0.30";"3.81";"5.95";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4876326";"";"None";"580.69";"2";"5.64";"24";"Cc1c(-c2nc3c(-c4ccc5c(c4)CCC[C@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cnn1C1CCOCC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.02";"0.30";"3.66";"6.81";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5204458";"";"None";"510.60";"1";"3.85";"24";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5cccc6ccccc56)C4)c23)CC1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"17.82";"0.33";"5.25";"8.79";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5177044";"";"None";"496.55";"0";"4.89";"44";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)Nc5ccccc5)c(F)c4)c23)CC1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"18.32";"0.34";"4.21";"8.83";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4787517";"";"None";"467.53";"0";"4.73";"8";"CN(C)C/C=C/C(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"17.42";"0.32";"3.41";"8.44";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4792062";"";"None";"521.58";"1";"4.34";"13";"O=C(C#CCCN1CCOCC1)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"17.44";"0.32";"4.76";"8.61";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4796130";"";"None";"534.62";"1";"4.25";"14";"CCN1CCN(CC#CC(=O)Nc2ccc3nccc(Oc4ccc(C(=O)Nc5ccccn5)cc4)c3c2)CC1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"16.09";"0.29";"4.35";"8.63";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4756092";"";"None";"578.67";"1";"4.65";"18";"CC#CC(=O)Nc1cc2c(Oc3ccc(C(=O)Nc4ccccn4)cc3)ccnc2cc1OCCCN1CCN(C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.55";"0.29";"4.35";"8.26";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5208901";"";"None";"433.56";"0";"3.37";"6";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(C(C)(C)C)CC1=O";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"16.99";"0.31";"4.00";"9.30";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5200748";"";"None";"517.56";"1";"3.40";"21";"CC(C)CN1CCN(Cc2ccc(-c3ccnc(Nc4cnn(CCO)c4)n3)cc2C(F)(F)F)C(=O)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.39";"0.33";"5.60";"9.05";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL3747417";"";"None";"529.62";"1";"4.82";"30";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"15.86";"0.29";"3.58";"7.78";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3747019";"";"None";"529.60";"1";"4.74";"26";"Cc1ccc(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)c(F)c1NC(=O)c1cc2ccccc2s1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.03";"0.29";"3.22";"7.37";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3747742";"";"None";"631.20";"2";"5.79";"19";"Cc1ccc(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)c(Cl)c1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"11.74";"0.23";"1.62";"7.44";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3745934";"";"None";"618.71";"2";"5.11";"11";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(F)c(NC(=O)c5cc6c(s5)CCCC6)c4F)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"13.78";"0.26";"3.41";"8.56";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL2057915";"";"None";"596.76";"2";"5.14";"1; GDC-0834";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@@H]3C(=O)N(C)CCN3C)cc2)n1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.16";"0.25";"2.71";"7.89";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3926242";"";"None";"562.56";"1";"4.43";"BDBM246394";"CCn1ncc2c1CCCC2(O)c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)nccn12";"IC50";"'='";"12.04";"nM";"7.92";"";"429695";"UO_0000065";"14.08";"0.26";"3.49";"5.81";"0";"CHEMBL3889024";"IMAP-FP Assay: Assay Method A: BTK enzymatic activity was determined in an IMAP-FP assay (Immobilized Metal ion Affinity-based fluorescence Polarization; Molecular Devices). Using this assay format, the potency (IC50) of each compound was determined from a 10 point (1:3 serial dilution, final compound concentration range in assay from 10 μM to 0.508 nM) titration curve using the following outlined procedure. To each well of a black Corning 384-well microplate (Corning Catalog #3575), 200 nL of compound (100 fold dilution in final assay volume of 20 μL) was dispensed, followed by the addition of 10 μL of 1× kinase buffer (10 mM Tris pH 7.2, 10 mM MgCl2, 0.01% Tween 20, 2 mM MnCl2, and 1 mM DTT) containing 0.16 ng/μL (2.1 nM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 10 μL kinase buffer containing 100 nM â¿¿Blk/Lyntideâ¿ IMAP substrate peptide (5-carboxyfluorescein-EFPIYDFLPAKKK-NH2; Molecular Devices Catalog #R7188), and 10 μM ATP. The final reaction in each well of 20 μL consists of 1.05 nM hBTK, 50 nM Blk/Lyntide IMAP substrate, and 5 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes and were immediately quenched by the addition of 40 μL IMAP detection beads resuspended in IMAP progressive binding buffer (beads were diluted 1:600 in 75% and 25% progressive binding buffer A and B, respectively; Molecular Devices). Plates were read on Packard microplate reader after 60 minutes binding equilibration using Fluorescence Polarization protocol. Specifically, fluorescence at 535 nm is measured using emission filters oriented both parallel and perpendicular to the polarized excitation filter.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3902397";"";"None";"559.56";"2";"5.04";"BDBM246403";"Nc1nccn2c([C@@H]3CCCn4c(C5CC5)nnc43)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"67.0";"nM";"7.17";"";"429710";"UO_0000065";"12.82";"0.24";"2.13";"5.57";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL5188545";"";"None";"447.59";"0";"3.62";"15";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC(C)(C)C)CC1=O";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"13.36";"0.25";"2.36";"7.55";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5208570";"";"None";"502.67";"1";"3.57";"24";"Cc1cc(-c2ccnc(Nc3cnn(C4CN(C)C4)c3)n2)ccc1CN1CCN(CC(C)(C)C)CC1=O";"IC50";"'='";"2650.0";"nM";"5.58";"";"";"UO_0000065";"11.09";"0.21";"2.01";"6.77";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5180966";"";"None";"431.54";"0";"3.13";"7";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(C2CCC2)CC1=O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"18.44";"0.34";"4.83";"10.05";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5204655";"";"None";"445.57";"0";"3.37";"8";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC2CCC2)CC1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.13";"0.35";"5.15";"10.76";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5207396";"";"None";"422.53";"0";"2.35";"33";"C=CC(=O)N(C)CCOc1cnccc1-c1ccc(CN2CCN(C)CC2=O)c(C)c1";"IC50";"'='";"315.0";"nM";"6.50";"";"";"UO_0000065";"15.39";"0.29";"4.15";"9.85";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL3622191";"";"None";"601.75";"2";"6.33";"32";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"13.16";"0.24";"1.59";"7.10";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL5188786";"";"None";"480.61";"0";"2.36";"42";"C=CC(=O)N(C)CCOc1c(N)ncnc1-c1ccc(CN2CCN(CC(C)C)CC2=O)c(C)c1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"18.30";"0.34";"6.44";"8.39";"0";"CHEMBL5133843";"Inhibition of BTK-dependent human TMD8 cell proliferation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TMD8";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5074640";"";"None";"648.74";"1";"4.48";"13d";"CN1CCN(C(=O)N2CC=C(c3cc4c(-c5cccc(-n6ccc7cc(C8CC8)cc(F)c7c6=O)c5CO)nc(N)nc4[nH]3)CC2)CC1";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"14.24";"0.26";"4.76";"6.76";"0";"CHEMBL5054197";"Inhibition of human BTK C481S mutant using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3896703";"";"None";"543.69";"2";"5.53";"BDBM200851";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(C3=CCN(S(C)(=O)=O)CC3)cc12";"IC50";"'='";"17.0";"nM";"7.77";"";"356882";"UO_0000065";"14.29";"0.27";"2.24";"7.19";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986267";"";"None";"279.27";"0";"2.94";"BDBM195832";"C#CC(=O)Nc1cc(-c2cnc3[nH]ccc3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348536";"UO_0000065";"21.95";"0.40";"3.19";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3967872";"";"None";"290.33";"0";"2.90";"BDBM195840";"CC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348544";"UO_0000065";"21.12";"0.38";"3.23";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3911910";"";"None";"283.31";"0";"3.45";"BDBM195774";"Cc1c[nH]c2ncc(-c3cccc(NC(=O)CF)c3)cc12";"IC50";"'='";"739.0";"nM";"6.13";"";"348511";"UO_0000065";"21.64";"0.40";"2.68";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4468148";"";"None";"415.50";"0";"4.11";"A14";"C=CC(=O)N1CCC[C@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"19.70";"0.36";"4.08";"8.77";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3787191";"";"None";"460.49";"0";"3.01";"16b";"C=CC(=O)Nc1cccc(-n2c(=O)n(C)c3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"4.11";"nM";"8.39";"";"";"UO_0000065";"18.21";"0.34";"5.38";"7.47";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3948653";"";"None";"474.59";"1";"5.05";"BDBM195777";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(CC)CC)c4)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348514";"UO_0000065";"12.92";"0.25";"1.08";"6.44";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3979809";"";"None";"321.38";"0";"2.95";"BDBM195797";"Cc1n[nH]c2ncc(-c3cccc(NC(=O)/C=C/N(C)C)c3)cc12";"IC50";"'='";"739.0";"nM";"6.13";"";"348520";"UO_0000065";"19.08";"0.35";"3.18";"8.30";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3914851";"";"None";"392.46";"1";"5.81";"BDBM195824";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(C)cc5[nH]4)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348529";"UO_0000065";"15.62";"0.28";"0.32";"8.33";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3920364";"";"None";"262.27";"0";"2.20";"BDBM195826";"C#CC(=O)Nc1cccc(-c2cnc3[nH]ccc3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348530";"UO_0000065";"23.38";"0.42";"3.93";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3702855";"";"None";"651.75";"1";"4.56";"BDBM143213";"CC(=O)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"1.9";"nM";"8.72";"";"369529";"UO_0000065";"13.38";"0.25";"4.16";"5.95";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4211372";"";"None";"473.56";"0";"4.74";"16";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3ccccc31)C2";"IC50";"'='";"0.94";"nM";"9.03";"";"";"UO_0000065";"19.06";"0.36";"4.29";"9.68";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4202941";"";"None";"571.69";"2";"5.14";"37";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C(F)F)s3)nc3cc(CNCC(C)(C)CO)ccc31)C2";"IC50";"'='";"0.95";"nM";"9.02";"";"";"UO_0000065";"15.78";"0.31";"3.88";"9.07";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4541798";"";"None";"400.44";"0";"1.64";"9f";"C#CC(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"11.1";"nM";"7.96";"";"";"UO_0000065";"19.86";"0.36";"6.31";"8.02";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3670106";"";"None";"615.78";"2";"5.81";"BDBM111965";"CC(C)N(C)Cc1ccc(Nc2cc(-c3cc(F)cc(N4CCc5c(sc6c5CCCC6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"3.4";"nM";"8.47";"";"233020";"UO_0000065";"13.75";"0.26";"2.66";"9.34";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL5172575";"";"None";"450.58";"0";"3.13";"30";"C=CC(=O)N(C)CCOc1cnccc1-c1ccc(CN2CCN(CCC)CC2=O)c(C)c1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"18.46";"0.34";"5.19";"12.61";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL2057912";"";"None";"371.44";"0";"4.98";"12, PCI-29732";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCC1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"21.77";"0.39";"3.11";"10.26";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1916891";"";"None";"432.50";"0";"4.15";"24";"Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"1.93";"nM";"8.71";"";"";"UO_0000065";"20.15";"0.37";"4.56";"13.25";"1";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2057914";"";"None";"461.57";"1";"6.69";"25, CGI560";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3cn4ccnc4c(Nc4ccccc4)n3)c2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"13.86";"0.25";"-0.29";"8.97";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2057922";"";"None";"591.68";"1";"4.22";"33";"Cc1c(NC(=O)c2ccc(N(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2ncc(N)n2n1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.71";"0.23";"3.30";"5.26";"0";"CHEMBL2060514";"Inhibition of human BTK by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2057919";"";"None";"522.54";"1";"4.26";"30";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(O)CO)ccc4c23)cccc1-n1cnc2ccc(F)cc2c1=O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.23";"0.28";"3.70";"5.93";"0";"CHEMBL2060657";"Inhibition of BTK in human Ramos cells by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057130";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307664";"";"";""
"CHEMBL1916713";"";"None";"468.56";"0";"4.37";"9";"COc1cc2nc(Nc3ccccc3C)c3cncn3c2cc1NC(=O)C#CCN1CCCCC1";"IC50";"'='";"0.847";"nM";"9.07";"";"";"UO_0000065";"19.36";"0.35";"4.70";"10.83";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL1916718";"";"None";"414.51";"0";"4.02";"22";"Cc1ccccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"3.99";"nM";"8.40";"";"";"UO_0000065";"20.26";"0.37";"4.38";"12.77";"0";"CHEMBL1918488";"Inhibition of human full-length BTK expressed in Sf9 cells using FAM-Srctide peptide as substrate after 60 mins by TR-FRET Assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308860";"";"";""
"CHEMBL3962478";"";"None";"386.42";"0";"3.69";"10k";"C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(OC)cc4)nc32)c1";"IC50";"'='";"97.1";"nM";"7.01";"";"";"UO_0000065";"18.15";"0.33";"3.32";"7.46";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3919900";"";"None";"518.60";"1";"2.77";"10f";"C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(S(C)(=O)=O)CC5)cc4)nc32)c1";"IC50";"'='";"17.1";"nM";"7.77";"";"";"UO_0000065";"14.98";"0.29";"5.00";"6.20";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4648782";"";"None";"489.58";"0";"2.87";"10";"CCC(=O)Nc1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cn(C)c1=O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.04";"0.30";"4.98";"7.18";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3621459";"";"None";"469.55";"0";"3.43";"3";"CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCN(C)CC5)cc4c23)c1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"15.03";"0.28";"3.63";"6.33";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622189";"";"None";"563.63";"2";"5.17";"30";"Cc1c(NC(=O)c2ccc(F)cc2)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"14.94";"0.27";"3.25";"7.55";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622197";"";"None";"433.90";"0";"4.21";"39";"NC(=O)c1cc(-c2ccc(Cl)cc2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12";"IC50";"'='";"308.0";"nM";"6.51";"";"";"UO_0000065";"15.01";"0.29";"2.30";"7.36";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3936156";"";"None";"571.01";"2";"5.41";"10";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"15.40";"0.29";"3.39";"6.57";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4540071";"";"None";"524.65";"2";"5.40";"30d";"C=CCNC(=S)SCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1";"IC50";"'='";"91.7";"nM";"7.04";"";"";"UO_0000065";"13.41";"0.27";"1.64";"7.02";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4443136";"";"None";"540.69";"2";"5.97";"30aj";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCCSC(=S)N(C)C)cc3)ncc2F)c1";"IC50";"'='";"35.4";"nM";"7.45";"";"";"UO_0000065";"13.78";"0.28";"1.48";"8.15";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3935716";"";"None";"601.71";"2";"5.53";"4";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ncnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c1CO";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"13.43";"0.25";"2.55";"7.78";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3787293";"";"None";"461.48";"0";"2.50";"16f";"C=CC(=O)Nc1cccc(-n2c(=O)n(CCOC)c3cnc(Nc4ccc(OC)nc4)nc32)c1";"IC50";"'='";"265.0";"nM";"6.58";"";"";"UO_0000065";"14.25";"0.26";"4.08";"5.25";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4645223";"";"None";"608.67";"2";"5.48";"46";"C=CC(=O)NCCOc1cc(C(OCCS(C)(=O)=O)c2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"11.75";"0.23";"1.67";"5.67";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"19.65";"0.36";"4.44";"8.73";"0";"CHEMBL4611176";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3402356";"";"None";"998.13";"4";"9.16";"1f";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOC(CNC(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)C3)cc2)n1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"6.47";"0.12";"-2.70";"2.97";"0";"CHEMBL3407011";"Inhibition of biotinylated and activated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4645440";"";"None";"376.48";"0";"1.92";"4d";"C=CS(=O)(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"89.8";"nM";"7.05";"";"";"UO_0000065";"18.72";"0.37";"5.13";"6.51";"0";"CHEMBL4616856";"Inhibition of BTK in human whole blood cells after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4243865";"";"None";"472.55";"0";"4.28";"11";"C=CC(=O)NCC1CCCN(c2ccc(C(N)=O)c(Oc3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"11.07";"0.20";"0.95";"4.90";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4435060";"";"None";"589.72";"2";"6.15";"30ae";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N(C)Cc4cccnc4)cc3)ncc2F)c1";"IC50";"'='";"30.7";"nM";"7.51";"";"";"UO_0000065";"12.74";"0.25";"1.36";"7.20";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"3";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"2.12";"nM";"8.67";"";"";"UO_0000065";"20.48";"0.38";"4.42";"8.91";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4463650";"";"None";"487.54";"0";"4.08";"13";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3)c2C)C1";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"17.32";"0.32";"4.36";"7.65";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4461398";"";"None";"492.53";"0";"4.16";"19";"C=CC(=O)NCCNc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"14.81";"0.28";"3.13";"5.98";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4463185";"";"None";"541.53";"1";"3.71";"16";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C(C)(C)O)c(F)c3F)c2C)C1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"14.07";"0.27";"3.91";"5.83";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4439622";"";"None";"521.57";"1";"4.86";"27";"C=CC(=O)N(CC)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"14.48";"0.27";"2.69";"6.84";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4437701";"";"None";"519.55";"1";"4.30";"31";"CC#CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"161.0";"nM";"6.79";"";"";"UO_0000065";"13.08";"0.24";"2.49";"6.15";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"4";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"15.12";"0.28";"2.14";"6.96";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4244928";"";"None";"445.56";"0";"4.63";"13";"C=C(C)C(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"18.05";"0.33";"3.41";"7.43";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4248271";"";"None";"427.50";"0";"4.46";"8";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"22.91";"0.42";"5.34";"9.85";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"21.33";"0.39";"5.18";"9.48";"1";"CHEMBL4233700";"Inhibition of full length recombinant human N-terminal His-tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229440";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4247474";"";"None";"524.97";"1";"3.80";"7c";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)NC(C)C(=O)OC)cc3)ncc2Cl)c1";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"15.35";"0.30";"4.26";"5.61";"0";"CHEMBL4233700";"Inhibition of full length recombinant human N-terminal His-tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229440";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3897842";"";"None";"417.45";"0";"2.94";"(-)-32";"Nc1ccc2c(c1)CC(n1nc(-c3cc(F)c4c(c3)NCCO4)c3c(N)ncnc31)C2";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"18.25";"0.34";"4.68";"6.52";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3897842";"";"None";"417.45";"0";"2.94";"(-)-32";"Nc1ccc2c(c1)CC(n1nc(-c3cc(F)c4c(c3)NCCO4)c3c(N)ncnc31)C2";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.95";"0.33";"4.55";"6.41";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4649614";"";"None";"503.60";"1";"3.26";"11";"CCCC(=O)Nc1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cn(C)c1=O";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"14.61";"0.27";"4.10";"6.72";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4643297";"";"None";"517.59";"1";"1.99";"30";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)C2(O)CC2)c1=O";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"12.34";"0.23";"4.40";"4.92";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5093591";"";"None";"192.18";"0";"0.17";"9";"COc1cccc(-c2n[nH]c(=O)[nH]2)n1";"IC50";"'='";"31622.78";"nM";"4.50";"";"";"UO_0000065";"23.42";"0.44";"4.33";"5.38";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5280844";"";"None";"478.94";"0";"4.59";"11; ARQ-531";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(NC3CC[C@@H](CO)OC3)c12";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"19.65";"0.38";"4.82";"8.60";"0";"CHEMBL5242630";"Inhibition of BTK C481S mutant (unknown origin) in the presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4063275";"";"None";"538.53";"2";"5.39";"32";"C[C@]1(C(=O)O)CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"16.80";"0.32";"3.66";"6.68";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4081452";"";"None";"562.56";"1";"4.61";"18";"Cn1nnnc1[C@H]1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"13.65";"0.26";"3.07";"5.41";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4070865";"";"None";"523.52";"1";"4.40";"20";"NC(=O)[C@H]1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.84";"0.28";"3.37";"5.50";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4074674";"";"None";"524.50";"2";"5.00";"22";"Nc1nccn2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nc2[C@H]1CC[C@@H](C(=O)O)CC1";"IC50";"'='";"1237.0";"nM";"5.91";"";"";"UO_0000065";"11.26";"0.21";"0.91";"4.36";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4066216";"";"None";"552.56";"2";"5.64";"35";"CC(C)[C@]1(C(=O)O)CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"13.70";"0.26";"1.93";"5.59";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4079005";"";"None";"562.48";"1";"3.86";"30";"Nc1nccn2c(C34C5C6C3C3C4C5C63C(=O)O)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.78";"0.33";"6.14";"7.38";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4075160";"";"None";"619.70";"2";"5.58";"3q";"O=C(N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1)N1CCOCC1";"IC50";"'='";"7.3";"nM";"8.14";"";"";"UO_0000065";"13.13";"0.24";"2.56";"7.85";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4103325";"";"None";"584.67";"2";"5.09";"3r";"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"10.92";"0.21";"1.30";"5.90";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"1, RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"27.3";"nM";"7.56";"";"";"UO_0000065";"12.47";"0.23";"2.80";"7.91";"1";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4211270";"";"None";"526.64";"2";"6.77";"2d";"COc1cc(Nc2nccc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)n2)cc(OC)c1OC";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"15.60";"0.29";"1.44";"8.68";"0";"CHEMBL4182608";"Inhibition of BTK (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4208579";"";"None";"461.57";"1";"6.92";"2c";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3ccnc(Nc4ccc5cc[nH]c5c4)n3)c2)cc1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"15.78";"0.28";"0.36";"8.81";"0";"CHEMBL4182608";"Inhibition of BTK (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4212308";"";"None";"476.58";"1";"6.62";"2b";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccnc(Nc2ccc3[nH]ncc3c2)n1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"15.52";"0.28";"0.78";"7.74";"0";"CHEMBL4182608";"Inhibition of BTK (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4520286";"";"None";"541.66";"1";"4.58";"34";"CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(OC4CCCCC4)c23)n1";"IC50";"'='";"1469.0";"nM";"5.83";"";"";"UO_0000065";"10.77";"0.20";"1.25";"4.70";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4576801";"";"None";"521.57";"1";"4.86";"28";"C/C=C/C(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"983.0";"nM";"6.01";"";"";"UO_0000065";"11.52";"0.22";"1.15";"5.44";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4441128";"";"None";"564.64";"1";"4.40";"29";"Cc1c(NC(=O)c2ccc(C3CC3)cc2F)cc(F)cc1-c1ncnc(N)c1OCCN(C)C(=O)/C=C/CN(C)C";"IC50";"'='";"151.0";"nM";"6.82";"";"";"UO_0000065";"12.08";"0.23";"2.42";"6.00";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"9a";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.38";"0.29";"3.58";"7.31";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3899411";"";"None";"575.60";"1";"4.64";"12b";"Cc1c(-c2c(C#N)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"14.28";"0.26";"3.58";"5.60";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL4161110";"";"None";"407.43";"0";"4.05";"16";"C=CC(=O)Nc1cccc(-n2c(=O)ccc3cnc4ccc(-c5cn[nH]c5)cc4c32)c1";"IC50";"'='";"17.7";"nM";"7.75";"";"";"UO_0000065";"19.03";"0.34";"3.70";"8.37";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4856467";"";"None";"445.48";"0";"1.86";"1";"C=CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"176.0";"nM";"6.75";"";"";"UO_0000065";"15.16";"0.28";"4.89";"4.53";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4855894";"";"None";"501.55";"1";"2.10";"39";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(OC)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"79.6";"nM";"7.10";"";"";"UO_0000065";"14.15";"0.26";"5.00";"4.48";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"20.53";"0.37";"4.83";"9.12";"1";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4125772";"";"None";"545.63";"2";"2.91";"4";"C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCSCC5)cc4OC)nc32)c1";"IC50";"'='";"806.0";"nM";"6.09";"";"";"UO_0000065";"11.17";"0.21";"3.18";"4.94";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4129387";"";"None";"570.65";"2";"2.89";"6";"C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1";"IC50";"'='";"364.0";"nM";"6.44";"";"";"UO_0000065";"11.28";"0.21";"3.55";"5.09";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4126986";"";"None";"559.63";"2";"3.34";"15";"C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1";"IC50";"'='";"349.0";"nM";"6.46";"";"";"UO_0000065";"11.54";"0.22";"3.12";"4.87";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL5198054";"";"None";"465.52";"0";"3.31";"15";"CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"247.0";"nM";"6.61";"";"";"UO_0000065";"14.19";"0.26";"3.30";"5.58";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"19; CC-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"17.28";"0.32";"3.07";"7.51";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4459438";"";"None";"465.58";"0";"4.12";"A28";"C=CS(=O)(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"15.78";"0.30";"3.23";"6.65";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3670095";"";"None";"653.76";"1";"3.68";"6";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"36.5";"nM";"7.44";"";"";"UO_0000065";"11.38";"0.21";"3.76";"6.88";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4549348";"";"None";"509.57";"1";"4.63";"7c";"COc1ccc(-c2cnc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCCCC6)cc5)c4c3c2)cn1";"IC50";"'='";"125.0";"nM";"6.90";"";"";"UO_0000065";"13.55";"0.25";"2.27";"6.74";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4455455";"";"None";"453.50";"0";"4.61";"5c";"CN(C)CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5ccc(O)cc5)cc4c32)cc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"15.05";"0.27";"2.21";"7.78";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3891185";"";"None";"589.70";"2";"5.16";"BDBM202109";"CN1CCC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cn2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"358187";"UO_0000065";"13.94";"0.26";"3.06";"7.31";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981948";"";"None";"573.70";"2";"5.98";"BDBM202110";"Cc1c(-c2ncnc3[nH]c(-c4cnn(C5CCN(C)CC5)c4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"13.0";"nM";"7.89";"";"358188";"UO_0000065";"13.75";"0.25";"1.91";"8.56";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900513";"";"None";"627.70";"2";"6.21";"BDBM202164";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCCC5C(=O)O)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"114.0";"nM";"6.94";"";"358241";"UO_0000065";"11.06";"0.20";"0.73";"5.39";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929529";"";"None";"642.76";"2";"6.29";"BDBM202176";"CC1(O)CCN(C(=O)c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cc2)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"358253";"UO_0000065";"12.52";"0.23";"1.76";"6.76";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959052";"";"None";"577.69";"2";"5.41";"BDBM202189";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)ccc6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"358266";"UO_0000065";"15.06";"0.28";"3.29";"8.53";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978618";"";"None";"594.69";"2";"5.66";"BDBM202206";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5CCOC5)CC4)cc23)c1CO";"IC50";"'='";"4.0";"nM";"8.40";"";"358282";"UO_0000065";"14.12";"0.26";"2.74";"9.24";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924953";"";"None";"596.76";"2";"5.12";"BDBM205242";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)NCCN4C)cc3)n2)cccc1N1Cc2cc(C(C)(C)C)sc2C1=O";"IC50";"'='";"95.0";"nM";"7.02";"";"363327";"UO_0000065";"11.77";"0.22";"1.90";"7.05";"0";"CHEMBL3887917";"Biochemical Btk Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2), 0.5 μM Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer, 0.5 μM PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6xHis tag was subcloned into pFastBac vector for making baculovirus carrying this epitope-tagged Btk.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886504";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949596";"";"None";"596.74";"2";"6.07";"BDBM202170";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"208.0";"nM";"6.68";"";"358247";"UO_0000065";"11.20";"0.20";"0.61";"7.82";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4085457";"RITLECITINIB";"4.0";"285.35";"0";"1.94";"11";"C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C";"IC50";"'='";"607.0";"nM";"6.22";"";"";"UO_0000065";"21.79";"0.40";"4.28";"8.41";"0";"CHEMBL4005779";"Inhibition of full length recombinant human His-tagged cytoplasmic BTK expressed in baculovirus expression system in presence of 1 mM ATP by KT236 probe based TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3702857";"";"None";"651.75";"1";"4.56";"BDBM143215";"CCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1=O";"IC50";"'='";"1.3";"nM";"8.89";"";"369531";"UO_0000065";"13.63";"0.25";"4.33";"6.07";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4111979";"";"None";"567.55";"2";"5.04";"BDBM255296";"Nc1nccn2c([C@@H]3CC[C@H]4CCCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"1.7";"nM";"8.77";"";"445201";"UO_0000065";"15.45";"0.29";"3.73";"7.40";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3923011";"";"None";"549.56";"1";"4.76";"BDBM255315";"C[C@H]1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]12";"IC50";"'='";"0.77";"nM";"9.11";"";"445220";"UO_0000065";"16.58";"0.31";"4.35";"7.69";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111143";"";"None";"685.67";"1";"4.28";"BDBM255335";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CN(C(=O)c4ccncc4)CC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.89";"nM";"9.05";"";"445241";"UO_0000065";"13.20";"0.25";"4.77";"5.62";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113946";"";"None";"563.58";"2";"5.15";"BDBM255345";"CC1(C)C[C@@H]2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"11.4";"nM";"7.94";"";"445251";"UO_0000065";"14.09";"0.26";"2.79";"6.70";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115467";"";"None";"556.48";"2";"5.17";"BDBM255445";"Cc1cnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)c(Cl)c2)s1";"IC50";"'='";"1.5";"nM";"8.82";"";"445352";"UO_0000065";"15.86";"0.33";"3.65";"7.45";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3962931";"";"None";"310.74";"0";"3.24";"BDBM195831";"CC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348535";"UO_0000065";"19.73";"0.38";"2.89";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4746262";"";"None";"511.56";"1";"4.42";"9";"C=CC(=O)N1CC(O)(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)C1";"IC50";"'='";"303.0";"nM";"6.52";"";"";"UO_0000065";"12.74";"0.23";"2.10";"5.86";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1002.0";"nM";"6.00";"";"";"UO_0000065";"13.62";"0.25";"1.78";"6.05";"0";"CHEMBL4668339";"Inhibition of BTK C481S (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665674";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL4297640";"VECABRUTINIB";"2.0";"529.93";"1";"2.65";"15";"NC(=O)[C@H]1CCN(c2ncnc(N)c2F)C[C@@H]1N1CCC[C@@H](Nc2cc(Cl)cc(C(F)(F)F)c2)C1=O";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"15.75";"0.32";"5.70";"6.40";"0";"CHEMBL4668339";"Inhibition of BTK C481S (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665674";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL248676";"";"None";"395.45";"0";"2.80";"43";"Cc1ccc2[nH]ncc2c1Nc1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"18.11";"0.35";"4.36";"5.16";"0";"CHEMBL923138";"Inhibition of Btk";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140683";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL3702837";"";"None";"596.67";"1";"4.21";"BDBM143188";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)NC1COC1";"IC50";"'='";"16.1";"nM";"7.79";"";"369511";"UO_0000065";"13.06";"0.24";"3.58";"5.40";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702849";"";"None";"665.82";"2";"5.82";"BDBM143203";"CC(C)(C)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"0.6";"nM";"9.22";"";"369523";"UO_0000065";"13.85";"0.26";"3.40";"7.12";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3657232";"";"None";"435.49";"1";"5.03";"BDBM134238";"CNC(=O)c1ccc(-c2cc3[nH]nc(N)c3c(-c3ccc(Oc4ccccc4)cc3)n2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"267627";"UO_0000065";"19.98";"0.36";"3.67";"8.21";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"384993";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"4";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"1182.0";"nM";"5.93";"";"";"UO_0000065";"13.80";"0.25";"1.58";"6.35";"0";"CHEMBL4358574";"Inhibition of BTK in human basophils assessed as reduction in anti-IgE mouse IgG1 antibody Le2-stimulated CD63 expression on basophil preincubated for 30 mins in presence of IgE antibody B11 followed by anti-IgE mouse IgG1 antibody Le2 stimulation and measured after 15 mins by flow cytometry";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4437701";"";"None";"519.55";"1";"4.30";"31";"CC#CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"14.43";"0.27";"3.19";"6.79";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4210336";"";"None";"497.53";"0";"4.02";"18g";"Cn1ccc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)n1";"IC50";"'='";"245.0";"nM";"6.61";"";"";"UO_0000065";"13.29";"0.24";"2.59";"5.34";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4216609";"";"None";"497.53";"0";"4.02";"18f";"Cn1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"16.95";"0.31";"4.41";"6.81";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4214732";"";"None";"483.51";"0";"4.01";"18e";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cn[nH]c2)n1";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"16.73";"0.31";"4.08";"6.01";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4202546";"";"None";"592.68";"2";"5.11";"18c";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2ccc(CN3CCOCC3)cc2)n1";"IC50";"'='";"309.0";"nM";"6.51";"";"";"UO_0000065";"10.98";"0.20";"1.40";"5.49";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4206900";"";"None";"578.65";"2";"5.12";"18a";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2ccc(N3CCOCC3)cc2)n1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"15.94";"0.29";"4.10";"7.78";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4211960";"";"None";"547.54";"1";"4.74";"25g";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(CC(F)F)c2)n1";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"15.49";"0.29";"3.74";"6.85";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4861412";"";"None";"457.47";"0";"3.50";"12";"COc1ccc(C(=O)NCc2ccc(-c3ccnc4[nH]c(-c5cnn(C)c5)nc34)cc2F)nc1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"15.74";"0.29";"3.70";"6.51";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4855455";"";"None";"508.60";"2";"5.66";"13";"Cn1cc(-c2nc3c(-c4ccc(CN5CCc6cc(C(C)(C)C)ccc6C5=O)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"17.15";"0.31";"3.06";"10.94";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4859888";"";"None";"496.58";"0";"4.51";"22B";"Cn1cc(-c2nc3c(-c4ccc5c(c4)CCC[C@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cn1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"18.04";"0.33";"4.45";"7.03";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"12.50";"0.23";"2.83";"7.93";"0";"CHEMBL4822449";"Inhibition of BTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4848010";"";"None";"566.67";"2";"5.33";"23";"CC(C)(C)c1noc(C(=O)NC2CCCc3cc(-c4ccnc5[nH]c(-c6cnn(C7CCOCC7)c6)nc45)ccc32)n1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"12.87";"0.24";"1.96";"5.34";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4868813";"";"None";"524.63";"2";"5.56";"29";"CC(C)n1cc(-c2nc3c(-c4ccc5c(c4)CCC[C@@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cn1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"13.85";"0.25";"1.71";"5.70";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4862532";"";"None";"552.68";"2";"6.17";"28";"Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"13.75";"0.25";"1.43";"5.97";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"BDBM2579";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"22.07";"nM";"7.66";"";"348669";"UO_0000065";"16.41";"0.30";"3.31";"11.02";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4468095";"";"None";"533.58";"1";"5.00";"21";"C=CC(=O)N1CCC[C@@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1290.0";"nM";"5.89";"";"";"UO_0000065";"11.04";"0.21";"0.89";"5.33";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4576801";"";"None";"521.57";"1";"4.86";"28";"C/C=C/C(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"104.0";"nM";"6.98";"";"";"UO_0000065";"13.39";"0.25";"2.12";"6.32";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"EUB0000638a";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"17.81";"0.32";"4.98";"7.00";"0";"CHEMBL5210344";"Affinity Biochemical interaction (IMAP (immobilized metal ion affinity-based fluorescence polarization) assay) EUB0000638a BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Covalent inhibitor | Protein family: Protein Kinase | Recommended concentration = 1.0 µM";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5210307";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Affinity Biochemical Source Knowledge: https://doi.org/10.1056/NEJMoa1509981";"INHIBITOR";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"23.3";"nM";"7.63";"";"";"UO_0000065";"16.36";"0.30";"3.28";"10.99";"0";"CHEMBL4328324";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3402586";"";"None";"564.62";"1";"4.87";"4y";"CNC(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"25.2";"nM";"7.60";"";"";"UO_0000065";"13.46";"0.25";"2.73";"6.54";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400974";"";"None";"502.55";"2";"6.10";"4b";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(-c4ccccc4)cc23)c1CO";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"14.13";"0.26";"1.00";"8.48";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3601223";"";"None";"508.03";"1";"4.37";"9";"C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1";"IC50";"'='";"794.0";"nM";"6.10";"";"";"UO_0000065";"12.01";"0.23";"1.73";"6.44";"0";"CHEMBL3603324";"Inhibition of BTK (unknown origin) by Z'-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600288";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL5075981";"";"None";"162.15";"0";"0.16";"7";"O=c1[nH]nc(-c2ccccn2)[nH]1";"IC50";"'='";"316227.77";"nM";"3.50";"";"";"UO_0000065";"21.58";"0.40";"3.34";"4.70";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5072186";"";"None";"269.31";"0";"2.13";"20";"CC(C)Nc1nc(-c2n[nH]c(=O)[nH]2)cc2ccccc12";"IC50";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"28.59";"0.53";"5.57";"8.91";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4791520";"";"None";"442.50";"0";"1.99";"B38";"C=CS(=O)(=O)N1CCC(Cn2nc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'='";"3220.0";"nM";"5.49";"";"";"UO_0000065";"12.41";"0.24";"3.50";"4.38";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4793094";"";"None";"441.51";"0";"2.59";"B33";"C=CS(=O)(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'='";"83550.0";"nM";"4.08";"";"";"UO_0000065";"9.24";"0.18";"1.49";"3.62";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL3917732";"";"None";"479.54";"0";"4.97";"20a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.38";"nM";"9.42";"";"";"UO_0000065";"19.64";"0.36";"4.45";"8.47";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3917732";"";"None";"479.54";"0";"4.97";"20a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"14.36";"0.26";"1.92";"6.19";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3926191";"";"None";"417.47";"0";"3.19";"25b";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC)cc3)nn21";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"16.49";"0.30";"3.70";"6.19";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4290540";"";"None";"465.51";"0";"0.67";"14";"C=CC(=O)N[C@H]1CCN(c2ncc(C(N)=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.98";"0.37";"8.63";"6.51";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4281335";"";"None";"464.57";"0";"2.42";"17";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)cc3)n2)C1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"19.85";"0.37";"6.80";"8.17";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4281335";"";"None";"464.57";"0";"2.42";"17";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)cc3)n2)C1";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"17.68";"0.33";"5.79";"7.28";"0";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4277875";"";"None";"448.57";"0";"2.44";"19";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)C1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.18";"0.34";"5.71";"7.87";"0";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4279430";"";"None";"448.57";"0";"2.40";"23";"C=CC(=O)N1CCN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)CC1";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"18.65";"0.35";"5.97";"8.83";"0";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3647968";"";"None";"476.56";"0";"3.98";"22";"C=CS(=O)(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"19.38";"0.37";"5.26";"7.95";"0";"CHEMBL4271410";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270507";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4558157";"";"None";"415.50";"0";"3.79";"A13";"C=CC(=O)NC1CCCN(c2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.02";"0.26";"2.03";"6.24";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4469004";"";"None";"401.47";"0";"3.72";"A15";"C=CC(=O)N1CC[C@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"20.57";"0.38";"4.54";"8.85";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4453568";"";"None";"465.50";"0";"4.63";"A21";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2cc(F)c(Oc3ccccc3)cc2F)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"14.60";"0.27";"2.17";"7.28";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4537274";"";"None";"443.55";"0";"4.66";"A23";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccc(C)cc3)cc2)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"17.46";"0.32";"3.08";"8.29";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3747672";"";"None";"651.62";"2";"6.14";"12";"CN1CCN(C)C(c2ccc(Nc3nc(-c4ccc(Cl)c(NC(=O)c5cc6c(s5)CCCC6)c4Cl)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"12.01";"0.24";"1.68";"7.86";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL5192697";"";"None";"421.51";"0";"3.41";"2";"C=CC(=O)Nc1cccc(CNc2nc(NC)nc(Nc3cc(C(C)(C)C)[nH]n3)n2)c1";"IC50";"'='";"98.28";"nM";"7.01";"";"";"UO_0000065";"16.62";"0.31";"3.60";"5.29";"0";"CHEMBL5130942";"Inhibition of BTK (unknown origin) using TK peptide as substrate incubated for 1 hr in presence of ATP by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126642";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5197209";"";"None";"443.94";"0";"3.47";"3";"CNc1nc(NCc2cccc(NC(=O)CCl)c2)nc(Nc2cc(C(C)(C)C)[nH]n2)n1";"IC50";"'='";"1898.5";"nM";"5.72";"";"";"UO_0000065";"12.89";"0.25";"2.25";"4.32";"0";"CHEMBL5130942";"Inhibition of BTK (unknown origin) using TK peptide as substrate incubated for 1 hr in presence of ATP by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126642";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3621509";"";"None";"504.59";"2";"5.27";"19";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccc(Oc5ccccc5)cc4)c23)CC1";"IC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"13.67";"0.25";"1.63";"7.52";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4784750";"";"None";"470.53";"0";"3.95";"17";"C=CC(=O)NC1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"17.00";"0.31";"4.05";"6.25";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4559706";"";"None";"407.43";"0";"4.92";"6f";"C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)c1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"17.50";"0.31";"2.21";"9.25";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4553092";"";"None";"469.50";"0";"3.70";"7a";"COc1ccc(-c2cnc3oc4ccc(=O)n(-c5ccc(NC(=O)CN(C)C)cc5)c4c3c2)cn1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.53";"0.27";"3.12";"6.66";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3884319";"";"None";"386.45";"0";"4.24";"33";"CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21";"IC50";"'='";"1879.0";"nM";"5.73";"";"";"UO_0000065";"14.82";"0.27";"1.49";"7.31";"0";"CHEMBL3876081";"Inhibition of human recombinant full length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875183";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4077064";"";"None";"447.50";"0";"4.01";"7; QL47";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.22";"0.33";"4.14";"11.17";"1";"CHEMBL4235178";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4871192";"";"None";"453.50";"0";"3.56";"19a";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"17.90";"0.33";"4.56";"7.68";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4868355";"";"None";"485.52";"0";"4.09";"18c";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5F)cc4)[nH]c23)CC1";"IC50";"'='";"27.9";"nM";"7.55";"";"";"UO_0000065";"15.56";"0.29";"3.46";"7.15";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4870320";"";"None";"467.53";"0";"3.87";"19i";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(C)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"17.57";"0.32";"4.34";"7.77";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4878626";"";"None";"570.05";"1";"4.57";"30";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccc(Cl)cc4)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"15.30";"0.29";"4.15";"5.84";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4852748";"";"None";"505.97";"1";"2.74";"40";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(Cl)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"19.4";"nM";"7.71";"";"";"UO_0000065";"15.24";"0.29";"4.97";"5.17";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4472236";"";"None";"520.64";"1";"3.51";"7r";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5csnn5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"213.0";"nM";"6.67";"";"";"UO_0000065";"12.81";"0.25";"3.16";"5.16";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4548153";"";"None";"566.69";"2";"5.61";"5o";"CCOC(=O)c1sc(-c2cccc(NC(=O)c3ccc(C#N)cc3)c2)nc1Nc1ccc(N2CCN(C)CC2)cc1";"IC50";"'='";"5169.0";"nM";"5.29";"";"";"UO_0000065";"9.33";"0.18";"-0.32";"4.78";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4587485";"";"None";"583.71";"2";"5.67";"7g";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(Nc4ccc(C(=O)N5CCOCC5)cc4)c(C(N)=O)s3)c2)cc1";"IC50";"'='";"333.0";"nM";"6.48";"";"";"UO_0000065";"11.10";"0.21";"0.81";"5.11";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL1916891";"";"None";"432.50";"0";"4.15";"36";"Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"16.92";"0.31";"3.17";"11.13";"0";"CHEMBL1919053";"Inhibition of BTK autophosphorylation at PY223 in human Ramos B cells after 20 mins by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1914368";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307664";"";"";""
"CHEMBL4216909";"";"None";"521.56";"1";"4.49";"18i";"Cn1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"20.2";"nM";"7.70";"";"";"UO_0000065";"14.75";"0.27";"3.20";"5.71";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4216609";"";"None";"497.53";"0";"4.02";"18f";"Cn1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"18.89";"0.35";"5.38";"7.59";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4226237";"";"None";"402.46";"0";"2.19";"8a";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"7.95";"nM";"8.10";"";"";"UO_0000065";"20.13";"0.37";"5.91";"8.17";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4228608";"";"None";"400.49";"0";"2.74";"8d";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCCc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"15.9";"nM";"7.80";"";"";"UO_0000065";"19.47";"0.36";"5.06";"8.67";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4225403";"";"None";"416.49";"0";"2.50";"8g";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3C)c3c(N)ncnc32)C1";"IC50";"'='";"49.23";"nM";"7.31";"";"";"UO_0000065";"17.55";"0.32";"4.81";"7.37";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4227235";"";"None";"416.49";"0";"2.50";"8i";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3ccc(C)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"26.89";"nM";"7.57";"";"";"UO_0000065";"18.18";"0.33";"5.07";"7.63";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4227934";"";"None";"432.48";"0";"2.20";"8k";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3cccc(OC)c3)c3c(N)ncnc32)C1";"IC50";"'='";"9.84";"nM";"8.01";"";"";"UO_0000065";"18.51";"0.34";"5.81";"7.39";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4224855";"";"None";"432.48";"0";"2.20";"8l";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3ccc(OC)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"89.62";"nM";"7.05";"";"";"UO_0000065";"16.30";"0.30";"4.85";"6.50";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4210081";"";"None";"560.68";"2";"4.20";"3e";"CC(C)(C)c1cnc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)s1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"9.99";"0.19";"1.40";"3.70";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217295";"";"None";"581.65";"1";"4.41";"3l";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(N3CCc4cc(C5CC5)cc(F)c4C3=O)c2CO)n1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"12.30";"0.23";"2.74";"5.52";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217816";"";"None";"579.64";"1";"4.51";"3m";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.40";"0.25";"3.26";"5.91";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4203192";"";"None";"548.58";"1";"4.69";"4h";"N#Cc1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1C1CC1";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"14.66";"0.27";"3.35";"5.45";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4205287";"";"None";"539.64";"1";"4.57";"3b";"CC(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)cc1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"15.94";"0.29";"4.03";"6.21";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209441";"SOFNOBRUTINIB";"2.0";"498.52";"0";"3.41";"4b";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"18.87";"0.35";"6.00";"6.88";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4208062";"";"None";"550.60";"1";"4.93";"4g";"CC(C)n1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"0.53";"nM";"9.28";"";"";"UO_0000065";"16.85";"0.31";"4.35";"6.28";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4203192";"";"None";"548.58";"1";"4.69";"4h";"N#Cc1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1C1CC1";"IC50";"'='";"0.86";"nM";"9.07";"";"";"UO_0000065";"16.53";"0.30";"4.38";"6.14";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3685419";"";"None";"454.54";"0";"3.64";"BDBM120742";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3n[nH]cc23)c1";"IC50";"'='";"187.0";"nM";"6.73";"";"248799";"UO_0000065";"14.80";"0.27";"3.09";"6.59";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3944305";"";"None";"327.75";"0";"3.98";"BDBM195837";"CC#CC(=O)Nc1cc(-c2cnc3[nH]cc(Cl)c3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348541";"UO_0000065";"18.71";"0.36";"2.15";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3943435";"";"None";"428.51";"1";"5.40";"BDBM195904";"Cc1cccc(-c2c[nH]c3ncc(-c4cccc(NC(=O)/C=C/CN(C)C)c4)cc23)c1F";"IC50";"'='";"7558.0";"nM";"5.12";"";"348549";"UO_0000065";"11.95";"0.22";"-0.28";"8.39";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3921295";"";"None";"354.84";"0";"3.94";"BDBM195908";"CN(C)C/C=C/C(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1";"IC50";"'='";"7558.0";"nM";"5.12";"";"348553";"UO_0000065";"14.43";"0.28";"1.18";"8.39";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3670084";"";"None";"580.69";"1";"3.86";"BDBM111941";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCOCC3)cn2)c1=O";"IC50";"'='";"10.1";"nM";"8.00";"";"232996";"UO_0000065";"13.77";"0.25";"4.14";"7.63";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670112";"";"None";"582.68";"1";"4.15";"BDBM111971";"CN1CCc2cc(Nc3nc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)ccc2C1";"IC50";"'='";"8.1";"nM";"8.09";"";"233026";"UO_0000065";"13.89";"0.26";"3.94";"8.46";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670098";"";"None";"617.75";"1";"4.91";"BDBM111956";"CN(C)CCOc1ccc(Nc2cc(-c3cc(F)cc(N4CCc5c(sc6c5CCCC6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"2.0";"nM";"8.70";"";"233011";"UO_0000065";"14.08";"0.27";"3.79";"8.71";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670105";"";"None";"530.60";"1";"4.05";"BDBM111964";"Cc1cc(Nc2cc(-c3cc(F)cc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)[nH]n1";"IC50";"'='";"2.2";"nM";"8.66";"";"233019";"UO_0000065";"16.32";"0.30";"4.61";"8.00";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670111";"";"None";"610.73";"1";"4.97";"BDBM111970";"CN1CCC(c2ccc(Nc3nc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)cc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"233025";"UO_0000065";"13.75";"0.25";"3.43";"8.78";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4557720";"";"None";"437.46";"0";"4.93";"6e";"C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5ccc(OC)nc5)cc4c32)c1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"16.22";"0.29";"2.17";"8.22";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"20.78";"0.38";"4.93";"9.23";"1";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"14.91";"0.27";"4.29";"9.46";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3622189";"";"None";"563.63";"2";"5.17";"5";"Cc1c(NC(=O)c2ccc(F)cc2)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.73";"0.27";"3.13";"7.44";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4467132";"";"None";"520.56";"2";"5.46";"19";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2cc(F)ccc2c1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.71";"0.30";"3.24";"7.63";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4439761";"";"None";"489.58";"1";"5.78";"13";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1N1Cc2ccccc2C1=O";"IC50";"'='";"154.0";"nM";"6.81";"";"";"UO_0000065";"13.91";"0.25";"1.03";"6.85";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4465380";"";"None";"503.60";"2";"5.83";"15";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1N1CCc2ccccc2C1=O";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.06";"0.27";"1.76";"7.63";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3939772";"";"None";"488.55";"1";"5.01";"22";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3)c12";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"13.07";"0.24";"1.38";"5.60";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3924792";"";"None";"604.50";"2";"6.56";"BDBM197177";"[C-]#[N+]/C(=C\C1CC1)C(=O)N1CCC(n2nc(-c3ccc(Oc4ccc(Cl)c(Cl)c4)c(OC)c3)c3c(N)ncnc32)CC1";"IC50";"'='";"365.0";"nM";"6.44";"";"350371";"UO_0000065";"10.65";"0.21";"-0.12";"5.71";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114674";"";"None";"526.69";"2";"5.53";"BDBM197201";"CC(C)(C)/C=C(\C#N)C(=O)N1CCC(Cc2[nH]c(C3CCC(Oc4ccccc4)CC3)c3c(N)ncnc23)C1";"IC50";"'='";"17.0";"nM";"7.77";"";"350373";"UO_0000065";"14.75";"0.27";"2.24";"6.43";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114730";"";"None";"518.62";"2";"5.63";"BDBM197226";"Cc1c(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc2n1C[C@H]1CCCN1C(=O)/C(C#N)=C/C1CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"350383";"UO_0000065";"14.43";"0.26";"1.85";"6.80";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3959434";"";"None";"580.67";"1";"4.98";"BDBM197216";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)NC1CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"350394";"UO_0000065";"13.64";"0.25";"2.94";"5.87";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3902317";"";"None";"568.66";"1";"4.79";"BDBM197248";"CN(C)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"0.4";"nM";"9.40";"";"350396";"UO_0000065";"16.53";"0.31";"4.61";"7.45";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114712";"";"None";"519.61";"2";"5.33";"BDBM197189";"N#C/C(=C\C1CC1)C(=O)NC1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"350419";"UO_0000065";"15.11";"0.28";"2.52";"5.96";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114718";"";"None";"558.59";"1";"4.68";"BDBM197230";"[C-]#[N+]/C(=C\C(C)(C)N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3)cc2F)c2c(N)ncnc21";"IC50";"'='";"1.6";"nM";"8.80";"";"350436";"UO_0000065";"15.75";"0.29";"4.12";"6.79";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4556666";"";"None";"499.49";"0";"3.99";"9g";"NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/CF)C2)c1N";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"14.11";"0.27";"3.06";"6.05";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4548556";"";"None";"481.50";"0";"4.04";"9d";"C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"14.91";"0.28";"3.14";"6.17";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4469663";"";"None";"437.89";"0";"3.19";"20a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cn4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"18.74";"0.36";"5.02";"6.03";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4456974";"";"None";"471.44";"0";"3.56";"20b";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(C(F)(F)F)n4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"15.65";"0.30";"3.82";"5.42";"0";"CHEMBL4385494";"Inhibition of BTK in human whole blood assessed as reduction in anti-human IgE antibody-stimulated histamine release pretreated for 2 hrs followed by anti-human IgE antibody-stimulation and measured after 30 mins by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4456283";"";"None";"436.90";"0";"3.79";"10";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"16.79";"0.32";"3.55";"5.96";"0";"CHEMBL4385495";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 1 hr followed by goat anti-human IgM F(ab')2-stimualtion and measured after 3 hrs by Fix/Lyse reagent based flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4798274";"";"None";"454.53";"0";"4.29";"B35";"C=CC(=O)N1CCC(Cn2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"2460.0";"nM";"5.61";"";"";"UO_0000065";"12.34";"0.23";"1.32";"5.66";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL5196444";"";"None";"563.71";"2";"5.66";"6; CTN06";"CC(C)Cc1nc2cc3c(cc2[nH]c1=O)nc(NC(=O)c1ccc(-c2ccncc2)cc1)n3CCCN1CCCCC1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"12.95";"0.24";"1.64";"6.71";"0";"CHEMBL5128189";"Inhibition of N-terminal His6-tagged human full length recombinant BTK expressed in baculovirus infected Sf21 insect cells using YIYGSFK as substrate preincubated for 5 mins followed by 33p-labeled ATP addition and measured after 1 hr by thin layer chromatography";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126539";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.083 hr";"INHIBITOR";""
"CHEMBL4206765";"";"None";"499.60";"0";"4.45";"97";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cc[nH]c(=O)c4)s3)nc3ccccc31)C2";"IC50";"'='";"0.33";"nM";"9.48";"";"";"UO_0000065";"18.98";"0.36";"5.03";"9.47";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3936156";"";"None";"571.01";"2";"5.41";"11";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"15.62";"0.30";"3.51";"6.66";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4856592";"";"None";"483.53";"0";"3.57";"19f";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"16.95";"0.31";"4.62";"7.13";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4875332";"";"None";"439.48";"0";"3.17";"27a";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)C1";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"19.43";"0.35";"5.37";"8.08";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4874095";"";"None";"471.49";"0";"3.70";"26b";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)C1";"IC50";"'='";"1109.0";"nM";"5.96";"";"";"UO_0000065";"12.63";"0.23";"2.26";"5.63";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4849585";"";"None";"457.47";"0";"3.31";"27c";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5F)cc4)[nH]c23)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"19.06";"0.35";"5.41";"8.25";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4856664";"";"None";"445.45";"0";"3.47";"28b";"C=CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)C1";"IC50";"'='";"772.0";"nM";"6.11";"";"";"UO_0000065";"13.72";"0.25";"2.64";"5.78";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4649352";"";"None";"338.41";"0";"1.60";"4e";"C#CC(=O)N[C@@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"26.16";"0.48";"7.25";"9.71";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4634162";"";"None";"338.41";"0";"1.60";"4f";"C#CC(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"29.12";"0.54";"8.25";"10.80";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4641586";"";"None";"376.48";"0";"1.92";"4c";"C=CS(=O)(=O)N[C@@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"20.06";"0.40";"5.63";"6.97";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4642103";"";"None";"362.46";"0";"1.53";"4i";"C=CS(=O)(=O)NC1CCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"18.68";"0.37";"5.24";"6.25";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4639665";"";"None";"455.21";"None";"None";"14f";"C=CC(=O)Nc1cccc(Nc2nc(Nc3cccc4c3B(O)OC4)ncc2C(F)(F)F)c1";"IC50";"'='";"267.8";"nM";"6.57";"";"";"UO_0000065";"14.44";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4859613";"";"None";"485.52";"0";"4.09";"18b";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"433.0";"nM";"6.36";"";"";"UO_0000065";"13.11";"0.24";"2.27";"6.02";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4871737";"";"None";"453.50";"0";"3.56";"26a";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)C1";"IC50";"'='";"349.0";"nM";"6.46";"";"";"UO_0000065";"14.24";"0.26";"2.90";"6.11";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4649284";"";"None";"324.38";"0";"1.53";"4m";"C#CC(=O)N1CC[C@H](Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"26.57";"0.49";"7.09";"9.45";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4640731";"";"None";"340.43";"0";"2.47";"4p";"C=CC(=O)N1CCCC(Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"21.24";"0.39";"4.76";"7.92";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4646648";"";"None";"338.41";"0";"1.92";"4o";"C#CC(=O)N1CCC(Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"23.04";"0.43";"5.88";"8.55";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL5276925";"";"None";"479.54";"0";"3.40";"25";"CC#CC(=O)NC1CCC[C@@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"17.77";"0.32";"5.12";"6.70";"0";"CHEMBL5243491";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241118";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4650323";"TOLEBRUTINIB";"3.0";"455.52";"0";"3.91";"8";"C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.76";"0.36";"5.09";"9.44";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5089109";"";"None";"503.65";"1";"4.98";"24";"CC(C)OC1C(C)N(C(=O)NC2CCCCc3cc(-c4ccnc(Nc5cnn(C)c5)n4)ccc32)C1C";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"13.49";"0.25";"1.82";"6.99";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5069979";"";"None";"596.76";"2";"5.14";"2; GDC-0834";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C3CN(C)CC(=O)N3C)cc2)n1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"11.43";"0.22";"1.68";"6.85";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5076817";"";"None";"486.58";"0";"4.50";"38";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)n2)cn1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"15.78";"0.29";"3.18";"6.21";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5083772";"BIIB-091";"2.0";"542.65";"2";"3.04";"51";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(C3COC3)CC[C@H]4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"14.04";"0.26";"4.58";"5.96";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1a";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"200.0";"nM";"";"Potential transcription error";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4616856";"Inhibition of BTK in human whole blood cells after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4112085";"";"None";"523.60";"1";"4.04";"BDBM255257";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(OC5CC5)ccn4)cc3)c12";"IC50";"'='";"0.24";"nM";"9.62";"";"445161";"UO_0000065";"18.37";"0.34";"5.58";"7.53";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3953056";"";"None";"537.50";"1";"4.34";"BDBM255253";"Nc1nccn2c([C@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"5.5";"nM";"8.26";"";"445157";"UO_0000065";"15.37";"0.29";"3.92";"6.47";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108579";"";"None";"594.60";"1";"3.03";"BDBM255317";"Nc1nccn2c([C@@H]3CC[C@H]4CN(CCO)CC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.13";"nM";"9.89";"";"445222";"UO_0000065";"16.63";"0.31";"6.86";"6.96";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109744";"";"None";"551.53";"1";"3.48";"BDBM255319";"Nc1nccn2c([C@@H]3CC[C@H]4C[C@H](O)C(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.081";"nM";"10.09";"";"445224";"UO_0000065";"18.30";"0.34";"6.61";"7.27";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3962290";"";"None";"596.74";"2";"5.71";"BDBM202089";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(-n6ccc7cc(C8CC8)ccc7c6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"358167";"UO_0000065";"13.67";"0.25";"2.44";"9.03";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950770";"";"None";"614.75";"2";"5.45";"BDBM202101";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"358179";"UO_0000065";"13.27";"0.24";"2.70";"8.34";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967820";"";"None";"603.72";"2";"6.37";"BDBM202126";"CC1(O)CCC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)CC1";"IC50";"'='";"3.8";"nM";"8.42";"";"358204";"UO_0000065";"13.95";"0.26";"2.05";"7.23";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4752442";"";"None";"492.56";"0";"3.27";"20";"C=CS(=O)(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"17.01";"0.33";"5.11";"6.15";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4874730";"";"None";"512.61";"1";"4.04";"17a";"CN(C)C/C=C/C(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"41.8";"nM";"7.38";"";"";"UO_0000065";"14.39";"0.27";"3.34";"6.77";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4872521";"";"None";"482.54";"0";"3.14";"24a";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)n(N)c23)CC1";"IC50";"'='";"676.0";"nM";"6.17";"";"";"UO_0000065";"12.79";"0.23";"3.03";"5.10";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4857353";"";"None";"489.48";"0";"3.84";"19e";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5F)cc4)[nH]c23)CC1";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"16.75";"0.31";"4.36";"7.76";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4846339";"";"None";"485.54";"0";"4.12";"12g";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5OC)cc4)[nH]c23)CC1";"IC50";"'='";"61.9";"nM";"7.21";"";"";"UO_0000065";"14.85";"0.27";"3.09";"6.27";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4107402";"";"None";"471.56";"0";"4.22";"31b";"C=CC(=O)N1CCC([C@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"16.88";"0.31";"3.74";"7.77";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3965549";"";"None";"443.51";"0";"3.44";"32";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"0.53";"nM";"9.28";"";"";"UO_0000065";"20.91";"0.38";"5.84";"9.05";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3977729";"";"None";"417.47";"0";"3.10";"33a";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"21.67";"0.40";"5.95";"8.13";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3977729";"";"None";"417.47";"0";"3.10";"33a";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.24";"nM";"9.62";"";"";"UO_0000065";"23.04";"0.42";"6.52";"8.65";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3944698";"";"None";"443.51";"0";"3.63";"34";"C=CC(=O)NC1(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"19.07";"0.35";"4.83";"7.60";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3916800";"";"None";"445.52";"0";"3.88";"35";"C=CC(=O)NC(C)(C)C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"16.58";"0.31";"3.51";"6.64";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3969103";"";"None";"439.52";"0";"4.89";"21-int";"CNc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.65";"0.25";"1.11";"6.37";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3924160";"";"None";"463.50";"1";"5.01";"13";"C=CC(=O)Nc1cccc(-c2c[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.47";"0.32";"3.09";"7.07";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3890068";"";"None";"461.52";"0";"3.20";"24";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCCOC)cc3)nn21";"IC50";"'='";"16.7";"nM";"7.78";"";"";"UO_0000065";"16.85";"0.31";"4.58";"6.45";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3910697";"";"None";"421.89";"0";"3.83";"29a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)cc3)nn21";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"19.86";"0.38";"4.55";"8.21";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"";"UO_0000065";"20.75";"0.38";"4.92";"9.22";"1";"CHEMBL4724374";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715884";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"1";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.72";"0.27";"2.08";"6.49";"1";"CHEMBL4672871";"Inhibition of BTK in human peripheral B cells assessed as reduction in anti-IgM/IgG-induced CD86 surface expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"B cell";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4863853";"";"None";"451.55";"0";"4.25";"9";"CC(C)Oc1ccc(N2C(=O)Nc3c(C(=O)N[C@@H]4CCCNC4)sc4nccc2c34)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"12.08";"0.23";"1.21";"5.71";"0";"CHEMBL4818905";"Binding affinity to recombinant unphosphorylated human GST-tagged BTK kinase domain (389 to 659 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4814076";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4762397";"";"None";"481.60";"1";"5.63";"4";"C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)c12";"IC50";"'='";"934.0";"nM";"6.03";"";"";"UO_0000065";"12.52";"0.23";"0.40";"6.63";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4110644";"";"None";"551.53";"1";"4.73";"24B";"C[C@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"13.06";"0.25";"2.47";"5.64";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4757041";"";"None";"582.56";"1";"3.80";"32";"CN1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)CC[C@H]2C1";"IC50";"'='";"104.0";"nM";"6.98";"";"";"UO_0000065";"11.99";"0.23";"3.18";"5.74";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4849446";"";"None";"478.60";"1";"5.56";"3";"Cc1cc(-c2ccnc3[nH]c(-c4cnn(C)c4)nc23)ccc1CNC(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"18.57";"0.34";"3.33";"10.04";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4214322";"";"None";"458.95";"1";"5.89";"9";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(Cl)c4)cc3)c3cnccc32)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"17.43";"0.33";"2.11";"13.28";"0";"CHEMBL4194325";"Inhibition of BTK (unknown origin) using peptide substrate after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190358";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4645126";"";"None";"516.55";"2";"5.93";"52";"C=CC(=O)NCCOc1cc(Cc2ccc(OC)cc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"13.75";"0.26";"1.17";"7.72";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4226239";"";"None";"386.46";"0";"2.35";"8c";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"102.4";"nM";"6.99";"";"";"UO_0000065";"18.09";"0.33";"4.64";"7.77";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4227768";"";"None";"401.47";"0";"2.22";"8e";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCNc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"18.1";"nM";"7.74";"";"";"UO_0000065";"19.28";"0.35";"5.52";"7.59";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4225882";"";"None";"418.53";"0";"2.90";"8f";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCSc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"10.95";"nM";"7.96";"";"";"UO_0000065";"19.02";"0.36";"5.06";"8.85";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4228138";"";"None";"444.54";"0";"3.31";"8o";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3cccc(C(C)C)c3)c3c(N)ncnc32)C1";"IC50";"'='";"45.35";"nM";"7.34";"";"";"UO_0000065";"16.52";"0.30";"4.03";"7.41";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4791140";"";"None";"458.59";"1";"5.27";"15";"Cc1cc(-c2ccnc(Nc3ccccn3)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"16.34";"0.31";"2.22";"8.09";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4749757";"";"None";"462.58";"0";"4.01";"22";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)c1nnc(C(C)(C)C)s1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.81";"0.36";"4.69";"7.87";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4760128";"";"None";"446.60";"1";"5.01";"23";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)C1CCC(C(C)(C)C)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.48";"0.36";"3.69";"10.27";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5087628";"";"None";"162.15";"0";"0.16";"8";"O=c1[nH]nc(-c2cccnc2)[nH]1";"IC50";"'='";"125892.54";"nM";"3.90";"";"";"UO_0000065";"24.05";"0.44";"3.74";"5.24";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5094686";"";"None";"242.24";"0";"1.32";"16";"COc1nc(-c2n[nH]c(=O)[nH]2)cc2ccccc12";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"26.42";"0.49";"5.08";"7.65";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3965549";"";"None";"443.51";"0";"3.44";"32a";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"19.83";"0.36";"5.36";"8.58";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3948065";"";"None";"437.46";"0";"4.50";"6";"C=CC(=O)Nc1ccc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2c1";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"21.70";"0.39";"4.99";"8.29";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3926191";"";"None";"417.47";"0";"3.19";"25a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC)cc3)nn21";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"20.89";"0.38";"5.53";"7.84";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3977729";"";"None";"417.47";"0";"3.10";"33";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"19.06";"0.35";"4.86";"7.15";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3899411";"";"None";"575.60";"1";"4.64";"BDBM230093";"Cc1c(-c2c(C#N)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"401950";"UO_0000065";"15.64";"0.29";"4.36";"6.13";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931086";"";"None";"564.62";"2";"5.07";"BDBM230105";"Cc1cc(C(N)=O)c2[nH]c3cc(C(C)(C)O)ccc3c2c1-c1cccc(-n2c(=O)c3cccc(F)c3n(C)c2=O)c1C";"IC50";"'='";"0.66";"nM";"9.18";"";"401964";"UO_0000065";"16.26";"0.30";"4.11";"7.46";"1";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"BDBM230107";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.55";"nM";"9.26";"";"401967";"UO_0000065";"15.76";"0.31";"3.57";"7.55";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3944101";"";"None";"571.01";"2";"5.18";"BDBM230108";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.85";"nM";"9.07";"";"401969";"UO_0000065";"15.89";"0.30";"3.89";"7.40";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912426";"";"None";"589.00";"2";"5.25";"BDBM230117";"Cn1c(=O)n(-c2cccc(-c3c(F)cc(C(N)=O)c4[nH]c5cc(C(C)(C)O)ccc5c34)c2Cl)c(=O)c2cccc(F)c21";"IC50";"'='";"1.5";"nM";"8.82";"";"401981";"UO_0000065";"14.98";"0.29";"3.57";"7.17";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931858";"";"None";"527.63";"1";"3.51";"BDBM191609";"CN(C/C=C/C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1)CCO";"IC50";"'='";"21.0";"nM";"7.68";"";"385037";"UO_0000065";"14.55";"0.27";"4.17";"6.26";"0";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4210857";"";"None";"538.70";"2";"5.42";"19";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C#N)cc3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2";"IC50";"'='";"1.34";"nM";"8.87";"";"";"UO_0000065";"16.47";"0.30";"3.45";"8.61";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4218914";"";"None";"555.65";"1";"4.86";"27";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C(F)F)s3)nc3cc(CN4CCOCC4)ccc31)C2";"IC50";"'='";"2.59";"nM";"8.59";"";"";"UO_0000065";"15.45";"0.30";"3.73";"10.77";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4216187";"";"None";"502.60";"1";"4.79";"50";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(NC)ccc31)C2";"IC50";"'='";"0.62";"nM";"9.21";"";"";"UO_0000065";"18.32";"0.35";"4.42";"8.74";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3903690";"";"None";"489.89";"0";"4.85";"BDBM250040";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(C(F)(F)F)c(Cl)c3)nn21";"IC50";"'='";"2.1";"nM";"8.68";"";"435969";"UO_0000065";"17.71";"0.35";"3.83";"8.50";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979645";"";"None";"508.02";"1";"4.67";"BDBM250055";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC[C@H]2C1CCN(C(=O)CCCl)CC1";"IC50";"'='";"5.7";"nM";"8.24";"";"435984";"UO_0000065";"16.23";"0.31";"3.57";"8.04";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968870";"";"None";"429.48";"0";"2.94";"BDBM250060";"CC#CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"4.3";"nM";"8.37";"";"435992";"UO_0000065";"19.48";"0.36";"5.43";"7.52";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3685424";"";"None";"453.91";"0";"4.64";"BDBM120747";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)c(F)c3)ncc2Cl)c1";"IC50";"'='";"518.0";"nM";"6.29";"";"248804";"UO_0000065";"13.85";"0.27";"1.65";"7.92";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3685428";"";"None";"294.14";"0";"3.57";"BDBM120751";"C=CC(=O)Nc1cccc(-c2nc(Cl)ncc2Cl)c1";"IC50";"'='";"14400.0";"nM";"4.84";"";"248808";"UO_0000065";"16.46";"0.35";"1.27";"8.82";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3685418";"";"None";"441.50";"0";"3.72";"BDBM120741";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)nc3n[nH]cc23)c1";"IC50";"'='";"45.0";"nM";"7.35";"";"248810";"UO_0000065";"16.64";"0.30";"3.63";"6.80";"0";"CHEMBL3705216";"Time Resolved-FRET Assay: Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay. Test compound are diluted to desired concentrations in kinase reaction buffer and briefly incubated with BTK kinase (as described above; Invitrogen). The reaction is initiated by the addition of ATP and enzyme substrate, HTRF® KinEASE-TK Substrate-biotin (Cisbio US, Bedford, Mass.). The composition of the reaction (10 μl) was: 1% v/v DMSO, 10 nM BTK, 60 μM ATP, and 1 μM substrate. After incubation at room temperature for 60 min, the enzyme reaction is stopped by EDTA-containing buffer, which also contains europium-labeled (Eu3+-Cryptate) anti-phosphotyrosine antibody (Cisbio) and Streptavidin-XL665 (Cisbio). The europium-labeled antibody generates a time-resolved FRET signal with the Stepavidin-XL665, which binds to the biotinylated TK substrate through the streptavidin conjugate when the substrate is phosphorylated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3924160";"";"None";"463.50";"1";"5.01";"13";"C=CC(=O)Nc1cccc(-c2c[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)c1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"18.49";"0.33";"3.56";"7.48";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3925102";"";"None";"455.52";"0";"4.11";"16";"C=CC(=O)N1CCC(c2c[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)CC1";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"21.70";"0.40";"5.78";"9.35";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3910697";"";"None";"421.89";"0";"3.83";"29";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)cc3)nn21";"IC50";"'='";"0.78";"nM";"9.11";"";"";"UO_0000065";"21.59";"0.41";"5.28";"8.93";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3965549";"";"None";"443.51";"0";"3.44";"32b";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"20.04";"0.37";"5.45";"8.67";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4436086";"";"None";"462.30";"1";"5.74";"9b";"Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1";"IC50";"'='";"287.0";"nM";"6.54";"";"";"UO_0000065";"14.15";"0.30";"0.80";"8.55";"0";"CHEMBL4412233";"Inhibition of BTK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411283";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL1421";"DASATINIB";"4.0";"488.02";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"17.46";"0.35";"5.21";"8.00";"0";"CHEMBL4412233";"Inhibition of BTK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411283";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3923793";"";"None";"487.61";"0";"4.28";"BDBM250519";"Cn1cc(Nc2nc(NC3CCCC(NC(=O)c4ccc(C(C)(C)C)cc4)C3)c3nc[nH]c3n2)cn1";"IC50";"'='";"56.94";"nM";"7.25";"";"436767";"UO_0000065";"14.86";"0.27";"2.96";"5.78";"0";"CHEMBL3889150";"FRET (Forster/Flouresence Resonance Energy Transfer) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 ul of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission). The negative control well values were averaged to obtain the mean minimum. The positive 'no inhibitor' control wells were averaged to obtain the mean maximum.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886966";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918168";"";"None";"489.60";"0";"4.84";"BDBM195782";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3n2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348519";"UO_0000065";"12.52";"0.24";"1.29";"5.67";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3912580";"";"None";"651.75";"1";"4.56";"BDBM143213";"CC(=O)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"1.9";"nM";"8.72";"";"279427";"UO_0000065";"13.38";"0.25";"4.16";"5.95";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647524";"";"None";"453.51";"0";"3.61";"BDBM143326";"C=CC(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)cn4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"279486";"UO_0000065";"19.40";"0.35";"5.19";"7.85";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3685419";"";"None";"454.54";"0";"3.64";"BDBM120742";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3n[nH]cc23)c1";"IC50";"'='";"562.0";"nM";"6.25";"";"248811";"UO_0000065";"13.75";"0.25";"2.61";"6.12";"0";"CHEMBL3705216";"Time Resolved-FRET Assay: Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay. Test compound are diluted to desired concentrations in kinase reaction buffer and briefly incubated with BTK kinase (as described above; Invitrogen). The reaction is initiated by the addition of ATP and enzyme substrate, HTRF® KinEASE-TK Substrate-biotin (Cisbio US, Bedford, Mass.). The composition of the reaction (10 μl) was: 1% v/v DMSO, 10 nM BTK, 60 μM ATP, and 1 μM substrate. After incubation at room temperature for 60 min, the enzyme reaction is stopped by EDTA-containing buffer, which also contains europium-labeled (Eu3+-Cryptate) anti-phosphotyrosine antibody (Cisbio) and Streptavidin-XL665 (Cisbio). The europium-labeled antibody generates a time-resolved FRET signal with the Stepavidin-XL665, which binds to the biotinylated TK substrate through the streptavidin conjugate when the substrate is phosphorylated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1000.0";"nM";"";"Potential transcription error";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4611177";"Inhibition of BTK C481S mutant (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3402357";"";"None";"366.47";"0";"2.64";"31";"CC(=O)Nc1cccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)c1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"14.54";"0.27";"2.69";"8.24";"0";"CHEMBL3407012";"Inhibition of biotinylated and unactivated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3685426";"";"None";"448.96";"0";"4.42";"BDBM120749";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)c1";"IC50";"'='";"1270.0";"nM";"5.90";"";"248806";"UO_0000065";"13.13";"0.25";"1.48";"8.03";"0";"CHEMBL3705215";"ADP Generation Assay: The primary assay for compound inhibitory activity was the ADP generation assay described herein. Test compounds were diluted to desired concentrations in kinase reaction buffer and briefly incubated with recombinant full-length human BTK kinase with a (His)6 tag (81.3 kDa; Invitrogen Corporation, Carlsbad, Calif.). The assay as described is based on volumes used in a standard 384 well format using solid, white-wall plates. The reaction was subsequently initiated by the addition of ATP and myelin basic protein (MBP) substrate (Millipore Corporation, Waltham, Mass.). Composition of the assay reaction mixture (5 mL volume) was: 5% v/v DMSO, 60 nM BTK, 1.6 μM ATP, and 20 μM MBP substrate. After incubation at room temperature for 60 min, 5 mL of the ADP-Glo reagent (Promega Corporation, Madison, Wis.) was added to each well and incubated for an additional 40 minutes.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4644905";"";"None";"422.44";"0";"4.86";"32";"C=CC(=O)NC1(COc2cccc3[nH]c(-c4n[nH]c5cc(C(F)F)ccc45)cc23)CC1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"17.39";"0.32";"2.49";"8.87";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5g";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"16.27";"0.31";"3.96";"7.34";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"21.97";"0.40";"5.46";"9.76";"0";"CHEMBL4326800";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325851";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4448630";"";"None";"446.94";"1";"5.64";"35";"O=C(Nc1ccc(Cl)cc1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"12.62";"0.24";"0.00";"6.56";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4445344";"";"None";"446.94";"1";"5.64";"34";"O=C(Nc1cccc(Cl)c1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"12.85";"0.25";"0.10";"6.68";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4461799";"";"None";"436.52";"0";"4.70";"26";"N#C/N=C(\Nc1ccccc1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"68000.0";"nM";"4.17";"";"";"UO_0000065";"9.55";"0.17";"-0.53";"3.97";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4552458";"";"None";"412.50";"0";"4.99";"13";"O=C(Nc1ccccc1)Nc1cccc([C@@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"15.51";"0.28";"1.41";"7.44";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4850816";"";"None";"480.53";"0";"3.63";"1";"CNC(=O)[C@H]1Cc2c([nH]c3ccccc23)CN1C(=O)c1occc1CNc1ccc2nccnc2c1";"IC50";"'='";"3.78";"nM";"8.42";"";"";"UO_0000065";"17.53";"0.32";"4.79";"7.25";"0";"CHEMBL4813334";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3355052";"";"None";"423.45";"0";"3.62";"I-25";"C=CC(=O)Nc1cccc(Nc2nc(N(C)c3ccc(OCCO)cc3)ncc2F)c1";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"16.52";"0.31";"3.38";"7.02";"0";"CHEMBL3379054";"Inhibition of BTK (unknown origin) by Omnia continuous read kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351331";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3702827";"";"None";"553.60";"1";"4.66";"BDBM143176";"CC1(/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)COC1";"IC50";"'='";"3.1";"nM";"8.51";"";"369500";"UO_0000065";"15.37";"0.28";"3.85";"6.44";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702830";"";"None";"623.74";"1";"5.00";"BDBM143179";"[C-]#[N+]/C(=C\C(C)(C)N1CCN(C)CC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.3";"nM";"9.52";"";"369503";"UO_0000065";"15.27";"0.28";"4.52";"8.66";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702845";"";"None";"622.70";"1";"4.73";"BDBM143199";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CC2(COC2)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"369519";"UO_0000065";"14.17";"0.26";"4.09";"6.52";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702846";"";"None";"622.70";"1";"4.56";"BDBM208976";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CC2(COC2)C1";"IC50";"'='";"5.6";"nM";"8.25";"";"369520";"UO_0000065";"13.25";"0.24";"3.69";"6.09";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966494";"";"None";"468.57";"0";"3.83";"10d";"C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(CC)CC5)cc4)nc32)c1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.85";"0.36";"5.47";"10.20";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4519813";"";"None";"438.51";"0";"1.95";"9h";"C=CS(=O)(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"19.10";"0.37";"6.43";"7.21";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4443849";"";"None";"317.35";"0";"2.77";"7";"Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)cnc12";"IC50";"'='";"72.8";"nM";"7.14";"";"";"UO_0000065";"22.49";"0.41";"4.37";"6.45";"0";"CHEMBL4335770";"Reversible inhibition of FAM-labeled peptide binding to full-length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus infected Sf21 insect cells at preincubated for 10 mins followed by FAM-labeled peptide addition and measured by off-chip mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334447";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4210252";"";"None";"564.69";"2";"5.92";"2d";"Cc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)nc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2C)n1";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"9.05";"0.17";"-0.81";"4.67";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4205287";"";"None";"539.64";"1";"4.57";"3b";"CC(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)cc1";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"13.13";"0.24";"2.52";"5.12";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4208482";"";"None";"565.68";"1";"4.65";"3h";"CC(C)(C)c1ccc2c(c1)CN(c1cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c1CO)C2=O";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"10.95";"0.20";"1.54";"4.77";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4214343";"";"None";"484.50";"0";"3.40";"4a";"Nc1nc(Nc2cn[nH]c2)nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)n1";"IC50";"'='";"9.3";"nM";"8.03";"";"";"UO_0000065";"16.58";"0.30";"4.63";"5.44";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4210252";"";"None";"564.69";"2";"5.92";"2d";"Cc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)nc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2C)n1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"13.23";"0.24";"1.55";"6.83";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209148";"";"None";"565.68";"2";"5.20";"2e";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(N)nc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"0.67";"nM";"9.17";"";"";"UO_0000065";"16.22";"0.30";"3.97";"6.78";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209666";"";"None";"540.63";"1";"3.51";"3d";"CN(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)cc1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"15.40";"0.28";"4.82";"5.87";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4208482";"";"None";"565.68";"1";"4.65";"3h";"CC(C)(C)c1ccc2c(c1)CN(c1cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c1CO)C2=O";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"14.89";"0.27";"3.77";"6.49";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209020";"";"None";"562.63";"2";"3.77";"3i";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(-n3ncc4cc(C5CC5)ccc4c3=O)c2CO)n1";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"14.87";"0.27";"4.60";"5.80";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209441";"SOFNOBRUTINIB";"2.0";"498.52";"0";"3.41";"4b";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.22";"0.28";"4.18";"5.55";"0";"CHEMBL4201930";"Inhibition of anti-IgM-stimulated BTK-mediated PLCgamma2 phosphorylation at Tyr1217 in human Ramos cells pre-incubated for 1 hr followed by anti-IgM stimulation for 10 mins by Western blotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5069609";"";"None";"552.57";"1";"4.88";"18f";"C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3F)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"16.57";"0.30";"4.27";"7.61";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4747506";"";"None";"465.52";"0";"3.31";"2; ACP-196";"CC#CC(=O)N1CCC[C@@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"100.9";"nM";"7.00";"";"";"UO_0000065";"15.03";"0.27";"3.69";"5.90";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4744271";"";"None";"523.61";"2";"6.09";"11";"C=CC(=O)N1CCCC(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)C1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"9.73";"0.18";"-0.99";"5.60";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4749522";"";"None";"604.73";"2";"6.47";"14";"Cc1c(NC(=O)c2ccc(C3CC3)cc2)cc(F)cc1-c1ncnc2[nH]cc(C3=CCN(C(=O)/C=C/CN4CCCC4)CC3)c12";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"12.54";"0.23";"1.12";"8.05";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4789435";"";"None";"535.62";"2";"6.39";"15";"C/C=C/C(=O)N1CC=C(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)CC1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"13.41";"0.25";"0.79";"7.89";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4566818";"";"None";"586.74";"2";"6.54";"3";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(-c3ccc(C(=O)N4CCN(C)CC4)cc3)cc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"13.44";"0.24";"1.35";"8.37";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4593663";"";"None";"521.60";"2";"6.00";"13";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)CC1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"17.34";"0.32";"3.05";"9.94";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4741884";"";"None";"518.57";"1";"4.39";"5b";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2ccccn2c1=O";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"12.32";"0.22";"2.00";"5.21";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL4755174";"";"None";"543.60";"1";"3.82";"24";"Cc1cccnc1NC(=O)c1ccc(-c2nc([C@@H]3CCCN(C(=O)C4(C)COC4)C3)n3ccnc(N)c23)c(F)c1";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"12.83";"0.24";"3.15";"5.46";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4784093";"";"None";"535.61";"1";"3.57";"29";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5nccs5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"126.0";"nM";"6.90";"";"";"UO_0000065";"12.88";"0.25";"3.33";"5.40";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4757180";"";"None";"585.64";"1";"4.05";"21";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(OC6CC6)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"13.22";"0.25";"3.69";"5.65";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4094125";"";"None";"579.58";"1";"4.39";"1";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.97";"0.26";"3.71";"6.34";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4750989";"";"None";"560.62";"1";"3.44";"30";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5ncc(C#N)s5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.34";"0.24";"3.48";"4.57";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4638609";"";"None";"487.56";"0";"2.63";"21";"Cn1cc(-c2ccnc(N3CCc4c(cc5n4CCCC5)C3=O)c2CO)cc(NC(=O)C2CC2)c1=O";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"14.38";"0.27";"4.38";"6.40";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4649410";"";"None";"503.58";"1";"2.93";"22";"Cn1cc(-c2ccnc(-n3ncc4c5c(sc4c3=O)CCCC5)c2CO)cc(NC(=O)C2CC2)c1=O";"IC50";"'='";"7.7";"nM";"8.11";"";"";"UO_0000065";"16.11";"0.31";"5.18";"6.81";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"6";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"12.99";"0.24";"5.07";"7.14";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4638307";"";"None";"535.55";"1";"3.37";"27";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@H]2F)c1=O";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"12.99";"0.24";"3.59";"5.84";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL460472";"";"None";"539.59";"1";"4.71";"59e, AMG-458";"COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"11.12";"0.20";"1.29";"4.98";"0";"CHEMBL2032465";"Inhibition of BTK";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029218";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4798188";"";"None";"569.56";"2";"5.29";"42";"CCC(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"0.28";"nM";"9.55";"";"";"UO_0000065";"16.77";"0.32";"4.26";"8.06";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4761778";"";"None";"599.59";"1";"4.91";"43";"COCCC(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.51";"0.28";"3.79";"6.81";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4751902";"";"None";"609.61";"1";"4.40";"35";"COc1cc(-c2nc([C@@H]3CCCN(C(=O)C4(C)COC4)C3)n3ccnc(N)c23)ccc1C(=O)Nc1cc(C(F)(F)F)ccn1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"12.01";"0.23";"2.92";"5.34";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4751902";"";"None";"609.61";"1";"4.40";"35";"COc1cc(-c2nc([C@@H]3CCCN(C(=O)C4(C)COC4)C3)n3ccnc(N)c23)ccc1C(=O)Nc1cc(C(F)(F)F)ccn1";"IC50";"'='";"0.98";"nM";"9.01";"";"";"UO_0000065";"14.78";"0.28";"4.61";"6.58";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4757012";"";"None";"544.59";"1";"3.21";"28";"Cc1cnc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)cn1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"14.37";"0.27";"4.61";"5.56";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4587672";"";"None";"455.56";"0";"4.89";"A31";"Nc1ncnc(NCC2CCN(C(=O)C3=CCC3)CC2)c1-c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"14.35";"0.26";"1.65";"7.00";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3910685";"";"None";"604.76";"2";"5.40";"BDBM205243";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)cccc1N1Cc2cc(C(C)(C)C)ccc2C1=O";"IC50";"'='";"29.4";"nM";"7.53";"";"363328";"UO_0000065";"12.45";"0.23";"2.13";"8.30";"0";"CHEMBL3887917";"Biochemical Btk Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2), 0.5 μM Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer, 0.5 μM PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6xHis tag was subcloned into pFastBac vector for making baculovirus carrying this epitope-tagged Btk.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886504";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4238999";"";"None";"444.49";"0";"3.96";"9";"C=CC(=O)N1CC[C@H](Nc2ccc(C(N)=O)c(Oc3ccc(Oc4ccccc4)cc3)n2)C1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"16.64";"0.31";"3.44";"6.93";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3665116";"";"None";"593.69";"1";"4.07";"BDBM111587";"Cc1c(-c2cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c(=O)n(C)c2)cccc1N1CNc2cc(N(C)C)ccc2C1=O";"IC50";"'='";"22.0";"nM";"7.66";"";"232403";"UO_0000065";"12.90";"0.24";"3.59";"6.83";"0";"CHEMBL3705846";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter. Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 um hydrophilic PVDF filter plates (Millipore).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638395";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3657226";"";"None";"385.45";"1";"5.12";"BDBM134231";"Nc1n[nH]c2nc(-c3cccs3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"240.0";"nM";"6.62";"";"267620";"UO_0000065";"17.17";"0.32";"1.50";"7.38";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4094125";"";"None";"579.58";"1";"4.39";"6";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"16.43";"0.31";"5.13";"7.45";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4455094";"";"None";"379.42";"0";"2.05";"17j";"Nc1ncnc2c1c(-c1ccc3c(c1)OCO3)cn2[C@H]1CCN(CC2CO2)C1";"IC50";"'='";"45.5";"nM";"7.34";"";"";"UO_0000065";"19.35";"0.36";"5.29";"8.07";"0";"CHEMBL4347057";"Inhibition of BTK (unknown origin) in the presence of ATP by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346659";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4645440";"";"None";"376.48";"0";"1.92";"4d";"C=CS(=O)(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"24.49";"0.48";"7.30";"8.52";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5a; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"25.71";"0.48";"7.39";"10.44";"0";"CHEMBL4616775";"Inhibition of BTK in human peripheral B cells assessed as reduction in CD86 surface expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4457726";"";"None";"567.59";"2";"5.76";"7a";"NC(=O)c1sc(-c2cccc(NC(=O)c3ccc(C(F)(F)F)cc3)c2)nc1Nc1ccc(N2CCOCC2)cc1";"IC50";"'='";"6754.0";"nM";"5.17";"";"";"UO_0000065";"9.11";"0.18";"-0.59";"4.72";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4446069";"";"None";"568.58";"2";"6.36";"6a";"O=C(Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)c(C(=O)O)s2)c1)c1ccc(C(F)(F)F)cc1";"IC50";"'='";"38109.0";"nM";"4.42";"";"";"UO_0000065";"7.77";"0.15";"-1.94";"4.26";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4097247";"";"None";"569.54";"1";"3.58";"14";"COCCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"12.71";"0.24";"3.66";"5.28";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4069387";"";"None";"569.56";"2";"5.15";"22";"CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"16.86";"0.32";"4.45";"8.10";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4099975";"";"None";"593.61";"1";"4.78";"12";"CC1(C(=O)N2CCCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"13.94";"0.26";"3.50";"6.48";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4753530";"";"None";"462.58";"0";"4.01";"19";"Cc1cc(-c2ccnc(Nc3cn(C)nn3)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"17.29";"0.33";"3.99";"7.24";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4649410";"";"None";"503.58";"1";"2.93";"22";"Cn1cc(-c2ccnc(-n3ncc4c5c(sc4c3=O)CCCC5)c2CO)cc(NC(=O)C2CC2)c1=O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"11.83";"0.23";"3.03";"5.00";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4638562";"";"None";"515.61";"1";"3.26";"13";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)C2CCC2)c1=O";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"15.36";"0.28";"4.66";"7.24";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4646580";"";"None";"531.61";"1";"2.64";"17";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)[C@@H]2CCCO2)c1=O";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"12.22";"0.23";"3.85";"5.47";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4646964";"";"None";"536.54";"1";"2.77";"29";"Cn1nc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"15.46";"0.29";"5.52";"6.28";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3912750";"";"None";"532.53";"1";"4.85";"BDBM246416";"Cn1ncc2c1CCC[C@@H]2c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)nccn12";"IC50";"'='";"740.0";"nM";"6.13";"";"429715";"UO_0000065";"11.51";"0.21";"1.28";"5.28";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3912497";"";"None";"326.41";"0";"2.82";"BDBM250518";"CC1CCCC(Nc2nc(Nc3cnn(C)c3)nc3[nH]cnc23)C1";"IC50";"'='";"40626.4";"nM";"4.39";"";"436766";"UO_0000065";"13.45";"0.25";"1.57";"4.56";"0";"CHEMBL3889150";"FRET (Forster/Flouresence Resonance Energy Transfer) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 ul of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission). The negative control well values were averaged to obtain the mean minimum. The positive 'no inhibitor' control wells were averaged to obtain the mean maximum.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886966";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3652677";"";"None";"564.42";"1";"4.51";"BDBM122438";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5ccc(Br)nc54)c3CO)ncc2c1";"IC50";"'='";"7.74";"nM";"8.11";"";"251018";"UO_0000065";"14.37";"0.30";"3.60";"6.99";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4868393";"";"None";"493.96";"0";"2.90";"22";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccc(Cl)cn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"29.2";"nM";"7.54";"";"";"UO_0000065";"15.25";"0.29";"4.63";"5.05";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4855655";"";"None";"465.54";"0";"2.31";"35";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3nccs3)cc2)c(C(N)=O)n1N";"IC50";"'='";"18.7";"nM";"7.73";"";"";"UO_0000065";"16.60";"0.32";"5.42";"5.18";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"ACP-196";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"23.5";"nM";"7.63";"";"";"UO_0000065";"16.39";"0.30";"4.32";"6.44";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4245727";"";"None";"464.53";"0";"1.28";"2";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"18.94";"0.35";"7.52";"6.77";"1";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4216788";"";"None";"494.56";"0";"3.68";"9";"C=CC(=O)N[C@@H](C)C(=O)NC1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"40.1";"nM";"7.40";"";"";"UO_0000065";"14.96";"0.27";"3.72";"5.96";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3586447";"";"None";"318.34";"0";"2.16";"6";"Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12";"IC50";"'='";"5.6";"nM";"8.25";"";"";"UO_0000065";"25.92";"0.47";"6.09";"6.68";"0";"CHEMBL4335770";"Reversible inhibition of FAM-labeled peptide binding to full-length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus infected Sf21 insect cells at preincubated for 10 mins followed by FAM-labeled peptide addition and measured by off-chip mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334447";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4566818";"";"None";"586.74";"2";"6.54";"7";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(-c3ccc(C(=O)N4CCN(C)CC4)cc3)cc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"13.44";"0.24";"1.35";"8.37";"1";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4576902";"";"None";"519.55";"1";"4.61";"23";"C=CC(=O)N1CC[C@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.98";"0.30";"3.69";"7.52";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3670078";"";"None";"524.63";"1";"3.47";"BDBM111935";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)cccc1N1CCn2c(cc3c2CCCC3)C1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"232990";"UO_0000065";"16.58";"0.30";"5.23";"8.36";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670080";"";"None";"537.65";"1";"4.52";"BDBM111937";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)n(C)n2)cccc1N1Cc2c(sc3ccccc23)C1=O";"IC50";"'='";"3200.0";"nM";"5.50";"";"232992";"UO_0000065";"10.22";"0.19";"0.97";"6.22";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670103";"";"None";"626.73";"1";"4.24";"BDBM111962";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(CN3CCOCC3)cn2)c1=O";"IC50";"'='";"2.34";"nM";"8.63";"";"233017";"UO_0000065";"13.77";"0.26";"4.39";"8.23";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670110";"";"None";"627.79";"2";"5.77";"BDBM111969";"CN1CCC(c2ccc(Nc3nc(-c4cc(F)cc(N5CCc6c(sc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)cc2)CC1";"IC50";"'='";"5.2";"nM";"8.28";"";"233024";"UO_0000065";"13.20";"0.25";"2.51";"9.13";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670117";"";"None";"613.76";"2";"5.73";"BDBM111976";"CN1CCCC1c1ccc(Nc2cc(-c3cc(F)cc(N4CCc5c(sc6c5CCCC6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"2.1";"nM";"8.68";"";"233031";"UO_0000065";"14.14";"0.27";"2.95";"9.57";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4583844";"";"None";"592.70";"2";"6.55";"30x";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4cccc(F)c4)cc3)ncc2F)c1";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"13.77";"0.27";"1.61";"8.14";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4435537";"";"None";"575.70";"2";"5.81";"30ac";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4ccccn4)cc3)ncc2F)c1";"IC50";"'='";"18.5";"nM";"7.73";"";"";"UO_0000065";"13.43";"0.26";"1.92";"6.84";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4466032";"";"None";"576.68";"2";"5.20";"30af";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4cnccn4)cc3)ncc2F)c1";"IC50";"'='";"8.49";"nM";"8.07";"";"";"UO_0000065";"14.00";"0.28";"2.87";"6.41";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3893726";"";"None";"433.48";"0";"3.73";"BDBM249207";"CC(C)(C)c1cc(F)c2c(=O)n(Cc3ccc(-c4cc[nH]c(=O)c4)cc3CO)ncc2c1";"IC50";"'='";"3144.94";"nM";"5.50";"";"434805";"UO_0000065";"12.69";"0.23";"1.77";"6.25";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"2";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"747.0";"nM";"6.13";"";"";"UO_0000065";"13.16";"0.24";"2.82";"5.17";"0";"CHEMBL4358574";"Inhibition of BTK in human basophils assessed as reduction in anti-IgE mouse IgG1 antibody Le2-stimulated CD63 expression on basophil preincubated for 30 mins in presence of IgE antibody B11 followed by anti-IgE mouse IgG1 antibody Le2 stimulation and measured after 15 mins by flow cytometry";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4106978";"";"None";"535.53";"1";"4.51";"BDBM255256";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.1";"nM";"10.00";"";"445160";"UO_0000065";"18.67";"0.35";"5.49";"8.44";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3922212";"";"None";"535.53";"1";"4.51";"BDBM255262";"Nc1nccn2c([C@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"15.3";"nM";"7.82";"";"445167";"UO_0000065";"14.59";"0.27";"3.31";"6.59";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3899763";"";"None";"555.49";"1";"4.48";"BDBM255264";"Nc1nccn2c([C@H]3CC[C@@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"1.3";"nM";"8.89";"";"445169";"UO_0000065";"16.00";"0.30";"4.41";"6.96";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112027";"";"None";"517.54";"1";"4.43";"BDBM255268";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)F)ccn4)cc3)c12";"IC50";"'='";"0.31";"nM";"9.51";"";"445173";"UO_0000065";"18.37";"0.34";"5.08";"8.02";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111650";"";"None";"495.59";"0";"4.06";"BDBM255269";"CCc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)c1";"IC50";"'='";"0.16";"nM";"9.80";"";"445174";"UO_0000065";"19.77";"0.36";"5.74";"8.27";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106497";"";"None";"549.56";"1";"4.82";"BDBM255273";"Cc1cc(-c2nc([C@@H]3CC[C@H]4CCC(=O)N4C3)n3ccnc(N)c23)ccc1C(=O)Nc1cc(C(F)(F)F)ccn1";"IC50";"'='";"0.41";"nM";"9.39";"";"445178";"UO_0000065";"17.08";"0.32";"4.57";"7.92";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108563";"";"None";"553.52";"1";"4.65";"BDBM255274";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.11";"nM";"9.96";"";"445179";"UO_0000065";"17.99";"0.34";"5.31";"8.40";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110290";"";"None";"553.52";"1";"4.65";"BDBM255275";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)c(F)c3)c12";"IC50";"'='";"0.45";"nM";"9.35";"";"445180";"UO_0000065";"16.89";"0.32";"4.70";"7.89";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108885";"";"None";"525.59";"1";"4.51";"BDBM255278";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CC5)ccn4)c(F)c3)c12";"IC50";"'='";"1.1";"nM";"8.96";"";"445183";"UO_0000065";"17.04";"0.31";"4.45";"7.56";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3922148";"";"None";"569.52";"1";"4.87";"BDBM255284";"C[C@@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.17";"nM";"9.77";"";"445189";"UO_0000065";"17.15";"0.33";"4.90";"7.65";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110644";"";"None";"551.53";"1";"4.73";"BDBM255300";"C[C@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.11";"nM";"9.96";"";"445205";"UO_0000065";"18.06";"0.34";"5.23";"7.80";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3905726";"";"None";"564.57";"1";"3.66";"BDBM255302";"CN1CC(=O)N2C[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]2C1";"IC50";"'='";"1.6";"nM";"8.80";"";"445207";"UO_0000065";"15.58";"0.29";"5.14";"7.22";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108593";"";"None";"551.53";"1";"3.48";"BDBM255310";"Nc1nccn2c([C@@H]3CC[C@H]4C[C@@H](O)C(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.13";"nM";"9.89";"";"445215";"UO_0000065";"17.92";"0.34";"6.41";"7.13";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4249247";"";"None";"431.54";"0";"3.61";"20";"C=CC(=O)NCc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"15.52";"0.29";"3.09";"6.19";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4239031";"";"None";"445.56";"0";"4.27";"17";"C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"17.56";"0.32";"3.55";"7.87";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4244928";"";"None";"445.56";"0";"4.63";"13";"C=C(C)C(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"14.67";"0.27";"1.91";"6.04";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4240731";"";"None";"445.56";"0";"4.63";"12";"C/C=C/C(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"14.44";"0.27";"1.80";"5.94";"0";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"BMS-935177; 1";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.09";"0.27";"2.27";"6.65";"1";"CHEMBL4235697";"Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4240879";"";"None";"467.59";"0";"4.00";"18";"C=CS(=O)(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C";"IC50";"'='";"0.079";"nM";"10.10";"";"";"UO_0000065";"21.61";"0.42";"6.10";"8.06";"0";"CHEMBL4235696";"Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229517";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4246563";"";"None";"407.43";"0";"4.92";"16b";"C=CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)cc1";"IC50";"'='";"136.0";"nM";"6.87";"";"";"UO_0000065";"16.85";"0.30";"1.95";"8.90";"0";"CHEMBL4235188";"Inhibition of recombinant full length human N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4077064";"";"None";"447.50";"0";"4.01";"29; QL47";"C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.22";"0.33";"4.14";"11.17";"0";"CHEMBL4271410";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270507";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3647971";"";"None";"454.53";"0";"4.61";"24";"C/C=C/C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"16.94";"0.31";"3.09";"7.76";"1";"CHEMBL4271410";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270507";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL3810269";"";"None";"443.51";"0";"3.67";"I1";"C=CC(=O)N1CCC[C@@H](Nc2ncnc(N)c2C(=O)c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"16.13";"0.30";"3.48";"6.48";"0";"CHEMBL3813051";"Inhibition of BTK (unknown origin) assessed as reduction in phosphorylation of coumarin and fluorescein-labeled FRET peptide substrate incubated for 1 hr by Z-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4167139";"";"None";"521.63";"2";"5.53";"13";"CC(C)(C)/C=C(/C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.10";"0.29";"2.87";"6.83";"0";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"ACP-196; 2";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.31";"0.33";"5.21";"7.19";"1";"CHEMBL4152874";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152198";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3948373";"";"None";"402.43";"0";"3.36";"27";"Nc1ncnc2c1c(-c1cc(F)c3c(c1)NCCO3)nn2C1Cc2ccccc2C1";"IC50";"'='";"104.0";"nM";"6.98";"";"";"UO_0000065";"17.35";"0.32";"3.62";"7.68";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"18.1";"nM";"7.74";"";"";"UO_0000065";"16.60";"0.30";"3.39";"11.15";"0";"CHEMBL4050186";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate in presence of [gamma-32P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4049399";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4463185";"";"None";"541.53";"1";"3.71";"16";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C(C)(C)O)c(F)c3F)c2C)C1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"15.95";"0.30";"4.93";"6.61";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4445790";"";"None";"533.58";"1";"5.00";"20";"C=CC(=O)N1CCC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3F)c2C)CC1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"15.80";"0.30";"3.43";"7.63";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"3";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"16.69";"0.30";"4.84";"7.01";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4450082";"";"None";"499.59";"1";"5.35";"11";"C=CC(=O)N(C)CC/C=C/c1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2)c1C";"IC50";"'='";"223.0";"nM";"6.65";"";"";"UO_0000065";"13.31";"0.25";"1.30";"6.57";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3923573";"";"None";"377.84";"0";"3.77";"17";"Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1Cc2ccccc2C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"20.79";"0.40";"4.08";"8.74";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4215249";"";"None";"435.49";"0";"4.01";"13R";"C=C1c2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2C[C@@H]1NC(=O)C#CC";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"19.48";"0.35";"4.47";"8.92";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4215470";"";"None";"506.57";"1";"3.82";"10";"C=CC(=O)NC1(C(=O)NC2Cn3c(c(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)C2=C)CC1";"IC50";"'='";"23.8";"nM";"7.62";"";"";"UO_0000065";"15.05";"0.27";"3.80";"6.14";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4476232";"";"None";"512.64";"2";"5.19";"30e";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N(C)C)cc3)ncc2F)c1";"IC50";"'='";"1.44";"nM";"8.84";"";"";"UO_0000065";"17.25";"0.35";"3.65";"9.67";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4476311";"";"None";"568.74";"2";"6.75";"30g";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N(CCC)CCC)cc3)ncc2F)c1";"IC50";"'='";"240.8";"nM";"6.62";"";"";"UO_0000065";"11.64";"0.23";"-0.13";"7.24";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4447148";"";"None";"623.82";"2";"6.43";"30ak";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCCSC(=S)N4CCN(C(C)C)CC4)cc3)ncc2F)c1";"IC50";"'='";"130.6";"nM";"6.88";"";"";"UO_0000065";"11.04";"0.22";"0.45";"7.27";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4435828";"";"None";"602.72";"2";"5.76";"31b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(=O)CCSC(=S)NCc4cccnc4)cc3)ncc2F)c1";"IC50";"'='";"23.7";"nM";"7.62";"";"";"UO_0000065";"12.65";"0.25";"1.87";"5.73";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5f";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.94";"nM";"9.03";"";"";"UO_0000065";"16.32";"0.31";"3.99";"7.36";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5f";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"14.26";"0.27";"2.85";"6.43";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4090117";"";"None";"678.84";"2";"3.97";"22";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4CCOCC4)CC3)cn2)c1=O";"IC50";"'='";"31.6";"nM";"7.50";"";"";"UO_0000065";"11.05";"0.20";"3.53";"6.20";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3962133";"";"None";"427.46";"0";"3.29";"10";"C=CC(=O)N1CCc2c([nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"20.64";"0.38";"5.53";"8.35";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3913116";"";"None";"441.49";"0";"3.33";"11";"C=CC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2CC1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"18.32";"0.33";"4.76";"7.65";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3917732";"";"None";"479.54";"0";"4.97";"20a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"17.77";"0.32";"3.55";"7.66";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3764886";"";"None";"227.19";"1";"-2.20";"PI-1";"N=C(N)NC(=N)N/C(=N/O)c1nonc1N";"IC50";"'='";"10910.0";"nM";"4.96";"";"";"UO_0000065";"21.84";"0.42";"7.16";"2.54";"0";"CHEMBL3767269";"Antagonist activity at human BTK-PH domain (2 to 170 residues) assessed as reduction in PI(3,4,5)P3/BTK-PH interaction after 30 mins by competitive SPR analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763051";"1";"Scientific Literature";"Medchemcomm";"2015";"None";"";"";""
"CHEMBL4446870";"";"None";"495.38";"0";"2.95";"9m";"Nc1ncnc2c1c(C#CCOc1ccccc1)nn2[C@@H]1CCCN(C(=O)/C=C/CBr)C1";"IC50";"'='";"13.2";"nM";"7.88";"";"";"UO_0000065";"15.91";"0.34";"4.93";"7.95";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3977729";"";"None";"417.47";"0";"3.10";"33a";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"63.3";"nM";"7.20";"";"";"UO_0000065";"17.24";"0.32";"4.10";"6.47";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3935234";"";"None";"437.46";"0";"4.50";"7";"C=CC(=O)Nc1ccc2c(c1)[nH]c1c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn12";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"17.95";"0.33";"3.35";"6.86";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3968222";"";"None";"427.46";"0";"3.29";"8";"C=CC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"23.05";"0.42";"6.56";"9.32";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4853848";"";"None";"473.54";"0";"2.42";"2";"C=CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(CC)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"39.3";"nM";"7.41";"";"";"UO_0000065";"15.64";"0.29";"4.99";"4.96";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4878506";"";"None";"501.59";"1";"3.37";"19";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(C)C)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"22.6";"nM";"7.65";"";"";"UO_0000065";"15.24";"0.28";"4.28";"5.12";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4864983";"";"None";"527.51";"1";"3.27";"26";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"16.24";"0.31";"5.30";"5.74";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4852838";"";"None";"560.62";"1";"3.79";"31";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccc(C#N)cc4)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"10.6";"nM";"7.97";"";"";"UO_0000065";"14.22";"0.26";"4.18";"4.61";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4877159";"";"None";"503.54";"1";"2.53";"45";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C)c(F)cn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"13.74";"0.26";"4.39";"4.64";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4847824";"";"None";"582.06";"1";"4.41";"48";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccc(Cl)cc4)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"14.8";"nM";"7.83";"";"";"UO_0000065";"13.45";"0.25";"3.42";"5.25";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4861285";"";"None";"572.63";"1";"3.63";"49";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccc(C#N)cc4)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"22.8";"nM";"7.64";"";"";"UO_0000065";"13.35";"0.24";"4.01";"4.42";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4248320";"";"None";"468.51";"0";"4.31";"6b";"COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN(C)C)cc5)c4c3c2)cn1";"IC50";"'='";"119.0";"nM";"6.92";"";"";"UO_0000065";"14.78";"0.27";"2.61";"7.73";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4872106";"";"None";"573.70";"2";"6.62";"1";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccnc2[nH]c(-c3ccc(C(=O)N4CCOCC4)cc3)nc12";"IC50";"'='";"1680.0";"nM";"5.78";"";"";"UO_0000065";"10.07";"0.18";"-0.85";"5.76";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4225328";"";"None";"436.90";"0";"2.84";"8m";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3cccc(Cl)c3)c3c(N)ncnc32)C1";"IC50";"'='";"18.11";"nM";"7.74";"";"";"UO_0000065";"17.72";"0.34";"4.90";"7.81";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3918568";"";"None";"585.04";"2";"5.42";"BDBM230086";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cc(F)ccc2n(C)c1=O";"IC50";"'='";"0.65";"nM";"9.19";"";"401943";"UO_0000065";"15.70";"0.30";"3.77";"7.46";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"BDBM230104";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.54";"nM";"9.27";"";"401963";"UO_0000065";"16.18";"0.30";"4.87";"7.53";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908440";"";"None";"571.01";"2";"5.41";"BDBM230124";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(Cl)cccc2c1=O";"IC50";"'='";"0.35";"nM";"9.46";"";"401989";"UO_0000065";"16.56";"0.31";"4.05";"7.06";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929953";"";"None";"558.59";"1";"4.39";"BDBM230129";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"0.9";"nM";"9.05";"";"401994";"UO_0000065";"16.19";"0.30";"4.66";"6.75";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912426";"";"None";"589.00";"2";"5.25";"BDBM230130";"Cn1c(=O)n(-c2cccc(-c3c(F)cc(C(N)=O)c4[nH]c5cc(C(C)(C)O)ccc5c34)c2Cl)c(=O)c2cccc(F)c21";"IC50";"'='";"1.4";"nM";"8.85";"";"401996";"UO_0000065";"15.03";"0.29";"3.60";"7.19";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955854";"";"None";"575.04";"1";"4.90";"BDBM230132";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)[nH]c2c(Cl)cccc2c1=O";"IC50";"'='";"0.45";"nM";"9.35";"";"401998";"UO_0000065";"16.25";"0.31";"4.45";"6.98";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3652661";"";"None";"595.56";"1";"4.76";"BDBM122422";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccc(C(F)(F)F)cn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.57";"nM";"9.24";"";"251002";"UO_0000065";"15.52";"0.29";"4.48";"6.56";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652670";"";"None";"435.46";"0";"2.60";"BDBM122431";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)cn4)c3CO)ncc2c1";"IC50";"'='";"267.74";"nM";"6.57";"";"251011";"UO_0000065";"15.09";"0.28";"3.97";"5.66";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3647973";"";"None";"440.51";"0";"4.22";"BDBM97678";"C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"3.6";"nM";"8.44";"";"214873";"UO_0000065";"19.17";"0.35";"4.22";"8.52";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4476482";"";"None";"397.43";"1";"5.28";"6b";"COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1";"IC50";"'='";"237.0";"nM";"6.62";"";"";"UO_0000065";"16.67";"0.30";"1.35";"10.11";"0";"CHEMBL4412233";"Inhibition of BTK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411283";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4216529";"";"None";"600.75";"2";"5.14";"42";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(CN[C@H]4CC[C@H](O)CC4)ccc31)C2";"IC50";"'='";"0.53";"nM";"9.28";"";"";"UO_0000065";"15.44";"0.29";"4.14";"7.39";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4762560";"";"None";"479.54";"1";"5.57";"6";"C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3cc4c(N)noc4cc32)C1";"IC50";"'='";"4664.0";"nM";"5.33";"";"";"UO_0000065";"11.12";"0.20";"-0.24";"5.36";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4761068";"";"None";"442.48";"0";"3.12";"12";"C=CC(=O)N1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"20.01";"0.37";"5.73";"7.43";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3915538";"";"None";"539.64";"1";"3.75";"BDBM191625";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C[C@@H]1CCCN1C(=O)/C=C/CN1CCOCC1";"IC50";"'='";"4.15";"nM";"8.38";"";"342663";"UO_0000065";"15.53";"0.29";"4.63";"7.51";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3652656";"";"None";"604.66";"1";"3.75";"BDBM122417";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccc(S(C)(=O)=O)cc5)n4)c3CO)ncc2c1";"IC50";"'='";"0.09";"nM";"10.05";"";"250997";"UO_0000065";"16.61";"0.32";"6.30";"6.19";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652664";"";"None";"527.56";"1";"3.74";"BDBM122425";"CC(C)(C)c1ccc2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccc(F)cn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.56";"nM";"9.25";"";"251005";"UO_0000065";"17.54";"0.32";"5.51";"6.56";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652682";"";"None";"566.67";"1";"3.66";"BDBM122444";"CN(C)Cc1ccc(Nc2nn(-c3cccc(-n4ncc5cc(C(C)(C)C)ccc5c4=O)c3CO)cc2C(N)=O)nc1";"IC50";"'='";"0.39";"nM";"9.41";"";"251024";"UO_0000065";"16.60";"0.31";"5.75";"6.53";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657242";"";"None";"410.43";"0";"4.73";"BDBM134249";"COc1ccc2cc(-c3nc(-c4ccc(C(=O)O)cc4)cc4[nH]nc(N)c34)ccc2c1";"IC50";"'='";"280.0";"nM";"6.55";"";"267638";"UO_0000065";"15.97";"0.29";"1.82";"5.74";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3649457";"";"None";"435.46";"0";"3.67";"BDBM122405";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-c4coc(C(N)=O)c4)c3CO)ncc2c1";"IC50";"'='";"51.35";"nM";"7.29";"";"250985";"UO_0000065";"16.74";"0.31";"3.62";"6.55";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652666";"";"None";"523.60";"1";"3.91";"BDBM122427";"Cc1ccc(Nc2nn(-c3cccc(-n4ncc5cc(C(C)(C)C)ccc5c4=O)c3CO)cc2C(N)=O)nc1";"IC50";"'='";"1.13";"nM";"8.95";"";"251007";"UO_0000065";"17.09";"0.31";"5.04";"6.35";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652667";"";"None";"605.65";"2";"3.14";"BDBM122428";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccc(S(C)(=O)=O)cn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.17";"nM";"9.77";"";"251008";"UO_0000065";"16.13";"0.31";"6.63";"5.58";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652668";"";"None";"552.57";"1";"3.61";"BDBM122429";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccc(C#N)cn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.18";"nM";"9.74";"";"251009";"UO_0000065";"17.64";"0.32";"6.13";"5.92";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3639515";"";"None";"618.69";"1";"2.99";"BDBM122440";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5ccc(N6CCS(=O)(=O)CC6)nc54)c3CO)ncc2c1";"IC50";"'='";"12.74";"nM";"7.89";"";"251020";"UO_0000065";"12.76";"0.25";"4.90";"5.15";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4115692";"";"None";"541.56";"1";"5.00";"BDBM197197";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccc(F)c(F)c3)cc2)c2c(N)ncnc21";"IC50";"'='";"9.6";"nM";"8.02";"";"350422";"UO_0000065";"14.80";"0.27";"3.02";"6.52";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4113872";"";"None";"537.50";"1";"4.34";"BDBM255254";"Nc1nccn2c([C@@H]3CC[C@@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"15.6";"nM";"7.81";"";"445158";"UO_0000065";"14.52";"0.27";"3.47";"6.11";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3968737";"";"None";"550.55";"1";"4.55";"BDBM255346";"C[C@@H]1OC(=N)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"1.3";"nM";"8.89";"";"445252";"UO_0000065";"16.14";"0.30";"4.34";"6.61";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111935";"";"None";"525.57";"1";"3.28";"BDBM255353";"COC(=O)c1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)c1";"IC50";"'='";"0.4";"nM";"9.40";"";"445259";"UO_0000065";"17.88";"0.33";"6.12";"6.49";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108285";"";"None";"549.56";"1";"4.82";"BDBM255369";"Cc1cc(C(F)(F)F)cc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)n1";"IC50";"'='";"4.8";"nM";"8.32";"";"445276";"UO_0000065";"15.14";"0.28";"3.50";"7.02";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115636";"";"None";"538.53";"1";"3.85";"BDBM255420";"Cn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)cc1C(F)(F)F";"IC50";"'='";"0.41";"nM";"9.39";"";"445327";"UO_0000065";"17.43";"0.33";"5.54";"7.60";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111981";"";"None";"484.56";"0";"3.14";"BDBM255424";"Cc1cc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)nn1C";"IC50";"'='";"6.5";"nM";"8.19";"";"445331";"UO_0000065";"16.90";"0.31";"5.05";"6.63";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3901371";"";"None";"628.78";"2";"5.84";"BDBM202088";"CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"358166";"UO_0000065";"13.08";"0.24";"2.38";"8.41";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960567";"";"None";"484.58";"1";"6.43";"BDBM200867";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCOCC3)cc12";"IC50";"'='";"99.0";"nM";"7.00";"";"356887";"UO_0000065";"14.45";"0.27";"0.57";"8.77";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903393";"";"None";"482.65";"1";"7.00";"BDBM200872";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(C3=CCSCC3)cc12";"IC50";"'='";"47.0";"nM";"7.33";"";"356889";"UO_0000065";"15.18";"0.29";"0.33";"10.37";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4864983";"";"None";"527.51";"1";"3.27";"26";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"8.965";"nM";"8.05";"";"";"UO_0000065";"15.26";"0.29";"4.78";"5.39";"0";"CHEMBL4841706";"Inhibition of BTK in human TMD8 cells assessed as reduction in BTK autophosphorylation at Tyr 223 residue after 4 hrs by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TMD8";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4578569";"";"None";"480.49";"1";"6.00";"36";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1C(F)(F)F";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"13.19";"0.25";"0.34";"7.37";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4442732";"";"None";"467.48";"0";"3.65";"9b";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"20.54";"0.39";"5.95";"8.24";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4456283";"";"None";"436.90";"0";"3.79";"10";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"8150.0";"nM";"5.09";"";"";"UO_0000065";"11.65";"0.22";"1.30";"4.13";"0";"CHEMBL4385493";"Inhibition of BTK in anti-CD3/CD28-stimulated human CD4-positive T cells assessed as reduction in cell proliferation pretreated for 30 mins followed by anti-CD3/CD28-stimulation and measured after 3 days by [3H]-thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4849850";"";"None";"464.57";"1";"5.88";"2";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccnc2[nH]c(-c3cnn(C)c3)nc12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"16.78";"0.30";"1.92";"8.81";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4850235";"";"None";"474.50";"0";"3.78";"5";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5nc(C(C)(C)C)no5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"19.81";"0.37";"5.62";"7.38";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4852395";"";"None";"501.52";"1";"4.45";"19";"COc1ccnc(-c2nc3c(-c4ccc(CNC(=O)c5nc(C(C)(C)C)no5)c(F)c4)ccnc3[nH]2)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.79";"0.33";"4.47";"6.77";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4862532";"";"None";"552.68";"2";"6.17";"28";"Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"16.69";"0.31";"3.05";"7.24";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4878421";"";"None";"538.41";"1";"3.01";"23";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(Br)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"15.52";"0.33";"5.35";"5.60";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4858294";"";"None";"588.71";"2";"6.70";"36";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"12.91";"0.24";"0.90";"6.77";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4875035";"";"None";"572.63";"2";"5.28";"47";"Cc1c(NC(=O)c2nc3ccccc3[nH]2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"13.02";"0.24";"2.18";"5.29";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4868813";"";"None";"524.63";"2";"5.56";"29";"CC(C)n1cc(-c2nc3c(-c4ccc5c(c4)CCC[C@@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cn1";"IC50";"'='";"0.23";"nM";"9.64";"";"";"UO_0000065";"18.37";"0.34";"4.08";"7.56";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4288997";"";"None";"470.52";"0";"3.04";"6";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4CCC(F)(F)CC4)cc3)n2)C1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"19.33";"0.37";"6.06";"8.78";"0";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4871425";"";"None";"486.58";"1";"5.03";"9";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5cc6c(s5)CCCC6)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"211.0";"nM";"6.68";"";"";"UO_0000065";"13.72";"0.26";"1.65";"7.54";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4846816";"";"None";"477.54";"0";"3.87";"16";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)N5CC(OC(C)(C)C)C5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"256.0";"nM";"6.59";"";"";"UO_0000065";"13.80";"0.26";"2.72";"6.53";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4862532";"";"None";"552.68";"2";"6.17";"28";"Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"12.73";"0.23";"0.87";"5.52";"0";"CHEMBL4822449";"Inhibition of BTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4846816";"";"None";"477.54";"0";"3.87";"16";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)N5CC(OC(C)(C)C)C5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.85";"0.35";"5.13";"8.91";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4869875";"";"None";"496.58";"0";"4.51";"22A";"Cn1cc(-c2nc3c(-c4ccc5c(c4)CCC[C@@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cn1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"17.56";"0.32";"4.21";"6.85";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4869875";"";"None";"496.58";"0";"4.51";"22A";"Cn1cc(-c2nc3c(-c4ccc5c(c4)CCC[C@@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cn1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"14.11";"0.26";"2.50";"5.50";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4114929";"";"None";"565.56";"1";"4.52";"5";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"17.11";"0.32";"5.16";"7.58";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4110727";"";"None";"578.56";"1";"3.61";"40";"NC(=O)c1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"348.0";"nM";"6.46";"";"";"UO_0000065";"11.16";"0.21";"2.85";"4.00";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4108825";"";"None";"569.52";"1";"3.89";"31";"Nc1nccn2c([C@@H]3CC[C@H]4COCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"14.46";"0.27";"4.35";"6.45";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4212285";"";"None";"525.59";"2";"5.06";"25b";"CC(C)n1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"16.33";"0.30";"3.53";"6.93";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4513599";"";"None";"520.56";"2";"5.46";"18";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccc(F)cc2c1=O";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.21";"0.26";"1.94";"6.49";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4550390";"";"None";"474.52";"0";"4.59";"21";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(CO)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"16.14";"0.29";"3.07";"6.72";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6d; BMS-986143";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"13.89";"0.27";"2.47";"6.66";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6g";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.90";"0.21";"1.04";"5.08";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4473176";"";"None";"520.56";"2";"5.46";"17";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2cccc(F)c2c1=O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.88";"0.27";"2.28";"6.79";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3426225";"";"None";"576.63";"1";"4.16";"1j";"CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"12.44";"0.23";"3.01";"6.82";"0";"CHEMBL3429881";"Inhibition of human Btk";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425429";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL5074849";"";"None";"242.24";"0";"1.32";"17";"COc1nc2ccccc2cc1-c1n[nH]c(=O)[nH]1";"IC50";"'='";"3162.28";"nM";"5.50";"";"";"UO_0000065";"22.70";"0.42";"4.18";"6.57";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5077105";"";"None";"255.28";"0";"1.74";"19";"CCNc1nc(-c2n[nH]c(=O)[nH]2)cc2ccccc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"27.42";"0.50";"5.26";"8.10";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5092641";"";"None";"351.37";"0";"1.48";"24";"C=CC(=O)N1CC[C@@H](Oc2nc(-c3n[nH]c(=O)[nH]3)cc3ccccc23)C1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"21.35";"0.39";"6.02";"7.21";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3966346";"";"None";"580.66";"2";"5.27";"13";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"261.0";"nM";"6.58";"";"";"UO_0000065";"11.34";"0.21";"1.31";"7.24";"0";"CHEMBL4178258";"Inhibition of human BTK assessed as decrease in anti-mouse IgD antibody stimulated BCR mediated CD69 upregulation in whole blood preincubated for 1 hr followed by antibody challenge after 4 hrs by flow cytometry";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL5198054";"";"None";"465.52";"0";"3.31";"15";"CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"207.0";"nM";"6.68";"";"";"UO_0000065";"14.36";"0.26";"3.37";"5.64";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"19; CC-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"854.0";"nM";"6.07";"";"";"UO_0000065";"14.33";"0.27";"1.82";"6.23";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4868212";"";"None";"499.58";"0";"2.46";"6";"C=CC(=O)N1CC2(CC(c3nc(-c4ccc(C(=O)Nc5cc(CC)ccn5)cc4)c(C(N)=O)n3N)C2)C1";"IC50";"'='";"85.7";"nM";"7.07";"";"";"UO_0000065";"14.15";"0.26";"4.61";"4.74";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4868899";"";"None";"499.58";"0";"2.65";"15";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(CC)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"17.9";"nM";"7.75";"";"";"UO_0000065";"15.51";"0.29";"5.10";"5.19";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4854001";"";"None";"484.52";"0";"2.12";"25";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C#N)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"17.1";"nM";"7.77";"";"";"UO_0000065";"16.03";"0.29";"5.65";"4.49";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4873198";"";"None";"491.53";"0";"2.70";"27";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C)c(F)cn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"44.5";"nM";"7.35";"";"";"UO_0000065";"14.96";"0.28";"4.65";"4.93";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4871608";"";"None";"496.53";"0";"1.96";"43";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C#N)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"45.6";"nM";"7.34";"";"";"UO_0000065";"14.78";"0.27";"5.38";"4.24";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4849268";"";"None";"547.62";"1";"3.75";"46";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccccc4)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"16.4";"nM";"7.79";"";"";"UO_0000065";"14.22";"0.26";"4.04";"5.22";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4085477";"";"None";"636.76";"2";"2.94";"7";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"54.9";"nM";"7.26";"";"";"UO_0000065";"11.40";"0.21";"4.32";"6.00";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4075845";"";"None";"651.83";"1";"4.84";"10";"CC1C=C(c2ccnc(N3CCc4c(sc5c4CCCC5)C3=O)c2CO)C=C(Nc2ccc(N3CCN(C4COC4)CC3)cc2)C1=O";"IC50";"'='";"121.1";"nM";"6.92";"";"";"UO_0000065";"10.61";"0.20";"2.08";"7.04";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4086408";"";"None";"648.81";"1";"4.28";"12";"CC1C=C(c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)C=C(Nc2ccc(N3CCN(C4COC4)CC3)cc2)C1=O";"IC50";"'='";"15.4";"nM";"7.81";"";"";"UO_0000065";"12.04";"0.22";"3.53";"7.57";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4074792";"";"None";"678.84";"2";"3.96";"32";"C[C@@H]1CN(c2ccc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc2)[C@@H](C)CN1C1COC1";"IC50";"'='";"10.2";"nM";"7.99";"";"";"UO_0000065";"11.77";"0.22";"4.03";"6.61";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4276669";"";"None";"378.44";"0";"1.60";"24";"C=CC(=O)N1C[C@H]2C[C@@H]1CN2c1ccc(C(N)=O)c(Nc2ccc(C)nc2)n1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"23.40";"0.43";"7.25";"8.48";"0";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"17.83";"0.33";"3.63";"7.92";"1";"CHEMBL4264700";"Inhibition of BTK in human whole blood";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4278717";"";"None";"435.53";"0";"2.19";"4";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4CCCCC4)nc3)n2)C1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"19.83";"0.37";"6.45";"7.42";"0";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4285083";"";"None";"492.58";"0";"2.05";"7";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)N4CC(C)OC(C)C4)cc3)n2)C1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"17.36";"0.32";"6.50";"6.58";"0";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4250200";"";"None";"444.49";"0";"3.60";"12";"C=CC(=O)N1CCN(c2ccc(C(N)=O)c(Oc3ccc(Oc4ccccc4)cc3)n2)CC1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"18.87";"0.35";"4.79";"8.56";"0";"CHEMBL4236252";"Inhibition of human full length BTK using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by microfluid mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4582434";"";"None";"441.50";"0";"2.47";"9j";"C/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"18.36";"0.34";"5.64";"6.59";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4648439";"";"None";"535.55";"1";"3.37";"24";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@H]2F)c1=O";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"12.59";"0.24";"3.37";"5.66";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4854853";"";"None";"550.42";"1";"2.85";"41";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(Br)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"22.6";"nM";"7.65";"";"";"UO_0000065";"13.89";"0.29";"4.80";"5.12";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4211960";"";"None";"547.54";"1";"4.74";"25g";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(CC(F)F)c2)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.71";"0.33";"4.96";"7.83";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4213985";"";"None";"523.57";"1";"4.81";"25d";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(C3CC3)c2)n1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"18.19";"0.33";"4.71";"7.69";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4202615";"";"None";"538.58";"1";"4.82";"18j";"CC(=O)c1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1C";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"16.89";"0.31";"4.28";"7.10";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4115906";"";"None";"None";"None";"None";"BDBM200825";"";"IC50";"'='";"4.0";"nM";"8.40";"";"356874";"UO_0000065";"";"";"";"";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647970";"";"None";"497.60";"0";"4.15";"BDBM97675";"CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.5";"nM";"8.60";"";"214879";"UO_0000065";"17.29";"0.32";"4.45";"8.40";"0";"CHEMBL3705285";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638659";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4204675";"";"None";"522.54";"1";"3.89";"4e";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"18.01";"0.33";"5.52";"6.37";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217003";"";"None";"553.67";"1";"4.74";"3a";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)cc1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"13.30";"0.25";"2.63";"5.32";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4215004";"";"None";"559.70";"1";"4.80";"3f";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)s1";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"10.87";"0.21";"1.29";"4.39";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3657213";"";"None";"268.32";"0";"2.99";"BDBM134218";"CC(C)Oc1ccc(-c2cncc3[nH]nc(N)c23)cc1";"IC50";"'='";"9310.0";"nM";"5.03";"";"267607";"UO_0000065";"18.75";"0.34";"2.04";"6.55";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657216";"";"None";"497.56";"1";"6.92";"BDBM134221";"Nc1n[nH]c2c(-c3ccc(NC(=O)c4ccccc4)cc3)ncc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"14860.0";"nM";"4.83";"";"267610";"UO_0000065";"9.70";"0.17";"-2.09";"4.56";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3685425";"";"None";"435.92";"0";"4.50";"BDBM120748";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2Cl)c1";"IC50";"'='";"47.0";"nM";"7.33";"";"248815";"UO_0000065";"16.81";"0.32";"2.83";"9.23";"0";"CHEMBL3705216";"Time Resolved-FRET Assay: Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay. Test compound are diluted to desired concentrations in kinase reaction buffer and briefly incubated with BTK kinase (as described above; Invitrogen). The reaction is initiated by the addition of ATP and enzyme substrate, HTRF® KinEASE-TK Substrate-biotin (Cisbio US, Bedford, Mass.). The composition of the reaction (10 μl) was: 1% v/v DMSO, 10 nM BTK, 60 μM ATP, and 1 μM substrate. After incubation at room temperature for 60 min, the enzyme reaction is stopped by EDTA-containing buffer, which also contains europium-labeled (Eu3+-Cryptate) anti-phosphotyrosine antibody (Cisbio) and Streptavidin-XL665 (Cisbio). The europium-labeled antibody generates a time-resolved FRET signal with the Stepavidin-XL665, which binds to the biotinylated TK substrate through the streptavidin conjugate when the substrate is phosphorylated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3909234";"";"None";"321.36";"0";"4.03";"BDBM195780";"CCC#CC(=O)Nc1cc(-c2cnc3[nH]cc(C)c3c2)ccc1F";"IC50";"'='";"739.0";"nM";"6.13";"";"348517";"UO_0000065";"19.08";"0.35";"2.10";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3942125";"";"None";"355.83";"0";"3.60";"BDBM195798";"Cc1n[nH]c2ncc(-c3ccc(Cl)c(NC(=O)/C=C/N(C)C)c3)cc12";"IC50";"'='";"739.0";"nM";"6.13";"";"348521";"UO_0000065";"17.23";"0.33";"2.53";"8.30";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3968188";"";"None";"312.76";"0";"3.71";"BDBM195799";"C=CC(=O)Nc1cc(-c2cnc3[nH]nc(C)c3c2)ccc1Cl";"IC50";"'='";"739.0";"nM";"6.13";"";"348522";"UO_0000065";"19.60";"0.38";"2.42";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4740150";"";"None";"405.53";"0";"4.62";"11";"Cc1cc(-c2ncnc3[nH]ccc23)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.02";"0.40";"3.90";"10.20";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.66";"0.38";"5.75";"9.26";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4761778";"";"None";"599.59";"1";"4.91";"43";"COCCC(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"0.36";"nM";"9.44";"";"";"UO_0000065";"15.75";"0.30";"4.53";"7.39";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4747860";"";"None";"609.61";"1";"4.40";"33";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CCCN(C(=O)C3(C)COC3)C2)n2ccnc(N)c12";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"14.70";"0.28";"4.56";"6.54";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3900123";"";"None";"606.62";"2";"6.69";"BDBM200771";"Cc1c(NC(=O)c2ccc(C3(C(F)(F)F)CC3)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"5.0";"nM";"8.30";"";"356847";"UO_0000065";"13.68";"0.26";"1.61";"8.81";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4280709";"";"None";"522.54";"1";"3.47";"7d";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)c(OC)c3)ncc2F)c1";"IC50";"'='";"17.1";"nM";"7.77";"";"";"UO_0000065";"14.86";"0.28";"4.30";"6.12";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4114685";"";"None";"554.63";"1";"4.45";"BDBM60898";"CNC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"16.0";"nM";"7.80";"";"312169";"UO_0000065";"14.06";"0.26";"3.35";"5.78";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114800";"";"None";"541.56";"2";"5.17";"BDBM60904";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4cc(F)cc(F)c4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.3";"nM";"8.64";"";"312172";"UO_0000065";"15.95";"0.29";"3.47";"7.03";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3657223";"";"None";"392.46";"1";"5.97";"BDBM134228";"Cc1ccccc1-c1ncc(-c2ccc(Oc3ccccc3)cc2)c2c(N)n[nH]c12";"IC50";"'='";"12680.0";"nM";"4.90";"";"267617";"UO_0000065";"12.48";"0.22";"-1.07";"6.37";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4114679";"";"None";"504.59";"2";"5.50";"BDBM197215";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"350431";"UO_0000065";"17.24";"0.31";"3.20";"7.90";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3972734";"";"None";"591.71";"2";"5.43";"BDBM205240";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)cccc1N1Cc2cc(C(C)(C)C)ccc2C1=O";"IC50";"'='";"36.4";"nM";"7.44";"";"363325";"UO_0000065";"12.57";"0.23";"2.01";"7.69";"0";"CHEMBL3887917";"Biochemical Btk Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2), 0.5 μM Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer, 0.5 μM PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6xHis tag was subcloned into pFastBac vector for making baculovirus carrying this epitope-tagged Btk.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886504";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114802";"";"None";"525.59";"2";"5.28";"BDBM197259";"CC(C)/C=C(\C#N)C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"350455";"UO_0000065";"16.55";"0.30";"3.42";"7.08";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3670132";"";"None";"667.79";"1";"3.93";"BDBM111991";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"7.8";"nM";"8.11";"";"233046";"UO_0000065";"12.14";"0.23";"4.18";"7.50";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670133";"";"None";"651.83";"2";"5.40";"BDBM111992";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CCCC5)C3=O)c2CO)nc(Nc2ccc(C3CCN(C4COC4)CC3)cc2)c1=O";"IC50";"'='";"17.1";"nM";"7.77";"";"233047";"UO_0000065";"11.92";"0.23";"2.37";"7.77";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670137";"";"None";"607.76";"1";"4.17";"BDBM111996";"CCN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCc6c(cc7n6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"16.6";"nM";"7.78";"";"233051";"UO_0000065";"12.80";"0.24";"3.61";"7.87";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3699638";"";"None";"529.67";"1";"4.65";"BDBM149463";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)cccc1N1Cc2cc(C(C)(C)C)sc2C1=O";"IC50";"'='";"4000.0";"nM";"5.40";"";"287909";"UO_0000065";"10.19";"0.19";"0.75";"5.44";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3670124";"";"None";"631.77";"2";"5.15";"BDBM111983";"CN(C)CCOc1ccc(Nc2cc(-c3cc(F)cc(N4CCc5c(sc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"3.0";"nM";"8.52";"";"233038";"UO_0000065";"13.49";"0.26";"3.37";"8.53";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3586444";"";"None";"279.30";"0";"1.68";"8";"Cc1ccncc1-c1cccc2c(N)c(C(N)=O)nnc12";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"14.32";"0.26";"2.32";"3.71";"0";"CHEMBL3588253";"Inhibition of BTK in human Raji cells after 30 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Raji";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585313";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307663";"";"";""
"CHEMBL3586447";"";"None";"318.34";"0";"2.16";"11";"Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"27.33";"0.50";"6.54";"7.04";"0";"CHEMBL3588277";"Inhibition of human recombinant Btk";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585313";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3402579";"";"None";"506.58";"2";"6.40";"4r";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCCCC4)cc23)c1CO";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"12.74";"0.23";"0.06";"7.70";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402583";"";"None";"549.61";"2";"5.07";"4v";"CC(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"21.4";"nM";"7.67";"";"";"UO_0000065";"13.95";"0.26";"2.60";"7.37";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3400174";"";"None";"585.66";"1";"4.49";"4za";"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"7.9";"nM";"8.10";"";"";"UO_0000065";"13.83";"0.26";"3.61";"6.69";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3647969";"";"None";"438.49";"0";"3.66";"BDBM97674";"C#CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"213458";"UO_0000065";"20.85";"0.38";"5.48";"9.22";"0";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3699648";"";"None";"559.70";"1";"3.84";"BDBM149473";"CN1CCn2nc(Nc3cc(-c4cccc(N5Cc6cc(C(C)(C)C)sc6C5=O)c4CO)nn(C)c3=O)cc2C1";"IC50";"'='";"55.0";"nM";"7.26";"";"287919";"UO_0000065";"12.97";"0.25";"3.42";"6.69";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3914504";"";"None";"551.63";"2";"5.89";"BDBM200767";"Cc1c(NC(=O)c2ccc3c(C)c[nH]c3c2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"3.0";"nM";"8.52";"";"356843";"UO_0000065";"15.45";"0.28";"2.63";"7.75";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929806";"";"None";"535.62";"1";"4.57";"BDBM200887";"CN(C)C(=O)N1CC=C(c2cc3c(-c4ccc(F)c(NC(=O)N5CC(OC(C)(C)C)C5)c4)ncnc3[nH]2)CC1";"IC50";"'='";"71.0";"nM";"7.15";"";"356910";"UO_0000065";"13.35";"0.25";"2.58";"6.70";"0";"CHEMBL3887839";"Cellular Assay: Alternatively, the present compounds might also be assessed for their capacity to inhibit Btk-dependent FcG receptor-induced IL-8 secretion in human cells. The human myeloid leukemia THP1 cell line (ATCC TIB202) was grown in RPMI 1640 medium supplemented with 10% FCS and 15 nM 1, 25-dihydroxy Vitamin D3 during 4 days before use to induced myeloid differentiation. A sufficient number of tissue-culture grade 384-well plates was coated with human IgG of unknown specificity by incubating overnight at 4° C. with 40 ul/well of a 50 ug/ml IgG solution in PBS. On the day of the experiment, plates were washed 5 times with 80 ul water on a Molecular Devices Aquamax DW4 plate washer. Solutions of the test compounds in 90% DMSO were added to each well on a Hamilton Microlab Star liquid handling station to 40 ul/well tissue culture medium and the total DMSO concentration was adjusted to 0.1%. Differentiated THP1 cells were then added in 40 ul/well to reach a final density of 5'000 cells/well in 80 ul culture medium. After 24 hours, IL-8 secretion was measured in the supernatant by the IL-8 HTRF assay following the protocol of the vendor (CisBio international).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"CHEMBL3307574";"";"";""
"CHEMBL4472627";"";"None";"456.55";"0";"3.81";"A26";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(C(=O)Nc3ccccc3)cc2)CC1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.97";"0.24";"2.11";"5.23";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4114706";"";"None";"558.59";"1";"4.32";"BDBM197276";"CC(C)(N)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3)cc2F)c2c(N)ncnc21";"IC50";"'='";"28.0";"nM";"7.55";"";"350437";"UO_0000065";"13.52";"0.25";"3.23";"5.07";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3912377";"";"None";"525.59";"2";"5.10";"BDBM197246";"CC(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"5.9";"nM";"8.23";"";"350442";"UO_0000065";"15.66";"0.29";"3.13";"6.69";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3942076";"";"None";"590.61";"1";"4.72";"BDBM197256";"CNC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"25.5";"nM";"7.59";"";"350454";"UO_0000065";"12.86";"0.24";"2.87";"5.63";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3980841";"";"None";"552.61";"1";"4.20";"BDBM197273";"N#C/C(=C\C1CCCN1)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"3.7";"nM";"8.43";"";"350462";"UO_0000065";"15.26";"0.28";"4.23";"6.25";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3919531";"";"None";"538.63";"2";"6.13";"BDBM200770";"C=C(C)c1ccc(C(=O)Nc2cc(F)cc(-c3ncnc4[nH]c(C5=CCN(C(=O)N(C)C)CC5)cc34)c2C)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"356846";"UO_0000065";"15.82";"0.29";"2.39";"9.05";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980902";"";"None";"483.59";"1";"6.00";"BDBM200844";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCNCC3)cc12";"IC50";"'='";"19.0";"nM";"7.72";"";"356878";"UO_0000065";"15.97";"0.29";"1.72";"9.34";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1230541";"";"None";"579.70";"2";"5.52";"13; CGI-1746";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"13.45";"0.25";"2.28";"7.39";"0";"CHEMBL5127265";"Inhibition of BTK C481S mutant (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5195945";"";"None";"527.56";"1";"3.61";"22";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"13.96";"0.26";"3.76";"5.76";"0";"CHEMBL5124384";"Inhibition of BTK T474M mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474M";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5187230";"";"None";"540.60";"1";"4.52";"21";"Cc1ccc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"15.31";"0.28";"3.76";"7.20";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5195945";"";"None";"527.56";"1";"3.61";"22";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"15.40";"0.28";"4.51";"6.36";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4754459";"";"None";"548.60";"1";"4.40";"5d";"COc1cccn2c(=O)n(-c3cccc(-c4ccc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)cc12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"14.07";"0.26";"3.32";"5.86";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4741099";"";"None";"553.02";"2";"5.04";"5e";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2cc(Cl)ccn2c1=O";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"15.39";"0.29";"3.47";"6.94";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4875092";"";"None";"472.51";"0";"1.48";"50";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cccnn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"2283.0";"nM";"5.64";"";"";"UO_0000065";"11.94";"0.22";"4.16";"3.48";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4851021";"";"None";"539.62";"2";"5.60";"27";"C=CC(=O)N1CC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccc(Oc3ccccc3)cc2C)C1";"IC50";"'='";"142.0";"nM";"6.85";"";"";"UO_0000065";"12.69";"0.24";"1.25";"6.59";"0";"CHEMBL4818911";"Inhibition of recombinant human BTK using KVEKIGEGTYGVVYK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4814076";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL3699640";"";"None";"488.62";"1";"5.05";"BDBM149465";"Cc1c(-c2cc(Nc3cc(C)n(C)n3)c(=O)[nH]n2)cccc1N1Cc2cc(C(C)(C)C)sc2C1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"287911";"UO_0000065";"17.44";"0.33";"3.47";"8.89";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4210340";"";"None";"464.53";"0";"3.93";"105";"CC#CC(=O)N1CCC[C@@H](n2nc(-c3ccc(C(=O)Nc4ccccn4)cc3)c3cnccc32)C1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.07";"0.27";"3.07";"7.53";"0";"CHEMBL4194325";"Inhibition of BTK (unknown origin) using peptide substrate after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190358";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4218219";"";"None";"504.56";"1";"4.35";"45";"C=CC(=O)N1CC[C@@H](n2nc(-c3ccc(Oc4cccc(OC)c4F)cc3)c3c2CCN(C(C)=O)C3)C1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"11.89";"0.22";"1.65";"7.80";"0";"CHEMBL4194325";"Inhibition of BTK (unknown origin) using peptide substrate after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190358";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1a";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"19.20";"0.35";"4.24";"8.53";"1";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3906908";"";"None";"463.50";"1";"5.01";"14";"C=CC(=O)Nc1cccc(-c2cn3nc(-c4ccc(Oc5ccccc5)cc4)c(C(N)=O)c3[nH]2)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.72";"0.27";"1.81";"5.96";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3979176";"";"None";"479.54";"0";"4.97";"19";"C=CC(=O)Nc1ccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)cc1";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"16.73";"0.30";"3.05";"7.21";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5i";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.86";"nM";"9.07";"";"";"UO_0000065";"16.90";"0.31";"4.54";"7.39";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6f";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"14.26";"0.27";"2.96";"6.64";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4741884";"";"None";"518.57";"1";"4.39";"5a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2ccccn2c1=O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"14.89";"0.27";"3.33";"6.30";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6f";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"14.33";"0.27";"3.00";"6.67";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3973566";"";"None";"484.56";"0";"3.22";"9";"CN(C)C/C=C/C(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"20.06";"0.37";"6.50";"8.92";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3922120";"";"None";"441.49";"0";"3.68";"12";"C=CC(=O)N1CCCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"0.15";"nM";"9.82";"";"";"UO_0000065";"22.25";"0.41";"6.14";"9.29";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4456283";"";"None";"436.90";"0";"3.79";"77; PF-303";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"0.64";"nM";"9.19";"";"";"UO_0000065";"21.04";"0.41";"5.40";"7.46";"1";"CHEMBL4351046";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350951";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL5171706";"";"None";"478.94";"0";"4.93";"8";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@H]3CCC[C@H](CO)O3)c12";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"19.65";"0.38";"4.48";"8.60";"0";"CHEMBL5124390";"Inhibition of BTK C481S mutant (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5169992";"";"None";"564.65";"2";"3.01";"17; GNE-431";"CN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)nn4ccnc34)cc2C1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.09";"0.26";"4.95";"6.54";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4455814";"";"None";"512.64";"2";"5.23";"30b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCC)cc3)ncc2F)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"15.26";"0.31";"2.59";"7.81";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4443744";"";"None";"538.67";"2";"5.72";"30k";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCCC4)cc3)ncc2F)c1";"IC50";"'='";"154.5";"nM";"6.81";"";"";"UO_0000065";"12.64";"0.25";"1.09";"7.45";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4537525";"";"None";"552.70";"2";"6.11";"30l";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCCCC4)cc3)ncc2F)c1";"IC50";"'='";"83.6";"nM";"7.08";"";"";"UO_0000065";"12.81";"0.25";"0.97";"7.74";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4576295";"";"None";"643.81";"2";"6.44";"30u";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCN(Cc5ccccc5)CC4)cc3)ncc2F)c1";"IC50";"'='";"283.5";"nM";"6.55";"";"";"UO_0000065";"10.17";"0.20";"0.11";"6.92";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"3; BMS986942";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.72";"0.29";"4.60";"7.31";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"3; BMS986942";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"12.15";"0.23";"2.56";"5.65";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4470534";"";"None";"524.65";"2";"5.38";"30i";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NC4CC4)cc3)ncc2F)c1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"16.40";"0.33";"3.22";"8.58";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4445733";"";"None";"597.74";"1";"4.23";"30q";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCN(CCO)CC4)cc3)ncc2F)c1";"IC50";"'='";"68.3";"nM";"7.17";"";"";"UO_0000065";"11.99";"0.24";"2.94";"6.24";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4564665";"";"None";"547.08";"2";"5.31";"7n";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccc(Cl)cc5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"614.0";"nM";"6.21";"";"";"UO_0000065";"11.35";"0.22";"0.90";"6.00";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4863836";"";"None";"535.61";"1";"3.92";"28";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccccc4)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"15.48";"0.28";"4.37";"5.56";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4862197";"";"None";"460.50";"0";"1.64";"34";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cccnn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"211.0";"nM";"6.68";"";"";"UO_0000065";"14.50";"0.27";"5.04";"4.12";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4548457";"";"None";"447.51";"0";"4.49";"A24";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3cccc(F)c3)cc2)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"17.98";"0.33";"3.56";"8.62";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4587672";"";"None";"455.56";"0";"4.89";"A31";"Nc1ncnc(NCC2CCN(C(=O)C3=CCC3)CC2)c1-c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"14.35";"0.26";"1.65";"7.00";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4475457";"";"None";"429.52";"0";"4.54";"A10";"C=CC(=O)N[C@H]1CC[C@@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"14.39";"0.26";"1.64";"6.05";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4469004";"";"None";"401.47";"0";"3.72";"A15";"C=CC(=O)N1CC[C@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"217.0";"nM";"6.66";"";"";"UO_0000065";"16.60";"0.30";"2.94";"7.14";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4515024";"";"None";"427.51";"0";"4.11";"A16";"C=CC(=O)N1CC2(CC(Nc3ncnc(N)c3-c3ccc(Oc4ccccc4)cc3)C2)C1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"16.80";"0.31";"3.07";"7.69";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4524580";"";"None";"335.34";"0";"2.91";"17";"Cc1cc2cn[nH]c2cc1-c1ccc(F)c2c(N)c(C(N)=O)cnc12";"IC50";"'='";"11.6";"nM";"7.94";"";"";"UO_0000065";"23.66";"0.43";"5.03";"7.17";"0";"CHEMBL4335770";"Reversible inhibition of FAM-labeled peptide binding to full-length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus infected Sf21 insect cells at preincubated for 10 mins followed by FAM-labeled peptide addition and measured by off-chip mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334447";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3908157";"";"None";"383.41";"0";"3.96";"BDBM250005";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c1cccc(N)c12";"IC50";"'='";"170.0";"nM";"6.77";"";"435934";"UO_0000065";"17.66";"0.32";"2.81";"6.08";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4449266";"";"None";"603.75";"2";"6.59";"30al";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCCSC(=S)NCc4cccnc4)cc3)ncc2F)c1";"IC50";"'='";"16.5";"nM";"7.78";"";"";"UO_0000065";"12.89";"0.25";"1.19";"6.88";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3977729";"";"None";"417.47";"0";"3.10";"BDBM249906";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.9";"nM";"9.05";"";"435834";"UO_0000065";"21.67";"0.40";"5.95";"8.13";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968704";"";"None";"461.52";"0";"2.90";"BDBM250020";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(OCc4ccccc4)c(OC)c3)nn21";"IC50";"'='";"54.0";"nM";"7.27";"";"435949";"UO_0000065";"15.75";"0.29";"4.37";"6.03";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3674682";"";"None";"619.72";"1";"4.36";"BDBM102445";"Cn1cc(-c2cccc(N3CCc4cc(C5CC5)ccc4C3=O)c2CO)nc(Nc2ccc(C(=O)N3CCC(O)CC3)cc2)c1=O";"IC50";"'='";"10.0";"nM";"8.00";"";"219975";"UO_0000065";"12.91";"0.24";"3.64";"6.25";"0";"CHEMBL3705343";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639178";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3702835";"";"None";"609.71";"1";"4.13";"BDBM143184";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCNCC1";"IC50";"'='";"4.7";"nM";"8.33";"";"279407";"UO_0000065";"13.66";"0.25";"4.20";"6.03";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4214492";"";"None";"423.48";"0";"4.17";"7R";"C=CC(=O)N[C@H]1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"19.40";"0.35";"4.04";"8.64";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4203826";"";"None";"480.57";"0";"4.10";"12";"C=C1c2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2CC1NC(=O)/C=C/CN(C)C";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"17.41";"0.32";"4.27";"8.51";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209048";"";"None";"427.51";"0";"4.31";"6";"CCC(=O)NC1CCc2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2C1";"IC50";"'='";"417.4";"nM";"6.38";"";"";"UO_0000065";"14.92";"0.27";"2.07";"6.71";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"21.33";"0.39";"5.18";"9.48";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4248320";"";"None";"468.51";"0";"4.31";"15a";"COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN(C)C)cc5)c4c3c2)cn1";"IC50";"'='";"237.0";"nM";"6.62";"";"";"UO_0000065";"14.14";"0.26";"2.32";"7.39";"0";"CHEMBL4235188";"Inhibition of recombinant full length human N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL5270006";"";"None";"472.57";"0";"4.61";"85";"CN1CCN(c2ccc(Nc3nc(Nc4cccc(F)c4)c4ncn(CC5CC5)c4n3)cc2)CC1";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"13.08";"0.24";"1.57";"8.34";"0";"CHEMBL5242663";"Inhibition of BTK (unknown origin) in the presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4110442";"";"None";"552.06";"1";"4.53";"BDBM255452";"COc1cc(C(=O)Nc2ncc(C)s2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"1.7";"nM";"8.77";"";"445359";"UO_0000065";"15.89";"0.32";"4.24";"6.87";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110390";"";"None";"601.54";"1";"4.80";"BDBM255469";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)cc(F)c1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(F)cnc(N)c12";"IC50";"'='";"0.4";"nM";"9.40";"";"445376";"UO_0000065";"15.62";"0.30";"4.60";"7.36";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4226237";"";"None";"402.46";"0";"2.19";"8";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"7.95";"nM";"8.10";"";"";"UO_0000065";"20.13";"0.37";"5.91";"8.17";"1";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4277754";"";"None";"493.57";"0";"1.45";"16";"C=CC(=O)N[C@H]1CCN(c2ncc(C(N)=O)c(Nc3ccc(C(=O)N4CC(C)OC(C)C4)cc3)n2)C1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"18.15";"0.34";"7.51";"6.27";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4290785";"";"None";"653.79";"2";"3.62";"10";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCC(N6CCN(C)CC6)CC5)cc4OC)nc32)c1";"IC50";"'='";"12.8";"nM";"7.89";"";"";"UO_0000065";"12.07";"0.22";"4.27";"6.08";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4293051";"";"None";"570.65";"2";"3.15";"5";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"47.4";"nM";"7.32";"";"";"UO_0000065";"12.83";"0.24";"4.17";"5.78";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL3358335";"";"None";"493.54";"0";"2.70";"2b";"CNC(=O)Nc1cc(-c2ccc(F)c(N3CCc4cc(N(C)C)ccc4C3=O)c2CO)cn(C)c1=O";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"11.01";"0.21";"2.73";"5.08";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4782725";"";"None";"551.60";"1";"4.35";"19";"CC#CC(=O)Nc1cc2c(Oc3ccc(C(=O)Nc4ccccn4)cc3)ccnc2cc1OCCN1CCOCC1";"IC50";"'='";"0.54";"nM";"9.27";"";"";"UO_0000065";"16.80";"0.31";"4.92";"8.07";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4469663";"";"None";"437.89";"0";"3.19";"20a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cn4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"20.09";"0.39";"5.61";"6.46";"0";"CHEMBL4385492";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human B cells assessed as reduction in cell proliferation pretreated for 30 mins followed by goat anti-human IgM F(ab')2-stimulation and measured after 3 days by [3H]-thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4456974";"";"None";"471.44";"0";"3.56";"20b";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(C(F)(F)F)n4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"15.87";"0.30";"3.92";"5.50";"0";"CHEMBL4385495";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 1 hr followed by goat anti-human IgM F(ab')2-stimualtion and measured after 3 hrs by Fix/Lyse reagent based flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3358339";"";"None";"624.67";"1";"3.66";"4b";"CN(C)c1cc(F)c2c(=O)n(-c3cccc(-c4cc(Nc5ccc(C(=O)N6CCOCC6)cn5)c(=O)n(C)c4)c3CO)ccc2c1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"11.84";"0.22";"3.74";"6.07";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3358342";"";"None";"602.74";"2";"5.01";"6a";"CCN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)ccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"9.62";"0.18";"0.79";"6.06";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"12.48";"0.23";"2.81";"7.91";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3358409";"";"None";"564.73";"2";"5.80";"16o";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(N3CCN(C)CC3)cn2)c(=O)n(C)c1";"IC50";"'='";"875.0";"nM";"6.06";"";"";"UO_0000065";"10.73";"0.20";"0.26";"7.34";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3358398";"";"None";"660.75";"2";"5.06";"16d";"Cn1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)cc(Nc2ccc(N3CCN(C(=O)C4CC4)CC3)cn2)c1=O";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"11.43";"0.21";"2.49";"6.70";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3358395";"";"None";"647.75";"2";"5.58";"16a";"Cn1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)cc(Nc2ccc(C3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"11.89";"0.22";"2.12";"7.58";"0";"CHEMBL3375466";"Inhibition of BTK (unknown origin) using biotin-labeled peptide substrate incubated for 1 hr by TR-FRET based HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4857459";"";"None";"538.66";"2";"5.87";"26";"Cc1c(-c2nc3c(-c4ccc5c(c4)CCC[C@@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cnn1C(C)C";"IC50";"'='";"137.0";"nM";"6.86";"";"";"UO_0000065";"12.74";"0.23";"0.99";"5.39";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4877846";"";"None";"566.71";"2";"6.56";"30";"Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"15.04";"0.28";"1.96";"6.69";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4455486";"";"None";"444.45";"0";"2.36";"2";"C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccccc4OC)nc32)c1";"IC50";"'='";"996.0";"nM";"6.00";"";"";"UO_0000065";"13.50";"0.25";"3.64";"5.00";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4126797";"";"None";"570.61";"2";"2.02";"5";"C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)nc32)c1";"IC50";"'='";"718.0";"nM";"6.14";"";"";"UO_0000065";"10.77";"0.20";"4.12";"4.28";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4129646";"";"None";"598.71";"2";"3.76";"8";"C=CC(=O)Nc1cccc(-n2c(=O)n(CCC)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.57";"0.23";"3.76";"5.94";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4128567";"";"None";"660.78";"2";"4.59";"11";"C=CC(=O)Nc1cccc(-n2c(=O)n(CCc3ccccc3)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"11.56";"0.21";"3.05";"6.03";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4127317";"";"None";"570.65";"2";"3.15";"13";"C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"518.0";"nM";"6.29";"";"";"UO_0000065";"11.01";"0.20";"3.14";"4.96";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"20.93";"0.38";"5.00";"9.30";"1";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL3702827";"";"None";"553.60";"1";"4.66";"23";"CC1(/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)COC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"14.73";"0.27";"3.49";"6.17";"0";"CHEMBL5104909";"Inhibition of biotinylated-labeled BTK-selective probe binding to BTK in human Ramos assessed as target occupancy pretreated for 1 hr followed by probe addition measured for 18 hrs by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL3908310";"";"None";"550.59";"1";"4.76";"7a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"15.53";"0.28";"3.79";"6.95";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3908310";"";"None";"550.59";"1";"4.76";"7a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"12.21";"0.22";"1.96";"5.46";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3647964";"";"None";"440.51";"0";"4.22";"BDBM97669";"C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"213464";"UO_0000065";"20.10";"0.37";"4.63";"8.93";"1";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL5193597";"";"None";"510.60";"1";"3.85";"25";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccc6ccccc6c5)C4)c23)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"17.34";"0.32";"5.00";"8.56";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702829";"";"None";"555.61";"1";"4.64";"22";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)CO";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"14.56";"0.27";"3.45";"5.65";"1";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5204545";"";"None";"523.57";"2";"5.03";"21";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.61";"0.30";"3.67";"7.08";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3947620";"";"None";"499.55";"0";"4.62";"20";"CC(C)/C=C(\C#N)C(=O)N[C@@H](C)Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"17.01";"0.31";"3.87";"6.45";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702842";"";"None";"511.56";"1";"4.57";"17";"CC(C)/C=C(\C#N)C(=O)N1CC(Cn2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"218.0";"nM";"6.66";"";"";"UO_0000065";"13.02";"0.24";"2.09";"5.42";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3612846";"";"None";"456.53";"1";"5.68";"13h";"Nc1ncc(-c2cnn(CCC(=O)O)c2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"16.82";"0.32";"2.00";"7.44";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4105470";"";"None";"439.49";"1";"5.35";"3b";"Cc1cc2c(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)ccnc2[nH]1";"IC50";"'='";"395.0";"nM";"6.40";"";"";"UO_0000065";"14.57";"0.27";"1.05";"9.03";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4466633";"";"None";"664.74";"1";"4.26";"Ent-3";"Cn1c2c(cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c1=O)-c1cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c1C[C@@H](O)C2";"IC50";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"10.27";"0.19";"2.57";"5.19";"0";"CHEMBL4321362";"Inhibition of BTK in goat F(ab')2 anti-human IgM-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 30 mins followed by goat F(ab')2 anti-human IgM-stimulation and measured after 20 hrs by flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4316621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4205446";"";"None";"496.55";"0";"4.62";"18h";"Cn1ccc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)c1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"14.52";"0.27";"2.59";"6.49";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3906926";"";"None";"497.53";"1";"5.11";"BDBM249885";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccc(F)cc4)cc3)nn21";"IC50";"'='";"1.7";"nM";"8.77";"";"435805";"UO_0000065";"17.63";"0.32";"3.66";"7.88";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929088";"";"None";"511.56";"2";"5.13";"BDBM249889";"C=CC(=O)N(C)c1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccc(F)cc4)cc3)nn21";"IC50";"'='";"19.0";"nM";"7.72";"";"435809";"UO_0000065";"15.09";"0.28";"2.59";"7.53";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927047";"";"None";"433.51";"0";"3.19";"BDBM249896";"NC(=O)c1c(-c2ccc(OC3CCOCC3)cc2)nn2c1NCCC2c1ccccc1N";"IC50";"'='";"3200.0";"nM";"5.50";"";"435818";"UO_0000065";"12.68";"0.23";"2.30";"4.68";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897084";"";"None";"373.42";"0";"2.87";"BDBM249924";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c3c([nH]c12)CCNC3";"IC50";"'='";"310.0";"nM";"6.51";"";"435854";"UO_0000065";"17.43";"0.32";"3.64";"6.68";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926833";"";"None";"411.42";"0";"3.32";"BDBM249948";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c(=O)c1cc(N)ccc12";"IC50";"'='";"480.0";"nM";"6.32";"";"435880";"UO_0000065";"15.36";"0.28";"3.00";"4.92";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894176";"";"None";"457.53";"0";"3.23";"BDBM249978";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(OCc5ccccc5)cc4)nn32)C1";"IC50";"'='";"2.6";"nM";"8.59";"";"435907";"UO_0000065";"18.76";"0.34";"5.36";"8.38";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921532";"";"None";"375.43";"0";"2.63";"BDBM249989";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NC[C@@H]1CNC[C@@H]12";"IC50";"'='";"8200.0";"nM";"5.09";"";"435918";"UO_0000065";"13.55";"0.25";"2.46";"5.40";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964516";"";"None";"383.41";"0";"3.96";"BDBM250003";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1[nH]c1cc(N)ccc12";"IC50";"'='";"23.0";"nM";"7.64";"";"435932";"UO_0000065";"19.92";"0.36";"3.68";"6.85";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985855";"";"None";"477.95";"0";"4.10";"BDBM250017";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)c(Cl)c4)nn32)C1";"IC50";"'='";"0.44";"nM";"9.36";"";"435946";"UO_0000065";"19.58";"0.38";"5.26";"9.13";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977203";"";"None";"471.56";"0";"4.28";"BDBM250026";"C=CC(=O)Nc1cc(C)ccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"5.6";"nM";"8.25";"";"435955";"UO_0000065";"17.50";"0.32";"3.97";"7.42";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960617";"";"None";"419.46";"0";"3.63";"BDBM250035";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(F)c(C)c3)nn21";"IC50";"'='";"0.38";"nM";"9.42";"";"435964";"UO_0000065";"22.46";"0.42";"5.79";"9.23";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894235";"";"None";"497.60";"0";"4.45";"BDBM250061";"CCC#CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.1";"nM";"8.96";"";"435993";"UO_0000065";"18.00";"0.33";"4.51";"8.74";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4528630";"";"None";"424.46";"1";"5.43";"A3";"C=CC(=O)Nc1cccc(Oc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)c1";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"20.11";"0.36";"3.11";"8.59";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"A18; M2951";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"18.74";"0.34";"3.70";"8.62";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4111181";"";"None";"506.57";"1";"3.67";"BDBM255287";"Cc1cc(-c2nc([C@@H]3CC[C@H]4CCC(=O)N4C3)n3ccnc(N)c23)ccc1C(=O)Nc1cc(C#N)ccn1";"IC50";"'='";"0.98";"nM";"9.01";"";"445192";"UO_0000065";"17.78";"0.32";"5.34";"6.33";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3916919";"";"None";"563.58";"2";"5.15";"BDBM255344";"CC1(C)C[C@H]2CC[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"0.14";"nM";"9.85";"";"445250";"UO_0000065";"17.48";"0.33";"4.70";"8.31";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113827";"";"None";"604.09";"2";"5.56";"BDBM255385";"CCOc1cc(C(=O)Nc2cc(C3CC3)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.78";"nM";"9.11";"";"445292";"UO_0000065";"15.08";"0.29";"3.55";"7.13";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113636";"";"None";"593.61";"2";"5.30";"BDBM255388";"CC(C)Oc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"5.7";"nM";"8.24";"";"445295";"UO_0000065";"13.89";"0.26";"2.94";"6.45";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115167";"";"None";"598.11";"2";"5.57";"BDBM255396";"Nc1ncc(Cl)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CC5)ccn4)cc3OC3CC3)c12";"IC50";"'='";"0.75";"nM";"9.12";"";"445303";"UO_0000065";"15.26";"0.29";"3.55";"7.14";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3901103";"";"None";"547.55";"1";"4.88";"BDBM246400";"CCn1ncc2c1CCC[C@@H]2n1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"5.9";"nM";"8.23";"";"429704";"UO_0000065";"15.03";"0.28";"3.35";"6.36";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110336";"";"None";"587.96";"2";"5.31";"BDBM255442";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3cc(F)c(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3Cl)c12";"IC50";"'='";"4.6";"nM";"8.34";"";"445349";"UO_0000065";"14.18";"0.28";"3.03";"7.04";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL5072020";"";"None";"522.58";"1";"4.40";"13a";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCNCC3)[nH]c2n1";"IC50";"'='";"0.65";"nM";"9.19";"";"";"UO_0000065";"17.58";"0.32";"4.79";"7.54";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5077961";"MILREBRUTINIB";"2.0";"578.65";"1";"4.51";"13f; AS-1763";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCN(C4COC4)CC3)[nH]c2n1";"IC50";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"15.68";"0.29";"4.56";"7.42";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.43";"0.37";"4.78";"9.08";"1";"CHEMBL5054205";"Inhibition of wild type BTK (unknown origin) in presence of 1 mM ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 1.0 mM";"INHIBITOR";""
"CHEMBL4216036";"";"None";"420.48";"0";"3.46";"4";"Nc1nc2c(s1)CC(n1nc(-c3cc(F)c4[nH]ccc4c3)c3c(N)ncnc31)CC2";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"18.21";"0.35";"4.20";"6.16";"0";"CHEMBL4190836";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190187";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4204140";"";"None";"563.66";"1";"4.27";"3j";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(N3CCc4cc(C5CC5)ccc4C3=O)c2CO)n1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"11.45";"0.21";"2.19";"4.98";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4205586";"";"None";"608.68";"1";"4.34";"3k";"CC(C)(C#N)c1cc(F)c2c(c1)CCN(c1cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c1CO)C2=O";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"11.43";"0.21";"2.62";"4.53";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4216339";"";"None";"536.57";"1";"4.37";"4f";"CCn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"15.28";"0.28";"3.83";"5.55";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4208062";"";"None";"550.60";"1";"4.93";"4g";"CC(C)n1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"15.02";"0.28";"3.34";"5.60";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4203409";"";"None";"549.68";"2";"6.22";"1";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccnc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"15.72";"0.29";"2.42";"8.96";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4210081";"";"None";"560.68";"2";"4.20";"3e";"CC(C)(C)c1cnc(C(=O)Nc2cccc(-c3nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n3)c2CO)s1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"13.95";"0.27";"3.62";"5.17";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4213416";"";"None";"557.68";"1";"4.39";"3g";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(NC(=O)c3cc4c(s3)CCCC4)c2CO)n1";"IC50";"'='";"0.81";"nM";"9.09";"";"";"UO_0000065";"16.30";"0.31";"4.70";"6.56";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209441";"SOFNOBRUTINIB";"2.0";"498.52";"0";"3.41";"4b";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.75";"0.29";"4.44";"5.74";"0";"CHEMBL4201929";"Inhibition of anti-IgM-stimulated BTK phosphorylation at Tyr223 in human Ramos cells pre-incubated for 1 hr followed by anti-IgM stimulation for 10 mins by Western blotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3786343";"OLMUTINIB";"4.0";"486.60";"1";"5.10";"HM-71224";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.50";"0.35";"3.90";"10.89";"0";"CHEMBL3813053";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3665118";"";"None";"591.67";"1";"3.74";"BDBM111589";"Cc1c(-c2cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c(=O)n(C)c2)cccc1-n1ncc2cc(N(C)C)ccc2c1=O";"IC50";"'='";"124.0";"nM";"6.91";"";"232405";"UO_0000065";"11.67";"0.21";"3.17";"6.03";"0";"CHEMBL3705846";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter. Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 um hydrophilic PVDF filter plates (Millipore).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638395";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3926191";"";"None";"417.47";"0";"3.19";"25b";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC)cc3)nn21";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"20.61";"0.38";"5.41";"7.73";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3965262";"";"None";"401.47";"0";"3.49";"27";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(C)cc3)nn21";"IC50";"'='";"3.9";"nM";"8.41";"";"";"UO_0000065";"20.95";"0.38";"4.92";"8.24";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL4441219";"";"None";"427.51";"0";"4.30";"A12";"C=CC(=O)NC12CCC(Nc3ncnc(N)c3-c3ccc(Oc4ccccc4)cc3)(C1)C2";"IC50";"'='";"9.9";"nM";"8.00";"";"";"UO_0000065";"18.72";"0.34";"3.70";"7.84";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4532368";"";"None";"451.96";"0";"4.41";"A29";"Nc1ncnc(NCC2CCN(C(=O)CCl)CC2)c1-c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"20.40";"0.39";"4.81";"9.88";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4468148";"";"None";"415.50";"0";"4.11";"A14";"C=CC(=O)N1CCC[C@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"143.0";"nM";"6.84";"";"";"UO_0000065";"16.47";"0.30";"2.73";"7.33";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4060453";"";"None";"635.77";"1";"3.54";"18";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"12.74";"0.24";"4.56";"7.49";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3670139";"";"None";"666.85";"1";"4.59";"16";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"10.57";"0.20";"2.46";"6.83";"0";"CHEMBL4036701";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of BCR-induced CD69 expression on B cells preincubated for 1 hr followed by blood stimulation measured after 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4643339";"";"None";"538.61";"1";"3.17";"32";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)c2cccnc2)c1=O";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"12.17";"0.22";"3.38";"5.36";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4799627";"";"None";"597.57";"1";"4.53";"2";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"11.63";"0.22";"2.42";"5.44";"0";"CHEMBL4717036";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4528322";"";"None";"518.57";"2";"5.48";"6b";"O=C(Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)c(C(=O)O)s2)c1)c1ccc(F)cc1";"IC50";"'='";"1120.0";"nM";"5.95";"";"";"UO_0000065";"11.48";"0.22";"0.47";"5.73";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4758341";"";"None";"614.03";"2";"5.04";"32";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)c(Cl)c4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"181.0";"nM";"6.74";"";"";"UO_0000065";"10.98";"0.21";"1.70";"5.28";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4757012";"";"None";"544.59";"1";"3.21";"28";"Cc1cnc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)cn1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"11.85";"0.22";"3.25";"4.59";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4764139";"";"None";"622.58";"2";"5.49";"44";"Cc1oncc1C(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"0.45";"nM";"9.35";"";"";"UO_0000065";"15.01";"0.28";"3.86";"6.47";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4756023";"";"None";"398.51";"1";"5.16";"7";"Cc1cc(-c2ncnc3[nH]ccc23)ccc1CNC(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"20.83";"0.38";"3.14";"11.75";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4783488";"";"None";"381.51";"0";"3.72";"13";"Cc1cc(-c2ccnc(N)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"21.55";"0.42";"4.50";"8.77";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4746275";"";"None";"458.59";"1";"5.27";"16";"Cc1cc(-c2ccnc(Nc3ccncc3)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"20.49";"0.39";"4.13";"10.14";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4746275";"";"None";"458.59";"1";"5.27";"16";"Cc1cc(-c2ccnc(Nc3ccncc3)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"11.50";"0.22";"0.01";"5.69";"0";"CHEMBL4701077";"Inhibition of BTK in human whole blood assessed as reduction in BTK phosphorylation measured after 30 mins by phosphotyrosine detection method";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3922230";"";"None";"614.75";"2";"5.45";"9";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"13.45";"0.25";"2.82";"8.45";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3900184";"";"None";"615.73";"2";"6.17";"6";"CN1CCC(Oc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"13.94";"0.25";"2.42";"8.27";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4163691";"POSELTINIB";"2.0";"470.53";"0";"4.64";"16";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1";"IC50";"'='";"1.95";"nM";"8.71";"";"";"UO_0000065";"18.51";"0.34";"4.07";"9.10";"0";"CHEMBL4714263";"Inhibition of BTK (unknown origin) One-hour enzymatic assay without pre-incubation";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4567605";"";"None";"557.65";"1";"4.94";"12";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)cccc1N1Cc2ccccc2C1=O";"IC50";"'='";"238.0";"nM";"6.62";"";"";"UO_0000065";"11.88";"0.22";"1.68";"6.45";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3747322";"";"None";"614.75";"2";"5.28";"14";"Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)ccc(F)c1NC(=O)c1cc2c(s1)CCCC2";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"12.78";"0.24";"2.57";"7.89";"0";"CHEMBL3748501";"Inhibition of BTK (unknown origin) by Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4108687";"";"None";"565.56";"2";"5.12";"25";"CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21";"IC50";"'='";"0.12";"nM";"9.92";"";"";"UO_0000065";"17.54";"0.33";"4.80";"7.77";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.98";"0.33";"3.70";"7.99";"1";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4079803";"";"None";"690.77";"1";"4.74";"21";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(N3CCN(CCC(F)(F)F)CC3)cn2)c1=O";"IC50";"'='";"116.1";"nM";"6.93";"";"";"UO_0000065";"10.04";"0.19";"2.20";"6.21";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4091764";"";"None";"362.79";"0";"3.89";"7";"COc1ccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)cc1OC";"IC50";"'='";"153.0";"nM";"6.82";"";"";"UO_0000065";"18.79";"0.37";"2.93";"9.46";"0";"CHEMBL4020190";"Inhibition of human N-terminal His-tagged BTK expressed in bacmid transfected Sf21 insect cells using TK-substrate-biotin after 40 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4783559";"";"None";"411.47";"0";"4.08";"17";"c1nc2c(Nc3ccc(N4CCOCC4)cc3)cc(-c3ccc4cn[nH]c4c3)nc2[nH]1";"IC50";"'='";"1450.0";"nM";"5.84";"";"";"UO_0000065";"14.19";"0.26";"1.76";"6.16";"0";"CHEMBL4773121";"Inhibition of BTK (unknown origin) using poly(Glu, Tyr) 4:1 as substrate incubated in presence of [gamma33P]ATP by image analyser";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765406";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL4785298";"";"None";"411.47";"0";"4.08";"18";"c1nc2c(Nc3ccc(N4CCOCC4)cc3)nc(-c3ccc4cn[nH]c4c3)cc2[nH]1";"IC50";"'='";"369.0";"nM";"6.43";"";"";"UO_0000065";"15.63";"0.28";"2.35";"6.79";"0";"CHEMBL4773121";"Inhibition of BTK (unknown origin) using poly(Glu, Tyr) 4:1 as substrate incubated in presence of [gamma33P]ATP by image analyser";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765406";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL5203006";"";"None";"405.51";"0";"2.59";"4";"CCN1CCN(Cc2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C)C(=O)C1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"15.50";"0.29";"3.69";"7.94";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5192152";"";"None";"531.58";"1";"3.79";"22";"CC(C)(C)CN1CCN(Cc2ccc(-c3ccnc(Nc4cnn(CCO)c4)n3)cc2C(F)(F)F)C(=O)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"17.68";"0.34";"5.61";"9.45";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL3402355";"";"None";"968.10";"3";"9.49";"1e";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)cc2)n1";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"7.40";"0.14";"-2.33";"3.59";"0";"CHEMBL3407011";"Inhibition of biotinylated and activated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3787055";"";"None";"543.61";"1";"4.37";"8d";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3)ncc2[S+](C)[O-])c1";"IC50";"'='";"5.65";"nM";"8.25";"";"";"UO_0000065";"15.17";"0.29";"3.88";"5.38";"0";"CHEMBL3789511";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3784966";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4279066";"";"None";"523.04";"2";"5.15";"7l";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)cc3C)ncc2Cl)c1";"IC50";"'='";"89.32";"nM";"7.05";"";"";"UO_0000065";"13.48";"0.26";"1.90";"7.00";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4286628";"";"None";"437.50";"0";"1.04";"3";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4CCOCC4)nc3)n2)C1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"19.79";"0.37";"7.62";"6.89";"0";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4466696";"";"None";"325.38";"0";"0.83";"32";"Cn1cc(-c2cc3nccnc3c(NC[C@@H]3CNCCO3)n2)cn1";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"20.28";"0.38";"5.77";"7.35";"0";"CHEMBL4433070";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4431389";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4878102";"";"None";"573.63";"1";"3.57";"18";"CC(C)(C)c1noc(C(=O)NCc2ccc(-c3ccnc4[nH]c(-c5cnn(CCN6CCOCC6)c5)nc34)cc2F)n1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"16.60";"0.31";"5.95";"6.81";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4469900";"";"None";"596.70";"1";"3.42";"39";"C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"11.01";"0.20";"3.15";"4.55";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4463563";"";"None";"596.70";"1";"3.42";"42";"C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1";"IC50";"'='";"1481.0";"nM";"5.83";"";"";"UO_0000065";"9.77";"0.18";"2.41";"4.03";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4095253";"";"None";"427.49";"0";"2.35";"B6";"C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21";"IC50";"'='";"88.6";"nM";"7.05";"";"";"UO_0000065";"16.50";"0.32";"4.70";"6.27";"0";"CHEMBL4058120";"Inhibition of recombinant human full length N-terminal His6-tagged BTK expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by LSNLYHQGKFLQT substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052785";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4218643";"";"None";"591.69";"2";"5.03";"18b";"CN1CCN(c2ccc(Nc3nc(N)cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)n3)cc2)CC1";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"13.99";"0.26";"3.25";"7.35";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6d; BMS-986143";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.26";"nM";"9.59";"";"";"UO_0000065";"16.32";"0.32";"3.90";"7.82";"1";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4210972";"";"None";"553.60";"1";"3.96";"25e";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(C3(CO)CC3)c2)n1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"16.66";"0.31";"5.26";"6.40";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4441551";"";"None";"555.70";"2";"6.04";"7c";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(Nc4ccc(N5CCOCC5)cc4)c(C(N)=O)s3)c2)cc1";"IC50";"'='";"2229.0";"nM";"5.65";"";"";"UO_0000065";"10.17";"0.19";"-0.39";"5.16";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4591291";"";"None";"519.55";"1";"4.61";"24";"C=CC(=O)N1CC[C@@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"15.64";"0.29";"3.51";"7.36";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4468719";"";"None";"509.56";"1";"4.69";"32";"CCC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"11.55";"0.22";"1.20";"5.33";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4513614";"";"None";"523.54";"1";"3.57";"15";"C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C(C)(C)O)cc3F)c2C)C1";"IC50";"'='";"108.0";"nM";"6.97";"";"";"UO_0000065";"13.31";"0.25";"3.40";"5.33";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4557061";"";"None";"493.51";"0";"4.12";"18";"C=CC(=O)NCCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"15.69";"0.29";"3.62";"6.50";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4591291";"";"None";"519.55";"1";"4.61";"24";"C=CC(=O)N1CC[C@@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"13.90";"0.26";"2.61";"6.54";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4471613";"";"None";"505.53";"1";"3.91";"30";"C#CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"17.30";"0.32";"4.83";"7.92";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4100424";"";"None";"547.55";"2";"5.20";"16";"Nc1nccn2c([C@@H]3CCC[C@H](c4nnc[nH]4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"17.39";"0.33";"4.32";"6.81";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4095276";"";"None";"538.53";"2";"5.39";"36";"CC1(C(=O)O)CCC(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)CC1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"15.50";"0.29";"2.96";"6.16";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4096195";"";"None";"566.58";"2";"5.81";"39";"CC(C)[C@@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"16.59";"0.31";"3.59";"6.94";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4070603";"";"None";"425.46";"1";"5.04";"3a";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]ccc23)c1CO";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"15.17";"0.28";"1.42";"9.10";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4094133";"";"None";"572.64";"2";"6.41";"3g";"CN(C)C(=O)c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1";"IC50";"'='";"94.2";"nM";"7.03";"";"";"UO_0000065";"12.27";"0.22";"0.62";"7.70";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3647972";"";"None";"462.94";"0";"4.27";"BDBM97677";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)CCl)C1";"IC50";"'='";"0.58";"nM";"9.24";"";"213457";"UO_0000065";"19.95";"0.38";"4.97";"9.31";"1";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4213985";"";"None";"523.57";"1";"4.81";"25d";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(C3CC3)c2)n1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"16.34";"0.30";"3.74";"6.90";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"213454";"UO_0000065";"20.75";"0.38";"4.92";"9.22";"0";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3958574";"";"None";"378.44";"1";"5.50";"BDBM195815";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccccc5[nH]4)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348528";"UO_0000065";"16.20";"0.29";"0.63";"8.33";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3926815";"";"None";"441.49";"0";"3.72";"15";"C=CC(=O)N1CCC(c2cn3nc(-c4ccc(Oc5ccccc5)cc4)c(C(N)=O)c3[nH]2)C1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"16.92";"0.31";"3.75";"7.06";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4473176";"";"None";"520.56";"2";"5.46";"17";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2cccc(F)c2c1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.95";"0.29";"2.84";"7.28";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4550390";"";"None";"474.52";"0";"4.59";"21";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(CO)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"17.96";"0.32";"3.93";"7.48";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"6";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.09";"0.27";"2.27";"6.65";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4285217";"";"None";"570.65";"2";"2.98";"4";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(CCC)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"21.8";"nM";"7.66";"";"";"UO_0000065";"13.43";"0.25";"4.68";"6.05";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4791135";"";"None";"522.56";"2";"5.19";"17";"CC#CC(=O)Nc1cc2c(Oc3ccc(C(=O)Nc4ccccn4)cc3)ccnc2cc1OC1CCOCC1";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"16.11";"0.29";"3.23";"7.54";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4794213";"";"None";"482.50";"0";"4.27";"20";"COCC#CC(=O)Nc1cc2c(Oc3ccc(C(=O)Nc4ccccn4)cc3)ccnc2cc1OC";"IC50";"'='";"0.96";"nM";"9.02";"";"";"UO_0000065";"18.69";"0.34";"4.75";"8.08";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4287216";"";"None";"276.30";"0";"-0.96";"7";"C=CC(=O)N[C@H]1CCN(c2ncc(C(N)=O)c(N)n2)C1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"24.41";"0.46";"7.70";"5.30";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.02";"0.40";"5.48";"9.78";"1";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4285813";"";"None";"482.56";"0";"2.56";"18";"C=CC(=O)N[C@H]1CCN(c2nc(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)cc3)c(C(N)=O)cc2F)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.28";"0.31";"5.29";"6.96";"0";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4292583";"";"None";"462.60";"0";"2.79";"20";"C=CC(=O)N(C)[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)C1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"15.97";"0.30";"4.60";"7.79";"0";"CHEMBL4264697";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human PBMC assessed as suppression of BCR-induced CD69 expression on B cells pretreated for 1 hr followed by blood stimulation measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4795673";"";"None";"511.56";"1";"4.92";"8";"C=CC(=O)N(C)C(=O)Cc1c[nH]c2ncnc(-c3cc(F)cc(NC(=O)c4ccc(C5CC5)cc4)c3C)c12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"15.24";"0.28";"2.88";"7.22";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4739958";"";"None";"523.61";"2";"6.09";"12";"C=CC(=O)N1CCC(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"14.75";"0.27";"1.63";"8.49";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4740933";"";"None";"509.59";"2";"5.70";"10";"C=CC(=O)N1CCC(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.29";"0.30";"2.60";"9.12";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4746262";"";"None";"511.56";"1";"4.42";"9";"C=CC(=O)N1CC(O)(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"17.31";"0.32";"4.43";"7.96";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4795673";"";"None";"511.56";"1";"4.92";"8";"C=CC(=O)N(C)C(=O)Cc1c[nH]c2ncnc(-c3cc(F)cc(NC(=O)c4ccc(C5CC5)cc4)c3C)c12";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.44";"0.32";"4.00";"8.26";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"18.84";"0.34";"4.08";"8.37";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4106583";"";"None";"593.57";"1";"4.44";"BDBM255404";"CC(=O)Oc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"3.9";"nM";"8.41";"";"445311";"UO_0000065";"14.17";"0.27";"3.97";"5.81";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106570";"";"None";"593.57";"1";"4.59";"BDBM255405";"CC(=O)Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3O)c12";"IC50";"'='";"4.4";"nM";"8.36";"";"445312";"UO_0000065";"14.08";"0.27";"3.77";"5.89";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113785";"";"None";"525.59";"1";"4.51";"BDBM255417";"Nc1ncc(F)n2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CC5)ccn4)cc3)c12";"IC50";"'='";"1.5";"nM";"8.82";"";"445324";"UO_0000065";"16.79";"0.31";"4.31";"7.45";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112520";"";"None";"525.49";"1";"4.11";"BDBM255422";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)on4)cc3)c12";"IC50";"'='";"245.4";"nM";"6.61";"";"445329";"UO_0000065";"12.58";"0.24";"2.50";"5.02";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113593";"";"None";"510.60";"1";"3.71";"BDBM255430";"Cn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)cc1C1CC1";"IC50";"'='";"0.93";"nM";"9.03";"";"445337";"UO_0000065";"17.69";"0.32";"5.32";"7.32";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110933";"";"None";"601.99";"2";"5.61";"BDBM255446";"Cc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"7.8";"nM";"8.11";"";"445353";"UO_0000065";"13.47";"0.26";"2.50";"6.84";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115078";"";"None";"546.03";"1";"4.46";"BDBM255459";"COc1cc(C(=O)Nc2ccc(C)cn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"1.4";"nM";"8.85";"";"445366";"UO_0000065";"16.21";"0.31";"4.39";"6.93";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113370";"";"None";"634.45";"2";"5.83";"BDBM255467";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)c(Cl)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"1.8";"nM";"8.74";"";"445374";"UO_0000065";"13.78";"0.28";"2.91";"6.85";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111662";"";"None";"611.60";"2";"5.30";"BDBM255468";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)cc(F)c1-c1nc([C@@H]2CC[C@H]3CC(C)(C)C(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.28";"nM";"9.55";"";"445375";"UO_0000065";"15.62";"0.30";"4.25";"7.48";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3621499";"";"None";"442.52";"0";"3.48";"9";"COc1ccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)cc1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"16.41";"0.30";"3.78";"7.92";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3621505";"";"None";"469.55";"0";"2.83";"15";"CNC(=O)c1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"15.22";"0.28";"4.32";"6.41";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622190";"";"None";"588.71";"2";"5.10";"31";"Cc1c(NC(=O)c2ccc(N(C)C)cc2)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"14.36";"0.26";"3.36";"7.37";"0";"CHEMBL3627421";"Inhibition of human recombinant BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3647966";"";"None";"426.48";"0";"3.83";"BDBM97671";"C=CC(=O)N1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"213461";"UO_0000065";"20.62";"0.38";"4.97";"8.87";"0";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3964073";"";"None";"422.29";"0";"3.88";"3";"Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1Cc2ccccc2C1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"18.76";"0.40";"4.04";"8.82";"1";"CHEMBL4190836";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190187";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4204802";"";"None";"537.62";"1";"4.32";"3c";"Nc1nc(Nc2ccc(N3CCOCC3)cc2)nc(-c2cccc(NC(=O)c3ccc(C4CC4)cc3)c2CO)n1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"12.75";"0.23";"2.53";"4.95";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4444564";"";"None";"469.55";"0";"3.11";"9k";"CC(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"9.7";"nM";"8.01";"";"";"UO_0000065";"17.07";"0.31";"4.90";"6.52";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL1090672";"";"None";"278.31";"0";"3.10";"4";"COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1";"IC50";"'='";"456.0";"nM";"6.34";"";"";"UO_0000065";"22.78";"0.41";"3.24";"11.53";"0";"CHEMBL4412233";"Inhibition of BTK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411283";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4473820";"";"None";"406.52";"0";"3.77";"1";"CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1";"IC50";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"14.27";"0.27";"2.03";"5.99";"0";"CHEMBL4331124";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330071";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3358406";"";"None";"576.68";"2";"5.26";"16l";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4)cn(C)c3=O)nc2)CC1";"IC50";"'='";"472.0";"nM";"6.33";"";"";"UO_0000065";"10.97";"0.20";"1.07";"8.39";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3977729";"";"None";"417.47";"0";"3.10";"33b";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"19.82";"0.36";"5.18";"7.44";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3910697";"";"None";"421.89";"0";"3.83";"29a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)cc3)nn21";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"13.80";"0.27";"1.99";"5.71";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4094515";"";"None";"676.77";"1";"4.79";"22";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N5CCOCC5)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"273.0";"nM";"6.56";"";"";"UO_0000065";"9.70";"0.18";"1.77";"4.89";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4059850";"";"None";"633.75";"2";"6.08";"17";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"11.83";"0.22";"1.41";"6.15";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4250380";"";"None";"494.55";"0";"4.84";"15h";"COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCCC6)cc5)c4c3c2)cn1";"IC50";"'='";"183.0";"nM";"6.74";"";"";"UO_0000065";"13.62";"0.25";"1.90";"7.52";"0";"CHEMBL4235188";"Inhibition of recombinant full length human N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4788086";"";"None";"465.56";"1";"5.21";"6";"C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cccc(NC(=O)c4ccc(C5CC5)cc4)c3C)c12";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"14.44";"0.26";"1.51";"7.39";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3400825";"";"None";"942.07";"4";"9.05";"1a";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)NCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)n1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"6.94";"0.13";"-2.51";"3.01";"0";"CHEMBL3407011";"Inhibition of biotinylated and activated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3929445";"";"None";"700.74";"2";"6.36";"BDBM202149";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cc(F)cc(-c2ccnc3[nH]c(-c4ccc(CN5CCN(CC(F)F)CC5)cn4)cc23)c1CO";"IC50";"'='";"0.65";"nM";"9.19";"";"358226";"UO_0000065";"13.11";"0.25";"2.83";"9.39";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959907";"";"None";"627.75";"2";"6.50";"BDBM202156";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCC(C)(O)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"51.0";"nM";"7.29";"";"358233";"UO_0000065";"11.62";"0.21";"0.79";"6.53";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952971";"";"None";"621.71";"2";"5.10";"BDBM202207";"O=C(CN1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1)N1CCC1";"IC50";"'='";"1.2";"nM";"8.92";"";"358283";"UO_0000065";"14.35";"0.26";"3.82";"8.75";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968064";"";"None";"566.63";"2";"5.41";"BDBM202209";"CC(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"3.6";"nM";"8.44";"";"358285";"UO_0000065";"14.90";"0.27";"3.03";"8.55";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3944128";"";"None";"619.70";"2";"5.92";"BDBM202219";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(OCCN5CCC5)cn4)cc23)c1CO";"IC50";"'='";"3.1";"nM";"8.51";"";"358294";"UO_0000065";"13.73";"0.25";"2.59";"8.20";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918358";"";"None";"693.75";"2";"6.22";"BDBM202220";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cc(F)cc(-c2ccnc3[nH]c(-c4ccc(OC5CCN(C6COC6)CC5)cn4)cc23)c1CO";"IC50";"'='";"1.15";"nM";"8.94";"";"358295";"UO_0000065";"12.89";"0.24";"2.72";"7.91";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979659";"";"None";"607.73";"2";"5.57";"BDBM202223";"CCN1CC(N2CC=C(c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)CC2)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"358297";"UO_0000065";"14.52";"0.27";"3.25";"10.39";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923814";"";"None";"635.74";"2";"5.35";"BDBM202226";"CCN1CC(C(=O)N2CC=C(c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)CC2)C1";"IC50";"'='";"0.75";"nM";"9.12";"";"358300";"UO_0000065";"14.35";"0.27";"3.77";"8.95";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963872";"";"None";"600.72";"2";"5.45";"BDBM202229";"CN1CCN(c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"358303";"UO_0000065";"14.19";"0.26";"3.07";"8.71";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897574";"";"None";"498.59";"0";"3.27";"BDBM249996";"CN(C)C/C=C/C(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2CC1";"IC50";"'='";"0.78";"nM";"9.11";"";"435925";"UO_0000065";"18.27";"0.34";"5.84";"8.36";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918154";"";"None";"417.47";"0";"3.19";"BDBM250044";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cccc(OC)c3)nn21";"IC50";"'='";"2.7";"nM";"8.57";"";"435973";"UO_0000065";"20.53";"0.38";"5.38";"7.70";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981330";"";"None";"465.52";"0";"3.84";"BDBM197209";"N#C/C(=C\C1CC1)C(=O)NCCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"4.8";"nM";"8.32";"";"350376";"UO_0000065";"17.87";"0.32";"4.48";"6.31";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114784";"";"None";"536.61";"2";"5.77";"BDBM197229";"Cc1c(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc2n1C[C@H]1CCCN1C(=O)/C(C#N)=C/C1CC1";"IC50";"'='";"56.0";"nM";"7.25";"";"350384";"UO_0000065";"13.51";"0.25";"1.48";"6.59";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114661";"";"None";"539.62";"2";"5.49";"BDBM60901";"CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"8.0";"nM";"8.10";"";"350390";"UO_0000065";"15.00";"0.28";"2.61";"6.59";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114651";"";"None";"543.58";"2";"5.24";"BDBM197238";"CC(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3c(F)cccc3F)cc2)c2c(N)ncnc21";"IC50";"'='";"100.0";"nM";"7.00";"";"350391";"UO_0000065";"12.88";"0.24";"1.76";"5.69";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114701";"";"None";"610.69";"1";"4.56";"BDBM197221";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCOCC1";"IC50";"'='";"26.5";"nM";"7.58";"";"350399";"UO_0000065";"12.41";"0.23";"3.02";"5.60";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3966346";"";"None";"580.66";"2";"5.27";"BDBM202197";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"22.0";"nM";"7.66";"";"358273";"UO_0000065";"13.19";"0.24";"2.39";"8.42";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934649";"";"None";"568.65";"2";"5.77";"BDBM200764";"Cc1c(NC(=O)c2ccc3c(c2)OCC3(C)C)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"4.0";"nM";"8.40";"";"356840";"UO_0000065";"14.77";"0.27";"2.63";"8.12";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903518";"";"None";"502.55";"1";"4.54";"BDBM200794";"CC(C)(O)c1ccc(C(=O)Nc2cccc(-c3ncnc4[nH]c(C5=CCOCC5)cc34)c2CO)c(F)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"356861";"UO_0000065";"15.76";"0.29";"3.38";"6.58";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975732";"";"None";"561.68";"2";"5.67";"BDBM200849";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(S(C)(=O)=O)CC3)cc12";"IC50";"'='";"30.0";"nM";"7.52";"";"356880";"UO_0000065";"13.39";"0.26";"1.85";"6.96";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969103";"";"None";"439.52";"0";"4.89";"BDBM249886";"CNc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"1000.0";"nM";"6.00";"";"435806";"UO_0000065";"13.65";"0.25";"1.11";"6.37";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904488";"";"None";"471.56";"0";"4.50";"BDBM249891";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC4CCCC4)cc3)nn21";"IC50";"'='";"1.3";"nM";"8.89";"";"435811";"UO_0000065";"18.84";"0.35";"4.39";"7.99";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937995";"";"None";"443.51";"0";"3.44";"BDBM250084";"C=CC(=O)N1CC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"435828";"UO_0000065";"20.04";"0.37";"5.45";"8.67";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4111503";"";"None";"443.51";"0";"3.44";"BDBM250085";"C=CC(=O)N1CC[C@@H]2[C@H](CNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"0.66";"nM";"9.18";"";"435830";"UO_0000065";"20.70";"0.38";"5.74";"8.96";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943386";"";"None";"443.51";"0";"3.44";"BDBM250086";"C=CC(=O)N1CC[C@H]2[C@@H](CNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"435831";"UO_0000065";"17.58";"0.32";"4.36";"7.61";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917502";"";"None";"451.49";"0";"4.48";"BDBM249940";"C=CC(=O)Nc1ccc2c(c1)-n1nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c1NC2";"IC50";"'='";"7.8";"nM";"8.11";"";"435872";"UO_0000065";"17.96";"0.33";"3.63";"7.29";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965549";"";"None";"443.51";"0";"3.44";"BDBM249902";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"40.0";"nM";"7.40";"";"435922";"UO_0000065";"16.68";"0.31";"3.96";"7.22";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916090";"";"None";"485.59";"0";"4.40";"BDBM250016";"C=CC(=O)N1CCC(C2(C)CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"435945";"UO_0000065";"18.53";"0.34";"4.60";"8.78";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4112880";"";"None";"635.02";"2";"5.04";"BDBM255365";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)n(C)n2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.67";"nM";"9.17";"";"445271";"UO_0000065";"14.45";"0.28";"4.13";"6.91";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111899";"";"None";"617.99";"2";"5.31";"BDBM255381";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)c(F)cc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"1.2";"nM";"8.92";"";"445288";"UO_0000065";"14.44";"0.28";"3.61";"6.98";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108745";"";"None";"605.62";"2";"5.44";"BDBM255389";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CCC3)c12";"IC50";"'='";"4.6";"nM";"8.34";"";"445296";"UO_0000065";"13.77";"0.26";"2.90";"6.53";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110184";"";"None";"586.10";"2";"5.42";"BDBM255458";"COc1cc(C(=O)Nc2cc(C3CCC3)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12";"IC50";"'='";"0.41";"nM";"9.39";"";"445365";"UO_0000065";"16.02";"0.31";"3.97";"7.35";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4552410";"";"None";"532.71";"2";"5.17";"7s";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)[C@H]5CC[C@H](C)CC5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"13.10";"0.25";"1.81";"6.74";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4476146";"";"None";"597.79";"2";"7.08";"7u";"CC(C)NC(=O)c1sc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2)nc1Nc1ccc(N2CCOCC2)cc1";"IC50";"'='";"62845.0";"nM";"4.20";"";"";"UO_0000065";"7.03";"0.13";"-2.88";"4.40";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4105206";"";"None";"574.66";"2";"6.07";"3o";"O=C(C1CC1)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"10.4";"nM";"7.98";"";"";"UO_0000065";"13.89";"0.25";"1.91";"8.75";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3917327";"";"None";"488.61";"1";"5.44";"BDBM195776";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348513";"UO_0000065";"12.55";"0.24";"0.69";"6.44";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4130016";"";"None";"674.81";"2";"4.98";"12";"C=CC(=O)Nc1cccc(-n2c(=O)n(CCCc3ccccc3)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"10.55";"0.19";"2.14";"5.62";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL3901385";"";"None";"335.79";"0";"4.24";"BDBM195765";"C#CC1(C(=O)Nc2cccc(-c3cnc4[nH]cc(Cl)c4c3)c2)CC1";"IC50";"'='";"739.0";"nM";"6.13";"";"348504";"UO_0000065";"18.26";"0.35";"1.89";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3902940";"";"None";"570.67";"2";"5.37";"BDBM200768";"Cc1c(NC(=O)c2ccc(C(C)(C)CO)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"2.0";"nM";"8.70";"";"356844";"UO_0000065";"15.24";"0.28";"3.33";"7.60";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973003";"";"None";"597.76";"2";"6.87";"BDBM202096";"Cc1c(-c2ccnc3[nH]c(-c4ccc(CN5CCN(C)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"103.0";"nM";"6.99";"";"358174";"UO_0000065";"11.69";"0.21";"0.12";"10.80";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927548";"";"None";"600.72";"2";"5.87";"BDBM202098";"CC1(O)CN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cc2)C1";"IC50";"'='";"6.0";"nM";"8.22";"";"358176";"UO_0000065";"13.69";"0.25";"2.35";"8.07";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891177";"";"None";"575.67";"2";"5.85";"BDBM202125";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4cnn(C5CCOCC5)c4)cc23)c1CO";"IC50";"'='";"43.0";"nM";"7.37";"";"358203";"UO_0000065";"12.80";"0.23";"1.52";"6.98";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3922230";"";"None";"614.75";"2";"5.45";"BDBM202130";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"358208";"UO_0000065";"13.50";"0.25";"2.85";"8.49";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951173";"";"None";"613.72";"2";"6.11";"BDBM202154";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCC(O)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"32.0";"nM";"7.50";"";"358231";"UO_0000065";"12.21";"0.22";"1.38";"6.71";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923452";"";"None";"613.72";"2";"6.11";"BDBM202155";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCCC(O)C5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"42.0";"nM";"7.38";"";"358232";"UO_0000065";"12.02";"0.22";"1.27";"6.61";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957615";"";"None";"598.71";"2";"5.56";"BDBM202158";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCNCC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"9.7";"nM";"8.01";"";"358235";"UO_0000065";"13.38";"0.24";"2.45";"7.75";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940111";"";"None";"582.71";"2";"5.73";"BDBM202171";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCNCC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"36.0";"nM";"7.44";"";"358248";"UO_0000065";"12.77";"0.23";"1.71";"7.90";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962739";"";"None";"580.66";"2";"5.27";"BDBM202202";"O=C1c2ccc(C3CC3)cc2OCCN1c1cc(F)cc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"2.5";"nM";"8.60";"";"358278";"UO_0000065";"14.81";"0.27";"3.33";"9.46";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967939";"";"None";"582.63";"1";"4.39";"BDBM202215";"O=C(CO)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"358291";"UO_0000065";"15.45";"0.29";"4.61";"7.56";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960361";"";"None";"552.65";"2";"5.89";"BDBM202224";"CCN1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"358298";"UO_0000065";"13.86";"0.26";"1.77";"9.37";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4068131";"";"None";"536.51";"1";"4.93";"28";"Nc1nccn2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nc2[C@]12CC[C@](C(=O)O)(CC1)C2";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"15.00";"0.28";"3.12";"5.94";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4096195";"";"None";"566.58";"2";"5.81";"39";"CC(C)[C@@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"13.59";"0.26";"1.89";"5.68";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3670113";"";"None";"610.73";"1";"4.79";"BDBM111972";"CCN1CCc2nc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)ccc2C1";"IC50";"'='";"2.8";"nM";"8.55";"";"233027";"UO_0000065";"14.00";"0.26";"3.76";"8.94";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670125";"";"None";"600.70";"1";"4.10";"BDBM111984";"CN(C)CCOc1ccc(Nc2cc(-c3cc(F)cc(N4CCn5c(cc6c5CCCC6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"4.2";"nM";"8.38";"";"233039";"UO_0000065";"13.94";"0.26";"4.28";"7.99";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670131";"";"None";"669.82";"2";"5.54";"BDBM111990";"Cn1cc(-c2cc(F)cc(N3CCc4c(sc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(C3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"4.9";"nM";"8.31";"";"233045";"UO_0000065";"12.41";"0.24";"2.77";"8.32";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3647514";"";"None";"452.52";"0";"4.22";"BDBM143316";"C=CC(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"279476";"UO_0000065";"19.89";"0.36";"4.78";"9.08";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114094";"";"None";"537.50";"1";"3.71";"26";"Nc1nccn2c([C@H]3CN4C(=O)CC[C@@H]4CO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"15.15";"0.29";"4.43";"6.37";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4286241";"";"None";"559.63";"2";"3.34";"9";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1";"IC50";"'='";"31.9";"nM";"7.50";"";"";"UO_0000065";"13.39";"0.25";"4.16";"5.65";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4276842";"";"None";"542.60";"2";"2.11";"2";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"236.6";"nM";"6.63";"";"";"UO_0000065";"12.21";"0.23";"4.52";"5.23";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL3953957";"";"None";"421.45";"0";"4.38";"BDBM249204";"CC(C)(C)c1cc(F)c2c(=O)n(Cc3ccc(-c4cc[nH]c(=O)c4)cc3F)ncc2c1";"IC50";"'='";"982.77";"nM";"6.01";"";"434802";"UO_0000065";"14.25";"0.26";"1.63";"8.87";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4850816";"";"None";"480.53";"0";"3.63";"1";"CNC(=O)[C@H]1Cc2c([nH]c3ccccc23)CN1C(=O)c1occc1CNc1ccc2nccnc2c1";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"19.27";"0.35";"5.63";"7.97";"0";"CHEMBL4813333";"Inhibition of recombinant wild type human N-terminal His6-tagged BTK expressed in baculovirus incubated for 20 mins by TR-FRET based competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.3333 hr";"INHIBITOR";""
"CHEMBL4854947";"";"None";"444.53";"0";"0.81";"6";"CNC(=O)[C@@H](Cc1ccc(C#N)cc1)NC(=O)[C@@H](NC(=O)[C@]1(C)CO1)[C@@H](C)OC(C)(C)C";"IC50";"'='";"58.1";"nM";"7.24";"";"";"UO_0000065";"16.28";"0.31";"6.43";"5.45";"0";"CHEMBL4813334";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4866645";"";"None";"512.57";"1";"1.64";"2";"CNC(=O)[C@H]1Cc2c([nH]c3ccccc23)CN1C(=O)[C@@H](Cc1ccccc1)NC(=O)c1c[nH]c(C(N)=O)c1";"IC50";"'='";"56.2";"nM";"7.25";"";"";"UO_0000065";"14.14";"0.26";"5.61";"4.73";"0";"CHEMBL4813341";"Inhibition of recombinant human N-terminal His-tagged BTK C481S mutant expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3605113";"";"None";"517.01";"2";"5.06";"24b";"CNC(=O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)c5cccc(Cl)c5)cc4)csc23)cn1";"IC50";"'='";"408.7";"nM";"6.39";"";"";"UO_0000065";"12.36";"0.24";"1.33";"5.56";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3612989";"";"None";"470.60";"1";"5.52";"14c";"CNC(=O)CN1C=C(c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)CCC1";"IC50";"'='";"455.7";"nM";"6.34";"";"";"UO_0000065";"13.47";"0.25";"0.82";"7.88";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"14";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"19.65";"0.36";"4.44";"8.73";"1";"CHEMBL4668340";"Inhibition of wild type BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665674";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3263646";"";"None";"575.67";"2";"5.79";"26";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(Nc4ccc(C(=O)N5CCOCC5)cc4)c4nc[nH]c4n3)c2)cc1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"13.00";"0.24";"1.69";"5.98";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL4106978";"";"None";"535.53";"1";"4.51";"4";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"14.23";"0.27";"3.11";"6.43";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4111689";"";"None";"549.56";"1";"4.97";"BDBM255311";"CNc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"12.7";"nM";"7.90";"";"445216";"UO_0000065";"14.37";"0.27";"2.93";"7.55";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111338";"";"None";"601.54";"2";"5.11";"BDBM255322";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC(F)F)c12";"IC50";"'='";"0.48";"nM";"9.32";"";"445227";"UO_0000065";"15.49";"0.30";"4.21";"7.30";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3984936";"";"None";"578.56";"2";"4.04";"BDBM246407";"CC(C)Oc1ccnc(NC(=O)c2ccc(-c3nc(N4CCn5c(nnc5C(F)(F)F)C4)n4ccnc(N)c34)cc2)c1";"IC50";"'='";"43.0";"nM";"7.37";"";"429716";"UO_0000065";"12.73";"0.24";"3.33";"5.21";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3670094";"";"None";"611.72";"1";"3.91";"19";"CN1CCN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.22";"0.26";"4.79";"8.80";"1";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4092347";"";"None";"550.04";"2";"6.21";"10k";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(NS(=O)(=O)c4ccc(C)cc4)c(C)c3)ncc2Cl)c1";"IC50";"'='";"1.05";"nM";"8.98";"";"";"UO_0000065";"16.32";"0.32";"2.77";"7.34";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4101411";"";"None";"597.68";"2";"4.71";"14; CHMFL-FLT3-213";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"11.75";"0.22";"2.31";"4.43";"0";"CHEMBL4031407";"Inhibition of BTK (unknown origin) using poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028866";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4644593";"";"None";"516.55";"2";"5.93";"50";"C=CC(=O)NCCOc1cc(Cc2ccccc2OC)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"13.03";"0.24";"0.80";"7.31";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4640099";"";"None";"396.40";"0";"4.33";"27";"C=CC(=O)NCCOc1cccc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"19.18";"0.36";"3.27";"9.18";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4634889";"";"None";"546.57";"2";"5.94";"53";"C=CC(=O)NCCOc1cc(Cc2c(OC)cccc2OC)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"331.0";"nM";"6.48";"";"";"UO_0000065";"11.86";"0.22";"0.54";"6.40";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL3647964";"";"None";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"21.33";"0.39";"5.18";"9.48";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4242598";"";"None";"456.50";"0";"3.74";"16";"C=CC(=O)N1C[C@@H]2C[C@H]1CN2c1ccc(C(N)=O)c(Oc2ccc(Oc3ccccc3)cc2)n1";"IC50";"'='";"9.7";"nM";"8.01";"";"";"UO_0000065";"17.55";"0.32";"4.27";"8.18";"0";"CHEMBL4236258";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced CD69 expression incubated for 1 hr by flow cytometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229542";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4129607";"";"None";"653.79";"2";"3.62";"16";"C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCC(N6CCN(C)CC6)CC5)cc4OC)nc32)c1";"IC50";"'='";"145.0";"nM";"6.84";"";"";"UO_0000065";"10.46";"0.19";"3.22";"5.27";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4126630";"";"None";"554.66";"1";"3.45";"18";"C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)c1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"16.40";"0.30";"5.65";"7.75";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL3922120";"";"None";"441.49";"0";"3.68";"12";"C=CC(=O)N1CCCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"19.99";"0.37";"5.14";"8.35";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"31a; BGB-3111";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"18.54";"0.34";"4.52";"8.53";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3962133";"";"None";"427.46";"0";"3.29";"10";"C=CC(=O)N1CCc2c([nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)C1";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"23.13";"0.42";"6.60";"9.35";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3906546";"";"None";"471.44";"0";"4.08";"26";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC(F)(F)F)cc3)nn21";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"17.77";"0.34";"4.30";"7.53";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3965549";"";"None";"443.51";"0";"3.44";"32a";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"20.83";"0.38";"5.80";"9.01";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4860487";"";"None";"481.56";"0";"3.96";"22a";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)n(C)c23)CC1";"IC50";"'='";"1622.0";"nM";"5.79";"";"";"UO_0000065";"12.02";"0.22";"1.83";"6.10";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4277912";"";"None";"570.65";"2";"3.15";"7";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(OC)c4)nc32)c1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"15.11";"0.28";"5.47";"6.81";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4465380";"";"None";"503.60";"2";"5.83";"15";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1N1CCc2ccccc2C1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.92";"0.31";"2.69";"8.57";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3939772";"";"None";"488.55";"1";"5.01";"22";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3)c12";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"15.06";"0.27";"2.35";"6.45";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"6";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.63";"0.28";"2.53";"6.89";"0";"CHEMBL4429405";"Inhibition of BTK in human PBMC assessed as suppression of FCgamma2aR/FCgamma3R stimulated TNFalpha production after 7 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4793026";"";"None";"483.55";"1";"5.35";"7";"C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cc(F)cc(NC(=O)c4ccc(C5CC5)cc4)c3C)c12";"IC50";"'='";"1260.0";"nM";"5.90";"";"";"UO_0000065";"12.20";"0.22";"0.55";"6.48";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL3929151";"";"None";"384.87";"0";"3.29";"BDBM250516";"O=C(NCc1cccc(Cl)c1)C1CCCC(Nc2ncnc3[nH]cnc23)C1";"IC50";"'='";"100000.0";"nM";"4.00";"";"436764";"UO_0000065";"10.39";"0.20";"0.71";"4.18";"0";"CHEMBL3889150";"FRET (Forster/Flouresence Resonance Energy Transfer) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 ul of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission). The negative control well values were averaged to obtain the mean minimum. The positive 'no inhibitor' control wells were averaged to obtain the mean maximum.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886966";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4869977";"";"None";"538.65";"2";"5.67";"41";"Cc1c(NC(=O)C2CCCCC2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"932.0";"nM";"6.03";"";"";"UO_0000065";"11.20";"0.21";"0.36";"5.37";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4756023";"";"None";"398.51";"1";"5.16";"7";"Cc1cc(-c2ncnc3[nH]ccc23)ccc1CNC(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"12.82";"0.23";"-0.05";"7.23";"0";"CHEMBL4701077";"Inhibition of BTK in human whole blood assessed as reduction in BTK phosphorylation measured after 30 mins by phosphotyrosine detection method";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5j";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"14.64";"0.27";"3.32";"6.41";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4741099";"";"None";"553.02";"2";"5.04";"5e";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2cc(Cl)ccn2c1=O";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.99";"0.19";"0.48";"4.51";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5j";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"91.0";"nM";"7.04";"";"";"UO_0000065";"13.12";"0.24";"2.51";"5.74";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6c";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"11.56";"0.23";"1.10";"5.54";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6c";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.32";"0.30";"3.31";"7.34";"0";"CHEMBL4672871";"Inhibition of BTK in human peripheral B cells assessed as reduction in anti-IgM/IgG-induced CD86 surface expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"B cell";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6c";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.81";"0.29";"3.01";"7.10";"0";"CHEMBL4672873";"Inhibition of BTK in human PBMC cells assessed as inhibition of FCepsilonR1/immune complex-induced TNFalpha production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4795828";"";"None";"457.54";"0";"4.42";"C1";"C=CC(=O)Nc1cc(Nc2ncnc(Nc3ccc(C(=O)N4CCCCC4)cc3)n2)ccc1C";"IC50";"'='";"146.0";"nM";"6.84";"";"";"UO_0000065";"14.94";"0.27";"2.42";"6.10";"0";"CHEMBL4769955";"Inhibition of BTK (unknown origin) by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765318";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL4061898";"";"None";"551.03";"2";"5.55";"10g";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NS(=O)(=O)c4ccc(OC)cc4)cc3)ncc2Cl)c1";"IC50";"'='";"9.14";"nM";"8.04";"";"";"UO_0000065";"14.59";"0.29";"2.49";"5.98";"0";"CHEMBL4053931";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052620";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4101977";"";"None";"371.80";"0";"4.00";"8";"C=CC(=O)Nc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1";"IC50";"'='";"1.91";"nM";"8.72";"";"";"UO_0000065";"23.45";"0.46";"4.72";"10.54";"0";"CHEMBL4020207";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition by filter binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4229083";"";"None";"404.47";"0";"2.85";"8a2";"C=CC(=O)N1CCC[C@@H](n2nc(/C=C\COc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"23.2";"nM";"7.63";"";"";"UO_0000065";"18.88";"0.35";"4.78";"7.70";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4229038";"";"None";"432.48";"0";"2.20";"8j";"C=CC(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3OC)c3c(N)ncnc32)C1";"IC50";"'='";"38.17";"nM";"7.42";"";"";"UO_0000065";"17.15";"0.32";"5.22";"6.84";"0";"CHEMBL4222711";"Inhibition of full length human N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using biotinylated substrate after 50 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219164";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL2057918";"";"None";"606.70";"1";"4.76";"1, RN486";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"13.2";"nM";"7.88";"";"";"UO_0000065";"12.99";"0.24";"3.12";"8.24";"1";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4857217";"";"None";"482.56";"1";"5.39";"4";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"17.01";"0.31";"2.82";"9.28";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4871425";"";"None";"486.58";"1";"5.03";"9";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5cc6c(s5)CCCC6)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.12";"0.36";"4.27";"10.51";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4876918";"";"None";"488.61";"1";"5.63";"14";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)C5CCC(C(C)(C)C)CC5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"16.01";"0.30";"2.19";"8.84";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4869628";"";"None";"459.53";"0";"4.11";"15";"CC1CC2(C1)CN(C(=O)NCc1ccc(-c3ccnc4[nH]c(-c5cnn(C)c5)nc34)cc1F)C2";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"16.44";"0.30";"3.44";"8.23";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4855916";"";"None";"482.55";"0";"4.13";"21";"Cn1cc(-c2nc3c(-c4ccc(C5(NC(=O)c6nc(C(C)(C)C)no6)CC5)cc4)ccnc3[nH]2)cn1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"17.76";"0.33";"4.44";"6.73";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4848010";"";"None";"566.67";"2";"5.33";"23";"CC(C)(C)c1noc(C(=O)NC2CCCc3cc(-c4ccnc5[nH]c(-c6cnn(C7CCOCC7)c6)nc45)ccc32)n1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"15.74";"0.29";"3.59";"6.53";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1,Imbruvica, PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.06";"0.35";"4.18";"8.47";"1";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3612841";"";"None";"481.58";"1";"5.65";"13c";"Nc1ncc(-c2cnn(C3CCCNC3=O)c2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"16.66";"0.31";"2.37";"8.44";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3647967";"";"None";"454.53";"0";"4.65";"BDBM97672";"C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"0.58";"nM";"9.24";"";"213460";"UO_0000065";"20.32";"0.37";"4.59";"8.56";"0";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"20.93";"0.38";"5.00";"9.30";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4284780";"";"None";"556.63";"2";"2.59";"3";"C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(CC)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"17.2";"nM";"7.76";"";"";"UO_0000065";"13.95";"0.26";"5.17";"6.13";"0";"CHEMBL4258932";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21insect cells using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257496";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";""
"CHEMBL4647342";"";"None";"515.61";"1";"3.26";"14";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)CC2CC2)c1=O";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"14.85";"0.28";"4.40";"7.00";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4644448";"";"None";"519.58";"1";"2.82";"20";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)[C@H]2C[C@H]2F)c1=O";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"16.21";"0.30";"5.60";"7.69";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4638277";"";"None";"552.55";"1";"4.12";"34";"Cn1cc(-c2cc(F)cc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@H]2F)c1=O";"IC50";"'='";"125.0";"nM";"6.90";"";"";"UO_0000065";"12.49";"0.24";"2.78";"6.50";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3889791";"";"None";"513.99";"2";"5.62";"BDBM249971";"C=CC(=O)Nc1cc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)ccc1Cl";"IC50";"'='";"1.1";"nM";"8.96";"";"435900";"UO_0000065";"17.43";"0.33";"3.34";"8.05";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4115303";"";"None";"429.48";"0";"3.05";"BDBM249990";"C=CC(=O)N1C[C@H]2CNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3[C@H]2C1";"IC50";"'='";"1.0";"nM";"9.00";"";"435919";"UO_0000065";"20.96";"0.38";"5.95";"8.78";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959953";"";"None";"529.00";"1";"4.81";"BDBM250024";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCc4ccccn4)c(Cl)c3)nn21";"IC50";"'='";"1.3";"nM";"8.89";"";"435953";"UO_0000065";"16.80";"0.32";"4.08";"7.16";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931690";"";"None";"489.89";"0";"4.85";"BDBM250041";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Cl)c(C(F)(F)F)c3)nn21";"IC50";"'='";"7.3";"nM";"8.14";"";"435970";"UO_0000065";"16.61";"0.33";"3.29";"7.97";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930626";"";"None";"447.50";"0";"3.20";"BDBM250046";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC)c(OC)c3)nn21";"IC50";"'='";"3.2";"nM";"8.49";"";"435975";"UO_0000065";"18.98";"0.35";"5.29";"7.05";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902845";"";"None";"506.01";"1";"4.88";"BDBM250051";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)c(Cl)c4)nn32)CC1";"IC50";"'='";"0.81";"nM";"9.09";"";"435980";"UO_0000065";"17.97";"0.34";"4.21";"8.87";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910506";"";"None";"442.52";"0";"3.99";"BDBM249965";"N#CN1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"124.0";"nM";"6.91";"";"435989";"UO_0000065";"15.61";"0.29";"2.92";"6.32";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910644";"";"None";"455.52";"0";"3.28";"BDBM250059";"CC#CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"4.7";"nM";"8.33";"";"435991";"UO_0000065";"18.28";"0.33";"5.05";"8.13";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4115042";"";"None";"549.56";"1";"4.75";"BDBM255276";"CC(F)(F)c1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2F)c1";"IC50";"'='";"0.54";"nM";"9.27";"";"445181";"UO_0000065";"16.86";"0.32";"4.52";"7.82";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3938520";"";"None";"549.56";"1";"4.76";"BDBM255316";"C[C@H]1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.085";"nM";"10.07";"";"445221";"UO_0000065";"18.32";"0.34";"5.31";"8.50";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3939080";"";"None";"551.53";"1";"3.48";"BDBM255324";"Nc1nccn2c([C@H]3CC[C@H]4C[C@@H](O)C(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.93";"nM";"9.03";"";"445229";"UO_0000065";"16.38";"0.31";"5.55";"6.51";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108295";"";"None";"565.56";"1";"4.14";"BDBM255328";"C[C@H]1OC[C@@H]2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"0.13";"nM";"9.89";"";"445233";"UO_0000065";"17.48";"0.33";"5.75";"7.74";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3908219";"";"None";"564.57";"1";"4.65";"BDBM255472";"CN1CC[C@H]2CC[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"445240";"UO_0000065";"15.10";"0.28";"3.87";"7.00";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4460221";"";"None";"520.56";"2";"5.46";"20";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2c(F)cccc2c1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.71";"0.30";"3.24";"7.63";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3977725";"";"None";"506.54";"2";"5.15";"23";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3F)c12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.58";"0.30";"3.25";"7.37";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4543505";"";"None";"507.57";"2";"5.92";"14";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1N1Cc2ccc(F)cc2C1=O";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"14.42";"0.26";"1.40";"7.36";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"6";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.11";"0.29";"2.78";"7.10";"0";"CHEMBL4429403";"Inhibition of BTK in human peripheral B cells assessed as suppression of BCR/anti-IgM/IgG stimulated CD69 surface expression after 18 hrs by FACS analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4752349";"";"None";"490.59";"0";"4.05";"B36";"C=CS(=O)(=O)N1CCC(Cn2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1790.0";"nM";"5.75";"";"";"UO_0000065";"11.71";"0.22";"1.70";"4.94";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4756276";"";"None";"462.55";"0";"2.77";"B34";"CN(C)C/C=C/C(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'='";"1710.0";"nM";"5.77";"";"";"UO_0000065";"12.47";"0.23";"3.00";"5.84";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4212860";"";"None";"580.69";"1";"3.78";"3n";"CC1(C)Cc2cc3n(c2C1)CCN(c1cccc(-c2nc(N)nc(Nc4ccc(N5CCOCC5)cc4)n2)c1CO)C3=O";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"12.70";"0.23";"3.60";"5.48";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4216339";"";"None";"536.57";"1";"4.37";"4f";"CCn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"17.21";"0.32";"4.87";"6.25";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4103954";"";"None";"581.57";"2";"5.29";"2";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"12.08";"0.23";"1.74";"5.93";"1";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL3699647";"";"None";"579.68";"2";"5.19";"BDBM149472";"Cc1c(-c2cc(Nc3cc(CN4CC(F)(F)C4)n(C)n3)c(=O)[nH]n2)cccc1N1Cc2cc(C(C)(C)C)sc2C1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"287918";"UO_0000065";"14.32";"0.28";"3.11";"8.37";"0";"CHEMBL3705508";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing IX Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta- glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3V04, 10 mM MgCl2), 0.5 ul Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing IX Cell Signaling kinase buffer, 0.5 ul PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6x His tag was subcloned into pFastBac vector for making baculo virus carrying this epitope-tagged Btk. Generation of baculovirus is done based on Invitrogen's instructions detailed in its published protocol 'Bac-to-Bac Baculovirus Expression Systems'.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638757";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4064534";"";"None";"491.60";"0";"4.91";"YKL-04-085";"Cc1ccc(-n2c(=O)ccc3ccc4ccc(-c5cnn(C)c5)cc4c32)cc1NC(=O)/C=C/CN(C)C";"IC50";"'='";"911.0";"nM";"6.04";"";"";"UO_0000065";"12.29";"0.22";"1.13";"8.37";"0";"CHEMBL4043034";"Inhibition of recombinant full length His-tagged human BTK cytoplasmic domain expressed in baculovirus expression system by Z'-Lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041550";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3944698";"";"None";"443.51";"0";"3.63";"BDBM249982";"C=CC(=O)NC1(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"3.5";"nM";"8.46";"";"435911";"UO_0000065";"19.07";"0.35";"4.83";"7.60";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959966";"";"None";"498.59";"0";"3.61";"BDBM249998";"CN(C)C/C=C/C(=O)N1CCCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"0.62";"nM";"9.21";"";"435927";"UO_0000065";"18.47";"0.34";"5.60";"8.45";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949568";"";"None";"514.57";"1";"3.70";"BDBM197274";"CC(Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)NC(=O)/C(C#N)=C/C(C)(C)N";"IC50";"'='";"6.0";"nM";"8.22";"";"350463";"UO_0000065";"15.98";"0.30";"4.52";"5.21";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3939197";"";"None";"457.53";"0";"3.76";"BDBM249916";"C=CC(=O)N1CCC2(CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"435846";"UO_0000065";"18.63";"0.34";"4.76";"8.32";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4072911";"";"None";"621.69";"1";"4.96";"20";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(OC)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"2610.0";"nM";"5.58";"";"";"UO_0000065";"8.98";"0.17";"0.62";"4.26";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4633058";"";"None";"535.55";"1";"3.37";"26";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@@H]2F)c1=O";"IC50";"'='";"326.0";"nM";"6.49";"";"";"UO_0000065";"12.11";"0.23";"3.12";"5.45";"0";"CHEMBL4622576";"Inhibition of BTK in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression preincubated for 1 hr followed by goat F(ab')2 anti-human IgM stimulation and measured after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4646782";"";"None";"475.55";"0";"2.48";"9";"CC(=O)Nc1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cn(C)c1=O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"16.45";"0.31";"5.34";"7.15";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4639728";"";"None";"503.60";"1";"3.12";"12";"CC(C)C(=O)Nc1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cn(C)c1=O";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"13.30";"0.25";"3.58";"6.12";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4638307";"";"None";"535.55";"1";"3.37";"27";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@H]2F)c1=O";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"15.20";"0.29";"4.77";"6.84";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4114563";"";"None";"436.54";"0";"2.71";"BDBM235159";"NC(=O)c1nc(N2CCC[C@@H](NC(=O)Cc3ccccc3)C2)sc1Nc1ccccn1";"IC50";"'='";"6236.0";"nM";"5.21";"";"409811";"UO_0000065";"11.92";"0.23";"2.50";"4.60";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4551429";"";"None";"452.56";"1";"5.86";"39, Mixture of enantiomer";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1C1CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"14.80";"0.27";"0.84";"7.79";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4435444";"";"None";"468.61";"1";"6.28";"37, Mixture of enantiomer";"CC(C)(C)c1ccccc1NC(=O)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.63";"0.27";"0.57";"7.98";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4577152";"";"None";"412.50";"0";"4.99";"11";"O=C(Nc1ccccc1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"14.78";"0.27";"1.11";"7.09";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4581632";"";"None";"372.43";"0";"4.07";"8";"O=C(NCCc1cccc(Nc2ncnc3[nH]ccc23)c1)Nc1ccccc1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"13.21";"0.24";"0.85";"5.19";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4114740";"";"None";"541.56";"2";"5.17";"BDBM60903";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cc(F)cc(F)c4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.1";"nM";"8.68";"";"312171";"UO_0000065";"16.02";"0.30";"3.51";"7.06";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4086348";"";"None";"551.53";"1";"3.61";"8";"CC1(C(=O)N2CC(c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"167.0";"nM";"6.78";"";"";"UO_0000065";"12.29";"0.23";"3.17";"5.31";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3920230";"";"None";"401.44";"1";"5.48";"BDBM195903";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc(C)c(F)cc4OC)c3c2)c1";"IC50";"'='";"7558.0";"nM";"5.12";"";"348548";"UO_0000065";"12.76";"0.23";"-0.36";"7.64";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647967";"";"None";"454.53";"0";"4.65";"BDBM97672";"C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"342622";"UO_0000065";"19.80";"0.36";"4.35";"8.34";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3937076";"";"None";"296.72";"0";"2.85";"BDBM195828";"C#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)n1";"IC50";"'='";"739.0";"nM";"6.13";"";"348532";"UO_0000065";"20.66";"0.40";"3.28";"8.68";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14f; (R)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.24";"0.30";"4.90";"7.56";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3900554";"BMS-986142";"2.0";"572.61";"1";"4.40";"14f; (R)-atropisomer";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.05";"0.26";"3.65";"6.54";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3670091";"";"None";"541.68";"2";"5.03";"BDBM111948";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CCCC5)C3=O)c2CO)cc(Nc2cc(C3CC3)n[nH]2)c1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"233003";"UO_0000065";"15.73";"0.30";"3.49";"8.25";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670094";"";"None";"611.72";"1";"3.91";"BDBM111951";"CN1CCN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"233006";"UO_0000065";"14.22";"0.26";"4.79";"8.80";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670100";"";"None";"644.82";"2";"5.21";"BDBM111958";"CN(C)CCN(C)c1ccc(Nc2cc(-c3cc(F)cc(N4CCc5c(sc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"4.0";"nM";"8.40";"";"233013";"UO_0000065";"13.02";"0.25";"3.19";"8.94";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670101";"";"None";"596.71";"1";"4.44";"BDBM111959";"CN1CC(c2ccc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc2)C1";"IC50";"'='";"4.7";"nM";"8.33";"";"233014";"UO_0000065";"13.96";"0.26";"3.89";"8.71";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670102";"";"None";"656.83";"2";"5.35";"BDBM111960";"CCN1CCN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCc6c(sc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"6.4";"nM";"8.19";"";"233015";"UO_0000065";"12.47";"0.24";"2.84";"8.72";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3639689";"";"None";"657.77";"1";"4.50";"BDBM111961";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(N3CCN(CCF)CC3)cn2)c1=O";"IC50";"'='";"6.35";"nM";"8.20";"";"233016";"UO_0000065";"12.46";"0.23";"3.70";"8.29";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670136";"";"None";"540.62";"1";"3.36";"BDBM111995";"Cn1cc(-c2cccc(N3CCc4c(cc5n4CCCC5)C3=O)c2CO)cc(Nc2cc3n(n2)CCOC3)c1=O";"IC50";"'='";"16.5";"nM";"7.78";"";"233050";"UO_0000065";"14.40";"0.27";"4.42";"7.30";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3965224";"";"None";"578.03";"1";"4.91";"BDBM230141";"Cc1c(-c2c(C#N)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.49";"nM";"9.31";"";"402007";"UO_0000065";"16.11";"0.30";"4.40";"6.36";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"19.22";"0.35";"4.25";"8.54";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4456283";"";"None";"436.90";"0";"3.79";"10";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"0.64";"nM";"9.19";"";"";"UO_0000065";"21.04";"0.41";"5.40";"7.46";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4518667";"";"None";"481.50";"0";"4.04";"9c";"C=C(C)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"247.0";"nM";"6.61";"";"";"UO_0000065";"13.72";"0.26";"2.57";"5.67";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4462332";"";"None";"455.88";"0";"3.33";"20c";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ncc(Cl)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"19.1";"nM";"7.72";"";"";"UO_0000065";"16.93";"0.33";"4.39";"5.67";"0";"CHEMBL4385492";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human B cells assessed as reduction in cell proliferation pretreated for 30 mins followed by goat anti-human IgM F(ab')2-stimulation and measured after 3 days by [3H]-thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4469663";"";"None";"437.89";"0";"3.19";"20a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cn4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"16.78";"0.32";"4.16";"5.40";"0";"CHEMBL4385495";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 1 hr followed by goat anti-human IgM F(ab')2-stimualtion and measured after 3 hrs by Fix/Lyse reagent based flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4456283";"";"None";"436.90";"0";"3.79";"10";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"20.07";"0.39";"4.98";"7.12";"0";"CHEMBL4385492";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human B cells assessed as reduction in cell proliferation pretreated for 30 mins followed by goat anti-human IgM F(ab')2-stimulation and measured after 3 days by [3H]-thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3897349";"";"None";"589.07";"1";"4.91";"BDBM230101";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"401961";"UO_0000065";"15.14";"0.29";"4.01";"7.25";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917869";"";"None";"559.05";"2";"5.10";"BDBM230153";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2sccn2c1=O";"IC50";"'='";"0.31";"nM";"9.51";"";"401974";"UO_0000065";"17.01";"0.33";"4.41";"7.76";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960384";"";"None";"591.43";"2";"5.75";"BDBM230118";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)cc(Cl)c(-c3cccc(-n4c(=O)[nH]c5c(F)cccc5c4=O)c3Cl)c12";"IC50";"'='";"0.35";"nM";"9.46";"";"401982";"UO_0000065";"15.99";"0.31";"3.71";"7.06";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4107482";"";"None";"581.56";"1";"4.74";"BDBM255339";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3[C@@H](C)OC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.13";"nM";"9.89";"";"445245";"UO_0000065";"17.00";"0.32";"5.15";"7.22";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111750";"";"None";"511.59";"1";"3.55";"BDBM255347";"CC(O)c1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)c1";"IC50";"'='";"9.7";"nM";"8.01";"";"445253";"UO_0000065";"15.66";"0.29";"4.46";"5.78";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3925479";"";"None";"479.54";"0";"4.97";"BDBM250076";"C=CC(=O)Nc1ccccc1[C@@H]1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"120.0";"nM";"6.92";"";"435797";"UO_0000065";"14.43";"0.26";"1.95";"6.22";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4789435";"";"None";"535.62";"2";"6.39";"15";"C/C=C/C(=O)N1CC=C(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"15.35";"0.28";"1.83";"9.04";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4073491";"";"None";"543.60";"2";"6.91";"3f";"CC(=O)c1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1";"IC50";"'='";"21.3";"nM";"7.67";"";"";"UO_0000065";"14.11";"0.26";"0.76";"8.72";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4111520";"";"None";"559.56";"1";"4.87";"BDBM255329";"N#C/N=C1\CC[C@@H]2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN12";"IC50";"'='";"0.46";"nM";"9.34";"";"445234";"UO_0000065";"16.69";"0.31";"4.47";"6.79";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113154";"";"None";"636.63";"1";"3.90";"BDBM255336";"CC(C)(C(=O)O)N1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]2C1";"IC50";"'='";"0.45";"nM";"9.35";"";"445242";"UO_0000065";"14.68";"0.28";"5.45";"5.88";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4106651";"";"None";"521.55";"1";"4.99";"BDBM255337";"Nc1nccn2c([C@@H]3CC[C@H]4CCCN4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.67";"nM";"9.17";"";"445243";"UO_0000065";"17.59";"0.33";"4.18";"9.04";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3902517";"";"None";"451.47";"0";"3.87";"BDBM249211";"CC(C)(C)c1cc(F)c2c(=O)n(Cc3cc(CO)c(-c4cc[nH]c(=O)c4)cc3F)ncc2c1";"IC50";"'='";"52269.88";"nM";"4.28";"";"434809";"UO_0000065";"9.48";"0.18";"0.41";"4.87";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943034";"";"None";"573.65";"2";"5.17";"BDBM202212";"N#CCC(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)ccc6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"358288";"UO_0000065";"15.55";"0.28";"3.75";"7.28";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4095477";"";"None";"502.60";"1";"3.99";"11";"Cn1cc(-c2cccc(N3Cc4nc(C(C)(C)C)sc4C3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"13.64";"0.26";"2.87";"6.06";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3670088";"";"None";"593.73";"1";"3.78";"17";"CN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.14";"0.26";"4.62";"8.49";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4112851";"";"None";"467.53";"0";"3.49";"BDBM255258";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4ccccn4)cc3)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"445162";"UO_0000065";"18.61";"0.34";"5.21";"7.34";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113354";"";"None";"507.60";"1";"4.37";"BDBM255270";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C5CC5)ccn4)cc3)c12";"IC50";"'='";"0.18";"nM";"9.74";"";"445175";"UO_0000065";"19.20";"0.35";"5.37";"8.22";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109782";"";"None";"536.52";"1";"3.91";"BDBM255271";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4nccc(C(F)(F)F)n4)cc3)c12";"IC50";"'='";"2.2";"nM";"8.66";"";"445176";"UO_0000065";"16.14";"0.30";"4.75";"6.59";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111685";"";"None";"510.53";"1";"3.50";"BDBM255285";"N#Cc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2F)c1";"IC50";"'='";"2.5";"nM";"8.60";"";"445190";"UO_0000065";"16.85";"0.31";"5.10";"6.05";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3612839";"";"None";"509.64";"2";"6.21";"13a";"Nc1ncc(-c2cnn(CC(=O)N3CCCCC3)c2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"12.2";"nM";"7.91";"";"";"UO_0000065";"15.53";"0.29";"1.70";"9.17";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4110388";"";"None";"579.58";"1";"4.91";"BDBM255320";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.16";"nM";"9.80";"";"445225";"UO_0000065";"16.90";"0.32";"4.89";"7.67";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109144";"";"None";"622.61";"1";"3.21";"BDBM255333";"COC(=O)CN1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]2C1";"IC50";"'='";"0.19";"nM";"9.72";"";"445238";"UO_0000065";"15.61";"0.30";"6.51";"6.57";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113482";"";"None";"536.52";"1";"3.91";"BDBM255354";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)cnn4)cc3)c12";"IC50";"'='";"1.2";"nM";"8.92";"";"445260";"UO_0000065";"16.63";"0.31";"5.01";"6.79";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4107467";"";"None";"517.59";"1";"4.65";"BDBM255356";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc5ccccc5cn4)cc3)c12";"IC50";"'='";"0.19";"nM";"9.72";"";"445262";"UO_0000065";"18.78";"0.34";"5.07";"8.20";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4066223";"";"None";"605.74";"2";"6.48";"34";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N(C)C";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"12.33";"0.23";"0.99";"6.64";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4286900";"";"None";"543.41";"1";"4.63";"7b";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)c(Cl)c3)ncc2Cl)c1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"16.74";"0.34";"4.47";"7.73";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4289281";"";"None";"539.04";"1";"4.85";"7m";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OCCCN4CCOCC4)c3)ncc2Cl)c1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"16.88";"0.33";"4.25";"8.28";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4637765";"";"None";"410.42";"0";"4.72";"37";"C/C=C/C(=O)NCCOc1cccc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"907.0";"nM";"6.04";"";"";"UO_0000065";"14.72";"0.28";"1.32";"7.30";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4635070";"";"None";"516.55";"2";"5.93";"51";"C=CC(=O)NCCOc1cc(Cc2cccc(OC)c2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"138.0";"nM";"6.86";"";"";"UO_0000065";"13.28";"0.25";"0.93";"7.45";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4639739";"";"None";"502.58";"2";"5.37";"55";"C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(-c5cn[nH]c5)ccc34)cc12";"IC50";"'='";"186.0";"nM";"6.73";"";"";"UO_0000065";"13.39";"0.24";"1.36";"6.04";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL3263648";"";"None";"589.70";"2";"6.09";"28";"Cc1ccc(-c2nc(Nc3ccc(C(=O)N4CCOCC4)cc3)c3nc[nH]c3n2)cc1NC(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"12.86";"0.24";"1.50";"6.06";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3605107";"";"None";"455.54";"0";"4.95";"14g";"CNC(=O)Cn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"12.8";"nM";"7.89";"";"";"UO_0000065";"17.33";"0.33";"2.94";"8.30";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4863078";"";"None";"455.52";"0";"4.11";"12a";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"15.99";"0.29";"3.17";"6.89";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3975003";"";"None";"454.54";"0";"3.44";"10b";"C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1";"IC50";"'='";"10.2";"nM";"7.99";"";"";"UO_0000065";"17.58";"0.32";"4.55";"8.76";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4870576";"";"None";"491.50";"0";"4.39";"12e";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5F)cc4)[nH]c23)CC1";"IC50";"'='";"54.8";"nM";"7.26";"";"";"UO_0000065";"14.77";"0.28";"2.87";"6.87";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4863193";"";"None";"441.49";"0";"3.68";"36a";"C=CC(=O)N1CCCc2nn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c3c2C1";"IC50";"'='";"1931.0";"nM";"5.71";"";"";"UO_0000065";"12.94";"0.24";"2.03";"5.41";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4074674";"";"None";"524.50";"2";"5.00";"22";"Nc1nccn2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nc2[C@H]1CC[C@@H](C(=O)O)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"17.73";"0.33";"4.30";"6.86";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4081444";"";"None";"564.57";"2";"5.71";"27";"Nc1nccn2c1c(-c1ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc1)nc2[C@]12CCC[C@](C(=O)O)(CC1)CC2";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"16.87";"0.32";"3.81";"7.03";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4440096";"";"None";"497.50";"0";"3.01";"9f";"NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/CO)C2)c1N";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"15.04";"0.28";"4.47";"5.47";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4591391";"";"None";"485.47";"0";"3.95";"9e";"C=C(F)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"13.94";"0.26";"2.82";"5.81";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4456974";"";"None";"471.44";"0";"3.56";"20b";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(C(F)(F)F)n4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"18.21";"0.34";"5.03";"6.31";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4436118";"";"None";"402.46";"0";"3.14";"11a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"0.37";"nM";"9.43";"";"";"UO_0000065";"23.44";"0.43";"6.29";"7.66";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4456974";"";"None";"471.44";"0";"3.56";"20b";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(C(F)(F)F)n4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"10100.0";"nM";"5.00";"";"";"UO_0000065";"10.60";"0.20";"1.44";"3.67";"0";"CHEMBL4385493";"Inhibition of BTK in anti-CD3/CD28-stimulated human CD4-positive T cells assessed as reduction in cell proliferation pretreated for 30 mins followed by anti-CD3/CD28-stimulation and measured after 3 days by [3H]-thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4462332";"";"None";"455.88";"0";"3.33";"20c";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ncc(Cl)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"14.56";"0.28";"3.31";"4.88";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4517013";"";"None";"430.49";"1";"5.13";"31";"O=C(Nc1cccc(F)c1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"13.75";"0.25";"0.79";"6.89";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3897911";"";"None";"493.57";"0";"5.00";"21";"C=CC(=O)N(C)c1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"232.6";"nM";"6.63";"";"";"UO_0000065";"13.44";"0.24";"1.63";"6.47";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3908905";"";"None";"405.43";"0";"3.32";"30";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(F)cc3)nn21";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"21.22";"0.39";"5.28";"8.43";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3917732";"";"None";"479.54";"0";"4.97";"20a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.62";"nM";"9.21";"";"";"UO_0000065";"19.20";"0.35";"4.24";"8.28";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3917026";"";"None";"457.53";"0";"3.97";"23b";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"15.13";"0.28";"2.95";"6.22";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3965262";"";"None";"401.47";"0";"3.49";"27";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(C)cc3)nn21";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"21.91";"0.40";"5.31";"8.62";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3908905";"";"None";"405.43";"0";"3.32";"30";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(F)cc3)nn21";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"21.51";"0.40";"5.40";"8.55";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3968928";"";"None";"598.75";"2";"6.26";"BDBM202073";"Cc1c(-c2ncnc3[nH]c(-c4ccc(CN5CCN(C)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"7.0";"nM";"8.15";"";"358152";"UO_0000065";"13.62";"0.25";"1.89";"10.51";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907763";"";"None";"629.76";"2";"6.05";"BDBM202087";"CC1(O)CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"358165";"UO_0000065";"12.95";"0.24";"2.10";"7.10";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900430";"";"None";"631.75";"2";"6.19";"BDBM202099";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)c(F)c2)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"358177";"UO_0000065";"12.74";"0.23";"1.86";"9.47";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968892";"";"None";"600.72";"2";"5.45";"BDBM202105";"CN1CCN(c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"358183";"UO_0000065";"13.19";"0.24";"2.47";"8.10";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986676";"";"None";"596.73";"2";"7.02";"BDBM202107";"CN1CC=C(c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cc2)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"358185";"UO_0000065";"13.34";"0.24";"0.94";"9.74";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977803";"";"None";"588.71";"2";"5.77";"BDBM202116";"CC(C)N1CC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)C1";"IC50";"'='";"6.5";"nM";"8.19";"";"358194";"UO_0000065";"13.91";"0.25";"2.42";"8.23";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957625";"";"None";"640.79";"2";"5.98";"BDBM202134";"O=C1c2ccc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(CN5CCN(C6CC6)CC5)cn4)cc23)c1CO";"IC50";"'='";"3.0";"nM";"8.52";"";"358212";"UO_0000065";"13.30";"0.24";"2.54";"8.71";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928872";"";"None";"597.72";"2";"7.14";"BDBM202157";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCCCC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"133.0";"nM";"6.88";"";"358242";"UO_0000065";"11.50";"0.21";"-0.26";"7.52";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937490";"";"None";"583.69";"2";"6.15";"BDBM202167";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCOCC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"130.0";"nM";"6.89";"";"358244";"UO_0000065";"11.80";"0.21";"0.74";"7.53";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3987117";"";"None";"597.72";"2";"6.28";"BDBM202168";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCC(O)CC5)cc4)cc23)cccc1N1CCc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"21.0";"nM";"7.68";"";"358245";"UO_0000065";"12.85";"0.23";"1.40";"7.50";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895812";"";"None";"647.71";"2";"5.39";"BDBM202227";"C=CC(=O)N1CCCC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ncnc4[nH]3)cn2)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"358301";"UO_0000065";"12.97";"0.24";"3.01";"6.49";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4092794";"";"None";"625.75";"1";"4.30";"28";"C[C@@H]1CN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CCN1C";"IC50";"'='";"12.7";"nM";"7.90";"";"";"UO_0000065";"12.62";"0.23";"3.60";"7.99";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4468002";"";"None";"413.49";"0";"4.38";"28";"O=C(Nc1cccnc1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"13.29";"0.24";"1.11";"5.56";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4550702";"";"None";"406.39";"0";"3.15";"9";"Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"15.86";"0.31";"3.29";"8.36";"0";"CHEMBL4479700";"Inhibition of full-length recombinant human His-tagged BTK expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4868372";"";"None";"534.41";"1";"4.88";"12h";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(Br)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"84.8";"nM";"7.07";"";"";"UO_0000065";"13.23";"0.28";"2.19";"6.69";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4871869";"";"None";"459.48";"0";"3.86";"25b";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)C1";"IC50";"'='";"931.0";"nM";"6.03";"";"";"UO_0000065";"13.13";"0.24";"2.17";"5.70";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4543505";"";"None";"507.57";"2";"5.92";"14";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1N1Cc2ccc(F)cc2C1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"17.14";"0.31";"2.78";"8.75";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3890068";"";"None";"461.52";"0";"3.20";"24";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCCOC)cc3)nn21";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"18.57";"0.34";"5.37";"7.11";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1a";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"21.20";"0.39";"5.12";"9.42";"0";"CHEMBL4414913";"Inhibition of human BTK using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3904488";"";"None";"471.56";"0";"4.50";"22";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC4CCCC4)cc3)nn21";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"18.84";"0.35";"4.39";"7.99";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3948532";"";"None";"498.60";"1";"6.55";"BDBM200808";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCC(O)CC3)cc12";"IC50";"'='";"46.0";"nM";"7.34";"";"356866";"UO_0000065";"14.72";"0.27";"0.79";"8.07";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941531";"";"None";"541.63";"2";"5.25";"BDBM200835";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3ncnc4[nH]c(C5=CCN(C(=O)CF)CC5)cc34)c2CO)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"356909";"UO_0000065";"14.21";"0.26";"2.45";"6.92";"0";"CHEMBL3887839";"Cellular Assay: Alternatively, the present compounds might also be assessed for their capacity to inhibit Btk-dependent FcG receptor-induced IL-8 secretion in human cells. The human myeloid leukemia THP1 cell line (ATCC TIB202) was grown in RPMI 1640 medium supplemented with 10% FCS and 15 nM 1, 25-dihydroxy Vitamin D3 during 4 days before use to induced myeloid differentiation. A sufficient number of tissue-culture grade 384-well plates was coated with human IgG of unknown specificity by incubating overnight at 4° C. with 40 ul/well of a 50 ug/ml IgG solution in PBS. On the day of the experiment, plates were washed 5 times with 80 ul water on a Molecular Devices Aquamax DW4 plate washer. Solutions of the test compounds in 90% DMSO were added to each well on a Hamilton Microlab Star liquid handling station to 40 ul/well tissue culture medium and the total DMSO concentration was adjusted to 0.1%. Differentiated THP1 cells were then added in 40 ul/well to reach a final density of 5'000 cells/well in 80 ul culture medium. After 24 hours, IL-8 secretion was measured in the supernatant by the IL-8 HTRF assay following the protocol of the vendor (CisBio international).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"CHEMBL3307574";"";"";""
"CHEMBL3670120";"";"None";"638.74";"1";"4.17";"BDBM111979";"Cn1cc(-c2cc(F)cc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc3c(n2)CCN(C2COC2)C3)c1=O";"IC50";"'='";"11.6";"nM";"7.94";"";"233034";"UO_0000065";"12.42";"0.23";"3.77";"7.57";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3670139";"";"None";"666.85";"1";"4.59";"BDBM111998";"Cn1cc(-c2cccc(N3CCc4c(sc5c4CC(C)(C)C5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"43.0";"nM";"7.37";"";"233053";"UO_0000065";"11.05";"0.21";"2.78";"7.14";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4087679";"";"None";"524.50";"2";"5.00";"4";"Nc1nccn2c([C@@H]3CCC[C@H](C(=O)O)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"17.92";"0.34";"4.40";"6.94";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4097957";"";"None";"522.49";"1";"4.47";"24";"Nc1nccn2c([C@H]3C[C@@H]4[C@H](C3)[C@H]4C(=O)O)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"19.14";"0.36";"5.53";"7.38";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4070853";"";"None";"566.58";"2";"5.89";"25";"CC(C)[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C[C@H]1C(=O)O";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"16.59";"0.31";"3.51";"6.94";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4642827";"";"None";"352.44";"0";"1.99";"4g";"CC#CC(=O)N[C@H]1CCCN(c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"20.99";"0.39";"5.41";"8.11";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.43";"0.37";"4.78";"9.08";"1";"CHEMBL4773121";"Inhibition of BTK (unknown origin) using poly(Glu, Tyr) 4:1 as substrate incubated in presence of [gamma33P]ATP by image analyser";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765406";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5i";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"14.39";"0.26";"3.19";"6.30";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4468226";"";"None";"664.74";"1";"4.26";"3";"Cn1c2c(cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c1=O)-c1cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c1C[C@H](O)C2";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"11.41";"0.21";"3.33";"5.76";"0";"CHEMBL4321362";"Inhibition of BTK in goat F(ab')2 anti-human IgM-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 30 mins followed by goat F(ab')2 anti-human IgM-stimulation and measured after 20 hrs by flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4316621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4117175";"";"None";"639.69";"2";"3.69";"2";"Cn1nc(-c2cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"11.94";"0.22";"3.95";"5.29";"0";"CHEMBL4321362";"Inhibition of BTK in goat F(ab')2 anti-human IgM-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 30 mins followed by goat F(ab')2 anti-human IgM-stimulation and measured after 20 hrs by flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4316621";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3894102";"";"None";"553.67";"1";"4.36";"BDBM191629";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CC[C@@H](NC(=O)/C=C/CN2CCOCC2)CC1";"IC50";"'='";"3.48";"nM";"8.46";"";"385059";"UO_0000065";"15.28";"0.28";"4.10";"7.02";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114799";"";"None";"604.50";"2";"6.21";"BDBM197182";"COc1cc(-c2nn(C3CCCN(C(=O)/C(C#N)=C/C4CC4)C3)c3ncnc(N)c23)ccc1Oc1ccc(Cl)c(Cl)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"350370";"UO_0000065";"14.89";"0.29";"2.79";"6.81";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4108729";"";"None";"543.58";"2";"5.24";"BDBM197239";"CC(C)/C=C(/C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2)c2c(N)ncnc21";"IC50";"'='";"7.0";"nM";"8.15";"";"350392";"UO_0000065";"15.00";"0.28";"2.91";"6.63";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3894476";"";"None";"505.58";"1";"4.89";"BDBM197178";"N#C/C(=C\C1CC1)C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"350416";"UO_0000065";"13.62";"0.25";"2.00";"5.60";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114689";"";"None";"523.57";"1";"4.86";"BDBM197187";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"4.0";"nM";"8.40";"";"350423";"UO_0000065";"16.04";"0.29";"3.54";"6.83";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114773";"";"None";"505.58";"1";"4.72";"BDBM197240";"N#C/C(=C\C1CC1)C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"2.6";"nM";"8.59";"";"350428";"UO_0000065";"16.98";"0.31";"3.87";"6.98";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114665";"";"None";"559.55";"2";"5.14";"BDBM197242";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3c(F)cccc3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"3.0";"nM";"8.52";"";"350430";"UO_0000065";"15.23";"0.28";"3.38";"6.93";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4107999";"";"None";"472.52";"0";"4.41";"BDBM197222";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1F)nn2C[C@H]1CCCN1C(=O)C1CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"350433";"UO_0000065";"16.93";"0.31";"3.59";"8.07";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4093393";"";"None";"531.59";"2";"6.72";"3d";"COc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cc1";"IC50";"'='";"56.3";"nM";"7.25";"";"";"UO_0000065";"13.64";"0.25";"0.53";"9.05";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3928390";"";"None";"674.78";"2";"5.36";"BDBM202142";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(CN5CCN(C6COC6)CC5)cn4)cc23)c1CO";"IC50";"'='";"2.0";"nM";"8.70";"";"358220";"UO_0000065";"12.89";"0.24";"3.34";"8.13";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948372";"";"None";"525.58";"1";"4.55";"BDBM202210";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1nccc(-c2ccnc3[nH]c(C4=CCNCC4)cc23)c1CO";"IC50";"'='";"618.0";"nM";"6.21";"";"358286";"UO_0000065";"11.81";"0.22";"1.66";"6.01";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984768";"";"None";"379.42";"0";"4.90";"BDBM195754";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccccc5[nH]4)c3n2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348501";"UO_0000065";"16.16";"0.29";"1.23";"7.09";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3963521";"";"None";"297.75";"0";"4.01";"BDBM195756";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348502";"UO_0000065";"20.59";"0.40";"2.12";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3938761";"";"None";"289.34";"0";"3.50";"BDBM195772";"CC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)c1";"IC50";"'='";"739.0";"nM";"6.13";"";"348509";"UO_0000065";"21.19";"0.38";"2.63";"10.61";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3934456";"";"None";"279.30";"0";"2.37";"BDBM195906";"C=CC(=O)Nc1cccc(-c2cnc3c(c2)CC(=O)N3)c1";"IC50";"'='";"7558.0";"nM";"5.12";"";"348551";"UO_0000065";"18.34";"0.33";"2.75";"7.20";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3982192";"";"None";"535.65";"1";"4.93";"BDBM202185";"Cc1c(-c2ncnc3[nH]c(C4=CCN(CCO)CC4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"611.0";"nM";"6.21";"";"358263";"UO_0000065";"11.60";"0.21";"1.28";"6.57";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114656";"";"None";"569.64";"2";"5.26";"BDBM197252";"CCOC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"3100.0";"nM";"5.51";"";"350448";"UO_0000065";"9.67";"0.18";"0.25";"4.17";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3905432";"";"None";"452.52";"0";"3.88";"BDBM191620";"CC#CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"4.16";"nM";"8.38";"";"385049";"UO_0000065";"18.52";"0.34";"4.50";"8.45";"0";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3652659";"";"None";"545.55";"1";"3.88";"BDBM122420";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccc(F)cn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.24";"nM";"9.62";"";"251000";"UO_0000065";"17.63";"0.33";"5.74";"6.82";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3891597";"";"None";"614.75";"2";"5.29";"BDBM205247";"CN1CCN(C)[C@@H](c2ccc(Nc3nc(-c4ccc(F)c(N5Cc6cc(C(C)(C)C)sc6C5=O)c4)cn(C)c3=O)cc2)C1=O";"IC50";"'='";"47.4";"nM";"7.32";"";"363330";"UO_0000065";"11.91";"0.23";"2.03";"8.07";"0";"CHEMBL3887917";"Biochemical Btk Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds is as follows. A master mix minus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM beta-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2), 0.5 μM Promega PTK Biotinylated peptide substrate 2, and 0.01% BSA. A master mix plus Btk enzyme is prepared containing 1x Cell Signaling kinase buffer, 0.5 μM PTK Biotinylated peptide substrate 2, 0.01% BSA, and 100 ng/well (0.06 mU/well) Btk enzyme. Btk enzyme is prepared as follows: full length human wildtype Btk (accession number NM-000061) with a C-terminal V5 and 6xHis tag was subcloned into pFastBac vector for making baculovirus carrying this epitope-tagged Btk.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886504";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3702843";"";"None";"596.67";"1";"4.17";"BDBM143195";"CC(C)(/C=C(\C#N)C(=O)N1CCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCOCC1";"IC50";"'='";"4.1";"nM";"8.39";"";"279415";"UO_0000065";"14.06";"0.26";"4.22";"6.19";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647516";"";"None";"464.53";"0";"4.05";"BDBM143318";"CC#CC(=O)N1CC2(CC(n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)C2)C1";"IC50";"'='";"0.83";"nM";"9.08";"";"279478";"UO_0000065";"19.55";"0.35";"5.03";"9.16";"0";"CHEMBL3706140";"HTRF Assay: An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of substrate. Assays were assembled in 384 well plates where 6 nM of full-length human His-tagged BTK (Life Technologies cat #PV3587) and test compound at varying concentrations were preincubated for 15 minutes at 28Â° C. Then, 1 uM of TK substrate-biotin and 30 uM ATP were added and incubated for an additional 30 minutes at 28Â° C. Phospohrylation was detected by adding 62.5 nM Streptavidin-XL665 and TK-Antibody Cryptate diluted 1:100 in HTRF detection buffer (Cisbio cat #62SDBRDF) and incubated for 60 minutes at RT. The plate was read on an Envision plate reader and the fluoresence is measured at 620 nm (cryptate) and 665 nm (XL665). A ratio is calculated (665/620) and converted to POC relative to control and blank wells.Assay Buffer:50 mM HEPES (Invitrogen #15630), 0.01% Brij-35 (sigma #B4184), 10 mM MgC12 (Sigma M1028), 1 mM EGTA.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638507";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4643319";"";"None";"552.55";"1";"4.12";"33";"Cn1cc(-c2cc(F)cc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.74";"0.30";"4.58";"8.19";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4638277";"";"None";"552.55";"1";"4.12";"34";"Cn1cc(-c2cc(F)cc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(NC(=O)[C@H]2C[C@H]2F)c1=O";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"15.78";"0.30";"4.60";"8.21";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5289459";"";"None";"477.40";"0";"4.18";"27";"CCC[C@@H](Nc1cc(Cl)cc(Cl)c1)C(=O)N1CCOCC(Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"13.76";"0.28";"2.39";"6.90";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL3358341";"";"None";"635.74";"1";"4.58";"5b";"CN1CCN(c2ccc(Nc3cc(-c4cccc(N5CCc6cc(C(C)(C)C#N)cc(F)c6C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"11.48";"0.21";"2.72";"6.20";"0";"CHEMBL3371883";"Inhibition of BTK in human whole blood assessed as decrease in CD69 positive cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351914";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"3";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"132.0";"nM";"6.88";"";"";"UO_0000065";"15.14";"0.28";"4.13";"6.35";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4440621";"";"None";"554.66";"1";"4.20";"43";"C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)c4)c23)CC1";"IC50";"'='";"942.0";"nM";"6.03";"";"";"UO_0000065";"10.86";"0.20";"1.83";"5.00";"0";"CHEMBL4349140";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using STK substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346710";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4797536";"";"None";"462.58";"1";"5.18";"18";"Cc1cc(-c2ccnc(Nc3conc3C)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"18.96";"0.36";"3.59";"8.29";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3921350";"";"None";"614.75";"2";"5.45";"2";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ncnc4[nH]3)cc2)CC1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"13.32";"0.24";"2.74";"8.37";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3893632";"";"None";"577.73";"2";"6.03";"BDBM197267";"CCN(CC)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"37.0";"nM";"7.43";"";"350412";"UO_0000065";"12.86";"0.24";"1.40";"6.56";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114765";"";"None";"521.63";"2";"5.53";"BDBM197180";"CC(C)(C)/C=C(\C#N)C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.7";"nM";"8.57";"";"350414";"UO_0000065";"16.43";"0.30";"3.04";"6.97";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3891008";"";"None";"521.63";"2";"5.53";"BDBM197181";"CC(C)(C)/C=C(\C#N)C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"980.0";"nM";"6.01";"";"350417";"UO_0000065";"11.52";"0.21";"0.48";"4.89";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4109432";"";"None";"522.58";"2";"5.64";"BDBM197219";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"3.3";"nM";"8.48";"";"350432";"UO_0000065";"16.23";"0.30";"2.84";"7.71";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4115689";"";"None";"561.57";"2";"5.35";"BDBM197227";"CC(C)/C=C(\C#N)C(=O)N1CC(F)(F)C[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"4.0";"nM";"8.40";"";"350440";"UO_0000065";"14.95";"0.28";"3.05";"6.83";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3973427";"";"None";"538.59";"1";"3.94";"BDBM197254";"N#C/C(=C\C1(N)CC1)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"52.0";"nM";"7.28";"";"350450";"UO_0000065";"13.52";"0.25";"3.34";"4.89";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3892680";"";"None";"610.69";"1";"4.56";"BDBM197220";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCOCC1";"IC50";"'='";"3.2";"nM";"8.49";"";"350451";"UO_0000065";"13.91";"0.26";"3.93";"6.27";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114772";"";"None";"540.60";"1";"4.36";"BDBM197234";"CC(C)(N)/C=C(\C#N)C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"350456";"UO_0000065";"15.77";"0.29";"4.16";"5.72";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3400826";"";"None";"956.09";"4";"9.44";"1b";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)NCCCNC(=S)Nc3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)cc2)n1";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"8.88";"0.17";"-0.95";"3.92";"0";"CHEMBL3407012";"Inhibition of biotinylated and unactivated BTK (unknown origin) using FITC-labeled Srctide peptide substrate and ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400106";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4446119";"";"None";"362.41";"0";"4.30";"9";"Cc1c(NC(=O)c2ccc(C3CC3)cc2)cc(F)cc1-c1cc(N)ncn1";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"14.17";"0.26";"0.84";"6.35";"0";"CHEMBL4358487";"Inhibition of full-length human recombinant BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate measured after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4445790";"";"None";"533.58";"1";"5.00";"20";"C=CC(=O)N1CCC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3F)c2C)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.84";"0.28";"2.92";"7.17";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4468095";"";"None";"533.58";"1";"5.00";"21";"C=CC(=O)N1CCC[C@@H]1COc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1869.0";"nM";"5.73";"";"";"UO_0000065";"10.74";"0.20";"0.73";"5.19";"0";"CHEMBL4358488";"Inhibition of BTK in vitamin D3 differentiated human THP1 cells assessed as inhibition of FCgammaR-induced IL8 production measured after 24 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4550284";"";"None";"521.57";"1";"4.86";"26";"C=CC(=O)N(C)CCCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"91.0";"nM";"7.04";"";"";"UO_0000065";"13.50";"0.25";"2.18";"6.38";"0";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"16.30";"0.30";"2.96";"7.24";"1";"CHEMBL4358489";"Inhibition of BTK in human B cells assessed as reduction in anti-IgM/IL4-stimulated CD69 expression on B cells preincubated for 60 mins followed by anti-IgM antibody/IL4 stimulation and measured after 16 hrs by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3400174";"";"None";"585.66";"1";"4.49";"4za";"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"15.8";"nM";"7.80";"";"";"UO_0000065";"13.32";"0.25";"3.31";"6.44";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3402588";"";"None";"563.63";"1";"4.93";"4zb";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"24.8";"nM";"7.61";"";"";"UO_0000065";"13.49";"0.25";"2.68";"7.90";"0";"CHEMBL3407032";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3896706";"";"None";"514.65";"2";"5.69";"BDBM200876";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(C3=CCS(=O)(=O)CC3)cc12";"IC50";"'='";"64.0";"nM";"7.19";"";"356891";"UO_0000065";"13.98";"0.27";"1.50";"6.86";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940129";"";"None";"523.68";"2";"6.16";"BDBM200881";"CN(C)C1CC=C(c2cc3c(-c4cccc(NC(=O)c5ccc(C(C)(C)C)cc5)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"356894";"UO_0000065";"16.61";"0.30";"2.54";"9.24";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968447";"";"None";"572.64";"1";"4.51";"BDBM200778";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(NC(=O)c5ccc(C(C)(C)O)cc5F)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"69.0";"nM";"7.16";"";"356907";"UO_0000065";"12.51";"0.23";"2.65";"5.32";"0";"CHEMBL3887839";"Cellular Assay: Alternatively, the present compounds might also be assessed for their capacity to inhibit Btk-dependent FcG receptor-induced IL-8 secretion in human cells. The human myeloid leukemia THP1 cell line (ATCC TIB202) was grown in RPMI 1640 medium supplemented with 10% FCS and 15 nM 1, 25-dihydroxy Vitamin D3 during 4 days before use to induced myeloid differentiation. A sufficient number of tissue-culture grade 384-well plates was coated with human IgG of unknown specificity by incubating overnight at 4° C. with 40 ul/well of a 50 ug/ml IgG solution in PBS. On the day of the experiment, plates were washed 5 times with 80 ul water on a Molecular Devices Aquamax DW4 plate washer. Solutions of the test compounds in 90% DMSO were added to each well on a Hamilton Microlab Star liquid handling station to 40 ul/well tissue culture medium and the total DMSO concentration was adjusted to 0.1%. Differentiated THP1 cells were then added in 40 ul/well to reach a final density of 5'000 cells/well in 80 ul culture medium. After 24 hours, IL-8 secretion was measured in the supernatant by the IL-8 HTRF assay following the protocol of the vendor (CisBio international).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"CHEMBL3307574";"";"";""
"CHEMBL3914067";"";"None";"583.69";"2";"6.75";"BDBM202161";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCCC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"137.0";"nM";"6.86";"";"358238";"UO_0000065";"11.76";"0.21";"0.11";"7.51";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898737";"";"None";"633.68";"2";"5.05";"BDBM202178";"CC1(O)CN(C(=O)c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)C1";"IC50";"'='";"43.0";"nM";"7.37";"";"358255";"UO_0000065";"11.63";"0.21";"2.32";"5.59";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894000";"";"None";"572.54";"2";"5.03";"BDBM230120";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cc(F)cc2c1=O";"IC50";"'='";"0.32";"nM";"9.49";"";"401985";"UO_0000065";"16.58";"0.31";"4.46";"7.09";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951540";"";"None";"607.06";"2";"5.05";"BDBM230155";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cc(F)cc(F)c2n(C)c1=O";"IC50";"'='";"0.84";"nM";"9.08";"";"401993";"UO_0000065";"14.95";"0.29";"4.03";"7.37";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948065";"";"None";"437.46";"0";"4.50";"BDBM249938";"C=CC(=O)Nc1ccc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2c1";"IC50";"'='";"0.32";"nM";"9.49";"";"435870";"UO_0000065";"21.70";"0.39";"4.99";"8.29";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959301";"";"None";"425.49";"0";"4.23";"BDBM249961";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCC(c1cccc(N)c1)C2";"IC50";"'='";"1900.0";"nM";"5.72";"";"435893";"UO_0000065";"13.45";"0.24";"1.49";"5.29";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904180";"";"None";"411.47";"0";"4.24";"BDBM249975";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2c1cccnc1";"IC50";"'='";"550.0";"nM";"6.26";"";"435904";"UO_0000065";"15.21";"0.28";"2.02";"6.58";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919346";"";"None";"536.64";"2";"5.02";"BDBM200783";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(NC(=O)c5ccc(C6CC6)cc5)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"356855";"UO_0000065";"16.77";"0.31";"3.98";"7.86";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4453432";"";"None";"595.73";"1";"4.79";"30r";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCN(C(C)=O)CC4)cc3)ncc2F)c1";"IC50";"'='";"80.3";"nM";"7.09";"";"";"UO_0000065";"11.91";"0.24";"2.31";"6.35";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4437107";"";"None";"589.72";"2";"6.20";"30ai";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCSC(=S)NCc4cccnc4)cc3)ncc2F)c1";"IC50";"'='";"2.39";"nM";"8.62";"";"";"UO_0000065";"14.62";"0.29";"2.42";"7.62";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3942777";"";"None";"551.53";"1";"4.73";"BDBM255299";"C[C@@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.14";"nM";"9.85";"";"445204";"UO_0000065";"17.87";"0.34";"5.12";"7.71";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4108687";"";"None";"565.56";"2";"5.12";"BDBM255303";"CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21";"IC50";"'='";"0.13";"nM";"9.89";"";"445208";"UO_0000065";"17.48";"0.33";"4.77";"7.74";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3896817";"";"None";"403.44";"0";"2.54";"BDBM249956";"C=CC(=O)NC1CNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn2C1";"IC50";"'='";"32.0";"nM";"7.50";"";"435888";"UO_0000065";"18.58";"0.34";"4.95";"6.74";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4449648";"";"None";"401.42";"0";"2.93";"10";"CC(C)N1Cc2cc(c(F)cc2F)OCCCNC(=O)c2cnn3ccc1nc23";"IC50";"'='";"9.67";"nM";"8.02";"";"";"UO_0000065";"19.97";"0.38";"5.08";"11.17";"0";"CHEMBL4349461";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346723";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3966567";"";"None";"411.47";"0";"4.24";"BDBM249976";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2c1ccccn1";"IC50";"'='";"830.0";"nM";"6.08";"";"435905";"UO_0000065";"14.78";"0.27";"1.84";"6.40";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929217";"";"None";"477.95";"0";"4.10";"BDBM249981";"C=CC(=O)N1CC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5cccc(Cl)c5)cc4)nn32)C1";"IC50";"'='";"0.48";"nM";"9.32";"";"435910";"UO_0000065";"19.50";"0.37";"5.22";"9.09";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954175";"";"None";"455.44";"0";"4.20";"BDBM250039";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(C(F)(F)F)cc3)nn21";"IC50";"'='";"4.2";"nM";"8.38";"";"435968";"UO_0000065";"18.39";"0.35";"4.18";"8.21";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958870";"";"None";"511.63";"1";"4.84";"BDBM250068";"CCCC#CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"3.9";"nM";"8.41";"";"436000";"UO_0000065";"16.44";"0.30";"3.57";"8.21";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4110832";"";"None";"572.98";"1";"4.50";"BDBM255432";"Cn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4c(Cl)cnc(N)c34)cc2)cc1C(F)(F)F";"IC50";"'='";"0.64";"nM";"9.19";"";"445339";"UO_0000065";"16.05";"0.31";"4.69";"7.45";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111119";"";"None";"458.57";"0";"2.33";"BDBM235163";"NC(=O)c1nc(N2CCC[C@@H](NS(=O)(=O)c3ccccc3)C2)sc1Nc1ccccn1";"IC50";"'='";"1614.8";"nM";"5.79";"";"409815";"UO_0000065";"12.63";"0.26";"3.46";"4.44";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114105";"";"None";"524.51";"1";"3.84";"BDBM255426";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4nc(C(F)(F)F)c[nH]4)cc3)c12";"IC50";"'='";"144.2";"nM";"6.84";"";"445333";"UO_0000065";"13.04";"0.25";"3.00";"5.09";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4112914";"";"None";"592.63";"2";"5.43";"BDBM255429";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)n(C5CCCC5)n4)cc3)c12";"IC50";"'='";"284.9";"nM";"6.54";"";"445336";"UO_0000065";"11.04";"0.21";"1.12";"5.30";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4070603";"";"None";"425.46";"1";"5.04";"3a";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]ccc23)c1CO";"IC50";"'='";"562.2";"nM";"6.25";"";"";"UO_0000065";"14.69";"0.27";"1.21";"8.81";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4113694";"";"None";"424.55";"0";"1.68";"BDBM235164";"CC(C)S(=O)(=O)N[C@@H]1CCCN(c2nc(C(N)=O)c(Nc3ccccn3)s2)C1";"IC50";"'='";"5803.8";"nM";"5.24";"";"409816";"UO_0000065";"12.33";"0.26";"3.56";"4.02";"0";"CHEMBL3888580";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease™: 10 nM Eu-streptavidin (Perkin-Elmer Catalog# AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog # STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog # PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10× concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10× stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C. After the incubation the plates were read on a BMG Pherastar Fluorescent plate reader (or equivalent) and used to measure the emission energy from the europium donor fluorophore (620 nm emission) and the FRET (665 nm emission).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886767";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.11";"nM";"9.96";"";"";"UO_0000065";"22.61";"0.41";"5.74";"10.04";"0";"CHEMBL4020207";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition by filter binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"20.03";"0.37";"4.60";"8.90";"0";"CHEMBL4020210";"Inhibition of BTK (unknown origin) preincubated for 1 hr followed by ATP addition measured after 1 hr by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017534";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3926657";"";"None";"506.57";"1";"4.47";"BDBM191610";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)/C=C/c2c[nH]cn2)C1";"IC50";"'='";"22.2";"nM";"7.65";"";"342646";"UO_0000065";"15.11";"0.28";"3.18";"5.99";"0";"CHEMBL3887529";"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886356";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4129781";"";"None";"598.71";"2";"3.93";"9";"C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1";"IC50";"'='";"359.0";"nM";"6.45";"";"";"UO_0000065";"10.76";"0.20";"2.51";"5.09";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL3401288";"";"None";"510.62";"2";"5.34";"28";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccn3ccnc3c2)n1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"14.23";"0.27";"1.93";"7.79";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401277";"";"None";"583.71";"2";"5.16";"17";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.87";"0.26";"2.94";"7.67";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401276";"";"None";"581.68";"1";"4.31";"16";"Cc1c(NC(=O)c2cnc(C(C)(C)C)cn2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"12.30";"0.23";"2.84";"5.45";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401274";"";"None";"581.68";"1";"4.31";"14";"Cc1c(NC(=O)c2ncc(C(C)(C)C)cn2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"12.55";"0.23";"2.99";"5.56";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401269";"";"None";"577.69";"2";"5.28";"9";"Cc1c(NC(=O)c2ccc(C3(C)CC3)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"13.02";"0.24";"2.24";"7.13";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3401267";"";"None";"593.73";"2";"5.91";"7";"CCC(C)(C)c1ccc(C(=O)Nc2cccc(-c3cn(C)c(=O)c(Nc4ccc(C(=O)N5CCOCC5)cc4)n3)c2C)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"12.46";"0.23";"1.49";"7.01";"0";"CHEMBL3406073";"Inhibition of BTK (unknown origin) by Lanthascreen method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400008";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3702851";"";"None";"637.72";"1";"4.17";"BDBM143205";"CN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"369525";"UO_0000065";"13.99";"0.26";"4.75";"6.09";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4439998";"";"None";"467.53";"0";"2.86";"9l";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"11.1";"nM";"7.96";"";"";"UO_0000065";"17.01";"0.31";"5.09";"6.47";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3952977";"";"None";"623.74";"1";"5.00";"BDBM143179";"[C-]#[N+]/C(=C/C(C)(C)N1CCN(C)CC1)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.3";"nM";"9.52";"";"279401";"UO_0000065";"15.27";"0.28";"4.52";"8.66";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4109830";"";"None";"417.47";"0";"3.10";"BDBM250087";"C=CC(=O)NC[C@H]1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"0.6";"nM";"9.22";"";"435835";"UO_0000065";"22.09";"0.41";"6.12";"8.29";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916950";"";"None";"431.50";"0";"3.44";"BDBM249908";"C=CC(=O)N(C)CC1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"1.1";"nM";"8.96";"";"435838";"UO_0000065";"20.76";"0.38";"5.52";"8.74";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982962";"";"None";"553.60";"1";"4.66";"BDBM143176";"CC1(/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)COC1";"IC50";"'='";"3.1";"nM";"8.51";"";"279398";"UO_0000065";"15.37";"0.28";"3.85";"6.44";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3985927";"";"None";"609.71";"1";"4.66";"BDBM143181";"[C-]#[N+]/C(=C/C(C)(C)N1CCNCC1)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"279403";"UO_0000065";"15.41";"0.29";"4.74";"7.91";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3942079";"";"None";"596.67";"1";"4.08";"BDBM143182";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CC(O)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"279404";"UO_0000065";"15.16";"0.28";"4.97";"6.18";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3967056";"";"None";"624.72";"1";"4.86";"BDBM143198";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCC(O)CC1";"IC50";"'='";"0.7";"nM";"9.15";"";"279416";"UO_0000065";"14.65";"0.27";"4.29";"6.25";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3935131";"";"None";"501.54";"1";"4.78";"BDBM249208";"Cn1cc(-c2cc(-c3ccc(Cn4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c(F)c3)cc(=O)[nH]2)cn1";"IC50";"'='";"14.19";"nM";"7.85";"";"434806";"UO_0000065";"15.65";"0.29";"3.07";"9.17";"0";"CHEMBL3889112";"TR-FRET (Time Resolved FRET) Assay: This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Resonance Energy Transfer) technology. The BTK-Eu complex was incubated on ice one hour prior to use at a starting concentration of 50 nM BTK-Bioease: 10 nM Eu-streptavidin (Perkin-Elmer Catalog #AD0062). The assay buffer consisted of 20 mM HEPES (pH 7.15), 0.1 mM DTT, 10 mM MgCl2, 0.5 mg/ml BSA with 3% Kinase Stabilizer (Fremont Biosolutions, Catalog #STB-K02). After 1 h, the reaction mixture from above was diluted 10 fold in assay buffer to make 5 nM BTK: 1 nM Eu-Streptavidin complex (donor fluorophore). 18 μl of a mixture of 0.11 nM BTK-Eu and 0.11 nM Kinase Tracer 178 (Invitrogen, Catalog #PV5593,) with BTK-Eu alone as no negative control, was then dispensed into 384-well flat bottom plates (Greiner, 784076). Compounds to be tested in assay were prepared as 10x concentrations and serial dilution in half-log increments was performed in DMSO so as to generate 10 point curves. To initiate the FRET reaction, compounds prepared as 10x stock in DMSO was added to the plates and the plates were incubated 18-24 h at 14° C.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886947";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4866645";"";"None";"512.57";"1";"1.64";"2";"CNC(=O)[C@H]1Cc2c([nH]c3ccccc23)CN1C(=O)[C@@H](Cc1ccccc1)NC(=O)c1c[nH]c(C(N)=O)c1";"IC50";"'='";"22.7";"nM";"7.64";"";"";"UO_0000065";"14.91";"0.27";"6.00";"4.99";"0";"CHEMBL4813334";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4873655";"";"None";"478.52";"0";"1.82";"5";"CNC(=O)[C@H]1Cc2c([nH]c3ccccc23)CN1C(=O)C[C@@H](Cc1cccc(F)c1)NC(=O)C1CO1";"IC50";"'='";"232.0";"nM";"6.63";"";"";"UO_0000065";"13.86";"0.26";"4.81";"6.21";"0";"CHEMBL4813334";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4460690";"";"None";"581.62";"2";"5.07";"7p";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccc(C(F)(F)F)cn5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"637.0";"nM";"6.20";"";"";"UO_0000065";"10.65";"0.21";"1.13";"5.32";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4543872";"";"None";"548.07";"2";"5.91";"6h";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccc(Cl)cc5)c4)sc3C(=O)O)cc2)CC1";"IC50";"'='";"134.0";"nM";"6.87";"";"";"UO_0000065";"12.54";"0.25";"0.96";"7.03";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"19.85";"0.36";"4.52";"8.82";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4593580";"";"None";"556.69";"2";"6.64";"6c";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3nc(Nc4ccc(N5CCOCC5)cc4)c(C(=O)O)s3)c2)cc1";"IC50";"'='";"5323.0";"nM";"5.27";"";"";"UO_0000065";"9.47";"0.18";"-1.37";"5.08";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4537375";"";"None";"543.65";"2";"5.41";"6d";"CN(C)c1ccc(C(=O)Nc2cccc(-c3nc(Nc4ccc(N5CCOCC5)cc4)c(C(=O)O)s3)c2)cc1";"IC50";"'='";"21045.0";"nM";"4.68";"";"";"UO_0000065";"8.60";"0.16";"-0.73";"4.37";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4454876";"";"None";"596.80";"2";"7.53";"30h";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N(CCCC)CCCC)cc3)ncc2F)c1";"IC50";"'='";"125.2";"nM";"6.90";"";"";"UO_0000065";"11.57";"0.23";"-0.63";"7.55";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4469663";"";"None";"437.89";"0";"3.19";"20a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cn4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"16.07";"0.31";"3.85";"5.17";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4473261";"";"None";"480.62";"1";"6.64";"40, Mixture of enantiomer";"O=C(Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1C1CCCC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.56";"0.27";"0.36";"8.15";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4558216";"";"None";"411.51";"0";"4.52";"23";"O=C(Cc1ccccc1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"45000.0";"nM";"4.35";"";"";"UO_0000065";"10.56";"0.19";"-0.17";"5.88";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6c";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"15.76";"0.31";"3.57";"7.55";"1";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4111121";"";"None";"608.58";"1";"3.12";"BDBM255358";"Nc1nccn2c([C@@H]3CC[C@H]4CN(CC(=O)O)CC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.22";"nM";"9.66";"";"445264";"UO_0000065";"15.87";"0.30";"6.54";"6.07";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3928649";"";"None";"533.52";"1";"4.40";"BDBM246410";"Cn1cc2c(n1)CCC[C@@H]2n1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"83.0";"nM";"7.08";"";"429701";"UO_0000065";"13.27";"0.25";"2.68";"5.47";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4114902";"";"None";"547.55";"1";"4.88";"BDBM246399";"CCn1ncc2c1CCC[C@H]2n1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"3.2";"nM";"8.49";"";"429702";"UO_0000065";"15.51";"0.29";"3.61";"6.56";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4113578";"";"None";"547.55";"1";"4.88";"BDBM246411";"CCn1cc2c(n1)CCC[C@H]2n1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"13.0";"nM";"7.89";"";"429703";"UO_0000065";"14.40";"0.27";"3.01";"6.09";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4115608";"";"None";"559.56";"2";"5.04";"BDBM246404";"Nc1nccn2c([C@H]3CCCn4c(C5CC5)nnc43)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"56.0";"nM";"7.25";"";"429711";"UO_0000065";"12.96";"0.24";"2.21";"5.63";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3941392";"";"None";"587.49";"1";"4.98";"BDBM246405";"Nc1nccn2c([C@H]3CCn4c(nnc4C(F)(F)F)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.81";"nM";"9.09";"";"429712";"UO_0000065";"15.48";"0.30";"4.11";"7.05";"0";"CHEMBL3889025";"LANCE-TR-FRET Assay: Assay Method B: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 μM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 μL) was dispensed, followed by the addition of 7.5 μL of 1× kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/μL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 μL 1× kinase buffer containing 8 μM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2), and 100 μM ATP. The final reaction in each well of 10 μL consists of 50 pM hBTK, 2 μM biotin-A5-peptide, and 25 μM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 μL of 1× quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886923";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110412";"";"None";"550.55";"1";"4.26";"BDBM255255";"CN1C[C@@H]2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"7.2";"nM";"8.14";"";"445159";"UO_0000065";"14.79";"0.28";"3.88";"6.69";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3903010";"";"None";"541.59";"1";"4.73";"BDBM255288";"C[C@@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C6CC6)ccn5)cc4F)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.39";"nM";"9.41";"";"445193";"UO_0000065";"17.37";"0.32";"4.68";"7.37";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4111645";"";"None";"550.55";"1";"3.32";"BDBM255291";"Nc1nccn2c([C@@H]3CC[C@H]4CNCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.22";"nM";"9.66";"";"445196";"UO_0000065";"17.54";"0.33";"6.34";"7.40";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4110653";"";"None";"523.60";"1";"4.59";"BDBM255298";"C[C@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C6CC6)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"0.17";"nM";"9.77";"";"445203";"UO_0000065";"18.66";"0.34";"5.18";"7.65";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4105470";"";"None";"439.49";"1";"5.35";"3b";"Cc1cc2c(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)ccnc2[nH]1";"IC50";"'='";"213.0";"nM";"6.67";"";"";"UO_0000065";"15.18";"0.28";"1.32";"9.41";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4091642";"";"None";"549.63";"2";"6.97";"3j";"CC(=O)c1cc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cs1";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"13.03";"0.24";"0.19";"8.14";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4101864";"";"None";"506.58";"2";"5.42";"3m";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]c(C4=CCNCC4)cc23)c1CO";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.82";"0.31";"3.10";"10.28";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4079989";"";"None";"562.65";"2";"5.53";"3t";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"15.15";"0.28";"2.99";"10.22";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3948065";"";"None";"437.46";"0";"4.50";"6";"C=CC(=O)Nc1ccc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2c1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"19.55";"0.35";"4.05";"7.47";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3921167";"";"None";"479.54";"0";"4.97";"18";"C=CC(=O)Nc1cccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"17.90";"0.33";"3.62";"7.72";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3921167";"";"None";"479.54";"0";"4.97";"18";"C=CC(=O)Nc1cccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)c1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"17.87";"0.33";"3.60";"7.70";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4084331";"";"None";"471.59";"1";"5.09";"1";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cc(Nc2ccncn2)c(=O)n(C)c1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"15.64";"0.30";"2.29";"8.30";"0";"CHEMBL4036699";"Inhibition of recombinant human full length His-tagged BTK expressed in baculovirus expression system by Z-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4060453";"";"None";"635.77";"1";"3.54";"18";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"11.26";"0.21";"3.62";"6.62";"0";"CHEMBL4036701";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of BCR-induced CD69 expression on B cells preincubated for 1 hr followed by blood stimulation measured after 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3670094";"";"None";"611.72";"1";"3.91";"19";"CN1CCN(c2ccc(Nc3cc(-c4cc(F)cc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"12.32";"0.23";"3.63";"7.62";"0";"CHEMBL4036701";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of BCR-induced CD69 expression on B cells preincubated for 1 hr followed by blood stimulation measured after 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033752";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"BDBM230081";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"2.1";"nM";"8.68";"";"401936";"UO_0000065";"14.83";"0.28";"3.26";"7.05";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939795";"";"None";"597.07";"2";"5.29";"BDBM230084";"COc1ccc2c(=O)n(-c3cccc(-c4c(Cl)cc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)n(C)c2c1";"IC50";"'='";"2.1";"nM";"8.68";"";"401940";"UO_0000065";"14.53";"0.28";"3.39";"6.56";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917989";"";"None";"504.54";"2";"5.49";"BDBM200790";"Cc1c(NC(=O)c2ccc(C(C)(C)O)cc2F)cc(F)cc1-c1ncnc2[nH]c(C3=CCOCC3)cc12";"IC50";"'='";"8.0";"nM";"8.10";"";"356860";"UO_0000065";"16.05";"0.30";"2.61";"8.09";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933887";"";"None";"532.64";"2";"5.82";"BDBM200803";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cc(F)cc1-c1ncnc2[nH]c(C3=CCS(=O)(=O)CC3)cc12";"IC50";"'='";"35.0";"nM";"7.46";"";"356864";"UO_0000065";"14.00";"0.27";"1.64";"7.11";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4103674";"";"None";"648.76";"2";"5.14";"45";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCCC(O)C1";"IC50";"'='";"244.0";"nM";"6.61";"";"";"UO_0000065";"10.19";"0.19";"1.47";"4.86";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4101519";"";"None";"617.75";"2";"6.67";"37";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)NC1CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"11.96";"0.22";"0.72";"6.09";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4074840";"";"None";"631.78";"2";"7.01";"36";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCCC1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"12.22";"0.22";"0.71";"6.86";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4077998";"";"None";"673.69";"2";"6.28";"25";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"IC50";"'='";"1261.0";"nM";"5.90";"";"";"UO_0000065";"8.76";"0.16";"-0.38";"4.84";"0";"CHEMBL4024931";"Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4552628";"";"None";"425.89";"0";"3.66";"27";"Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"11.47";"0.24";"1.23";"5.73";"0";"CHEMBL4479700";"Inhibition of full-length recombinant human His-tagged BTK expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4282893";"";"None";"465.56";"0";"1.81";"8";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4C[C@@H](C)O[C@@H](C)C4)nc3)n2)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"18.73";"0.35";"6.91";"6.94";"0";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3652660";"";"None";"544.59";"1";"3.38";"BDBM122421";"Cc1cc(Nc2nn(-c3cccc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cc2C(N)=O)nn1C";"IC50";"'='";"0.29";"nM";"9.54";"";"251001";"UO_0000065";"17.51";"0.33";"6.16";"6.54";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3685424";"";"None";"453.91";"0";"4.64";"BDBM120747";"C=CC(=O)Nc1cccc(-c2nc(Nc3ccc(N4CCOCC4)c(F)c3)ncc2Cl)c1";"IC50";"'='";"287.0";"nM";"6.54";"";"248814";"UO_0000065";"14.41";"0.28";"1.90";"8.24";"0";"CHEMBL3705216";"Time Resolved-FRET Assay: Activity of compounds was routinely confirmed using a secondary assay as described herein. The secondary assay was a time resolved-FRET kinase assay. Test compound are diluted to desired concentrations in kinase reaction buffer and briefly incubated with BTK kinase (as described above; Invitrogen). The reaction is initiated by the addition of ATP and enzyme substrate, HTRF® KinEASE-TK Substrate-biotin (Cisbio US, Bedford, Mass.). The composition of the reaction (10 μl) was: 1% v/v DMSO, 10 nM BTK, 60 μM ATP, and 1 μM substrate. After incubation at room temperature for 60 min, the enzyme reaction is stopped by EDTA-containing buffer, which also contains europium-labeled (Eu3+-Cryptate) anti-phosphotyrosine antibody (Cisbio) and Streptavidin-XL665 (Cisbio). The europium-labeled antibody generates a time-resolved FRET signal with the Stepavidin-XL665, which binds to the biotinylated TK substrate through the streptavidin conjugate when the substrate is phosphorylated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638547";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3972359";"";"None";"505.58";"1";"4.89";"BDBM197204";"N#C/C(=C\C1CC1)C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.7";"nM";"8.77";"";"350424";"UO_0000065";"17.35";"0.32";"3.88";"7.13";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3922830";"";"None";"559.55";"2";"5.10";"BDBM197200";"N#C/C(=C\C1CC1)C(=O)N1CC(F)(F)C[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"3.0";"nM";"8.52";"";"350438";"UO_0000065";"15.23";"0.28";"3.42";"6.93";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3967663";"";"None";"613.76";"2";"6.05";"BDBM202094";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cc2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"358172";"UO_0000065";"13.89";"0.25";"2.47";"10.04";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959033";"";"None";"648.74";"2";"5.68";"BDBM202122";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4cnn(C5CCN(C6COC6)CC5)c4)cc23)c1CO";"IC50";"'='";"1.7";"nM";"8.77";"";"358200";"UO_0000065";"13.52";"0.25";"3.09";"8.06";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963720";"";"None";"642.80";"2";"6.23";"BDBM202136";"CC(C)N1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"358214";"UO_0000065";"13.53";"0.25";"2.47";"8.89";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941978";"";"None";"615.68";"1";"4.43";"BDBM202147";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cc(F)cc(-c2ccnc3[nH]c(CN4CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"1.3";"nM";"8.89";"";"358224";"UO_0000065";"14.43";"0.27";"4.46";"9.44";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895833";"";"None";"599.69";"2";"5.99";"BDBM202163";"COC1CN(C(=O)c2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5C)ncnc4[nH]3)cc2)C1";"IC50";"'='";"162.0";"nM";"6.79";"";"358240";"UO_0000065";"11.32";"0.21";"0.80";"6.75";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906165";"";"None";"614.71";"2";"5.57";"BDBM202184";"Cc1c(-c2nc(N)nc3[nH]c(-c4ccc(C(=O)N5CCOCC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"55.0";"nM";"7.26";"";"358261";"UO_0000065";"11.81";"0.22";"1.69";"5.73";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967425";"";"None";"546.58";"2";"5.40";"BDBM202191";"O=C(O)c1ccc(-c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)ccc6C5=O)c4CO)ccnc3[nH]2)nc1";"IC50";"'='";"46.0";"nM";"7.34";"";"358268";"UO_0000065";"13.42";"0.24";"1.94";"5.70";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936823";"";"None";"595.68";"2";"5.55";"BDBM202199";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"358275";"UO_0000065";"15.11";"0.28";"3.45";"8.82";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3970328";"";"None";"623.73";"2";"6.33";"BDBM202204";"CCN(CC)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"14.6";"nM";"7.84";"";"358280";"UO_0000065";"12.56";"0.23";"1.51";"7.68";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946460";"";"None";"596.70";"2";"5.64";"BDBM202208";"CC(C)(O)CN1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"358284";"UO_0000065";"14.84";"0.27";"3.21";"8.69";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929335";"";"None";"580.66";"2";"5.84";"BDBM202216";"NC(=O)CC1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"5.3";"nM";"8.28";"";"358292";"UO_0000065";"14.25";"0.26";"2.44";"6.81";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982709";"";"None";"585.67";"1";"4.88";"BDBM202228";"N#CCN1CC(n2cc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5CO)ccnc4[nH]3)cn2)C1";"IC50";"'='";"12.0";"nM";"7.92";"";"358302";"UO_0000065";"13.52";"0.25";"3.04";"6.42";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975610";"";"None";"559.55";"2";"5.14";"BDBM197212";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3cccc(F)c3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"1.8";"nM";"8.74";"";"350382";"UO_0000065";"15.63";"0.29";"3.60";"7.11";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114710";"";"None";"543.58";"2";"5.24";"BDBM197198";"CC(C)/C=C(\C#N)C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3cccc(F)c3)cc2F)c2c(N)ncnc21";"IC50";"'='";"11.0";"nM";"7.96";"";"350387";"UO_0000065";"14.64";"0.27";"2.72";"6.47";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3921806";"";"None";"504.59";"2";"5.50";"BDBM60905";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"350401";"UO_0000065";"15.85";"0.29";"2.50";"7.27";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114793";"";"None";"605.62";"2";"5.71";"BDBM197261";"CCOC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(F)c4F)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"7.3";"nM";"8.14";"";"350406";"UO_0000065";"13.44";"0.25";"2.43";"6.16";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114748";"";"None";"548.69";"2";"6.60";"BDBM197266";"CC(C)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"1.0";"nM";"9.00";"";"350408";"UO_0000065";"16.40";"0.30";"2.40";"8.18";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114659";"";"None";"618.53";"2";"6.28";"BDBM197179";"COc1cc(-c2nn(CC3CCCN(C(=O)/C(C#N)=C/C4CC4)C3)c3ncnc(N)c23)ccc1Oc1ccc(Cl)c(Cl)c1";"IC50";"'='";"61.0";"nM";"7.21";"";"350369";"UO_0000065";"11.66";"0.23";"0.93";"5.46";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4068919";"";"None";"538.53";"2";"5.18";"38";"C[C@]1(C(=O)O)CC[C@@](C)(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"18.01";"0.34";"4.52";"7.16";"0";"CHEMBL3999900";"Inhibition of 6-His-tagged recombinant full length BTK (unknown origin) expressed in baculovirus-transfected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4084927";"";"None";"566.58";"2";"6.03";"33";"CC(C)[C@]1(C(=O)O)CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)C1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"12.17";"0.23";"0.86";"5.09";"0";"CHEMBL3999901";"Inhibition of BTK in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997842";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3936823";"";"None";"595.68";"2";"5.55";"14";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.11";"0.28";"3.45";"8.82";"1";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3966346";"";"None";"580.66";"2";"5.27";"13";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"14.65";"0.27";"3.24";"9.36";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3959033";"";"None";"648.74";"2";"5.68";"12";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4cnn(C5CCN(C6COC6)CC5)c4)cc23)c1CO";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"13.52";"0.25";"3.09";"8.06";"1";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3890115";"";"None";"562.67";"1";"4.97";"BDBM200857";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(N5CCc6cc(C7CC7)ccc6C5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"356884";"UO_0000065";"13.81";"0.25";"2.80";"7.35";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908775";"";"None";"572.71";"2";"6.28";"BDBM200765";"Cc1c(NC(=O)c2cc3c(s2)CCC(C)C3)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12";"IC50";"'='";"27.0";"nM";"7.57";"";"356906";"UO_0000065";"13.22";"0.25";"1.29";"8.03";"0";"CHEMBL3887839";"Cellular Assay: Alternatively, the present compounds might also be assessed for their capacity to inhibit Btk-dependent FcG receptor-induced IL-8 secretion in human cells. The human myeloid leukemia THP1 cell line (ATCC TIB202) was grown in RPMI 1640 medium supplemented with 10% FCS and 15 nM 1, 25-dihydroxy Vitamin D3 during 4 days before use to induced myeloid differentiation. A sufficient number of tissue-culture grade 384-well plates was coated with human IgG of unknown specificity by incubating overnight at 4° C. with 40 ul/well of a 50 ug/ml IgG solution in PBS. On the day of the experiment, plates were washed 5 times with 80 ul water on a Molecular Devices Aquamax DW4 plate washer. Solutions of the test compounds in 90% DMSO were added to each well on a Hamilton Microlab Star liquid handling station to 40 ul/well tissue culture medium and the total DMSO concentration was adjusted to 0.1%. Differentiated THP1 cells were then added in 40 ul/well to reach a final density of 5'000 cells/well in 80 ul culture medium. After 24 hours, IL-8 secretion was measured in the supernatant by the IL-8 HTRF assay following the protocol of the vendor (CisBio international).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"CHEMBL3307574";"";"";""
"CHEMBL3670130";"";"None";"558.66";"1";"4.54";"BDBM111989";"CCn1nc(Nc2cc(-c3cc(F)cc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)cc1C";"IC50";"'='";"9.9";"nM";"8.00";"";"233044";"UO_0000065";"14.33";"0.27";"3.46";"8.22";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4216939";"";"None";"591.64";"2";"5.31";"18";"N#CCC(=O)N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"15.08";"0.28";"3.61";"7.28";"0";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4460221";"";"None";"520.56";"2";"5.46";"20";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2c(F)cccc2c1=O";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"14.35";"0.26";"2.01";"6.55";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4554269";"";"None";"501.59";"2";"5.93";"16";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1ccc2ccccc2c1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.55";"0.30";"2.37";"8.21";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4205977";"";"None";"476.58";"1";"6.62";"2a";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccnc(Nc2ccc3cn[nH]c3c2)n1";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"13.34";"0.24";"-0.26";"6.65";"0";"CHEMBL4182608";"Inhibition of BTK (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL5080260";"";"None";"538.61";"2";"5.06";"24d";"C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(OCC(C)=O)c4)nc32)c1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"16.89";"0.31";"4.04";"7.10";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5076601";"";"None";"508.58";"2";"5.29";"24e";"C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(C(C)=O)c4)nc32)c1";"IC50";"'='";"38.8";"nM";"7.41";"";"";"UO_0000065";"14.57";"0.27";"2.12";"6.23";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5093755";"";"None";"489.62";"0";"4.19";"25";"CC(C)CC1(O)CN(C(=O)NC2CCCCc3cc(-c4ccnc(Nc5cnn(C)c5)n4)ccc32)C1";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"17.20";"0.32";"4.23";"7.78";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5087183";"";"None";"473.63";"1";"5.08";"26";"CC(C)C1CCN(C(=O)NC2CCCCc3cc(-c4ccnc(Nc5cnn(C)c5)n4)ccc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.64";"0.36";"4.22";"10.57";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5083399";"";"None";"502.65";"1";"4.97";"30";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)c3nnc(C(C)(C)C)s3)n2)cn1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.75";"0.34";"3.95";"8.07";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5090589";"";"None";"486.58";"0";"4.50";"33";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)c3nnc(C(C)(C)C)o3)n2)cn1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.12";"0.35";"4.80";"7.52";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"385035";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4877739";"";"None";"471.52";"0";"3.73";"25f";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)C1";"IC50";"'='";"683.0";"nM";"6.17";"";"";"UO_0000065";"13.08";"0.24";"2.44";"5.36";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3929922";"";"None";"452.52";"0";"4.05";"BDBM191621";"CC#CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"385051";"UO_0000065";"19.22";"0.35";"4.65";"8.77";"0";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647970";"";"None";"497.60";"0";"4.15";"BDBM97675";"CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.1";"nM";"8.96";"";"385036";"UO_0000065";"18.00";"0.33";"4.81";"8.75";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647973";"";"None";"440.51";"0";"4.22";"BDBM97678";"C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"3.1";"nM";"8.51";"";"385040";"UO_0000065";"19.32";"0.35";"4.29";"8.58";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5081318";"";"None";"486.58";"0";"2.58";"45";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCNC[C@H]4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"18.70";"0.35";"6.52";"7.14";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4114660";"";"None";"568.65";"2";"6.57";"BDBM197224";"CCOC(C)(C)/C=C(\C#N)C(=O)C1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"7.0";"nM";"8.15";"";"350405";"UO_0000065";"14.34";"0.27";"1.58";"6.32";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114703";"";"None";"499.55";"0";"4.62";"BDBM197270";"CC(C)/C=C(\C#N)C(=O)N[C@H](C)Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"3.0";"nM";"8.52";"";"350409";"UO_0000065";"17.06";"0.31";"3.90";"6.47";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114765";"";"None";"521.63";"2";"5.53";"BDBM197180";"CC(C)(C)/C=C(\C#N)C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"350415";"UO_0000065";"17.04";"0.31";"3.36";"7.23";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114719";"";"None";"507.60";"2";"5.48";"BDBM197184";"CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@H]1n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"5.4";"nM";"8.27";"";"350418";"UO_0000065";"16.29";"0.30";"2.79";"6.72";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114702";"";"None";"523.57";"2";"5.03";"BDBM197191";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(F)c4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.7";"nM";"8.77";"";"350420";"UO_0000065";"16.75";"0.31";"3.74";"7.13";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4115679";"";"None";"519.61";"2";"5.03";"BDBM197203";"Cc1cc(Oc2ccccc2)ccc1-c1nn(C[C@@H]2CCCN2C(=O)/C(C#N)=C/C2CC2)c2ncnc(N)c12";"IC50";"'='";"5.0";"nM";"8.30";"";"350434";"UO_0000065";"15.98";"0.29";"3.27";"6.75";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3922858";"";"None";"559.55";"2";"5.14";"BDBM197214";"N#C/C(=C\C1CC1)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3c(F)cccc3F)cc2F)c2c(N)ncnc21";"IC50";"'='";"16.0";"nM";"7.80";"";"350446";"UO_0000065";"13.93";"0.26";"2.66";"6.34";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4114722";"";"None";"543.60";"1";"4.78";"BDBM197271";"CCOC(C)(C)/C=C(\C#N)C(=O)N[C@H](C)Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"5.0";"nM";"8.30";"";"350461";"UO_0000065";"15.27";"0.28";"3.52";"5.89";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL5286154";"";"None";"435.31";"0";"3.02";"25";"O=C(CNc1cc(Cl)cc(Cl)c1)N1CCOCC(Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"15.99";"0.33";"3.94";"7.31";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5274179";"";"None";"433.34";"0";"4.17";"41";"C[C@@H]1[C@H](Nc2ncnc3[nH]ccc23)CCCN1C(=O)CNc1cc(Cl)cc(Cl)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"20.07";"0.41";"4.53";"10.12";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL3657218";"";"None";"447.33";"1";"6.97";"BDBM134223";"Nc1n[nH]c2c(-c3ccc(Cl)c(Cl)c3)ncc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"9180.0";"nM";"5.04";"";"267612";"UO_0000065";"11.26";"0.22";"-1.93";"6.56";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3657225";"";"None";"462.43";"1";"6.57";"BDBM134230";"Nc1n[nH]c2c(-c3cccc(OC(F)(F)F)c3)ncc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"13840.0";"nM";"4.86";"";"267619";"UO_0000065";"10.51";"0.20";"-1.71";"5.65";"0";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL2057923";"";"None";"422.44";"1";"5.36";"BDBM134237";"Nc1n[nH]c2cc(-c3ccc(C(=O)O)cc3)nc(-c3ccc(Oc4ccccc4)cc3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"267626";"UO_0000065";"21.30";"0.38";"3.64";"7.89";"1";"CHEMBL3705416";"Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (20 uM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT in 1.6% DMSO), with a final volume of 30 uL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and no inhibitor controls for 0% inhibition. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638930";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3808573";"";"None";"443.51";"0";"3.67";"II1";"C=CC(=O)N1CCC(Nc2ncnc(N)c2C(=O)c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"13.46";"0.25";"2.30";"5.41";"0";"CHEMBL3813051";"Inhibition of BTK (unknown origin) assessed as reduction in phosphorylation of coumarin and fluorescein-labeled FRET peptide substrate incubated for 1 hr by Z-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4245357";"";"None";"508.58";"2";"5.23";"15e";"COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCCCC6)cc5)c4c3c2)cn1";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"13.71";"0.25";"1.74";"7.78";"0";"CHEMBL4235188";"Inhibition of recombinant full length human N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229497";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4278652";"";"None";"538.99";"1";"3.99";"7c";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)c(OC)c3)ncc2Cl)c1";"IC50";"'='";"10.5";"nM";"7.98";"";"";"UO_0000065";"14.80";"0.29";"3.99";"6.29";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4290692";"";"None";"509.01";"1";"4.84";"7e";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)cc3)ncc2Cl)c1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"18.12";"0.35";"4.38";"9.16";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4294772";"";"None";"570.53";"2";"5.80";"7g";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(CC)CC4)c(Cl)c3)ncc2Cl)c1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.30";"0.33";"3.50";"9.83";"0";"CHEMBL4252316";"Inhibition of recombinant full-length N-terminal His-tagged human BTK expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251566";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4203077";"";"None";"586.76";"2";"6.27";"4";"C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2";"IC50";"'='";"0.64";"nM";"9.19";"";"";"UO_0000065";"15.67";"0.30";"2.92";"8.73";"0";"CHEMBL4199505";"Inhibition of BTK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196110";"1";"Scientific Literature";"ACS Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3936249";"";"None";"585.04";"2";"5.42";"9a";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.04";"0.23";"1.63";"5.72";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3899411";"";"None";"575.60";"1";"4.64";"12b";"Cc1c(-c2c(C#N)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.02";"0.22";"2.28";"4.71";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3896019";"";"None";"568.58";"1";"4.90";"12c";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.00";"0.26";"3.06";"6.46";"0";"CHEMBL3858906";"Inhibition of BTK in human Ramos-B cells assessed as suppression of BCR/anti-IgG-stimulated Ca2+ flux after 1 hr incubation in dark by FLIPR1 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307664";"";"";""
"CHEMBL3976719";"";"None";"554.62";"1";"4.26";"14b";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"11.58";"0.21";"2.16";"5.22";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3944049";"";"None";"589.07";"1";"4.91";"14c";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"14.57";"0.28";"3.68";"6.97";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3944049";"";"None";"589.07";"1";"4.91";"14c";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"10.96";"0.21";"1.55";"5.24";"0";"CHEMBL3858907";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM/IgG-stimulated CD69 surface expression after 18 hrs with agitation by FITC-staining based FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4251213";"";"None";"496.91";"0";"3.32";"7a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)NCC(=O)O)cc3)ncc2Cl)c1";"IC50";"'='";"11.2";"nM";"7.95";"";"";"UO_0000065";"16.00";"0.31";"4.63";"5.14";"0";"CHEMBL4233700";"Inhibition of full length recombinant human N-terminal His-tagged BTK expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229440";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL5202699";"";"None";"341.38";"0";"0.36";"1";"C=CC(=O)N1CC2CC1CN2c1nc(NC)nc(Nc2cc[nH]n2)n1";"IC50";"'='";"16.11";"nM";"7.79";"";"";"UO_0000065";"22.83";"0.43";"7.43";"6.78";"0";"CHEMBL5130942";"Inhibition of BTK (unknown origin) using TK peptide as substrate incubated for 1 hr in presence of ATP by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126642";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4866284";"";"None";"497.56";"0";"3.96";"18g";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5OC)cc4)[nH]c23)CC1";"IC50";"'='";"62.5";"nM";"7.20";"";"";"UO_0000065";"14.48";"0.27";"3.24";"6.27";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4871140";"";"None";"471.49";"0";"3.70";"26c";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5F)cc4)[nH]c23)C1";"IC50";"'='";"623.0";"nM";"6.21";"";"";"UO_0000065";"13.16";"0.24";"2.51";"5.87";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4869123";"";"None";"457.47";"0";"3.31";"29b";"CC#CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)C1";"IC50";"'='";"505.0";"nM";"6.30";"";"";"UO_0000065";"13.76";"0.25";"2.99";"5.96";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4856208";"";"None";"457.49";"0";"3.34";"28g";"C=CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)C1";"IC50";"'='";"34.7";"nM";"7.46";"";"";"UO_0000065";"16.31";"0.30";"4.12";"6.49";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4867893";"";"None";"455.47";"0";"2.79";"30g";"C#CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)C1";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"18.15";"0.33";"5.48";"7.19";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4878064";"";"None";"461.48";"0";"4.46";"32a";"C#CC(=O)Nc1ccc(-c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)cc1";"IC50";"'='";"82.6";"nM";"7.08";"";"";"UO_0000065";"15.35";"0.28";"2.62";"6.19";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4876114";"";"None";"484.56";"0";"3.22";"35a";"CN(C)C/C=C/C(=O)N1CCc2nn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c3c2C1";"IC50";"'='";"408.0";"nM";"6.39";"";"";"UO_0000065";"13.19";"0.24";"3.17";"5.86";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3665115";"";"None";"471.56";"0";"4.11";"BDBM111586";"CNC(=O)Nc1cc(-c2cccc(-n3cnc4cc(C(C)(C)C)ccc4c3=O)c2C)cn(C)c1=O";"IC50";"'='";"112.0";"nM";"6.95";"";"262411";"UO_0000065";"14.74";"0.27";"2.84";"7.09";"1";"CHEMBL3705524";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 um hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 uM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 uM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 uM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 uM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 uCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639153";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3674681";"";"None";"623.69";"1";"4.32";"BDBM102444";"Cn1cc(-c2cccc(N3CCc4cc(C5(F)CC5)ccc4C3=O)c2CO)nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c1=O";"IC50";"'='";"10.0";"nM";"8.00";"";"219974";"UO_0000065";"12.83";"0.24";"3.68";"6.84";"0";"CHEMBL3705343";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639178";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3702843";"";"None";"596.67";"1";"4.17";"BDBM143195";"CC(C)(/C=C(\C#N)C(=O)N1CCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCOCC1";"IC50";"'='";"4.1";"nM";"8.39";"";"369517";"UO_0000065";"14.06";"0.26";"4.22";"6.19";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3889694";"";"None";"511.63";"1";"4.59";"BDBM191613";"CN(C)C/C=C/C(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"385042";"UO_0000065";"17.31";"0.32";"4.26";"7.96";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3647969";"";"None";"438.49";"0";"3.66";"BDBM97674";"C#CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"327857";"UO_0000065";"20.85";"0.38";"5.48";"9.22";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647973";"";"None";"440.51";"0";"4.22";"BDBM97678";"C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"3.6";"nM";"8.44";"";"327858";"UO_0000065";"19.17";"0.35";"4.22";"8.52";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3647970";"";"None";"497.60";"0";"4.15";"BDBM97675";"CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"2.5";"nM";"8.60";"";"327864";"UO_0000065";"17.29";"0.32";"4.45";"8.40";"1";"CHEMBL3887275";"Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. Measurements were performed in a reaction volume of 50 uL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 uM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25uL of 1x Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1x Lance buffer were added in a 25 uL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886252";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4103954";"";"None";"581.57";"2";"5.29";"2";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.44";"0.27";"3.11";"7.09";"1";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4111979";"";"None";"567.55";"2";"5.04";"30";"Nc1nccn2c([C@@H]3CC[C@H]4CCCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"13.05";"0.25";"2.37";"6.25";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4111886";"";"None";"579.54";"1";"4.21";"41";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3C(=O)O)c12";"IC50";"'='";"1410.0";"nM";"5.85";"";"";"UO_0000065";"10.10";"0.19";"1.64";"3.76";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4782472";"";"None";"619.53";"2";"5.41";"45";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC(F)(F)F)c12";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"11.51";"0.22";"1.72";"5.58";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4110388";"";"None";"579.58";"1";"4.91";"34";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"12.14";"0.23";"2.13";"5.51";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL3702837";"";"None";"596.67";"1";"4.21";"BDBM143188";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)NC1COC1";"IC50";"'='";"16.1";"nM";"7.79";"";"279409";"UO_0000065";"13.06";"0.24";"3.58";"5.40";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3903174";"";"None";"637.76";"2";"5.04";"BDBM143201";"CCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"0.9";"nM";"9.05";"";"279419";"UO_0000065";"14.18";"0.26";"4.01";"6.99";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3890663";"";"None";"665.82";"2";"5.82";"BDBM143203";"CC(C)(C)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"0.6";"nM";"9.22";"";"279421";"UO_0000065";"13.85";"0.26";"3.40";"7.12";"0";"CHEMBL3706082";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639296";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3263653";"";"None";"513.60";"1";"4.53";"33";"Cc1c(NC(=O)C(C)(C)C)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'='";"109.0";"nM";"6.96";"";"";"UO_0000065";"13.56";"0.25";"2.43";"5.56";"0";"CHEMBL3270595";"Inhibition of full length human wild type his-tagged BTK expressed in Sf9 cells using biotinylated peptide as substrate after 1 hr by Fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"15.89";"0.30";"3.67";"7.12";"0";"CHEMBL4701077";"Inhibition of BTK in human whole blood assessed as reduction in BTK phosphorylation measured after 30 mins by phosphotyrosine detection method";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4436118";"";"None";"402.46";"0";"3.14";"11a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"21.25";"0.39";"5.41";"6.94";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4456283";"";"None";"436.90";"0";"3.79";"10";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"16.75";"0.32";"3.53";"5.94";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4559065";"";"None";"517.48";"1";"4.29";"9h";"NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/C(F)F)C2)c1N";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"18.14";"0.35";"5.10";"8.06";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4473486";"";"None";"526.66";"2";"5.62";"30c";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NC(C)C)cc3)ncc2F)c1";"IC50";"'='";"98.2";"nM";"7.01";"";"";"UO_0000065";"13.31";"0.27";"1.39";"6.99";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL5179333";"";"None";"531.66";"2";"5.49";"33";"CC#CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)cc4)c23)CC1";"IC50";"'='";"11.1";"nM";"7.96";"";"";"UO_0000065";"14.96";"0.27";"2.46";"8.74";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5191633";"";"None";"610.69";"1";"4.73";"27";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCOCC1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"15.10";"0.28";"4.49";"6.81";"0";"CHEMBL5104909";"Inhibition of biotinylated-labeled BTK-selective probe binding to BTK in human Ramos assessed as target occupancy pretreated for 1 hr followed by probe addition measured for 18 hrs by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4782313";"";"None";"447.59";"0";"4.51";"24";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CCC(C(C)(C)C)C1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"14.42";"0.27";"1.95";"7.34";"0";"CHEMBL4701077";"Inhibition of BTK in human whole blood assessed as reduction in BTK phosphorylation measured after 30 mins by phosphotyrosine detection method";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4279430";"";"None";"448.57";"0";"2.40";"23";"C=CC(=O)N1CCN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"21.23";"0.39";"7.12";"10.05";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4785747";"";"None";"470.53";"0";"3.90";"14";"C=CC(=O)N1CCCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"6.7";"nM";"8.17";"";"";"UO_0000065";"17.37";"0.32";"4.27";"6.86";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4759591";"";"None";"468.52";"0";"3.35";"24";"CC#CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"16.91";"0.31";"4.57";"6.65";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5076235";"";"None";"897.34";"2";"3.74";"4e";"O=C(CNc1ncnc2[nH]cc(C(=O)c3ccc(Oc4ccccc4)cc3Cl)c12)NCCOCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O";"IC50";"'='";"2203.5";"nM";"5.66";"";"";"UO_0000065";"6.30";"0.12";"1.92";"2.34";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5177608";"";"None";"478.36";"0";"3.87";"68";"O=C1[C@H](Nc2cc(Cl)c(F)c(Cl)c2)CCCN1[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"16.19";"0.33";"3.87";"8.60";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4111979";"";"None";"567.55";"2";"5.04";"30";"Nc1nccn2c([C@@H]3CC[C@H]4CCCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"15.45";"0.29";"3.73";"7.40";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3942777";"";"None";"551.53";"1";"4.73";"24A";"C[C@@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"15.07";"0.28";"3.58";"6.51";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4110412";"";"None";"550.55";"1";"4.26";"28";"CN1C[C@@H]2CC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CN2C1=O";"IC50";"'='";"403.0";"nM";"6.39";"";"";"UO_0000065";"11.62";"0.22";"2.13";"5.25";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4108563";"";"None";"553.52";"1";"4.65";"33";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"15.17";"0.29";"3.75";"7.09";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4111338";"";"None";"601.54";"2";"5.11";"35";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC(F)F)c12";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"12.80";"0.24";"2.59";"6.03";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4110264";"";"None";"599.56";"2";"5.62";"43";"CC(F)(F)c1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"822.0";"nM";"6.08";"";"";"UO_0000065";"10.15";"0.19";"0.47";"5.13";"1";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4108687";"";"None";"565.56";"2";"5.12";"25";"CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"12.80";"0.24";"2.12";"5.67";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.89";"nM";"9.05";"";"";"UO_0000065";"20.55";"0.37";"4.83";"9.13";"0";"CHEMBL4769955";"Inhibition of BTK (unknown origin) by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765318";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"10350.0";"nM";"4.99";"";"";"UO_0000065";"11.32";"0.21";"0.77";"5.03";"0";"CHEMBL4769972";"Inhibition of BTK in human TMD8 cells assessed as reduction in cell proliferation incubated for 24 hrs by CCK-8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TMD8";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765318";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 24.0 hr";"INHIBITOR";""
"CHEMBL3810269";"";"None";"443.51";"0";"3.67";"1";"C=CC(=O)N1CCC[C@@H](Nc2ncnc(N)c2C(=O)c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"921.0";"nM";"6.04";"";"";"UO_0000065";"13.61";"0.25";"2.37";"5.47";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4794424";"";"None";"455.52";"0";"3.78";"3";"C=CC(=O)N1CCC[C@@H](Nc2ncnc(N)c2-n2ncc3cc(Oc4ccccc4)ccc32)C1";"IC50";"'='";"1675.0";"nM";"5.78";"";"";"UO_0000065";"12.68";"0.23";"2.00";"5.19";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5197246";"";"None";"406.45";"0";"1.58";"18";"C=CC(=O)NCCNc1ncnc2[nH]cc(C(=O)N3CC(Oc4ccccc4)C3)c12";"IC50";"'='";"92.9";"nM";"7.03";"";"";"UO_0000065";"17.30";"0.32";"5.45";"6.27";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4789404";"";"None";"548.60";"1";"4.40";"5c";"COc1ccn2c(=O)n(-c3cccc(-c4ccc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)cc2c1";"IC50";"'='";"0.63";"nM";"9.20";"";"";"UO_0000065";"16.77";"0.31";"4.80";"6.98";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5h";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"16.97";"0.32";"4.35";"7.66";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6h";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"13.02";"0.25";"2.25";"6.06";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL4204719";"";"None";"511.56";"1";"4.50";"25a";"CCn1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"18.37";"0.34";"4.90";"7.59";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4855796";"";"None";"473.54";"0";"1.98";"8";"C=CC(=O)N1CCC(Cc2nc(-c3ccc(C(=O)Nc4ccccn4)cc3)c(C(N)=O)n2N)CC1";"IC50";"'='";"176.0";"nM";"6.75";"";"";"UO_0000065";"14.26";"0.26";"4.77";"4.53";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4850186";"";"None";"473.54";"0";"2.56";"17";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"18.1";"nM";"7.74";"";"";"UO_0000065";"16.35";"0.30";"5.18";"5.19";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4860527";"";"None";"493.96";"0";"2.90";"21";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(Cl)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"11.2";"nM";"7.95";"";"";"UO_0000065";"16.10";"0.31";"5.05";"5.33";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4873581";"";"None";"585.41";"1";"2.85";"24";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(I)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"14.03";"0.32";"5.36";"5.50";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4863913";"";"None";"553.60";"1";"4.06";"29";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccc(F)cc4)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.99";"0.28";"4.24";"5.56";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4875477";"";"None";"458.52";"0";"2.85";"32";"C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccc3)cc2)c(C(N)=O)n1N";"IC50";"'='";"571.0";"nM";"6.24";"";"";"UO_0000065";"13.62";"0.25";"3.39";"4.58";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4868737";"";"None";"485.55";"0";"2.40";"38";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccc(C)cn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"129.0";"nM";"6.89";"";"";"UO_0000065";"14.19";"0.26";"4.49";"4.62";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4865483";"";"None";"565.61";"1";"3.89";"47";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccc(F)cc4)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"14.7";"nM";"7.83";"";"";"UO_0000065";"13.85";"0.25";"3.94";"5.25";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4851021";"";"None";"539.62";"2";"5.60";"27";"C=CC(=O)N1CC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccc(Oc3ccccc3)cc2C)C1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"13.11";"0.25";"1.48";"6.81";"0";"CHEMBL4818941";"Inhibition of BTK in human whole blood assessed as inhibition of IgM-induced B-cell activation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4814076";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL5071372";"";"None";"478.94";"0";"4.59";"1; ARQ531";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@H]3CC[C@H](CO)OC3)c12";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"16.88";"0.32";"3.50";"7.39";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL4572535";"";"None";"430.51";"0";"3.75";"A25";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccncc3)cc2)CC1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"14.25";"0.26";"2.39";"5.78";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL5085807";"";"None";"540.62";"2";"5.12";"24a";"C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(OCCOC)c4)nc32)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"15.53";"0.29";"3.28";"6.98";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5094370";"";"None";"490.57";"0";"1.65";"25b";"C=CC(=O)N1CC[C@H](n2c(=O)cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1";"IC50";"'='";"14.6";"nM";"7.84";"";"";"UO_0000065";"15.97";"0.30";"6.19";"7.21";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3605112";"";"None";"459.96";"1";"5.85";"24a";"Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)c5cccc(Cl)c5)cc4)csc23)cn1";"IC50";"'='";"420.9";"nM";"6.38";"";"";"UO_0000065";"13.86";"0.27";"0.53";"7.43";"0";"CHEMBL3607488";"Inhibition of human recombinant BTK incubated for 5 mins by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603780";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3670083";"";"None";"524.63";"1";"4.23";"BDBM111940";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2cc(C3CC3)n[nH]2)c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"232995";"UO_0000065";"17.15";"0.32";"4.77";"8.32";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4162994";"";"None";"431.50";"1";"5.64";"13";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccccc5)cc4c32)ccc1C";"IC50";"'='";"25.3";"nM";"7.60";"";"";"UO_0000065";"17.61";"0.31";"1.96";"11.87";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL4079989";"";"None";"562.65";"2";"5.53";"3t";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO";"IC50";"'='";"31.4";"nM";"7.50";"";"";"UO_0000065";"13.34";"0.24";"1.97";"9.00";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4083867";"";"None";"505.55";"2";"5.44";"3l";"Cn1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)n1";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"15.87";"0.29";"2.58";"9.04";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4105206";"";"None";"574.66";"2";"6.07";"3o";"O=C(C1CC1)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"13.57";"0.25";"1.73";"8.55";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4075160";"";"None";"619.70";"2";"5.58";"3q";"O=C(N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)CC1)N1CCOCC1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"11.90";"0.22";"1.80";"7.11";"0";"CHEMBL4000360";"Inhibition of BTK in human Ramos cells assessed as inhibition of anti human IgM-induced calcium influx preincubated for 20 mins in dark followed by anti human IgM induction for 8 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3899411";"";"None";"575.60";"1";"4.64";"BDBM230093";"Cc1c(-c2c(C#N)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.27";"nM";"9.57";"";"401951";"UO_0000065";"16.62";"0.30";"4.93";"6.51";"1";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896019";"";"None";"568.58";"1";"4.90";"BDBM230123";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.65";"nM";"9.19";"";"401953";"UO_0000065";"16.16";"0.30";"4.29";"7.46";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907348";"";"None";"554.55";"1";"4.89";"BDBM230097";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"0.48";"nM";"9.32";"";"401956";"UO_0000065";"16.80";"0.31";"4.43";"6.96";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945518";"";"None";"554.55";"1";"4.89";"BDBM230122";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2cc(F)ccc2c1=O";"IC50";"'='";"0.3";"nM";"9.52";"";"401986";"UO_0000065";"17.17";"0.32";"4.63";"7.11";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896019";"";"None";"568.58";"1";"4.90";"BDBM230123";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"0.48";"nM";"9.32";"";"401987";"UO_0000065";"16.39";"0.30";"4.42";"7.57";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945408";"";"None";"575.04";"1";"4.90";"BDBM230126";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)[nH]c2c(F)cccc2c1=O";"IC50";"'='";"0.62";"nM";"9.21";"";"401991";"UO_0000065";"16.01";"0.31";"4.31";"6.87";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912426";"";"None";"589.00";"2";"5.25";"BDBM230117";"Cn1c(=O)n(-c2cccc(-c3c(F)cc(C(N)=O)c4[nH]c5cc(C(C)(C)O)ccc5c34)c2Cl)c(=O)c2cccc(F)c21";"IC50";"'='";"0.18";"nM";"9.74";"";"401995";"UO_0000065";"16.54";"0.32";"4.49";"7.92";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894000";"";"None";"572.54";"2";"5.03";"BDBM230120";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)[nH]c2c(F)cc(F)cc2c1=O";"IC50";"'='";"0.26";"nM";"9.59";"";"402008";"UO_0000065";"16.74";"0.31";"4.56";"7.15";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4756290";"";"None";"599.59";"1";"4.65";"48";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C(C)(C)O";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"15.84";"0.30";"4.84";"6.84";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4796764";"";"None";"543.60";"1";"3.82";"16";"Cc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"16.41";"0.30";"5.10";"6.98";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4781173";"";"None";"613.62";"1";"4.90";"47";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C(C)(C)CO";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"12.97";"0.25";"3.06";"5.74";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4757180";"";"None";"585.64";"1";"4.05";"21";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(OC6CC6)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"15.85";"0.29";"5.23";"6.78";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4744308";"";"None";"554.59";"1";"3.38";"19";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C#N)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.37";"nM";"9.43";"";"";"UO_0000065";"17.01";"0.31";"6.05";"6.22";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4747860";"";"None";"609.61";"1";"4.40";"33";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CCCN(C(=O)C3(C)COC3)C2)n2ccnc(N)c12";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"12.14";"0.23";"3.00";"5.40";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4545868";"";"None";"388.43";"0";"1.80";"9b";"C=CC(=O)N1CC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"18.8";"nM";"7.73";"";"";"UO_0000065";"19.89";"0.36";"5.93";"7.79";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL2057914";"";"None";"461.57";"1";"6.69";"CGI-560";"CC(C)(C)c1ccc(C(=O)Nc2cccc(-c3cn4ccnc4c(Nc4ccccc4)n3)c2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"13.86";"0.25";"-0.29";"8.97";"1";"CHEMBL4369293";"Inhibition of C-terminal V5-His6 tagged human full-length Btk expressed in Sf9 cells by Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4368870";"1";"Scientific Literature";"Medchemcomm";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4541650";"";"None";"565.07";"2";"5.45";"7o";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccc(F)c(Cl)c5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"12.77";"0.25";"1.76";"6.96";"0";"CHEMBL4360844";"Inhibition of human recombinant full length N-terminal His tagged BTK C481S mutant expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4278321";"";"None";"434.54";"0";"2.80";"5";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(N4CCCCC4)cc3)n2)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"20.45";"0.38";"6.09";"8.58";"0";"CHEMBL4264020";"Inhibition of full length human BTK (8 to 80 residues) using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate after 90 mins by off-chip mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4546543";"";"None";"438.49";"0";"4.30";"5b";"CN(C)CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"16.65";"0.30";"3.00";"9.08";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL5274187";"";"None";"487.56";"0";"3.93";"9";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)c(O)c4)nn32)CC1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"17.99";"0.33";"4.84";"7.15";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4763873";"";"None";"507.55";"1";"3.95";"12";"O=C(C#CCN1CCOCC1)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1";"IC50";"'='";"0.26";"nM";"9.59";"";"";"UO_0000065";"18.88";"0.34";"5.64";"9.07";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3702841";"";"None";"636.73";"2";"5.09";"BDBM143193";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N(C1CC1)C1COC1";"IC50";"'='";"26.0";"nM";"7.58";"";"369515";"UO_0000065";"11.91";"0.22";"2.50";"5.60";"1";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912688";"";"None";"649.72";"2";"5.55";"BDBM202218";"O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(-c4ccc(OCCN5CCOCC5)cn4)cc23)c1CO";"IC50";"'='";"2.9";"nM";"8.54";"";"358293";"UO_0000065";"13.14";"0.24";"2.99";"7.55";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4245727";"";"None";"464.53";"0";"1.28";"12";"C=CC(=O)N[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"19.00";"0.35";"7.54";"6.79";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4292583";"";"None";"462.60";"0";"2.79";"20";"C=CC(=O)N(C)[C@H]1CCN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"19.21";"0.36";"6.10";"9.37";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.54";"nM";"9.27";"";"";"UO_0000065";"21.04";"0.38";"5.05";"9.35";"0";"CHEMBL4201924";"Inhibition of N-terminal DYKDDDDK tagged biotinylated activated human recombinant BTK using FITC-labeled Srctide peptide substrate by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4215184";"";"None";"550.66";"2";"5.61";"2c";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"14.88";"0.27";"2.58";"7.49";"0";"CHEMBL4201925";"Inhibition of N-terminal DYKDDDDK tagged biotinylated unactivated human recombinant BTK using FITC-labeled Srctide peptide substrate by by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4196213";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3358408";"";"None";"632.74";"2";"5.34";"16n";"Cc1c(-c2cc(Nc3ccc(N4CCN(C5COC5)CC4)cn3)c(=O)n(C)c2)cccc1-n1ccc2cc(C3CC3)cc(F)c2c1=O";"IC50";"'='";"171.0";"nM";"6.77";"";"";"UO_0000065";"10.69";"0.20";"1.43";"8.00";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3358407";"";"None";"590.70";"2";"5.57";"16m";"Cc1c(-c2cc(Nc3ccc(N4CCN(C)CC4)cn3)c(=O)n(C)c2)cccc1-n1ccc2cc(C3CC3)cc(F)c2c1=O";"IC50";"'='";"254.0";"nM";"6.59";"";"";"UO_0000065";"11.17";"0.20";"1.03";"8.75";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3358402";"";"None";"592.70";"2";"3.20";"16h";"CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(N(C)C)ncc6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"1030.0";"nM";"5.99";"";"";"UO_0000065";"10.10";"0.19";"2.79";"5.36";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3358398";"";"None";"660.75";"2";"5.06";"16d";"Cn1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)cc(Nc2ccc(N3CCN(C(=O)C4CC4)CC3)cn2)c1=O";"IC50";"'='";"4360.0";"nM";"5.36";"";"";"UO_0000065";"8.11";"0.15";"0.30";"4.76";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3358397";"";"None";"661.78";"1";"4.44";"16c";"CN1CC(N2CCN(c3ccc(Nc4cc(-c5cccc(-n6ccc7cc(C8CC8)cc(F)c7c6=O)c5CO)cn(C)c4=O)nc3)CC2)C1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"11.31";"0.21";"3.04";"7.57";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3358396";"";"None";"648.74";"1";"4.52";"16b";"Cn1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"12.48";"0.23";"3.58";"7.72";"0";"CHEMBL3375467";"Inhibition of BTK in human Ramos cells assessed as reduction in IgM-induced calcium influx incubated for 20 mins by Fluo-4 dye based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351827";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL5201075";"";"None";"460.59";"0";"2.13";"10";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC2CN(C)C2)CC1=O";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"11.15";"0.21";"3.01";"6.23";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5188750";"";"None";"478.64";"0";"3.77";"27";"C=CC(=O)N(C)CCOc1cnccc1-c1ccc(CN2CCN(CC(C)(C)C)CC2=O)c(C)c1";"IC50";"'='";"0.44";"nM";"9.36";"";"";"UO_0000065";"19.55";"0.37";"5.59";"14.18";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5207401";"";"None";"436.56";"0";"2.74";"32";"C=CC(=O)N(C)CCOc1cnccc1-c1ccc(CN2CCN(CC)CC2=O)c(C)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.17";"0.32";"4.75";"11.36";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5188786";"";"None";"480.61";"0";"2.36";"42";"C=CC(=O)N(C)CCOc1c(N)ncnc1-c1ccc(CN2CCN(CC(C)C)CC2=O)c(C)c1";"IC50";"'='";"0.22";"nM";"9.66";"";"";"UO_0000065";"20.09";"0.38";"7.30";"9.21";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5192675";"";"None";"488.64";"0";"3.18";"18";"Cc1cc(-c2ccnc(Nc3cnn(C4CN(C)C4)c3)n2)ccc1CN1CCN(CC(C)C)CC1=O";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"13.21";"0.24";"3.28";"7.83";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"4; AVL-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"21.78";"0.41";"4.97";"9.47";"0";"CHEMBL3864052";"Inhibition of recombinant human N-terminal His-tagged BTK expressed in baculovirus infected sf9 cells using poly(4:1 Glu,Tyr) as substrate by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862041";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308860";"";"";""
"CHEMBL5169992";"";"None";"564.65";"2";"3.01";"12; GNE-431";"CN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)nn4ccnc34)cc2C1";"IC50";"'='";"8.4";"nM";"8.08";"";"";"UO_0000065";"14.30";"0.26";"5.07";"6.64";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5195670";"";"None";"442.48";"0";"2.92";"13";"C=CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"345.0";"nM";"6.46";"";"";"UO_0000065";"14.60";"0.27";"3.54";"5.97";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4075449";"";"None";"421.46";"0";"4.36";"9; QL-X-138";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cn[nH]c5)cc4c32)ccc1C";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"19.05";"0.34";"3.67";"8.66";"1";"CHEMBL5128200";"Inhibition of BTK (unknown origin) transfected in HEK293T cells assessed as reduction in BTK phosphorylation preincubated for 30 mins followed by ATP addition and measured after 20 mins by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293T";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126539";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL4764045";"";"None";"381.51";"0";"3.72";"12";"Cc1cc(-c2cc(N)ncn2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"21.09";"0.41";"4.33";"8.58";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3652657";"";"None";"530.56";"1";"3.08";"BDBM122418";"Cn1ccc(Nc2nn(-c3cccc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cc2C(N)=O)n1";"IC50";"'='";"0.22";"nM";"9.66";"";"250998";"UO_0000065";"18.20";"0.34";"6.58";"6.62";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3649453";"";"None";"452.51";"0";"3.54";"BDBM122401";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-c4nc(C(N)=O)cs4)c3CO)ncc2c1";"IC50";"'='";"129.9";"nM";"6.89";"";"250981";"UO_0000065";"15.22";"0.29";"3.35";"6.20";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3649455";"";"None";"448.50";"0";"3.42";"BDBM122403";"Cn1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc1C(N)=O";"IC50";"'='";"2.51";"nM";"8.60";"";"250983";"UO_0000065";"19.18";"0.36";"5.18";"8.34";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3649456";"";"None";"435.46";"0";"3.67";"BDBM122404";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-c4ccc(C(N)=O)o4)c3CO)ncc2c1";"IC50";"'='";"832.5";"nM";"6.08";"";"250984";"UO_0000065";"13.96";"0.26";"2.41";"5.46";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3649461";"";"None";"485.52";"0";"3.75";"BDBM122409";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5cccnc54)c3CO)ncc2c1";"IC50";"'='";"3.2";"nM";"8.49";"";"250989";"UO_0000065";"17.50";"0.32";"4.74";"7.32";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652649";"";"None";"449.49";"0";"2.81";"BDBM122410";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc1C(N)=O";"IC50";"'='";"20.0";"nM";"7.70";"";"250990";"UO_0000065";"17.13";"0.32";"4.89";"6.64";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL4754065";"";"None";"461.60";"0";"4.61";"21";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)c1cnc(C(C)(C)C)s1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"13.79";"0.26";"1.76";"6.52";"0";"CHEMBL4701077";"Inhibition of BTK in human whole blood assessed as reduction in BTK phosphorylation measured after 30 mins by phosphotyrosine detection method";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"14.4";"nM";"7.84";"";"";"UO_0000065";"17.80";"0.32";"3.62";"7.91";"0";"CHEMBL4189647";"Inhibition of recombinant full-length N-terminal His-tagged human BTK C481S mutant expressed in baculovirus infected Sf9 insect cells using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4203756";"";"None";"491.47";"1";"5.19";"18";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccc(C(F)(F)F)cc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"7.4";"nM";"8.13";"";"";"UO_0000065";"16.54";"0.31";"2.94";"8.55";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4214532";"";"None";"435.49";"0";"4.01";"13S";"C=C1c2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2C[C@H]1NC(=O)C#CC";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"21.58";"0.39";"5.39";"9.89";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4211949";"";"None";"423.48";"0";"4.17";"7S";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"22.19";"0.40";"5.23";"9.89";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217471";"";"None";"425.49";"0";"4.39";"15";"C=C1c2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2CC1NC(=O)CC";"IC50";"'='";"62.6";"nM";"7.20";"";"";"UO_0000065";"16.93";"0.31";"2.81";"7.58";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3670129";"";"None";"579.71";"1";"3.43";"BDBM111988";"Cn1cc(-c2cccc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCNCC3)cn2)c1=O";"IC50";"'='";"6.1";"nM";"8.21";"";"233043";"UO_0000065";"14.17";"0.26";"4.78";"7.63";"0";"CHEMBL3705848";"Biochemical Assay: A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen assay can be used to evaluate Btk activity through quantification of its phosphorylated peptide product. The FRET (Fluorescence Resonance Energy Transfer) that occurs between the fluorescein on the peptide product and the terbium on the detection antibody decreases with the addition of inhibitors of Btk that reduce the phosphorylation of the peptide.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639120";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3894703";"";"None";"457.53";"0";"3.62";"BDBM250053";"C=CC(=O)N1CC(C2(C)CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)C1";"IC50";"'='";"1.2";"nM";"8.92";"";"435982";"UO_0000065";"19.50";"0.36";"5.30";"8.70";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920744";"";"None";"375.41";"0";"3.76";"7";"COc1cc(F)cc(-c2nn(C3CCc4ccccc43)c3ncnc(N)c23)c1";"IC50";"'='";"584.0";"nM";"6.23";"";"";"UO_0000065";"16.60";"0.30";"2.47";"7.91";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3924678";"";"None";"361.38";"0";"3.46";"10";"Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCc2ccccc21";"IC50";"'='";"217.0";"nM";"6.66";"";"";"UO_0000065";"18.44";"0.34";"3.20";"7.42";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3983045";"";"None";"373.42";"0";"3.13";"20";"COc1ccc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)cc1O";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"18.95";"0.35";"3.95";"7.14";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3907591";"";"None";"379.37";"0";"3.40";"21";"Nc1ncnc2c1c(-c1cc(O)c(F)c(F)c1)nn2C1Cc2ccccc2C1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"19.95";"0.37";"4.17";"8.42";"0";"CHEMBL3865685";"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate after 20 mins by [gamma-33P]ATP based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3864190";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4796406";"";"None";"510.64";"1";"4.83";"B32";"CN(C)C/C=C/C(=O)N1CCC(Cn2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"7340.0";"nM";"5.13";"";"";"UO_0000065";"10.05";"0.18";"0.30";"5.74";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL4749370";"";"None";"453.55";"0";"4.90";"B1";"C=CC(=O)N1CCC(Cn2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"6090.0";"nM";"5.21";"";"";"UO_0000065";"11.50";"0.21";"0.32";"6.05";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"13.83";"0.25";"1.87";"6.14";"0";"CHEMBL4720158";"Inhibition of BTK (unknown origin) by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715815";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"INHIBITOR";""
"CHEMBL3402571";"";"None";"559.65";"2";"6.17";"4j";"CN(C)Cc1ccc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)cc1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"13.37";"0.24";"1.31";"8.60";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3402572";"";"None";"601.68";"2";"5.94";"4k";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ncnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c1CO";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"13.16";"0.24";"1.98";"8.23";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL3912276";"";"None";"498.65";"1";"6.02";"BDBM200875";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(C3=CC[S+]([O-])CC3)cc12";"IC50";"'='";"24.0";"nM";"7.62";"";"356890";"UO_0000065";"15.28";"0.29";"1.60";"8.13";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926464";"";"None";"507.68";"2";"6.98";"BDBM200901";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ncnc2[nH]c(C3=CCC(N(C)C)CC3)cc12";"IC50";"'='";"8.0";"nM";"8.10";"";"356905";"UO_0000065";"15.95";"0.29";"1.12";"10.96";"0";"CHEMBL3887838";"Biochemical Enzyme Assay: The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepared with 8-point serial dilutions for the test compounds on a Thermo CatX workstation equipped with a Innovadyne Nanodrop Express. The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (4 uM FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2, 164 uM ATP) in kinase buffer (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 18 mM MgCl2, 1 mM MnCl2) and 4.5 ul per well of enzyme solution (6.4 nM full-length human recombinant BTK) in kinase buffer. Kinase reactions were incubated at 30° C. for 60 minutes and subsequently terminated by addition of 16 ul per well of stop solution (100 mM HEPES pH 7.5, 5% DMSO, 0.1% Caliper coating reagent, 10 mM EDTA, and 0.015% Brij35). Kinase reactions were analyzed on a Caliper LC3000 workstation by separating phosphorylated and unphosphorylated peptides and kinase activities were calculated from the amounts of newly formed phospho-peptide. Inhibition data were calculated by comparison to control reactions without enzyme (100% inhibition) and without inhibitors (0% inhibition).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886469";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4554990";"";"None";"423.48";"1";"5.39";"A8";"C=CC(=O)Nc1cccc(Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.83";"0.36";"3.01";"8.22";"0";"CHEMBL4375192";"Covalent inhibition of N-terminal GST-fused human BTK (2-659(end) amino acids) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 as substrate incubated for 90 mins by microfluidic off-Chip Mobility Shift Assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4441219";"";"None";"427.51";"0";"4.30";"A12";"C=CC(=O)NC12CCC(Nc3ncnc(N)c3-c3ccc(Oc4ccccc4)cc3)(C1)C2";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"16.74";"0.31";"2.85";"7.00";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4476695";"";"None";"445.52";"0";"3.47";"A19";"C=CC(=O)N1CCC(O)(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"17.03";"0.31";"4.12";"6.68";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"A18; M2951";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"8600.0";"nM";"5.07";"";"";"UO_0000065";"11.79";"0.22";"0.72";"5.43";"0";"CHEMBL4375216";"Inhibition of BTK Cys481S mutant (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4532368";"";"None";"451.96";"0";"4.41";"A29";"Nc1ncnc(NCC2CCN(C(=O)CCl)CC2)c1-c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"15.04";"0.29";"2.39";"7.28";"0";"CHEMBL4375195";"Inhibition of BTK in human PBMC cells assessed as reduction in anti-IgM-stimulated CD69 expression on B cells preincubated for 60 mins followed by goat F(ab')2 anti-human IgM stimulation and measured after overnight incubation by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373703";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4585613";"";"None";"531.61";"2";"5.40";"6g";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccccc5F)c4)sc3C(=O)O)cc2)CC1";"IC50";"'='";"21888.0";"nM";"4.66";"";"";"UO_0000065";"8.77";"0.17";"-0.74";"4.76";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4579565";"";"None";"595.60";"2";"5.40";"7e";"NC(=O)c1sc(-c2cccc(NC(=O)c3ccc(C(F)(F)F)cc3)c2)nc1Nc1ccc(C(=O)N2CCOCC2)cc1";"IC50";"'='";"617.0";"nM";"6.21";"";"";"UO_0000065";"10.43";"0.20";"0.81";"4.90";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"18.93";"0.35";"4.12";"8.41";"1";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5187230";"";"None";"540.60";"1";"4.52";"21";"Cc1ccc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"14.98";"0.28";"3.58";"7.05";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6g";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"14.22";"0.27";"2.94";"6.62";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5188351";"";"None";"418.42";"0";"3.17";"13";"O=C(CNc1ccccc1C(F)(F)F)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"15.46";"0.29";"3.30";"7.53";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5184781";"";"None";"368.42";"0";"2.29";"20";"O=C(CNc1cccc(F)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"18.89";"0.35";"4.67";"8.10";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5197469";"";"None";"402.86";"0";"2.95";"22";"O=C(CNc1cccc(Cl)c1F)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"16.53";"0.32";"3.71";"7.75";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5176609";"";"None";"469.95";"0";"3.46";"53";"O=C([C@H](Nc1cc(F)cc(Cl)c1)C1CC1)N1CC[C@@H]2CCN(c3ncnc4[nH]ncc34)C[C@@H]21";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.15";"0.37";"5.54";"10.00";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5180753";"";"None";"418.42";"0";"3.17";"15";"O=C(CNc1ccc(C(F)(F)F)cc1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"12.55";"0.24";"2.08";"6.11";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5202266";"";"None";"525.59";"2";"5.10";"13";"CC(C)/C=C(/C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"15.66";"0.29";"3.13";"6.69";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5169419";"";"None";"609.71";"1";"4.30";"32";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCNCC1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"15.41";"0.29";"5.10";"6.80";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3979355";"";"None";"665.77";"2";"4.42";"(S)-12";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"12.58";"0.23";"3.96";"6.04";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4466870";"";"None";"564.62";"1";"4.57";"10";"Cc1c(NC(=O)c2ccc(F)cn2)cccc1-c1ccc(C(N)=O)c2[nH]c3cc(C(=O)N4CCN(C)CC4)ccc3c12";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.25";"0.26";"3.48";"6.47";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4567605";"";"None";"557.65";"1";"4.94";"12";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)cccc1N1Cc2ccccc2C1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.89";"0.27";"3.36";"8.08";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4439745";"";"None";"567.72";"1";"4.87";"30o";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCN(C)CC4)cc3)ncc2F)c1";"IC50";"'='";"35.6";"nM";"7.45";"";"";"UO_0000065";"13.12";"0.26";"2.58";"7.87";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4461112";"";"None";"575.70";"2";"5.81";"30ab";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NCc4cccnc4)cc3)ncc2F)c1";"IC50";"'='";"1.15";"nM";"8.94";"";"";"UO_0000065";"15.53";"0.31";"3.13";"7.90";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4459604";"";"None";"588.69";"2";"5.37";"31a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(=O)CSC(=S)NCc4cccnc4)cc3)ncc2F)c1";"IC50";"'='";"18.4";"nM";"7.74";"";"";"UO_0000065";"13.14";"0.26";"2.37";"5.82";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL5187334";"";"None";"458.52";"0";"2.29";"12";"CC#CC(=O)N1CCCC(Nc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)C1";"IC50";"'='";"153.3";"nM";"6.81";"";"";"UO_0000065";"14.86";"0.27";"4.52";"6.59";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4748568";"";"None";"428.45";"0";"2.73";"13";"C=CC(=O)N1CC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"18.69";"0.34";"5.28";"6.72";"0";"CHEMBL4730742";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using TK1 as substrate incubated for 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725429";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4743222";"";"None";"452.47";"0";"4.64";"16";"CC#CC(=O)Nc1cc2c(Oc3ccc(C(=O)Nc4ccccn4)cc3)ccnc2cc1OC";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"19.50";"0.35";"4.18";"8.61";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3702839";"";"None";"610.69";"1";"4.73";"BDBM143191";"CN(C1COC1)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.6";"nM";"9.22";"";"369513";"UO_0000065";"15.10";"0.28";"4.49";"6.81";"0";"CHEMBL3888040";"Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886550";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4741954";"";"None";"479.64";"1";"5.04";"17";"Cc1nnc(Nc2nccc(-c3ccc(CNC(=O)c4cnc(C(C)(C)C)s4)c(C)c3)n2)s1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"15.42";"0.31";"2.36";"7.01";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4789778";"";"None";"328.38";"0";"3.55";"5";"O=C(NCc1ccc(-c2ncnc3[nH]ccc23)cc1)c1ccccc1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"16.54";"0.30";"1.88";"7.69";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"5a; BMS-986195";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"21.98";"0.41";"6.01";"8.93";"0";"CHEMBL4616765";"Inhibition of BTK in human Ramos B cells assessed as reduction in BCR-stimulated calcium flux after 1 hr in dark condition measured for 180 sec";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3967108";"";"None";"646.77";"2";"5.98";"11";"CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"83.5";"nM";"7.08";"";"";"UO_0000065";"10.94";"0.20";"1.10";"7.24";"0";"CHEMBL4178258";"Inhibition of human BTK assessed as decrease in anti-mouse IgD antibody stimulated BCR mediated CD69 upregulation in whole blood preincubated for 1 hr followed by antibody challenge after 4 hrs by flow cytometry";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4215275";"";"None";"502.55";"2";"5.40";"89";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(OC)c4F)cc3)c3cncc(OC)c32)C1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.93";"0.26";"1.60";"8.89";"0";"CHEMBL4194325";"Inhibition of BTK (unknown origin) using peptide substrate after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190358";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL5279959";"";"None";"602.09";"1";"4.54";"25";"CNc1ncc2cc(-c3cc(OC)cc(OC)c3Cl)c(=O)n(CCc3ccc(NC(=O)/C(C#N)=C/C(C)(C)N)cc3)c2n1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"15.45";"0.30";"4.76";"5.92";"0";"CHEMBL5233528";"Inhibition of human BTK (382 to 659 residues) expressed in baculovirus infected Sf21 insect cells preincubated for 15 mins followed by ATP addition and measured upto 180 mins by microfluidic capillary electrophoresis analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233212";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL5275119";"";"None";"401.47";"0";"3.72";"6; M7583";"C=CC(=O)N1CC[C@@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"23.17";"0.42";"5.58";"9.96";"0";"CHEMBL5242619";"Irreversible inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5273873";"";"None";"419.32";"0";"3.78";"8";"O=C(CNc1cc(Cl)cc(Cl)c1)N1CCC[C@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"15.31";"0.31";"2.64";"7.47";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL4755977";"";"None";"551.60";"1";"4.35";"21";"COc1cc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2cc1NC(=O)C#CCCN1CCOCC1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"16.00";"0.29";"4.47";"7.68";"0";"CHEMBL4726192";"Inhibition of His-tagged recombinant human His-tagged full length BTK expressed in baculovirus expression system using Tyr01 peptide as substrate preincubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5077877";"";"None";"533.03";"2";"5.68";"6";"CCNC(=O)N[C@H]1CC[C@@H](Nc2ncnc3[nH]cc(C(=O)c4ccc(Oc5ccccc5)cc4Cl)c23)CC1";"IC50";"'='";"25.2";"nM";"7.60";"";"";"UO_0000065";"14.26";"0.27";"1.92";"6.28";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5094571";"";"None";"985.45";"2";"3.78";"4g";"O=C(CNc1ncnc2[nH]cc(C(=O)c3ccc(Oc4ccccc4)cc3Cl)c12)NCCOCCOCCOCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O";"IC50";"'='";"1390.5";"nM";"5.86";"";"";"UO_0000065";"5.94";"0.11";"2.08";"2.25";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"14";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL4714263";"Inhibition of BTK (unknown origin) One-hour enzymatic assay without pre-incubation";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3702854";"RILZABRUTINIB";"3.0";"665.77";"2";"4.42";"21";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"13.35";"0.25";"4.47";"6.41";"0";"CHEMBL4714263";"Inhibition of BTK (unknown origin) One-hour enzymatic assay without pre-incubation";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4650323";"TOLEBRUTINIB";"3.0";"455.52";"0";"3.91";"20";"C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"20.10";"0.37";"5.24";"9.60";"0";"CHEMBL4714265";"Inhibition of human BTK in human microglia cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Microglia";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";""
"CHEMBL4559065";"";"None";"517.48";"1";"4.29";"9h";"NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/C(F)F)C2)c1N";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"13.41";"0.26";"2.65";"5.96";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4556666";"";"None";"499.49";"0";"3.99";"9g";"NC(=O)c1c(-c2ccc(Oc3ccc(F)cc3F)cc2)nn([C@@H]2CCCN(C(=O)/C=C/CF)C2)c1N";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"17.15";"0.33";"4.58";"7.36";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4591391";"";"None";"485.47";"0";"3.95";"9e";"C=C(F)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"17.05";"0.32";"4.33";"7.11";"0";"CHEMBL4385484";"Inhibition of full-length human His-tagged BTK expressed in baculovirus expression system using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4560385";"";"None";"438.44";"0";"3.42";"9a";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"16.59";"0.31";"3.86";"5.91";"0";"CHEMBL4385495";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 1 hr followed by goat anti-human IgM F(ab')2-stimualtion and measured after 3 hrs by Fix/Lyse reagent based flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL5089713";"";"None";"234.26";"0";"1.19";"13";"CC(C)COc1cccc(-c2n[nH]c(=O)[nH]2)n1";"IC50";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"24.76";"0.47";"4.61";"6.93";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4851951";"";"None";"538.66";"2";"5.87";"27";"Cc1nn(C(C)C)cc1-c1nc2c(-c3ccc4c(c3)CCC[C@@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"13.38";"0.25";"1.34";"5.66";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"1";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.63";"0.28";"2.53";"6.89";"1";"CHEMBL4672873";"Inhibition of BTK in human PBMC cells assessed as inhibition of FCepsilonR1/immune complex-induced TNFalpha production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5207862";"";"None";"460.37";"0";"3.64";"47";"O=C(N[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1)[C@H](Nc1cc(Cl)cc(Cl)c1)C1CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"17.29";"0.35";"4.32";"8.05";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5198805";"";"None";"458.52";"0";"2.29";"10";"CC#CC(=O)N1CCC(Nc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)CC1";"IC50";"'='";"973.8";"nM";"6.01";"";"";"UO_0000065";"13.11";"0.24";"3.72";"5.81";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5206497";"";"None";"533.68";"2";"5.58";"39";"CC#CC(=O)N1CCC(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)cc4)c23)CC1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"16.22";"0.30";"3.08";"9.52";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5077961";"MILREBRUTINIB";"2.0";"578.65";"1";"4.51";"13f; AS-1763";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCN(C4COC4)CC3)[nH]c2n1";"IC50";"'='";"5.88";"nM";"8.23";"";"";"UO_0000065";"14.22";"0.26";"3.72";"6.73";"0";"CHEMBL5054206";"Inhibition of BTK C481S mutant (unknown origin) in presence of 1 mM ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 1.0 mM";"INHIBITOR";""
"CHEMBL5199196";"";"None";"457.94";"0";"3.37";"51";"C[C@H]1CCN(c2ncnc3[nH]ncc23)C[C@@H]1NC(=O)[C@H](Nc1cc(F)cc(Cl)c1)C1CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"18.34";"0.36";"5.03";"8.50";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4303247";"";"None";"384.87";"0";"2.81";"21";"O=C(CNc1cccc(Cl)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"18.44";"0.36";"4.29";"8.26";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5198691";"";"None";"461.40";"0";"4.49";"42";"CC(C)[C@@H](Nc1cc(Cl)cc(Cl)c1)C(=O)N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.99";"0.37";"3.81";"9.66";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5182743";"";"None";"492.93";"0";"4.61";"46";"O=C(N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1)[C@H](Nc1cc(Cl)cc(C(F)(F)F)c1)C1CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"15.15";"0.30";"2.86";"8.69";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5190107";"";"None";"525.59";"2";"5.28";"16";"CC(C)/C=C(\C#N)C(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"15.6";"nM";"7.81";"";"";"UO_0000065";"14.85";"0.27";"2.53";"6.35";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4638862";"";"None";"464.39";"1";"5.26";"38";"O=C(/C=C/C(F)(F)F)NCCOc1cccc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"16.85";"0.32";"2.56";"9.45";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4849220";"";"None";"474.50";"0";"3.78";"7";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5noc(C(C)(C)C)n5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"19.81";"0.37";"5.62";"7.38";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4855860";"";"None";"496.58";"0";"4.51";"22";"Cn1cc(-c2nc3c(-c4ccc5c(c4)CCCC5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cn1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"18.44";"0.34";"4.64";"7.19";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4857263";"";"None";"473.51";"0";"4.38";"8";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5cc(C(C)(C)C)no5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"15.02";"0.28";"2.73";"6.21";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4855860";"";"None";"496.58";"0";"4.51";"22";"Cn1cc(-c2nc3c(-c4ccc5c(c4)CCCC5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cn1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"14.64";"0.27";"2.76";"5.70";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4876326";"";"None";"580.69";"2";"5.64";"24";"Cc1c(-c2nc3c(-c4ccc5c(c4)CCC[C@H]5NC(=O)c4nc(C(C)(C)C)no4)ccnc3[nH]2)cnn1C1CCOCC1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.96";"0.24";"1.88";"5.51";"0";"CHEMBL4822450";"Inhibition of BTK in human PBMC";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4202615";"";"None";"538.58";"1";"4.82";"18j";"CC(=O)c1cc(Nc2nc(N)cc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1C";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"15.28";"0.28";"3.41";"6.43";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4206900";"";"None";"578.65";"2";"5.12";"18a";"Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2ccc(N3CCOCC3)cc2)n1";"IC50";"'='";"12.9";"nM";"7.89";"";"";"UO_0000065";"13.63";"0.25";"2.77";"6.66";"0";"CHEMBL4182611";"Inhibition of N-terminal DYKDDDDK tagged and biotinylated BTK activated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4103954";"";"None";"581.57";"2";"5.29";"2";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"0.31";"nM";"9.51";"";"";"UO_0000065";"16.35";"0.31";"4.22";"8.02";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4106978";"";"None";"535.53";"1";"4.51";"4";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"18.67";"0.35";"5.49";"8.44";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4782472";"";"None";"619.53";"2";"5.41";"45";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC(F)(F)F)c12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"12.91";"0.25";"2.59";"6.26";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4749037";"";"None";"537.50";"1";"4.34";"3";"Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"15.32";"0.29";"3.90";"6.45";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4110644";"";"None";"551.53";"1";"4.73";"24B";"C[C@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"15.40";"0.29";"3.76";"6.65";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4110993";"";"None";"551.53";"1";"4.22";"36";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3O)c12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.43";"0.27";"3.74";"5.74";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL3942777";"";"None";"551.53";"1";"4.73";"24A";"C[C@@H]1OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]12";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"12.81";"0.24";"2.34";"5.53";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL5169775";"";"None";"463.59";"0";"2.68";"19";"Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)ccc1CN1CCN(CC(C)C)CC1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.38";"0.34";"5.84";"8.57";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL4114094";"";"None";"537.50";"1";"3.71";"26";"Nc1nccn2c([C@H]3CN4C(=O)CC[C@@H]4CO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"263.0";"nM";"6.58";"";"";"UO_0000065";"12.24";"0.23";"2.87";"5.15";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4107779";"";"None";"591.59";"2";"5.05";"37";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12";"IC50";"'='";"494.0";"nM";"6.31";"";"";"UO_0000065";"10.66";"0.20";"1.26";"4.94";"0";"CHEMBL4727417";"Inhibition of BTK in human whole blood assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with anti-CD79b for 3 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4756638";"";"None";"558.62";"1";"3.46";"26";"CCc1cc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)ncn1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"14.12";"0.26";"4.43";"5.61";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4799627";"";"None";"597.57";"1";"4.53";"2";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"15.89";"0.30";"4.96";"7.43";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5172511";"";"None";"488.00";"1";"5.86";"23";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Cn4cc(C)nc4CC)cc3)ncc2Cl)c1";"IC50";"'='";"17.67";"nM";"7.75";"";"";"UO_0000065";"15.89";"0.30";"1.89";"8.01";"0";"CHEMBL5150907";"Inhibition of BTK (unknown origin) incubated for 60 mins by ADP-Glo kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4096669";"";"None";"583.55";"1";"4.48";"38";"C[C@H]1CO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"16.10";"0.31";"4.92";"7.36";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4086348";"";"None";"551.53";"1";"3.61";"8";"CC1(C(=O)N2CC(c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"14.92";"0.28";"4.62";"6.44";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4865481";"";"None";"483.55";"0";"4.79";"11";"Cn1cc(-c2nc3c(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cn5)c(F)c4)ccnc3[nH]2)cn1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"18.25";"0.33";"4.03";"8.70";"0";"CHEMBL4822448";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819115";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4202814";"";"None";"519.49";"1";"4.04";"21";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"17.51";"0.33";"5.06";"7.12";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4211579";"";"None";"425.49";"0";"4.09";"5R";"C=CC(=O)N[C@@H]1CCc2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2C1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"20.03";"0.36";"4.43";"8.97";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4204398";"";"None";"480.53";"0";"3.29";"8";"C=CC(=O)NCC(=O)NC1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"23.6";"nM";"7.63";"";"";"UO_0000065";"15.87";"0.29";"4.34";"6.14";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5206888";"";"None";"612.74";"2";"2.93";"16";"COCCN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2C1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"12.53";"0.23";"4.75";"6.26";"0";"CHEMBL5124384";"Inhibition of BTK T474M mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474M";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5195670";"";"None";"442.48";"0";"2.92";"13";"C=CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"18.63";"0.34";"5.32";"7.61";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5177238";"";"None";"543.60";"1";"3.86";"20";"Cc1cc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nn1C";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"15.79";"0.29";"4.73";"7.16";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5197089";"";"None";"440.55";"0";"4.24";"18";"CCC(=O)N1CCC[C@@H](n2nc(-c3ccc(Cc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"18.90";"0.34";"4.09";"9.26";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4203739";"";"None";"509.57";"1";"2.89";"24";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(C(=O)N[C@@H](COC)c4ccccn4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"16.42";"0.30";"5.48";"6.10";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4203064";"";"None";"507.47";"2";"5.07";"19";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccc(OC(F)(F)F)cc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"16.66";"0.31";"3.39";"8.11";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217114";"";"None";"441.47";"0";"4.31";"17";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccc(F)cc4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"19.61";"0.36";"4.35";"9.11";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209342";"";"None";"425.49";"0";"4.09";"5";"C=CC(=O)NC1CCc2c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc3n2C1";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"19.45";"0.35";"4.19";"8.71";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4850816";"";"None";"480.53";"0";"3.63";"1";"CNC(=O)[C@H]1Cc2c([nH]c3ccccc23)CN1C(=O)c1occc1CNc1ccc2nccnc2c1";"IC50";"'='";"3.04";"nM";"8.52";"";"";"UO_0000065";"17.72";"0.32";"4.89";"7.33";"0";"CHEMBL4813341";"Inhibition of recombinant human N-terminal His-tagged BTK C481S mutant expressed in baculovirus infected in Sf9 cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811293";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL2437471";"";"None";"428.45";"0";"3.36";"3z";"C=CC(=O)Nc1cccc(-n2c(=O)c(C)nc3cnc(Nc4ccc(OC)cc4)nc32)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"20.82";"0.38";"5.56";"8.03";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4460184";"";"None";"566.73";"2";"6.55";"30j";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NC4CCCCC4)cc3)ncc2F)c1";"IC50";"'='";"115.2";"nM";"6.94";"";"";"UO_0000065";"12.24";"0.24";"0.39";"6.92";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4462242";"";"None";"554.67";"1";"4.96";"30m";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)N4CCOCC4)cc3)ncc2F)c1";"IC50";"'='";"29.9";"nM";"7.52";"";"";"UO_0000065";"13.57";"0.27";"2.56";"7.48";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL5270872";"";"None";"402.86";"0";"3.27";"15";"O=C(CNc1cc(F)cc(Cl)c1)N1CCC[C@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"15.02";"0.30";"2.78";"7.04";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5290011";"";"None";"433.34";"0";"4.03";"37";"CC1CC(Nc2ncnc3[nH]ccc23)CN(C(=O)CNc2cc(Cl)cc(Cl)c2)C1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"16.95";"0.35";"3.32";"8.55";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5090290";"";"None";"475.60";"0";"4.21";"23";"CC(C)OC1CN(C(=O)N[C@@H]2CCCCc3cc(-c4ccnc(Nc5cnn(C)c5)n4)ccc32)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"19.76";"0.37";"5.19";"9.67";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5289054";"";"None";"433.34";"0";"4.17";"36";"CC1CCC(Nc2ncnc3[nH]ccc23)CN1C(=O)CNc1cc(Cl)cc(Cl)c1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"16.95";"0.35";"3.18";"8.55";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5278149";"";"None";"468.56";"0";"4.83";"3";"C=CC(=O)N1CCC[C@H](n2nc(-c3c(C)cc(Oc4ccccc4)cc3C)c3c(N)ncnc32)C1";"IC50";"'='";"314.0";"nM";"6.50";"";"";"UO_0000065";"13.88";"0.25";"1.67";"6.56";"0";"CHEMBL5258467";"Covalent inhibition of NanoLuc fused BTK (unknown origin) expressed in HEK293 cells incubated for 90 mins by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257057";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL3908310";"";"None";"550.59";"1";"4.76";"7a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"15.69";"0.29";"3.88";"7.02";"0";"CHEMBL3858905";"Inhibition of full length recombinant human His-tagged BTK expressed in baculovirus using fluoresceinated peptide incubated for 60 mins by fluorescent assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856250";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL5183488";"";"None";"408.47";"0";"4.50";"34";"Nc1cccc(Cn2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)c1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"17.44";"0.31";"2.62";"6.79";"1";"CHEMBL5150921";"Inhibition of BTK (unknown origin) incubated for 40 mins by radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL4755698";"";"None";"405.46";"0";"2.83";"44";"C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'='";"21.7";"nM";"7.66";"";"";"UO_0000065";"18.90";"0.35";"4.83";"8.02";"0";"CHEMBL5150935";"Inhibition of BTK (unknown origin) using Poly(Glu4,Tyr1) as substrate in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5082457";"";"None";"192.18";"0";"0.17";"10";"COc1ncccc1-c1n[nH]c(=O)[nH]1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"20.81";"0.39";"3.83";"4.78";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5075973";"";"None";"234.26";"0";"1.26";"14";"Cc1cc(OC(C)C)nc(-c2n[nH]c(=O)[nH]2)c1";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"28.17";"0.53";"5.34";"7.89";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4741884";"";"None";"518.57";"1";"4.39";"5a";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2ccccn2c1=O";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"16.91";"0.31";"4.38";"7.15";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4745935";"";"None";"410.43";"0";"4.80";"6";"C=CC(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"20.60";"0.37";"3.66";"9.07";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4752700";"";"None";"438.49";"1";"5.36";"7";"C=CC(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4cc(CC)ccn4)cc3)c2c1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"20.34";"0.37";"3.56";"9.57";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4800082";"";"None";"422.44";"0";"4.64";"9";"CC#CC(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"19.71";"0.36";"3.69";"8.93";"0";"CHEMBL4726179";"Inhibition of human recombinant full length N-terminal His6-tagged BTK expressed in baculovirus infected Sf9 cells using fluorescein labeled Blk/Lyntide substrate preincubated with enzyme for 60 mins followed by further incubation with substrate and ATP for 120 mins by IMAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4782725";"";"None";"551.60";"1";"4.35";"19";"CC#CC(=O)Nc1cc2c(Oc3ccc(C(=O)Nc4ccccn4)cc3)ccnc2cc1OCCN1CCOCC1";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"14.65";"0.27";"3.73";"7.03";"0";"CHEMBL4726192";"Inhibition of His-tagged recombinant human His-tagged full length BTK expressed in baculovirus expression system using Tyr01 peptide as substrate preincubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4106651";"";"None";"521.55";"1";"4.99";"29";"Nc1nccn2c([C@@H]3CC[C@H]4CCCN4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.67";"nM";"9.17";"";"";"UO_0000065";"17.59";"0.33";"4.18";"9.04";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4757041";"";"None";"582.56";"1";"3.80";"32";"CN1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)CC[C@H]2C1";"IC50";"'='";"0.26";"nM";"9.59";"";"";"UO_0000065";"16.45";"0.31";"5.79";"7.87";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4744308";"";"None";"554.59";"1";"3.38";"19";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C#N)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"13.62";"0.25";"4.17";"4.98";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4473373";"";"None";"498.61";"0";"4.84";"30a";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCSC(=S)NC)cc3)ncc2F)c1";"IC50";"'='";"8.21";"nM";"8.09";"";"";"UO_0000065";"16.22";"0.32";"3.25";"8.07";"0";"CHEMBL4350910";"Inhibition of human recombinant full length BTK expressed in baculovirus in Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate incubated for 1 hr by ADP-Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346765";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4572913";"";"None";"524.57";"1";"3.58";"9i";"CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"13.70";"0.26";"3.61";"6.00";"0";"CHEMBL4385483";"Inhibition of full-length human C-terminal His6-tagged BTK C481S mutant expressed in Sf9 insect cells using FAM-Srctide peptide as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4462332";"";"None";"455.88";"0";"3.33";"20c";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ncc(Cl)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"15.47";"0.30";"3.72";"5.18";"0";"CHEMBL4385495";"Inhibition of BTK in goat anti-human IgM F(ab')2-stimulated human whole blood assessed as suppression of CD69 expression on B cells pretreated for 1 hr followed by goat anti-human IgM F(ab')2-stimualtion and measured after 3 hrs by Fix/Lyse reagent based flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382291";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4788780";"";"None";"611.60";"1";"4.79";"49";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1(O)CCC1";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"15.18";"0.29";"4.49";"6.69";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4784814";"";"None";"585.56";"1";"4.26";"46";"C[C@H](O)C(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"0.15";"nM";"9.82";"";"";"UO_0000065";"16.78";"0.32";"5.56";"7.08";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4094125";"";"None";"579.58";"1";"4.39";"1";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.27";"nM";"9.57";"";"";"UO_0000065";"16.51";"0.31";"5.18";"7.49";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4752314";"";"None";"555.54";"1";"4.90";"41";"CC(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"3.9";"nM";"8.41";"";"";"UO_0000065";"15.14";"0.29";"3.51";"7.10";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4778161";"";"None";"629.59";"2";"5.02";"38";"CC1(C(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]2C(F)F)COC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"12.23";"0.23";"2.68";"6.03";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL3919539";"";"None";"465.47";"0";"3.86";"BDBM249949";"C=CC(=O)Nc1ccc2c(c1)c(=O)[nH]c1c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn12";"IC50";"'='";"21.0";"nM";"7.68";"";"435881";"UO_0000065";"16.49";"0.30";"3.82";"5.84";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975936";"";"None";"484.33";"0";"4.08";"BDBM250030";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(F)c(Br)c3)nn21";"IC50";"'='";"1.2";"nM";"8.92";"";"435959";"UO_0000065";"18.42";"0.39";"4.84";"8.74";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969173";"";"None";"528.66";"1";"4.15";"BDBM250049";"CN(C)C/C=C/C(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"435978";"UO_0000065";"16.75";"0.31";"4.70";"8.37";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5289611";"";"None";"418.42";"0";"3.49";"12";"O=C(CNc1cccc(C(F)(F)F)c1)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"13.35";"0.25";"2.10";"6.50";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5276135";"";"None";"448.36";"0";"3.59";"30";"CN(c1ncnc2[nH]ncc12)C1CCCCN(C(=O)CNc2cc(Cl)cc(Cl)c2)C1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"17.08";"0.35";"4.07";"8.50";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5284310";"";"None";"449.34";"0";"3.04";"33";"CN(c1ncnc2[nH]ccc12)C1COCCN(C(=O)CNc2cc(Cl)cc(Cl)c2)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.36";"0.40";"5.66";"10.07";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5276931";"";"None";"433.34";"0";"3.80";"34";"CN(c1ncnc2[nH]ccc12)[C@@H]1CCCN(C(=O)CNc2cc(Cl)cc(Cl)c2)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.16";"0.39";"4.50";"10.76";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"Zanubrutinib";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.72";"0.36";"5.08";"9.08";"1";"CHEMBL5107926";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104233";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4644207";"";"None";"519.58";"1";"2.82";"19";"Cn1cc(-c2ccnc(N3CCn4c(cc5c4CC(C)(C)C5)C3=O)c2CO)cc(NC(=O)[C@@H]2C[C@@H]2F)c1=O";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"16.63";"0.31";"5.82";"7.89";"0";"CHEMBL4622573";"Inhibition of BTK in human whole blood assessed as reduction in autophosphorylation at Y223 residue incubated for 1 hr by mesoscale assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619817";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4873676";"";"None";"473.51";"0";"4.25";"12b";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"494.0";"nM";"6.31";"";"";"UO_0000065";"13.32";"0.25";"2.06";"5.97";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4857245";"";"None";"473.51";"0";"4.25";"12c";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5F)cc4)[nH]c23)CC1";"IC50";"'='";"14.7";"nM";"7.83";"";"";"UO_0000065";"16.54";"0.31";"3.58";"7.41";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4861061";"";"None";"485.54";"0";"4.12";"12f";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.05";"0.26";"2.70";"5.94";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4743911";"";"None";"630.03";"1";"4.68";"23";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(OC(F)(F)Cl)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"13.19";"0.26";"3.63";"6.07";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4783242";"";"None";"595.64";"1";"3.69";"22";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(-n6cccn6)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"12.30";"0.23";"3.64";"5.03";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4787427";"";"None";"615.56";"1";"4.67";"36";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)c(F)c4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"15.25";"0.29";"4.72";"7.35";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4782313";"";"None";"447.59";"0";"4.51";"24";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CCC(C(C)(C)C)C1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"21.67";"0.40";"5.19";"11.03";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4796367";"";"None";"433.56";"0";"4.12";"25";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(CC(C)C)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"21.68";"0.40";"5.28";"10.68";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5072020";"";"None";"522.58";"1";"4.40";"13a";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCNCC3)[nH]c2n1";"IC50";"'='";"0.99";"nM";"9.00";"";"";"UO_0000065";"17.23";"0.32";"4.60";"7.39";"0";"CHEMBL5054197";"Inhibition of human BTK C481S mutant using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"6";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.11";"0.29";"2.78";"7.10";"0";"CHEMBL4429402";"Inhibition of BTK in human tonsillar B cells assessed as suppression of BCR/anti-IgM/IgG stimulated cell proliferation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4874339";"";"None";"485.55";"0";"2.40";"37";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"58.1";"nM";"7.24";"";"";"UO_0000065";"14.90";"0.27";"4.84";"4.85";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5076374";"";"None";"564.62";"1";"4.66";"12";"CC(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)nc(N)nc3[nH]2)CC1";"IC50";"'='";"0.71";"nM";"9.15";"";"";"UO_0000065";"16.20";"0.30";"4.49";"7.03";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5089998";"";"None";"809.24";"2";"3.71";"4c";"O=C(CNc1ncnc2[nH]cc(C(=O)c3ccc(Oc4ccccc4)cc3Cl)c12)NCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O";"IC50";"'='";"3775.0";"nM";"5.42";"";"";"UO_0000065";"6.70";"0.13";"1.71";"2.43";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5075076";"";"None";"892.37";"4";"5.20";"6b";"O=C1CCC(N2C(=O)c3cccc(NCCOCCOCCNC(=O)N[C@H]4CC[C@@H](Nc5ncnc6[nH]cc(C(=O)c7ccc(Oc8ccccc8)cc7Cl)c56)CC4)c3C2=O)C(=O)N1";"IC50";"'='";"15.5";"nM";"7.81";"";"";"UO_0000065";"8.75";"0.17";"2.61";"3.32";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL4633931";"";"None";"338.41";"0";"1.92";"4q";"C#CC(=O)N1CCCC(Nc2ccc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"22.27";"0.41";"5.62";"8.26";"0";"CHEMBL4616764";"Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4616583";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL4642642";"";"None";"455.21";"None";"None";"14h";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)COB4O)ncc2C(F)(F)F)c1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"20.26";"None";"None";"None";"0";"CHEMBL4610787";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4536906";"";"None";"502.60";"1";"4.25";"7q";"CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5ccco5)c4)sc3C(N)=O)cc2)CC1";"IC50";"'='";"73.0";"nM";"7.14";"";"";"UO_0000065";"14.20";"0.27";"2.89";"6.11";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4562578";"";"None";"559.67";"2";"5.87";"5m";"CCOC(=O)c1sc(-c2cccc(NC(=O)c3ccccc3F)c2)nc1Nc1ccc(N2CCN(C)CC2)cc1";"IC50";"'='";"2096.0";"nM";"5.68";"";"";"UO_0000065";"10.15";"0.19";"-0.19";"6.54";"0";"CHEMBL4360839";"Inhibition of human recombinant full length N-terminal His tagged BTK expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359830";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4785181";"";"None";"412.46";"0";"3.48";"11";"c1nc2c(Nc3ccc(N4CCOCC4)cc3)nc(-c3ccc4cn[nH]c4c3)nc2[nH]1";"IC50";"'='";"73.0";"nM";"7.14";"";"";"UO_0000065";"17.30";"0.31";"3.66";"6.63";"0";"CHEMBL4773121";"Inhibition of BTK (unknown origin) using poly(Glu, Tyr) 4:1 as substrate incubated in presence of [gamma33P]ATP by image analyser";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765406";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL4594348";"ELSUBRUTINIB";"2.0";"297.36";"0";"2.16";"15";"C=CC(=O)N1CCC[C@@H](c2ccc(C(N)=O)c3[nH]ccc23)C1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"25.16";"0.46";"5.32";"9.45";"0";"CHEMBL4714263";"Inhibition of BTK (unknown origin) One-hour enzymatic assay without pre-incubation";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3612990";"";"None";"453.57";"1";"6.49";"14d";"C=CC(=O)N1C=C(c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)CCC1";"IC50";"'='";"342.6";"nM";"6.46";"";"";"UO_0000065";"14.25";"0.27";"-0.02";"9.45";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3612848";"";"None";"438.51";"1";"6.03";"13j";"C=CC(=O)n1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1";"IC50";"'='";"1687.0";"nM";"5.77";"";"";"UO_0000065";"13.16";"0.25";"-0.26";"6.95";"0";"CHEMBL3614375";"Inhibition of BTK (unknown origin) after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3611978";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.34";"nM";"9.47";"";"";"UO_0000065";"21.49";"0.39";"5.25";"9.55";"0";"CHEMBL3874808";"Inhibition of human recombinant full-length N-terminal His-tagged BTK expressed in baculovirus infected Sf9 insect cells measured after 60 mins by ADP-Glo kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3872267";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308860";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"15.07";"0.27";"2.42";"6.69";"0";"CHEMBL4358574";"Inhibition of BTK in human basophils assessed as reduction in anti-IgE mouse IgG1 antibody Le2-stimulated CD63 expression on basophil preincubated for 30 mins in presence of IgE antibody B11 followed by anti-IgE mouse IgG1 antibody Le2 stimulation and measured after 15 mins by flow cytometry";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354855";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4569508";"";"None";"529.59";"2";"5.28";"1";"O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"12.34";"0.24";"1.26";"9.11";"0";"CHEMBL4479700";"Inhibition of full-length recombinant human His-tagged BTK expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4297640";"VECABRUTINIB";"2.0";"529.93";"1";"2.65";"10; SNS-062";"NC(=O)[C@H]1CCN(c2ncnc(N)c2F)C[C@@H]1N1CCC[C@@H](Nc2cc(Cl)cc(C(F)(F)F)c2)C1=O";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"16.91";"0.34";"6.31";"6.87";"0";"CHEMBL5127267";"Inhibition of human BTK C481S mutant measured by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5171706";"";"None";"478.94";"0";"4.93";"8";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@H]3CCC[C@H](CO)O3)c12";"IC50";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"18.94";"0.36";"4.14";"8.29";"0";"CHEMBL5124389";"Inhibition of wild-type BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3928203";"";"None";"632.74";"2";"5.59";"10";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"14.22";"0.26";"3.41";"9.20";"1";"CHEMBL4178244";"Inhibition of recombinant human full length BTK preincubated for 10 mins followed by Tk-biotin peptide substrate addition after 90 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177534";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL5204333";"";"None";"641.65";"2";"6.09";"28; CHEMBL4114502";"Nc1nccn2c([C@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OCc3ccccc3)c12";"IC50";"'='";"10.7";"nM";"7.97";"";"";"UO_0000065";"12.42";"0.23";"1.88";"6.24";"0";"CHEMBL5124392";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5205173";"";"None";"514.59";"2";"6.28";"4";"Cc1ccc(NC(=O)c2cccc(-c3ccccc3)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"660.2";"nM";"6.18";"";"";"UO_0000065";"12.01";"0.22";"-0.10";"5.06";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5193711";"";"None";"468.52";"1";"5.11";"8";"Cc1ccc(NC(=O)OCc2ccccc2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"444.5";"nM";"6.35";"";"";"UO_0000065";"13.56";"0.25";"1.24";"4.84";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5188422";"";"None";"504.55";"2";"5.47";"16";"Cc1ccc(NC(=O)c2ccc3cc(O)ccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"212.4";"nM";"6.67";"";"";"UO_0000065";"13.23";"0.24";"1.20";"4.69";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5184304";"";"None";"543.59";"2";"5.71";"21";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4ccc5cnccc5c4)ccc3C)cn2)c1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"13.34";"0.24";"1.54";"5.25";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5169523";"";"None";"683.82";"2";"6.10";"25";"Cc1ccc(NC(=O)c2ccc3cnccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(NC3CCN(C(=O)/C=C/CN(C)C)CC3)c2)nc1";"IC50";"'='";"202.0";"nM";"6.70";"";"";"UO_0000065";"9.79";"0.18";"0.59";"4.63";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"5; CC-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"21.25";"0.40";"4.75";"9.24";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5266823";"";"None";"479.61";"0";"3.96";"30";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5c(C)csc5c4)nn32)CC1";"IC50";"'='";"111.0";"nM";"6.96";"";"";"UO_0000065";"14.50";"0.28";"2.99";"6.79";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5276374";"";"None";"453.54";"0";"2.76";"(S)-20a; BGB-8035";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(C)c(OC)c4)nn32)CC1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"19.75";"0.37";"6.20";"8.02";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5276374";"";"None";"453.54";"0";"2.76";"(S)-20a; BGB-8035";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(C)c(OC)c4)nn32)CC1";"IC50";"'='";"13.9";"nM";"7.86";"";"";"UO_0000065";"17.32";"0.33";"5.10";"7.03";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4853953";"";"None";"505.60";"1";"4.67";"10";"C=CC(=O)N1CCC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccc(OC(C)C)cc2)C1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"13.69";"0.26";"2.25";"6.66";"0";"CHEMBL4818905";"Binding affinity to recombinant unphosphorylated human GST-tagged BTK kinase domain (389 to 659 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4814076";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5191840";"";"None";"956.12";"2";"4.39";"C9";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)[C@H]2CCCC[C@H]2C(=O)NCC#CCN2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"8.42";"0.15";"3.66";"4.00";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4859682";"";"None";"470.53";"0";"4.11";"42";"CC(=O)Nc1cccc(-c2cc3[nH]cnc3c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)c1C";"IC50";"'='";"545.0";"nM";"6.26";"";"";"UO_0000065";"13.31";"0.24";"2.15";"5.58";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4873565";"";"None";"522.57";"1";"4.12";"46";"Cc1c(NC(=O)c2c[nH]cn2)cccc1-c1cc2[nH]cnc2c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"13.59";"0.25";"2.98";"5.04";"0";"CHEMBL4819975";"Inhibition of human BTK using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP measured by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819006";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5086077";"";"None";"455.95";"0";"3.59";"10";"CC(C)OC1CN(C(=O)NCc2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2Cl)C1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"19.57";"0.38";"5.33";"9.18";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4203409";"";"None";"549.68";"2";"6.22";"2e";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1ccnc(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.64";"0.27";"1.83";"8.34";"0";"CHEMBL4182608";"Inhibition of BTK (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL5266164";"";"None";"436.41";"0";"3.63";"13";"O=C(CNc1cc(F)cc(C(F)(F)F)c1)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"12.84";"0.25";"1.97";"6.52";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5175284";"";"None";"434.42";"0";"3.05";"19";"O=C(CNc1cccc(OC(F)(F)F)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"12.13";"0.23";"2.22";"5.53";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5197235";"";"None";"457.94";"0";"3.46";"50";"CN(C(=O)[C@H](Nc1cc(F)cc(Cl)c1)C1CC1)[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"17.57";"0.34";"4.59";"8.94";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5173088";"";"None";"395.29";"0";"2.56";"31";"Nc1cc(N2CCC[C@@H](NC(=O)CNc3cc(Cl)cc(Cl)c3)C2)ncn1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"18.15";"0.38";"4.61";"7.46";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4303247";"";"None";"384.87";"0";"2.81";"21";"O=C(CNc1cccc(Cl)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"17.46";"0.34";"3.91";"7.82";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3647967";"";"None";"454.53";"0";"4.65";"BDBM97672";"C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"385043";"UO_0000065";"19.80";"0.36";"4.35";"8.34";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980550";"";"None";"511.63";"1";"4.59";"BDBM220129";"CN(C)C/C=C/C(=O)NC1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"1.38";"nM";"8.86";"";"385052";"UO_0000065";"17.32";"0.32";"4.27";"7.97";"0";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894938";"";"None";"400.44";"0";"3.17";"BDBM191606";"C=CC(=O)NCCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21";"IC50";"'='";"0.32";"nM";"9.49";"";"385057";"UO_0000065";"23.71";"0.43";"6.32";"8.80";"1";"CHEMBL3888236";"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886627";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892680";"";"None";"610.69";"1";"4.56";"BDBM197220";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCOCC1";"IC50";"'='";"0.7";"nM";"9.15";"";"350457";"UO_0000065";"14.99";"0.28";"4.59";"6.76";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3968888";"";"None";"553.60";"1";"4.48";"BDBM197228";"CC1(/C=C(\C#N)C(=O)N2CCC[C@H]2Cn2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)COC1";"IC50";"'='";"32.5";"nM";"7.49";"";"350465";"UO_0000065";"13.53";"0.25";"3.01";"5.67";"0";"CHEMBL3887135";"Enzymatic Activity Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of Formula (IA), (I′) or (I). Serial dilutions of test compounds were incubated with human recombinant Btk (2 nM), ATP (40 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). Percent inhibition was calculated for each compound dilution and the concentration that produced 50% inhibition was calculated.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886180";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"BDBM194087";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1662.0";"nM";"5.78";"";"346409";"UO_0000065";"12.72";"0.23";"3.03";"5.34";"0";"CHEMBL3887630";"Z'-LYTE Kinase Assay: The measurement of Btk enzyme inhibitory activity was performed using the following reagents: Z'-LYTE Kinase Assay Kit-Tyr 1 (containing Tyr 1 peptide, Thy 1 phospho-peptide, 5x kinase buffer, ATP, development reagent B, development buffer, and stop reagent), Tyr 1 peptide (Invitrogen), and Btk (Invitrogen) according to the instructions accompanying the kit.First 5 uL/well of either a solution prepared by diluting the test compound in dimethyl sulfoxide (DMSO) or DMSO alone was added to the wells of a 96-well assay plate together with 10 uL/well of substrate/enzyme mixture and allowed to react for 20 minutes at 30° C. The substrate/enzyme mixture solutions were prepared by dilution in kinase buffer (DL-dithiothreitol (DTT; 2.7 mM) and 1.33x kinase buffer) so that the final concentration of Tyr-1 peptide would be 4 uM, and the final concentration of Btk would be 5 nM. Next 5 uL/well of adenosine triphosphate was added (ATP; final concentration 36 uM).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886389";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3955997";"";"None";"660.79";"2";"6.36";"BDBM202143";"CC1CN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC(C)N1C";"IC50";"'='";"1.7";"nM";"8.77";"";"358221";"UO_0000065";"13.27";"0.24";"2.41";"8.96";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896189";"";"None";"608.75";"2";"6.43";"BDBM202190";"CN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)ccc7C6=O)c5)c(C#N)cnc4[nH]3)cc2)CC1";"IC50";"'='";"82.0";"nM";"7.09";"";"358267";"UO_0000065";"11.64";"0.21";"0.66";"8.01";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957396";"";"None";"607.69";"2";"5.69";"BDBM202198";"O=C(N1CC=C(c2cc3c(-c4cccc(N5CCOc6cc(C7CC7)cc(F)c6C5=O)c4CO)ccnc3[nH]2)CC1)N1CCC1";"IC50";"'='";"1.0";"nM";"9.00";"";"358274";"UO_0000065";"14.81";"0.27";"3.31";"8.82";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950134";"";"None";"612.73";"2";"5.90";"BDBM202153";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cc23)cccc1N1CCOc2cc(C3CC3)ccc2C1=O";"IC50";"'='";"20.0";"nM";"7.70";"";"358230";"UO_0000065";"12.57";"0.23";"1.80";"8.13";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895937";"";"None";"596.69";"2";"5.77";"BDBM202172";"Cc1c(-c2ncnc3[nH]c(-c4ccc(C(=O)N5CCC(O)CC5)cc4)cc23)cccc1-n1ncc2cc(C3CC3)ccc2c1=O";"IC50";"'='";"44.0";"nM";"7.36";"";"358249";"UO_0000065";"12.33";"0.22";"1.59";"6.29";"0";"CHEMBL3887851";"Recombinant Human BTK Inhibition Assay: The inhibition assays were performed using the generic tyrosine kinase assay kit from C is Bio (HTRF KinEASE-TK #62TK0PEB). The assay is based on the principle of fluorescence resonance energy transfer (FRET) between the Europium Cryptate labeled anti-phosphotyrosine antibody and streptavidin labeled fluorophore, XL-665. In an uninhibited kinase reaction the biotinylated peptide substrate (Tk-Biotin) gets phosphorylated at an intermediate tyrosine site which is captured by anti-phosphotyrosine antibody which eventually acts as a FRET donor. The streptavidin labeled XL-665 binds strongly to the Tk-Biotin substrate and act as a FRET acceptor. The resultant FRET signal is measured at 665 nm. A ratio of this specific fluorescence (665 nm) to the background fluorescence (620 nm), conferred by the free antibody, is directly proportional to the kinase activity. Inhibition of the kinase activity by a pharmacological intervention such as a Btk inhibitor of the present disclosure will result into decreased FRET signal.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886475";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4206284";"";"None";"451.49";"0";"3.03";"20";"C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(C(=O)Nc4ccccn4)cc3)c3c(N)ncnc32)C1=C";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"20.60";"0.37";"6.27";"7.28";"0";"CHEMBL4189646";"Inhibition of recombinant human BTK using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184325";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5266785";"";"None";"531.61";"1";"4.24";"11";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(Oc5ccccc5)c(OC)c4)nn32)CC1";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"15.27";"0.28";"3.88";"6.71";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5283553";"";"None";"527.25";"1";"4.50";"14";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(Cl)c(Br)c(Cl)c4)nn32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.50";"0.38";"4.20";"9.33";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5271932";"";"None";"481.60";"0";"3.40";"22";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(CCC)c(OC)c4)nn32)CC1";"IC50";"'='";"0.97";"nM";"9.01";"";"";"UO_0000065";"18.72";"0.35";"5.61";"8.07";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5275348";"";"None";"518.41";"1";"3.21";"(S)-17a";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(Br)c(OC)c4)nn32)CC1";"IC50";"'='";"0.57";"nM";"9.24";"";"";"UO_0000065";"17.83";"0.38";"6.03";"8.28";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5278071";"";"None";"481.60";"0";"3.57";"23";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C(C)C)c(OC)c4)nn32)CC1";"IC50";"'='";"21.3";"nM";"7.67";"";"";"UO_0000065";"15.93";"0.30";"4.10";"6.87";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5288751";"";"None";"479.58";"0";"3.32";"(S)-24a";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(C5CC5)c(OC)c4)nn32)CC1";"IC50";"'='";"14.4";"nM";"7.84";"";"";"UO_0000065";"16.35";"0.31";"4.52";"7.02";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4205974";"";"None";"454.53";"1";"5.17";"59";"C=CC(=O)N1CC[C@@H](n2nc(-c3ccc(Oc4cccc(OC)c4C)cc3)c3cnccc32)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"17.60";"0.32";"2.83";"11.51";"0";"CHEMBL4194325";"Inhibition of BTK (unknown origin) using peptide substrate after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190358";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4279353";"";"None";"474.61";"0";"2.83";"21";"C=CC(=O)N[C@@H]1CN(c2ccc(C(N)=O)c(Nc3ccc(CCN4CCCC4)cc3)n2)CC12CC2";"IC50";"'='";"0.09";"nM";"10.05";"";"";"UO_0000065";"21.17";"0.39";"7.22";"9.70";"0";"CHEMBL4264696";"Inhibition of recombinant human full length N-terminal GST-tagged BTK (2 to 659 residues) expressed in baculovirus expression system using FITC-AHA-EEPLYWSFPAKKK-NH2 substrate measured after 90 mins by off-chip mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261605";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL2057912";"";"None";"371.44";"0";"4.98";"28; PCI 29732";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCC1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"21.77";"0.39";"3.11";"10.26";"1";"CHEMBL5243490";"Inhibition of recombinant BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241118";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5169992";"";"None";"564.65";"2";"3.01";"17; GNE-431";"CN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)nn4ccnc34)cc2C1";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"15.04";"0.28";"5.48";"6.98";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5187230";"";"None";"540.60";"1";"4.52";"21";"Cc1ccc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"15.21";"0.28";"3.70";"7.15";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4162057";"";"None";"596.76";"2";"5.14";"GDC-0834";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C3C(=O)N(C)CCN3C)cc2)n1";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"13.79";"0.26";"3.09";"8.26";"1";"CHEMBL5241481";"Reversible inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5273455";"";"None";"607.69";"1";"4.15";"RN-486";"CN1CCN(c2ccc(Nc3nc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.82";"0.25";"4.25";"7.74";"0";"CHEMBL5241481";"Reversible inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"15.98";"0.30";"3.71";"7.16";"0";"CHEMBL4701116";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgD-induced B cell activation preincubated for 30 mins followed by rabbit F(ab')2 anti-human IgD stimulation and measured after 18 to 22 hrs by CD19-APC and CD69-PE staining based flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME: 18-22.5";"INHIBITOR";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"16.53";"0.31";"3.95";"7.41";"0";"CHEMBL4701173";"Inhibition of BTK in human PBMC assessed as suppression of TNFalpha/FcgammaR-induced monocyte activation by measuring reduction in cytokine production";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL4757354";"";"None";"427.51";"0";"3.95";"10";"CC(C)(C)c1ccc(C(=O)NCc2ccc(-c3ncnc4[nH]ccc34)cc2C(N)=O)cc1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"12.85";"0.23";"1.54";"4.83";"0";"CHEMBL4701067";"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4846509";"";"None";"483.57";"0";"4.89";"15a";"CC/C=C/C(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"119.0";"nM";"6.92";"";"";"UO_0000065";"14.32";"0.26";"2.03";"6.55";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4878090";"";"None";"467.53";"0";"3.95";"18a";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"17.77";"0.32";"4.36";"7.86";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4852264";"";"None";"457.47";"0";"3.31";"27b";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)C1";"IC50";"'='";"103.0";"nM";"6.99";"";"";"UO_0000065";"15.27";"0.28";"3.68";"6.61";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4863088";"";"None";"425.45";"0";"2.78";"30a";"C#CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)C1";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"19.97";"0.36";"5.71";"8.04";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4849212";"";"None";"427.46";"0";"3.29";"34a";"C=CC(=O)N1CCc2nn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c3c2C1";"IC50";"'='";"99.6";"nM";"7.00";"";"";"UO_0000065";"16.38";"0.30";"3.71";"6.62";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3647965";"";"None";"426.48";"0";"3.83";"BDBM97670";"C=CC(=O)N1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"213462";"UO_0000065";"20.45";"0.37";"4.89";"8.80";"0";"CHEMBL3705255";"In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 μL using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 μM peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 μL of 1× Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1× Lance buffer were added in a 25 μL volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (πEx) of 330 nm and detection wavelengths (πEm) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639278";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL4247514";"";"None";"523.59";"1";"3.99";"6a";"COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCN(C)CC6)cc5)c4c3c2)cn1";"IC50";"'='";"153.0";"nM";"6.82";"";"";"UO_0000065";"13.02";"0.24";"2.83";"7.34";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4564014";"";"None";"425.42";"1";"5.06";"6g";"C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5ccc(F)nc5)cc4c32)c1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"14.71";"0.27";"1.20";"8.12";"0";"CHEMBL4423372";"Inhibition of BTK (unknown origin) by ADP-gloassay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4422626";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL5090623";"";"None";"461.57";"0";"3.82";"15";"CC(C)OC1CN(C(=O)NC2CCCc3cc(-c4ccnc(Nc5cnn(C)c5)n4)ccc32)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"19.25";"0.36";"5.07";"9.14";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4861647";"";"None";"427.46";"0";"3.33";"28a";"C=CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)C1";"IC50";"'='";"19.1";"nM";"7.72";"";"";"UO_0000065";"18.06";"0.33";"4.39";"7.30";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4467132";"";"None";"520.56";"2";"5.46";"19";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2cc(F)ccc2c1=O";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"14.64";"0.27";"2.16";"6.68";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4513599";"";"None";"520.56";"2";"5.46";"18";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccc(F)cc2c1=O";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"15.67";"0.29";"2.69";"7.15";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3649449";"";"None";"434.52";"0";"3.40";"BDBM122397";"CC(C)(C)c1ccc2c(=O)n(-c3cccc(-c4nc(C(N)=O)cs4)c3CO)ncc2c1";"IC50";"'='";"280.83";"nM";"6.55";"";"250977";"UO_0000065";"15.08";"0.29";"3.15";"5.90";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652653";"";"None";"654.75";"2";"4.60";"BDBM122414";"CC(C)(CN1CCC1)Oc1ccc(Nc2nn(-c3cccc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cc2C(N)=O)nc1";"IC50";"'='";"0.18";"nM";"9.74";"";"250994";"UO_0000065";"14.88";"0.28";"5.14";"6.35";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652655";"";"None";"527.56";"1";"3.74";"BDBM122416";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c(Nc5ccccn5)n4)c3CO)ncc2c1";"IC50";"'='";"0.36";"nM";"9.44";"";"250996";"UO_0000065";"17.90";"0.33";"5.70";"6.70";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652676";"";"None";"596.06";"2";"6.07";"BDBM122437";"CC(C)(C)c1cc(F)c2c(=O)n(-c3cccc(-n4cc(C(N)=O)c5ccc(-c6ccccc6Cl)nc54)c3CO)ncc2c1";"IC50";"'='";"28.35";"nM";"7.55";"";"251017";"UO_0000065";"12.66";"0.24";"1.48";"6.50";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL3652679";"";"None";"571.66";"1";"3.73";"BDBM122441";"CN(C)CCNc1ccc2c(C(N)=O)cn(-c3cccc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)c2n1";"IC50";"'='";"3562.18";"nM";"5.45";"";"251021";"UO_0000065";"9.53";"0.18";"1.72";"4.15";"0";"CHEMBL3705288";"Inhibition Assay: Plates assayed are 96-well polypropylene (Greiner) and 96-well 1.2 μm hydrophilic PVDF filter plates (Millipore). Concentrations reported here are final assay concentrations: 10-100 μM compounds in DMSO (Burdick and Jackson), 5-10 nM Btk enzyme (His-tagged, full-length), 30 μM peptide substrate (Biotin-Aca-AAAEEIYGEI-NH2), 100 μM ATP (Sigma), 8 mM imidazole (Sigma, pH 7.2), 8 mM glycerol-2-phosphate (Sigma), 200 μM EGTA (Roche Diagnostics), 1 mM MnCl2 (Sigma), 20 mM MgCl2 (Sigma), 0.1 mg/ml BSA (Sigma), 2 mM DTT (Sigma), 1 μCi 33P ATP (Amersham), 20% streptavidin sepharose beads (Amersham), 50 mM EDTA (Gibco), 2 M NaCl (Gibco), 2 M NaCl w/1% phosphoric acid (Gibco), microscint-20 (Perkin Elmer).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639151";"37";"BindingDB Database";"";"2014";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"20.65";"0.38";"4.88";"9.17";"1";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5188454";"";"None";"446.56";"0";"1.79";"9";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC2CNC2)CC1=O";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"12.04";"0.22";"3.59";"5.89";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5179923";"";"None";"481.55";"0";"3.62";"12";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC2CC(F)(F)C2)CC1=O";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"15.68";"0.29";"3.93";"9.54";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5208570";"";"None";"502.67";"1";"3.57";"24";"Cc1cc(-c2ccnc(Nc3cnn(C4CN(C)C4)c3)n2)ccc1CN1CCN(CC(C)(C)C)CC1=O";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"16.22";"0.30";"4.58";"9.89";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5191642";"";"None";"467.61";"0";"3.00";"25";"CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(CC(C)(C)C)CC2=O)c(C)c1";"IC50";"'='";"1716.0";"nM";"5.76";"";"";"UO_0000065";"12.33";"0.23";"2.77";"7.31";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5197926";"";"None";"464.61";"0";"3.38";"28";"C=CC(=O)N(C)CCOc1cnccc1-c1ccc(CN2CCN(CC(C)C)CC2=O)c(C)c1";"IC50";"'='";"0.65";"nM";"9.19";"";"";"UO_0000065";"19.77";"0.37";"5.81";"13.92";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5189311";"";"None";"450.58";"0";"3.13";"31";"C=CC(=O)N(C)CCOc1cnccc1-c1ccc(CN2CCN(C(C)C)CC2=O)c(C)c1";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"18.95";"0.35";"5.41";"12.94";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5186635";"";"None";"477.61";"0";"2.92";"34";"C=CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(CC3(C)CC3)CC2=O)c(C)c1";"IC50";"'='";"0.98";"nM";"9.01";"";"";"UO_0000065";"18.86";"0.35";"6.09";"11.42";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5179299";"";"None";"491.51";"0";"2.68";"37";"C=CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(CC(F)(F)F)CC2=O)c(C)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"16.12";"0.31";"5.24";"10.04";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL4483575";"REMIBRUTINIB";"3.0";"507.54";"1";"4.47";"46; LOU064";"C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.58";"0.33";"4.45";"8.08";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5192152";"";"None";"531.58";"1";"3.79";"22";"CC(C)(C)CN1CCN(Cc2ccc(-c3ccnc(Nc4cnn(CCO)c4)n3)cc2C(F)(F)F)C(=O)C1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"11.89";"0.23";"2.53";"6.36";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5083788";"";"None";"496.62";"0";"4.91";"28";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)c3cnc(C(C)(C)C)nc3)n2)cn1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"17.16";"0.31";"3.61";"7.71";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5087011";"";"None";"485.60";"0";"4.16";"32";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"19.97";"0.37";"5.54";"8.40";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.07";"0.30";"3.75";"7.20";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"5; CC-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"17.47";"0.33";"3.15";"7.60";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5091935";"";"None";"477.61";"0";"3.90";"16";"CC(C)OC1CN(C(=O)NC2CCCCC3C=C(c4ccnc(Nc5cnn(C)c5)n4)C=CC32)C1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"15.12";"0.28";"3.32";"7.43";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5089327";"";"None";"486.58";"0";"4.50";"36";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nnc(C(C)(C)C)o3)n2)cn1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.14";"0.30";"3.35";"6.35";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5091935";"";"None";"477.61";"0";"3.90";"16";"CC(C)OC1CN(C(=O)NC2CCCCC3C=C(c4ccnc(Nc5cnn(C)c5)n4)C=CC32)C1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"19.17";"0.36";"5.25";"9.42";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4874448";"";"None";"616.11";"2";"6.14";"38k";"CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1";"IC50";"'='";"718.2";"nM";"6.14";"";"";"UO_0000065";"9.97";"0.20";"0.00";"9.06";"0";"CHEMBL4839140";"Inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4837240";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6e";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"14.36";"0.27";"3.02";"6.69";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4868610";"";"None";"441.49";"0";"3.33";"37a";"C=CC(=O)N1CCc2nn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c3c2CC1";"IC50";"'='";"1181.0";"nM";"5.93";"";"";"UO_0000065";"13.43";"0.25";"2.60";"5.61";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5179757";"";"None";"432.53";"0";"2.77";"1";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)NCCc4ccccc4)c23)CC1";"IC50";"'='";"17.3";"nM";"7.76";"";"";"UO_0000065";"17.95";"0.33";"4.99";"7.54";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4107939";"";"None";"560.54";"1";"4.38";"42";"N#Cc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"14.63";"0.27";"3.82";"5.76";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4108687";"";"None";"565.56";"2";"5.12";"25";"CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"15.12";"0.28";"3.43";"6.70";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL5183811";"";"None";"523.57";"1";"4.86";"28";"N#C/C(=C/C1CC1)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"17.2";"nM";"7.76";"";"";"UO_0000065";"14.83";"0.27";"2.90";"6.32";"0";"CHEMBL5104909";"Inhibition of biotinylated-labeled BTK-selective probe binding to BTK in human Ramos assessed as target occupancy pretreated for 1 hr followed by probe addition measured for 18 hrs by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL3402586";"";"None";"564.62";"1";"4.87";"4y";"CNC(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"51.3";"nM";"7.29";"";"";"UO_0000065";"12.91";"0.24";"2.42";"6.28";"0";"CHEMBL3407033";"Inhibition of BTK in human Ramos cells after 20 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399979";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"CHEMBL3307664";"";"";""
"CHEMBL5186944";"";"None";"462.56";"1";"2.08";"78a";"CC(C)Nc1ccc2nnc(-c3cc(-c4cnn(C5CCN(CCO)CC5)c4)cnc3N)n2n1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"16.17";"0.30";"5.40";"5.53";"0";"CHEMBL5104394";"Inhibition of BTK (unknown origin) incubated for 30 mins in presence of ATP by fluorescence based analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104091";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"16.30";"0.30";"2.96";"7.24";"1";"CHEMBL5124384";"Inhibition of BTK T474M mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474M";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.72";"nM";"9.14";"";"";"UO_0000065";"20.75";"0.38";"4.92";"9.22";"1";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5198054";"";"None";"465.52";"0";"3.31";"15";"CC#CC(=O)N1CCCC1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"16.64";"0.30";"4.43";"6.54";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5197089";"";"None";"440.55";"0";"4.24";"18";"CCC(=O)N1CCC[C@@H](n2nc(-c3ccc(Cc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"18.86";"0.34";"4.07";"9.24";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"19; CC-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"18.08";"0.34";"3.41";"7.86";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5195670";"";"None";"442.48";"0";"2.92";"13";"C=CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"174.0";"nM";"6.76";"";"";"UO_0000065";"15.28";"0.28";"3.84";"6.24";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5195945";"";"None";"527.56";"1";"3.61";"22";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"7.4";"nM";"8.13";"";"";"UO_0000065";"15.41";"0.28";"4.52";"6.36";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5177238";"";"None";"543.60";"1";"3.86";"20";"Cc1cc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nn1C";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"13.65";"0.25";"3.56";"6.19";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4109377";"";"None";"654.65";"1";"4.88";"26";"Nc1nccn2c([C@@H]3CC[C@H]4CN(C(=O)c5ccccc5)CC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"14.82";"0.28";"4.82";"6.99";"0";"CHEMBL5124392";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4107779";"";"None";"591.59";"2";"5.05";"27";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"14.97";"0.28";"3.80";"6.93";"0";"CHEMBL5124392";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5208265";"";"None";"460.54";"0";"2.70";"7";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)CC1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"20.02";"0.37";"6.52";"8.91";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5182063";"";"None";"395.29";"0";"2.56";"32";"Nc1nccc(N2CCC[C@@H](NC(=O)CNc3cc(Cl)cc(Cl)c3)C2)n1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"15.18";"0.32";"3.44";"6.24";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5177588";"";"None";"433.34";"0";"3.85";"37";"C[C@@H](Nc1cc(Cl)cc(Cl)c1)C(=O)N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"18.12";"0.37";"4.00";"9.14";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5275020";"";"None";"452.87";"0";"4.15";"14";"O=C(CNc1cc(Cl)cc(C(F)(F)F)c1)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"13.66";"0.27";"2.04";"7.20";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5183488";"";"None";"408.47";"0";"4.50";"74";"Nc1cccc(Cn2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)c1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"17.44";"0.31";"2.62";"6.79";"0";"CHEMBL5242648";"Inhibition of BTK (unknown origin) incubated for 40 mins in the presence of ATP by scintillation based radiometric protein kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL4447328";"";"None";"431.50";"0";"3.37";"I-2";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"22.64";"0.42";"6.40";"8.39";"0";"CHEMBL4414892";"Inhibition of recombinant BTK (unknown origin) preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3925102";"";"None";"455.52";"0";"4.11";"16";"C=CC(=O)N1CCC(c2c[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn23)CC1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"19.97";"0.37";"4.99";"8.60";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3904488";"";"None";"471.56";"0";"4.50";"22";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OC4CCCC4)cc3)nn21";"IC50";"'='";"26.3";"nM";"7.58";"";"";"UO_0000065";"16.07";"0.30";"3.08";"6.81";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3917026";"";"None";"457.53";"0";"3.97";"23a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"18.80";"0.35";"4.63";"7.73";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3944698";"";"None";"443.51";"0";"3.63";"34";"C=CC(=O)NC1(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"18.9";"nM";"7.72";"";"";"UO_0000065";"17.41";"0.32";"4.09";"6.94";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3913116";"";"None";"441.49";"0";"3.33";"11";"C=CC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2CC1";"IC50";"'='";"0.36";"nM";"9.44";"";"";"UO_0000065";"21.39";"0.39";"6.11";"8.93";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3897911";"";"None";"493.57";"0";"5.00";"21";"C=CC(=O)N(C)c1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)nn21";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"16.87";"0.31";"3.33";"8.13";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3917026";"";"None";"457.53";"0";"3.97";"23a";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"19.50";"0.36";"4.95";"8.02";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"31a; BGB-3111";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"20.19";"0.37";"5.30";"9.29";"0";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL3949083";"";"None";"425.49";"0";"4.43";"20-int";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCCC2c1ccccc1N";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"15.74";"0.29";"2.27";"6.19";"1";"CHEMBL4414894";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3308860";"";"";""
"CHEMBL4128726";"";"None";"414.43";"0";"2.35";"1";"C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccccc4)nc32)c1";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"19.80";"0.36";"5.86";"7.40";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4126358";"";"None";"584.68";"2";"3.37";"7";"C=CC(=O)Nc1cccc(-n2c(=O)n(CC)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1";"IC50";"'='";"396.0";"nM";"6.40";"";"";"UO_0000065";"10.95";"0.20";"3.03";"5.06";"0";"CHEMBL4390265";"Inhibition of BTK (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387758";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";""
"CHEMBL4218643";"";"None";"591.69";"2";"5.03";"18b";"CN1CCN(c2ccc(Nc3nc(N)cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)n3)cc2)CC1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"15.88";"0.29";"4.37";"8.35";"0";"CHEMBL4182612";"Inhibition of His-tagged lambda phosphatase pre-treated N-terminal DYKDDDDK tagged and biotinylated BTK unactivated form (unknown origin) using FITC-labeled Srctide substrate and ATP by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL3290148";"";"None";"617.59";"2";"5.29";"38";"C=CC(=O)NCC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"12.77";"0.24";"2.60";"5.11";"0";"CHEMBL3292449";"Inhibition of Btk in human Ramos cells assessed as inhibition of PLC-gamma2 phosphorylation at Tyr1217 after 1 hr by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286193";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3307664";"";"";""
"CHEMBL4209441";"SOFNOBRUTINIB";"2.0";"498.52";"0";"3.41";"4; AS-0871";"Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"14.13";"0.26";"3.64";"5.15";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4066176";"";"None";"664.81";"2";"3.57";"9";"C[C@@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"11.58";"0.21";"4.13";"6.36";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3973566";"";"None";"484.56";"0";"3.22";"9";"CN(C)C/C=C/C(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"16.91";"0.31";"4.97";"7.52";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL3979176";"";"None";"479.54";"0";"4.97";"19";"C=CC(=O)Nc1ccc(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)cc1";"IC50";"'='";"43.4";"nM";"7.36";"";"";"UO_0000065";"15.35";"0.28";"2.39";"6.62";"0";"CHEMBL4414893";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue preincubated for 1 hr followed by pervanadate or Na3VO4 stimulation for 20 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414549";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307664";"";"";""
"CHEMBL5083772";"BIIB-091";"2.0";"542.65";"2";"3.04";"51";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(C3COC3)CC[C@H]4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"15.24";"0.28";"5.23";"6.46";"0";"CHEMBL5043294";"Inhibition of BTK in anti-IgM stimulated human PBMC cells assessed as reduction in PLCgamma2 phosphorylation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4554269";"";"None";"501.59";"2";"5.93";"16";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1ccc2ccccc2c1=O";"IC50";"'='";"144.0";"nM";"6.84";"";"";"UO_0000065";"13.64";"0.25";"0.91";"6.77";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3977725";"";"None";"506.54";"2";"5.15";"23";"CC(C)(O)c1ccc2c(c1)[nH]c1c(C(N)=O)ccc(-c3cccc(-n4cnc5ccccc5c4=O)c3F)c12";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"14.85";"0.27";"2.37";"6.60";"0";"CHEMBL4429374";"Inhibition of BTK in human RamosB cells assessed as suppression of BCR/anti-IgM stimulated calcium flux pre-incubated for 1 hr followed by BCR/anti-IgM stimulation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL5172741";"";"None";"846.95";"2";"3.77";"C8";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)C2(C(=O)N3CCN(CC#Cc4ccc5c(c4)CN(C4CCC(=O)NC4=O)C5=O)CC3)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"9.50";"0.17";"4.28";"4.25";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5169701";"";"None";"889.03";"2";"4.79";"C10";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)[C@H]2CCCC[C@H]2C(=O)N2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"9.05";"0.17";"3.26";"4.25";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"5.6";"nM";"8.25";"";"";"UO_0000065";"18.73";"0.34";"4.03";"8.32";"1";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"6";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.96";"0.31";"3.20";"7.48";"0";"CHEMBL4429365";"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL5179158";"";"None";"889.03";"2";"4.79";"C12";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)[C@H]2CC[C@H](C(=O)N3CCN(CC#Cc4ccc5c(c4)CN(C4CCC(=O)NC4=O)C5=O)CC3)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"9.05";"0.17";"3.26";"4.25";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5177238";"";"None";"543.60";"1";"3.86";"20";"Cc1cc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nn1C";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"15.68";"0.29";"4.66";"7.11";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5195670";"";"None";"442.48";"0";"2.92";"13";"C=CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"703.0";"nM";"6.15";"";"";"UO_0000065";"13.91";"0.25";"3.23";"5.68";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5197089";"";"None";"440.55";"0";"4.24";"18";"CCC(=O)N1CCC[C@@H](n2nc(-c3ccc(Cc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"16.95";"0.31";"3.23";"8.30";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4593663";"";"None";"521.60";"2";"6.00";"13";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)CC1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"14.37";"0.26";"1.49";"8.24";"0";"CHEMBL4668242";"Inhibition of BTK in human whole blood assessed as reduction in polyclonal anti-IgM antibody/human IL4-stimulated CD69 cell surface expression on B cells incubated for 16 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 16.0 hr";"INHIBITOR";""
"CHEMBL4739958";"";"None";"523.61";"2";"6.09";"12";"C=CC(=O)N1CCC(c2c[nH]c3ncnc(-c4cc(F)cc(NC(=O)c5ccc(C6CC6)cc5)c4C)c23)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.19";"0.32";"2.91";"9.89";"0";"CHEMBL4668253";"Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665670";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4754443";"";"None";"991.16";"3";"6.00";"31; DD-03-171";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCN(CCCCCCNC(=O)CNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)n1";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"8.37";"0.16";"2.29";"3.70";"0";"CHEMBL4668347";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665674";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"DEGRADER";""
"CHEMBL4756476";"NEMTABRUTINIB";"3.0";"478.94";"0";"4.59";"16; ARQ531";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@@H]3CC[C@@H](CO)OC3)c12";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"19.65";"0.38";"4.82";"8.60";"0";"CHEMBL4668351";"Inhibition of wild type human BTK C481S mutant using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665674";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6f";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"17.02";"0.32";"4.54";"7.93";"1";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"1";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.09";"0.27";"2.27";"6.65";"1";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4789404";"";"None";"548.60";"1";"4.40";"5c";"COc1ccn2c(=O)n(-c3cccc(-c4ccc(C(N)=O)c5[nH]c6cc(C(C)(C)O)ccc6c45)c3C)c(=O)cc2c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"14.07";"0.26";"3.32";"5.86";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5k";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.43";"0.26";"3.21";"6.32";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6d; BMS-986143";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"12.02";"0.24";"1.37";"5.76";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"5.49";"nM";"8.26";"";"";"UO_0000065";"18.75";"0.34";"4.04";"8.33";"1";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3290123";"";"None";"506.49";"2";"5.63";"3";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"42.1";"nM";"7.38";"";"";"UO_0000065";"14.56";"0.27";"1.75";"6.04";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5189322";"";"None";"504.55";"2";"5.88";"14";"Cc1ccc(NC(=O)c2cccc(-c3ccco3)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"360.3";"nM";"6.44";"";"";"UO_0000065";"12.77";"0.23";"0.56";"4.77";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5202420";"";"None";"626.72";"2";"6.17";"23";"C=CC(=O)N1CCC(Nc2cccc(Nc3ncc(NC(=O)c4cc(NC(=O)c5ccc6cnccc6c5)ccc4C)cn3)c2)CC1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"11.55";"0.21";"1.07";"5.12";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL4163691";"POSELTINIB";"2.0";"470.53";"0";"4.64";"6";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.13";"0.35";"4.36";"9.40";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5083772";"BIIB-091";"2.0";"542.65";"2";"3.04";"51";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(C3COC3)CC[C@H]4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"14.11";"0.26";"4.62";"5.99";"0";"CHEMBL5043311";"Inhibition of human BTK assessed as reduction in OVA323-329 specific T cells proliferation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T cell";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5177629";"";"None";"510.64";"2";"5.91";"9";"Cc1ccc(NC(=O)CC23CC4CC(CC(C4)C2)C3)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"338.5";"nM";"6.47";"";"";"UO_0000065";"12.67";"0.23";"0.56";"5.30";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5204459";"";"None";"518.58";"2";"5.78";"17";"COc1ccc2cc(C(=O)Nc3ccc(C)c(C(=O)Nc4cnc(Nc5cccc(N)c5)nc4)c3)ccc2c1";"IC50";"'='";"63.8";"nM";"7.20";"";"";"UO_0000065";"13.87";"0.25";"1.42";"5.48";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5171731";"";"None";"408.47";"0";"4.50";"35";"Nc1ccc(Cn2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)cc1";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"17.35";"0.31";"2.59";"6.76";"0";"CHEMBL5150921";"Inhibition of BTK (unknown origin) incubated for 40 mins by radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"12.9";"nM";"7.89";"";"";"UO_0000065";"17.91";"0.33";"3.67";"7.96";"0";"CHEMBL5054206";"Inhibition of BTK C481S mutant (unknown origin) in presence of 1 mM ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 1.0 mM";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"BDBM230106";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.22";"nM";"9.66";"";"401965";"UO_0000065";"16.91";"0.32";"4.48";"7.88";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4871949";"";"None";"469.55";"0";"4.12";"21a";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)n(C)c23)CC1";"IC50";"'='";"709.0";"nM";"6.15";"";"";"UO_0000065";"13.10";"0.24";"2.03";"6.48";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4856336";"";"None";"481.56";"0";"4.26";"18i";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(C)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"99.9";"nM";"7.00";"";"";"UO_0000065";"14.54";"0.27";"2.74";"6.62";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5077901";"";"None";"500.56";"1";"4.19";"18l";"C=CC(=O)Nc1cccc(-n2c(=O)c(C(C)C)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"16.67";"0.31";"4.16";"6.94";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4871640";"";"None";"469.50";"0";"3.18";"29g";"CC#CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)C1";"IC50";"'='";"153.0";"nM";"6.82";"";"";"UO_0000065";"14.52";"0.27";"3.64";"5.93";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.66";"0.38";"5.75";"9.26";"1";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5083323";"";"None";"486.58";"0";"4.50";"34";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)c3noc(C(C)(C)C)n3)n2)cn1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"19.57";"0.36";"5.02";"7.70";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4741099";"";"None";"553.02";"2";"5.04";"5e";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2cc(Cl)ccn2c1=O";"IC50";"'='";"0.49";"nM";"9.31";"";"";"UO_0000065";"16.83";"0.32";"4.27";"7.59";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6f";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.22";"nM";"9.66";"";"";"UO_0000065";"16.91";"0.32";"4.48";"7.88";"1";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5085368";"";"None";"941.39";"2";"3.76";"4f";"O=C(CNc1ncnc2[nH]cc(C(=O)c3ccc(Oc4ccccc4)cc3Cl)c12)NCCOCCOCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O";"IC50";"'='";"1209.5";"nM";"5.92";"";"";"UO_0000065";"6.29";"0.12";"2.16";"2.36";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6d; BMS-986143";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.62";"0.27";"2.31";"6.53";"0";"CHEMBL4672804";"Inhibition of BTK in human Ramos B cells assessed as reduction in goat anti human IgM-stimulated calcium flux preincubated for 1 hr followed by goat anti human IgM addition and measured for 180 secs by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5206366";"";"None";"520.66";"1";"4.42";"13; JNJ-64264681";"C=CC(=O)N[C@H]1CCC[C@H]1NC(=O)c1sc2nccc3c2c1NC(=O)N3[C@@H]1CN=C(CC(C)C)C=C1C";"IC50";"'='";"558.0";"nM";"6.25";"";"";"UO_0000065";"12.01";"0.23";"1.83";"5.40";"0";"CHEMBL5152666";"Inhibition of recombinant human BTK by radiometric kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150028";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5188669";"";"None";"540.60";"1";"4.36";"24";"CC(C)(N)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"15.77";"0.29";"4.16";"5.72";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4114703";"";"None";"499.55";"0";"4.62";"19";"CC(C)/C=C(\C#N)C(=O)N[C@H](C)Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"17.09";"0.32";"3.92";"6.48";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702858";"";"None";"623.69";"1";"3.83";"34";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCNC(=O)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"14.25";"0.26";"5.06";"5.72";"1";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5265797";"";"None";"421.55";"0";"3.36";"12";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(C)c(C)c(C)c4)nn32)CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"18.12";"0.34";"4.28";"8.19";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5287777";"";"None";"536.86";"1";"4.24";"16";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(Cl)c(Br)c(OCC)c4)nn32)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.47";"0.32";"3.53";"7.58";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3973435";"";"None";"471.56";"0";"4.22";"3; BGB-3111";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"18.01";"0.33";"4.27";"8.29";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5272121";"";"None";"522.83";"1";"3.85";"15";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(Cl)c(Br)c(OC)c4)nn32)CC1";"IC50";"'='";"28.2";"nM";"7.55";"";"";"UO_0000065";"14.44";"0.32";"3.70";"7.37";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5286702";"";"None";"518.41";"1";"3.21";"17";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(Br)c(OC)c4)nn32)CC1";"IC50";"'='";"33.5";"nM";"7.47";"";"";"UO_0000065";"14.42";"0.31";"4.26";"6.69";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5273525";"";"None";"465.58";"0";"3.65";"29";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5ccsc5c4)nn32)CC1";"IC50";"'='";"63.3";"nM";"7.20";"";"";"UO_0000065";"15.46";"0.30";"3.55";"7.02";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4297674";"BRANEBRUTINIB";"2.0";"370.43";"0";"2.13";"Branebrutinib";"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"24.08";"0.45";"6.79";"9.78";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5269683";"";"None";"467.57";"0";"3.01";"21";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(CC)c(OC)c4)nn32)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"18.87";"0.35";"5.81";"7.90";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3927476";"";"None";"438.49";"0";"3.66";"BDBM250090";"N#C/C=C/CN1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"40.0";"nM";"7.40";"";"435863";"UO_0000065";"16.87";"0.31";"3.74";"6.58";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963772";"";"None";"397.44";"0";"3.94";"BDBM249939";"NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)nn2c1NCc1ccc(N)cc1-2";"IC50";"'='";"190.0";"nM";"6.72";"";"435871";"UO_0000065";"16.91";"0.31";"2.78";"6.21";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930480";"";"None";"395.46";"0";"2.10";"BDBM249987";"C=CC(=O)NCC1CCNc2c(C(N)=O)c(-c3ccc(OCC4CC4)cc3)nn21";"IC50";"'='";"94.0";"nM";"7.03";"";"435916";"UO_0000065";"17.77";"0.33";"4.93";"6.32";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3922120";"";"None";"441.49";"0";"3.68";"BDBM249997";"C=CC(=O)N1CCCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"0.15";"nM";"9.82";"";"435926";"UO_0000065";"22.25";"0.41";"6.14";"9.29";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4111890";"";"None";"431.50";"0";"3.50";"BDBM250008";"C=CC(=O)Nc1ccccc1[C@H]1CCNc2c(C(N)=O)c(-c3ccc(C)c(OC)c3)nn21";"IC50";"'='";"0.23";"nM";"9.64";"";"435937";"UO_0000065";"22.34";"0.41";"6.14";"8.66";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4095379";"";"None";"625.75";"1";"4.30";"25";"C[C@@H]1CN(C)CCN1c1ccc(Nc2cc(-c3cc(F)cc(N4CCn5c(cc6c5CCCC6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"16.9";"nM";"7.77";"";"";"UO_0000065";"12.42";"0.23";"3.47";"7.86";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4096669";"";"None";"583.55";"1";"4.48";"38";"C[C@H]1CO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"14.18";"0.27";"3.80";"6.48";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4081661";"";"None";"595.60";"2";"5.68";"18";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)CCC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.69";"0.26";"2.47";"6.88";"0";"CHEMBL4057948";"Inhibition of BTK in human PBMC assessed as reduction in anti-IgM-induced MIP1beta";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4079820";"";"None";"541.51";"1";"4.51";"20";"CC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"18.47";"0.35";"5.49";"8.44";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4096526";"";"None";"593.61";"1";"4.82";"11";"CC1(C(=O)N[C@@H]2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"10.7";"nM";"7.97";"";"";"UO_0000065";"13.43";"0.25";"3.15";"5.84";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL5271284";"";"None";"454.53";"0";"4.53";"2";"C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3C)c3c(N)ncnc32)C1";"IC50";"'='";"109.0";"nM";"6.96";"";"";"UO_0000065";"15.32";"0.28";"2.43";"7.02";"0";"CHEMBL5258467";"Covalent inhibition of NanoLuc fused BTK (unknown origin) expressed in HEK293 cells incubated for 90 mins by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257057";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL44577";"";"None";"483.62";"0";"4.60";"11; KIN-8194";"CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"18.68";"0.34";"4.44";"10.59";"0";"CHEMBL5128194";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126539";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5197089";"";"None";"440.55";"0";"4.24";"18";"CCC(=O)N1CCC[C@@H](n2nc(-c3ccc(Cc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"468.0";"nM";"6.33";"";"";"UO_0000065";"14.37";"0.26";"2.09";"7.04";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3919033";"";"None";"371.42";"1";"5.47";"BDBM195905";"C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(C)c4F)c3c2)c1";"IC50";"'='";"7558.0";"nM";"5.12";"";"348550";"UO_0000065";"13.79";"0.25";"-0.35";"8.86";"0";"CHEMBL3887688";"Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL5273525";"";"None";"465.58";"0";"3.65";"29";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5ccsc5c4)nn32)CC1";"IC50";"'='";"333.0";"nM";"6.48";"";"";"UO_0000065";"13.91";"0.27";"2.83";"6.32";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4110307";"";"None";"594.60";"1";"4.39";"BDBM255395";"Cn1nc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)c(OC3CC3)c2)cc1C(F)(F)F";"IC50";"'='";"0.59";"nM";"9.23";"";"445302";"UO_0000065";"15.52";"0.29";"4.84";"6.96";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL4109500";"";"None";"488.58";"0";"3.26";"BDBM255431";"Cc1nnc(NC(=O)c2ccc(-c3nc([C@@H]4CC[C@H]5CCC(=O)N5C4)n4ccnc(N)c34)cc2)s1";"IC50";"'='";"272.1";"nM";"6.57";"";"445338";"UO_0000065";"13.44";"0.26";"3.31";"5.00";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL3945118";"";"None";"472.55";"0";"3.06";"BDBM249929";"CN(C)CCC(=O)N1CCc2[nH]c3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn3c2C1";"IC50";"'='";"37.0";"nM";"7.43";"";"435860";"UO_0000065";"15.73";"0.29";"4.37";"6.82";"0";"CHEMBL3889138";"Time-Resolved Fluorescence Resonance Energy Transfer Assay: Compounds disclosed herein were tested for inhibition of Btk kinase activity in an assay based on time-resolved fluorescence resonance energy transfer methodology. Recombinant Btk was pre-incubated with the compounds disclosed herein at room temperature for 1 hour in an assay buffer containing 50 mM Tris pH7.4, 10 mM MgCl2, 2 mM MnCl2, 0.1 mM EDTA, 1 mM DT, 20 nM SEB, 0.1% BSA, 0.005% tween-20. The reactions were initiated by the addition of ATP (at the concentration of ATP Km) and peptide substrate (Biotin-AVLESEEELYSSARQ-NH2). After incubating at room temperature for 1 h, an equal volume of stop solution containing 50 mM HEPES pH7.0, 800 mM KF, 20 mM EDTA, 0.1% BSA, Eu cryptate-conjugated p-Tyr66 antibody and streptavidin-labeled XL665 was added to stop the reaction. Plates were further incubated at room temperature for 1 hour, and then the TR-FRET signals (ex337 nm, em 620 nm/665 nm) were read on BMG PHERAstar FS instrument. The residual enzyme activity in presence of increasing concentrations of compounds was calculated based on the ratio of fluorescence at 615 nm to that at 665 nm. The IC50 for each compound was derived from fitting the data to the four-parameter logistic equation by Graphpad Prism software.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886959";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3674680";"";"None";"563.66";"1";"4.47";"BDBM102443";"CN(C)C(=O)c1ccc(Nc2nc(-c3cccc(N4CCc5cc(C6CC6)ccc5C4=O)c3CO)cn(C)c2=O)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"219973";"UO_0000065";"13.88";"0.25";"3.35";"7.26";"0";"CHEMBL3705343";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639178";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"2";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"17.10";"0.31";"4.65";"6.72";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3932338";"";"None";"483.57";"0";"4.06";"6a";"CC#CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"15.1";"nM";"7.82";"";"";"UO_0000065";"16.17";"0.30";"3.76";"7.63";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4297640";"VECABRUTINIB";"2.0";"529.93";"1";"2.65";"10; SNS-062";"NC(=O)[C@H]1CCN(c2ncnc(N)c2F)C[C@@H]1N1CCC[C@@H](Nc2cc(Cl)cc(C(F)(F)F)c2)C1=O";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"15.73";"0.32";"5.69";"6.39";"1";"CHEMBL5127266";"Inhibition of recombinant human BTK measured by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"20.03";"0.37";"4.60";"8.90";"1";"CHEMBL5127254";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5169992";"";"None";"564.65";"2";"3.01";"12; GNE-431";"CN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)nn4ccnc34)cc2C1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"15.23";"0.28";"5.59";"7.07";"1";"CHEMBL5127265";"Inhibition of BTK C481S mutant (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5282968";"";"None";"462.51";"1";"5.04";"75";"C=CC(=O)Nc1cccc(Cn2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.79";"0.28";"2.26";"6.76";"0";"CHEMBL5242648";"Inhibition of BTK (unknown origin) incubated for 40 mins in the presence of ATP by scintillation based radiometric protein kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL4862552";"";"None";"507.62";"1";"4.90";"11";"CCC(=O)N1CCC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccc(OC(C)C)cc2)C1";"IC50";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"10.21";"0.20";"0.28";"4.99";"0";"CHEMBL4818905";"Binding affinity to recombinant unphosphorylated human GST-tagged BTK kinase domain (389 to 659 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4814076";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5180755";"";"None";"511.91";"1";"3.91";"52";"O=C(N[C@H]1CN(c2ncnc3[nH]ncc23)CC[C@@H]1C(F)(F)F)[C@H](Nc1cc(F)cc(Cl)c1)C1CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.22";"0.32";"4.39";"8.40";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5197549";"";"None";"494.56";"0";"3.32";"33";"C=CC(=O)N1CC2CC(n3nc(-c4ccc(C(=O)Nc5ccccn5)cc4)c4c(N)ncnc43)CC2C1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.20";"0.33";"5.68";"6.82";"0";"CHEMBL5150914";"Inhibition of recombinant human wild type BTK using Poly(Glu4,Tyr1) and ATP as substrate measured after 2 hrs by ADP-Glo kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3973435";"";"None";"471.56";"0";"4.22";"3; BGB-3111";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.63";"nM";"9.20";"";"";"UO_0000065";"19.51";"0.36";"4.98";"8.98";"1";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3935034";"";"None";"507.54";"1";"4.50";"7";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5F)cc4)nn32)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.58";"0.33";"4.42";"8.70";"1";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5286702";"";"None";"518.41";"1";"3.21";"17";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(Br)c(OC)c4)nn32)CC1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"17.28";"0.37";"5.75";"8.02";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5267491";"";"None";"479.58";"0";"3.32";"24";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C5CC5)c(OC)c4)nn32)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"18.53";"0.35";"5.57";"7.95";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"4; ONO/GS-4059";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"5.6";"nM";"8.25";"";"";"UO_0000065";"18.16";"0.33";"5.50";"7.62";"0";"CHEMBL5127254";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5272842";"";"None";"411.44";"1";"5.06";"73";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2Cc1ccccc1F";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"18.01";"0.33";"2.35";"9.40";"0";"CHEMBL5242648";"Inhibition of BTK (unknown origin) incubated for 40 mins in the presence of ATP by scintillation based radiometric protein kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL5087785";"";"None";"472.51";"0";"3.38";"18d";"C=CC(=O)Nc1cccc(-n2c(=O)c(C)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"17.90";"0.33";"5.08";"7.03";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5189426";"";"None";"521.60";"2";"5.37";"40";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C6CC6)cc5)c(F)c4)c23)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.10";"0.31";"3.55";"9.81";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5187873";"";"None";"452.87";"0";"3.83";"27";"O=C(CNc1cc(Cl)cc(C(F)(F)F)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"16.31";"0.33";"3.56";"8.60";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5182804";"";"None";"476.62";"0";"3.52";"29";"C=CC(=O)N(C)CCOc1cnccc1-c1ccc(CN2CCN(CC3CCC3)CC2=O)c(C)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"18.72";"0.35";"5.40";"13.52";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5204339";"";"None";"477.61";"0";"2.92";"36";"C=CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(CC3CCC3)CC2=O)c(C)c1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"18.42";"0.34";"5.88";"11.15";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5207026";"";"None";"465.60";"0";"2.86";"38";"C=CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(CC(C)(C)C)CC2=O)cc1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"16.69";"0.31";"4.91";"9.85";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5170448";"";"None";"479.63";"0";"2.96";"41";"C=CC(=O)N(C)CCOc1c(-c2ccc(CN3CCN(CC(C)C)CC3=O)c(C)c2)ccnc1N";"IC50";"'='";"0.69";"nM";"9.16";"";"";"UO_0000065";"19.10";"0.36";"6.20";"9.96";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5175002";"";"None";"595.58";"1";"3.88";"11; CHEMBL4115000";"Nc1nccn2c([C@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OCCO)c12";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.04";"0.28";"5.08";"6.05";"0";"CHEMBL5124392";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4857664";"";"None";"469.55";"0";"4.50";"14a";"C/C=C/C(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"1510.0";"nM";"5.82";"";"";"UO_0000065";"12.40";"0.23";"1.32";"5.51";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4870107";"";"None";"426.48";"0";"3.88";"20a";"N#CN1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"13238.0";"nM";"4.88";"";"";"UO_0000065";"11.44";"0.21";"1.00";"4.34";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4870437";"";"None";"441.49";"0";"3.72";"25a";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)C1";"IC50";"'='";"129.0";"nM";"6.89";"";"";"UO_0000065";"15.60";"0.29";"3.17";"6.52";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5202754";"";"None";"508.56";"1";"4.72";"45";"CC#CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)Nc5ccccc5)c(F)c4)c23)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"17.41";"0.32";"4.13";"8.60";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4564973";"";"None";"544.64";"1";"4.20";"50";"O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"16.52";"0.31";"4.80";"7.99";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL4558071";"";"None";"430.49";"1";"5.13";"32";"O=C(Nc1ccc(F)cc1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"13.67";"0.25";"0.76";"6.85";"0";"CHEMBL4389078";"Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluorescent-labeled polyGAT peptide as substrate incubated for 30 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"CHEMBL4106362";"";"";""
"CHEMBL5201319";"";"None";"444.50";"0";"3.14";"14";"CCC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"191.0";"nM";"6.72";"";"";"UO_0000065";"15.12";"0.28";"3.58";"6.21";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5187230";"";"None";"540.60";"1";"4.52";"21";"Cc1ccc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"13.77";"0.25";"2.92";"6.48";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3902845";"";"None";"506.01";"1";"4.88";"8";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)c(Cl)c4)nn32)CC1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"17.98";"0.35";"4.22";"8.88";"1";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5270042";"";"None";"462.55";"0";"2.93";"28";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5ccn(C)c5c4)nn32)CC1";"IC50";"'='";"8.4";"nM";"8.08";"";"";"UO_0000065";"17.46";"0.32";"5.15";"7.52";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5169765";"";"None";"442.93";"0";"3.82";"64";"O=C1[C@H](Nc2cc(F)cc(Cl)c2)CCCN1[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"18.96";"0.37";"4.58";"10.89";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5178185";"";"None";"462.56";"0";"1.89";"11";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC2CN(O)C2)CC1=O";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"15.34";"0.29";"5.21";"6.91";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5275596";"";"None";"518.41";"1";"3.21";"(R)-17b";"C=CC(=O)N1CCC([C@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(Br)c(OC)c4)nn32)CC1";"IC50";"'='";"95.4";"nM";"7.02";"";"";"UO_0000065";"13.54";"0.29";"3.81";"6.28";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5269628";"";"None";"465.55";"0";"2.76";"31";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5c(c4)OCCC5)nn32)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.87";"0.32";"5.09";"7.03";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5271284";"";"None";"454.53";"0";"4.53";"2";"C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3C)c3c(N)ncnc32)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"19.90";"0.36";"4.52";"9.12";"0";"CHEMBL5258477";"Inhibition of BTK (unknown origin) by Z'LYTE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257057";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5191588";"";"None";"446.51";"0";"2.13";"15";"C=CC(=O)NC1CCCN(c2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)C1";"IC50";"'='";"5410.2";"nM";"5.27";"";"";"UO_0000065";"11.80";"0.22";"3.14";"5.09";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5206093";"";"None";"476.54";"0";"1.81";"17";"C=CC(=O)N1CCC(O)(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)CC1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"18.17";"0.34";"6.85";"7.00";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5085807";"";"None";"540.62";"2";"5.12";"24a";"C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(OCCOC)c4)nc32)c1";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"15.46";"0.29";"3.24";"6.95";"0";"CHEMBL5045470";"Inhibition of BTK phosphorylation in human U-937 cells incubated for 4 hrs by Western blot assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-937";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL5077665";"";"None";"486.53";"0";"3.63";"18m";"C=CC(=O)Nc1cccc(-n2c(=O)c(CC)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"30.7";"nM";"7.51";"";"";"UO_0000065";"15.44";"0.29";"3.88";"6.25";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5191633";"";"None";"610.69";"1";"4.73";"27";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCOCC1";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"11.73";"0.22";"2.43";"5.29";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702855";"";"None";"651.75";"1";"4.56";"36";"CC(=O)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"13.38";"0.25";"4.16";"5.95";"1";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5195816";"";"None";"651.79";"2";"5.42";"37";"C[C@@H]1CN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)C[C@H](C)N1C";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"13.96";"0.26";"3.68";"7.03";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5184084";"";"None";"610.69";"1";"4.56";"31";"CC(C)(/C=C(/C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCOCC1";"IC50";"'='";"35.9";"nM";"7.45";"";"";"UO_0000065";"12.19";"0.23";"2.88";"5.50";"0";"CHEMBL5104909";"Inhibition of biotinylated-labeled BTK-selective probe binding to BTK in human Ramos assessed as target occupancy pretreated for 1 hr followed by probe addition measured for 18 hrs by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL5185546";"";"None";"832.92";"2";"3.54";"C6";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)/C=C/C(=O)N2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"9.66";"0.18";"4.51";"4.25";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5191518";"";"None";"956.12";"2";"4.39";"C11";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)[C@H]2CC[C@H](C(=O)NCC#CCN3CCN(CC#Cc4ccc5c(c4)CN(C4CCC(=O)NC4=O)C5=O)CC3)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"8.42";"0.15";"3.66";"4.00";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4075449";"";"None";"421.46";"0";"4.36";"16; QL-X-138";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cn[nH]c5)cc4c32)ccc1C";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"19.05";"0.34";"3.67";"8.66";"0";"CHEMBL5137645";"Inhibition of FLAG-tagged BTK (unknown origin) transfected into HEK293T cells incubated for 30 mins followed by ATP addition measured after 20 mins by Western blotting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5136973";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"34";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"20.19";"0.37";"5.30";"9.29";"1";"CHEMBL5131614";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5094253";"";"None";"832.32";"4";"5.95";"6a";"O=C1CCC(N2C(=O)c3cccc(NCCCCNC(=O)N[C@H]4CC[C@@H](Nc5ncnc6[nH]cc(C(=O)c7ccc(Oc8ccccc8)cc7Cl)c56)CC4)c3C2=O)C(=O)N1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"9.18";"0.17";"1.69";"3.53";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"7";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.33";"0.35";"3.95";"8.89";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5088454";"";"None";"487.65";"1";"5.47";"27";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)N3CC[C@@H](C(C)(C)C)C3)n2)cn1";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"20.27";"0.38";"4.42";"11.24";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5094998";"";"None";"500.61";"1";"3.27";"48";"CN1CC[C@@H](NC(=O)c2cn(C(C)(C)C)nn2)c2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"18.17";"0.34";"5.83";"7.67";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5083974";"";"None";"649.73";"1";"3.97";"13e";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCN(C(=O)CN4CCOCC4)CC3)[nH]c2n1";"IC50";"'='";"0.69";"nM";"9.16";"";"";"UO_0000065";"14.10";"0.26";"5.19";"6.42";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5077961";"MILREBRUTINIB";"2.0";"578.65";"1";"4.51";"13f; AS-1763";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCN(C4COC4)CC3)[nH]c2n1";"IC50";"'='";"0.99";"nM";"9.00";"";"";"UO_0000065";"15.56";"0.29";"4.49";"7.36";"0";"CHEMBL5054197";"Inhibition of human BTK C481S mutant using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5077961";"MILREBRUTINIB";"2.0";"578.65";"1";"4.51";"13f; AS-1763";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCN(C4COC4)CC3)[nH]c2n1";"IC50";"'='";"3.72";"nM";"8.43";"";"";"UO_0000065";"14.57";"0.27";"3.92";"6.89";"0";"CHEMBL5054205";"Inhibition of wild type BTK (unknown origin) in presence of 1 mM ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 1.0 mM";"INHIBITOR";""
"CHEMBL5087083";"";"None";"453.52";"0";"3.39";"13";"Cc1c(CNC(=O)N2CC(OC(C)C)C2)ccc(-c2ccnc(Nc3cnn(C)c3)n2)c1F";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"19.75";"0.37";"5.57";"9.22";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5090290";"";"None";"475.60";"0";"4.21";"23";"CC(C)OC1CN(C(=O)N[C@@H]2CCCCc3cc(-c4ccnc(Nc5cnn(C)c5)n4)ccc32)C1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.35";"0.28";"3.09";"7.51";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4110388";"";"None";"579.58";"1";"4.91";"34";"CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.80";"0.26";"3.09";"6.26";"0";"CHEMBL4727416";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4531607";"";"None";"414.47";"0";"2.03";"9g";"CC#CC(=O)N1CCC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)C1";"IC50";"'='";"28.3";"nM";"7.55";"";"";"UO_0000065";"18.21";"0.33";"5.52";"7.61";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL5069979";"";"None";"596.76";"2";"5.14";"2; GDC-0834";"Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc(C3CN(C)CC(=O)N3C)cc2)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.08";"0.29";"3.86";"9.04";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5083885";"";"None";"339.36";"0";"1.31";"23";"CC(=O)N1CC[C@H](Oc2nc(-c3n[nH]c(=O)[nH]3)cc3ccccc23)C1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"22.10";"0.41";"6.19";"7.21";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5073223";"";"None";"489.50";"0";"3.96";"11";"CC(C)OC1CN(C(=O)NCc2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C(F)(F)F)C1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"18.70";"0.36";"5.19";"9.42";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5084997";"";"None";"486.58";"0";"4.50";"35";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)c3nc(C(C)(C)C)no3)n2)cn1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"19.57";"0.36";"5.02";"7.70";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5087083";"";"None";"453.52";"0";"3.39";"13";"Cc1c(CNC(=O)N2CC(OC(C)C)C2)ccc(-c2ccnc(Nc3cnn(C)c3)n2)c1F";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"13.84";"0.26";"2.89";"6.46";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL449216";"";"None";"188.19";"0";"0.31";"4";"NC(=O)c1nnc2ccccc2c1N";"IC50";"'='";"3162.28";"nM";"5.50";"";"";"UO_0000065";"29.23";"0.54";"5.19";"5.80";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL93815";"";"None";"161.16";"0";"1.18";"6";"Oc1n[nH]c(-c2ccccc2)n1";"IC50";"'='";"501187.23";"nM";"3.30";"";"";"UO_0000065";"20.48";"0.38";"2.12";"5.34";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5080191";"";"None";"206.21";"0";"0.56";"11";"CCOc1cccc(-c2n[nH]c(=O)[nH]2)n1";"IC50";"'='";"6309.57";"nM";"5.20";"";"";"UO_0000065";"25.22";"0.47";"4.64";"6.22";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5083068";"";"None";"270.29";"0";"2.10";"22";"CCCOc1nc(-c2n[nH]c(=O)[nH]2)cc2ccccc12";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"28.12";"0.52";"5.50";"9.08";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4850665";"";"None";"483.57";"0";"4.89";"15a";"CC(C)=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1";"IC50";"'='";"41442.0";"nM";"4.38";"";"";"UO_0000065";"9.06";"0.17";"-0.51";"4.15";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4877720";"";"None";"470.53";"0";"3.30";"23a";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)n(N)c23)CC1";"IC50";"'='";"218.0";"nM";"6.66";"";"";"UO_0000065";"14.16";"0.26";"3.36";"5.51";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4871465";"";"None";"473.51";"0";"4.25";"12d";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5cccc(F)c5)cc4)[nH]c23)CC1";"IC50";"'='";"60.2";"nM";"7.22";"";"";"UO_0000065";"15.25";"0.28";"2.97";"6.83";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4866177";"";"None";"546.43";"1";"4.71";"18h";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(Br)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"12.46";"0.26";"2.10";"6.44";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5271932";"";"None";"481.60";"0";"3.40";"22";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(CCC)c(OC)c4)nn32)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"15.99";"0.30";"4.30";"6.89";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5288582";"";"None";"449.51";"0";"3.19";"27";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5ccoc5c4)nn32)CC1";"IC50";"'='";"241.4";"nM";"6.62";"";"";"UO_0000065";"14.72";"0.27";"3.43";"5.72";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"18.62";"0.34";"3.98";"8.27";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3674679";"";"None";"496.57";"0";"3.50";"BDBM102442";"Cn1cc(Nc2nc(-c3cccc(N4CCc5cc(C6CC6)ccc5C4=O)c3CO)cn(C)c2=O)cn1";"IC50";"'='";"16.0";"nM";"7.80";"";"219972";"UO_0000065";"15.70";"0.29";"4.30";"7.40";"0";"CHEMBL3705343";"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639178";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL5203118";"";"None";"515.57";"1";"3.89";"65";"C=CC(=O)Nc1cccc(N2C(=O)OCc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"16.15";"0.30";"4.44";"7.43";"1";"CHEMBL5150935";"Inhibition of BTK (unknown origin) using Poly(Glu4,Tyr1) as substrate in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5193859";"";"None";"916.06";"2";"3.75";"C2";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)CCCC(=O)NCC#CCN2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"8.78";"0.16";"4.30";"4.00";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4875714";"";"None";"485.55";"0";"2.26";"16";"C#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(CC)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.48";"0.30";"5.74";"5.36";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4855886";"";"None";"597.42";"1";"2.69";"42";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(I)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"10.7";"nM";"7.97";"";"";"UO_0000065";"13.34";"0.30";"5.28";"5.34";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4847730";"";"None";"539.52";"1";"3.11";"44";"CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N";"IC50";"'='";"7.3";"nM";"8.14";"";"";"UO_0000065";"15.08";"0.28";"5.03";"5.45";"0";"CHEMBL4841669";"Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4840351";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5g";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"12.85";"0.24";"2.07";"5.80";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5i";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"13.28";"0.24";"2.59";"5.81";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL5277370";"";"None";"463.93";"0";"3.67";"27";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)nc1)nn2[C@@H]1CCCN(C(=O)CCl)C1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"16.04";"0.31";"3.77";"6.64";"0";"CHEMBL5243492";"Inhibition of BTK (unknown origin) in the presence of ATP measured after 40 mins by radiometry analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241118";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL4752700";"";"None";"438.49";"1";"5.36";"7";"C=CC(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4cc(CC)ccn4)cc3)c2c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.15";"0.35";"3.04";"9.01";"0";"CHEMBL4726192";"Inhibition of His-tagged recombinant human His-tagged full length BTK expressed in baculovirus expression system using Tyr01 peptide as substrate preincubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3290141";"";"None";"488.55";"1";"5.77";"6";"Cc1ccc(NC(=O)c2ccc3ccccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"78.8";"nM";"7.10";"";"";"UO_0000065";"14.54";"0.26";"1.33";"5.82";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"34";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"18.54";"0.34";"4.52";"8.53";"1";"CHEMBL5153405";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150054";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4071754";"";"None";"648.77";"1";"3.33";"18";"CC(=O)N1CC2(C1)CN(c1ccc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc1)C2";"IC50";"'='";"33.4";"nM";"7.48";"";"";"UO_0000065";"11.52";"0.21";"4.15";"5.80";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"29; GDC-0853";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"12.18";"0.23";"4.53";"6.69";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5195259";"";"None";"459.48";"0";"3.14";"5";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC(F)(F)F)CC1=O";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"14.79";"0.28";"3.66";"8.58";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5184493";"";"None";"461.57";"0";"2.61";"13";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC2CCOC2)CC1=O";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"14.61";"0.27";"4.13";"7.63";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL4093436";"";"None";"596.67";"1";"4.21";"45";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)NC1COC1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"14.62";"0.27";"4.51";"6.05";"0";"CHEMBL4029958";"Inhibition of recombinant full length BTK (unknown origin) using peptide substrate by capillary elctrophoresis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028823";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4646367";"";"None";"554.52";"2";"6.94";"48";"C=CC(=O)NCCOc1cc(Cc2cccc(C(F)(F)F)c2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"256.0";"nM";"6.59";"";"";"UO_0000065";"11.89";"0.23";"-0.35";"7.96";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4638552";"";"None";"418.83";"0";"4.38";"36";"O=C(CCl)NCCOc1cccc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"19.22";"0.38";"3.67";"9.72";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4648013";"";"None";"453.49";"0";"4.26";"39";"CN(C)C/C=C/C(=O)NCCOc1cccc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.23";"0.25";"1.74";"6.97";"0";"CHEMBL4603779";"Inhibition of BTK (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602634";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL5173111";"";"None";"888.00";"2";"2.97";"B2";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)CC(=O)NCC#CCN2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"24.4";"nM";"7.61";"";"";"UO_0000065";"8.57";"0.16";"4.64";"3.78";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5180131";"";"None";"749.88";"2";"4.78";"C13";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(C2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"10.73";"0.20";"3.27";"5.30";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5274913";"";"None";"472.57";"0";"4.61";"88";"CN1CCN(c2ccc(Nc3nc(Nc4ccc(F)cc4)c4ncn(CC5CC5)c4n3)cc2)CC1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"12.46";"0.23";"1.28";"7.94";"0";"CHEMBL5242663";"Inhibition of BTK (unknown origin) in the presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5285367";"";"None";"490.56";"0";"4.75";"89";"CN1CCN(c2ccc(Nc3nc(Nc4cccc(F)c4)c4ncn(CC5CC5)c4n3)cc2F)CC1";"IC50";"'='";"1810.0";"nM";"5.74";"";"";"UO_0000065";"11.71";"0.22";"0.99";"7.75";"0";"CHEMBL5242663";"Inhibition of BTK (unknown origin) in the presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5266943";"";"None";"447.37";"0";"4.19";"31";"CN(c1ncnc2[nH]ccc12)C1CCCCN(C(=O)CNc2cc(Cl)cc(Cl)c2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"17.98";"0.37";"3.86";"10.43";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"19; CC-292";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"908.0";"nM";"6.04";"";"";"UO_0000065";"14.27";"0.27";"1.79";"6.20";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5206888";"";"None";"612.74";"2";"2.93";"16";"COCCN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2C1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"12.13";"0.23";"4.50";"6.06";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5195945";"";"None";"527.56";"1";"3.61";"22";"Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccncn2)c1=O";"IC50";"'='";"439.0";"nM";"6.36";"";"";"UO_0000065";"12.05";"0.22";"2.75";"4.97";"0";"CHEMBL5124388";"Inhibition of BTK T474I mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474I";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5169992";"";"None";"564.65";"2";"3.01";"17; GNE-431";"CN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)nn4ccnc34)cc2C1";"IC50";"'='";"8.8";"nM";"8.06";"";"";"UO_0000065";"14.27";"0.26";"5.05";"6.62";"0";"CHEMBL5124384";"Inhibition of BTK T474M mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474M";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5187230";"";"None";"540.60";"1";"4.52";"21";"Cc1ccc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"14.24";"0.26";"3.18";"6.70";"0";"CHEMBL5124384";"Inhibition of BTK T474M mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474M";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5169992";"";"None";"564.65";"2";"3.01";"17; GNE-431";"CN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)nn4ccnc34)cc2C1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"15.23";"0.28";"5.59";"7.07";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"(S)-3";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"20.19";"0.37";"5.30";"9.29";"1";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5290606";"";"None";"571.62";"2";"5.69";"BMS-986142";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1N1C(=O)c2cccc(F)c2C(C)C1=O";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.27";"0.30";"3.61";"7.98";"0";"CHEMBL5241481";"Reversible inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5271975";"";"None";"663.82";"1";"4.18";"Fenebrutinib";"CC1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3cccc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.06";"0.28";"5.82";"9.25";"0";"CHEMBL5241481";"Reversible inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5194482";"";"None";"495.59";"0";"3.46";"10f";"C=CC(=O)Nc1cccc(Cn2c(=O)ccc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1";"IC50";"'='";"15.6";"nM";"7.81";"";"";"UO_0000065";"15.75";"0.29";"4.35";"8.18";"0";"CHEMBL5146948";"Inhibition of BTK (unknown origin) incubated for 1 hr in the presence of ATP by FRET based Z'-LYTE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3702850";"";"None";"667.79";"2";"4.66";"39";"COCCN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"13.48";"0.25";"4.34";"6.49";"1";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5195504";"";"None";"494.98";"0";"3.35";"22";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5cccc(Cl)c5)C4)c23)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"18.79";"0.36";"5.95";"8.99";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5175574";"";"None";"474.57";"0";"2.84";"27";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(OCc5ccccc5)C4)c23)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.33";"0.34";"5.86";"8.41";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5196670";"";"None";"533.68";"2";"5.96";"2";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(C)c4)c23)CC1";"IC50";"'='";"1.34";"nM";"8.87";"";"";"UO_0000065";"16.63";"0.30";"2.91";"9.75";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5085223";"";"None";"449.90";"0";"4.18";"4";"CCNC(=O)CNc1ncnc2[nH]cc(C(=O)c3ccc(Oc4ccccc4)cc3Cl)c12";"IC50";"'='";"407.1";"nM";"6.39";"";"";"UO_0000065";"14.20";"0.27";"2.21";"5.86";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5186030";"";"None";"402.86";"0";"2.95";"25";"O=C(CNc1cc(Cl)ccc1F)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"15.00";"0.29";"3.09";"7.03";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5196798";"";"None";"419.32";"0";"3.46";"26";"O=C(CNc1cc(Cl)cc(Cl)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"18.41";"0.38";"4.26";"8.98";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5207901";"";"None";"637.76";"2";"5.08";"38";"C[C@@H]1CN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)C[C@H](C)N1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"14.05";"0.26";"3.88";"6.48";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3987197";"";"None";"571.01";"2";"5.41";"BDBM230135";"Cc1cc(C(N)=O)c2[nH]c3cc(C(C)(C)O)ccc3c2c1-c1cccc(-n2c(=O)[nH]c3c(F)cccc3c2=O)c1Cl";"IC50";"'='";"0.34";"nM";"9.47";"";"402001";"UO_0000065";"16.58";"0.32";"4.06";"7.07";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901061";"";"None";"550.55";"1";"3.32";"BDBM255308";"Nc1nccn2c([C@H]3CC[C@H]4CNCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"0.28";"nM";"9.55";"";"445213";"UO_0000065";"17.35";"0.33";"6.23";"7.32";"0";"CHEMBL3889266";"LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated 'A5' peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887017";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";"";"";""
"CHEMBL5188524";"";"None";"519.65";"2";"5.65";"32";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)cc4)c23)CC1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"16.55";"0.30";"2.95";"9.45";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5179204";"";"None";"547.70";"2";"5.89";"35";"CC#CC(=O)N1CCC(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(C)c4)c23)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"16.17";"0.29";"2.96";"9.73";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5187153";"";"None";"521.67";"2";"5.74";"38";"C=CC(=O)N1CCC(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)cc4)c23)CC1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"16.63";"0.30";"2.94";"9.54";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4091642";"";"None";"549.63";"2";"6.97";"3j";"CC(=O)c1cc(-c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)ccnc3[nH]2)cs1";"IC50";"'='";"78.1";"nM";"7.11";"";"";"UO_0000065";"12.93";"0.24";"0.14";"8.08";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4303247";"";"None";"384.87";"0";"2.81";"9; SNS-062";"O=C(CNc1cccc(Cl)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"22.66";"0.44";"5.91";"10.15";"0";"CHEMBL5242624";"Reversible inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5267491";"";"None";"479.58";"0";"3.32";"24";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C5CC5)c(OC)c4)nn32)CC1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"15.75";"0.29";"4.23";"6.76";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5282956";"";"None";"461.52";"0";"3.50";"35";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cc(OC)c(C)c(OC)c3)nn21";"IC50";"'='";"21.9";"nM";"7.66";"";"";"UO_0000065";"16.60";"0.31";"4.16";"6.36";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5197174";"";"None";"490.56";"0";"4.75";"39";"CN1CCN(c2ccc(Nc3nc(Nc4ccc(F)c(F)c4)c4ncn(CC5CC5)c4n3)cc2)CC1";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"12.71";"0.24";"1.49";"8.41";"1";"CHEMBL5150924";"Inhibition of BTK (unknown origin) using Poly(Glu4,Tyr1) as substrate in presence of ATP by radiometric kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5278149";"";"None";"468.56";"0";"4.83";"3";"C=CC(=O)N1CCC[C@H](n2nc(-c3c(C)cc(Oc4ccccc4)cc3C)c3c(N)ncnc32)C1";"IC50";"'='";"12.8";"nM";"7.89";"";"";"UO_0000065";"16.84";"0.31";"3.06";"7.96";"0";"CHEMBL5258477";"Inhibition of BTK (unknown origin) by Z'LYTE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257057";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5206407";"";"None";"463.93";"0";"3.67";"77";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)nc1)nn2C1CCCN(C(=O)CCl)C1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"16.04";"0.31";"3.77";"6.64";"0";"CHEMBL5242648";"Inhibition of BTK (unknown origin) incubated for 40 mins in the presence of ATP by scintillation based radiometric protein kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL5185980";"";"None";"471.54";"1";"5.34";"24";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Cn4cc(C)nc4CC)cc3)ncc2F)c1";"IC50";"'='";"42.4";"nM";"7.37";"";"";"UO_0000065";"15.64";"0.29";"2.03";"7.62";"0";"CHEMBL5150907";"Inhibition of BTK (unknown origin) incubated for 60 mins by ADP-Glo kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4107779";"";"None";"591.59";"2";"5.05";"37";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"15.61";"0.29";"4.19";"7.23";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5266477";"";"None";"482.80";"0";"4.39";"13";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(Cl)c(Cl)c(Cl)c4)nn32)CC1";"IC50";"'='";"136.2";"nM";"6.87";"";"";"UO_0000065";"14.22";"0.30";"2.48";"7.36";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"6";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"12.46";"0.22";"0.94";"5.49";"0";"CHEMBL4429406";"Inhibition of BTK in human whole blood assessed as suppression of BCR/anti-IgM stimulated CD69 surface expression on B cells after 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428066";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4108825";"";"None";"569.52";"1";"3.89";"31";"Nc1nccn2c([C@@H]3CC[C@H]4COCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.56";"0.33";"6.11";"7.83";"0";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4108563";"";"None";"553.52";"1";"4.65";"33";"Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12";"IC50";"'='";"0.11";"nM";"9.96";"";"";"UO_0000065";"17.99";"0.34";"5.31";"8.40";"1";"CHEMBL4727415";"Inhibition of recombinant full length BTK (unknown origin) expressed in baculovirus infected Sf9 cells using Biotin-EQEDEPEGDYFEWLE-NH2 peptide as substrate incubated for 60 mins followed by further incubation with substrate and ATP for 120 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725309";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4751655";"";"None";"611.60";"2";"5.06";"50";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CCCO1";"IC50";"'='";"0.22";"nM";"9.66";"";"";"UO_0000065";"15.79";"0.30";"4.60";"7.56";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4798236";"";"None";"585.56";"1";"4.26";"45";"C[C@@H](O)C(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"16.60";"0.32";"5.46";"7.01";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4794146";"";"None";"663.58";"2";"5.29";"34";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4OC(F)(F)F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"11.18";"0.22";"2.13";"5.42";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4743945";"";"None";"530.56";"1";"2.90";"25";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cccnn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"13.55";"0.25";"4.29";"5.11";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4798236";"";"None";"585.56";"1";"4.26";"45";"C[C@@H](O)C(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"14.21";"0.27";"4.06";"6.00";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4746292";"";"None";"623.64";"1";"4.40";"39";"COC[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c3c(N)nccn23)CN1C(=O)C1(C)COC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.47";"0.25";"4.00";"6.13";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL5199233";"";"None";"930.08";"2";"4.14";"C3";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)CCCCC(=O)NCC#CCN2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"8.65";"0.16";"3.91";"4.00";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"BDBM230151";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"0.26";"nM";"9.59";"";"401968";"UO_0000065";"16.32";"0.32";"3.90";"7.82";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923822";"";"None";"554.55";"1";"4.66";"BDBM230154";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"401976";"UO_0000065";"17.49";"0.32";"5.04";"7.91";"0";"CHEMBL3888436";"Btk Enzyme Assay: To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP (20 μM), and assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 0.015% Brij 35 surfactant and 4 mM DTT in 1.6% DMSO), with a final volume of 30 μL. After incubating at room temperature for 60 min, the reaction was terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886711";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5206716";"";"None";"446.51";"0";"2.45";"11";"C=CC(=O)N1CCCC(Nc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"19.53";"0.36";"6.27";"8.43";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5171858";"";"None";"432.48";"0";"2.06";"13";"C=CC(=O)N1CCC(Nc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)C1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"19.30";"0.36";"6.29";"8.07";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5205889";"";"None";"528.54";"1";"3.72";"23";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5cccc(C(F)(F)F)c5)C4)c23)CC1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"16.64";"0.32";"5.08";"8.50";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5184628";"";"None";"426.52";"0";"2.04";"28";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(OC(C)C)C4)c23)CC1";"IC50";"'='";"23.2";"nM";"7.63";"";"";"UO_0000065";"17.90";"0.34";"5.59";"7.38";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5177238";"";"None";"543.60";"1";"3.86";"20";"Cc1cc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nn1C";"IC50";"'='";"9.9";"nM";"8.00";"";"";"UO_0000065";"14.72";"0.27";"4.14";"6.68";"0";"CHEMBL5124384";"Inhibition of BTK T474M mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"T474M";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5206888";"";"None";"612.74";"2";"2.93";"16";"COCCN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2C1";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"13.38";"0.25";"5.27";"6.68";"0";"CHEMBL5124386";"Inhibition of BTK C481S mutant (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"17.34";"0.32";"3.42";"7.70";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5206888";"";"None";"612.74";"2";"2.93";"16";"COCCN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)cc2C1";"IC50";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"13.23";"0.25";"5.18";"6.61";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4111143";"";"None";"685.67";"1";"4.28";"23; CHEMBL4112274";"COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CN(C(=O)c4ccncc4)CC(=O)N3C2)n2ccnc(N)c12";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"14.15";"0.26";"5.42";"6.03";"0";"CHEMBL5124392";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5189116";"";"None";"477.61";"0";"3.07";"23";"Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)ccc1CN1CCN(CC(C)(C)C)CC1=O";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"12.75";"0.24";"3.02";"6.13";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL4756476";"NEMTABRUTINIB";"3.0";"478.94";"0";"4.59";"7; ARQ 531, MK-1026";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@@H]3CC[C@@H](CO)OC3)c12";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"19.65";"0.38";"4.82";"8.60";"1";"CHEMBL5127265";"Inhibition of BTK C481S mutant (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5188545";"";"None";"447.59";"0";"3.62";"15";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC(C)(C)C)CC1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.11";"0.37";"5.38";"11.37";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5170218";"";"None";"433.56";"0";"3.23";"14";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC(C)C)CC1=O";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"15.01";"0.28";"3.28";"8.22";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5208592";"";"None";"472.55";"0";"2.54";"8";"CC#CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)CC1";"IC50";"'='";"16.4";"nM";"7.79";"";"";"UO_0000065";"16.47";"0.30";"5.25";"7.53";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5206968";"";"None";"444.50";"0";"1.90";"14";"CC#CC(=O)N1CCC(Nc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)C1";"IC50";"'='";"68.5";"nM";"7.16";"";"";"UO_0000065";"16.12";"0.30";"5.26";"6.93";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5193942";"";"None";"481.53";"0";"4.50";"42";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccccc5)c(F)c4)c23)CC1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"19.01";"0.35";"4.65";"10.06";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4065907";"";"None";"543.48";"1";"3.70";"21";"CC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"17.29";"0.33";"5.70";"7.36";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4066585";"";"None";"497.48";"0";"3.48";"7";"Nc1nccn2c(CN3CCOCC3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12";"IC50";"'='";"132.0";"nM";"6.88";"";"";"UO_0000065";"13.83";"0.26";"3.40";"6.22";"0";"CHEMBL4057947";"Inhibition of recombinant full-length His6-tagged BTK (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated A5 peptide as substrate preincubated for 60 mins followed by substrate addition measured after 120 mins by LANCE TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052776";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL5190915";"";"None";"461.90";"0";"3.36";"67";"O=C1[C@H](Nc2cc(F)c(F)c(Cl)c2)CCCN1[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"15.75";"0.31";"3.92";"8.08";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4790832";"";"None";"453.55";"0";"4.90";"45";"C=CC(=O)N1CCC[C@@H](Cn2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.71";"nM";"8.77";"";"";"UO_0000065";"19.33";"0.35";"3.87";"10.16";"0";"CHEMBL5150935";"Inhibition of BTK (unknown origin) using Poly(Glu4,Tyr1) as substrate in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5283553";"";"None";"527.25";"1";"4.50";"14";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(Cl)c(Br)c(Cl)c4)nn32)CC1";"IC50";"'='";"74.8";"nM";"7.13";"";"";"UO_0000065";"13.52";"0.31";"2.63";"7.64";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5266996";"";"None";"384.87";"0";"3.13";"11";"O=C(CNc1cccc(Cl)c1)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"15.48";"0.30";"2.83";"6.93";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5269357";"";"None";"402.86";"0";"3.27";"16";"O=C(CNc1cc(F)cc(Cl)c1)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"17.62";"0.35";"3.83";"8.26";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5274214";"";"None";"434.33";"0";"3.56";"29";"O=C(CNc1cc(Cl)cc(Cl)c1)N1CCCCC(Nc2ncnc3[nH]ncc23)C1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"16.96";"0.35";"3.81";"7.45";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5286967";"";"None";"523.66";"1";"2.67";"53";"O=C(CNc1ccccc1S(=O)(=O)N1CCCCC1)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"13.96";"0.27";"4.64";"6.38";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL4090364";"";"None";"506.91";"2";"7.27";"6; KIN-281";"CCN(CC)CCCC(C)Nc1nc(/C=C/c2c(Cl)cc(Cl)cc2Cl)nc2ccc(N)cc12";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"10.21";"0.21";"-2.10";"7.71";"0";"CHEMBL4035086";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033661";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL5174837";"";"None";"532.58";"2";"6.42";"10";"Cc1ccc(NC(=O)c2cccc(-c3ccc(F)cc3)c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"694.3";"nM";"6.16";"";"";"UO_0000065";"11.56";"0.21";"-0.26";"5.05";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"Spebrutinib";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.96";"0.41";"5.05";"9.55";"0";"CHEMBL5241480";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5073944";"";"None";"256.26";"0";"1.71";"18";"CCOc1nc(-c2n[nH]c(=O)[nH]2)cc2ccccc12";"IC50";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"28.49";"0.52";"5.59";"8.73";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4850428";"";"None";"483.53";"0";"3.57";"26f";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)C1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"12.95";"0.24";"2.69";"5.45";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4870818";"";"None";"483.53";"0";"3.57";"26g";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5OC)cc4)[nH]c23)C1";"IC50";"'='";"6331.0";"nM";"5.20";"";"";"UO_0000065";"10.75";"0.20";"1.63";"4.52";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5176706";"";"None";"902.03";"2";"3.36";"C1";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)CCC(=O)NCC#CCN2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"8.92";"0.16";"4.69";"4.00";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5176012";"";"None";"914.04";"2";"3.36";"C7";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)C2(C(=O)NCC#CCN3CCN(CC#Cc4ccc5c(c4)CN(C4CCC(=O)NC4=O)C5=O)CC3)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"8.80";"0.16";"4.69";"4.00";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5183474";"";"None";"488.59";"0";"3.48";"6";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CCC(Oc5ccccc5)CC4)c23)CC1";"IC50";"'='";"26.2";"nM";"7.58";"";"";"UO_0000065";"15.52";"0.29";"4.10";"7.33";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5188432";"";"None";"446.51";"0";"2.45";"9";"C=CC(=O)N1CCC(Nc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccccc5)C4)c23)CC1";"IC50";"'='";"593.1";"nM";"6.23";"";"";"UO_0000065";"13.95";"0.26";"3.78";"6.02";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5206496";"";"None";"478.53";"0";"2.84";"19";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5ccc(F)cc5)C4)c23)CC1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"19.13";"0.36";"6.31";"8.85";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5188373";"";"None";"701.60";"3";"5.61";"8j";"COCC1CN(C2CCN(c3cc(OC)c(Nc4ncc(Br)c(Nc5ccc6c(c5P(C)(C)=O)OCCO6)n4)cc3C)CC2)C1";"IC50";"'='";"183.0";"nM";"6.74";"";"";"UO_0000065";"9.60";"0.20";"1.13";"6.11";"0";"CHEMBL5117952";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113487";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib (PCI-32765)";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL5241479";"Irreversible inhibition of recombinant human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"Evobrutinib";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"18.74";"0.34";"3.70";"8.62";"1";"CHEMBL5241480";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5191643";"";"None";"418.50";"0";"2.72";"3";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)NCc4ccccc4)c23)CC1";"IC50";"'='";"52.3";"nM";"7.28";"";"";"UO_0000065";"17.40";"0.32";"4.56";"7.07";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.02";"0.40";"5.48";"9.78";"1";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5180302";"";"None";"478.53";"0";"2.84";"20";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)N4CC(Oc5cccc(F)c5)C4)c23)CC1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"19.64";"0.37";"6.56";"9.08";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5179080";"";"None";"533.61";"2";"5.21";"41";"CC#CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C6CC6)cc5)c(F)c4)c23)CC1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"16.34";"0.30";"3.51";"9.59";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5175032";"";"None";"459.38";"0";"4.24";"41";"O=C(N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1)[C@H](Nc1cc(Cl)cc(Cl)c1)C1CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"17.32";"0.35";"3.72";"9.26";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5189116";"";"None";"477.61";"0";"3.07";"23";"Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)ccc1CN1CCN(CC(C)(C)C)CC1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.84";"0.35";"5.93";"9.05";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5180944";"";"None";"479.63";"0";"3.17";"26";"C=CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(CC(C)(C)C)CC2=O)c(C)c1";"IC50";"'='";"1.35";"nM";"8.87";"";"";"UO_0000065";"18.49";"0.35";"5.70";"11.25";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5201319";"";"None";"444.50";"0";"3.14";"14";"CCC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"219.0";"nM";"6.66";"";"";"UO_0000065";"14.98";"0.28";"3.52";"6.15";"0";"CHEMBL5124385";"Inhibition of His-tagged full-length recombinant wild-type human BTK (Ala2 to Ser659 residues) expressed in baculovirus infected insect cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3942924";"";"None";"552.68";"2";"5.44";"25; CHEMBL3942924";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(NC(=O)c5ccc(C(C)(C)C)cc5)c4CO)ncnc3[nH]2)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"13.72";"0.25";"2.15";"6.63";"1";"CHEMBL5124392";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5187554";"";"None";"466.51";"0";"2.87";"2; ACP-196";"CC#CC(=O)N1CCC[C@H]1n1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)ncnc21";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"17.78";"0.32";"5.42";"6.29";"0";"CHEMBL5127254";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5269279";"";"None";"450.33";"0";"2.44";"32";"CN(c1ncnc2[nH]ncc12)C1COCCN(C(=O)CNc2cc(Cl)cc(Cl)c2)C1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.11";"0.37";"5.71";"8.21";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"acalabrutinib";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.31";"0.33";"5.21";"7.19";"1";"CHEMBL5241479";"Irreversible inhibition of recombinant human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.11";"0.38";"5.08";"9.38";"1";"CHEMBL5242619";"Irreversible inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5274555";"";"None";"463.37";"0";"3.79";"26";"CC[C@@H](Nc1cc(Cl)cc(Cl)c1)C(=O)N1CCOCC(Nc2ncnc3[nH]ccc23)C1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"14.37";"0.29";"2.87";"7.00";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5269111";"";"None";"447.37";"0";"4.19";"42, s-rac";"CC1C(N(C)c2ncnc3[nH]ccc23)CCCN1C(=O)CNc1cc(Cl)cc(Cl)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.44";"0.40";"4.51";"11.28";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5196798";"";"None";"419.32";"0";"3.46";"7";"O=C(CNc1cc(Cl)cc(Cl)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"18.81";"0.38";"4.43";"9.18";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5200748";"";"None";"517.56";"1";"3.40";"21";"CC(C)CN1CCN(Cc2ccc(-c3ccnc(Nc4cnn(CCO)c4)n3)cc2C(F)(F)F)C(=O)C1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"13.37";"0.26";"3.52";"6.96";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5289623";"";"None";"449.51";"0";"4.32";"128";"C=CC(=O)N1CCc2ccc(N3C(=O)CCc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21";"IC50";"'='";"6.59";"nM";"8.18";"";"";"UO_0000065";"18.20";"0.33";"3.86";"11.47";"0";"CHEMBL5242633";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5189379";"";"None";"623.74";"1";"4.65";"26";"CN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"15.27";"0.28";"4.87";"7.36";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5178314";"";"None";"568.66";"1";"4.96";"25";"CN(C)C(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"15.91";"0.29";"4.09";"7.17";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702827";"";"None";"553.60";"1";"4.66";"23";"CC1(/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)COC1";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"15.37";"0.28";"3.85";"6.44";"1";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702838";"";"None";"511.56";"1";"4.71";"18";"CC(C)/C=C(\C#N)C(=O)N1CCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.42";"0.30";"3.69";"6.83";"1";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5170583";"";"None";"525.59";"2";"5.28";"15";"CC(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"16.59";"0.31";"3.44";"7.09";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5199293";"";"None";"539.62";"2";"5.49";"29";"CC(C)(C)/C=C(/C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"13.07";"0.24";"1.56";"5.73";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3702856";"";"None";"667.75";"2";"4.78";"35";"COC(=O)N1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"13.00";"0.24";"3.90";"5.57";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"STS";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.00";"0.27";"2.65";"10.08";"0";"CHEMBL5264737";"Inhibition of N-terminal GST-tagged full length human BTK (2 to 659 residues) expressed in Sf21 insect cells using 5-FAM-EAIYAAPFAKKK as substrate incubated for 60 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5260843";"1";"Scientific Literature";"J Med Chem";"2019";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5080657";"";"None";"449.56";"0";"3.81";"14";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1C(C)NC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.62";"0.33";"4.11";"8.15";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4784093";"";"None";"535.61";"1";"3.57";"29";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5nccs5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"15.86";"0.31";"4.92";"6.65";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4778161";"";"None";"629.59";"2";"5.02";"38";"CC1(C(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@@H]2C(F)F)COC1";"IC50";"'='";"0.86";"nM";"9.07";"";"";"UO_0000065";"14.40";"0.28";"4.05";"7.10";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4853615";"";"None";"443.44";"0";"2.92";"30b";"C#CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)C1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"18.76";"0.34";"5.40";"7.87";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5089990";"";"None";"212.21";"0";"1.31";"15";"O=c1[nH]nc(-c2cc3ccccc3cn2)[nH]1";"IC50";"'='";"5011.87";"nM";"5.30";"";"";"UO_0000065";"24.98";"0.45";"3.99";"7.12";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3928976";"";"None";"587.46";"2";"5.69";"6d; BMS-986143";"Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"12.37";"0.24";"1.58";"5.93";"0";"CHEMBL4672875";"Inhibition of BTK in human whole blood assessed as reduction in FCepsilonR1/anti-IgE-induced CD63 surface expression on basophils";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5083645";"";"None";"506.52";"1";"4.84";"18c";"C=CC(=O)Nc1cccc(-n2c(=O)c(Oc3ccccc3)nc3cnc(Nc4ccc(OC)cc4)nc32)c1";"IC50";"'='";"17.7";"nM";"7.75";"";"";"UO_0000065";"15.30";"0.28";"2.91";"6.45";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"20.65";"0.38";"4.88";"9.17";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL3918580";"";"None";"502.57";"2";"5.32";"1";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.96";"0.31";"3.20";"7.48";"1";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5k";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"16.63";"0.30";"4.39";"7.28";"0";"CHEMBL4672802";"Inhibition of recombinant full-length His-tagged human BTK expressed in baculovirus expression system using fluoresceinated peptide as substrate incubated for 60 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4751952";"";"None";"553.02";"2";"5.04";"5f";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.51";"0.24";"1.88";"5.65";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL4743497";"";"None";"536.56";"1";"4.53";"5k";"Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(F)cccn2c1=O";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"13.24";"0.24";"2.57";"5.79";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL3891545";"";"None";"571.01";"2";"5.18";"6f";"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"12.60";"0.24";"2.01";"5.87";"0";"CHEMBL4672805";"Inhibition of BTK in human whole blood assessed as reduction in goat anti human IgM/human IL4-stimulated CD69 cell surface expression on peripheral B cells incubated for 18 hrs by FACS analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665894";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 18.0 hr";"INHIBITOR";""
"CHEMBL5205957";"";"None";"442.93";"0";"3.73";"45";"O=C(N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1)[C@H](Nc1cc(F)cc(Cl)c1)C1CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.06";"0.35";"4.27";"9.31";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5206309";"";"None";"443.91";"0";"3.22";"63";"O=C1[C@H](Nc2cc(F)cc(Cl)c2)CCCN1[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.02";"0.35";"4.78";"8.88";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3702854";"RILZABRUTINIB";"3.0";"665.77";"2";"4.42";"12; PRN1008";"CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"13.35";"0.25";"4.47";"6.41";"1";"CHEMBL5104971";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5178047";"";"None";"834.94";"2";"3.77";"B1";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)CCC(=O)N2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"9.82";"0.18";"4.43";"4.33";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5209299";"";"None";"900.01";"2";"3.14";"C5";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)/C=C/C(=O)NCC#CCN2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"8.94";"0.16";"4.91";"4.00";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5189231";"";"None";"551.67";"2";"5.72";"37";"CC#CC(=O)N1CCC(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(F)c4)c23)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"16.17";"0.30";"3.20";"9.81";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5186533";"";"None";"420.30";"0";"2.86";"29";"O=C(CNc1cc(Cl)cc(Cl)c1)N[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.03";"0.39";"5.14";"8.09";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5076659";"";"None";"422.83";"0";"4.13";"2";"O=C(O)CNc1ncnc2[nH]cc(C(=O)c3ccc(Oc4ccccc4)cc3Cl)c12";"IC50";"'='";"81.4";"nM";"7.09";"";"";"UO_0000065";"16.77";"0.32";"2.96";"6.05";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5289797";"";"None";"454.58";"0";"4.48";"87";"CN1CCN(c2ccc(Nc3nc(Nc4ccccc4)c4ncn(CC5CC5)c4n3)cc2)CC1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"13.30";"0.24";"1.57";"8.15";"0";"CHEMBL5242663";"Inhibition of BTK (unknown origin) in the presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5089841";"";"None";"540.62";"2";"5.12";"18h";"C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"11.2";"nM";"7.95";"";"";"UO_0000065";"14.71";"0.27";"2.83";"6.61";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"20.03";"0.37";"4.60";"8.90";"1";"CHEMBL5258446";"Inhibition of BTK (unknown origin) using Blk/Lyntide as substrate preincubated for 1 hr followed by substrate addition and measured after 2 hrs in presence of ATP by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257057";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4758341";"";"None";"614.03";"2";"5.04";"32";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)c(Cl)c4)c4c(N)nccn34)C2)COC1";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"13.36";"0.26";"3.16";"6.42";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4103954";"";"None";"581.57";"2";"5.29";"3";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"0.31";"nM";"9.51";"";"";"UO_0000065";"16.35";"0.31";"4.22";"8.02";"0";"CHEMBL4717034";"Reversible inhibition of recombinant full length BTK (unknown origin) baculovirus infected Sf9 cells using biotinylated EQEDEPEGDYFEWLE-NH2 peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 120 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4798188";"";"None";"569.56";"2";"5.29";"42";"CCC(=O)N1C[C@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CC[C@@H]1C";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"15.44";"0.29";"3.51";"7.42";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4787427";"";"None";"615.56";"1";"4.67";"36";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)c(F)c4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"12.58";"0.24";"3.07";"6.06";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4800034";"";"None";"579.58";"1";"4.45";"17";"CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"12.54";"0.24";"2.82";"5.69";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4103954";"";"None";"581.57";"2";"5.29";"3";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.44";"0.27";"3.11";"7.09";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL5280787";"";"None";"433.34";"0";"4.17";"39, s-rac";"CC1C(Nc2ncnc3[nH]ccc23)CCCN1C(=O)CNc1cc(Cl)cc(Cl)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.16";"0.39";"4.13";"9.66";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5267533";"";"None";"433.34";"0";"4.17";"40";"C[C@H]1[C@H](Nc2ncnc3[nH]ccc23)CCCN1C(=O)CNc1cc(Cl)cc(Cl)c1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"16.70";"0.34";"3.07";"8.42";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5287698";"";"None";"478.91";"0";"4.17";"49";"O=C(CNc1cc(Cl)cc(C(F)(F)F)c1)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.16";"0.36";"4.53";"11.28";"0";"CHEMBL5240393";"Inhibition of unphosphorylated BTK (unknown origin) in the presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5236642";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";""
"CHEMBL5200275";"";"None";"529.60";"1";"4.45";"66";"C=CC(=O)Nc1cccc(N2C(=O)OC(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"15.40";"0.29";"3.70";"7.27";"0";"CHEMBL5150935";"Inhibition of BTK (unknown origin) using Poly(Glu4,Tyr1) as substrate in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"4";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"296.9";"nM";"6.53";"";"";"UO_0000065";"14.02";"0.25";"3.22";"5.51";"0";"CHEMBL4023752";"Inhibition of BTK in human whole blood derived-basophils assessed as suppression of IgE mediated-FcepsilonR ligation-stimulated CD63 expression";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5088574";"";"None";"564.69";"1";"4.84";"24b";"C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(N5CCN(C)CC5)c4)nc32)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.87";"0.27";"3.56";"7.76";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5283628";"";"None";"457.54";"0";"3.62";"21";"CN1CCC(n2cc(Nc3nc(OC4(C)CC4)c4nc(-c5cncnc5)ccc4n3)cn2)CC1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"16.08";"0.30";"3.74";"6.89";"0";"CHEMBL5246679";"Inhibition of BTK (unknown origin) in presence of 25 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244269";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"EUB0000646a";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"18.54";"0.34";"4.52";"8.53";"0";"CHEMBL5210135";"Affinity On-target Cellular interaction (HTRF-based assay (Cisbio; phosphorylation of BTK on Y223)) EUB0000646a BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Covalent inhibitor | Protein family: Protein Kinase | Recommended concentration = 1.0 µM";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5210121";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Affinity On-target Cellular Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00687";"INHIBITOR";""
"CHEMBL4101864";"";"None";"506.58";"2";"5.42";"3m";"O=c1c2c(F)cc(C3CC3)cc2ccn1-c1cccc(-c2ccnc3[nH]c(C4=CCNCC4)cc23)c1CO";"IC50";"'='";"28.3";"nM";"7.55";"";"";"UO_0000065";"14.90";"0.27";"2.13";"9.10";"0";"CHEMBL4000359";"Inhibition of recombinant human His-tagged full length BTK expressed in baculovirus using biotin labeled peptide substrate after 1 hr by HRTF kinase/TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4000147";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4101904";"";"None";"636.76";"2";"2.94";"8";"Cn1cc(-c2cncc(N3CCn4c(cc5c4CCCC5)C3=O)c2CO)cc(Nc2ccc(N3CCN(C4COC4)CC3)cn2)c1=O";"IC50";"'='";"64.4";"nM";"7.19";"";"";"UO_0000065";"11.29";"0.21";"4.25";"5.94";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4060356";"";"None";"636.76";"1";"3.33";"17";"CC(=O)N1CCN(c2ccc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CC(C)(C)C7)C5=O)c4CO)cn(C)c3=O)nc2)CC1";"IC50";"'='";"66.5";"nM";"7.18";"";"";"UO_0000065";"11.27";"0.21";"3.85";"5.57";"0";"CHEMBL4023698";"Inhibition of BTK in human whole blood-derived CD19+ B cells assessed as suppression of anti-IgM stimulated-CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by FACS analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5207196";"";"None";"445.57";"0";"3.37";"16";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC2(C)CC2)CC1=O";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.30";"0.34";"4.78";"10.30";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5206619";"";"None";"483.54";"0";"1.74";"40";"C=CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(C3CCOC3)CC2=O)c(F)c1";"IC50";"'='";"268.0";"nM";"6.57";"";"";"UO_0000065";"13.59";"0.26";"4.83";"7.46";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5170919";"";"None";"484.00";"0";"3.03";"20";"CC(C)CN1CCN(Cc2ccc(-c3ccnc(Nc4cnn(CCO)c4)n3)cc2Cl)C(=O)C1";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"12.41";"0.24";"2.97";"6.04";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5170218";"";"None";"433.56";"0";"3.23";"14";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC(C)C)CC1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.66";"0.36";"5.29";"10.76";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL4857322";"";"None";"469.50";"0";"3.18";"27f";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)C1";"IC50";"'='";"11.9";"nM";"7.92";"";"";"UO_0000065";"16.88";"0.31";"4.74";"6.89";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4846287";"";"None";"463.50";"1";"5.01";"31a";"C=CC(=O)Nc1ccc(-c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)cc1";"IC50";"'='";"1722.0";"nM";"5.76";"";"";"UO_0000065";"12.44";"0.22";"0.75";"5.03";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4878459";"";"None";"463.50";"1";"5.01";"33a";"C=CC(=O)Nc1cccc(-c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)c1";"IC50";"'='";"223.0";"nM";"6.65";"";"";"UO_0000065";"14.35";"0.26";"1.64";"5.81";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4756476";"NEMTABRUTINIB";"3.0";"478.94";"0";"4.59";"ARQ531";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@@H]3CC[C@@H](CO)OC3)c12";"IC50";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"18.94";"0.36";"4.48";"8.29";"1";"CHEMBL5241481";"Reversible inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"1; BIIB068";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"15.33";"0.29";"3.43";"6.87";"0";"CHEMBL4701117";"Inhibition of BTK in human PBMC assessed as reduction in goat F(ab')2 anti-human IgM antibody-induced B cell activation measured after 3 days by celltiter-glo assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699451";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 72.0 hr";"INHIBITOR";""
"CHEMBL5189642";"";"None";"489.54";"1";"5.16";"18";"Cc1ccc(NC(=O)c2ccc3ncccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"13.05";"0.24";"1.23";"4.73";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5204121";"";"None";"489.54";"1";"5.16";"20";"Cc1ccc(NC(=O)c2ccc3cnccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"407.2";"nM";"6.39";"";"";"UO_0000065";"13.05";"0.24";"1.23";"4.74";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5201299";"";"None";"460.37";"0";"3.73";"66";"O=C1[C@H](Nc2cc(Cl)cc(Cl)c2)CCCN1[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.59";"0.36";"4.37";"8.99";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5198455";"";"None";"493.54";"0";"4.33";"43";"CC#CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccccc5)c(F)c4)c23)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.24";"0.33";"4.67";"9.89";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5193942";"";"None";"481.53";"0";"4.50";"42";"C=CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccccc5)c(F)c4)c23)CC1";"IC50";"'='";"1.49";"nM";"8.83";"";"";"UO_0000065";"18.33";"0.33";"4.33";"9.70";"0";"CHEMBL5106255";"Inhibition of BTK in human TMD8 cells assessed as inhibition of BTK autophosphorylation at Tyr223 measured by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TMD8";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5173824";"";"None";"458.57";"0";"3.12";"17";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CN1CCN(CC(C)(C)C#N)CC1=O";"IC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"15.27";"0.28";"3.88";"6.80";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5197765";"";"None";"465.60";"0";"2.78";"35";"C=CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(CC(C)C)CC2=O)c(C)c1";"IC50";"'='";"0.83";"nM";"9.08";"";"";"UO_0000065";"19.50";"0.36";"6.30";"11.51";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5173641";"";"None";"483.59";"0";"3.00";"39";"C=CC(=O)N(C)CCOc1cncnc1-c1ccc(CN2CCN(CC(C)(C)C)CC2=O)c(F)c1";"IC50";"'='";"0.44";"nM";"9.36";"";"";"UO_0000065";"19.35";"0.37";"6.36";"11.86";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5169775";"";"None";"463.59";"0";"2.68";"19";"Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)ccc1CN1CCN(CC(C)C)CC1=O";"IC50";"'='";"590.0";"nM";"6.23";"";"";"UO_0000065";"13.44";"0.25";"3.55";"6.27";"0";"CHEMBL5133801";"Inhibition of pBTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5271354";"";"None";"493.61";"0";"3.50";"25";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C5(C)CC5)c(OC)c4)nn32)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"15.60";"0.29";"4.20";"6.89";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5288582";"";"None";"449.51";"0";"3.19";"27";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5ccoc5c4)nn32)CC1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"14.86";"0.28";"3.49";"5.78";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5177238";"";"None";"543.60";"1";"3.86";"20";"Cc1cc(Nc2cc(-c3ccnc(-n4ncc5cc(C(C)(C)C)cc(F)c5c4=O)c3CO)cn(C)c2=O)nn1C";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"14.72";"0.27";"4.14";"6.67";"0";"CHEMBL5124387";"Inhibition of BTK C481R mutant (unknown origin) expressed in baculovirus infected Trichoplusia ni pro cells incubated for 30 mins in presence of ATP by Microfluidic chip based mobility shift assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Tni PRO";"None";"";"Q06187";"C481R";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5269683";"";"None";"467.57";"0";"3.01";"21";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(CC)c(OC)c4)nn32)CC1";"IC50";"'='";"29.1";"nM";"7.54";"";"";"UO_0000065";"16.12";"0.30";"4.53";"6.75";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5272694";"";"None";"507.64";"1";"4.11";"26";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C5CCCC5)c(OC)c4)nn32)CC1";"IC50";"'='";"49.4";"nM";"7.31";"";"";"UO_0000065";"14.39";"0.27";"3.20";"6.54";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5268388";"";"None";"479.58";"0";"3.11";"33";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5c(c4)OCC5(C)C)nn32)CC1";"IC50";"'='";"77.5";"nM";"7.11";"";"";"UO_0000065";"14.83";"0.28";"4.00";"6.37";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"(S)-3";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"18.54";"0.34";"4.52";"8.53";"1";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5089431";"";"None";"450.88";"0";"4.61";"3";"CCOC(=O)CNc1ncnc2[nH]cc(C(=O)c3ccc(Oc4ccccc4)cc3Cl)c12";"IC50";"'='";"5968.0";"nM";"5.22";"";"";"UO_0000065";"11.59";"0.22";"0.61";"4.92";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5089407";"";"None";"936.42";"4";"5.22";"6c";"O=C1CCC(N2C(=O)c3cccc(NCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](Nc5ncnc6[nH]cc(C(=O)c7ccc(Oc8ccccc8)cc7Cl)c56)CC4)c3C2=O)C(=O)N1";"IC50";"'='";"22.3";"nM";"7.65";"";"";"UO_0000065";"8.17";"0.16";"2.43";"3.13";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5071105";"";"None";"1024.53";"None";"None";"6e";"O=C1CCC(N2C(=O)c3cccc(NCCOCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](Nc5ncnc6[nH]cc(C(=O)c7ccc(Oc8ccccc8)cc7Cl)c56)CC4)c3C2=O)C(=O)N1";"IC50";"'='";"56.4";"nM";"7.25";"";"";"UO_0000065";"7.08";"None";"None";"None";"0";"CHEMBL5056781";"Inhibition of full length N-terminal GST fusion tagged human BTK expressed in baculovirus expression system using FAM-P2 peptide solution as substrate incubated for 10 mins in presence of ATP by microplate reader assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL5202915";"";"None";"484.95";"1";"5.09";"36";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2Cc1cccc(NC(=O)CCl)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"15.61";"0.30";"2.48";"7.01";"1";"CHEMBL5150921";"Inhibition of BTK (unknown origin) incubated for 40 mins by radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL5188067";"";"None";"482.49";"0";"2.45";"18";"O=C(CNc1cccc(S(=O)(=O)C(F)(F)F)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"860.0";"nM";"6.07";"";"";"UO_0000065";"12.57";"0.25";"3.62";"5.05";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5176639";"";"None";"435.32";"0";"2.48";"30";"O=C1Cc2c(ncnc2N2CCC[C@@H](NC(=O)CNc3cc(Cl)cc(Cl)c3)C2)N1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"15.82";"0.32";"4.41";"6.94";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5189304";"";"None";"475.38";"0";"3.48";"44";"O=C(N[C@@H]1CCCN(c2ncnc3[nH]ccc23)C1)[C@H](Nc1cc(Cl)cc(Cl)c1)C1COC1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"12.25";"0.25";"2.34";"6.12";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5188619";"";"None";"443.91";"0";"3.22";"54, Diastereomeric mixture";"O=C1C(Nc2cc(F)cc(Cl)c2)CCCN1[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"17.62";"0.34";"4.60";"8.69";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5192675";"";"None";"488.64";"0";"3.18";"18";"Cc1cc(-c2ccnc(Nc3cnn(C4CN(C)C4)c3)n2)ccc1CN1CCN(CC(C)C)CC1=O";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"16.69";"0.31";"4.97";"9.89";"0";"CHEMBL5133797";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL4468226";"";"None";"664.74";"1";"4.26";"11c";"Cn1c2c(cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c1=O)-c1cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c1C[C@H](O)C2";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"11.46";"0.21";"3.36";"5.79";"0";"CHEMBL5104720";"Inhibition of BTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104099";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5179394";"";"None";"493.92";"0";"4.00";"49";"O=C(N[C@@H]1CCCN(c2ncnc3[nH]ncc23)C1)[C@H](Nc1cc(Cl)cc(C(F)(F)F)c1)C1CC1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"14.67";"0.29";"3.24";"7.33";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4116419";"";"None";"638.70";"1";"4.29";"11a";"Cn1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"14.09";"0.26";"4.71";"6.84";"0";"CHEMBL5104720";"Inhibition of BTK in human whole blood";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104099";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5071372";"";"None";"478.94";"0";"4.59";"1; ARQ531";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@H]3CC[C@H](CO)OC3)c12";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"19.65";"0.38";"4.82";"8.60";"0";"CHEMBL5056786";"Inhibition of BTK C481S mutant (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5085099";"";"None";"441.47";"0";"4.02";"8";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc[nH]c2n1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"16.52";"0.30";"3.27";"6.64";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5069689";"";"None";"490.52";"0";"4.72";"18a";"C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3)nc3cnc(Nc4ccc(OC)cc4)nc32)c1";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"17.35";"0.31";"3.79";"7.66";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5087214";"";"None";"504.55";"1";"4.64";"18b";"C=CC(=O)Nc1cccc(-n2c(=O)c(Cc3ccccc3)nc3cnc(Nc4ccc(OC)cc4)nc32)c1";"IC50";"'='";"24.9";"nM";"7.60";"";"";"UO_0000065";"15.07";"0.27";"2.96";"6.85";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5076283";"";"None";"534.58";"1";"4.74";"18e";"C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"16.03";"0.29";"3.83";"7.13";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5075594";"";"None";"569.02";"2";"5.39";"18g";"C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3Cl)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"15.18";"0.29";"3.25";"7.18";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5086054";"";"None";"498.54";"0";"3.95";"18j";"C=CC(=O)Nc1cccc(-n2c(=O)c(C3CC3)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"16.69";"0.31";"4.37";"6.92";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5272121";"";"None";"522.83";"1";"3.85";"15";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(Cl)c(Br)c(OC)c4)nn32)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.06";"0.38";"5.07";"8.70";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5278071";"";"None";"481.60";"0";"3.57";"23";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C(C)C)c(OC)c4)nn32)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"18.52";"0.35";"5.35";"7.99";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5282956";"";"None";"461.52";"0";"3.50";"35";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cc(OC)c(C)c(OC)c3)nn21";"IC50";"'='";"0.33";"nM";"9.48";"";"";"UO_0000065";"20.54";"0.38";"5.98";"7.87";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5272404";"";"None";"487.56";"0";"4.07";"36";"C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cc(OC)c(C4CC4)c(OC)c3)nn21";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.46";"0.34";"4.93";"7.47";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5283304";"";"None";"479.58";"0";"3.15";"32";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5c(c4)OC(C)(C)C5)nn32)CC1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"15.47";"0.29";"4.27";"6.64";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5071372";"";"None";"478.94";"0";"4.59";"1; ARQ531";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@H]3CC[C@H](CO)OC3)c12";"IC50";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"18.94";"0.36";"4.48";"8.29";"0";"CHEMBL5056785";"Inhibition of wild type BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055646";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4560385";"";"None";"438.44";"0";"3.42";"31; PF-06250112";"N#CN1CCC[C@@H](n2nc(-c3ccc(Oc4ccc(F)cc4F)cc3)c(C(N)=O)c2N)C1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.21";"0.40";"5.88";"7.55";"1";"CHEMBL5243499";"Inhibition of wild type BTK (unknown origin) in presence of 1 uM ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241118";"1";"Scientific Literature";"RSC Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4876450";"";"None";"471.49";"0";"3.70";"19d";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5cccc(F)c5)cc4)[nH]c23)CC1";"IC50";"'='";"14.6";"nM";"7.84";"";"";"UO_0000065";"16.62";"0.31";"4.14";"7.41";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4873420";"";"None";"497.56";"0";"3.96";"18f";"CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)CC1";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"13.69";"0.25";"2.85";"5.92";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4863138";"";"None";"483.53";"0";"3.57";"19g";"C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5OC)cc4)[nH]c23)CC1";"IC50";"'='";"13.6";"nM";"7.87";"";"";"UO_0000065";"16.27";"0.30";"4.30";"6.84";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4859054";"";"None";"471.52";"0";"3.73";"25g";"C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5OC)cc4)[nH]c23)C1";"IC50";"'='";"926.0";"nM";"6.03";"";"";"UO_0000065";"12.80";"0.24";"2.30";"5.25";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4848746";"";"None";"439.48";"0";"3.17";"29a";"CC#CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)C1";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"15.36";"0.28";"3.58";"6.38";"0";"CHEMBL4843875";"Inhibition of full-length N-terminal GST tagged BTK (1 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4842353";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"18.07";"0.33";"3.74";"8.03";"0";"CHEMBL5150445";"Inhibition of BTK autophosphorylation in anti-IgG stimulated human DOHH-2 cells preincubated for 1 hr followed by compound washout and anti-IgG stimulation for 2 mins by chemiluminescence based Western blotting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"DOHH-2";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149968";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5175307";"";"None";"958.14";"2";"4.92";"C4";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)CCCCCCC(=O)NCC#CCN2CCN(CC#Cc3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"8.40";"0.15";"3.13";"4.00";"0";"CHEMBL5136243";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131541";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5189379";"";"None";"623.74";"1";"4.65";"26";"CN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'='";"6.7";"nM";"8.17";"";"";"UO_0000065";"13.10";"0.24";"3.52";"6.32";"0";"CHEMBL5104909";"Inhibition of biotinylated-labeled BTK-selective probe binding to BTK in human Ramos assessed as target occupancy pretreated for 1 hr followed by probe addition measured for 18 hrs by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL5083772";"BIIB-091";"2.0";"542.65";"2";"3.04";"51";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(C3COC3)CC[C@H]4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"9.51";"0.18";"2.12";"4.03";"0";"CHEMBL5043293";"Inhibition of BTK in human Ramos cells assessed as reduction in PLCgamma2 phosphorylation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5073223";"";"None";"489.50";"0";"3.96";"11";"CC(C)OC1CN(C(=O)NCc2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C(F)(F)F)C1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"14.07";"0.27";"2.93";"7.08";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"4; BGB-3111";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"17.93";"0.33";"4.24";"8.25";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL2437462";"";"None";"482.55";"0";"2.80";"25a";"C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"18.49";"0.34";"6.12";"8.24";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL4650323";"TOLEBRUTINIB";"3.0";"455.52";"0";"3.91";"30; SAR442168";"C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"19.58";"0.36";"5.01";"9.35";"0";"CHEMBL5150291";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149965";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4793094";"";"None";"441.51";"0";"2.59";"46";"C=CS(=O)(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1";"IC50";"'='";"1.32";"nM";"8.88";"";"";"UO_0000065";"20.11";"0.39";"6.29";"7.89";"0";"CHEMBL5150935";"Inhibition of BTK (unknown origin) using Poly(Glu4,Tyr1) as substrate in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149979";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5269771";"";"None";"559.91";"1";"2.98";"Vecabrutinib";"NC(=O)[C@H]1CCN(c2ncnc([N+](=O)[O-])c2F)C[C@@H]1N1CCCC(Nc2cc(Cl)cc(C(F)(F)F)c2)C1=O";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"15.25";"0.31";"5.56";"5.78";"0";"CHEMBL5241481";"Reversible inhibition of human BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241065";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5188786";"";"None";"480.61";"0";"2.36";"42";"C=CC(=O)N(C)CCOc1c(N)ncnc1-c1ccc(CN2CCN(CC(C)C)CC2=O)c(C)c1";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"17.70";"0.33";"6.15";"8.11";"0";"CHEMBL5133842";"Inhibition of BTK in human Ramos cells assessed as target occupancy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";""
"CHEMBL5280412";"";"None";"469.54";"0";"2.46";"18";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(OC)c(OC)c4)nn32)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"16.66";"0.31";"5.36";"6.47";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3932338";"";"None";"483.57";"0";"4.06";"6a";"CC#CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"18.45";"0.34";"4.86";"8.70";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5089878";"";"None";"501.66";"2";"5.57";"29";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)c3cnc(C(C)(C)C)s3)n2)cn1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"18.98";"0.36";"3.95";"9.76";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5087793";"";"None";"526.60";"1";"4.73";"18i";"C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCC3)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"16.44";"0.30";"3.93";"7.20";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL2437479";"";"None";"414.43";"0";"3.05";"26a";"C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(OC)cc4)nc32)c1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"21.10";"0.39";"5.69";"7.88";"0";"CHEMBL5045465";"Inhibition of human BTK using poly-Glu-Tyr (4:1) as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042540";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5078703";"";"None";"517.56";"2";"5.69";"7";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(-c3ccccc3)[nH]c2n1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.17";"0.28";"2.16";"7.15";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5074640";"";"None";"648.74";"1";"4.48";"13d";"CN1CCN(C(=O)N2CC=C(c3cc4c(-c5cccc(-n6ccc7cc(C8CC8)cc(F)c7c6=O)c5CO)nc(N)nc4[nH]3)CC2)CC1";"IC50";"'='";"0.65";"nM";"9.19";"";"";"UO_0000065";"14.16";"0.26";"4.71";"6.73";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5091956";"";"None";"593.66";"1";"4.79";"13c";"CN(C)C(=O)N1CC=C(c2cc3c(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)nc(N)nc3[nH]2)CC1";"IC50";"'='";"0.95";"nM";"9.02";"";"";"UO_0000065";"15.20";"0.28";"4.23";"6.76";"0";"CHEMBL5054197";"Inhibition of human BTK C481S mutant using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"EUB0000646a";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"20.19";"0.37";"5.30";"9.29";"0";"CHEMBL5210354";"Affinity Biochemical interaction (33P-ATP and filter-binding assay (Reaction Biology)) EUB0000646a BTK";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Covalent inhibitor | Protein family: Protein Kinase | Recommended concentration = 1.0 µM";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5210307";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Affinity Biochemical Source Knowledge: https://doi.org/10.1021/acs.jmedchem.9b00687";"INHIBITOR";""
"CHEMBL5202670";"";"None";"536.56";"2";"5.26";"11; XMU-MP-3";"Cc1cc(Nc2ncc3c(n2)N(C)CN(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)n(C)n1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.48";"0.27";"2.51";"8.52";"0";"CHEMBL5127269";"Inhibition of BTK C481S mutant (unknown origin) measured by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q06187";"C481S";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"21.20";"0.39";"5.12";"9.42";"1";"CHEMBL5131614";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4514143";"";"None";"416.49";"0";"2.62";"9a";"C=CC(=O)N[C@H]1CC[C@@H](n2nc(C#CCOc3ccccc3)c3c(N)ncnc32)CC1";"IC50";"'='";"14.8";"nM";"7.83";"";"";"UO_0000065";"18.80";"0.34";"5.21";"7.25";"0";"CHEMBL4372282";"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4371038";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL5271514";"";"None";"474.95";"0";"4.78";"78";"C=C(Cl)C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"18.11";"0.35";"3.82";"8.67";"0";"CHEMBL5242618";"Competitive inhibition of recombinant human BTK incubated for 10 mins in the presence of ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.1667 hr";"INHIBITOR";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"EUB0000638a";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.31";"0.33";"5.21";"7.19";"1";"CHEMBL5242619";"Irreversible inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5202670";"";"None";"536.56";"2";"5.26";"11; XMU-MP-3";"Cc1cc(Nc2ncc3c(n2)N(C)CN(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)n(C)n1";"IC50";"'='";"10.7";"nM";"7.97";"";"";"UO_0000065";"14.86";"0.28";"2.71";"8.74";"0";"CHEMBL5127268";"Inhibition of full-length wild-type BTK (unknown origin) measured by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"11";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"20.03";"0.37";"4.60";"8.90";"1";"CHEMBL5135831";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131516";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3707348";"ACALABRUTINIB";"4.0";"465.52";"0";"3.31";"13";"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"17.81";"0.32";"4.98";"7.00";"0";"CHEMBL5135831";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131516";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4751655";"";"None";"611.60";"2";"5.06";"50";"C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CCCO1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"14.04";"0.27";"3.53";"6.72";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4741355";"";"None";"544.59";"1";"3.21";"27";"Cc1ccnc(NC(=O)c2ccc(-c3nc([C@@H]4CCCN(C(=O)C5(C)COC5)C4)n4ccnc(N)c34)c(F)c2)n1";"IC50";"'='";"9967.0";"nM";"5.00";"";"";"UO_0000065";"9.18";"0.17";"1.79";"3.56";"0";"CHEMBL4717035";"Inhibition of BTK in human PBMC assessed as reduction in cell surface CD69 expression preincubated for 1 hr followed by stimulation with goat anti-human IgM F(ab')2 for 18 hrs by immunostaining analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715708";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"TIME = 19.0 hr";"INHIBITOR";""
"CHEMBL4075449";"";"None";"421.46";"0";"4.36";"6";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cn[nH]c5)cc4c32)ccc1C";"IC50";"'='";"5.34";"nM";"8.27";"";"";"UO_0000065";"19.63";"0.35";"3.91";"8.93";"0";"CHEMBL4130920";"Inhibition of recombinant full length His-tagged human BTK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4130348";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";""
"CHEMBL5169992";"";"None";"564.65";"2";"3.01";"12; GNE-431";"CN1CCn2nc(Nc3cc(-c4ccnc(N5CCn6c(cc7c6CCCC7)C5=O)c4CO)nn4ccnc34)cc2C1";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"15.04";"0.28";"5.48";"6.98";"1";"CHEMBL5127254";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"16.70";"0.30";"3.14";"7.42";"0";"CHEMBL5258467";"Covalent inhibition of NanoLuc fused BTK (unknown origin) expressed in HEK293 cells incubated for 90 mins by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257057";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"29; GDC-0853";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"13.32";"0.25";"5.28";"7.32";"0";"CHEMBL4023749";"Inhibition of BTK in human isolated primary B cells assessed as inhibition of CD40L-induced cell proliferation by [3H]thymidine incorporation assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4065122";"FENEBRUTINIB";"3.0";"664.81";"2";"3.57";"29; GDC-0853";"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"13.37";"0.25";"5.32";"7.34";"0";"CHEMBL4023751";"Inhibition of BTK in human mononuclear cell-derived monocytes assessed as inhibition of FCgammaR3 activation-induced TNFalpha production by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"171.0";"nM";"6.77";"";"";"UO_0000065";"15.36";"0.28";"2.55";"6.82";"0";"CHEMBL4023752";"Inhibition of BTK in human whole blood derived-basophils assessed as suppression of IgE mediated-FcepsilonR ligation-stimulated CD63 expression";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020831";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL5073653";"";"None";"270.29";"0";"2.10";"21";"CC(C)Oc1nc(-c2n[nH]c(=O)[nH]2)cc2ccccc12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"29.60";"0.55";"5.90";"9.56";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL1230541";"";"None";"579.70";"2";"5.52";"13; CGI-1746";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1";"IC50";"'='";"8.9";"nM";"8.05";"";"";"UO_0000065";"13.89";"0.26";"2.53";"7.63";"0";"CHEMBL5127254";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5198600";"";"None";"437.47";"1";"6.10";"11";"FC(F)(F)c1cccc(Nc2cccc(C3CCCN(c4ncnc5[nH]ccc45)C3)c2)c1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"12.18";"0.23";"-0.77";"9.37";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5187968";"";"None";"402.86";"0";"2.95";"23";"O=C(CNc1ccc(F)c(Cl)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"14.53";"0.29";"2.90";"6.81";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4756476";"NEMTABRUTINIB";"3.0";"478.94";"0";"4.59";"7; ARQ 531, MK-1026";"O=C(c1ccc(Oc2ccccc2)cc1Cl)c1c[nH]c2ncnc(N[C@@H]3CC[C@@H](CO)OC3)c12";"IC50";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"18.94";"0.36";"4.48";"8.29";"1";"CHEMBL5127264";"Inhibition of full-length wild-type BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126513";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3936761";"ZANUBRUTINIB";"4.0";"471.56";"0";"4.22";"Zanubrutinib";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"19.72";"0.36";"5.08";"9.08";"0";"CHEMBL5135831";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131516";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5077961";"MILREBRUTINIB";"2.0";"578.65";"1";"4.51";"13f; AS-1763";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCN(C4COC4)CC3)[nH]c2n1";"IC50";"'='";"1.69";"nM";"8.77";"";"";"UO_0000065";"15.16";"0.28";"4.26";"7.17";"0";"CHEMBL5054208";"Inhibition of BTK in human Ramos cells assessed as reduction of IgM stimulated PLCgamma2 (Y1217) phosphorylation after 24 hrs by western blot assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"INHIBITOR";""
"CHEMBL4071161";"TIRABRUTINIB";"4.0";"454.49";"0";"2.75";"5";"CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"16.58";"0.30";"4.79";"6.96";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5203733";"";"None";"525.59";"2";"5.10";"14";"CC(C)/C=C(/C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"15.90";"0.29";"3.26";"6.80";"0";"CHEMBL5104905";"Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104103";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5203573";"";"None";"448.53";"0";"2.60";"5";"C=CC(=O)N1CCC(CNc2ncnc3[nH]cc(C(=O)NCCOc4ccccc4)c23)CC1";"IC50";"'='";"8.4";"nM";"8.08";"";"";"UO_0000065";"18.00";"0.33";"5.48";"7.20";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5196932";"";"None";"549.65";"2";"5.63";"31";"CC#CC(=O)N1CC=C(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(F)c4)c23)CC1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"16.55";"0.30";"3.47";"10.00";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5193930";"";"None";"539.66";"2";"5.88";"36";"C=CC(=O)N1CCC(c2c[nH]c3ncnc(-c4ccc(CNC(=O)c5ccc(C(C)(C)C)cc5)c(F)c4)c23)CC1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"16.16";"0.30";"2.84";"9.59";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL3701238";"FUTIBATINIB";"4.0";"418.46";"0";"1.78";"Futibatinib";"C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1";"IC50";"'='";"94.9";"nM";"7.02";"";"";"UO_0000065";"16.78";"0.31";"5.24";"6.48";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5094211";"";"None";"518.55";"2";"5.08";"11";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(-c3ccncc3)[nH]c2n1";"IC50";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"19.00";"0.35";"4.77";"8.03";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5082144";"";"None";"521.60";"2";"5.98";"13b";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCCCC3)[nH]c2n1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"16.46";"0.30";"2.61";"7.82";"0";"CHEMBL5054195";"Inhibition of human BTK-A using phosphorylated substrate in presence of ATP by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"1; PCI-32765";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"'='";"1.09";"nM";"8.96";"";"";"UO_0000065";"20.35";"0.37";"4.74";"9.04";"0";"CHEMBL5054207";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue incubated for 24 hrs by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"INHIBITOR";""
"CHEMBL5077961";"MILREBRUTINIB";"2.0";"578.65";"1";"4.51";"13f; AS-1763";"Nc1nc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)c2cc(C3=CCN(C4COC4)CC3)[nH]c2n1";"IC50";"'='";"1.38";"nM";"8.86";"";"";"UO_0000065";"15.31";"0.28";"4.35";"7.25";"0";"CHEMBL5054207";"Inhibition of BTK in human Ramos cells assessed as reduction in BTK phosphorylation at Tyr223 residue incubated for 24 hrs by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053510";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"INHIBITOR";""
"CHEMBL5200336";"";"None";"552.56";"1";"4.46";"24; CHEMBL3987197";"Cc1cc(C(N)=O)c2[nH]c3cc(C(C)(C)O)ccc3c2c1-c1cccc(-n2c(=O)[nH]c3c(F)cccc3c2=O)c1O";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"17.23";"0.32";"5.06";"6.18";"0";"CHEMBL5124392";"Inhibition of BTK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120879";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5202915";"";"None";"484.95";"1";"5.09";"72";"Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2Cc1cccc(NC(=O)CCl)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"15.61";"0.30";"2.48";"7.01";"0";"CHEMBL5242648";"Inhibition of BTK (unknown origin) incubated for 40 mins in the presence of ATP by scintillation based radiometric protein kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241098";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL4577152";"";"None";"412.50";"0";"4.99";"9";"O=C(Nc1ccccc1)Nc1cccc(C2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"14.78";"0.27";"1.11";"7.09";"1";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5207027";"";"None";"418.42";"0";"3.17";"14";"O=C(CNc1cccc(C(F)(F)F)c1)NC1CCCN(c2ncnc3[nH]ccc23)C1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"16.54";"0.32";"3.75";"8.05";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5275348";"";"None";"518.41";"1";"3.21";"(S)-17a";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(Br)c(OC)c4)nn32)CC1";"IC50";"'='";"10.8";"nM";"7.97";"";"";"UO_0000065";"15.37";"0.33";"4.76";"7.13";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL4650321";"ORELABRUTINIB";"3.0";"427.50";"0";"4.53";"4";"C=CC(=O)N1CCC(c2ccc(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)n2)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"18.01";"0.33";"3.17";"9.00";"0";"CHEMBL5251905";"Inhibition of BTK phosphorylation at Tyr 223 residue in human Ramos cell incubated for 3 hrs by HTRF-based analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5276374";"";"None";"453.54";"0";"2.76";"(S)-20a; BGB-8035";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(C)c(OC)c4)nn32)CC1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"18.49";"0.35";"5.63";"7.51";"0";"CHEMBL5251910";"Inhibition of human BTK preincubated with compound for 1 hrs followed by ATP/33P-ATP addition and measured after 2 hrs by radioactive filter-binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 3.0 hr";"INHIBITOR";""
"CHEMBL5093905";"";"None";"499.62";"0";"4.24";"31";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCCC4NC(=O)c3nnc(C(C)(C)C)n3C)n2)cn1";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"17.18";"0.32";"4.35";"7.44";"0";"CHEMBL5043203";"Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5090623";"";"None";"461.57";"0";"3.82";"15";"CC(C)OC1CN(C(=O)NC2CCCc3cc(-c4ccnc(Nc5cnn(C)c5)n4)ccc32)C1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"13.02";"0.24";"2.19";"6.18";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5085931";"";"None";"485.60";"0";"4.16";"39";"Cn1cc(Nc2nccc(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"15.00";"0.28";"3.12";"6.31";"0";"CHEMBL5043204";"Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5042486";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4072833";"EVOBRUTINIB";"3.0";"429.52";"0";"4.35";"Evobrutinib";"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1";"IC50";"'='";"1.83";"nM";"8.74";"";"";"UO_0000065";"20.34";"0.37";"4.39";"9.36";"0";"CHEMBL5106226";"Inhibition of BTK (unknown origin) measured by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104164";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5177636";"";"None";"392.51";"0";"3.28";"16";"CC(C)c1cccc(NCC(=O)NC2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"15.67";"0.29";"2.87";"7.15";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5177786";"";"None";"375.44";"0";"2.03";"17";"N#Cc1cccc(NCC(=O)NC2CCCN(c3ncnc4[nH]ccc34)C2)c1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"15.37";"0.28";"3.74";"5.26";"0";"CHEMBL5098382";"Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096196";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5272694";"";"None";"507.64";"1";"4.11";"26";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(C5CCCC5)c(OC)c4)nn32)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"17.38";"0.33";"4.71";"7.90";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5289355";"";"None";"479.58";"0";"3.32";"(R)-24b";"C=CC(=O)N1CCC([C@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(C5CC5)c(OC)c4)nn32)CC1";"IC50";"'='";"94.3";"nM";"7.03";"";"";"UO_0000065";"14.65";"0.27";"3.71";"6.29";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3927293";"";"None";"501.59";"1";"4.23";"10";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)c(OC)c4)nn32)CC1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"17.86";"0.33";"4.73";"8.02";"1";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5266477";"";"None";"482.80";"0";"4.39";"13";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(Cl)c(Cl)c(Cl)c4)nn32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.02";"0.38";"4.31";"9.33";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5289250";"";"None";"473.96";"0";"3.10";"19";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c(Cl)c(OC)c4)nn32)CC1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"18.23";"0.36";"5.54";"7.73";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5268388";"";"None";"479.58";"0";"3.11";"33";"C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4cc(OC)c5c(c4)OCC5(C)C)nn32)CC1";"IC50";"'='";"864.0";"nM";"6.06";"";"";"UO_0000065";"12.64";"0.24";"2.95";"5.43";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5288751";"";"None";"479.58";"0";"3.32";"(S)-24a";"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(C5CC5)c(OC)c4)nn32)CC1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"19.09";"0.36";"5.83";"8.20";"0";"CHEMBL5251899";"Inhibition of N-terminal His-tagged recombinant human BTK (393 to 659 residues) expressed in baculovirus infected Sf9 cells using Biotin-AVLESEEELYSSARQ-NH2 as substrate preincubated for 1 hrs followed by substrate addition in presence of ATP at Km concentration and measured after 1 hrs by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247657";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5079178";"";"None";"201.19";"0";"0.64";"5";"O=c1[nH]nc(-c2nc3ccccc3[nH]2)[nH]1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"24.85";"0.46";"4.36";"5.54";"0";"CHEMBL5031679";"Inhibition of Btk (unknown origin) assessed as inhibition of phosphorylation of FAM-labelled peptide substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5030537";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5203627";"";"None";"538.61";"2";"6.92";"7";"Cc1ccc(NC(=O)c2ccc3cc4ccccc4cc3c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"318.9";"nM";"6.50";"";"";"UO_0000065";"12.06";"0.22";"-0.42";"5.32";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5204295";"";"None";"567.45";"2";"6.53";"15";"Cc1ccc(NC(=O)c2ccc3cc(Br)ccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(N)c2)nc1";"IC50";"'='";"145.1";"nM";"6.84";"";"";"UO_0000065";"12.05";"0.25";"0.31";"5.60";"0";"CHEMBL5156272";"Inhibition of wild type N-terminal GST tagged BTK (unknown origin) (2 to 659 residues) expressed in sf21 insect cell using TK as substrate incubated for 50 mins in presence of ATP by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.8333 hr";"INHIBITOR";""
"CHEMBL5184304";"";"None";"543.59";"2";"5.71";"21";"C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4ccc5cnccc5c4)ccc3C)cn2)c1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"12.80";"0.23";"1.25";"5.04";"0";"CHEMBL5156277";"Inhibition of (S)-3-(3-(5-acrylamido-6-(3-(5-(2-methyl-5-(3-(trifluoromethyl)benzamido)benzamido)pyrimidin-2-ylamino)phenylamino)-6-oxohexylamino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide binding to BTK in human NAMALVA cells preincubated for 1 hr followed by compound washout for three times and treated with probe for 1 hr by competitive labeling assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NAMALVA";"None";"";"";"";"CHEMBL5251";"Tyrosine-protein kinase BTK";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154670";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
